Name,Risk,Return,Website,NCT,Condition
1,0.99946633,191.3459215,https://clinicaltrials.gov/study/NCT00003184,NCT00003184,Breast Cancer
2,0.99702468,158.6461807,https://clinicaltrials.gov/study/NCT01529684,NCT01529684,Advanced Solid Tumors|Pharmacokinetics of 14C-OSI-906
3,0.997917745,163.4386264,https://clinicaltrials.gov/study/NCT00470184,NCT00470184,Esophageal Cancer
4,0.994687686,154.9772283,https://clinicaltrials.gov/study/NCT00666484,NCT00666484,Lymphoma|Neurotoxicity
5,0.998496338,171.6795977,https://clinicaltrials.gov/study/NCT03895684,NCT03895684,Advanced Solid Tumors
6,0.996387994,156.202827,https://clinicaltrials.gov/study/NCT03707028,NCT03707028,Gastric Cancer|Gastroesophageal Junction Adenocarcinoma
7,0.998373625,169.3692023,https://clinicaltrials.gov/study/NCT00711828,NCT00711828,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia
8,0.995428738,155.5833938,https://clinicaltrials.gov/study/NCT00533728,NCT00533728,Non-Hodgkin's Lymphoma
9,0.99929479,186.8964871,https://clinicaltrials.gov/study/NCT00077428,NCT00077428,Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Salivary Gland Adenoid Cystic Carcinoma|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer
10,0.98494803,138.3115636,https://clinicaltrials.gov/study/NCT00706628,NCT00706628,Prostatic Neoplasms
11,0.989307552,151.1351091,https://clinicaltrials.gov/study/NCT00148928,NCT00148928,"Neoplasms, Prostate"
12,0.989836246,150.4579097,https://clinicaltrials.gov/study/NCT00941928,NCT00941928,Leukemia|Pediatric Cancer
13,0.998602754,181.2967258,https://clinicaltrials.gov/study/NCT00030628,NCT00030628,Metastatic Cancer
14,0.779808749,7.734633003,https://clinicaltrials.gov/study/NCT00420628,NCT00420628,Chalazion|Hordeolum
15,0.98793426,150.6808209,https://clinicaltrials.gov/study/NCT02980341,NCT02980341,Metastatic Breast Cancer
16,0.984982699,128.0769135,https://clinicaltrials.gov/study/NCT01484041,NCT01484041,Breast Cancer
17,0.983972998,119.4225022,https://clinicaltrials.gov/study/NCT01707823,NCT01707823,Adenocarcinoma of the Lung|Recurrent Non-small Cell Lung Cancer|Stage IA Non-small Cell Lung Cancer|Stage IB Non-small Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer
18,0.997681422,167.78386,https://clinicaltrials.gov/study/NCT03020823,NCT03020823,Head and Neck Neoplasms
19,0.996370807,158.2951612,https://clinicaltrials.gov/study/NCT00718523,NCT00718523,Ovarian Neoplasms
20,0.998624704,177.0584474,https://clinicaltrials.gov/study/NCT01668823,NCT01668823,Adenocarcinoma of the Lung|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage 0 Non-small Cell Lung Cancer
21,0.980656909,99.21531703,https://clinicaltrials.gov/study/NCT01939223,NCT01939223,Colorectal Neoplasms
22,0.977856108,113.7335548,https://clinicaltrials.gov/study/NCT00003623,NCT00003623,Bladder Cancer
23,0.817520159,10.66179102,https://clinicaltrials.gov/study/NCT00125684,NCT00125684,Cancer|Pain
24,0.992443515,151.9864812,https://clinicaltrials.gov/study/NCT00817284,NCT00817284,Glioblastoma Multiforme
25,0.99722331,158.9373337,https://clinicaltrials.gov/study/NCT01854684,NCT01854684,Recurrent Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer
26,0.996128227,157.017528,https://clinicaltrials.gov/study/NCT03032484,NCT03032484,Astrocytoma
27,0.994999768,154.7450788,https://clinicaltrials.gov/study/NCT01352884,NCT01352884,Cancer
28,0.972505267,64.88097099,https://clinicaltrials.gov/study/NCT01228084,NCT01228084,Adenocarcinoma of the Prostate|Recurrent Prostate Cancer
29,0.999705718,180.2100331,https://clinicaltrials.gov/study/NCT00068484,NCT00068484,"Unspecified Adult Solid Tumor, Protocol Specific"
30,0.997965698,163.9306201,https://clinicaltrials.gov/study/NCT01169584,NCT01169584,Neuroblastoma|Rhabdomyosarcoma|Lymphoma|Wilm's Tumor|Ewing's Sarcoma
31,0.989970564,150.8053112,https://clinicaltrials.gov/study/NCT01542684,NCT01542684,Leukemia
32,0.995380499,158.6196712,https://clinicaltrials.gov/study/NCT02820584,NCT02820584,de Novo Glioblastoma
33,0.97774698,102.8700071,https://clinicaltrials.gov/study/NCT00983684,NCT00983684,Invasive Breast Cancer|Breast Cancer
34,0.990135825,150.4197465,https://clinicaltrials.gov/study/NCT02229084,NCT02229084,Breast Cancer|Breast Neoplasms
35,0.964222452,50.83003545,https://clinicaltrials.gov/study/NCT01668784,NCT01668784,Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
36,0.986531621,94.17530599,https://clinicaltrials.gov/study/NCT00570284,NCT00570284,Cancer
37,0.970379805,83.5703479,https://clinicaltrials.gov/study/NCT02093728,NCT02093728,Solid Tumours
38,0.995917147,156.9467878,https://clinicaltrials.gov/study/NCT03366428,NCT03366428,Malignant Neoplasm of Breast
39,0.999388724,185.2907843,https://clinicaltrials.gov/study/NCT00095628,NCT00095628,Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Stage IVA Salivary Gland Cancer|Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVB Salivary Gland Cancer|Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVC Salivary Gland Cancer|Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
40,0.997277089,163.9228859,https://clinicaltrials.gov/study/NCT00004228,NCT00004228,Lymphoma
41,0.581434127,4.539342806,https://clinicaltrials.gov/study/NCT02256228,NCT02256228,Pain
42,0.901362732,19.05832563,https://clinicaltrials.gov/study/NCT00993928,NCT00993928,Cancer Survivor|Fatigue|Psychosocial Effects of Cancer and Its Treatment|Sleep Disorders
43,0.976860385,90.21916199,https://clinicaltrials.gov/study/NCT01562028,NCT01562028,Lung Cancer
44,0.998500288,173.6149,https://clinicaltrials.gov/study/NCT01617928,NCT01617928,Solid Tumors
45,0.995592384,155.7393197,https://clinicaltrials.gov/study/NCT02046928,NCT02046928,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma|CLL|SLL
46,0.966341014,65.11046094,https://clinicaltrials.gov/study/NCT00186628,NCT00186628,"Leukemia, Mast-Cell|Mantle-cell Lymphoma"
47,0.928152559,28.98050671,https://clinicaltrials.gov/study/NCT05694728,NCT05694728,Human Papilloma Virus Infection
48,0.995534661,156.3995138,https://clinicaltrials.gov/study/NCT00338728,NCT00338728,Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Positive|KIT Positive|PDGFR Positive|Postmenopausal|Progesterone Receptor Positive|Prognostic Stage IV Breast Cancer AJCC v8
49,0.993985749,154.2081235,https://clinicaltrials.gov/study/NCT00269828,NCT00269828,NSCLC
50,0.993953154,152.9429851,https://clinicaltrials.gov/study/NCT00003928,NCT00003928,Kidney Cancer
51,0.996991415,159.7156159,https://clinicaltrials.gov/study/NCT00496223,NCT00496223,Melanoma
52,0.990136246,150.7374426,https://clinicaltrials.gov/study/NCT00848523,NCT00848523,Recurrent Malignant Gliomas
53,0.958021845,40.3206049,https://clinicaltrials.gov/study/NCT00540384,NCT00540384,Anemia|Solid Tumors
54,0.996712656,159.4446434,https://clinicaltrials.gov/study/NCT00258284,NCT00258284,Prostate Cancer
55,0.997965824,166.7231346,https://clinicaltrials.gov/study/NCT01112384,NCT01112384,Metastatic Sarcoma
56,0.736252988,7.646786237,https://clinicaltrials.gov/study/NCT03792984,NCT03792984,Polycystic Ovary Syndrome|Vitamin D Deficiency/Insufficiency
57,0.919275378,19.92330818,https://clinicaltrials.gov/study/NCT02036684,NCT02036684,Prostate Cancer Patients Undergoing Radical Prostatectomy
58,0.996421894,161.6720656,https://clinicaltrials.gov/study/NCT02511184,NCT02511184,ALK-positive Advanced NSCLC
59,0.96750214,53.13052316,https://clinicaltrials.gov/study/NCT02257684,NCT02257684,Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma
60,0.989577019,150.7218653,https://clinicaltrials.gov/study/NCT00338884,NCT00338884,"Carcinoma, Renal Cell"
61,0.972519631,69.12379458,https://clinicaltrials.gov/study/NCT00934128,NCT00934128,Advanced Cancers
62,0.997540104,163.5944203,https://clinicaltrials.gov/study/NCT02171728,NCT02171728,Neoplasms
63,0.9211943,24.75423047,https://clinicaltrials.gov/study/NCT02340728,NCT02340728,Pancreatic Cancer|Unresectable Biliary-pancreatic Malignancies
64,0.997258303,161.3155312,https://clinicaltrials.gov/study/NCT00054028,NCT00054028,Recurrent Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer
65,0.998521818,168.1856202,https://clinicaltrials.gov/study/NCT00109928,NCT00109928,Lymphoma
66,0.996324016,158.4695243,https://clinicaltrials.gov/study/NCT01819428,NCT01819428,Adenocarcinoma of Lung Stage IIIB|Adenocarcinoma of Lung Stage IV
67,0.997476559,162.9311537,https://clinicaltrials.gov/study/NCT01632228,NCT01632228,Glioblastoma
68,0.996399961,158.6247773,https://clinicaltrials.gov/study/NCT01264328,NCT01264328,Head and Neck Cancer
69,0.999307441,188.5216681,https://clinicaltrials.gov/study/NCT00003328,NCT00003328,Head and Neck Cancer
70,0.952390745,45.42578461,https://clinicaltrials.gov/study/NCT01724528,NCT01724528,Tumor Lysis Syndrome
71,0.986910298,145.4068375,https://clinicaltrials.gov/study/NCT02348528,NCT02348528,Multiple Myeloma
72,0.99649888,157.5533372,https://clinicaltrials.gov/study/NCT03045328,NCT03045328,Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma
73,0.919287179,27.28739732,https://clinicaltrials.gov/study/NCT01901328,NCT01901328,Opioid-Induced Constipation
74,0.989161057,150.4064965,https://clinicaltrials.gov/study/NCT01227928,NCT01227928,"Neoplasms, Ovarian"
75,0.992603154,151.7447295,https://clinicaltrials.gov/study/NCT03392428,NCT03392428,Cancer of the Prostate|Metastatic Cancer
76,0.996272967,156.8921492,https://clinicaltrials.gov/study/NCT00086528,NCT00086528,Cancer
77,0.998628853,177.0003983,https://clinicaltrials.gov/study/NCT00675428,NCT00675428,Multiple Myeloma
78,0.999514455,186.2087197,https://clinicaltrials.gov/study/NCT00288028,NCT00288028,Multiple Myeloma and Plasma Cell Neoplasm
79,0.999403932,187.9604502,https://clinicaltrials.gov/study/NCT00669578,NCT00669578,Chronic Myeloproliferative Disorders|Secondary Myelofibrosis
80,0.989702399,150.6059937,https://clinicaltrials.gov/study/NCT03712358,NCT03712358,Melanoma
81,0.98593058,150.1635476,https://clinicaltrials.gov/study/NCT02697058,NCT02697058,Metastatic Pancreatic Cancer
82,0.9994674,192.5242978,https://clinicaltrials.gov/study/NCT00416858,NCT00416858,Esophageal Cancer
83,0.996693266,162.1422507,https://clinicaltrials.gov/study/NCT00462358,NCT00462358,Advanced Solid Tumors
84,0.993807573,153.8649752,https://clinicaltrials.gov/study/NCT05622058,NCT05622058,Prevention of Chemotherapy-induced Myelosuppression
85,0.991039188,151.7765284,https://clinicaltrials.gov/study/NCT05204758,NCT05204758,Advanced Lung Adenocarcinoma
86,0.995734452,156.6290379,https://clinicaltrials.gov/study/NCT02069158,NCT02069158,Breast Cancer|NSCLC|Ovary Cancer|Endometrial Cancer|Small Cell Lung Cancer (SCLC)|Head and Neck (HNSCC)
87,0.812396646,8.702396714,https://clinicaltrials.gov/study/NCT03885258,NCT03885258,Pineal Tumor
88,0.998250432,171.3000189,https://clinicaltrials.gov/study/NCT00003958,NCT00003958,Adult Malignant Mesenchymoma|Adult Rhabdomyosarcoma|Alveolar Childhood Rhabdomyosarcoma|Childhood Malignant Mesenchymoma|Embryonal Childhood Rhabdomyosarcoma|Embryonal-botryoid Childhood Rhabdomyosarcoma|Nonmetastatic Childhood Soft Tissue Sarcoma|Previously Untreated Childhood Rhabdomyosarcoma|Stage I Adult Soft Tissue Sarcoma|Stage II Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma
89,0.998536148,173.8008259,https://clinicaltrials.gov/study/NCT00936858,NCT00936858,Thyroid Cancer
90,0.966182939,59.59305233,https://clinicaltrials.gov/study/NCT02305758,NCT02305758,Untreated Metastatic Colorectal Cancer
91,0.89767227,17.38813779,https://clinicaltrials.gov/study/NCT05900258,NCT05900258,Actinic Keratosis
92,0.993007148,152.4814413,https://clinicaltrials.gov/study/NCT00822458,NCT00822458,Recurrent Childhood Medulloblastoma
93,0.960373013,49.27781075,https://clinicaltrials.gov/study/NCT00171158,NCT00171158,Philadelphia Chromosome Positive CML
94,0.967171342,54.78619213,https://clinicaltrials.gov/study/NCT00632723,NCT00632723,Breast Cancer
95,0.974069187,82.57657449,https://clinicaltrials.gov/study/NCT02420223,NCT02420223,Multiple Myeloma
96,0.996836111,159.6647886,https://clinicaltrials.gov/study/NCT00323323,NCT00323323,Non-Hodgkin's Lymphoma
97,0.687658198,5.32205053,https://clinicaltrials.gov/study/NCT04297423,NCT04297423,Colorectal Cancer
98,0.995766663,156.9239116,https://clinicaltrials.gov/study/NCT01776723,NCT01776723,Myelomonocytic Leukemia
99,0.998102932,170.4776003,https://clinicaltrials.gov/study/NCT01026623,NCT01026623,Hormone-Resistant Prostate Cancer|Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer
100,0.998107841,167.044172,https://clinicaltrials.gov/study/NCT02608684,NCT02608684,Ovarian Cancer
101,0.971758693,78.30640918,https://clinicaltrials.gov/study/NCT00327223,NCT00327223,Neoplasm Metastasis
102,0.997335229,164.784073,https://clinicaltrials.gov/study/NCT00005884,NCT00005884,Non-melanomatous Skin Cancer
103,0.997145994,162.5984108,https://clinicaltrials.gov/study/NCT00779584,NCT00779584,"Hodgkin Disease|Lymphoma, Non-Hodgkin|Neoplasms"
104,0.988426776,147.4312682,https://clinicaltrials.gov/study/NCT02921984,NCT02921984,Salivary Gland Tumors|Head and Neck Cancer
105,0.999080356,185.807902,https://clinicaltrials.gov/study/NCT01390584,NCT01390584,Lymphoma
106,0.965929598,45.72063542,https://clinicaltrials.gov/study/NCT03172884,NCT03172884,"Hepatic Insufficiency, Renal Insufficiency"
107,0.984582643,116.4688023,https://clinicaltrials.gov/study/NCT01461928,NCT01461928,Non-Hodgkin's Lymphoma
108,0.887742024,17.604876,https://clinicaltrials.gov/study/NCT00272428,NCT00272428,Healthy
109,0.998600009,176.9552565,https://clinicaltrials.gov/study/NCT00275028,NCT00275028,Fallopian Tube Cancer|Primary Peritoneal Serous Adenocarcinoma|Recurrent Ovarian Epithelial Cancer|Stage I Ovarian Epithelial Cancer|Stage II Ovarian Epithelial Cancer
110,0.999417736,183.2018472,https://clinicaltrials.gov/study/NCT04156828,NCT04156828,Grade 3b Follicular Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Follicular Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Non-Hodgkin's Lymphoma
111,0.980923412,90.7516442,https://clinicaltrials.gov/study/NCT00667628,NCT00667628,Advanced Hepatocellular Carcinoma
112,0.981423573,86.82911689,https://clinicaltrials.gov/study/NCT00841828,NCT00841828,Breast Cancer
113,0.963553196,54.87836454,https://clinicaltrials.gov/study/NCT03239223,NCT03239223,HSIL|HSIL of Cervix|High-Grade Squamous Intraepithelial Lesions|High-grade Cervical Intraepithelial Neoplasia|Human Papilloma Virus|Cervical Cancer|Cervical Intraepithelial Neoplasia|Cervical Neoplasm|Cervical Dysplasia|CIN
114,0.99596303,156.2184468,https://clinicaltrials.gov/study/NCT00955084,NCT00955084,Advanced Malignancies
115,0.958449321,53.25910004,https://clinicaltrials.gov/study/NCT01697384,NCT01697384,Prostate Cancer|Adenocarcinoma of the Prostate
116,0.98949568,150.1145937,https://clinicaltrials.gov/study/NCT01073384,NCT01073384,Enteritis
117,0.911061261,21.27897793,https://clinicaltrials.gov/study/NCT00415584,NCT00415584,Secondary Hyperparathyroidism|Hypercalcemia
118,0.997689098,165.2307697,https://clinicaltrials.gov/study/NCT01183884,NCT01183884,Neuroblastoma
119,0.998251969,169.6114329,https://clinicaltrials.gov/study/NCT00550784,NCT00550784,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
120,0.985428159,135.7262165,https://clinicaltrials.gov/study/NCT01672684,NCT01672684,Depression|Post-traumatic Stress Disorder|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
121,0.973695429,65.78659573,https://clinicaltrials.gov/study/NCT01094184,NCT01094184,Breast Cancer
122,0.981977795,112.1001844,https://clinicaltrials.gov/study/NCT02851784,NCT02851784,Hepatocellular Carcinoma
123,0.980003717,91.98256854,https://clinicaltrials.gov/study/NCT02572284,NCT02572284,Prostate Cancer
124,0.749346056,5.30806567,https://clinicaltrials.gov/study/NCT02526784,NCT02526784,Prostate Cancer
125,0.999147498,183.8901198,https://clinicaltrials.gov/study/NCT01251484,NCT01251484,Recurrent Glioblastoma
126,0.636216973,4.920715882,https://clinicaltrials.gov/study/NCT00484484,NCT00484484,Pain
127,0.993611246,153.4530274,https://clinicaltrials.gov/study/NCT02326584,NCT02326584,Acute Myeloid Leukemia|Acute Myelogenous Leukemia
128,0.999276283,179.7555384,https://clinicaltrials.gov/study/NCT00060684,NCT00060684,"Lymphoma, Low-Grade|Lymphoma, Small Lymphocytic|Lymphoma, Mixed-Cell, Follicular|Lymphoma, Small Cleaved-Cell, Follicular"
129,0.9989415,189.6659532,https://clinicaltrials.gov/study/NCT01100528,NCT01100528,"Ciliary Body and Choroid Melanoma, Medium/Large Size|Ciliary Body and Choroid Melanoma, Small Size|Iris Melanoma|Recurrent Intraocular Melanoma"
130,0.998653149,179.3891099,https://clinicaltrials.gov/study/NCT00132028,NCT00132028,Adult Favorable Prognosis Hodgkin Lymphoma|Adult Lymphocyte Depletion Hodgkin Lymphoma|Adult Lymphocyte Predominant Hodgkin Lymphoma|Adult Mixed Cellularity Hodgkin Lymphoma|Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma|Adult Nodular Sclerosis Hodgkin Lymphoma|Adult Unfavorable Prognosis Hodgkin Lymphoma|Recurrent Adult Hodgkin Lymphoma
131,0.993907929,153.4788795,https://clinicaltrials.gov/study/NCT00542828,NCT00542828,Myelodysplastic Syndrome (MDS)
132,0.678757471,4.69061647,https://clinicaltrials.gov/study/NCT03293628,NCT03293628,Cervical Intraepithelial Neoplasia|Cervix Neoplasm
133,0.998505,175.4880699,https://clinicaltrials.gov/study/NCT00003528,NCT00003528,Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia
134,0.996149496,156.6480062,https://clinicaltrials.gov/study/NCT01815528,NCT01815528,Recurrent Epithelial Ovarian Cancer
135,0.991691651,150.8066671,https://clinicaltrials.gov/study/NCT01734928,NCT01734928,Multiple Myeloma
136,0.900150037,22.31317787,https://clinicaltrials.gov/study/NCT00438828,NCT00438828,Cancer
137,0.989332505,151.2931587,https://clinicaltrials.gov/study/NCT01428128,NCT01428128,Cancer Other Than Leukemia
138,0.998226024,166.4499616,https://clinicaltrials.gov/study/NCT01675128,NCT01675128,Colorectal Neoplasms|Colorectal Carcinoma|Colorectal Tumors
139,0.999326464,184.0981503,https://clinicaltrials.gov/study/NCT01546428,NCT01546428,Advanced Solid Tumor
140,0.996103227,157.5623323,https://clinicaltrials.gov/study/NCT00002828,NCT00002828,Colorectal Cancer
141,0.995747655,158.0656988,https://clinicaltrials.gov/study/NCT03614728,NCT03614728,Neoplasms
142,0.988239973,150.112545,https://clinicaltrials.gov/study/NCT05319028,NCT05319028,Non-GCB/ABC Diffuse Large B-Cell Lymphoma|With and Without MyD88 and/or CD79B Mutations
143,0.998640747,177.614942,https://clinicaltrials.gov/study/NCT05270928,NCT05270928,Relapsed/Refractory Multiple Myeloma
144,0.998400515,174.4712685,https://clinicaltrials.gov/study/NCT00837928,NCT00837928,"Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
145,0.993148391,151.9314842,https://clinicaltrials.gov/study/NCT00983528,NCT00983528,Acute Lymphoblastic Leukemia
146,0.982148591,113.1981818,https://clinicaltrials.gov/study/NCT04237584,NCT04237584,Metastatic Castration-resistant Prostate Cancer
147,0.993591342,152.916111,https://clinicaltrials.gov/study/NCT01610284,NCT01610284,Breast Cancer
148,0.972123451,69.32409334,https://clinicaltrials.gov/study/NCT01270984,NCT01270984,Chronic Myeloid Leukemia|Gastrointestinal Stromal Tumors
149,0.9873113,150.1508083,https://clinicaltrials.gov/study/NCT00594984,NCT00594984,Metastatic Colorectal Cancer (MCRC)
150,0.990614001,151.9760622,https://clinicaltrials.gov/study/NCT01705184,NCT01705184,Non-small Cell Lung Cancer Metastatic|Nonsquamous Nonsmall Cell Neoplasm of Lung
151,0.998988038,183.6826699,https://clinicaltrials.gov/study/NCT01402284,NCT01402284,Multiple Myeloma
152,0.995484978,155.6090562,https://clinicaltrials.gov/study/NCT00589784,NCT00589784,CNS Cancer|Meningioma|Intracranial Hemangiopericytoma|Hemangioblastoma|Neurofibromatosis
153,0.997874153,166.2705257,https://clinicaltrials.gov/study/NCT01291784,NCT01291784,"Myelofibrosis|Primary Myelofibrosis|Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase|Post-essential Thrombocythemia Related Myelofibrosis"
154,0.984601859,126.6626366,https://clinicaltrials.gov/study/NCT00295984,NCT00295984,Sarcoma
155,0.987545965,147.0326474,https://clinicaltrials.gov/study/NCT01147484,NCT01147484,Recurrent Breast Cancer
156,0.999312775,190.0252667,https://clinicaltrials.gov/study/NCT03991884,NCT03991884,Recurrent B Acute Lymphoblastic Leukemia|Recurrent B Lymphoblastic Lymphoma|Refractory B Acute Lymphoblastic Leukemia|Refractory B Lymphoblastic Lymphoma
157,0.96451615,56.1929478,https://clinicaltrials.gov/study/NCT01978184,NCT01978184,Pancreatic Cancer
158,0.991113909,151.8142208,https://clinicaltrials.gov/study/NCT00869284,NCT00869284,Lymphoma
159,0.988789391,150.8461773,https://clinicaltrials.gov/study/NCT00263484,NCT00263484,Multiple Myeloma
160,0.99281411,153.1938912,https://clinicaltrials.gov/study/NCT00549328,NCT00549328,"Lung Cancer, Non-Small Cell"
161,0.945558741,42.5917395,https://clinicaltrials.gov/study/NCT00628628,NCT00628628,Tumor Lysis Syndrome
162,0.998716989,178.9688486,https://clinicaltrials.gov/study/NCT00401128,NCT00401128,Kidney Cancer
163,0.80485534,9.718365051,https://clinicaltrials.gov/study/NCT03476928,NCT03476928,Uterine Fibroids and Heavy Menstrual Bleeding
164,0.999551036,184.4176456,https://clinicaltrials.gov/study/NCT00126828,NCT00126828,"Carcinoma, Small Cell"
165,0.999227291,181.9947008,https://clinicaltrials.gov/study/NCT00085501,NCT00085501,Lung Cancer
166,0.998889338,172.966394,https://clinicaltrials.gov/study/NCT00718601,NCT00718601,Multiple Myeloma
167,0.996174931,158.8965408,https://clinicaltrials.gov/study/NCT00286780,NCT00286780,Chronic Lymphocytic Leukemia
168,0.97558566,93.15589643,https://clinicaltrials.gov/study/NCT02260180,NCT02260180,Seborrheic Keratosis
169,0.991689309,151.6800679,https://clinicaltrials.gov/study/NCT00462280,NCT00462280,Precancerous Condition|Stage 0 Melanoma|Stage I Melanoma|Stage II Melanoma
170,0.995811729,154.0600651,https://clinicaltrials.gov/study/NCT04155580,NCT04155580,Acute Myeloid Leukemia
171,0.98729322,150.407077,https://clinicaltrials.gov/study/NCT00002880,NCT00002880,Lymphoma
172,0.996141388,159.2215682,https://clinicaltrials.gov/study/NCT02564380,NCT02564380,Metastatic Squamous Non-small Cell Lung Cancer
173,0.996494426,160.2273995,https://clinicaltrials.gov/study/NCT00574080,NCT00574080,Multiple Myeloma
174,0.986755209,124.3883815,https://clinicaltrials.gov/study/NCT03025880,NCT03025880,Advanced Breast Cancer
175,0.984782445,120.0733365,https://clinicaltrials.gov/study/NCT02708680,NCT02708680,Breast Cancer
176,0.989439434,150.5322235,https://clinicaltrials.gov/study/NCT01957280,NCT01957280,Solid Tumors
177,0.981309421,88.10455176,https://clinicaltrials.gov/study/NCT01677780,NCT01677780,"Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute"
178,0.982211814,108.799782,https://clinicaltrials.gov/study/NCT01965080,NCT01965080,Endometrial Cancer
179,0.977049833,88.09561674,https://clinicaltrials.gov/study/NCT01875380,NCT01875380,Colorectal Neoplasms|Metastatic Disease
180,0.999324406,182.8088067,https://clinicaltrials.gov/study/NCT00003880,NCT00003880,Ovarian Cancer|Primary Peritoneal Cavity Cancer
181,0.891607429,19.05519136,https://clinicaltrials.gov/study/NCT02080624,NCT02080624,Sturge- Weber Syndrome
182,0.975253055,80.43292881,https://clinicaltrials.gov/study/NCT01282424,NCT01282424,Follicular Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma|Marginal Zone Lymphoma
183,0.746837209,6.585989503,https://clinicaltrials.gov/study/NCT01955824,NCT01955824,Lung Cancer|Tuberculosis|Sarcoidosis|Interstitial Lung Disease
184,0.996808952,156.2788659,https://clinicaltrials.gov/study/NCT00064324,NCT00064324,Recurrent Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
185,0.969920157,59.04422508,https://clinicaltrials.gov/study/NCT01234324,NCT01234324,Stomach Neoplasms|Gastroesophageal Junction Neoplasms
186,0.990073689,150.3367474,https://clinicaltrials.gov/study/NCT02677324,NCT02677324,Waldenstrom Macroglobulinemia
187,0.996522045,159.6571825,https://clinicaltrials.gov/study/NCT00354224,NCT00354224,Gastric Cancer
188,0.997763162,164.1040636,https://clinicaltrials.gov/study/NCT00109824,NCT00109824,Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Mantle Cell Lymphoma
189,0.999814609,182.1346161,https://clinicaltrials.gov/study/NCT01571024,NCT01571024,Advanced Solid Tumors|Metastatic Colorectal Cancer|Metastatic Pancreatic Cancer
190,0.99781509,164.906694,https://clinicaltrials.gov/study/NCT00016224,NCT00016224,Ovarian Cancer
191,0.987199636,150.5125737,https://clinicaltrials.gov/study/NCT00599924,NCT00599924,Colorectal Neoplasms|Neoplasms
192,0.996484691,158.9159439,https://clinicaltrials.gov/study/NCT05997524,NCT05997524,Advanced Gastric Carcinoma
193,0.98209961,99.96781473,https://clinicaltrials.gov/study/NCT00766324,NCT00766324,Metastatic Hormone Refractory Prostate Cancer
194,0.999527594,190.1305505,https://clinicaltrials.gov/study/NCT00005624,NCT00005624,Multiple Myeloma
195,0.956052307,39.42801364,https://clinicaltrials.gov/study/NCT04597801,NCT04597801,Intracranial Tumor
196,0.998146732,167.9772958,https://clinicaltrials.gov/study/NCT03366480,NCT03366480,Endometrial Cancer|Squamous Non-Small Cell Lung Cancer
197,0.994409365,154.4835002,https://clinicaltrials.gov/study/NCT02200380,NCT02200380,For Donors|Related Donors Giving Peripheral Blood Stem Cells (PBSC) to a Sibling|For Recipients|Acute Myelogenous Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Myelodysplastic Syndrome (MDS)|Chronic Myelogenous Leukemia (CML)|Non-Hodgkins Lymphoma (NHL)|Hodgkins Disease (HD)|Chronic Lymphocytic Leukemia (CLL)
198,0.999353042,182.7669168,https://clinicaltrials.gov/study/NCT00068380,NCT00068380,Recurrent Gastric Cancer|Stage IV Gastric Cancer
199,0.998371325,176.3178578,https://clinicaltrials.gov/study/NCT00568880,NCT00568880,Multiple Myeloma and Plasma Cell Neoplasm
200,0.988083974,150.7165183,https://clinicaltrials.gov/study/NCT03042780,NCT03042780,Gastro-enteropancreatic Neuroendocrine Tumor|Pancreatic Cancer|Neuroendocrine Carcinomas of Pancreas|Islet Cell Carcinoma
201,0.998415991,171.9137832,https://clinicaltrials.gov/study/NCT02309580,NCT02309580,T-cell Lymphoma|Relapsed and Refractory T-cell Lymphoma
202,0.912222076,20.91570979,https://clinicaltrials.gov/study/NCT01191580,NCT01191580,Major Depression
203,0.995415923,155.0405355,https://clinicaltrials.gov/study/NCT01948180,NCT01948180,"Lymphoma, Extranodal NK-T-Cell|EBV"
204,0.999191588,188.8673776,https://clinicaltrials.gov/study/NCT01270880,NCT01270880,Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
205,0.934301021,28.87092397,https://clinicaltrials.gov/study/NCT01668680,NCT01668680,Colorectal Cancer Metastatic
206,0.97299891,84.58443338,https://clinicaltrials.gov/study/NCT00431080,NCT00431080,Breast Cancer
207,0.98297759,129.0564994,https://clinicaltrials.gov/study/NCT00124280,NCT00124280,Non-small-cell Lung Carcinoma
208,0.941677459,32.00911882,https://clinicaltrials.gov/study/NCT00979680,NCT00979680,Rectal Cancer
209,0.996935956,158.5200335,https://clinicaltrials.gov/study/NCT00005980,NCT00005980,Breast Cancer
210,0.992486238,152.647012,https://clinicaltrials.gov/study/NCT01023880,NCT01023880,Multiple Myeloma
211,0.994057506,153.8856709,https://clinicaltrials.gov/study/NCT00086580,NCT00086580,B-Cell Chronic Lymphocytic Leukemia
212,0.983565688,112.2017889,https://clinicaltrials.gov/study/NCT02830880,NCT02830880,Prostate Cancer
213,0.997530226,161.5591467,https://clinicaltrials.gov/study/NCT01048580,NCT01048580,Colon Cancer
214,0.999568555,183.0735758,https://clinicaltrials.gov/study/NCT00091624,NCT00091624,Multiple Myeloma
215,0.983664395,142.2395742,https://clinicaltrials.gov/study/NCT01312324,NCT01312324,Locally Advanced Stage III or IV Thymic Cancer
216,0.992039891,152.1941726,https://clinicaltrials.gov/study/NCT00633724,NCT00633724,Non Small Cell Lung Cancer
217,0.998133562,165.3257761,https://clinicaltrials.gov/study/NCT00053924,NCT00053924,Pancreatic Cancer
218,0.963808053,42.19224371,https://clinicaltrials.gov/study/NCT00265824,NCT00265824,Colorectal Cancer
219,0.990290722,151.2575908,https://clinicaltrials.gov/study/NCT00849524,NCT00849524,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
220,0.98627381,131.3823716,https://clinicaltrials.gov/study/NCT00644124,NCT00644124,"Lymphoma, Non-Hodgkin"
221,0.974517722,73.42287148,https://clinicaltrials.gov/study/NCT00857324,NCT00857324,Multiple Myeloma
222,0.997638188,166.0768902,https://clinicaltrials.gov/study/NCT03232424,NCT03232424,"Glioblastoma, Adult"
223,0.996923453,157.4643134,https://clinicaltrials.gov/study/NCT00081224,NCT00081224,Colorectal Cancer
224,0.99849967,173.1301095,https://clinicaltrials.gov/study/NCT02418624,NCT02418624,Breast Cancer|Ovarian Cancer|Advanced Cancer
225,0.99498242,153.6020546,https://clinicaltrials.gov/study/NCT02683824,NCT02683824,Healthy Subject|Pancreatic Carcinoma
226,0.981867156,112.9116588,https://clinicaltrials.gov/study/NCT04080024,NCT04080024,Breast Cancer|Pancreas Cancer
227,0.994649821,154.2104964,https://clinicaltrials.gov/study/NCT00003501,NCT00003501,Non-hodgkins Lymphoma
228,0.990705861,151.4588304,https://clinicaltrials.gov/study/NCT03213301,NCT03213301,"Malignant Pleural Mesothelioma, Advanced"
229,0.99885845,173.6744763,https://clinicaltrials.gov/study/NCT00002801,NCT00002801,Colorectal Cancer
230,0.994941476,154.1434751,https://clinicaltrials.gov/study/NCT00381901,NCT00381901,Breast Cancer
231,0.999517209,193.828391,https://clinicaltrials.gov/study/NCT00048880,NCT00048880,Neoplasms
232,0.797719518,8.693483893,https://clinicaltrials.gov/study/NCT02950480,NCT02950480,Breast Cancer
233,0.994458839,154.9169668,https://clinicaltrials.gov/study/NCT03101280,NCT03101280,Gynecologic Neoplasms
234,0.996832766,159.0001366,https://clinicaltrials.gov/study/NCT01222780,NCT01222780,Sarcoma|Neuroblastoma|Wilms Tumor|Leukemia|Lymphoma|Brain Tumors
235,0.994161643,154.4766587,https://clinicaltrials.gov/study/NCT00779480,NCT00779480,Acute Myelogenous Leukemia (AML)
236,0.784062447,6.282987419,https://clinicaltrials.gov/study/NCT04795180,NCT04795180,Rectal Cancer
237,0.991098491,150.6892699,https://clinicaltrials.gov/study/NCT00570180,NCT00570180,Multiple Myeloma
238,0.998760189,182.5731506,https://clinicaltrials.gov/study/NCT03265080,NCT03265080,Colon Cancer Metastatic|Head and Neck Cancer Metastatic|Metastatic Non-Small Cell Lung Cancer|Urothelial Carcinoma|Metastatic Melanoma
239,0.98947732,151.2736668,https://clinicaltrials.gov/study/NCT02559024,NCT02559024,Colorectal Neoplasms
240,0.973983296,86.40876436,https://clinicaltrials.gov/study/NCT00497224,NCT00497224,Cancer|Pancreas
241,0.99944184,184.1990436,https://clinicaltrials.gov/study/NCT01964924,NCT01964924,Estrogen Receptor Negative|HER2/Neu Negative|Invasive Breast Carcinoma|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma
242,0.953534425,44.2224801,https://clinicaltrials.gov/study/NCT01272024,NCT01272024,Cancer
243,0.954405382,52.21800655,https://clinicaltrials.gov/study/NCT02256124,NCT02256124,Neurofibromatosis Type 1
244,0.99817364,169.8689596,https://clinicaltrials.gov/study/NCT01344824,NCT01344824,Lung Cancer
245,0.964139547,51.40884182,https://clinicaltrials.gov/study/NCT01985724,NCT01985724,Breast Cancer
246,0.997213658,159.7755615,https://clinicaltrials.gov/study/NCT02443324,NCT02443324,"Gastric Adenocarcinoma|Adenocarcinoma of the Gastroesophageal Junction|Non-small Cell Lung Cancer|Carcinoma, Transitional Cell|Biliary Tract Cancer"
247,0.993989785,153.4804573,https://clinicaltrials.gov/study/NCT02573324,NCT02573324,Glioblastoma|Gliosarcoma
248,0.998580352,169.3339439,https://clinicaltrials.gov/study/NCT04775680,NCT04775680,Solid Tumor|Non Hodgkin Lymphoma
249,0.994307502,154.7005176,https://clinicaltrials.gov/study/NCT03735680,NCT03735680,Breast Cancer|Head and Neck Squamous Cell Carcinoma|Colorectal Cancer|Prostate Cancer|Ovarian Cancer|Urothelial Carcinoma|Non-small Cell Lung Cancer
250,0.940825498,26.88897172,https://clinicaltrials.gov/study/NCT00463580,NCT00463580,Depression
251,0.967447103,69.12260797,https://clinicaltrials.gov/study/NCT03863080,NCT03863080,Myasthenia Gravis
252,0.993505266,153.0742183,https://clinicaltrials.gov/study/NCT03824080,NCT03824080,Acute Myeloid Leukemia|High-risk Myelodysplastic Syndrome|Low-risk Myelodysplastic Syndrome
253,0.989763945,151.1086389,https://clinicaltrials.gov/study/NCT01264380,NCT01264380,Malignant Melanoma
254,0.705601875,6.582782926,https://clinicaltrials.gov/study/NCT02122380,NCT02122380,Polycystic Ovary Syndrome
255,0.809728862,8.918814327,https://clinicaltrials.gov/study/NCT00904280,NCT00904280,"Cancers, Pain|Lower Back Pain"
256,0.991568376,152.1556185,https://clinicaltrials.gov/study/NCT04032080,NCT04032080,Triple Negative Breast Cancer
257,0.870255349,12.04226816,https://clinicaltrials.gov/study/NCT00418080,NCT00418080,Prostate Cancer
258,0.993287315,152.202727,https://clinicaltrials.gov/study/NCT02339324,NCT02339324,Melanoma
259,0.991881865,152.2235636,https://clinicaltrials.gov/study/NCT01333124,NCT01333124,Resectable Pancreatic Carcinoma
260,0.99895056,183.7818677,https://clinicaltrials.gov/study/NCT00027924,NCT00027924,Leukemia|Myelodysplastic Syndromes
261,0.999256148,191.7349408,https://clinicaltrials.gov/study/NCT00415324,NCT00415324,"Unspecified Adult Solid Tumor, Protocol Specific"
262,0.9500352,36.12349579,https://clinicaltrials.gov/study/NCT00416624,NCT00416624,"Anemia|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Precancerous Condition|Unspecified Adult Solid Tumor, Protocol Specific"
263,0.995156867,154.341152,https://clinicaltrials.gov/study/NCT01918124,NCT01918124,Prosthesis Survival
264,0.984521841,140.2612182,https://clinicaltrials.gov/study/NCT03963024,NCT03963024,"Irradiated Bone Marrow|Transplant-Related Hematologic Malignancy|Leukemia, Acute|Multiple Myeloma|Graft Vs Host Disease"
265,0.99862887,177.3186631,https://clinicaltrials.gov/study/NCT00003224,NCT00003224,Melanoma (Skin)
266,0.997016891,158.5291724,https://clinicaltrials.gov/study/NCT02607124,NCT02607124,High Grade Glioma|Diffuse Intrinsic Pontine Glioma|Bithalamic High Grade Glioma
267,0.989955955,151.0196727,https://clinicaltrials.gov/study/NCT02063724,NCT02063724,Breast Cancer
268,0.999314546,183.1777072,https://clinicaltrials.gov/study/NCT00003124,NCT00003124,Prostate Cancer
269,0.862129826,13.85129131,https://clinicaltrials.gov/study/NCT03040024,NCT03040024,Otolaryngeal Cancer
270,0.998843557,183.0568959,https://clinicaltrials.gov/study/NCT00024024,NCT00024024,Sarcoma
271,0.99482074,154.7849099,https://clinicaltrials.gov/study/NCT03483324,NCT03483324,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia in Remission|Myelodysplastic Syndromes|Other Acute Leukemias
272,0.999554464,187.1916775,https://clinicaltrials.gov/study/NCT01421524,NCT01421524,"Multiple Myeloma|Lymphoma, Large B-Cell, Diffuse|Pleiotropic Pathway Modifier|Glioblastoma|Lymphoma|Primary Central Nervous System Lymphoma"
273,0.885718672,14.46390407,https://clinicaltrials.gov/study/NCT01824524,NCT01824524,Pain
274,0.939615834,30.35432723,https://clinicaltrials.gov/study/NCT00437424,NCT00437424,"Carcinoma, Hepatocellular"
275,0.985001096,115.237891,https://clinicaltrials.gov/study/NCT00967824,NCT00967824,Breast Cancer
276,0.998224568,167.5254537,https://clinicaltrials.gov/study/NCT02132624,NCT02132624,B Cell Lymphoma|B Cell Leukemia
277,0.999712439,190.9993731,https://clinicaltrials.gov/study/NCT00002480,NCT00002480,Prostate Cancer
278,0.998788888,179.1379397,https://clinicaltrials.gov/study/NCT00389480,NCT00389480,Tumors
279,0.999305248,188.0208281,https://clinicaltrials.gov/study/NCT00052780,NCT00052780,Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma
280,0.982166198,123.9518888,https://clinicaltrials.gov/study/NCT00172380,NCT00172380,NSCLC
281,0.852790475,14.33973801,https://clinicaltrials.gov/study/NCT02439580,NCT02439580,Colorectal Cancer
282,0.995451528,156.4675248,https://clinicaltrials.gov/study/NCT00652080,NCT00652080,Squamous Cell Carcinoma
283,0.996723436,159.1202838,https://clinicaltrials.gov/study/NCT01101880,NCT01101880,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Refractory Anemia With Excess Blasts|Untreated Adult Acute Myeloid Leukemia|Myeloproliferative Neoplasm With 10% Blasts or Higher
284,0.934809499,28.80113878,https://clinicaltrials.gov/study/NCT00952380,NCT00952380,Venous Thromboembolism
285,0.998775061,176.480818,https://clinicaltrials.gov/study/NCT00024180,NCT00024180,Leukemia|Lymphoma
286,0.997465468,161.7431549,https://clinicaltrials.gov/study/NCT00072280,NCT00072280,Sarcoma
287,0.997221168,161.3686627,https://clinicaltrials.gov/study/NCT02472080,NCT02472080,Thyroid Cancer
288,0.999320813,189.1740892,https://clinicaltrials.gov/study/NCT01468324,NCT01468324,Glioblastoma Multiforme
289,0.943674152,34.31561099,https://clinicaltrials.gov/study/NCT01240824,NCT01240824,Bladder Cancer
290,0.97294165,68.87364974,https://clinicaltrials.gov/study/NCT00372424,NCT00372424,Breast Cancer
291,0.990508912,151.0590689,https://clinicaltrials.gov/study/NCT01550224,NCT01550224,Acute Myeloid Leukemia With 11q23-abnormality in Relapse
292,0.996397262,158.3493763,https://clinicaltrials.gov/study/NCT00527124,NCT00527124,Adenocarcinoma of the Prostate|Stage IV Prostate Cancer
293,0.916830019,22.18100933,https://clinicaltrials.gov/study/NCT01304524,NCT01304524,Cervical Intraepithelial Neoplasia
294,0.877788952,16.40607306,https://clinicaltrials.gov/study/NCT04718324,NCT04718324,Breast Disease|Breast Cancer|Breast Neoplasms
295,0.995652717,157.2958789,https://clinicaltrials.gov/study/NCT03515824,NCT03515824,Neoplasms|Colorectal Neoplasms|Head and Neck Neoplasms
296,0.997787579,166.3521714,https://clinicaltrials.gov/study/NCT00562224,NCT00562224,"Neoplasms by Site|Lymphoma, Non-hodgkin|Hodgkin Disease|Multiple Myeloma|Leukemia, Lymphocytic, Chronic"
297,0.991200689,151.0826461,https://clinicaltrials.gov/study/NCT01606124,NCT01606124,Advanced Colorectal Adenomas|Adenocarcinoma of the Colon|Stage I Colon Cancer|Stage II Colon Cancer|Stage III Colon Cancer
298,0.993700728,152.9703846,https://clinicaltrials.gov/study/NCT01222624,NCT01222624,Solid Tumors
299,0.996605304,161.1390544,https://clinicaltrials.gov/study/NCT01004224,NCT01004224,"Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3|Squamous Lung Cancer With FGFR1 Amplification|Bladder Cancer With FGFR3 Mutation or Fusion|Advanced Solid Tumors With FGFR1 Amplication|Advanced Solid Tumors With FGFR2 Amplication|Advanced Solid Tumors With FGFR3 Mutation"
300,0.992980878,152.5246849,https://clinicaltrials.gov/study/NCT00618124,NCT00618124,Solid Tumors|Breast Cancer|Neoplasms
301,0.953754479,41.97339352,https://clinicaltrials.gov/study/NCT03578224,NCT03578224,Esophagus
302,0.997727261,168.9042371,https://clinicaltrials.gov/study/NCT00061880,NCT00061880,Lymphoma
303,0.966411304,54.77095137,https://clinicaltrials.gov/study/NCT00802880,NCT00802880,Sarcoma
304,0.993567992,153.3353769,https://clinicaltrials.gov/study/NCT00546780,NCT00546780,Multiple Myeloma
305,0.992966608,152.5358682,https://clinicaltrials.gov/study/NCT02447380,NCT02447380,Advanced Gastric Adenocarcinoma
306,0.967561416,63.48790302,https://clinicaltrials.gov/study/NCT01183780,NCT01183780,Colorectal Cancer
307,0.989603291,151.0710498,https://clinicaltrials.gov/study/NCT00258180,NCT00258180,"Diarrhea|Gastrointestinal Complications|Unspecified Childhood Solid Tumor, Protocol Specific"
308,0.994672059,154.7437579,https://clinicaltrials.gov/study/NCT03418480,NCT03418480,Human Papilloma Virus Related Carcinoma|Head and Neck Neoplasm|Cervical Neoplasm|Penile Neoplasms Malignant|Unknown Primary Tumors
309,0.991422137,151.631394,https://clinicaltrials.gov/study/NCT01160380,NCT01160380,Fatigue|Multiple Myeloma
310,0.968098524,59.71257228,https://clinicaltrials.gov/study/NCT00385580,NCT00385580,Prostate Cancer
311,0.995522334,157.3442717,https://clinicaltrials.gov/study/NCT00819780,NCT00819780,Colon Cancer|Colorectal Cancer|Rectal Cancer|Metastatic Colorectal Cancer
312,0.995180088,155.6495882,https://clinicaltrials.gov/study/NCT00761280,NCT00761280,Anaplastic Astrocytoma|Glioblastoma
313,0.994056179,154.8577779,https://clinicaltrials.gov/study/NCT00332280,NCT00332280,"Gastrointestinal Cancer|Prostate Cancer|Genital Neoplasms, Female"
314,0.996647879,157.9321705,https://clinicaltrials.gov/study/NCT01270724,NCT01270724,CNS Germ Cell Tumor
315,0.989389021,150.8364385,https://clinicaltrials.gov/study/NCT01002924,NCT01002924,Solid Tumors
316,0.9982878,174.4984308,https://clinicaltrials.gov/study/NCT03233724,NCT03233724,"Carcinoma, Non-Small-Cell Lung|Lung Cancer|Non-Small Cell Lung Cancer|Carcinoma, Esophageal|Malignant Pleural Mesotheliomas"
317,0.998640302,178.3251339,https://clinicaltrials.gov/study/NCT03033524,NCT03033524,Recurrent Glioblastoma
318,0.995442539,156.1062649,https://clinicaltrials.gov/study/NCT01199224,NCT01199224,Solid Tumors
319,0.995614167,157.5987712,https://clinicaltrials.gov/study/NCT03609424,NCT03609424,Gastrointestinal Stromal Tumors
320,0.996497094,157.9362852,https://clinicaltrials.gov/study/NCT03281824,NCT03281824,HER2-positive Breast Cancer
321,0.994672133,155.2757988,https://clinicaltrials.gov/study/NCT00085124,NCT00085124,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
322,0.990550002,151.982828,https://clinicaltrials.gov/study/NCT00619424,NCT00619424,"Lung Cancer, Non-Small Cell"
323,0.922062689,27.45992683,https://clinicaltrials.gov/study/NCT01110824,NCT01110824,Acute Myeloid Leukemia|Precursor-cell Lymphoblastic Leukemia-Lymphoma|Lymphoid Neoplasm|Multiple Myeloma|Lymphoma|Autologous Hematopoietic Stem Cell Transplantation
324,0.98992715,151.3304109,https://clinicaltrials.gov/study/NCT03251924,NCT03251924,Cancer|Tumors|Neoplasm|Malignancy
325,0.998328071,169.8087195,https://clinicaltrials.gov/study/NCT04338724,NCT04338724,Advanced Solid Tumor
326,0.937421244,35.94849056,https://clinicaltrials.gov/study/NCT03558724,NCT03558724,Esophageal Cancer
327,0.927508036,25.73302676,https://clinicaltrials.gov/study/NCT02111824,NCT02111824,Lung Neoplasms|Thoracic Neoplasms|Neoplasms by Site|Neoplasms|Lung Diseases
328,0.995365688,154.618444,https://clinicaltrials.gov/study/NCT00003524,NCT00003524,Stomach (Gastric) Cancer
329,0.984200433,130.1930572,https://clinicaltrials.gov/study/NCT03337724,NCT03337724,Breast Cancer
330,0.999191537,185.0293283,https://clinicaltrials.gov/study/NCT00562380,NCT00562380,"Lymphoma|Prostate Cancer|Sarcoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
331,0.926898986,28.4209763,https://clinicaltrials.gov/study/NCT00831480,NCT00831480,Kidney Cancer
332,0.959564676,32.86806638,https://clinicaltrials.gov/study/NCT00198380,NCT00198380,Pneumonic-type Adenocarcinoma (P-ADC)|Lung Adenocarcinoma With Bronchiolo-alveolar Feature
333,0.999252942,187.933273,https://clinicaltrials.gov/study/NCT00896480,NCT00896480,Melanoma
334,0.994098383,154.6820311,https://clinicaltrials.gov/study/NCT02435680,NCT02435680,Advanced Triple Negative Breast Cancer (TNBC) With High TAMs
335,0.993264215,152.277164,https://clinicaltrials.gov/study/NCT03109080,NCT03109080,"Breast Neoplasms, Triple-Negative|Breast Neoplasm Malignant Female|Radiotherapy Side Effect"
336,0.923155731,20.61623947,https://clinicaltrials.gov/study/NCT03655080,NCT03655080,Cord Compression
337,0.99583646,157.8553261,https://clinicaltrials.gov/study/NCT00719524,NCT00719524,Neoplasms
338,0.996455832,158.3742647,https://clinicaltrials.gov/study/NCT01795924,NCT01795924,Acute Myelogenous Leukemia|Myelodysplastic Syndrome
339,0.998928607,181.6406672,https://clinicaltrials.gov/study/NCT02499224,NCT02499224,Solid Tumors
340,0.998031506,172.5879227,https://clinicaltrials.gov/study/NCT00784524,NCT00784524,Breast Cancer
341,0.920982204,22.94862853,https://clinicaltrials.gov/study/NCT00200824,NCT00200824,Breast Cancer|Prostate Cancer
342,0.999288645,188.1468105,https://clinicaltrials.gov/study/NCT02460224,NCT02460224,Advanced Solid Tumors
343,0.998716541,183.7645879,https://clinicaltrials.gov/study/NCT00003624,NCT00003624,Cervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Neurotoxicity|Ovarian Cancer|Primary Peritoneal Cavity Cancer|Sarcoma
344,0.999070487,185.2717984,https://clinicaltrials.gov/study/NCT00451880,NCT00451880,Cancer|Non-small-cell Lung Cancer|Colorectal Cancer|Papillary Thyroid Cancer|Melanoma
345,0.999089423,188.6725148,https://clinicaltrials.gov/study/NCT01079780,NCT01079780,Colorectal Cancer
346,0.98535265,131.8102517,https://clinicaltrials.gov/study/NCT00055380,NCT00055380,Cancer
347,0.96465314,57.37009029,https://clinicaltrials.gov/study/NCT00031980,NCT00031980,Anemia|Leukemia|Neutropenia|Thrombocytopenia
348,0.9833561,116.5449965,https://clinicaltrials.gov/study/NCT01484080,NCT01484080,Breast Cancer
349,0.934592593,28.55345173,https://clinicaltrials.gov/study/NCT00165880,NCT00165880,Metastatic Breast Cancer
350,0.983654424,128.8286918,https://clinicaltrials.gov/study/NCT00726180,NCT00726180,Breast Cancer
351,0.988360553,151.0283186,https://clinicaltrials.gov/study/NCT00001880,NCT00001880,Neoplasm Metastasis
352,0.945218053,34.25270562,https://clinicaltrials.gov/study/NCT03164980,NCT03164980,Quality of Life|Ovarian Cancer|Recurrent Ovarian Carcinoma
353,0.870257348,12.59762868,https://clinicaltrials.gov/study/NCT02867280,NCT02867280,Hepatocellular Carcinoma|Recurrence
354,0.993420812,152.7059608,https://clinicaltrials.gov/study/NCT00412880,NCT00412880,"Carcinoma, Small Cell"
355,0.983160559,86.54283869,https://clinicaltrials.gov/study/NCT03018080,NCT03018080,Breast - Female|Male Breast Cancer
356,0.999448258,192.5157041,https://clinicaltrials.gov/study/NCT00274924,NCT00274924,Lymphoma
357,0.99907319,190.4482075,https://clinicaltrials.gov/study/NCT01392924,NCT01392924,Neoplasm Malignant
358,0.994190154,154.0009292,https://clinicaltrials.gov/study/NCT00454324,NCT00454324,Small Cell Lung Cancer
359,0.986322415,138.4695776,https://clinicaltrials.gov/study/NCT00076024,NCT00076024,Breast Neoplasms
360,0.996521728,156.3042457,https://clinicaltrials.gov/study/NCT02885324,NCT02885324,Glioblastoma Multiforme|Anaplastic Astrocytoma|Malignant Brain Tumor|High Grade Glioma
361,0.993442411,153.0567267,https://clinicaltrials.gov/study/NCT02335424,NCT02335424,Urothelial Cancer
362,0.99512007,156.1177264,https://clinicaltrials.gov/study/NCT02374424,NCT02374424,"Diffuse, Large B-Cell, Lymphoma"
363,0.998819556,176.7995555,https://clinicaltrials.gov/study/NCT01445080,NCT01445080,"Blastic Phase|Childhood Acute Promyelocytic Leukemia With PML-RARA|Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Childhood Solid Neoplasm|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Juvenile Myelomonocytic Leukemia|Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Disease"
364,0.989787458,150.6686873,https://clinicaltrials.gov/study/NCT01998880,NCT01998880,"Lymphocytic Leukemia, Chronic"
365,0.98713265,135.4515939,https://clinicaltrials.gov/study/NCT02069080,NCT02069080,Cancer
366,0.998697294,174.0259803,https://clinicaltrials.gov/study/NCT03534180,NCT03534180,Anaplastic Large Cell Lymphoma|Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
367,0.933546768,24.01837906,https://clinicaltrials.gov/study/NCT04518124,NCT04518124,Angiosarcoma
368,0.99627725,159.111526,https://clinicaltrials.gov/study/NCT03284424,NCT03284424,Squamous Cell Carcinoma
369,0.996649947,161.9426501,https://clinicaltrials.gov/study/NCT01850524,NCT01850524,Multiple Myeloma
370,0.995371429,154.9529742,https://clinicaltrials.gov/study/NCT03215524,NCT03215524,Multiple Myeloma
371,0.992448852,151.6514832,https://clinicaltrials.gov/study/NCT01342224,NCT01342224,Locally Advanced Pancreatic Adenocarcinoma
372,0.990529608,150.7428617,https://clinicaltrials.gov/study/NCT01087424,NCT01087424,Diffuse Large B-Cell Lymphoma
373,0.996775465,160.0867588,https://clinicaltrials.gov/study/NCT00060424,NCT00060424,B-Cell Prolymphocytic Leukemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|T-Cell Prolymphocytic Leukemia
374,0.998684284,180.1156655,https://clinicaltrials.gov/study/NCT00008424,NCT00008424,"Unspecified Childhood Solid Tumor, Protocol Specific"
375,0.984170049,150.4107516,https://clinicaltrials.gov/study/NCT03661424,NCT03661424,Breast Cancer Female|Leptomeningeal Metastases
376,0.997412646,162.28459,https://clinicaltrials.gov/study/NCT00092924,NCT00092924,"Carcinoma, Non-Small-Cell Lung"
377,0.910019484,19.99566904,https://clinicaltrials.gov/study/NCT00272324,NCT00272324,Colorectal Cancer|Polyps|Adenomas
378,0.971368869,59.87751841,https://clinicaltrials.gov/study/NCT01331824,NCT01331824,Bladder Cancer
379,0.932860746,32.12810705,https://clinicaltrials.gov/study/NCT02835924,NCT02835924,Metastatic Colorectal Cancer
380,0.987953688,150.3555218,https://clinicaltrials.gov/study/NCT03833180,NCT03833180,Chronic Lymphocytic Leukemia|Mantle Cell Lymphoma|Follicular Lymphoma|Marginal Zone Lymphoma|Diffuse Large B-cell Lymphoma|Richter Transformation Lymphoma|Burkitt Lymphoma|Lymphoplasmacytoid Lymphoma|T-cell Non-Hodgkin Lymphoma|Acute Lymphoid Leukemia|Acute Myeloid Leukemia|Waldenstrom Macroglobulinemia
381,0.999763653,172.3166359,https://clinicaltrials.gov/study/NCT03081780,NCT03081780,Refractory Acute Myelogenous Leukemia|Relapsed Acute Myelogenous Leukemia
382,0.989788007,151.1367744,https://clinicaltrials.gov/study/NCT00449280,NCT00449280,Advanced Solid Tumor
383,0.983670093,131.584278,https://clinicaltrials.gov/study/NCT02678780,NCT02678780,Neuroendocrine Tumors
384,0.995485029,156.9334751,https://clinicaltrials.gov/study/NCT00882180,NCT00882180,Solid Tumors
385,0.982017658,131.6228039,https://clinicaltrials.gov/study/NCT03263780,NCT03263780,Prostate Cancer
386,0.998171477,175.6363475,https://clinicaltrials.gov/study/NCT00590824,NCT00590824,Melanoma
387,0.987391415,150.2121006,https://clinicaltrials.gov/study/NCT00423124,NCT00423124,Hematological Malignancies
388,0.998437544,175.0654441,https://clinicaltrials.gov/study/NCT00004224,NCT00004224,Brain and Central Nervous System Tumors
389,0.822517064,12.91092888,https://clinicaltrials.gov/study/NCT00029224,NCT00029224,Breast Cancer|Multiple Myeloma|Prostate Cancer
390,0.800336805,7.822841798,https://clinicaltrials.gov/study/NCT02281136,NCT02281136,"Keratosis, Actinic"
391,0.995985279,159.2394143,https://clinicaltrials.gov/study/NCT00001436,NCT00001436,Neoplasm Metastasis|Osteosarcoma
392,0.975236391,82.28973806,https://clinicaltrials.gov/study/NCT02636036,NCT02636036,Colorectal Cancer|Squamous Cell Carcinoma of the Head and Neck|Epithelial Tumor
393,0.999525997,182.1154673,https://clinicaltrials.gov/study/NCT00108134,NCT00108134,Basal Cell Carcinoma
394,0.932171515,29.06364163,https://clinicaltrials.gov/study/NCT02697734,NCT02697734,Cushing's Disease
395,0.987205018,147.0891284,https://clinicaltrials.gov/study/NCT02584634,NCT02584634,Non-Small Cell Lung Cancer
396,0.9897685,151.2705668,https://clinicaltrials.gov/study/NCT04370834,NCT04370834,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Pneumonia|Pneumonitis|Severe Acute Respiratory Distress Syndrome|Symptomatic COVID-19 Infection Laboratory-Confirmed
397,0.966282246,53.70472969,https://clinicaltrials.gov/study/NCT03352934,NCT03352934,Cancer
398,0.980423087,96.07569752,https://clinicaltrials.gov/study/NCT00755534,NCT00755534,Colorectal Cancer
399,0.99118551,151.5194043,https://clinicaltrials.gov/study/NCT00151034,NCT00151034,Urologic Neoplasms
400,0.998837038,176.2956504,https://clinicaltrials.gov/study/NCT03092934,NCT03092934,"Neoplasms|Neoplasm Metastasis|Triple Negative Breast Neoplasms|Head and Neck Neoplasms|Breast Neoplasms|Solid Tumor, Adult|Small Cell Lung Carcinoma"
401,0.99520616,155.6472346,https://clinicaltrials.gov/study/NCT01460901,NCT01460901,Neuroblastoma
402,0.998743165,184.4705514,https://clinicaltrials.gov/study/NCT04445701,NCT04445701,Multiple Myeloma
403,0.995399362,154.7284629,https://clinicaltrials.gov/study/NCT05493501,NCT05493501,NSCLC
404,0.983776429,124.5437803,https://clinicaltrials.gov/study/NCT03841201,NCT03841201,Advanced Hepatocellular Carcinoma
405,0.999751587,177.6762383,https://clinicaltrials.gov/study/NCT01122901,NCT01122901,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
406,0.971122514,58.5865851,https://clinicaltrials.gov/study/NCT03205501,NCT03205501,Barrett Esophagus|Esophageal Cancer|Dysplasia in Barrett Esophagus
407,0.997850005,172.3237039,https://clinicaltrials.gov/study/NCT04235101,NCT04235101,Solid Tumor
408,0.993306532,153.5616169,https://clinicaltrials.gov/study/NCT00054301,NCT00054301,Breast Cancer
409,0.990841389,151.0723437,https://clinicaltrials.gov/study/NCT04203901,NCT04203901,Advanced Renal Cell Carcinoma
410,0.980317758,102.6874016,https://clinicaltrials.gov/study/NCT00983801,NCT00983801,Stomach Neoplasms
411,0.977365986,96.80463591,https://clinicaltrials.gov/study/NCT00076401,NCT00076401,"Leukemia|Leukemia, Lymphocytic, Chronic"
412,0.996860112,162.012609,https://clinicaltrials.gov/study/NCT05169801,NCT05169801,Non-small Cell Lung Cancer(NSCLC)
413,0.996242101,159.9924065,https://clinicaltrials.gov/study/NCT00089180,NCT00089180,Actinic Keratosis|Basal Cell Carcinoma of the Skin|Recurrent Skin Cancer|Squamous Cell Carcinoma of the Skin
414,0.99053106,151.4088558,https://clinicaltrials.gov/study/NCT01149434,NCT01149434,Cancer|Neuroendocrine|Ovarian Cancer|Colon Cancer
415,0.994853,155.9394086,https://clinicaltrials.gov/study/NCT03588936,NCT03588936,Acute Leukemia|Chronic Leukemia|Lymphoma|Myelodysplastic Syndromes
416,0.971972601,60.13727946,https://clinicaltrials.gov/study/NCT00483834,NCT00483834,Colorectal Cancer
417,0.979147963,97.53521778,https://clinicaltrials.gov/study/NCT00325234,NCT00325234,Breast Cancer
418,0.992263699,151.7242441,https://clinicaltrials.gov/study/NCT00858234,NCT00858234,Multiple Myeloma
419,0.925017371,22.7717546,https://clinicaltrials.gov/study/NCT00182234,NCT00182234,Continuity of Care|Quality of Life
420,0.998706108,174.3694536,https://clinicaltrials.gov/study/NCT00084734,NCT00084734,"Unspecified Adult Solid Tumor, Protocol Specific"
421,0.997253186,160.9988428,https://clinicaltrials.gov/study/NCT00408434,NCT00408434,Neoplasm
422,0.993620672,152.0235143,https://clinicaltrials.gov/study/NCT00040534,NCT00040534,Neoplasms
423,0.999539857,188.7189745,https://clinicaltrials.gov/study/NCT00437034,NCT00437034,Stage II Multiple Myeloma|Stage III Multiple Myeloma
424,0.99472386,154.547531,https://clinicaltrials.gov/study/NCT00003934,NCT00003934,Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Promyelocytic Leukemia (M3)|Childhood Acute Promyelocytic Leukemia (M3)|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
425,0.999603027,178.8655467,https://clinicaltrials.gov/study/NCT00003101,NCT00003101,Brain and Central Nervous System Tumors
426,0.772137639,8.804009609,https://clinicaltrials.gov/study/NCT02555501,NCT02555501,Oral Mucositis
427,0.998852689,178.7251209,https://clinicaltrials.gov/study/NCT00005601,NCT00005601,Lymphoma
428,0.991230056,152.5350497,https://clinicaltrials.gov/study/NCT01024101,NCT01024101,Head and Neck Cancer
429,0.993164915,152.4241237,https://clinicaltrials.gov/study/NCT00691301,NCT00691301,Cervical Cancer
430,0.999707988,187.3699919,https://clinicaltrials.gov/study/NCT00869401,NCT00869401,Brain and Central Nervous System Tumors
431,0.989482658,151.3979679,https://clinicaltrials.gov/study/NCT00001901,NCT00001901,Vasculitis|Wegener's Granulomatosis
432,0.99434961,154.4797306,https://clinicaltrials.gov/study/NCT01325701,NCT01325701,Diffuse Large Cell B-lymphoma
433,0.996610972,158.1811729,https://clinicaltrials.gov/study/NCT03343301,NCT03343301,Gastrointestinal Cancer|Gastrointestinal Cancer Metastatic|Gastric Cancer
434,0.986403495,127.4368453,https://clinicaltrials.gov/study/NCT00249301,NCT00249301,Breast Neoplasm|Colon Neoplasm|Pancreatic Neoplasm|Bladder Neoplasm
435,0.83733779,11.57474831,https://clinicaltrials.gov/study/NCT01121601,NCT01121601,Patient With Hepatic Metastasis
436,0.967390431,49.55632328,https://clinicaltrials.gov/study/NCT00146601,NCT00146601,Breast Cancer
437,0.915867072,24.34309497,https://clinicaltrials.gov/study/NCT00431236,NCT00431236,"Nausea and Vomiting, Chemotherapy-Induced"
438,0.815622271,10.62733918,https://clinicaltrials.gov/study/NCT02628236,NCT02628236,"Keratosis, Actinic"
439,0.994562483,153.6877386,https://clinicaltrials.gov/study/NCT00634634,NCT00634634,Metastatic Breast Cancer
440,0.997793992,168.7848581,https://clinicaltrials.gov/study/NCT01956734,NCT01956734,Glioblastoma Multiforme|Recurrent Tumor
441,0.993848442,153.3826939,https://clinicaltrials.gov/study/NCT02935634,NCT02935634,Advanced Gastric Cancer
442,0.983235616,110.8667228,https://clinicaltrials.gov/study/NCT03311334,NCT03311334,Renal Cell Carcinoma (RCC)|Urothelial Carcinoma|Primary Peritoneal Cancer|Platinum-resistant Ovarian Cancer (PROC)|Serous Epithelial Ovarian Cancer|Fallopian Tube Cancer
443,0.560153598,3.991739744,https://clinicaltrials.gov/study/NCT03649334,NCT03649334,Hematological Malignancy (Leukemia- Lymphoma)
444,0.98554285,146.3266967,https://clinicaltrials.gov/study/NCT02726334,NCT02726334,Colorectal Cancer
445,0.979818464,96.56243299,https://clinicaltrials.gov/study/NCT02784834,NCT02784834,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
446,0.98007129,103.6083862,https://clinicaltrials.gov/study/NCT00903734,NCT00903734,Advanced Cancers
447,0.998331316,169.4202017,https://clinicaltrials.gov/study/NCT04939701,NCT04939701,Ovarian Cancer|NSCLC|ESCC|Solid Tumors
448,0.970914913,62.89375922,https://clinicaltrials.gov/study/NCT03676101,NCT03676101,Cervical Cancers|Vulvar Cancer|Vaginal Cancer|CIN1|CIN2|CIN 3|AIS|Invasive Carcinoma|Mild Dysplasia of Vulva|Moderate Dysplasia of Vulva|Vin III|VaIN1|VaIN2|VaIN3|Genital Wart
449,0.999729786,179.1278624,https://clinicaltrials.gov/study/NCT01514201,NCT01514201,Anaplastic Astrocytoma|Brain Stem Glioma|Childhood Mixed Glioma|Fibrillary Astrocytoma|Giant Cell Glioblastoma|Glioblastoma|Gliosarcoma|Untreated Childhood Anaplastic Astrocytoma|Untreated Childhood Brain Stem Glioma|Untreated Childhood Fibrillary Astrocytoma|Untreated Childhood Giant Cell Glioblastoma|Untreated Childhood Glioblastoma|Untreated Childhood Gliosarcoma
450,0.998474426,174.0037706,https://clinicaltrials.gov/study/NCT00058201,NCT00058201,Pancreatic Cancer
451,0.999829371,183.5265781,https://clinicaltrials.gov/study/NCT01861301,NCT01861301,Epithelioid Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatoid Mesothelioma|Stage II Pleural Mesothelioma|Stage III Pleural Mesothelioma|Stage IV Pleural Mesothelioma
452,0.994063761,153.0319883,https://clinicaltrials.gov/study/NCT00092001,NCT00092001,"Carcinoma, Non-Small-Cell Lung"
453,0.985254091,145.0522205,https://clinicaltrials.gov/study/NCT00081601,NCT00081601,Prostate Cancer
454,0.968997697,65.69583998,https://clinicaltrials.gov/study/NCT00367601,NCT00367601,Lung Cancer
455,0.999256883,189.7188472,https://clinicaltrials.gov/study/NCT01134601,NCT01134601,Non-Metastatic Adenocarcinoma of the Rectum
456,0.994402485,156.5447516,https://clinicaltrials.gov/study/NCT01418001,NCT01418001,Sarcoma|Leiomyosarcoma|Malignant Peripheral Nerve Sheath Tumor|Malignant Fibrous|Histiocytoma/Undifferentiated Pleomorphic Sarcoma
457,0.988461865,150.681582,https://clinicaltrials.gov/study/NCT01639001,NCT01639001,NSCLC (Non-small Cell Lung Cancer)
458,0.98632588,133.9593497,https://clinicaltrials.gov/study/NCT00192036,NCT00192036,Non Small Cell Lung Cancer
459,0.90848898,20.56907822,https://clinicaltrials.gov/study/NCT02038036,NCT02038036,Polycythemia Vera
460,0.998298682,173.5883792,https://clinicaltrials.gov/study/NCT00080834,NCT00080834,Colorectal Cancer
461,0.998465624,168.2808307,https://clinicaltrials.gov/study/NCT00005834,NCT00005834,Multiple Myeloma
462,0.997404122,162.9071313,https://clinicaltrials.gov/study/NCT00301834,NCT00301834,Congenital Amegakaryocytic Thrombocytopenia|Diamond-blackfan Anemia|Leukemia|Myelodysplastic Syndromes|Severe Congenital Neutropenia
463,0.998412636,173.2501459,https://clinicaltrials.gov/study/NCT03052634,NCT03052634,Advanced Breast Cancer
464,0.996636623,159.6739646,https://clinicaltrials.gov/study/NCT00979134,NCT00979134,Cancer|Advanced Solid Malignancies
465,0.986397165,135.5807029,https://clinicaltrials.gov/study/NCT00035334,NCT00035334,Secondary (AA) Amyloidosis|Rheumatoid Arthritis|Nephrotic Syndrome|Familial Mediterranean Syndrome|Kidney Diseases|Gastrointestinal Diseases
466,0.998819008,195.1521241,https://clinicaltrials.gov/study/NCT02767934,NCT02767934,B Acute Lymphoblastic Leukemia|Minimal Residual Disease|Recurrent Acute Lymphoblastic Leukemia|T Acute Lymphoblastic Leukemia
467,0.962934864,52.5001985,https://clinicaltrials.gov/study/NCT02312934,NCT02312934,Chemo Brain|Chemotherapy-related Cognitive Impairment|Chemo Fog|Breast Cancer|Chemobrain
468,0.989662519,150.5465632,https://clinicaltrials.gov/study/NCT04194034,NCT04194034,Colorectal Neoplasms
469,0.992403225,151.718264,https://clinicaltrials.gov/study/NCT03360734,NCT03360734,"Solid Tumor, Adult"
470,0.998831278,178.5436374,https://clinicaltrials.gov/study/NCT00002601,NCT00002601,Sarcoma
471,0.981407911,92.09225023,https://clinicaltrials.gov/study/NCT02702401,NCT02702401,Hepatocellular Carcinoma
472,0.993722744,153.265754,https://clinicaltrials.gov/study/NCT01724801,NCT01724801,Brain Metastasis|Non Small Cell Lung Cancer
473,0.988243057,151.2981778,https://clinicaltrials.gov/study/NCT00870701,NCT00870701,Soft Tissue Sarcoma of Members
474,0.98696461,150.4650652,https://clinicaltrials.gov/study/NCT03056001,NCT03056001,"Soft Tissue Sarcoma, Adult|Soft Tissue Sarcoma, Child"
475,0.999226142,189.7293837,https://clinicaltrials.gov/study/NCT00005801,NCT00005801,Leukemia
476,0.982094418,101.1580742,https://clinicaltrials.gov/study/NCT02582801,NCT02582801,Breast Cancer
477,0.860082113,13.98153888,https://clinicaltrials.gov/study/NCT02066636,NCT02066636,Non Small Cell Lung Cancer (NSCLC)
478,0.788612492,9.743450186,https://clinicaltrials.gov/study/NCT04327934,NCT04327934,Polycystic Ovary Syndrome|Hypertension
479,0.998860308,175.9596217,https://clinicaltrials.gov/study/NCT02316834,NCT02316834,Fallopian Tube Serous Adenocarcinoma|High Grade Ovarian Serous Adenocarcinoma|Ovarian Mass|Primary Peritoneal Serous Adenocarcinoma|Stage III Fallopian Tube Cancer AJCC v7|Stage III Ovarian Cancer AJCC v6 and v7|Stage III Primary Peritoneal Cancer AJCC v7|Stage IIIA Fallopian Tube Cancer AJCC v7|Stage IIIA Ovarian Cancer AJCC v6 and v7|Stage IIIA Primary Peritoneal Cancer AJCC v7|Stage IIIB Fallopian Tube Cancer AJCC v7|Stage IIIB Ovarian Cancer AJCC v6 and v7|Stage IIIB Primary Peritoneal Cancer AJCC v7|Stage IIIC Fallopian Tube Cancer AJCC v7|Stage IIIC Ovarian Cancer AJCC v6 and v7|Stage IIIC Primary Peritoneal Cancer AJCC v7|Stage IV Fallopian Tube Cancer AJCC v6 and v7|Stage IV Ovarian Cancer AJCC v6 and v7|Stage IV Primary Peritoneal Cancer AJCC v7
480,0.995508673,158.2391926,https://clinicaltrials.gov/study/NCT01191034,NCT01191034,Metastatic Melanoma
481,0.997209075,160.4237141,https://clinicaltrials.gov/study/NCT00716534,NCT00716534,Advanced or Metastatic Non-Small Cell Lung Cancer
482,0.955142354,47.45387913,https://clinicaltrials.gov/study/NCT01309334,NCT01309334,Multiple Myeloma
483,0.99564824,158.0760408,https://clinicaltrials.gov/study/NCT00006034,NCT00006034,Bladder Cancer
484,0.981458642,114.464438,https://clinicaltrials.gov/study/NCT00502034,NCT00502034,"Carcinoma, Renal Cell"
485,0.971522825,82.50541847,https://clinicaltrials.gov/study/NCT01530334,NCT01530334,Lung Cancer
486,0.992545839,152.4756779,https://clinicaltrials.gov/study/NCT00671034,NCT00671034,Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia|Childhood B Acute Lymphoblastic Leukemia
487,0.990650008,151.9996702,https://clinicaltrials.gov/study/NCT00256334,NCT00256334,Colon Cancer|Cancer
488,0.983309731,115.9200353,https://clinicaltrials.gov/study/NCT01431534,NCT01431534,Solid Tumors
489,0.998411229,171.6693493,https://clinicaltrials.gov/study/NCT00747734,NCT00747734,Solid Cancers
490,0.853789129,14.37011059,https://clinicaltrials.gov/study/NCT00575601,NCT00575601,Polycystic Ovary Syndrome
491,0.98494623,141.0135388,https://clinicaltrials.gov/study/NCT00181701,NCT00181701,Ovarian Carcinoma
492,0.991419733,151.3422124,https://clinicaltrials.gov/study/NCT02500901,NCT02500901,Metastatic Prostate Cancer
493,0.94562307,33.32322363,https://clinicaltrials.gov/study/NCT02985801,NCT02985801,Pancreatic Insufficiency|Pancreatic Cancer|Pancreatic Enzyme Abnormality
494,0.98341759,117.4972152,https://clinicaltrials.gov/study/NCT01572701,NCT01572701,Prostate Cancer
495,0.998689453,168.3804557,https://clinicaltrials.gov/study/NCT00063401,NCT00063401,Ovarian Cancer|Peritoneal Neoplasms|Fallopian Tube Neoplasms
496,0.999326352,190.2432933,https://clinicaltrials.gov/study/NCT01473901,NCT01473901,Glioblastoma
497,0.990417699,151.2076655,https://clinicaltrials.gov/study/NCT01376401,NCT01376401,Multiple Myeloma
498,0.999044904,183.2183012,https://clinicaltrials.gov/study/NCT00612001,NCT00612001,Brain and Central Nervous System Tumors
499,0.997585925,163.0089888,https://clinicaltrials.gov/study/NCT00101101,NCT00101101,Lymphoma
500,0.903015453,15.10854804,https://clinicaltrials.gov/study/NCT01031901,NCT01031901,Tuberous Sclerosis|Neurofibromatoses|Angiofibroma|Neurofibroma
501,0.999807792,197.4932368,https://clinicaltrials.gov/study/NCT01585701,NCT01585701,Advanced Solid Tumours
502,0.99814581,168.1571684,https://clinicaltrials.gov/study/NCT00322101,NCT00322101,"Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Acute Myeloid Leukemia/Transient Myeloproliferative Disorder|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|de Novo Myelodysplastic Syndromes|Myelodysplastic Syndrome With Isolated Del(5q)|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes"
503,0.973114997,85.23108536,https://clinicaltrials.gov/study/NCT03659136,NCT03659136,Breast Neoplasms
504,0.986508494,136.002694,https://clinicaltrials.gov/study/NCT02522234,NCT02522234,Neutropenia
505,0.999595837,196.2485123,https://clinicaltrials.gov/study/NCT00305734,NCT00305734,Recurrent Nasopharyngeal Cancer|Stage IV Nasopharyngeal Cancer
506,0.979315532,97.6873954,https://clinicaltrials.gov/study/NCT01548534,NCT01548534,Metastatic Breast Cancer|Progesterone Receptor Positive Tumor|Estrogen Receptor Positive Tumor|HER-2 Negative Tumor
507,0.943122829,32.18423367,https://clinicaltrials.gov/study/NCT00411034,NCT00411034,"Analgesics, Opioid|Pain"
508,0.996446826,158.0450917,https://clinicaltrials.gov/study/NCT02270034,NCT02270034,Glioblastoma Multiforme (Grade IV) of Cerebellum
509,0.9992492,193.3319633,https://clinicaltrials.gov/study/NCT00003434,NCT00003434,Pancreatic Cancer
510,0.997547223,162.6714659,https://clinicaltrials.gov/study/NCT04728334,NCT04728334,Neoplasms Malignant
511,0.995376645,157.4168581,https://clinicaltrials.gov/study/NCT03011034,NCT03011034,Myelodysplastic Syndromes
512,0.99673274,158.0185871,https://clinicaltrials.gov/study/NCT01158534,NCT01158534,Renal Cell Cancer|Stage IV Renal Cell Cancer
513,0.988113186,151.0523626,https://clinicaltrials.gov/study/NCT01118234,NCT01118234,Chronic Lymphocytic Leukemia
514,0.997755917,164.6196402,https://clinicaltrials.gov/study/NCT01481701,NCT01481701,Ovarian Carcinoma|Relapse
515,0.997676355,162.9628607,https://clinicaltrials.gov/study/NCT03734601,NCT03734601,Acute Myeloid Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorder|Chronic Lymphocytic Leukemia|B-cell Lymphoma|T-cell Lymphoma|Non Hodgkin Lymphoma|Hodgkin Lymphoma|Chronic Myelomonocytic Leukemia
516,0.997602036,161.0265538,https://clinicaltrials.gov/study/NCT00088101,NCT00088101,Hematological Malignancies|Leukemia|Lymphoma|Metastatic or Unresectable Solid Tumors
517,0.881462544,15.83604342,https://clinicaltrials.gov/study/NCT01538901,NCT01538901,Actinic Keratoses
518,0.999529419,186.6085787,https://clinicaltrials.gov/study/NCT00509301,NCT00509301,Recurrent Glioblastoma Multiforme
519,0.877861332,14.27337374,https://clinicaltrials.gov/study/NCT03407001,NCT03407001,Cirrhosis
520,0.899466852,20.63582253,https://clinicaltrials.gov/study/NCT02764801,NCT02764801,"Hepatocellular Carcinoma|Chemoembolization, Therapeutic"
521,0.992256961,151.8550523,https://clinicaltrials.gov/study/NCT01492101,NCT01492101,Locally Recurrent Breast Cancer|Metastatic Breast Cancer
522,0.996837449,156.5627911,https://clinicaltrials.gov/study/NCT02456701,NCT02456701,Thyroid Cancer
523,0.988060633,145.4205287,https://clinicaltrials.gov/study/NCT00689936,NCT00689936,Multiple Myeloma
524,0.630582376,4.745677682,https://clinicaltrials.gov/study/NCT00502736,NCT00502736,Pain; Bone Neoplasms; Neoplasm Metastasis
525,0.999094297,196.8636084,https://clinicaltrials.gov/study/NCT00019136,NCT00019136,Ovarian Cancer
526,0.997558041,162.2716906,https://clinicaltrials.gov/study/NCT00656734,NCT00656734,Kidney Cancer
527,0.997172825,161.7593835,https://clinicaltrials.gov/study/NCT01711034,NCT01711034,Solid Tumors
528,0.990035273,151.4269743,https://clinicaltrials.gov/study/NCT00905034,NCT00905034,"Leukemia, Lymphocytic, Acute"
529,0.999298604,184.4617604,https://clinicaltrials.gov/study/NCT00096434,NCT00096434,Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
530,0.988615772,150.6271815,https://clinicaltrials.gov/study/NCT04693234,NCT04693234,Cervical Cancer
531,0.994420924,153.5242121,https://clinicaltrials.gov/study/NCT00264134,NCT00264134,Non-small Cell Lung Cancer|Extensive Stage Unresectable
532,0.9983201,171.2740909,https://clinicaltrials.gov/study/NCT05144334,NCT05144334,Advanced Solid Tumor|Non Hodgkin Lymphoma|Acute Myeloid Leukemia
533,0.99972878,193.6782116,https://clinicaltrials.gov/study/NCT02101034,NCT02101034,"Carcinoma, Squamous Cell of Head and Neck"
534,0.999725599,188.2444888,https://clinicaltrials.gov/study/NCT01298401,NCT01298401,Pancreatic Cancer
535,0.737596247,6.035489055,https://clinicaltrials.gov/study/NCT00628901,NCT00628901,Leiomyoma|Uterine Fibroids|Uterine Neoplasms|Menorrhagia|Leiomyomatosis
536,0.989543179,151.5752204,https://clinicaltrials.gov/study/NCT04194801,NCT04194801,Hepatocellular Carcinoma
537,0.997489023,162.4492396,https://clinicaltrials.gov/study/NCT02984501,NCT02984501,Pancreatic Cancer
538,0.981103677,109.6871073,https://clinicaltrials.gov/study/NCT00192101,NCT00192101,Metastatic Breast Cancer
539,0.988611655,150.1230766,https://clinicaltrials.gov/study/NCT01626001,NCT01626001,Esophagus Cancer|Lung Cancer
540,0.986994142,150.3386565,https://clinicaltrials.gov/study/NCT02186301,NCT02186301,Non-Small Cell Lung Cancer
541,0.996368032,157.231591,https://clinicaltrials.gov/study/NCT00622401,NCT00622401,Breast Cancer
542,0.971112313,54.41212131,https://clinicaltrials.gov/study/NCT01719536,NCT01719536,NSCLC
543,0.997653232,164.6926475,https://clinicaltrials.gov/study/NCT01610336,NCT01610336,Non-small Cell Lung Cancer
544,0.99487092,155.5592032,https://clinicaltrials.gov/study/NCT00232934,NCT00232934,Multiple Myeloma
545,0.979792384,95.8168247,https://clinicaltrials.gov/study/NCT01228734,NCT01228734,Metastatic Colorectal Cancer
546,0.999289485,183.5723842,https://clinicaltrials.gov/study/NCT00075634,NCT00075634,"Recurrent Neuroblastoma|Unspecified Childhood Solid Tumor, Protocol Specific"
547,0.929827266,25.46513993,https://clinicaltrials.gov/study/NCT04936334,NCT04936334,Prostate Cancer
548,0.843258714,12.44676139,https://clinicaltrials.gov/study/NCT00958334,NCT00958334,Uterine Fibroids
549,0.875926321,14.62279617,https://clinicaltrials.gov/study/NCT03349034,NCT03349034,Head and Neck Cancer|Free Tissue Transfer
550,0.987397855,129.6057418,https://clinicaltrials.gov/study/NCT04131634,NCT04131634,Urothelial Cancer
551,0.992998798,152.2796877,https://clinicaltrials.gov/study/NCT03499834,NCT03499834,Non-small Cell Lung Cancer (NSCLC) Stage IV
552,0.996861479,159.6042675,https://clinicaltrials.gov/study/NCT02527434,NCT02527434,Urothelial Bladder Cancer|Triple-negative Breast Cancer|Pancreatic Ductal Adenocarcinoma
553,0.985880488,130.531342,https://clinicaltrials.gov/study/NCT02016534,NCT02016534,Stomach Neoplasms
554,0.842080834,13.93372574,https://clinicaltrials.gov/study/NCT02666534,NCT02666534,Microinvasive Squamous Cell Carcinoma
555,0.992318786,151.9336038,https://clinicaltrials.gov/study/NCT01856101,NCT01856101,Carcinoma Transitional Cell
556,0.998859928,188.63908,https://clinicaltrials.gov/study/NCT01975701,NCT01975701,Recurrent Glioblastoma or Other Glioma Subtypes
557,0.999576477,191.4415751,https://clinicaltrials.gov/study/NCT00004901,NCT00004901,Head and Neck Cancer
558,0.99642168,157.5296023,https://clinicaltrials.gov/study/NCT00089401,NCT00089401,Colorectal Cancer|Metastatic Cancer
559,0.985597199,121.4217879,https://clinicaltrials.gov/study/NCT00283101,NCT00283101,"Leukemia, Lymphocytic, Chronic"
560,0.993323219,152.8454815,https://clinicaltrials.gov/study/NCT01009801,NCT01009801,Liver Cancer
561,0.996804939,160.0301132,https://clinicaltrials.gov/study/NCT01288534,NCT01288534,Prostate Cancer
562,0.977380808,107.0074424,https://clinicaltrials.gov/study/NCT01990534,NCT01990534,Hodgkin Lymphoma
563,0.993982892,153.4657215,https://clinicaltrials.gov/study/NCT00895934,NCT00895934,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia
564,0.919110671,22.59031772,https://clinicaltrials.gov/study/NCT03130634,NCT03130634,Metastatic Colorectal Cancer
565,0.983740641,99.44052449,https://clinicaltrials.gov/study/NCT00608634,NCT00608634,Precancerous Condition
566,0.991368419,150.7184447,https://clinicaltrials.gov/study/NCT00522834,NCT00522834,Melanoma
567,0.984825617,115.0404013,https://clinicaltrials.gov/study/NCT03302234,NCT03302234,"Carcinoma, Non-Small-Cell Lung"
568,0.989224991,151.5182504,https://clinicaltrials.gov/study/NCT00862134,NCT00862134,Non-Small Cell Lung Cancer
569,0.999406082,201.5418359,https://clinicaltrials.gov/study/NCT02158234,NCT02158234,Squamous Cell Carcinoma of the Head and Neck
570,0.991586042,150.6761262,https://clinicaltrials.gov/study/NCT01854034,NCT01854034,Non Small Cell Lung Cancer
571,0.996104158,158.0228415,https://clinicaltrials.gov/study/NCT02972034,NCT02972034,Neoplasms|Colorectal Cancer
572,0.914098977,24.95485228,https://clinicaltrials.gov/study/NCT00132301,NCT00132301,Prostate Cancer
573,0.762087293,6.2956352,https://clinicaltrials.gov/study/NCT03122301,NCT03122301,Hot Flashes|Hot Flushes|Vasomotor Symptoms
574,0.935279843,30.84059586,https://clinicaltrials.gov/study/NCT01096901,NCT01096901,Obesity|Overweight
575,0.99767014,164.3119306,https://clinicaltrials.gov/study/NCT00522301,NCT00522301,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
576,0.995316941,155.7384203,https://clinicaltrials.gov/study/NCT03070301,NCT03070301,Neuroendocrine Tumors
577,0.991315887,152.2120675,https://clinicaltrials.gov/study/NCT03792841,NCT03792841,Metastatic Castration-resistant Prostate Cancer|Prostate Cancer
578,0.969584404,52.27656111,https://clinicaltrials.gov/study/NCT01985841,NCT01985841,Breast Cancer
579,0.991840361,151.4602329,https://clinicaltrials.gov/study/NCT00054041,NCT00054041,Cervical Cancer|Cervical Intraepithelial Neoplasia Grade 3|Human Papilloma Virus Infection
580,0.994185767,152.7263779,https://clinicaltrials.gov/study/NCT03727841,NCT03727841,Anaplastic Ependymoma|Ependymoma|Ependymomas
581,0.967005196,55.18314764,https://clinicaltrials.gov/study/NCT03627741,NCT03627741,Fibromatosis
582,0.997844943,160.232841,https://clinicaltrials.gov/study/NCT01078441,NCT01078441,Refractory Multiple Myeloma
583,0.647486092,4.974880481,https://clinicaltrials.gov/study/NCT04532736,NCT04532736,Nasal Polyposis
584,0.976442249,67.37661844,https://clinicaltrials.gov/study/NCT02998736,NCT02998736,Abdominal Cancer
585,0.994687271,155.2145479,https://clinicaltrials.gov/study/NCT01254136,NCT01254136,Breast Cancer
586,0.993803166,153.9996738,https://clinicaltrials.gov/study/NCT03344536,NCT03344536,Breast Cancer
587,0.997140089,162.8477988,https://clinicaltrials.gov/study/NCT01014936,NCT01014936,"Patients With Solid Tumors, Either Refractory to Standard Therapy or for Which no Effective Standard Therapy is Available"
588,0.989094742,150.7616035,https://clinicaltrials.gov/study/NCT01736436,NCT01736436,Myelodysplastic Syndrome
589,0.964878329,59.2843391,https://clinicaltrials.gov/study/NCT04805736,NCT04805736,Breast Cancer
590,0.625906587,5.522668677,https://clinicaltrials.gov/study/NCT04955236,NCT04955236,Posterior Fossa Tumor
591,0.593922892,4.322023379,https://clinicaltrials.gov/study/NCT02726828,NCT02726828,Postoperative Pain
592,0.99693599,158.0650894,https://clinicaltrials.gov/study/NCT02366728,NCT02366728,"Glioblastoma|Astrocytoma, Grade IV|Giant Cell Glioblastoma|Glioblastoma Multiforme"
593,0.993577495,152.2293796,https://clinicaltrials.gov/study/NCT03106428,NCT03106428,Acute Myeloid Leukemia|Multiple Myeloma|Diffuse Large B-cell Lymphoma
594,0.998251386,167.3784044,https://clinicaltrials.gov/study/NCT00356928,NCT00356928,Leukemia|Myelodysplastic Syndromes
595,0.988871083,150.7130232,https://clinicaltrials.gov/study/NCT01911728,NCT01911728,Pharmacokinetics of MDV3100|Castration Resistant Prostate Cancer (CRPC)
596,0.999112948,188.9333017,https://clinicaltrials.gov/study/NCT00033241,NCT00033241,"Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
597,0.936378117,35.12145387,https://clinicaltrials.gov/study/NCT01387841,NCT01387841,Breast Cancer|Malignant Female Reproductive System Neoplasm|Lymphomas|Chemotherapy-induced Nausea and Vomiting
598,0.994736873,155.513518,https://clinicaltrials.gov/study/NCT00809341,NCT00809341,Non-Hodgkin's Lymphoma
599,0.999765362,183.4943244,https://clinicaltrials.gov/study/NCT02049541,NCT02049541,Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrm Macroglobulinemia
600,0.999023006,179.1503757,https://clinicaltrials.gov/study/NCT00226941,NCT00226941,Rectal Cancer|Colo-rectal Cancer
601,0.983078287,143.7694651,https://clinicaltrials.gov/study/NCT01099436,NCT01099436,Breast Cancer
602,0.994510499,153.5285453,https://clinicaltrials.gov/study/NCT04262336,NCT04262336,Ototoxicity
603,0.819392884,9.703395835,https://clinicaltrials.gov/study/NCT00800436,NCT00800436,Breast Cancer
604,0.990790441,151.5349869,https://clinicaltrials.gov/study/NCT00862836,NCT00862836,Ovarian Cancer
605,0.993053814,153.2581689,https://clinicaltrials.gov/study/NCT03132636,NCT03132636,"Carcinoma, Basal Cell"
606,0.994781144,155.6885065,https://clinicaltrials.gov/study/NCT04742036,NCT04742036,Advanced Solid Tumours
607,0.998242057,175.3308798,https://clinicaltrials.gov/study/NCT01058434,NCT01058434,Relapsed or Refractory Multiple Myeloma
608,0.991449343,151.9115865,https://clinicaltrials.gov/study/NCT02229734,NCT02229734,Prostate Cancer
609,0.998771833,187.9127454,https://clinicaltrials.gov/study/NCT00107536,NCT00107536,Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
610,0.992666197,151.4967961,https://clinicaltrials.gov/study/NCT01358734,NCT01358734,Acute Myeloid Leukemia|Acute Myelogenous Leukemia
611,0.919805227,19.27523986,https://clinicaltrials.gov/study/NCT02077634,NCT02077634,Prostate Cancer
612,0.988095992,146.4746859,https://clinicaltrials.gov/study/NCT00591734,NCT00591734,Metastatic Melanoma
613,0.999489767,180.9111228,https://clinicaltrials.gov/study/NCT00002634,NCT00002634,Neuroblastoma
614,0.995715516,157.5447369,https://clinicaltrials.gov/study/NCT00048334,NCT00048334,Neoplasms
615,0.928129927,30.81854519,https://clinicaltrials.gov/study/NCT02526134,NCT02526134,Oesophageal Cancer|Rectal Cancer
616,0.982491921,99.97740299,https://clinicaltrials.gov/study/NCT00452634,NCT00452634,Small Cell Lung Cancer
617,0.986067745,136.8628452,https://clinicaltrials.gov/study/NCT00832234,NCT00832234,Waldenstroms Macroglobulinemia
618,0.997741726,166.335325,https://clinicaltrials.gov/study/NCT00313534,NCT00313534,Prostate Cancer
619,0.999467486,182.8160896,https://clinicaltrials.gov/study/NCT01419834,NCT01419834,Neuroblastoma
620,0.974886538,75.6774016,https://clinicaltrials.gov/study/NCT04676334,NCT04676334,Metastatic Castration-Resistant Prostate Cancer|Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer|Other Solid Tumor
621,0.690403119,5.485811729,https://clinicaltrials.gov/study/NCT00210834,NCT00210834,Anemia
622,0.994952582,156.0981519,https://clinicaltrials.gov/study/NCT02186834,NCT02186834,Multiple Myeloma
623,0.992821379,150.8018572,https://clinicaltrials.gov/study/NCT01453101,NCT01453101,Multiple Myeloma
624,0.99745612,157.6798775,https://clinicaltrials.gov/study/NCT02325401,NCT02325401,Head and Neck Cancer
625,0.995642263,158.4586102,https://clinicaltrials.gov/study/NCT03011528,NCT03011528,Ewing Sarcoma Family of Tumors
626,0.998402403,175.2073997,https://clinicaltrials.gov/study/NCT00052728,NCT00052728,Breast Cancer
627,0.998338376,171.3094796,https://clinicaltrials.gov/study/NCT03595228,NCT03595228,Chordoma
628,0.791881492,8.980141593,https://clinicaltrials.gov/study/NCT01836328,NCT01836328,Pain
629,0.991494241,152.3790715,https://clinicaltrials.gov/study/NCT00321828,NCT00321828,Colorectal Cancer
630,0.982750707,117.6056279,https://clinicaltrials.gov/study/NCT00411541,NCT00411541,Acute Lymphoblastic Leukemia
631,0.862318848,14.04674998,https://clinicaltrials.gov/study/NCT00252941,NCT00252941,Prostate Cancer|Post-Brachytherapy Bladder Outlet Obstruction
632,0.987193545,128.7361257,https://clinicaltrials.gov/study/NCT03622541,NCT03622541,FLT3-ITD Mutation|AML
633,0.937696983,29.04542638,https://clinicaltrials.gov/study/NCT00273741,NCT00273741,Asthenia|Neoplasms
634,0.993355098,153.518666,https://clinicaltrials.gov/study/NCT00663741,NCT00663741,Gastric Cancer
635,0.952500196,45.98641503,https://clinicaltrials.gov/study/NCT00190541,NCT00190541,Rectal Neoplasms
636,0.997483736,162.1016813,https://clinicaltrials.gov/study/NCT01317641,NCT01317641,Prostate Cancer
637,0.998602955,177.2781595,https://clinicaltrials.gov/study/NCT00603941,NCT00603941,Anaplastic Thyroid Cancer
638,0.998873263,182.2440479,https://clinicaltrials.gov/study/NCT01325441,NCT01325441,Cancer
639,0.995928517,156.685092,https://clinicaltrials.gov/study/NCT02265341,NCT02265341,Malignant Hepatobiliary Neoplasm
640,0.993402029,152.1665951,https://clinicaltrials.gov/study/NCT01829841,NCT01829841,Renal Cell Cancer|Metastatic Renal Cell Cancer
641,0.997516756,161.9857619,https://clinicaltrials.gov/study/NCT01196741,NCT01196741,Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
642,0.998590018,175.8201147,https://clinicaltrials.gov/study/NCT02160041,NCT02160041,Solid Tumor|Hematologic Malignancies
643,0.837430829,11.37760077,https://clinicaltrials.gov/study/NCT00676936,NCT00676936,Cancer|Pain
644,0.998731464,182.708498,https://clinicaltrials.gov/study/NCT00004241,NCT00004241,"AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Primary CNS Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Chondrosarcoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Metastatic Osteosarcoma|Nodal Marginal Zone B-cell Lymphoma|Ovarian Sarcoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Osteosarcoma|Recurrent Small Lymphocytic Lymphoma|Recurrent Uterine Sarcoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult Soft Tissue Sarcoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides/Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Stage IV Uterine Sarcoma|Unspecified Adult Solid Tumor, Protocol Specific"
645,0.977877354,84.69595207,https://clinicaltrials.gov/study/NCT00184041,NCT00184041,Acute Lymphoblastic Leukemia
646,0.992219483,151.4881732,https://clinicaltrials.gov/study/NCT04099641,NCT04099641,Gastric Cancer|GastroEsophageal Cancer
647,0.988152498,150.8396252,https://clinicaltrials.gov/study/NCT02096341,NCT02096341,Malignant Solid Tumor|Lymphomas
648,0.94542973,35.60382895,https://clinicaltrials.gov/study/NCT01133041,NCT01133041,Diminutive Colon Polyp|Adenomatous Polyp|Hyperplastic Polyp|Colonoscopy
649,0.99796401,164.7665672,https://clinicaltrials.gov/study/NCT00727441,NCT00727441,Pancreatic Cancer
650,0.987094526,150.0197574,https://clinicaltrials.gov/study/NCT00476541,NCT00476541,Acute Myeloid Leukemia
651,0.991493394,150.8379452,https://clinicaltrials.gov/study/NCT00004941,NCT00004941,Crohn's Disease
652,0.98132575,89.25574662,https://clinicaltrials.gov/study/NCT05476341,NCT05476341,Rectal Cancer|Lung Cancer|Ovarian Cancer|Cervical Cancer|Glioblastoma
653,0.998049964,166.1215924,https://clinicaltrials.gov/study/NCT02702141,NCT02702141,Non-Hodgkin Lymphoma|DLBCL|Diffuse Large B-cell Lymphoma|Grade 3 Follicular Lymphoma
654,0.999690504,201.4721556,https://clinicaltrials.gov/study/NCT00002941,NCT00002941,Lymphoma
655,0.99768183,164.9404336,https://clinicaltrials.gov/study/NCT00389441,NCT00389441,Thyroid Neoplasms
656,0.998762853,184.2175943,https://clinicaltrials.gov/study/NCT00003941,NCT00003941,Mediastinal Cancer|Metastatic Cancer|Testicular Germ Cell Tumor
657,0.988760478,150.0940644,https://clinicaltrials.gov/study/NCT01715441,NCT01715441,Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
658,0.919408397,24.22013232,https://clinicaltrials.gov/study/NCT02158936,NCT02158936,Thrombocytopaenia
659,0.783777286,7.556587391,https://clinicaltrials.gov/study/NCT01229436,NCT01229436,Dupuytren's Contracture
660,0.988273278,150.2265567,https://clinicaltrials.gov/study/NCT00887536,NCT00887536,Breast Cancer
661,0.935986634,38.78611821,https://clinicaltrials.gov/study/NCT01129336,NCT01129336,First or Second Line HER2-negative Breast Cancer|Metastatic Disease Without Bone Metastasis
662,0.991473679,151.4431285,https://clinicaltrials.gov/study/NCT00866736,NCT00866736,Chronic Myeloid Leukemia
663,0.981143745,116.9606348,https://clinicaltrials.gov/study/NCT00591136,NCT00591136,Solid Tumors
664,0.998446841,174.7898222,https://clinicaltrials.gov/study/NCT00214136,NCT00214136,Prostate Cancer
665,0.998158997,166.5125986,https://clinicaltrials.gov/study/NCT00609336,NCT00609336,Adenocarcinoma of the Pancreas|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer
666,0.998950409,191.605419,https://clinicaltrials.gov/study/NCT00193336,NCT00193336,Lung Cancer
667,0.996734779,157.9996891,https://clinicaltrials.gov/study/NCT01689636,NCT01689636,Ovarian Cancer|Healthy Volunteers
668,0.993677682,153.1477522,https://clinicaltrials.gov/study/NCT01793636,NCT01793636,Metastatic Clear Cell Renal Carcinoma
669,0.749985885,6.103497198,https://clinicaltrials.gov/study/NCT01335828,NCT01335828,Thyroid Nodules
670,0.949940772,32.43152411,https://clinicaltrials.gov/study/NCT04797728,NCT04797728,Breast Cancer|Hormone Receptor Positive Breast Carcinoma
671,0.976856624,95.50783025,https://clinicaltrials.gov/study/NCT03972228,NCT03972228,Lung Tumor|Lung Cancer
672,0.969345241,57.43562655,https://clinicaltrials.gov/study/NCT00280241,NCT00280241,Chronic Lymphocytic Leukemia
673,0.880708829,13.37014411,https://clinicaltrials.gov/study/NCT03803241,NCT03803241,Colorectal Cancer
674,0.998635131,172.7952459,https://clinicaltrials.gov/study/NCT00785941,NCT00785941,Advanced Solid Tumors
675,0.99072856,151.3563533,https://clinicaltrials.gov/study/NCT00189241,NCT00189241,Basal Cell Carcinoma
676,0.885255531,17.56586058,https://clinicaltrials.gov/study/NCT00306241,NCT00306241,"Infections, Papillomavirus"
677,0.994522001,153.0518404,https://clinicaltrials.gov/study/NCT01663441,NCT01663441,Chemotherapy-induced Thrombocytopenia
678,0.991274274,151.5048876,https://clinicaltrials.gov/study/NCT04069936,NCT04069936,"Non Small Cell Lung Cancer|Lung Cancer|Lung Cancer Metastatic|Lung Cancer, Non-small Cell|Non Small Cell Lung Cancer Metastatic|NSCLC|Non-small Cell Lung Cancer|Non-small Cell Lung Cancer Metastatic"
679,0.938944552,28.8687394,https://clinicaltrials.gov/study/NCT03200236,NCT03200236,"Smoking, Tobacco|Tobacco-Related Carcinoma|Tobacco Use|Lung Cancer Screening"
680,0.615823507,3.421147067,https://clinicaltrials.gov/study/NCT00994136,NCT00994136,"Oncology, Medical|Hematologic Disease"
681,0.645815692,5.281034992,https://clinicaltrials.gov/study/NCT01783236,NCT01783236,Lung Tumor
682,0.97496125,59.33913968,https://clinicaltrials.gov/study/NCT00520936,NCT00520936,"Osteosarcoma|Medulloblastoma|Sarcoma, Ewing's|Neuroblastoma (Measurable Disease)|Neuroblastoma (Metaiodobenzylguanidine|Positive Evaluable)|Rhabdomyosarcoma|Ependymoma|Non-brainstem High-grade Glioma"
683,0.991278577,151.3568333,https://clinicaltrials.gov/study/NCT00558636,NCT00558636,"Carcinoma, Non-Small-Cell Lung"
684,0.99877472,176.8684988,https://clinicaltrials.gov/study/NCT03776136,NCT03776136,Advanced Melanoma
685,0.999511543,192.8650241,https://clinicaltrials.gov/study/NCT00045136,NCT00045136,Multiple Myeloma and Plasma Cell Neoplasm
686,0.983868698,95.50673915,https://clinicaltrials.gov/study/NCT01404936,NCT01404936,Lymphoma
687,0.998039532,168.3544988,https://clinicaltrials.gov/study/NCT01349036,NCT01349036,Recurrent Glioblastoma
688,0.996207064,156.2432544,https://clinicaltrials.gov/study/NCT01146834,NCT01146834,Multiple Myeloma
689,0.99538065,156.092959,https://clinicaltrials.gov/study/NCT00923234,NCT00923234,Myelodysplastic Syndromes|Acute Myelogenous Leukemia
690,0.999379228,190.6710169,https://clinicaltrials.gov/study/NCT00074334,NCT00074334,Brain and Central Nervous System Tumors
691,0.996299043,158.3527262,https://clinicaltrials.gov/study/NCT00390234,NCT00390234,Fallopian Tube Cancer|Female Reproductive Cancer|Ovarian Carcinosarcoma|Ovarian Sarcoma|Recurrent Ovarian Epithelial Cancer|Recurrent Uterine Sarcoma|Stage III Ovarian Epithelial Cancer|Stage III Uterine Sarcoma|Stage IV Ovarian Epithelial Cancer|Stage IV Uterine Sarcoma|Uterine Carcinosarcoma|Uterine Leiomyosarcoma
692,0.990454475,151.7236181,https://clinicaltrials.gov/study/NCT00758134,NCT00758134,NON-SMALL CELL LUNG CANCER
693,0.999349325,193.9519156,https://clinicaltrials.gov/study/NCT00003334,NCT00003334,Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Sarcoma
694,0.977463265,78.4549368,https://clinicaltrials.gov/study/NCT01709734,NCT01709734,Prostate Cancer
695,0.999568299,190.1099891,https://clinicaltrials.gov/study/NCT00021034,NCT00021034,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
696,0.997000282,159.0042342,https://clinicaltrials.gov/study/NCT00906334,NCT00906334,Myelodysplastic Syndrome
697,0.998160353,170.8022461,https://clinicaltrials.gov/study/NCT03618134,NCT03618134,Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC (American Joint Committee on Cancer) v8|Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Human Papillomavirus Positive|Oropharyngeal Squamous Cell Carcinoma|p16 Positive Neoplastic Cells Present|Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
698,0.984764278,105.9265644,https://clinicaltrials.gov/study/NCT00034034,NCT00034034,Colorectal Neoplasms
699,0.998299209,169.6238215,https://clinicaltrials.gov/study/NCT01345201,NCT01345201,Solid Tumors
700,0.997704078,162.1386006,https://clinicaltrials.gov/study/NCT00086801,NCT00086801,Lymphoma
701,0.999475447,189.1663053,https://clinicaltrials.gov/study/NCT00924001,NCT00924001,"Melanoma|Malignant Melanoma|Melanoma, Experimental"
702,0.999556686,182.8809406,https://clinicaltrials.gov/study/NCT02049801,NCT02049801,Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia
703,0.994518651,154.0535141,https://clinicaltrials.gov/study/NCT00570401,NCT00570401,Lung Cancer
704,0.994982917,154.4774387,https://clinicaltrials.gov/study/NCT00276601,NCT00276601,Leukemia
705,0.982800197,123.7394299,https://clinicaltrials.gov/study/NCT02296801,NCT02296801,Breast Cancer|Breast Carcinoma|Breast Tumors
706,0.994314455,153.9235906,https://clinicaltrials.gov/study/NCT01521936,NCT01521936,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Untreated Adult Acute Myeloid Leukemia
707,0.993178095,154.0370485,https://clinicaltrials.gov/study/NCT00395434,NCT00395434,Tumors
708,0.94793188,41.16867118,https://clinicaltrials.gov/study/NCT00984334,NCT00984334,Chronic Pain|Opioid Induced Constipation
709,0.974499355,87.65421757,https://clinicaltrials.gov/study/NCT04208334,NCT04208334,Cancer Cachexia|Head and Neck Cancer|Head and Neck Neoplasms
710,0.999294191,188.635341,https://clinicaltrials.gov/study/NCT04958434,NCT04958434,Locally Advanced or Metastatic Cancers|Metastatic Human Papillomavirus-Related Malignant Neoplasm
711,0.995158691,156.4613158,https://clinicaltrials.gov/study/NCT01496534,NCT01496534,Solid Tumors|Bladder Cancer
712,0.990544312,151.8472067,https://clinicaltrials.gov/study/NCT01783834,NCT01783834,Previous Treated Metastatic Non-small Cell Lung Cancer
713,0.999421315,184.5136248,https://clinicaltrials.gov/study/NCT02095834,NCT02095834,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
714,0.995466577,157.5957264,https://clinicaltrials.gov/study/NCT03748134,NCT03748134,Esophageal Squamous Cell Carcinoma
715,0.674821755,5.740132202,https://clinicaltrials.gov/study/NCT04255134,NCT04255134,Rheumatoid Arthritis
716,0.998564282,173.4712209,https://clinicaltrials.gov/study/NCT00005634,NCT00005634,"Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Prostate Cancer|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
717,0.997947393,165.3270013,https://clinicaltrials.gov/study/NCT00687934,NCT00687934,Solid Tumors
718,0.995122788,156.4308193,https://clinicaltrials.gov/study/NCT00750334,NCT00750334,Myelodysplastic Syndromes
719,0.995121662,156.5432944,https://clinicaltrials.gov/study/NCT00125034,NCT00125034,Neoplasm Metastasis|Colorectal Cancer
720,0.865714952,12.35189888,https://clinicaltrials.gov/study/NCT03430934,NCT03430934,Skin Cancer
721,0.816929623,8.792919656,https://clinicaltrials.gov/study/NCT03990701,NCT03990701,Primary Aldosteronism|Primary Aldosteronism Due to Aldosterone Producing Adenoma
722,0.99382224,153.1323526,https://clinicaltrials.gov/study/NCT00944801,NCT00944801,Glioblastoma
723,0.991331142,152.5809083,https://clinicaltrials.gov/study/NCT03209401,NCT03209401,"Solid Tumor, Adult|Homologous Recombination Deficiency"
724,0.997117608,161.3853704,https://clinicaltrials.gov/study/NCT02395601,NCT02395601,B-Cell Lymphoma
725,0.978756844,90.38580064,https://clinicaltrials.gov/study/NCT01152801,NCT01152801,Metastatic Renal Cell Carcinoma
726,0.96787104,63.25888193,https://clinicaltrials.gov/study/NCT02196701,NCT02196701,Psoriasis
727,0.983278996,104.109791,https://clinicaltrials.gov/study/NCT00609401,NCT00609401,Metastatic Disease|Renal Cell Carcinoma
728,0.996743123,157.2624868,https://clinicaltrials.gov/study/NCT00658801,NCT00658801,Pancreatic Cancer
729,0.997891594,166.6985021,https://clinicaltrials.gov/study/NCT00354601,NCT00354601,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
730,0.998777429,177.2300338,https://clinicaltrials.gov/study/NCT00825201,NCT00825201,"Ovarian Cancer|Peritoneal Cavity Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
731,0.995855665,155.5460418,https://clinicaltrials.gov/study/NCT02485834,NCT02485834,Adenocarcinoma of the Gastroesophageal Junction|Gastric Adenocarcinoma|Gastric Cancer
732,0.998676404,185.4205981,https://clinicaltrials.gov/study/NCT03572634,NCT03572634,Chronic Lymphocytic Leukemia|CLL|SLL|Small Lymphocytic Lymphoma
733,0.955291903,41.09347413,https://clinicaltrials.gov/study/NCT01506934,NCT01506934,Advanced or Metastatic Solid Tumors
734,0.987039097,137.029694,https://clinicaltrials.gov/study/NCT01523834,NCT01523834,Diffuse Large B-cell Lymphoma
735,0.99129207,151.3084463,https://clinicaltrials.gov/study/NCT00885534,NCT00885534,Melanoma|Skin Cancer
736,0.922089444,23.26646047,https://clinicaltrials.gov/study/NCT02453334,NCT02453334,Cancer and Chemotherapy Related Anemia
737,0.998272026,176.2259917,https://clinicaltrials.gov/study/NCT00004934,NCT00004934,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
738,0.959451949,39.22305413,https://clinicaltrials.gov/study/NCT01258634,NCT01258634,Osteosarcoma|Lung Metastases
739,0.920527195,26.74713901,https://clinicaltrials.gov/study/NCT01454934,NCT01454934,Non-Small Cell Lung Cancer (NSCLC)
740,0.532521323,2.931757955,https://clinicaltrials.gov/study/NCT04162834,NCT04162834,Kidney Cancer
741,0.998526543,173.5545197,https://clinicaltrials.gov/study/NCT04851834,NCT04851834,Advanced Solid Tumor|Platinum-Resistant Ovarian Cancer|Platinum-Resistant Urothelial Carcinoma|High-grade Glioma
742,0.998223145,166.9114389,https://clinicaltrials.gov/study/NCT00002534,NCT00002534,Leukemia
743,0.960008224,43.57525658,https://clinicaltrials.gov/study/NCT00216034,NCT00216034,Gastric Cancer
744,0.986787967,150.1555957,https://clinicaltrials.gov/study/NCT00721734,NCT00721734,Multiple Myeloma|Renal Insufficiency
745,0.953947936,45.13786067,https://clinicaltrials.gov/study/NCT02744534,NCT02744534,Prostatic Neoplasms
746,0.965584843,49.47596116,https://clinicaltrials.gov/study/NCT00576901,NCT00576901,Breast Cancer
747,0.989954675,150.6102938,https://clinicaltrials.gov/study/NCT03117101,NCT03117101,Advanced Solid Tumors
748,0.982686722,101.3265676,https://clinicaltrials.gov/study/NCT00030901,NCT00030901,Precancerous/Nonmalignant Condition|Prostate Cancer
749,0.98988925,150.1234478,https://clinicaltrials.gov/study/NCT00190528,NCT00190528,Cervical Neoplasms
750,0.999570211,185.0485518,https://clinicaltrials.gov/study/NCT01653028,NCT01653028,Myxofibrosarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Leiomyosarcoma|Recurrent Liposarcoma|Recurrent Malignant Peripheral Nerve Sheath Tumor|Recurrent Undifferentiated Pleomorphic Sarcoma|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7
751,0.957445618,52.34005634,https://clinicaltrials.gov/study/NCT00444041,NCT00444041,Metastatic Colorectal Cancer
752,0.993969803,153.6575147,https://clinicaltrials.gov/study/NCT00320541,NCT00320541,Breast Cancer
753,0.596197222,2.441254715,https://clinicaltrials.gov/study/NCT01909141,NCT01909141,Polycystic Ovary Syndrome|Infertility
754,0.997777795,171.6651088,https://clinicaltrials.gov/study/NCT01491841,NCT01491841,Non-Hodgkin's Lymphoma
755,0.995727283,156.3205666,https://clinicaltrials.gov/study/NCT00910741,NCT00910741,Locally Advanced and Metastatic Pancreatic Cancer
756,0.986802087,139.2533504,https://clinicaltrials.gov/study/NCT00436241,NCT00436241,Gastric Cancer
757,0.974864325,80.12295262,https://clinicaltrials.gov/study/NCT03690141,NCT03690141,Castrate-resistant Prostate Cancer (CRPC)
758,0.997643072,166.5716469,https://clinicaltrials.gov/study/NCT00068341,NCT00068341,Breast Cancer
759,0.982649453,91.72355603,https://clinicaltrials.gov/study/NCT00115141,NCT00115141,Warts
760,0.999068457,190.8172196,https://clinicaltrials.gov/study/NCT00329641,NCT00329641,"Ciliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Metastatic Intraocular Melanoma|Recurrent Intraocular Melanoma"
761,0.999304031,192.2455887,https://clinicaltrials.gov/study/NCT02020941,NCT02020941,Refractory Multiple Myeloma
762,0.946454755,31.57645304,https://clinicaltrials.gov/study/NCT02670941,NCT02670941,Chemotherapy Symptoms
763,0.996212966,157.3409188,https://clinicaltrials.gov/study/NCT00003041,NCT00003041,Breast Cancer
764,0.998337348,172.7492714,https://clinicaltrials.gov/study/NCT04256941,NCT04256941,Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8
765,0.997296704,160.3528024,https://clinicaltrials.gov/study/NCT00761241,NCT00761241,Pancreatic Cancer
766,0.964112857,57.8294433,https://clinicaltrials.gov/study/NCT02357836,NCT02357836,Non-small Cell Lung Cancer
767,0.991018546,151.1910948,https://clinicaltrials.gov/study/NCT05382936,NCT05382936,Advanced Solid Tumor
768,0.834125436,13.46248623,https://clinicaltrials.gov/study/NCT01198236,NCT01198236,Invasive Fungal Infection
769,0.980273058,122.3299877,https://clinicaltrials.gov/study/NCT00455936,NCT00455936,Lung Cancer
770,0.996531002,154.0216086,https://clinicaltrials.gov/study/NCT00085436,NCT00085436,Kidney Cancer
771,0.989677854,150.161832,https://clinicaltrials.gov/study/NCT04305236,NCT04305236,Breast Neoplasm|Hormone Receptor Positive Breast Carcinoma
772,0.992544002,153.8776392,https://clinicaltrials.gov/study/NCT00669136,NCT00669136,"Hepatocellular Carcinoma|Hepatoma|Liver Cancer, Adult|Liver Cell Carcinoma|Liver Cell Carcinoma, Adult|Cancer of Liver|Cancer of the Liver|Cancer, Hepatocellular|Hepatic Cancer|Hepatic Neoplasms|Hepatocellular Cancer|Liver Cancer|Neoplasms, Hepatic|Neoplasms, Liver"
773,0.999394989,195.1767915,https://clinicaltrials.gov/study/NCT02798536,NCT02798536,Mesothelioma
774,0.993364641,153.1945995,https://clinicaltrials.gov/study/NCT00936936,NCT00936936,Testicular Cancer
775,0.997866291,169.3727649,https://clinicaltrials.gov/study/NCT01120236,NCT01120236,Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer
776,0.992855722,152.3987827,https://clinicaltrials.gov/study/NCT01926236,NCT01926236,Biliary Tract Cancer|Gallbladder Cancer|Cholangiocarcinoma|Ampullary Cancer
777,0.995990658,155.0891593,https://clinicaltrials.gov/study/NCT01425736,NCT01425736,Head and Neck Squamous Cell Carcinoma
778,0.986894362,150.344696,https://clinicaltrials.gov/study/NCT02064036,NCT02064036,Adenocarcinoma of the Prostate
779,0.996919462,162.1953518,https://clinicaltrials.gov/study/NCT00770536,NCT00770536,Cancer|Carcinoma|Fallopian Tube Cancer|Gynecological Malignancies|Metastases|Oncology|Ovarian Cancer|Solid Tumors|Tumors
780,0.978616447,95.40811486,https://clinicaltrials.gov/study/NCT02101736,NCT02101736,NF1|Neurofibromatosis|Plexiform Neurofibromas
781,0.995034952,155.7196149,https://clinicaltrials.gov/study/NCT02236936,NCT02236936,Squamous Cell Carcinoma of the Hypopharynx Stage III|Squamous Cell Carcinoma of the Hypopharynx Stage IV|Laryngeal Squamous Cell Carcinoma Stage III|Laryngeal Squamous Cell Carcinoma Stage IV|Oropharyngeal Squamous Cell Carcinoma Stage III|Oropharyngeal Squamous Cell Carcinoma Stage IV|Squamous Cell Carcinoma of the Oral Cavity Stage III|Squamous Cell Carcinoma of the Oral Cavity Stage IV|Locally Advanced Malignant Neoplasm
782,0.942233403,32.69869677,https://clinicaltrials.gov/study/NCT00110136,NCT00110136,Breast Cancer|Hot Flashes
783,0.989110871,150.62986,https://clinicaltrials.gov/study/NCT01658436,NCT01658436,Pancreatic Neuroendocrine Tumors (pNET)
784,0.988485538,150.9164351,https://clinicaltrials.gov/study/NCT02105636,NCT02105636,Squamous Cell Carcinoma of the Head and Neck
785,0.997285018,164.1166834,https://clinicaltrials.gov/study/NCT02343536,NCT02343536,"Lymphoma, Large B-Cell, Diffuse|Lymphoma, Follicular"
786,0.984231222,146.4315983,https://clinicaltrials.gov/study/NCT04561336,NCT04561336,Metastatic Colorectal Cancer|RAS Wild Type
787,0.998562574,174.6470021,https://clinicaltrials.gov/study/NCT00026936,NCT00026936,Neoplasm
788,0.998994369,182.5148219,https://clinicaltrials.gov/study/NCT00602836,NCT00602836,Leukemia|Lymphoma
789,0.88027989,16.35191046,https://clinicaltrials.gov/study/NCT01853423,NCT01853423,Facial Angiofibroma
790,0.999225748,182.1543211,https://clinicaltrials.gov/study/NCT01247623,NCT01247623,Malignant Melanoma
791,0.997921788,163.1678231,https://clinicaltrials.gov/study/NCT01498328,NCT01498328,Glioblastoma|Small Cell Glioblastoma|Giant Cell Glioblastoma|Gliosarcoma|Glioblastoma With Oligodendroglial Component|Recurrent Glioblastoma|Relapsed Glioblastoma
792,0.994570408,153.7323982,https://clinicaltrials.gov/study/NCT01042028,NCT01042028,Pancreatic Cancer
793,0.989449851,151.4408656,https://clinicaltrials.gov/study/NCT00096941,NCT00096941,Solid Cancers
794,0.999645786,189.7894876,https://clinicaltrials.gov/study/NCT00003541,NCT00003541,Lymphoma
795,0.967303964,70.97342123,https://clinicaltrials.gov/study/NCT00532441,NCT00532441,Hepatocellular Carcinoma
796,0.999297395,185.4612908,https://clinicaltrials.gov/study/NCT00016341,NCT00016341,Endometrial Cancer
797,0.940778284,33.44114852,https://clinicaltrials.gov/study/NCT01360541,NCT01360541,Barrett Oesophagus|Low Grade Dysplasia
798,0.991406328,151.9358087,https://clinicaltrials.gov/study/NCT00790036,NCT00790036,Diffuse Large B-cell Lymphoma
799,0.999653365,192.2646719,https://clinicaltrials.gov/study/NCT01237236,NCT01237236,Advanced Solid Tumor|Lymphomas
800,0.969345831,74.88371573,https://clinicaltrials.gov/study/NCT00311636,NCT00311636,Breast Cancer
801,0.999831789,180.3066487,https://clinicaltrials.gov/study/NCT00010036,NCT00010036,Brain and Central Nervous System Tumors
802,0.990935543,151.7618732,https://clinicaltrials.gov/study/NCT00033436,NCT00033436,Bladder Cancer
803,0.963693713,44.66206466,https://clinicaltrials.gov/study/NCT03413436,NCT03413436,Esophageal Cancer
804,0.999196495,189.6458406,https://clinicaltrials.gov/study/NCT00031941,NCT00031941,"Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
805,0.986623411,150.2774431,https://clinicaltrials.gov/study/NCT00336141,NCT00336141,Colorectal Cancer
806,0.997923582,165.8027696,https://clinicaltrials.gov/study/NCT02482441,NCT02482441,Advanced Relapsed Tumors|Refractory Solid Tumors
807,0.99883256,172.3480093,https://clinicaltrials.gov/study/NCT00005641,NCT00005641,Chronic Myeloproliferative Disorders|Graft Versus Host Disease|Leukemia|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
808,0.953068847,44.22205003,https://clinicaltrials.gov/study/NCT01381341,NCT01381341,Advanced Solid Tumors
809,0.984167401,93.34878722,https://clinicaltrials.gov/study/NCT01117441,NCT01117441,Leukemia
810,0.985811591,150.0208312,https://clinicaltrials.gov/study/NCT00971841,NCT00971841,Esophageal Cancer
811,0.981396601,127.5628761,https://clinicaltrials.gov/study/NCT00619541,NCT00619541,Hepatocellular Carcinoma
812,0.999495304,184.6206575,https://clinicaltrials.gov/study/NCT04424641,NCT04424641,Locally Advanced or Metastatic Solid Tumor(s)|Prostate Cancer|Esophageal Cancer|Triple Negative Breast Cancer (TNBC)|Squamous Cell Carcinoma of Head and Neck (SCCHN)|Non-small Cell Lung Cancer (NSCLC)|Bladder Cancer|Uterine Cancer
813,0.998784907,175.5195886,https://clinicaltrials.gov/study/NCT00041041,NCT00041041,Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer
814,0.921294634,20.79829155,https://clinicaltrials.gov/study/NCT02470741,NCT02470741,Leiomyoma|Uterine Fibroids
815,0.9929585,152.5748268,https://clinicaltrials.gov/study/NCT03988036,NCT03988036,Breast Cancer
816,0.947148697,38.05821442,https://clinicaltrials.gov/study/NCT02074436,NCT02074436,Hematological Malignancies|Thrombocytopenia
817,0.875460455,14.39650636,https://clinicaltrials.gov/study/NCT01012336,NCT01012336,Chemotherapy-Induced Nausea and Vomiting|Ovarian Cancer
818,0.985977784,134.2490283,https://clinicaltrials.gov/study/NCT01759836,NCT01759836,Prostatic Neoplasms
819,0.933922963,26.87985341,https://clinicaltrials.gov/study/NCT00580736,NCT00580736,Port Wine Stain|Nevus of Ota|Tattoos|Scars|Acne|Hypertrichosis|Sebaceous Gland Diseases
820,0.999051598,187.7031481,https://clinicaltrials.gov/study/NCT00119236,NCT00119236,"Unspecified Adult Solid Tumor, Protocol Specific"
821,0.887321871,17.71074407,https://clinicaltrials.gov/study/NCT00140036,NCT00140036,Colorectal Neoplasms
822,0.994780131,154.1163134,https://clinicaltrials.gov/study/NCT00064636,NCT00064636,Advanced Non-Small Cell Lung Cancer|Other Solid Tumors
823,0.980263427,86.17496238,https://clinicaltrials.gov/study/NCT00563836,NCT00563836,Ovarian Cancer|Epithelial Ovarian Cancer
824,0.998169482,169.385931,https://clinicaltrials.gov/study/NCT00041236,NCT00041236,Sarcoma
825,0.912119014,20.9173267,https://clinicaltrials.gov/study/NCT01310036,NCT01310036,Non-Squamous Non-Small Cell Lung Cancer
826,0.962215159,55.70467017,https://clinicaltrials.gov/study/NCT01276236,NCT01276236,Kaposi's Sarcoma
827,0.992392722,152.0277191,https://clinicaltrials.gov/study/NCT01633541,NCT01633541,Laryngeal Cancer
828,0.972201307,65.85057941,https://clinicaltrials.gov/study/NCT00698841,NCT00698841,Advanced Cancer
829,0.5610789,4.135356802,https://clinicaltrials.gov/study/NCT00888641,NCT00888641,Kidney Neoplasm
830,0.999779424,196.6752677,https://clinicaltrials.gov/study/NCT00609141,NCT00609141,"Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Unspecified Childhood Solid Tumor, Protocol Specific"
831,0.98339264,143.6955037,https://clinicaltrials.gov/study/NCT00063141,NCT00063141,Colorectal Cancer
832,0.938764223,34.46827689,https://clinicaltrials.gov/study/NCT06184841,NCT06184841,Hepatic Arterial Infusion Chemotherapy|Liver Metastases|Esophageal Squamous Cell Carcinoma
833,0.887626704,18.55565134,https://clinicaltrials.gov/study/NCT02622841,NCT02622841,Neoplasm Metastasis
834,0.987461101,150.1668359,https://clinicaltrials.gov/study/NCT01161836,NCT01161836,Advanced Solid Tumors
835,0.98923504,150.7272581,https://clinicaltrials.gov/study/NCT02850536,NCT02850536,Liver Metastases
836,0.76695086,7.363830021,https://clinicaltrials.gov/study/NCT01468636,NCT01468636,Genital Warts|HPV
837,0.993413478,151.6667277,https://clinicaltrials.gov/study/NCT02243436,NCT02243436,CLASSICAL HODGKIN LYMPHOMA
838,0.999543661,188.3665481,https://clinicaltrials.gov/study/NCT04158141,NCT04158141,Pleural Biphasic Mesothelioma|Pleural Epithelioid Mesothelioma|Stage I Pleural Malignant Mesothelioma AJCC v8|Stage IA Pleural Malignant Mesothelioma AJCC v8|Stage IB Pleural Malignant Mesothelioma AJCC v8|Stage II Pleural Malignant Mesothelioma AJCC v8|Stage IIIA Pleural Malignant Mesothelioma AJCC v8
839,0.997492656,161.8212541,https://clinicaltrials.gov/study/NCT02262741,NCT02262741,Squamous Cell Carcinoma of the Head and Neck
840,0.995576035,155.826962,https://clinicaltrials.gov/study/NCT01993641,NCT01993641,Myelodysplastic Syndrome|MDS
841,0.993296677,153.1711006,https://clinicaltrials.gov/study/NCT02700841,NCT02700841,Plasma Cell Myeloma
842,0.998831299,191.792205,https://clinicaltrials.gov/study/NCT02379741,NCT02379741,Neoplasms|Solid Tumors
843,0.996833086,158.6614225,https://clinicaltrials.gov/study/NCT00001341,NCT00001341,Neoplasm
844,0.992074125,151.6547567,https://clinicaltrials.gov/study/NCT03980041,NCT03980041,Bladder Cancer|Urothelial Carcinoma|Solid Tumor|Advanced Cancer
845,0.998701092,183.9898284,https://clinicaltrials.gov/study/NCT00004141,NCT00004141,Melanoma (Skin)
846,0.700540648,4.514014252,https://clinicaltrials.gov/study/NCT00051441,NCT00051441,Stomatitis|Radiation Effects
847,0.995090062,153.767123,https://clinicaltrials.gov/study/NCT03083041,NCT03083041,"Carcinoma, Non-Small-Cell Lung"
848,0.564549142,4.421463727,https://clinicaltrials.gov/study/NCT00216541,NCT00216541,Anemia|Neoplasms
849,0.990214123,151.1901843,https://clinicaltrials.gov/study/NCT01506336,NCT01506336,Gastro Intestinal Stromal Tumor
850,0.999715164,188.806429,https://clinicaltrials.gov/study/NCT03422536,NCT03422536,Head and Neck Basaloid Carcinoma|Recurrent Head and Neck Squamous Cell Carcinoma|Recurrent Oropharyngeal Squamous Cell Carcinoma|Squamous Cell Carcinoma of Unknown Primary Origin|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma|Stage IV Oropharyngeal Squamous Cell Carcinoma|Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma|Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma|Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma|Stage IVA Oropharyngeal Squamous Cell Carcinoma|Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma|Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma|Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma|Stage IVB Oropharyngeal Squamous Cell Carcinoma|Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma|Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma|Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma|Stage IVC Oropharyngeal Squamous Cell Carcinoma|Head and Neck Cancer|Oropharyngeal Cancer|HNSCC|Stage IV Lip and Oral Cavity Squamous Cell Carcinoma
851,0.999070471,193.206801,https://clinicaltrials.gov/study/NCT04614636,NCT04614636,"Acute Myeloid Leukemia|AML, Adult|Multiple Myeloma|Myeloma"
852,0.99603433,157.4169003,https://clinicaltrials.gov/study/NCT01752036,NCT01752036,Solid Tumor Spine Metastases
853,0.991075771,151.311899,https://clinicaltrials.gov/study/NCT01727336,NCT01727336,Advanced Renal Cell Carcinoma
854,0.997537839,162.6860203,https://clinicaltrials.gov/study/NCT01485536,NCT01485536,Lymphoma
855,0.992455825,152.6995016,https://clinicaltrials.gov/study/NCT01222936,NCT01222936,Small Cell Lung Carcinoma
856,0.969020695,52.93347395,https://clinicaltrials.gov/study/NCT02667236,NCT02667236,Seborrheic Keratosis
857,0.995858574,157.9526459,https://clinicaltrials.gov/study/NCT01030536,NCT01030536,Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia
858,0.996665726,158.4597949,https://clinicaltrials.gov/study/NCT01248936,NCT01248936,Malignant Melanoma
859,0.984004458,95.83169459,https://clinicaltrials.gov/study/NCT00032136,NCT00032136,Breast Cancer
860,0.989126124,150.0137037,https://clinicaltrials.gov/study/NCT00987636,NCT00987636,Ewing's Sarcoma
861,0.999413562,188.4941588,https://clinicaltrials.gov/study/NCT00892736,NCT00892736,Basal-Like Breast Carcinoma|BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Breast Carcinoma|Estrogen Receptor Negative|HER2/Neu Negative|Hereditary Breast and Ovarian Cancer Syndrome|Ovarian Carcinoma|Pancreatic Carcinoma|Progesterone Receptor Negative|Prostate Carcinoma|Recurrent Breast Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Solid Neoplasm|Triple-Negative Breast Carcinoma
862,0.876215863,16.59401222,https://clinicaltrials.gov/study/NCT05053841,NCT05053841,Metformin|Breast Cancer
863,0.876642565,16.35444126,https://clinicaltrials.gov/study/NCT01092741,NCT01092741,Leukemia
864,0.889428206,14.22135991,https://clinicaltrials.gov/study/NCT00645541,NCT00645541,Breast Cancer
865,0.96553255,53.04789914,https://clinicaltrials.gov/study/NCT02680041,NCT02680041,Prostate Cancer
866,0.986071405,148.6521355,https://clinicaltrials.gov/study/NCT00145041,NCT00145041,Malignant Melanoma
867,0.984525768,119.7372704,https://clinicaltrials.gov/study/NCT01948141,NCT01948141,Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage III Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
868,0.992096511,152.0299324,https://clinicaltrials.gov/study/NCT04397341,NCT04397341,Locally Advanced Head and Neck Carcinoma
869,0.995437501,154.6825958,https://clinicaltrials.gov/study/NCT00906841,NCT00906841,B-cell Lymphoma
870,0.998860938,182.7688238,https://clinicaltrials.gov/study/NCT02404441,NCT02404441,Melanoma|Non-small Sell Lung Cancer (NSCLC)|Triple Negative Breast Cancer|Anaplastic Thyroid Cancer|Other Solid Tumors
871,0.993314073,153.3151189,https://clinicaltrials.gov/study/NCT00003336,NCT00003336,Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
872,0.995080503,153.9827707,https://clinicaltrials.gov/study/NCT00199836,NCT00199836,Cancer|Neoplasm
873,0.998658273,176.69181,https://clinicaltrials.gov/study/NCT00112736,NCT00112736,Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Pilocytic Astrocytoma|Adult Pineal Gland Astrocytoma|Adult Subependymal Giant Cell Astrocytoma|Recurrent Adult Brain Tumor
874,0.981332095,116.1707081,https://clinicaltrials.gov/study/NCT02521441,NCT02521441,Neutropenia
875,0.999551975,185.5216655,https://clinicaltrials.gov/study/NCT00006041,NCT00006041,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
876,0.973086901,81.41510893,https://clinicaltrials.gov/study/NCT01911741,NCT01911741,Healthy Subjects|Castration Resistant Prostate Cancer (CRPC)|Relative Bioavailability|MDV3100
877,0.95406975,41.60540239,https://clinicaltrials.gov/study/NCT00954941,NCT00954941,Hematologic Diseases|Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Chronic Myelogenous Leukemia
878,0.999645719,175.5006465,https://clinicaltrials.gov/study/NCT00288041,NCT00288041,"Ciliary Body and Choroid Melanoma, Medium/Large Size|Extraocular Extension Melanoma|Iris Melanoma|Recurrent Intraocular Melanoma|Recurrent Melanoma|Stage IV Melanoma"
879,0.994152779,154.6285634,https://clinicaltrials.gov/study/NCT00295841,NCT00295841,Leukemia
880,0.991826593,153.2016766,https://clinicaltrials.gov/study/NCT04236141,NCT04236141,"Diffuse, Large B-Cell, Lymphoma"
881,0.976142259,87.94583568,https://clinicaltrials.gov/study/NCT02565641,NCT02565641,Pancreatic Cancer
882,0.976203631,78.10450142,https://clinicaltrials.gov/study/NCT01658241,NCT01658241,Nodal Lymphoma|Lymphoma With Cutaneous Involvement|Lymphoma in Leukemic Phase|Marrow Involvement With Lymphoma|Multiple Myeloma
883,0.99429594,153.5181014,https://clinicaltrials.gov/study/NCT02109341,NCT02109341,Metastatic Pancreatic Cancer
884,0.988829979,150.727184,https://clinicaltrials.gov/study/NCT00636441,NCT00636441,Early-Stage Breast Cancer
885,0.997174676,160.7251632,https://clinicaltrials.gov/study/NCT01079741,NCT01079741,Melanoma
886,0.998899446,186.914503,https://clinicaltrials.gov/study/NCT00550836,NCT00550836,Pancreatic Cancer
887,0.997361413,160.5895641,https://clinicaltrials.gov/study/NCT00437736,NCT00437736,Cancer
888,0.990769327,152.9060999,https://clinicaltrials.gov/study/NCT00415636,NCT00415636,Cancer
889,0.99737377,163.8836699,https://clinicaltrials.gov/study/NCT00130936,NCT00130936,Gastric Cancer|Esophageal Cancer|Tumors
890,0.987574178,120.2093948,https://clinicaltrials.gov/study/NCT03989336,NCT03989336,Ovarian Cancer
891,0.988950899,150.1777966,https://clinicaltrials.gov/study/NCT04134936,NCT04134936,Diffuse Large B-cell Lymphoma
892,0.988466793,131.2600459,https://clinicaltrials.gov/study/NCT01272141,NCT01272141,Breast Neoplasms|Breast Cancer|Cancer of the Breast
893,0.984402975,150.0213433,https://clinicaltrials.gov/study/NCT00516841,NCT00516841,Ovarian Cancer|Peritoneal Neoplasms
894,0.994449396,153.8251553,https://clinicaltrials.gov/study/NCT00632541,NCT00632541,Metastatic Breast Cancer
895,0.997873014,168.2908834,https://clinicaltrials.gov/study/NCT00826241,NCT00826241,Brain Tumors|Spinal Cord Tumors
896,0.999240781,186.5192023,https://clinicaltrials.gov/study/NCT04418141,NCT04418141,Advanced Solid Tumor|B Cell Lymphoma
897,0.993303589,153.5763295,https://clinicaltrials.gov/study/NCT03913741,NCT03913741,Solid Tumor
898,0.991817748,152.2494326,https://clinicaltrials.gov/study/NCT00965341,NCT00965341,Advanced Cancer
899,0.994456489,154.9171153,https://clinicaltrials.gov/study/NCT00299741,NCT00299741,Prostate Cancer
900,0.985012803,117.4676304,https://clinicaltrials.gov/study/NCT00988741,NCT00988741,Unresectable Hepatocellular Carcinoma
901,0.980593363,102.8123196,https://clinicaltrials.gov/study/NCT00679341,NCT00679341,Breast Cancer
902,0.999024511,186.9653511,https://clinicaltrials.gov/study/NCT00624936,NCT00624936,Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
903,0.997154154,163.2100028,https://clinicaltrials.gov/study/NCT04015336,NCT04015336,Papillomavirus Infections|Oropharyngeal Neoplasms
904,0.996548259,160.8513527,https://clinicaltrials.gov/study/NCT00831636,NCT00831636,Ovarian Cancer
905,0.972185834,68.67708831,https://clinicaltrials.gov/study/NCT00446836,NCT00446836,Prostatic Neoplasms
906,0.992126314,153.0180317,https://clinicaltrials.gov/study/NCT02496741,NCT02496741,Glioma|Cholangiocarcinoma|Chondrosarcoma
907,0.790633181,8.282472396,https://clinicaltrials.gov/study/NCT02551341,NCT02551341,Prostate Cancer
908,0.974222586,65.80742932,https://clinicaltrials.gov/study/NCT00080041,NCT00080041,Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Lung Neoplasms
909,0.982200108,131.501499,https://clinicaltrials.gov/study/NCT01545141,NCT01545141,"Colorectal Cancer|Colorectal Carcinoma|Colorectal Tumors|Neoplasms, Colorectal"
910,0.993750993,153.0324845,https://clinicaltrials.gov/study/NCT02071641,NCT02071641,Metastatic Renal Cell Carcinoma
911,0.992041458,151.253663,https://clinicaltrials.gov/study/NCT01540136,NCT01540136,Nasopharyngeal Carcinoma
912,0.968057394,62.23438202,https://clinicaltrials.gov/study/NCT03262636,NCT03262636,"Brain Tumor, Primary|Brain Tumor, Recurrent"
913,0.996346692,157.3428937,https://clinicaltrials.gov/study/NCT01079936,NCT01079936,Myeloma|Stem Cell Transplantation
914,0.876172686,11.32533693,https://clinicaltrials.gov/study/NCT01091636,NCT01091636,Epithelial Ovarian Cancer
915,0.994234171,154.0692691,https://clinicaltrials.gov/study/NCT00004136,NCT00004136,Liver Cancer|Metastatic Cancer
916,0.999278084,189.491256,https://clinicaltrials.gov/study/NCT01018836,NCT01018836,"Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
917,0.982858258,98.23268547,https://clinicaltrials.gov/study/NCT00289341,NCT00289341,Prostate Cancer
918,0.999160675,186.4207063,https://clinicaltrials.gov/study/NCT00101036,NCT00101036,Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
919,0.961706221,57.20444417,https://clinicaltrials.gov/study/NCT04585841,NCT04585841,Lean Body Mass|Cannabis|Cancer|Nausea|Cachexia|Emesis|Appetitive Behavior
920,0.92330519,25.21739309,https://clinicaltrials.gov/study/NCT01516736,NCT01516736,Chemotherapy-induced Neutropenia|Breast Cancer
921,0.991768032,151.612793,https://clinicaltrials.gov/study/NCT00073736,NCT00073736,Hepatocellular Carcinoma
922,0.94092191,29.59420088,https://clinicaltrials.gov/study/NCT01441336,NCT01441336,Advanced Gastric Cancer|Laparoscopic Gastrectomy
923,0.996221129,159.0595571,https://clinicaltrials.gov/study/NCT00496236,NCT00496236,Head and Neck Cancer|Head and Neck Neoplasms
924,0.995312557,155.0047479,https://clinicaltrials.gov/study/NCT00394836,NCT00394836,"Lymphoma, Follicular"
925,0.998675941,180.5240754,https://clinicaltrials.gov/study/NCT00003436,NCT00003436,Leukemia|Myelodysplastic Syndromes
926,0.993707452,153.2704264,https://clinicaltrials.gov/study/NCT04099836,NCT04099836,Non Small Cell Lung Cancer
927,0.943067607,26.38792588,https://clinicaltrials.gov/study/NCT00254436,NCT00254436,Gastrointestinal Cancer|Rectal Cancer
928,0.999692867,185.7239465,https://clinicaltrials.gov/study/NCT03189836,NCT03189836,Lymphoma
929,0.898173528,18.19321779,https://clinicaltrials.gov/study/NCT00294736,NCT00294736,NSCLC
930,0.713066513,5.684864322,https://clinicaltrials.gov/study/NCT03252223,NCT03252223,Polycystic Ovary Syndrome|Healthy|Anovulation|Hyperandrogenism
931,0.984375517,133.4442458,https://clinicaltrials.gov/study/NCT01103323,NCT01103323,Metastatic Colorectal Cancer
932,0.95000626,49.29417991,https://clinicaltrials.gov/study/NCT01468623,NCT01468623,"Colorectal Cancer, Metastatic"
933,0.995644709,155.2480266,https://clinicaltrials.gov/study/NCT01048723,NCT01048723,Sarcoma
934,0.971168455,70.44208754,https://clinicaltrials.gov/study/NCT00303823,NCT00303823,Cervical Cancer|Cervical Intraepithelial Neoplasia Grade 1|Human Papilloma Virus Infection
935,0.993230532,153.2410868,https://clinicaltrials.gov/study/NCT01754623,NCT01754623,Pancreatic Cancer
936,0.891359241,17.7915714,https://clinicaltrials.gov/study/NCT02652923,NCT02652923,Breast Cancer
937,0.986866039,137.9182495,https://clinicaltrials.gov/study/NCT02274623,NCT02274623,"Breast Cancer|Prostate Cancer|Bone Neoplasms|Hypocalcemia|Hyperparathyroidism, Secondary"
938,0.992396495,151.7877069,https://clinicaltrials.gov/study/NCT02955823,NCT02955823,Diffuse Large B-cells Non-Hodgkin Lymphoma
939,0.994595936,153.8375003,https://clinicaltrials.gov/study/NCT00588523,NCT00588523,CNS Cancer|CNS BRAIN
940,0.996200746,157.2931336,https://clinicaltrials.gov/study/NCT02838823,NCT02838823,Breast Cancer
941,0.955486022,53.68212005,https://clinicaltrials.gov/study/NCT00385788,NCT00385788,Hodgkin's Disease
942,0.99328332,153.5018375,https://clinicaltrials.gov/study/NCT01897038,NCT01897038,"Carcinoma, Hepatocellular"
943,0.885924538,19.14872927,https://clinicaltrials.gov/study/NCT02953938,NCT02953938,Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
944,0.996468074,156.8160342,https://clinicaltrials.gov/study/NCT00390338,NCT00390338,Melanoma (Skin)
945,0.994024692,154.0542224,https://clinicaltrials.gov/study/NCT02927938,NCT02927938,Acute Myeloid Leukemia (AML)
946,0.995374046,156.5966816,https://clinicaltrials.gov/study/NCT02677038,NCT02677038,Metastatic Pancreatic Adenocarcinoma|Pancreatic Ductal Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v6 and v7
947,0.941739979,33.59817269,https://clinicaltrials.gov/study/NCT02140138,NCT02140138,Prostate Carcinoma
948,0.995676429,155.4507202,https://clinicaltrials.gov/study/NCT02237638,NCT02237638,Metastatic Cancer
949,0.984778283,147.6143461,https://clinicaltrials.gov/study/NCT00078572,NCT00078572,Breast Cancer
950,0.958102461,33.85164749,https://clinicaltrials.gov/study/NCT02159872,NCT02159872,Leukemia
951,0.999313784,188.0393893,https://clinicaltrials.gov/study/NCT00003172,NCT00003172,Gastric Cancer
952,0.980123283,125.9900035,https://clinicaltrials.gov/study/NCT02717572,NCT02717572,"Solid Tumor, Adult"
953,0.986582149,129.249019,https://clinicaltrials.gov/study/NCT00311272,NCT00311272,Colorectal Neoplasms
954,0.998786742,180.6553829,https://clinicaltrials.gov/study/NCT01213472,NCT01213472,Melanoma
955,0.995191102,156.9600326,https://clinicaltrials.gov/study/NCT01375972,NCT01375972,Metastatic Biliary Cancer
956,0.999539031,188.3089782,https://clinicaltrials.gov/study/NCT01781572,NCT01781572,Locally Advanced or Metastatic NRAS Mutant Melanoma
957,0.999054762,183.8024549,https://clinicaltrials.gov/study/NCT00003162,NCT00003162,Breast Cancer|Metastatic Cancer|Pain|Prostate Cancer
958,0.983990151,112.6146339,https://clinicaltrials.gov/study/NCT01256762,NCT01256762,Locally Recurrent or Metastatic Breast Cancer
959,0.998339824,171.0338029,https://clinicaltrials.gov/study/NCT00119262,NCT00119262,Male Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer
960,0.981989826,114.3003226,https://clinicaltrials.gov/study/NCT02303262,NCT02303262,Metastatic Leiomyosarcoma
961,0.998929072,183.5288304,https://clinicaltrials.gov/study/NCT00459862,NCT00459862,Advanced Malignant Mesothelioma|Localized Malignant Mesothelioma|Recurrent Malignant Mesothelioma
962,0.992931415,153.3707712,https://clinicaltrials.gov/study/NCT03599362,NCT03599362,Pancreatic Cancer
963,0.999448923,190.7237521,https://clinicaltrials.gov/study/NCT00054262,NCT00054262,Liver Cancer
964,0.999479553,190.1120969,https://clinicaltrials.gov/study/NCT04106362,NCT04106362,Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|KRAS Protein Variant|Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8|Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
965,0.978283176,78.14454461,https://clinicaltrials.gov/study/NCT00575562,NCT00575562,Colorectal Cancer
966,0.99832681,170.9557124,https://clinicaltrials.gov/study/NCT01646762,NCT01646762,Refractory Plasma Cell Myeloma
967,0.981984652,105.5961985,https://clinicaltrials.gov/study/NCT01295710,NCT01295710,GVHD|Adult Acute Myeloid Leukemia|Adult Acute Lymphoid Leukemia|Myelodysplastic Syndrome
968,0.983816954,135.6525972,https://clinicaltrials.gov/study/NCT01103310,NCT01103310,Diagnostic Imaging|Neoplasms
969,0.999478986,195.7399458,https://clinicaltrials.gov/study/NCT00290810,NCT00290810,B-cell Chronic Lymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia
970,0.984500195,119.1796706,https://clinicaltrials.gov/study/NCT01056510,NCT01056510,"Lymphocytic Leukemia, Chronic"
971,0.998741921,178.7091571,https://clinicaltrials.gov/study/NCT00098488,NCT00098488,B-cell Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Refractory Chronic Lymphocytic Leukemia
972,0.986573701,130.6943936,https://clinicaltrials.gov/study/NCT01498588,NCT01498588,"Breast Neoplasms|Breast Cancer|Breast Tumors|Cancer of the Breast|Neoplasms, Breast|Tumors, Breast"
973,0.98706461,135.9155998,https://clinicaltrials.gov/study/NCT00414388,NCT00414388,Prostate Cancer
974,0.985375594,145.8208483,https://clinicaltrials.gov/study/NCT00770588,NCT00770588,Non-small Cell Lung Cancer (NSCLC)
975,0.963287373,48.388188,https://clinicaltrials.gov/study/NCT03997188,NCT03997188,Breast Cancer Female|Dysphagia|Adjuvant Radiotherapy
976,0.996971046,161.0850055,https://clinicaltrials.gov/study/NCT00511238,NCT00511238,Multiple Myeloma
977,0.861631392,12.25843321,https://clinicaltrials.gov/study/NCT01976338,NCT01976338,Macular Edema Secondary to Branch Retinal Vein Occlusion
978,0.976509374,63.891827,https://clinicaltrials.gov/study/NCT04983238,NCT04983238,Metastatic Breast Cancer
979,0.992016271,151.1744571,https://clinicaltrials.gov/study/NCT04693338,NCT04693338,Anatomic Stage 0 Breast Cancer AJCC v8|Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8
980,0.998750601,175.4931627,https://clinicaltrials.gov/study/NCT04857138,NCT04857138,Solid Tumors
981,0.933103088,27.56841133,https://clinicaltrials.gov/study/NCT03679338,NCT03679338,Nonresectable Bile Duct Cancer
982,0.993255159,152.248806,https://clinicaltrials.gov/study/NCT03549338,NCT03549338,Metastatic Colorectal Cancer|Colorectal Cancer Metastatic|Carcinoma
983,0.999583221,192.0525007,https://clinicaltrials.gov/study/NCT01058538,NCT01058538,Advanced Solid Tumours
984,0.998519513,176.9131508,https://clinicaltrials.gov/study/NCT03291938,NCT03291938,Advanced Malignant Solid Neoplasm|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Negative|HER2/Neu Negative|Metastatic Malignant Solid Neoplasm|Pancreatic Ductal Adenocarcinoma|Progesterone Receptor Negative|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Lymphoma|Refractory Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Triple-Negative Breast Carcinoma|Unresectable Solid Neoplasm
985,0.99187108,152.5690353,https://clinicaltrials.gov/study/NCT01546038,NCT01546038,Acute Myeloid Leukemia
986,0.998742048,177.1406623,https://clinicaltrials.gov/study/NCT01940172,NCT01940172,Relapsed Epithelial Ovarian Cancer|Relapsed Primary Peritoneal Cancer|Relapsed Fallopian Tube Cancer
987,0.997113241,160.63575,https://clinicaltrials.gov/study/NCT02127372,NCT02127372,Non-small Cell Lung Cancer
988,0.98915626,151.1163707,https://clinicaltrials.gov/study/NCT02204072,NCT02204072,"Prostatic Neoplasms, Castration-Resistant"
989,0.996722017,161.5873845,https://clinicaltrials.gov/study/NCT00428272,NCT00428272,Ewing's Sarcoma|Osteosarcoma|Neuroblastoma|Rhabdomyosarcoma
990,0.996858594,156.8371944,https://clinicaltrials.gov/study/NCT02343172,NCT02343172,Liposarcoma
991,0.988609211,150.4176216,https://clinicaltrials.gov/study/NCT01466972,NCT01466972,Breast Cancer|Breast Neoplasm
992,0.986515231,150.0546565,https://clinicaltrials.gov/study/NCT00807872,NCT00807872,Primary Amyloidosis
993,0.670332042,5.937058152,https://clinicaltrials.gov/study/NCT01459172,NCT01459172,Breast Cancer
994,0.994449632,153.9249728,https://clinicaltrials.gov/study/NCT01305772,NCT01305772,Squamous Cell Carcinoma of the Head and Neck
995,0.9885931,150.328565,https://clinicaltrials.gov/study/NCT02529072,NCT02529072,Malignant Glioma|Astrocytoma|Glioblastoma
996,0.972269592,70.27987529,https://clinicaltrials.gov/study/NCT01680172,NCT01680172,Cancer|Depression|Anxiety
997,0.866093539,14.54219852,https://clinicaltrials.gov/study/NCT03900572,NCT03900572,HPV Infections
998,0.991269874,151.6368389,https://clinicaltrials.gov/study/NCT00198172,NCT00198172,Germ Cell Tumor
999,0.971118847,47.74291769,https://clinicaltrials.gov/study/NCT00001862,NCT00001862,Juvenile Rheumatoid Arthritis|Uveitis
1000,0.991268925,151.5067282,https://clinicaltrials.gov/study/NCT01482962,NCT01482962,Relapsed Peripheral T-Cell Lymphoma|Refractory Peripheral T-Cell Lymphoma
1001,0.994467214,155.1466265,https://clinicaltrials.gov/study/NCT01185262,NCT01185262,Chronic Lymphocytic Leukemia
1002,0.997579293,163.560801,https://clinicaltrials.gov/study/NCT00730262,NCT00730262,Glioblastoma Multiforme
1003,0.949413771,42.1569267,https://clinicaltrials.gov/study/NCT00072462,NCT00072462,Breast Cancer
1004,0.961291001,46.8831983,https://clinicaltrials.gov/study/NCT04249362,NCT04249362,Non-small Cell Lung Cancer
1005,0.993040791,153.7510674,https://clinicaltrials.gov/study/NCT00718562,NCT00718562,Gastrointestinal Stromal Tumors
1006,0.981192042,95.4394213,https://clinicaltrials.gov/study/NCT00043862,NCT00043862,"Lung Cancer, Small Cell|Small Cell Lung Cancer"
1007,0.999082569,188.8486597,https://clinicaltrials.gov/study/NCT00002862,NCT00002862,"Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific"
1008,0.997552536,164.2796385,https://clinicaltrials.gov/study/NCT04547062,NCT04547062,Acute Myeloid Leukemia (AML)
1009,0.979606223,103.3039003,https://clinicaltrials.gov/study/NCT05908838,NCT05908838,Gastric Cancer (Diagnosis)
1010,0.998804823,180.000077,https://clinicaltrials.gov/study/NCT01943838,NCT01943838,Neoplasm Malignant
1011,0.995140041,153.8964835,https://clinicaltrials.gov/study/NCT01211938,NCT01211938,Squamous Cell Carcinoma
1012,0.915341126,23.46225011,https://clinicaltrials.gov/study/NCT00347438,NCT00347438,Breast Cancer
1013,0.945754617,31.17811797,https://clinicaltrials.gov/study/NCT01500538,NCT01500538,Follicular Lymphoma|Marginal Zone Lymphoma|Mantle Cell Lymphoma
1014,0.997785274,164.0769913,https://clinicaltrials.gov/study/NCT03134638,NCT03134638,Advanced Solid Tumors|Ovarian Cancer|Breast Cancer
1015,0.99578498,156.6867076,https://clinicaltrials.gov/study/NCT00866138,NCT00866138,Multiple Myeloma
1016,0.987151891,150.1660957,https://clinicaltrials.gov/study/NCT00183872,NCT00183872,Gastric Cancer|Esophageal Neoplasms
1017,0.999143486,190.605078,https://clinicaltrials.gov/study/NCT01989572,NCT01989572,Iris Melanoma|Medium/Large Size Posterior Uveal Melanoma|Mucosal Melanoma|Ocular Melanoma With Extraocular Extension|Recurrent Melanoma|Recurrent Uveal Melanoma|Small Size Posterior Uveal Melanoma|Stage IIA Cutaneous Melanoma AJCC v6 and v7|Stage IIA Uveal Melanoma AJCC v7|Stage IIB Cutaneous Melanoma AJCC v6 and v7|Stage IIB Uveal Melanoma AJCC v7|Stage IIC Cutaneous Melanoma AJCC v6 and v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIA Uveal Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIB Uveal Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IIIC Uveal Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Uveal Melanoma AJCC v7
1018,0.983365731,111.8969468,https://clinicaltrials.gov/study/NCT00295672,NCT00295672,Lung Neoplasm
1019,0.998413561,171.9893412,https://clinicaltrials.gov/study/NCT00268372,NCT00268372,Head and Neck Cancer
1020,0.998287385,168.9198511,https://clinicaltrials.gov/study/NCT00004072,NCT00004072,Multiple Myeloma and Plasma Cell Neoplasm
1021,0.98747658,150.1882501,https://clinicaltrials.gov/study/NCT01901172,NCT01901172,Neoplasms
1022,0.981261215,113.3216612,https://clinicaltrials.gov/study/NCT02917772,NCT02917772,"Carcinoma, Renal Cell|Clear-cell Metastatic Renal Cell Carcinoma"
1023,0.904875483,20.28952903,https://clinicaltrials.gov/study/NCT02662972,NCT02662972,Trigeminal Neuralgia|Headache Disorders
1024,0.977708502,93.24336308,https://clinicaltrials.gov/study/NCT00828672,NCT00828672,Locally Advanced Rectal Cancer
1025,0.999583984,184.4726694,https://clinicaltrials.gov/study/NCT00039572,NCT00039572,Brain and Central Nervous System Tumors|Melanoma (Skin)|Metastatic Cancer
1026,0.997572625,163.9468673,https://clinicaltrials.gov/study/NCT00949962,NCT00949962,Prostate Cancer
1027,0.534331505,3.710748781,https://clinicaltrials.gov/study/NCT02040662,NCT02040662,Lung Cancer
1028,0.964976479,52.79046255,https://clinicaltrials.gov/study/NCT05592262,NCT05592262,Malignant Tumor
1029,0.998610725,173.2652151,https://clinicaltrials.gov/study/NCT01693562,NCT01693562,Advanced Solid Tumors
1030,0.971416522,86.67847527,https://clinicaltrials.gov/study/NCT02279862,NCT02279862,Prostate Cancer
1031,0.984569797,112.7920031,https://clinicaltrials.gov/study/NCT02442362,NCT02442362,Gastric Cancer
1032,0.995543415,154.8355551,https://clinicaltrials.gov/study/NCT00062062,NCT00062062,Lung Cancer
1033,0.996174668,157.0486942,https://clinicaltrials.gov/study/NCT05354362,NCT05354362,Relapsed/Refractory Diffuse Large B-cell Lymphoma
1034,0.998469357,171.9867094,https://clinicaltrials.gov/study/NCT02365662,NCT02365662,Head and Neck Squamous Cell Carcinoma|Non-small Cell Lung Cancer|Triple Negative Breast Cancer|Colorectal Carcinoma|Glioblastoma Multiforme
1035,0.995593551,157.7620043,https://clinicaltrials.gov/study/NCT01692262,NCT01692262,"Metastatic Castrate-Resistant Prostate Cancer (mCRPC),|Efficacy,|Safety and Tolerability,|Pharmacokinetics,|Pharmacodynamics,|Tumour Response."
1036,0.995827581,157.5538474,https://clinicaltrials.gov/study/NCT02285062,NCT02285062,"Lymphoma, Large B-Cell, Diffuse"
1037,0.963736187,51.61655574,https://clinicaltrials.gov/study/NCT03106662,NCT03106662,Hematopoietic Stem Cell Transplantation
1038,0.993040562,151.9258405,https://clinicaltrials.gov/study/NCT02200562,NCT02200562,Stage III or IV Melanoma
1039,0.993042806,153.0927545,https://clinicaltrials.gov/study/NCT01677988,NCT01677988,Adenocarcinoma of Head of Pancreas
1040,0.924369156,24.3400654,https://clinicaltrials.gov/study/NCT01616238,NCT01616238,Acute Lymphoblastic Leukaemia
1041,0.992345437,151.8312089,https://clinicaltrials.gov/study/NCT01751438,NCT01751438,Prostate Cancer
1042,0.997523209,164.590735,https://clinicaltrials.gov/study/NCT00597038,NCT00597038,Metastatic Melanoma
1043,0.996401543,156.9118103,https://clinicaltrials.gov/study/NCT03138538,NCT03138538,Advanced Solid Tumors|Metastatic Renal Cell Carcinoma
1044,0.885218323,19.0948795,https://clinicaltrials.gov/study/NCT03176238,NCT03176238,Post Menopausal Breast Cancer
1045,0.994591051,154.889819,https://clinicaltrials.gov/study/NCT02560038,NCT02560038,Urinary Bladder Neoplasms
1046,0.99978652,179.7707359,https://clinicaltrials.gov/study/NCT00002572,NCT00002572,Brain and Central Nervous System Tumors
1047,0.998250545,170.7398349,https://clinicaltrials.gov/study/NCT00002772,NCT00002772,Breast Cancer
1048,0.977884171,91.4986752,https://clinicaltrials.gov/study/NCT05520372,NCT05520372,Patients With Cancer
1049,0.994286518,154.2069259,https://clinicaltrials.gov/study/NCT02270372,NCT02270372,Advanced Breast Carcinoma|Advanced Ovarian Carcinoma
1050,0.989686239,151.0749856,https://clinicaltrials.gov/study/NCT03093272,NCT03093272,Prostate Cancer
1051,0.998252031,165.5692966,https://clinicaltrials.gov/study/NCT03579472,NCT03579472,Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8
1052,0.8922633,18.73160308,https://clinicaltrials.gov/study/NCT00148772,NCT00148772,Prostate Cancer
1053,0.995547546,156.2527769,https://clinicaltrials.gov/study/NCT00555672,NCT00555672,Stomach Neoplasms
1054,0.995320369,156.6783928,https://clinicaltrials.gov/study/NCT00005872,NCT00005872,Lung Cancer
1055,0.873684175,14.50883506,https://clinicaltrials.gov/study/NCT01512472,NCT01512472,Prostate Cancer Recurrent
1056,0.906357684,20.50240392,https://clinicaltrials.gov/study/NCT01695772,NCT01695772,Colorectal Cancer
1057,0.97730088,93.74407887,https://clinicaltrials.gov/study/NCT02178072,NCT02178072,Head and Neck Squamous Cell Carcinoma
1058,0.989152616,150.8695465,https://clinicaltrials.gov/study/NCT00929162,NCT00929162,Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
1059,0.9994322,181.6381095,https://clinicaltrials.gov/study/NCT00003362,NCT00003362,Melanoma (Skin)
1060,0.994804589,153.6979932,https://clinicaltrials.gov/study/NCT00585962,NCT00585962,Prostate Cancer
1061,0.999683545,187.5923119,https://clinicaltrials.gov/study/NCT00003862,NCT00003862,Gastric Cancer
1062,0.994081741,152.5989244,https://clinicaltrials.gov/study/NCT01251562,NCT01251562,Solid Tumors
1063,0.950147694,36.969553,https://clinicaltrials.gov/study/NCT03477162,NCT03477162,Thoracic Neoplasm
1064,0.949680397,37.59564314,https://clinicaltrials.gov/study/NCT00511862,NCT00511862,"Colorectal Cancer|Carcinoma, Neuroendocrine|Neoplasm Metastasis"
1065,0.992835734,153.3628016,https://clinicaltrials.gov/study/NCT01416662,NCT01416662,Pancreatic Cancer
1066,0.989240576,150.1915144,https://clinicaltrials.gov/study/NCT03187262,NCT03187262,Waldenstrm Macroglobulinemia
1067,0.997431401,162.1957482,https://clinicaltrials.gov/study/NCT00002662,NCT00002662,Breast Cancer
1068,0.998385026,172.4305932,https://clinicaltrials.gov/study/NCT00544362,NCT00544362,Esophageal Cancer
1069,0.978075094,86.66954955,https://clinicaltrials.gov/study/NCT01325688,NCT01325688,Superficial Basal Cell Carcinoma
1070,0.993397035,153.9435594,https://clinicaltrials.gov/study/NCT02071888,NCT02071888,"Non-Hodgkin's Lymphoma (NHL)|Multiple Myeloma|Waldenstrom's Macroglobulinemia (WM)|Other B-cell NHL Subtypes, Including WM|T-cell NHL"
1071,0.983381396,122.303042,https://clinicaltrials.gov/study/NCT00519688,NCT00519688,Hepatocellular Carcinoma
1072,0.992586739,152.3936023,https://clinicaltrials.gov/study/NCT00617188,NCT00617188,Ovarian Cancer
1073,0.9919222,153.1260477,https://clinicaltrials.gov/study/NCT01297088,NCT01297088,Diagnostic Imaging
1074,0.981646416,120.7051837,https://clinicaltrials.gov/study/NCT01351038,NCT01351038,KRAS Wild Type|Resectable Type II Gastric Adenocarcinoma
1075,0.997319776,160.2655102,https://clinicaltrials.gov/study/NCT02732938,NCT02732938,Metastatic Pancreatic Ductal Adenocarcinoma
1076,0.996730436,159.1698329,https://clinicaltrials.gov/study/NCT00827138,NCT00827138,Chronic Myeloid Leukemia
1077,0.998317875,172.3355919,https://clinicaltrials.gov/study/NCT00087438,NCT00087438,Lung Cancer
1078,0.992847844,152.3785843,https://clinicaltrials.gov/study/NCT01538238,NCT01538238,Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
1079,0.996263613,157.6037628,https://clinicaltrials.gov/study/NCT01139138,NCT01139138,"Colorectal Cancer|Colorectal Carcinoma|Colorectal Tumors|Neoplasms, Colorectal"
1080,0.999486865,191.1895123,https://clinicaltrials.gov/study/NCT00005838,NCT00005838,Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer
1081,0.999245251,187.241366,https://clinicaltrials.gov/study/NCT00794638,NCT00794638,Non-Hodgkin's Lymphoma|Diffuse Large B-Cell Lymphoma|Mantle Cell Lymphoma|Follicular Lymphoma
1082,0.99879915,176.4235065,https://clinicaltrials.gov/study/NCT03490838,NCT03490838,Prostatic Neoplasm
1083,0.998807761,173.2569706,https://clinicaltrials.gov/study/NCT00301938,NCT00301938,Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Acute Promyelocytic Leukemia (M3)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Blastic Phase Chronic Myelogenous Leukemia|Myelodysplastic/Myeloproliferative Neoplasms|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|T-cell Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia
1084,0.999426818,185.084112,https://clinicaltrials.gov/study/NCT00091338,NCT00091338,Melanoma (Skin)
1085,0.984405484,133.6311767,https://clinicaltrials.gov/study/NCT02873338,NCT02873338,Acute Myeloid Leukemia
1086,0.999418618,193.2765132,https://clinicaltrials.gov/study/NCT00066638,NCT00066638,DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
1087,0.970495775,72.26816501,https://clinicaltrials.gov/study/NCT01286038,NCT01286038,Myelodysplastic Syndrome (MDS)|Thrombocytopenia
1088,0.756199481,7.111947752,https://clinicaltrials.gov/study/NCT00247338,NCT00247338,Gastrointestinal Neoplasms|Postoperative Complications
1089,0.983230594,121.6499653,https://clinicaltrials.gov/study/NCT00659438,NCT00659438,Prostate Cancer
1090,0.974045642,75.84932781,https://clinicaltrials.gov/study/NCT00595972,NCT00595972,Gastric Cancer
1091,0.896986853,17.76982191,https://clinicaltrials.gov/study/NCT01908972,NCT01908972,Hemangioma
1092,0.972202322,69.40886143,https://clinicaltrials.gov/study/NCT00455572,NCT00455572,"Lung Cancer, Non-Small Cell"
1093,0.991182779,151.424412,https://clinicaltrials.gov/study/NCT03977272,NCT03977272,Pancreatic Cancer
1094,0.93694366,30.12201693,https://clinicaltrials.gov/study/NCT00364572,NCT00364572,Sciatica
1095,0.999783608,189.9406423,https://clinicaltrials.gov/study/NCT00101972,NCT00101972,Cancer
1096,0.995783101,155.3783234,https://clinicaltrials.gov/study/NCT05074472,NCT05074472,"Solid Tumor, Adult|Pancreatic Ductal; Adenocarcinoma|Ovarian Serous Adenocarcinoma|Biliary Cancer Metastatic|Ovarian Serous Cystadenocarcinoma"
1097,0.990907634,151.8711809,https://clinicaltrials.gov/study/NCT02197572,NCT02197572,Advanced Solid Tumors
1098,0.996900528,160.6246816,https://clinicaltrials.gov/study/NCT00302172,NCT00302172,Cancer|Tumor
1099,0.982110932,109.2993418,https://clinicaltrials.gov/study/NCT02999672,NCT02999672,Bladder Cancer|Pancreas Cancer|Cholangiocellular Carcinoma
1100,0.996252451,155.9714911,https://clinicaltrials.gov/study/NCT00722072,NCT00722072,Breast Cancer
1101,0.915143386,22.78404675,https://clinicaltrials.gov/study/NCT01641172,NCT01641172,Testicular Cancer
1102,0.975175951,107.161567,https://clinicaltrials.gov/study/NCT02795572,NCT02795572,Peripheral Neuropathy in Breast Cancer Patient
1103,0.952953563,44.5148695,https://clinicaltrials.gov/study/NCT01205672,NCT01205672,Endometrial Cancer
1104,0.999842728,183.205776,https://clinicaltrials.gov/study/NCT01604772,NCT01604772,Recurrent Oral Cavity Adenoid Cystic Carcinoma|Recurrent Salivary Gland Carcinoma|Salivary Gland Adenoid Cystic Carcinoma|Stage IVA Major Salivary Gland Cancer AJCC v7|Stage IVA Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7|Stage IVB Major Salivary Gland Cancer AJCC v7|Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7|Stage IVC Major Salivary Gland Cancer AJCC v7|Stage IVC Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7
1105,0.999123716,186.14714,https://clinicaltrials.gov/study/NCT05191472,NCT05191472,"Multiple Myeloma|Multiple Myeloma in Relapse|Multiple Myeloma, Refractory|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma"
1106,0.999115995,184.6499328,https://clinicaltrials.gov/study/NCT00027872,NCT00027872,"Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Erythroid Leukemia (M6)|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Cellular Diagnosis, Adult Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia"
1107,0.999102781,184.2182944,https://clinicaltrials.gov/study/NCT00979862,NCT00979862,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm
1108,0.993316223,153.6219607,https://clinicaltrials.gov/study/NCT03585062,NCT03585062,Pancreatic Cancer|Neoadjuvant Chemotherapy
1109,0.880354479,17.59995207,https://clinicaltrials.gov/study/NCT03543462,NCT03543462,Ovarian Cancer
1110,0.991677005,151.3707111,https://clinicaltrials.gov/study/NCT02359162,NCT02359162,"Lymphoma, Extranodal NK-T-Cell"
1111,0.99703258,160.8840531,https://clinicaltrials.gov/study/NCT00055562,NCT00055562,Melanoma|Neoplasm Metastasis
1112,0.999605967,188.9735007,https://clinicaltrials.gov/study/NCT00004262,NCT00004262,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma
1113,0.995823577,157.9165736,https://clinicaltrials.gov/study/NCT01987362,NCT01987362,"Solid Tumors, Advanced Solid Tumors"
1114,0.990712865,151.4191476,https://clinicaltrials.gov/study/NCT00006462,NCT00006462,Leukemia
1115,0.998162854,167.8438344,https://clinicaltrials.gov/study/NCT00509288,NCT00509288,Melanoma|Skin Cancer
1116,0.979409702,96.3979737,https://clinicaltrials.gov/study/NCT00002188,NCT00002188,"Sarcoma, Kaposi|HIV Infections"
1117,0.998969526,186.1533623,https://clinicaltrials.gov/study/NCT00041288,NCT00041288,Leukemia|Lymphoma
1118,0.998991205,174.353635,https://clinicaltrials.gov/study/NCT00082888,NCT00082888,Anaplastic Large Cell Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Nodal Marginal Zone Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma
1119,0.994559001,153.7715699,https://clinicaltrials.gov/study/NCT01042288,NCT01042288,Non-Small-Cell Lung Cancer
1120,0.993342854,151.9800587,https://clinicaltrials.gov/study/NCT00440388,NCT00440388,Follicular Lymphoma
1121,0.993577454,153.5716696,https://clinicaltrials.gov/study/NCT03374488,NCT03374488,UC (Urothelial Cancer)
1122,0.989149729,150.0564332,https://clinicaltrials.gov/study/NCT01207388,NCT01207388,B-cell Acute Lymphoblastic Leukemia
1123,0.997629898,166.1733766,https://clinicaltrials.gov/study/NCT00361088,NCT00361088,Multiple Myeloma
1124,0.995189143,155.6816903,https://clinicaltrials.gov/study/NCT00060138,NCT00060138,Breast Cancer|Hypercalcemia of Malignancy|Metastatic Cancer|Pain
1125,0.999385213,188.3179609,https://clinicaltrials.gov/study/NCT00703638,NCT00703638,Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Mesothelioma|Pancreatic Cancer|Prostate Cancer|Sarcoma
1126,0.998866798,179.2618901,https://clinicaltrials.gov/study/NCT00785538,NCT00785538,Advanced Solid Tumors
1127,0.998345355,167.2720626,https://clinicaltrials.gov/study/NCT00003638,NCT00003638,Breast Cancer
1128,0.918951949,28.93125897,https://clinicaltrials.gov/study/NCT03618238,NCT03618238,"Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type"
1129,0.97288002,75.35725317,https://clinicaltrials.gov/study/NCT00272038,NCT00272038,Prostate Cancer
1130,0.997130089,159.4397325,https://clinicaltrials.gov/study/NCT01488838,NCT01488838,Malignant Salivary Gland Tumors
1131,0.998340906,172.0985236,https://clinicaltrials.gov/study/NCT00673738,NCT00673738,Lung Cancer
1132,0.996947455,158.4031256,https://clinicaltrials.gov/study/NCT01352338,NCT01352338,Multiple Myeloma
1133,0.998681739,178.4225227,https://clinicaltrials.gov/study/NCT00040638,NCT00040638,"Carcinoma, Non-small-cell Lung"
1134,0.958199835,53.03984358,https://clinicaltrials.gov/study/NCT01010672,NCT01010672,Sarcoma
1135,0.992028103,152.6467045,https://clinicaltrials.gov/study/NCT00126672,NCT00126672,Nonmalignant Neoplasm|Tuberous Sclerosis|Lymphangioleimyomatosis|Kidney Angiomyolipoma
1136,0.998066445,167.844935,https://clinicaltrials.gov/study/NCT02909972,NCT02909972,Acute Myeloid Leukemia|Myelodysplastic Syndromes
1137,0.98964814,100.8272928,https://clinicaltrials.gov/study/NCT04427072,NCT04427072,"Carcinoma, Non-Small-Cell Lung"
1138,0.997644124,166.1635874,https://clinicaltrials.gov/study/NCT00436072,NCT00436072,Colorectal Cancer
1139,0.592077341,3.988346164,https://clinicaltrials.gov/study/NCT00324272,NCT00324272,"Malignant Melanoma|Carcinoma, Squamous Cell"
1140,0.65441401,4.74850473,https://clinicaltrials.gov/study/NCT02037672,NCT02037672,PCOS|Obesity
1141,0.987394129,150.1210339,https://clinicaltrials.gov/study/NCT00783172,NCT00783172,Pancreatic Cancer
1142,0.998349831,171.31604,https://clinicaltrials.gov/study/NCT00963872,NCT00963872,Leukemia|Lymphoma|Multiple Myeloma|Myelodysplastic Syndromes
1143,0.991361935,151.4637654,https://clinicaltrials.gov/study/NCT00650572,NCT00650572,Cancer
1144,0.986419655,120.7171692,https://clinicaltrials.gov/study/NCT00064272,NCT00064272,"Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific"
1145,0.988945834,150.8676501,https://clinicaltrials.gov/study/NCT01721772,NCT01721772,Melanoma
1146,0.998777229,175.7151192,https://clinicaltrials.gov/study/NCT02547662,NCT02547662,Plasma Cell Leukemia|Plasma Cell Myeloma|Plasmacytoma
1147,0.990800036,151.5219608,https://clinicaltrials.gov/study/NCT03146962,NCT03146962,Colorectal Cancer|Pancreatic Cancer|Lung Cancer
1148,0.925993685,26.93607875,https://clinicaltrials.gov/study/NCT00355862,NCT00355862,Hepatocellular Carcinoma
1149,0.984751618,123.3914655,https://clinicaltrials.gov/study/NCT00275262,NCT00275262,"Hodgkin Disease|Lymphoma, Non-Hodgkin|Multiple Myeloma|Mantle Cell Lymphoma"
1150,0.998776539,179.1411411,https://clinicaltrials.gov/study/NCT00744562,NCT00744562,Solid Tumors
1151,0.997203184,157.8145406,https://clinicaltrials.gov/study/NCT00006262,NCT00006262,Ovarian Cancer
1152,0.987392308,149.9440843,https://clinicaltrials.gov/study/NCT01273662,NCT01273662,Hepatocellular Carcinoma
1153,0.994156203,153.682637,https://clinicaltrials.gov/study/NCT00895362,NCT00895362,Advanced Cancers
1154,0.998649996,180.4854928,https://clinicaltrials.gov/study/NCT03517488,NCT03517488,Melanoma|Breast Carcinoma|Hepatocellular Carcinoma|Urothelial Carcinoma|Squamous Cell Carcinoma of the Head and Neck|Renal Cell Carcinoma|Colorectal Carcinoma|Non-small Cell Lung Carcinoma|Gastric or Gastroesophageal Junction Adenocarcinoma|Endometrial Carcinoma|Mesothelioma|Neuroendocrine Carcinoma|Cervical Cancer|Small Cell Lung Carcinoma|Squamous Cell Carcinoma of the Anus|Castration-Resistant Prostate Carcinoma|Nasopharyngeal Carcinoma|Cholangiocarcinoma|Basal Cell Carcinoma|Ovarian Carcinoma|Fallopian Tube Carcinoma|Thymoma|Thymic Carcinoma|Squamous Cell Carcinoma of the Penis|Vulvar Carcinoma|Solid Tumors With Published Evidence of Anti-tumor Activity With Anti-PD1/PDL1 and/or Anti-CTLA4-directed Therapy|Malignant Adnexal Neoplasms|Non-squamous Cell Salivary Gland Carcinoma
1155,0.993117241,153.2396776,https://clinicaltrials.gov/study/NCT00814788,NCT00814788,Prostate Cancer
1156,0.973513781,83.56325851,https://clinicaltrials.gov/study/NCT01429038,NCT01429038,Liver Failure|Kidney Failure
1157,0.998023504,169.0606488,https://clinicaltrials.gov/study/NCT01041638,NCT01041638,High Risk Neuroblastoma
1158,0.996665072,157.5464089,https://clinicaltrials.gov/study/NCT00036738,NCT00036738,"Adult Acute Lymphoblastic Leukemia in Remission|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Blastic Phase|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase of Disease|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Disease"
1159,0.993536145,152.3382083,https://clinicaltrials.gov/study/NCT00589238,NCT00589238,Breast Cancer
1160,0.956150512,41.93682492,https://clinicaltrials.gov/study/NCT01072838,NCT01072838,Breast Cancer
1161,0.837084821,13.39969375,https://clinicaltrials.gov/study/NCT03031938,NCT03031938,Osteoarthritis|Cancer Pain|Recurrent Low Back Pain
1162,0.978542215,73.63514596,https://clinicaltrials.gov/study/NCT03564938,NCT03564938,Metastatic Colorectal Cancer
1163,0.998010261,165.7255585,https://clinicaltrials.gov/study/NCT00450138,NCT00450138,Head and Neck Cancer
1164,0.984747925,120.1749958,https://clinicaltrials.gov/study/NCT00932438,NCT00932438,Colon Cancer With Metastases to the Liver
1165,0.999009746,177.4682311,https://clinicaltrials.gov/study/NCT02773238,NCT02773238,Stage IIB Lung Non-Small Cell Carcinoma AJCC v7|Stage IIIA Lung Non-Small Cell Cancer AJCC v7|Stage IIIB Lung Non-Small Cell Cancer AJCC v7
1166,0.919737405,26.04362222,https://clinicaltrials.gov/study/NCT02236572,NCT02236572,Breast Cancer
1167,0.852472051,13.58648611,https://clinicaltrials.gov/study/NCT00936572,NCT00936572,Colorectal Cancer
1168,0.996400346,159.4896859,https://clinicaltrials.gov/study/NCT04169672,NCT04169672,Advanced Solid Tumors
1169,0.86367759,14.8131734,https://clinicaltrials.gov/study/NCT00454272,NCT00454272,Infection|Febrile Neutropenia
1170,0.997939344,165.8406007,https://clinicaltrials.gov/study/NCT02255162,NCT02255162,Acute Myeloid Leukemia (AML)|Acute Myelocytic Leukemia|Acute Myelogenous Leukemia|Acute Granulocytic Leukemia|Acute Non-Lymphocytic Leukemia
1171,0.886574722,20.59861948,https://clinicaltrials.gov/study/NCT00147862,NCT00147862,Head and Neck Neoplasms
1172,0.98859805,150.1652085,https://clinicaltrials.gov/study/NCT01336062,NCT01336062,Gastric Adenocarcinoma
1173,0.990285512,151.3201372,https://clinicaltrials.gov/study/NCT01572662,NCT01572662,Leukemia|Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Lymphocytic Leukemia|Myeloproliferative Diseases|Non-Hodgkins Lymphoma|Hodgkins Lymphoma|Multiple Myeloma|Myelodysplastic Syndrome
1174,0.96961751,70.26125009,https://clinicaltrials.gov/study/NCT00669162,NCT00669162,Prostate Cancer
1175,0.968068171,61.63525924,https://clinicaltrials.gov/study/NCT00561262,NCT00561262,Prostate Cancer
1176,0.849126447,9.007395755,https://clinicaltrials.gov/study/NCT02970162,NCT02970162,Lambert-Eaton Myasthenic Syndrome
1177,0.963291516,52.82369398,https://clinicaltrials.gov/study/NCT00381862,NCT00381862,Colorectal Cancer|Nausea and Vomiting
1178,0.997737409,166.5415961,https://clinicaltrials.gov/study/NCT00032162,NCT00032162,Cervical Cancer|Endometrial Cancer|Fallopian Tube Cancer|Ovarian Cancer|Sarcoma
1179,0.989941223,150.5940793,https://clinicaltrials.gov/study/NCT01674062,NCT01674062,Breast Cancer
1180,0.999413555,189.8073448,https://clinicaltrials.gov/study/NCT00003962,NCT00003962,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm
1181,0.972938086,83.26252852,https://clinicaltrials.gov/study/NCT03386162,NCT03386162,"Breast Cancer, PI3K, Alpelisib"
1182,0.991113131,150.9536683,https://clinicaltrials.gov/study/NCT02012062,NCT02012062,Nasopharyngeal Carcinoma
1183,0.927609061,28.58287201,https://clinicaltrials.gov/study/NCT02324088,NCT02324088,Inflammatory Breast Cancer
1184,0.995724554,156.698844,https://clinicaltrials.gov/study/NCT00004688,NCT00004688,Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Gliomas|Glioblastoma Multiforme|Recurrent Brain Tumor
1185,0.987716719,150.1551847,https://clinicaltrials.gov/study/NCT02490488,NCT02490488,Ovarian Cancer
1186,0.996285599,158.4590158,https://clinicaltrials.gov/study/NCT02990338,NCT02990338,Plasma Cell Myeloma
1187,0.982059087,111.522257,https://clinicaltrials.gov/study/NCT03243838,NCT03243838,Triple-Negative Breast Cancer
1188,0.994124686,151.8076049,https://clinicaltrials.gov/study/NCT02190838,NCT02190838,Melanoma
1189,0.993098972,152.7604651,https://clinicaltrials.gov/study/NCT01864538,NCT01864538,Metastatic Melanoma
1190,0.987649719,150.0707811,https://clinicaltrials.gov/study/NCT01276938,NCT01276938,Breast Neoplasms|Toxicity
1191,0.999835965,191.2381952,https://clinicaltrials.gov/study/NCT02881138,NCT02881138,Solid Tumors
1192,0.999479178,189.3503143,https://clinicaltrials.gov/study/NCT00017238,NCT00017238,"Unspecified Adult Solid Tumor, Protocol Specific"
1193,0.96961272,65.92385459,https://clinicaltrials.gov/study/NCT00358072,NCT00358072,Acute Lymphoblastic Leukemia
1194,0.990299353,151.2713125,https://clinicaltrials.gov/study/NCT00034372,NCT00034372,Ovarian Neoplasms
1195,0.988515776,150.7848977,https://clinicaltrials.gov/study/NCT02512172,NCT02512172,Colorectal Cancer
1196,0.773648912,8.574888221,https://clinicaltrials.gov/study/NCT00965172,NCT00965172,Sarcoma|Oral Mucositis
1197,0.998916067,188.0096048,https://clinicaltrials.gov/study/NCT02353572,NCT02353572,Plasma Cell Myeloma|Plasmacytosis|Recurrent Plasma Cell Myeloma|Smoldering Plasma Cell Myeloma
1198,0.998708031,177.980028,https://clinicaltrials.gov/study/NCT00023972,NCT00023972,Pancreatic Cancer
1199,0.948397503,41.40423436,https://clinicaltrials.gov/study/NCT00910572,NCT00910572,Hepatocellular Carcinoma|Liver Cancer
1200,0.994166522,153.6168177,https://clinicaltrials.gov/study/NCT01633372,NCT01633372,MPN (Myeloproliferative Neoplasms)
1201,0.999115569,192.4271466,https://clinicaltrials.gov/study/NCT00068172,NCT00068172,Melanoma
1202,0.999061947,181.9606503,https://clinicaltrials.gov/study/NCT00003972,NCT00003972,Breast Cancer
1203,0.986774743,150.1841909,https://clinicaltrials.gov/study/NCT01621672,NCT01621672,Multiple Myeloma
1204,0.930265067,28.47791016,https://clinicaltrials.gov/study/NCT00918762,NCT00918762,Head and Neck Cancer|Perioperative/Postoperative Complications|Precancerous Condition
1205,0.994930602,155.8093422,https://clinicaltrials.gov/study/NCT04636762,NCT04636762,Extensive-stage Small Cell Lung Cancer
1206,0.993012583,152.0822139,https://clinicaltrials.gov/study/NCT00328562,NCT00328562,Non-Small Cell Lung Carcinoma (NSCLC)
1207,0.977860091,75.78675014,https://clinicaltrials.gov/study/NCT04264962,NCT04264962,Hepatocellular Carcinoma
1208,0.668903222,4.851725561,https://clinicaltrials.gov/study/NCT03006562,NCT03006562,Prostate Cancer|Venous Thromboembolism|Lymphocele After Surgical Procedure|Deep Venous Thrombosis|Pulmonary Embolism
1209,0.946866252,41.3070818,https://clinicaltrials.gov/study/NCT00903162,NCT00903162,Breast Cancer
1210,0.975477829,86.06949025,https://clinicaltrials.gov/study/NCT03451162,NCT03451162,Breast Cancer
1211,0.992571136,151.9404225,https://clinicaltrials.gov/study/NCT03327662,NCT03327662,Adenocarcinoma of the Prostate
1212,0.797242505,8.747836304,https://clinicaltrials.gov/study/NCT00743262,NCT00743262,Total Laryngectomy
1213,0.999425948,188.9753072,https://clinicaltrials.gov/study/NCT00003288,NCT00003288,"Unspecified Childhood Solid Tumor, Protocol Specific"
1214,0.999687828,188.8580957,https://clinicaltrials.gov/study/NCT02155088,NCT02155088,Pancreatic Cancer
1215,0.969123452,64.2937919,https://clinicaltrials.gov/study/NCT01814488,NCT01814488,Acute Leukemia
1216,0.996791167,160.3406395,https://clinicaltrials.gov/study/NCT03158688,NCT03158688,Relapsed Multiple Myeloma|Refractory Multiple Myeloma
1217,0.996281593,158.297408,https://clinicaltrials.gov/study/NCT04746638,NCT04746638,Prostate Cancer|Breast Cancer Female
1218,0.972603255,68.43453912,https://clinicaltrials.gov/study/NCT00002938,NCT00002938,Prostate Cancer
1219,0.967112888,67.91646752,https://clinicaltrials.gov/study/NCT04277338,NCT04277338,Primary Breast Cancer
1220,0.998578155,170.699083,https://clinicaltrials.gov/study/NCT00257738,NCT00257738,Squamous Cell Carcinoma of the Head and Neck
1221,0.999045223,191.9106556,https://clinicaltrials.gov/study/NCT00019838,NCT00019838,Leukemia|Lymphoma
1222,0.99573579,155.9791388,https://clinicaltrials.gov/study/NCT01860638,NCT01860638,Glioblastoma
1223,0.979874444,109.0196511,https://clinicaltrials.gov/study/NCT00901238,NCT00901238,Retinoblastoma
1224,0.99849301,174.409338,https://clinicaltrials.gov/study/NCT00064038,NCT00064038,Multiple Myeloma|Plasma Cell Neoplasm
1225,0.985750243,136.7292409,https://clinicaltrials.gov/study/NCT00018538,NCT00018538,Prostate Cancer
1226,0.99090927,151.5503001,https://clinicaltrials.gov/study/NCT01503372,NCT01503372,Advanced Gastric Cancer
1227,0.95620323,40.20352642,https://clinicaltrials.gov/study/NCT00109538,NCT00109538,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Myelodysplasia|Myelomonocytic"
1228,0.996833611,163.1999565,https://clinicaltrials.gov/study/NCT01864772,NCT01864772,Metastatic or Recurrent Head and Neck Squamous Cell Cancer
1229,0.982019387,100.2242187,https://clinicaltrials.gov/study/NCT00203372,NCT00203372,Breast Cancer
1230,0.999072497,184.2702788,https://clinicaltrials.gov/study/NCT00495872,NCT00495872,Solid Tumors
1231,0.992208554,152.4896867,https://clinicaltrials.gov/study/NCT03687372,NCT03687372,Common Wart
1232,0.973976849,66.20233116,https://clinicaltrials.gov/study/NCT01339572,NCT01339572,Non-Hodgkin's Lymphoma|Multiple Myeloma
1233,0.999660777,182.8001918,https://clinicaltrials.gov/study/NCT00040872,NCT00040872,Neuroblastoma
1234,0.994538554,153.8580023,https://clinicaltrials.gov/study/NCT00060372,NCT00060372,"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Childhood Myelodysplastic Syndromes|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Disseminated Neuroblastoma|Malignant Neoplasm|Ovarian Choriocarcinoma|Ovarian Embryonal Carcinoma|Ovarian Immature Teratoma|Ovarian Mature Teratoma|Ovarian Mixed Germ Cell Tumor|Ovarian Monodermal and Highly Specialized Teratoma|Ovarian Polyembryoma|Ovarian Yolk Sac Tumor|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Mantle Cell Lymphoma|Recurrent Neuroblastoma|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Refractory Chronic Lymphocytic Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage II Ovarian Epithelial Cancer|Stage III Malignant Testicular Germ Cell Tumor|Stage III Multiple Myeloma|Stage III Ovarian Epithelial Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Stage IV Ovarian Epithelial Cancer|Testicular Choriocarcinoma|Testicular Choriocarcinoma and Embryonal Carcinoma|Testicular Choriocarcinoma and Seminoma|Testicular Choriocarcinoma and Teratoma|Testicular Choriocarcinoma and Yolk Sac Tumor|Testicular Embryonal Carcinoma|Testicular Embryonal Carcinoma and Seminoma|Testicular Embryonal Carcinoma and Teratoma|Testicular Embryonal Carcinoma and Teratoma With Seminoma|Testicular Embryonal Carcinoma and Yolk Sac Tumor|Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma|Testicular Teratoma|Testicular Yolk Sac Tumor|Testicular Yolk Sac Tumor and Teratoma|Testicular Yolk Sac Tumor and Teratoma With Seminoma"
1235,0.997055078,159.4710489,https://clinicaltrials.gov/study/NCT01842672,NCT01842672,Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Lymphoblastic Lymphoma|Diffuse Large B-cell Lymphoma|Burkitt Lymphoma/Leukemia
1236,0.997377149,161.3662485,https://clinicaltrials.gov/study/NCT00002872,NCT00002872,Metastatic Cancer
1237,0.99148469,152.1715021,https://clinicaltrials.gov/study/NCT00543972,NCT00543972,Myeloid Leukemia
1238,0.962734454,45.56419425,https://clinicaltrials.gov/study/NCT00558272,NCT00558272,Breast Cancer|Prostate Cancer|Bone Neoplasms
1239,0.999618367,186.9019906,https://clinicaltrials.gov/study/NCT00891072,NCT00891072,"Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Peripheral T-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Small Lymphocytic Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Waldenstrm Macroglobulinemia"
1240,0.997986641,165.0786258,https://clinicaltrials.gov/study/NCT05067972,NCT05067972,Ovarian Neoplasms|Endometrial Neoplasms|Breast Neoplasms
1241,0.991932217,152.3476671,https://clinicaltrials.gov/study/NCT02345772,NCT02345772,HER2-positive Breast Cancer|ER-positive Breast Cancer
1242,0.994803013,156.6355985,https://clinicaltrials.gov/study/NCT03292172,NCT03292172,Advanced Ovarian Cancer|Triple Negative Breast Cancer
1243,0.999672841,191.8158282,https://clinicaltrials.gov/study/NCT00017472,NCT00017472,Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Splenic Marginal Zone Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Small Lymphocytic Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma
1244,0.989649901,150.6799161,https://clinicaltrials.gov/study/NCT00091572,NCT00091572,Melanoma
1245,0.898431504,18.88489463,https://clinicaltrials.gov/study/NCT00532272,NCT00532272,Metastatic Breast Cancer
1246,0.990780085,151.587969,https://clinicaltrials.gov/study/NCT01843062,NCT01843062,Differentiated Thyroid Cancer
1247,0.94499338,31.55656862,https://clinicaltrials.gov/study/NCT01029262,NCT01029262,Anemia
1248,0.741090724,7.925904944,https://clinicaltrials.gov/study/NCT02784262,NCT02784262,Chronic Disease|Nasal Polyposis|Rhinitis
1249,0.937959509,33.63315542,https://clinicaltrials.gov/study/NCT00272662,NCT00272662,Chemotherapy Induced Anemia|Cancer
1250,0.998768215,182.5049358,https://clinicaltrials.gov/study/NCT01241162,NCT01241162,Neuroblastoma|Ewings Sarcoma|Osteogenic Sarcoma|Rhabdomyosarcoma|Synovial Sarcoma
1251,0.974046601,78.05134153,https://clinicaltrials.gov/study/NCT02168062,NCT02168062,Prostate Adenocarcinoma
1252,0.99878956,180.4786334,https://clinicaltrials.gov/study/NCT00001188,NCT00001188,Sarcoma
1253,0.999278128,193.8568581,https://clinicaltrials.gov/study/NCT01742988,NCT01742988,Lymphoma|Relapsed Lymphoma|Refractory Lymphoma|Relapsed and/or Refractory Lymphoma|Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL)|Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)|Double-hit Lymphoma (DHL)|Triple-hit Lymphoma (THL)|Double-expressor Lymphoma (DEL)|High-grade B-cell Lymphoma (HGBL)
1254,0.669045838,4.471430985,https://clinicaltrials.gov/study/NCT03172988,NCT03172988,"Carcinoma, Non-Small-Cell Lung|Surgery|Dexamethasone|Flubiprofen Axetil|Long-term Effects Secondary to Cancer Therapy in Adults"
1255,0.996082602,156.0607504,https://clinicaltrials.gov/study/NCT00654238,NCT00654238,Metastatic Differentiated Thyroid Cancer|Metastatic Poorly Differentiated Thyroid Cancer|Metastatic Anaplastic Thyroid Cancer|Metastatic Medullary Thyroid Cancer
1256,0.999831849,185.5511556,https://clinicaltrials.gov/study/NCT00334438,NCT00334438,Lymphoma
1257,0.975596164,79.76382782,https://clinicaltrials.gov/study/NCT00216138,NCT00216138,Head and Neck Cancer
1258,0.99780061,164.2906326,https://clinicaltrials.gov/study/NCT00398138,NCT00398138,Leukemia|Lung Cancer|Malignant Mesothelioma|Myelodysplastic Syndromes|Primary Peritoneal Cavity Cancer
1259,0.988357952,150.1814113,https://clinicaltrials.gov/study/NCT00179738,NCT00179738,Prostate Cancer
1260,0.989193083,150.7075649,https://clinicaltrials.gov/study/NCT01685138,NCT01685138,Non-Small Cell Lung Cancer
1261,0.965322558,53.85037102,https://clinicaltrials.gov/study/NCT05075538,NCT05075538,Cancer
1262,0.994852182,153.3183633,https://clinicaltrials.gov/study/NCT00003838,NCT00003838,Myeloproliferative Disorders|Acute Myelogenous Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome|Acute Lymphoblastic Leukemia
1263,0.998938792,193.0952625,https://clinicaltrials.gov/study/NCT00706238,NCT00706238,Melanoma
1264,0.997147689,158.0726369,https://clinicaltrials.gov/study/NCT00335738,NCT00335738,Intraocular Retinoblastoma
1265,0.988748895,151.4843451,https://clinicaltrials.gov/study/NCT01234038,NCT01234038,Non-small Cell Lung Cancer
1266,0.970044261,76.73333186,https://clinicaltrials.gov/study/NCT01508572,NCT01508572,Breast Cancer
1267,0.995636614,156.2818811,https://clinicaltrials.gov/study/NCT01370772,NCT01370772,B-cell Chronic Lymphocytic Leukemia CLL
1268,0.998818862,179.0874745,https://clinicaltrials.gov/study/NCT00217438,NCT00217438,Refractory Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma
1269,0.998578467,176.7881196,https://clinicaltrials.gov/study/NCT00001572,NCT00001572,B Cell Lymphoma|Follicular Lymphoma|Neoplasm
1270,0.998315626,173.8523742,https://clinicaltrials.gov/study/NCT01173172,NCT01173172,Head and Neck Cancer
1271,0.964157415,64.11862996,https://clinicaltrials.gov/study/NCT03929172,NCT03929172,Papillomavirus Infections
1272,0.975101647,87.85433655,https://clinicaltrials.gov/study/NCT03306472,NCT03306472,Breast Cancer
1273,0.925372956,28.5081163,https://clinicaltrials.gov/study/NCT01972672,NCT01972672,Hepatocellular Carcinoma (HCC)
1274,0.997843157,161.8568645,https://clinicaltrials.gov/study/NCT03199872,NCT03199872,Prostate Cancer
1275,0.998878831,181.9237268,https://clinicaltrials.gov/study/NCT01713972,NCT01713972,"Unspecified Adult Solid Tumor, Protocol Specific"
1276,0.993968026,154.1070432,https://clinicaltrials.gov/study/NCT02885272,NCT02885272,Brain Glioblastoma
1277,0.998668004,173.9681543,https://clinicaltrials.gov/study/NCT01399372,NCT01399372,Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity
1278,0.973256795,57.80061948,https://clinicaltrials.gov/study/NCT01175772,NCT01175772,Ovarian Carcinoma
1279,0.968258405,60.58434612,https://clinicaltrials.gov/study/NCT01261572,NCT01261572,Prostatic Neoplasms
1280,0.997552352,166.0056623,https://clinicaltrials.gov/study/NCT01004172,NCT01004172,Metastatic Breast Cancer|Breast Cancer|Progressive Breast Cancer
1281,0.974013708,76.64027833,https://clinicaltrials.gov/study/NCT00671372,NCT00671372,Colorectal Cancer
1282,0.999161764,185.6497387,https://clinicaltrials.gov/study/NCT01973062,NCT01973062,Primary Central Nervous System Non-Hodgkin Lymphoma
1283,0.985156228,103.1870872,https://clinicaltrials.gov/study/NCT02581462,NCT02581462,Stomach Cancer|Gastroesophageal Junction Cancer
1284,0.990767389,151.4335337,https://clinicaltrials.gov/study/NCT00006062,NCT00006062,Liver Disease
1285,0.993567289,152.0912522,https://clinicaltrials.gov/study/NCT00411762,NCT00411762,Pancreatic Cancer
1286,0.990841226,151.2026265,https://clinicaltrials.gov/study/NCT02013362,NCT02013362,Peripheral T-cell Lymphoma
1287,0.968855901,50.46906202,https://clinicaltrials.gov/study/NCT02112162,NCT02112162,Rectal Neoplasms
1288,0.949256192,33.94230541,https://clinicaltrials.gov/study/NCT04409288,NCT04409288,Prostate Cancer
1289,0.984255943,127.1829967,https://clinicaltrials.gov/study/NCT01453088,NCT01453088,Multiple Myeloma
1290,0.995512454,154.4803731,https://clinicaltrials.gov/study/NCT01733238,NCT01733238,"Lymphoma, Non-Hodgkin's"
1291,0.999171262,180.7219096,https://clinicaltrials.gov/study/NCT00080938,NCT00080938,Lung Cancer|Metastatic Cancer
1292,0.992874779,152.6613015,https://clinicaltrials.gov/study/NCT00418938,NCT00418938,Cancer|Colon Cancer|Colorectal Cancer|Metastatic Cancer|Rectal Cancer|Metastatic Colorectal Cancer
1293,0.985494894,114.7035148,https://clinicaltrials.gov/study/NCT01572038,NCT01572038,Breast Neoplasms
1294,0.998614916,180.4810257,https://clinicaltrials.gov/study/NCT01977638,NCT01977638,Advanced Cancer
1295,0.988083567,150.6481022,https://clinicaltrials.gov/study/NCT01236638,NCT01236638,Primary Myelofibrosis|Post-Polycythemia Vera Myelofibrosis|Post-Essential Thrombocythemia Myelofibrosis
1296,0.946599132,35.52875376,https://clinicaltrials.gov/study/NCT00968838,NCT00968838,Leukemia
1297,0.998468631,170.7970712,https://clinicaltrials.gov/study/NCT01874938,NCT01874938,Gastric Cancer
1298,0.96512105,65.18254549,https://clinicaltrials.gov/study/NCT00771472,NCT00771472,Lymphoma
1299,0.996445957,159.7719412,https://clinicaltrials.gov/study/NCT00217672,NCT00217672,Breast Cancer
1300,0.998008074,166.069292,https://clinicaltrials.gov/study/NCT00450372,NCT00450372,Melanoma (Skin)
1301,0.995585708,156.8752154,https://clinicaltrials.gov/study/NCT01576172,NCT01576172,Castration-Resistant Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer AJCC v7
1302,0.994365137,153.9630955,https://clinicaltrials.gov/study/NCT01704872,NCT01704872,Neuroblastoma
1303,0.989329873,150.2342336,https://clinicaltrials.gov/study/NCT03669172,NCT03669172,ACUTE LEUKEMIA
1304,0.907540154,20.39942298,https://clinicaltrials.gov/study/NCT01962272,NCT01962272,Esophageal Cancer|Gastric Cancer|Uterine Cancer
1305,0.9747037,82.14631068,https://clinicaltrials.gov/study/NCT01491672,NCT01491672,Metastatic Renal Cell Carcinoma
1306,0.998881386,178.4142315,https://clinicaltrials.gov/study/NCT02035072,NCT02035072,Unresectable Pancreatic Cancer|Nonmetastatic Pancreatic Cancer|Locally Advanced Pancreatic Cancer
1307,0.997995681,164.2759245,https://clinicaltrials.gov/study/NCT03051672,NCT03051672,Metastatic Breast Cancer
1308,0.994253288,153.6184718,https://clinicaltrials.gov/study/NCT00049062,NCT00049062,Breast Cancer
1309,0.978133896,68.8036999,https://clinicaltrials.gov/study/NCT03439462,NCT03439462,Colorectal Cancer Metastatic
1310,0.976558106,90.00911812,https://clinicaltrials.gov/study/NCT02840162,NCT02840162,Adenocarcinoma of the Prostate|Prostate Cancer
1311,0.998574869,174.5579267,https://clinicaltrials.gov/study/NCT02412462,NCT02412462,Solid Tumor|Metastatic Cancer
1312,0.997955022,161.0323676,https://clinicaltrials.gov/study/NCT00240162,NCT00240162,Multiple Myeloma
1313,0.975658244,82.18900334,https://clinicaltrials.gov/study/NCT04060862,NCT04060862,Breast Cancer
1314,0.955242176,43.43142321,https://clinicaltrials.gov/study/NCT03646162,NCT03646162,Prostate Cancer Metastatic
1315,0.999415271,185.8293497,https://clinicaltrials.gov/study/NCT00085462,NCT00085462,Melanoma (Skin)
1316,0.973725618,59.99127681,https://clinicaltrials.gov/study/NCT03436862,NCT03436862,Hodgkin Lymphoma
1317,0.880247649,14.87304371,https://clinicaltrials.gov/study/NCT00094562,NCT00094562,Cancer|Cancer Cachexia|Chronic Obstructive Pulmonary Disease|Chronic Heart Failure|Rheumatoid Arthritis
1318,0.970891042,81.25456301,https://clinicaltrials.gov/study/NCT01883362,NCT01883362,Acute Myeloid Leukemia
1319,0.934275506,29.57325568,https://clinicaltrials.gov/study/NCT00949910,NCT00949910,Non-Small Cell Lung Cancer
1320,0.974446421,74.79335328,https://clinicaltrials.gov/study/NCT00513162,NCT00513162,Neuroectodermal Tumor|Brain Metastases|Advanced Cancer
1321,0.991011831,151.6618769,https://clinicaltrials.gov/study/NCT04111510,NCT04111510,Metastatic Triple Negative Breast Cancer
1322,0.993908747,153.1213923,https://clinicaltrials.gov/study/NCT01334710,NCT01334710,Liver Cancer
1323,0.998611674,176.892712,https://clinicaltrials.gov/study/NCT01514110,NCT01514110,Gastric Cancer
1324,0.996395511,157.3582384,https://clinicaltrials.gov/study/NCT00191646,NCT00191646,"Genital Neoplasms, Female|Fallopian Tube Neoplasms|Ovarian Neoplasms|Pelvic Neoplasms|Peritoneal Neoplasms"
1325,0.998237004,169.8488079,https://clinicaltrials.gov/study/NCT01533246,NCT01533246,Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
1326,0.998974997,180.1606681,https://clinicaltrials.gov/study/NCT00217646,NCT00217646,Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|Blastic Phase|de Novo Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndrome
1327,0.99746697,160.5886864,https://clinicaltrials.gov/study/NCT00884546,NCT00884546,"Advanced Cancer, Various, NOS"
1328,0.997079751,160.423928,https://clinicaltrials.gov/study/NCT00992446,NCT00992446,Adult Diffuse Large B-Cell Lymphoma|B-Cell Non-Hodgkin Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma|Non-Hodgkin Lymphoma|T-Cell Non-Hodgkin Lymphoma
1329,0.981001335,130.2667976,https://clinicaltrials.gov/study/NCT01548846,NCT01548846,Head and Neck Cancer|Radiotherapy by Tomotherapy Exclusive|With or Without Concurrent Chemotherapy
1330,0.997729142,162.6951098,https://clinicaltrials.gov/study/NCT00264446,NCT00264446,Neoplasms
1331,0.994950167,156.342268,https://clinicaltrials.gov/study/NCT00047346,NCT00047346,Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
1332,0.997707009,162.9670188,https://clinicaltrials.gov/study/NCT00568646,NCT00568646,Pancreatic Cancer
1333,0.974832151,55.87889719,https://clinicaltrials.gov/study/NCT02202746,NCT02202746,Breast Cancer|Metastatic Breast Cancer|MBC|HER2 Positive|HER2|Estrogen Receptor Positive|ER|Triple Negative
1334,0.997739379,166.5601499,https://clinicaltrials.gov/study/NCT02631746,NCT02631746,Acute Adult T-Cell Leukemia/Lymphoma|Adult T-Cell Leukemia/Lymphoma|Chronic Adult T-Cell Leukemia/Lymphoma|HTLV-1 Infection|Lymphomatous Adult T-Cell Leukemia/Lymphoma|Smoldering Adult T-Cell Leukemia/Lymphoma
1335,0.999231605,194.9214865,https://clinicaltrials.gov/study/NCT01097746,NCT01097746,Fallopian Tube Carcinoma|Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Fallopian Tube Undifferentiated Carcinoma|FIGO Stage III Ovarian Cancer|FIGO Stage IIIA Ovarian Cancer|FIGO Stage IIIA1 Ovarian Cancer|FIGO Stage IIIA1(i) Ovarian Cancer|FIGO Stage IIIA1(ii) Ovarian Cancer|FIGO Stage IIIA2 Ovarian Cancer|FIGO Stage IIIB Ovarian Cancer|FIGO Stage IIIC Ovarian Cancer|FIGO Stage IVA Ovarian Cancer|FIGO Stage IVB Ovarian Cancer|Malignant Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Transitional Cell Carcinoma|Ovarian Undifferentiated Carcinoma|Primary Peritoneal Carcinoma|Primary Peritoneal Serous Adenocarcinoma
1336,0.989705935,151.7759096,https://clinicaltrials.gov/study/NCT03101046,NCT03101046,Prostate Carcinoma|Castration-resistant Prostate Cancer|Circulating Tumor Cells|Chemotherapy
1337,0.999537041,192.8147554,https://clinicaltrials.gov/study/NCT00008073,NCT00008073,"Unspecified Adult Solid Tumor, Protocol Specific"
1338,0.998725143,183.942272,https://clinicaltrials.gov/study/NCT00882973,NCT00882973,Pancreatic Cancer
1339,0.985975363,134.1064732,https://clinicaltrials.gov/study/NCT01950273,NCT01950273,"Lymphoma, Follicular"
1340,0.986566462,150.4107595,https://clinicaltrials.gov/study/NCT01687673,NCT01687673,Hepatocellular Carcinoma
1341,0.987831664,150.5997675,https://clinicaltrials.gov/study/NCT02420873,NCT02420873,Leukemia
1342,0.983090243,102.591967,https://clinicaltrials.gov/study/NCT01833273,NCT01833273,Glioblastoma Multiform (Grade IV Astrocytoma)
1343,0.975899866,95.7030964,https://clinicaltrials.gov/study/NCT01991873,NCT01991873,Metastatic Colorectal Cancer
1344,0.99944108,187.149863,https://clinicaltrials.gov/study/NCT02713373,NCT02713373,Recurrent Colorectal Carcinoma|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer
1345,0.874273307,15.0086915,https://clinicaltrials.gov/study/NCT01318473,NCT01318473,Cancer
1346,0.999317855,181.8831508,https://clinicaltrials.gov/study/NCT03927573,NCT03927573,Non-small Cell Lung Cancer|Prostate Cancer|Renal Cancer|Transitional Cell Carcinoma
1347,0.998281047,167.6518929,https://clinicaltrials.gov/study/NCT04849273,NCT04849273,Non Small Cell Lung Cancer|Non-Small Cell Lung Cancer|NSCLC|Advanced Solid Tumor|Metastatic Solid Tumor|ALK Gene Mutation
1348,0.965418718,48.62869961,https://clinicaltrials.gov/study/NCT00587873,NCT00587873,Hodgkin's Disease
1349,0.997296503,163.942678,https://clinicaltrials.gov/study/NCT01421173,NCT01421173,Lymphoma
1350,0.998165131,169.7210609,https://clinicaltrials.gov/study/NCT00006364,NCT00006364,"Childhood Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia|Relapsing Chronic Myelogenous Leukemia"
1351,0.98686048,150.0162018,https://clinicaltrials.gov/study/NCT00034164,NCT00034164,"Carcinoma, Non-Small-Cell Lung"
1352,0.961887494,45.24413807,https://clinicaltrials.gov/study/NCT01037764,NCT01037764,Acute Lymphoid Leukemia
1353,0.982171499,121.7611865,https://clinicaltrials.gov/study/NCT01139164,NCT01139164,Hematological Malignancies
1354,0.934025798,31.5110576,https://clinicaltrials.gov/study/NCT02992964,NCT02992964,Refractory or Recurrent Hypermutated Malignancies|Biallelic Mismatch Repair Deficiency (bMMRD) Positive Patients
1355,0.99286375,152.2556582,https://clinicaltrials.gov/study/NCT02210364,NCT02210364,Metastatic Breast Cancer|Pancreatic Cancer|Metastatic Colorectal Cancer
1356,0.998683345,175.1368968,https://clinicaltrials.gov/study/NCT01204164,NCT01204164,AML|ALL|Blast Crisis|MDS|Multiple Myeloma
1357,0.998519676,181.2704004,https://clinicaltrials.gov/study/NCT00003364,NCT00003364,Lung Cancer
1358,0.948776618,32.82783526,https://clinicaltrials.gov/study/NCT00530764,NCT00530764,Palliative Care|Pain|Cancer
1359,0.988380877,150.2877342,https://clinicaltrials.gov/study/NCT02826564,NCT02826564,Metastatic Urothelial Cancer
1360,0.995493447,157.2595306,https://clinicaltrials.gov/study/NCT03762564,NCT03762564,Squamous Cell Carcinoma of the Esophagus
1361,0.991020924,151.6950009,https://clinicaltrials.gov/study/NCT00626561,NCT00626561,Cervical Cancer|Uterine Cancer
1362,0.998940092,185.235689,https://clinicaltrials.gov/study/NCT00004061,NCT00004061,Leukemia|Lymphoma|Oral Complications
1363,0.971412526,77.5369653,https://clinicaltrials.gov/study/NCT00505661,NCT00505661,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
1364,0.9885987,150.2502435,https://clinicaltrials.gov/study/NCT00253461,NCT00253461,"Lung Cancer|Metastatic Cancer|Ovarian Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
1365,0.555924572,3.135400216,https://clinicaltrials.gov/study/NCT03456661,NCT03456661,"Breast Cancer|Mastectomy, Modified Radical"
1366,0.997893154,162.2643994,https://clinicaltrials.gov/study/NCT00038246,NCT00038246,Prostate Cancer
1367,0.997847071,164.6331658,https://clinicaltrials.gov/study/NCT00725946,NCT00725946,Breast Cancer|Breast Cancer Early Stage Breast Cancer (Stage 1-3)|Breast Cancer Metastatic Breast Cancer
1368,0.98818593,150.4493506,https://clinicaltrials.gov/study/NCT03839446,NCT03839446,Acute Myeloid Leukemia
1369,0.959921287,59.80968194,https://clinicaltrials.gov/study/NCT00352846,NCT00352846,Non-Hodgkin's Lymphoma|Lymphoma
1370,0.943918492,35.07046128,https://clinicaltrials.gov/study/NCT01472146,NCT01472146,Breast Cancer|Breast Disease|Neoplasms|Neoplasms by Site
1371,0.999632419,190.3280493,https://clinicaltrials.gov/study/NCT00244946,NCT00244946,Lymphoma
1372,0.792804275,9.314458831,https://clinicaltrials.gov/study/NCT00468546,NCT00468546,Rheumatoid Arthritis
1373,0.98903539,150.6365185,https://clinicaltrials.gov/study/NCT00057746,NCT00057746,Lung Cancer
1374,0.997257439,158.2613517,https://clinicaltrials.gov/study/NCT00193973,NCT00193973,Primary Central Nervous System Lymphoma
1375,0.996138346,157.9432926,https://clinicaltrials.gov/study/NCT02147873,NCT02147873,Myelodysplastic Syndrome (MDS)|Chronic Myelomonocytic Leukemia (CMML)
1376,0.934198337,25.06247962,https://clinicaltrials.gov/study/NCT00659373,NCT00659373,Breast Cancer|Fatigue|Sleep Disorders
1377,0.979626305,107.0185663,https://clinicaltrials.gov/study/NCT00465673,NCT00465673,Breast Cancer
1378,0.999049876,187.0342628,https://clinicaltrials.gov/study/NCT00002873,NCT00002873,Breast Cancer
1379,0.990927431,150.8651579,https://clinicaltrials.gov/study/NCT00893373,NCT00893373,Acute Myeloid Leukemia (AML)
1380,0.992292044,152.2548556,https://clinicaltrials.gov/study/NCT00049673,NCT00049673,Multiple Myeloma and Plasma Cell Neoplasm
1381,0.995163506,156.5081285,https://clinicaltrials.gov/study/NCT01839773,NCT01839773,Stage IV Gastric Cancer
1382,0.99889825,188.1515558,https://clinicaltrials.gov/study/NCT02535364,NCT02535364,Acute Lymphoblastic Leukemia
1383,0.996877917,162.8255657,https://clinicaltrials.gov/study/NCT02472964,NCT02472964,Breast Cancer
1384,0.999100105,191.0375246,https://clinicaltrials.gov/study/NCT00364364,NCT00364364,Pancreatic Cancer
1385,0.995215554,153.5870209,https://clinicaltrials.gov/study/NCT01543464,NCT01543464,Malignant Melanoma
1386,0.958454503,44.41698202,https://clinicaltrials.gov/study/NCT01720264,NCT01720264,"Acute Myeloid Leukemia|Acute Lymphoid Leukemia|Hematopoetic Myelodysplasia|Leukemia, Myelogenous, Chronic|Lymphoma, Non-Hodgkin"
1387,0.991951219,151.6166319,https://clinicaltrials.gov/study/NCT01262664,NCT01262664,Prostate Cancer
1388,0.998269203,169.0233059,https://clinicaltrials.gov/study/NCT00064064,NCT00064064,Lung Cancer
1389,0.997803649,162.9214632,https://clinicaltrials.gov/study/NCT00170664,NCT00170664,Ovarian Cancer
1390,0.997716716,165.9957424,https://clinicaltrials.gov/study/NCT00116961,NCT00116961,Multiple Myeloma
1391,0.992920957,153.7025118,https://clinicaltrials.gov/study/NCT00083161,NCT00083161,Lung Cancer
1392,0.999232978,191.562921,https://clinicaltrials.gov/study/NCT00278161,NCT00278161,Leukemia|Lymphoma
1393,0.991399799,152.2174332,https://clinicaltrials.gov/study/NCT04592861,NCT04592861,Pancreatic Cancer
1394,0.974022084,64.18061002,https://clinicaltrials.gov/study/NCT03009461,NCT03009461,HepatoCellular Carcinoma|Portal Vein Thrombosis
1395,0.998333278,176.7430826,https://clinicaltrials.gov/study/NCT01894061,NCT01894061,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
1396,0.999276201,192.5575507,https://clinicaltrials.gov/study/NCT01078961,NCT01078961,Melanoma
1397,0.997739387,168.8835858,https://clinicaltrials.gov/study/NCT01134861,NCT01134861,Lung Cancer
1398,0.995807504,155.5387427,https://clinicaltrials.gov/study/NCT00787761,NCT00787761,Myeloproliferative Disorders|Kidney Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
1399,0.996683459,157.3775567,https://clinicaltrials.gov/study/NCT00949988,NCT00949988,Chronic Lymphocytic Leukemia
1400,0.989918594,151.3462244,https://clinicaltrials.gov/study/NCT00206388,NCT00206388,NEUROBLASTOMA
1401,0.998033525,162.7492587,https://clinicaltrials.gov/study/NCT01462838,NCT01462838,HPV-induced Cancers
1402,0.997845471,169.7337465,https://clinicaltrials.gov/study/NCT01991938,NCT01991938,Non Hematologic Cancers|Metastatic Cancer|Lymphoma
1403,0.992966539,152.5215302,https://clinicaltrials.gov/study/NCT01200238,NCT01200238,Ocular Melanoma
1404,0.999099965,184.7126443,https://clinicaltrials.gov/study/NCT00006038,NCT00006038,Esophageal Cancer|Gastric Cancer
1405,0.957119562,51.35435569,https://clinicaltrials.gov/study/NCT02181738,NCT02181738,Hodgkin Disease
1406,0.574210883,3.628587855,https://clinicaltrials.gov/study/NCT02548338,NCT02548338,Breast Neoplasms
1407,0.992177885,152.2103711,https://clinicaltrials.gov/study/NCT00107172,NCT00107172,Lung Cancer
1408,0.998416048,165.1658734,https://clinicaltrials.gov/study/NCT03596372,NCT03596372,Advanced CEACAM6-expressing Solid Tumors
1409,0.9903564,150.3725278,https://clinicaltrials.gov/study/NCT03790072,NCT03790072,Acute Myeloid Leukemia
1410,0.987002901,150.1412492,https://clinicaltrials.gov/study/NCT02375672,NCT02375672,Colorectal Cancer
1411,0.91870969,31.32493683,https://clinicaltrials.gov/study/NCT00216372,NCT00216372,Intestinal Obstruction|Carcinoma|Peritoneal Neoplasms
1412,0.986525282,119.9416434,https://clinicaltrials.gov/study/NCT00251472,NCT00251472,Metastatic Breast Cancer
1413,0.991271338,150.6764667,https://clinicaltrials.gov/study/NCT00122772,NCT00122772,Cervix Cancer
1414,0.998609514,171.4149308,https://clinicaltrials.gov/study/NCT00820872,NCT00820872,Breast Cancer
1415,0.991241341,151.3448646,https://clinicaltrials.gov/study/NCT03158272,NCT03158272,Advanced Malignancies
1416,0.995511404,156.322436,https://clinicaltrials.gov/study/NCT00813072,NCT00813072,Stomach Neoplasms|Esophageal Neoplasms
1417,0.985062209,111.0957634,https://clinicaltrials.gov/study/NCT02703272,NCT02703272,"Lymphoma, Non-Hodgkin"
1418,0.919015593,19.87381602,https://clinicaltrials.gov/study/NCT01667562,NCT01667562,Non-Small Cell Lung Cancer
1419,0.99747995,161.5976598,https://clinicaltrials.gov/study/NCT00519662,NCT00519662,Advanced Solid Tumors
1420,0.998906104,177.3940985,https://clinicaltrials.gov/study/NCT00004062,NCT00004062,Head and Neck Cancer
1421,0.96307926,41.00981044,https://clinicaltrials.gov/study/NCT00026962,NCT00026962,Breast Cancer
1422,0.999034818,185.9937997,https://clinicaltrials.gov/study/NCT01398462,NCT01398462,Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia|Myelodysplastic Syndrome|Myelofibrosis
1423,0.998966752,197.2277084,https://clinicaltrials.gov/study/NCT00002562,NCT00002562,Cervical Cancer|Vaginal Cancer
1424,0.987007657,131.4037605,https://clinicaltrials.gov/study/NCT02610062,NCT02610062,Acute Myeloid Leukemia
1425,0.987886685,150.1262716,https://clinicaltrials.gov/study/NCT00116662,NCT00116662,Warts
1426,0.982452164,96.93287469,https://clinicaltrials.gov/study/NCT00246662,NCT00246662,"Leukemia, Lymphocytic, Acute|Leukemia, Nonlymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes"
1427,0.973749551,66.00013216,https://clinicaltrials.gov/study/NCT05041062,NCT05041062,Mesothelioma|Peritoneal Mesothelioma
1428,0.996202367,155.4759539,https://clinicaltrials.gov/study/NCT02097810,NCT02097810,Locally Advanced Solid Tumors|Metastatic Solid Tumors
1429,0.915330268,22.53183523,https://clinicaltrials.gov/study/NCT02383810,NCT02383810,Drug and/or Toxin-induced Diarrhea
1430,0.993579114,153.0230313,https://clinicaltrials.gov/study/NCT00888810,NCT00888810,Cancer|Ovarian|Relapse|Chemotherapy
1431,0.99385511,153.4397258,https://clinicaltrials.gov/study/NCT00273910,NCT00273910,High-Risk Melanoma
1432,0.99632031,155.6896199,https://clinicaltrials.gov/study/NCT01801046,NCT01801046,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myeloid Leukemia in Remission|Childhood Acute Myelomonocytic Leukemia (M4)|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
1433,0.926266632,29.7409226,https://clinicaltrials.gov/study/NCT00987246,NCT00987246,Actinic Keratosis
1434,0.994193867,156.5562591,https://clinicaltrials.gov/study/NCT00753246,NCT00753246,Adults With Glioblastoma Multiforma
1435,0.996850153,161.2788914,https://clinicaltrials.gov/study/NCT00002646,NCT00002646,Breast Cancer
1436,0.986918624,139.7721097,https://clinicaltrials.gov/study/NCT00208546,NCT00208546,Colorectal Cancer
1437,0.936711641,29.48947082,https://clinicaltrials.gov/study/NCT00520546,NCT00520546,Prostate Cancer
1438,0.997859876,162.5941998,https://clinicaltrials.gov/study/NCT02298946,NCT02298946,Colorectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma
1439,0.985789239,133.7730443,https://clinicaltrials.gov/study/NCT02685046,NCT02685046,Colonic Neoplasms
1440,0.974137444,92.71833777,https://clinicaltrials.gov/study/NCT01452646,NCT01452646,Acute Myeloid Leukemia
1441,0.999517798,188.3744935,https://clinicaltrials.gov/study/NCT01547546,NCT01547546,"Glioblastoma, Glioma"
1442,0.991195879,151.3223314,https://clinicaltrials.gov/study/NCT00969046,NCT00969046,Colon Cancer
1443,0.99083728,151.3207607,https://clinicaltrials.gov/study/NCT00314873,NCT00314873,Thymic Carcinoma
1444,0.994286902,153.3100992,https://clinicaltrials.gov/study/NCT00291473,NCT00291473,Esophageal Cancer|Lung Cancer|Stomach Cancer|Breast Cancer|Ovarian Cancer
1445,0.984633689,150.2446463,https://clinicaltrials.gov/study/NCT05275673,NCT05275673,Non-Small Cell Lung Cancer|Squamous Non-small-cell Lung Cancer|Squamous Non-Small Cell Neoplasm of Lung|NFE2L2 Gene Mutation
1446,0.999299944,180.223475,https://clinicaltrials.gov/study/NCT00217373,NCT00217373,Adult Solid Neoplasm
1447,0.976350836,91.06270195,https://clinicaltrials.gov/study/NCT01808573,NCT01808573,HER2+ Metastatic Breast Cancer (MBC)
1448,0.559029835,3.484317698,https://clinicaltrials.gov/study/NCT02305173,NCT02305173,"Respiratory; Disorder, Functional, Impaired"
1449,0.990113476,150.8148141,https://clinicaltrials.gov/study/NCT02264873,NCT02264873,"Leukemia, Lymphoblastic, Acute|Leukemia, Myeloid Acute|Hematopoetic Myelodysplasia"
1450,0.987486443,111.572899,https://clinicaltrials.gov/study/NCT01009073,NCT01009073,Solid Tumors
1451,0.99394367,154.1584778,https://clinicaltrials.gov/study/NCT03397173,NCT03397173,Myelodysplastic Syndromes|Myeloproliferative Neoplasm|Acute Myeloid Leukemia
1452,0.934504772,31.35660291,https://clinicaltrials.gov/study/NCT00372073,NCT00372073,Non-small Cell Lung Cancer
1453,0.999681014,182.1065514,https://clinicaltrials.gov/study/NCT00004073,NCT00004073,Brain and Central Nervous System Tumors
1454,0.99697872,162.7607568,https://clinicaltrials.gov/study/NCT00063973,NCT00063973,Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Ependymoblastoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebellar Astrocytoma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebellar Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Medulloepithelioma|Childhood Mixed Glioma|Childhood Oligodendroglioma|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma
1455,0.97500698,75.87125976,https://clinicaltrials.gov/study/NCT01911273,NCT01911273,"Carcinoma, Hepatocellular"
1456,0.723266679,5.378557763,https://clinicaltrials.gov/study/NCT04448873,NCT04448873,Kaposiform Hemangioendothelioma|Kasabach-Merritt Syndrome
1457,0.994680191,155.6995327,https://clinicaltrials.gov/study/NCT00165373,NCT00165373,Solid Tumors
1458,0.997165783,162.4921644,https://clinicaltrials.gov/study/NCT00587964,NCT00587964,Brain Metastasis|Bladder Cancer|Breast Cancer|Cervical Cancer|Colon Cancer|HEENT Cancer|Lung Cancer|Melanoma|Pancreatic Cancer|Prostate Cancer|Rectal Cancer|Sarcoma|Testicular Cancer
1459,0.922984642,22.68010572,https://clinicaltrials.gov/study/NCT01245764,NCT01245764,Papillomavirus Infections
1460,0.99964885,185.9918213,https://clinicaltrials.gov/study/NCT00335764,NCT00335764,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
1461,0.990209679,150.9410415,https://clinicaltrials.gov/study/NCT00390364,NCT00390364,Colorectal Cancer
1462,0.971476598,65.91281426,https://clinicaltrials.gov/study/NCT01353664,NCT01353664,Lymphoma|Cancer
1463,0.993947342,154.3077789,https://clinicaltrials.gov/study/NCT00814164,NCT00814164,Leukemia
1464,0.552134171,3.420503779,https://clinicaltrials.gov/study/NCT01975064,NCT01975064,Breast Neoplasms|Colonic Neoplasms|Rectal Neoplasms
1465,0.995212269,155.9091099,https://clinicaltrials.gov/study/NCT01015664,NCT01015664,Squamous Cell Carcinoma of the Head and Neck
1466,0.998945403,177.2832634,https://clinicaltrials.gov/study/NCT03213964,NCT03213964,Epithelial Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
1467,0.982102101,115.1147469,https://clinicaltrials.gov/study/NCT01254864,NCT01254864,Prostate Cancer
1468,0.96811112,74.66322482,https://clinicaltrials.gov/study/NCT02484664,NCT02484664,Lymphangioleiomyomatosis (LAM)
1469,0.999208689,190.9144507,https://clinicaltrials.gov/study/NCT00623064,NCT00623064,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter
1470,0.931576509,29.95184992,https://clinicaltrials.gov/study/NCT01877564,NCT01877564,Adenocarcinoma of the Endometrium
1471,0.998026282,168.0497751,https://clinicaltrials.gov/study/NCT03797261,NCT03797261,Acute Myeloid Leukemia|Non-Hodgkin's Lymphoma|Diffuse Large B-cell Lymphoma
1472,0.859465807,13.2098195,https://clinicaltrials.gov/study/NCT01656161,NCT01656161,Prostate Cancer
1473,0.998037095,167.5962559,https://clinicaltrials.gov/study/NCT02664961,NCT02664961,Gestational Trophoblastic Neoplasia|Choriocarcinoma|Placental Site Trophoblastic Tumor|Epithelioid Trophoblastic Tumor
1474,0.983939484,115.9042647,https://clinicaltrials.gov/study/NCT03693846,NCT03693846,Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum
1475,0.999512594,187.1716098,https://clinicaltrials.gov/study/NCT00004146,NCT00004146,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma
1476,0.99521382,155.5241337,https://clinicaltrials.gov/study/NCT00261846,NCT00261846,Chronic Myeloid Leukemia
1477,0.955555638,48.78329038,https://clinicaltrials.gov/study/NCT00334646,NCT00334646,"Nausea and Vomiting, Chemotherapy-Induced"
1478,0.993071028,152.1560812,https://clinicaltrials.gov/study/NCT00749346,NCT00749346,Non-small Cell Lung Cancer|NSCLC
1479,0.999302551,183.1743994,https://clinicaltrials.gov/study/NCT00002546,NCT00002546,Sarcoma
1480,0.982755244,140.6469613,https://clinicaltrials.gov/study/NCT01151046,NCT01151046,Her2 Negative Breast Cancer Patients
1481,0.99486296,154.5018018,https://clinicaltrials.gov/study/NCT00673673,NCT00673673,Gastroesophageal Cancer|Gastric Cancer
1482,0.99250582,151.7167242,https://clinicaltrials.gov/study/NCT01700673,NCT01700673,Acute Myeloid Leukemia|Myelodysplastic Syndrome
1483,0.999552547,193.5930315,https://clinicaltrials.gov/study/NCT00003173,NCT00003173,"Brain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Ovarian Cancer|Retinoblastoma|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific"
1484,0.998956714,180.5560656,https://clinicaltrials.gov/study/NCT00028873,NCT00028873,Breast Cancer
1485,0.990965839,150.7361239,https://clinicaltrials.gov/study/NCT01506973,NCT01506973,Advanced Adenocarcinoma|Metastatic Adenocarcinoma
1486,0.994713999,156.7619529,https://clinicaltrials.gov/study/NCT01256073,NCT01256073,Acute Myeloid Leukemia
1487,0.641020754,3.935043989,https://clinicaltrials.gov/study/NCT00204373,NCT00204373,Zollinger-Ellison Syndrome|Multiple Endocrine Neoplasia
1488,0.994167288,153.2131324,https://clinicaltrials.gov/study/NCT03051373,NCT03051373,"Carcinoma, Transitional Cell"
1489,0.954435813,43.84006352,https://clinicaltrials.gov/study/NCT02699073,NCT02699073,Metastatic Colorectal Cancer
1490,0.994109814,152.9056849,https://clinicaltrials.gov/study/NCT00075673,NCT00075673,Breast Cancer
1491,0.951103753,28.17843717,https://clinicaltrials.gov/study/NCT01403064,NCT01403064,Oral Mucositis
1492,0.989830144,151.5092718,https://clinicaltrials.gov/study/NCT01702064,NCT01702064,Chronic Phase Chronic Myeloid Leukemia
1493,0.997736546,160.3883515,https://clinicaltrials.gov/study/NCT00006864,NCT00006864,Kidney Cancer
1494,0.997324568,159.1348092,https://clinicaltrials.gov/study/NCT01707264,NCT01707264,Primary Amyloidosis
1495,0.99629967,156.3872638,https://clinicaltrials.gov/study/NCT02989064,NCT02989064,Urothelial Carcinoma|Head and Neck Cancer|Melanoma|Bladder Urothelial Carcinoma
1496,0.920837405,26.29882477,https://clinicaltrials.gov/study/NCT00555464,NCT00555464,Hemangioma
1497,0.977486114,82.47247544,https://clinicaltrials.gov/study/NCT00075764,NCT00075764,Breast Cancer
1498,0.981861175,98.48829063,https://clinicaltrials.gov/study/NCT02686164,NCT02686164,Tumors
1499,0.997729827,161.8407622,https://clinicaltrials.gov/study/NCT00989664,NCT00989664,"Lymphoma, Non-Hodgkin"
1500,0.993584916,152.4906371,https://clinicaltrials.gov/study/NCT00937664,NCT00937664,Cancer|Solid Tumors|Advanced Solid Malignancies
1501,0.991086188,151.0770314,https://clinicaltrials.gov/study/NCT02626364,NCT02626364,Recurrent/Refractory Glioblastoma
1502,0.981924943,112.0152383,https://clinicaltrials.gov/study/NCT00968864,NCT00968864,Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Myeloid Leukemia|Myelodysplastic Syndrome|Lymphomas|Bone Marrow Failure|Hemoglobinopathy|Immune Deficiency|Osteopetrosis
1503,0.993693163,154.1074296,https://clinicaltrials.gov/study/NCT00449761,NCT00449761,"Leukemia, Myeloid, Chronic"
1504,0.578081415,3.721401185,https://clinicaltrials.gov/study/NCT00068861,NCT00068861,Polycystic Ovary Syndrome|Infertility|Pregnancy
1505,0.996927147,160.5431127,https://clinicaltrials.gov/study/NCT03144661,NCT03144661,Hepatocellular Carcinoma (HCC)|Cholangiocarcinoma|Esophageal Cancer|Nasopharyngeal Cancer|Ovarian Cancer|Solid Tumors
1506,0.95168894,35.4939767,https://clinicaltrials.gov/study/NCT00232661,NCT00232661,Breast Cancer
1507,0.998924312,177.6654454,https://clinicaltrials.gov/study/NCT02509546,NCT02509546,Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia
1508,0.999175696,185.5417572,https://clinicaltrials.gov/study/NCT00003546,NCT00003546,Pancreatic Cancer
1509,0.992885315,153.1838038,https://clinicaltrials.gov/study/NCT00078546,NCT00078546,Nasopharyngeal Cancer|EBV Infections
1510,0.997296491,162.2222762,https://clinicaltrials.gov/study/NCT00446446,NCT00446446,Cancer|Carcinoma|Head and Neck Cancer|Metastases|Metastatic Cancer|Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck|Oncology|Squamous Cell Carcinoma|Tumors
1511,0.995501599,157.0156847,https://clinicaltrials.gov/study/NCT00774046,NCT00774046,Myelodysplastic Syndrome|Acute Myeloid Leukemia
1512,0.99653733,158.5840297,https://clinicaltrials.gov/study/NCT02195973,NCT02195973,Recurrent Ovarian Cancer
1513,0.996207316,159.7533203,https://clinicaltrials.gov/study/NCT00006473,NCT00006473,Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Waldenstrm Macroglobulinemia
1514,0.998928895,180.9529063,https://clinicaltrials.gov/study/NCT00320073,NCT00320073,"Unspecified Adult Solid Tumor, Protocol Specific"
1515,0.990479448,150.5247896,https://clinicaltrials.gov/study/NCT02115373,NCT02115373,"Carcinoma, Hepatocellular"
1516,0.993030906,153.2033088,https://clinicaltrials.gov/study/NCT04242173,NCT04242173,Cutaneous Squamous Cell Carcinoma|Cutaneous Squamous Cell Carcinoma of the Head and Neck
1517,0.995982646,155.6610099,https://clinicaltrials.gov/study/NCT02907073,NCT02907073,Myeloma|Endometrial Cancer
1518,0.996788453,159.1841251,https://clinicaltrials.gov/study/NCT00091273,NCT00091273,Ovarian Cancer|Primary Peritoneal Cavity Cancer
1519,0.969507476,54.54920923,https://clinicaltrials.gov/study/NCT00122473,NCT00122473,Dermatofibrosarcoma
1520,0.996165165,157.7923016,https://clinicaltrials.gov/study/NCT00946673,NCT00946673,"Brain Cancer|Neoplasm Metastasis|Lung Cancer|Carcinoma, Non-Small-Cell Lung"
1521,0.9931174,152.3784618,https://clinicaltrials.gov/study/NCT00765973,NCT00765973,Small Cell Lung Cancer|Ovarian Cancer|Solid Tumors
1522,0.983552865,125.4697807,https://clinicaltrials.gov/study/NCT00776373,NCT00776373,ALL|Burkitt's Lymphoma|Lymphoblastic Leukemia|CML
1523,0.995691802,154.5425492,https://clinicaltrials.gov/study/NCT00292864,NCT00292864,Tumors
1524,0.841594233,13.64988711,https://clinicaltrials.gov/study/NCT01356264,NCT01356264,Colorectal Cancer|Colorectal Cancer Stage III
1525,0.999808592,187.4474904,https://clinicaltrials.gov/study/NCT00004864,NCT00004864,"Unspecified Adult Solid Tumor, Protocol Specific"
1526,0.999463757,188.6924594,https://clinicaltrials.gov/study/NCT00017264,NCT00017264,Brain and Central Nervous System Tumors
1527,0.975786471,77.86149245,https://clinicaltrials.gov/study/NCT00426764,NCT00426764,Peripheral T-cell Lymphoma
1528,0.992517979,151.6713099,https://clinicaltrials.gov/study/NCT01003964,NCT01003964,Non Small Cell Lung Cancer
1529,0.997357094,164.9047756,https://clinicaltrials.gov/study/NCT01630564,NCT01630564,Hematopoietic and Lymphoid Cell Neoplasm
1530,0.988670786,150.5220754,https://clinicaltrials.gov/study/NCT02115464,NCT02115464,Lung Cancer
1531,0.931096677,32.69726307,https://clinicaltrials.gov/study/NCT02852564,NCT02852564,Bladder Cancer
1532,0.995047739,154.1761359,https://clinicaltrials.gov/study/NCT03306264,NCT03306264,Myelodysplastic Syndromes|Chronic Myelomonocytic Leukemia|Acute Myeloid Leukemia
1533,0.911945675,22.7038365,https://clinicaltrials.gov/study/NCT01214564,NCT01214564,Seborrheic Keratosis
1534,0.997845158,165.7551718,https://clinicaltrials.gov/study/NCT02203864,NCT02203864,Melanoma
1535,0.997071094,159.1030388,https://clinicaltrials.gov/study/NCT00104364,NCT00104364,Cancer
1536,0.992713118,153.3625317,https://clinicaltrials.gov/study/NCT04318561,NCT04318561,Neuroendocrine Tumors
1537,0.999892585,191.0676562,https://clinicaltrials.gov/study/NCT00049361,NCT00049361,"Brain and Central Nervous System Tumors|Unspecified Adult Solid Tumor, Protocol Specific"
1538,0.994481569,153.4174402,https://clinicaltrials.gov/study/NCT01253161,NCT01253161,Neuroendocrine Tumors|Carcinoid Tumors
1539,0.986756022,130.2022963,https://clinicaltrials.gov/study/NCT01450761,NCT01450761,Small Cell Lung Carcinoma
1540,0.99337576,153.5718649,https://clinicaltrials.gov/study/NCT02192346,NCT02192346,Metastatic Carcinoma|Metastatic Sarcoma|Metastatic Lymphoma
1541,0.994411756,155.9589806,https://clinicaltrials.gov/study/NCT00671710,NCT00671710,Brain Tumors
1542,0.990710044,151.4307614,https://clinicaltrials.gov/study/NCT03241810,NCT03241810,Metastatic Breast Cancer
1543,0.990217123,150.4424096,https://clinicaltrials.gov/study/NCT00287846,NCT00287846,Desmoid Tumor
1544,0.998801016,179.2729106,https://clinicaltrials.gov/study/NCT01612546,NCT01612546,Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Esophageal Cancer|Recurrent Gastric Cancer|Squamous Cell Carcinoma of the Esophagus|Stage IIIB Esophageal Cancer|Stage IIIB Gastric Cancer|Stage IIIC Esophageal Cancer|Stage IIIC Gastric Cancer|Stage IV Esophageal Cancer|Stage IV Gastric Cancer
1545,0.872014771,14.95503583,https://clinicaltrials.gov/study/NCT01585246,NCT01585246,Prostate Cancer
1546,0.98665593,147.6134639,https://clinicaltrials.gov/study/NCT02106546,NCT02106546,Squamous Non-Small Cell Lung Cancer
1547,0.995924885,156.8820541,https://clinicaltrials.gov/study/NCT01386346,NCT01386346,Esophageal Cancer|Malignant Neoplasm of Cardio-esophageal Junction of Stomach
1548,0.997206984,162.3513974,https://clinicaltrials.gov/study/NCT01528046,NCT01528046,Solid Tumors|Primary Brain Tumors
1549,0.989446676,151.0577993,https://clinicaltrials.gov/study/NCT03653546,NCT03653546,Non-small Cell Lung Cancer|EGFR Gene Mutation|Brain Metastases
1550,0.999066404,194.7224151,https://clinicaltrials.gov/study/NCT01222546,NCT01222546,Solid Tumors
1551,0.974706872,96.36157371,https://clinicaltrials.gov/study/NCT00793546,NCT00793546,Advanced Breast Cancer
1552,0.999826538,182.054592,https://clinicaltrials.gov/study/NCT00617773,NCT00617773,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cancer
1553,0.985581975,150.1154813,https://clinicaltrials.gov/study/NCT02358473,NCT02358473,Non-Small Cell Lung Cancer
1554,0.974232498,90.04363265,https://clinicaltrials.gov/study/NCT00208273,NCT00208273,Breast Cancer
1555,0.859942576,15.47422723,https://clinicaltrials.gov/study/NCT00486473,NCT00486473,Breast Cancer
1556,0.997570648,162.5131157,https://clinicaltrials.gov/study/NCT00427973,NCT00427973,Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
1557,0.972740982,81.52073134,https://clinicaltrials.gov/study/NCT00252473,NCT00252473,Head and Neck Neoplasms
1558,0.947638117,30.35232479,https://clinicaltrials.gov/study/NCT01405573,NCT01405573,Advanced Adult Hepatocellular Carcinoma
1559,0.966638018,66.59750611,https://clinicaltrials.gov/study/NCT00015873,NCT00015873,Leukemia
1560,0.995963767,157.1802624,https://clinicaltrials.gov/study/NCT00157573,NCT00157573,Ovarian Cancer|Fallopian Tube Cancer
1561,0.904256072,21.47703486,https://clinicaltrials.gov/study/NCT01512173,NCT01512173,Infantile Hemangioma
1562,0.980604578,99.27840463,https://clinicaltrials.gov/study/NCT00422773,NCT00422773,Metastatic Colorectal Cancer
1563,0.760575925,8.722148608,https://clinicaltrials.gov/study/NCT01782573,NCT01782573,Liver Tumors
1564,0.938460649,27.98985827,https://clinicaltrials.gov/study/NCT02384473,NCT02384473,Adult Soft Tissue Sarcoma|Bone Sarcoma|Retroperitoneal Sarcoma
1565,0.999224497,192.2152849,https://clinicaltrials.gov/study/NCT01123473,NCT01123473,Adenocarcinoma of the Gastroesophageal Junction|Gastric Cancer
1566,0.998165695,172.91059,https://clinicaltrials.gov/study/NCT03126864,NCT03126864,Hematopoietic/Lymphoid Cancer|Acute Myeloid Leukemia
1567,0.996583287,157.7509576,https://clinicaltrials.gov/study/NCT02859064,NCT02859064,Neuroendocrine Tumors|Gastrointestinal Neoplasms|Carcinoid Tumors
1568,0.932484916,31.00841692,https://clinicaltrials.gov/study/NCT00038064,NCT00038064,Neoplasms|Anemia
1569,0.997622865,164.8365314,https://clinicaltrials.gov/study/NCT00052364,NCT00052364,Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
1570,0.995439449,156.7096862,https://clinicaltrials.gov/study/NCT00031564,NCT00031564,Kidney Cancer
1571,0.957612944,46.32013741,https://clinicaltrials.gov/study/NCT00369564,NCT00369564,Kidney Cancer|Leukemia|Lymphoma|Neurotoxicity|Peripheral Neuropathy|Sarcoma
1572,0.854745987,14.9787874,https://clinicaltrials.gov/study/NCT00812864,NCT00812864,Breast Cancer|Colorectal Cancer
1573,0.997439694,163.465843,https://clinicaltrials.gov/study/NCT00612664,NCT00612664,Melanoma
1574,0.987650947,150.5677051,https://clinicaltrials.gov/study/NCT02888964,NCT02888964,"Leukemia, Myeloid, Chronic-Phase"
1575,0.997163567,160.430273,https://clinicaltrials.gov/study/NCT00984464,NCT00984464,Metastatic Melanoma
1576,0.996410511,159.1094743,https://clinicaltrials.gov/study/NCT02018861,NCT02018861,B-Cell Malignancies
1577,0.987064983,128.3456551,https://clinicaltrials.gov/study/NCT00799461,NCT00799461,"Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Atypical Chronic Myeloid Leukemia, BCR-ABL Negative|Blastic Phase Chronic Myelogenous Leukemia|Cancer Survivor|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|de Novo Myelodysplastic Syndromes|Depression|Disseminated Neuroblastoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Fatigue|Long-term Effects Secondary to Cancer Therapy in Adults|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Psychosocial Effects of Cancer and Its Treatment|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma"
1578,0.995964647,157.1118358,https://clinicaltrials.gov/study/NCT01920061,NCT01920061,Neoplasm
1579,0.969090179,71.06739414,https://clinicaltrials.gov/study/NCT03351361,NCT03351361,Advanced Non Small Cell Lung Cancer
1580,0.988098668,150.1155547,https://clinicaltrials.gov/study/NCT03535961,NCT03535961,Breast Cancer
1581,0.988468595,150.3773181,https://clinicaltrials.gov/study/NCT04969861,NCT04969861,Metastatic Head and Neck Cancer|Recurrent Head and Neck Cancer
1582,0.687106286,5.268744052,https://clinicaltrials.gov/study/NCT01576146,NCT01576146,Secondary Hyperparathyroidism
1583,0.982045085,119.8190511,https://clinicaltrials.gov/study/NCT02337946,NCT02337946,Colorectal Carcinoma
1584,0.988997175,150.811223,https://clinicaltrials.gov/study/NCT01565746,NCT01565746,Prostatic Neoplasms
1585,0.94887951,36.85614274,https://clinicaltrials.gov/study/NCT00230646,NCT00230646,Colon Cancer|Rectal Cancer
1586,0.999331745,186.5079386,https://clinicaltrials.gov/study/NCT00625846,NCT00625846,Recurrent Thyroid Gland Carcinoma|Stage III Differentiated Thyroid Gland Carcinoma AJCC v7|Stage III Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7|Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7|Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7|Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7|Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7|Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7|Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7|Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7|Thyroid Gland Anaplastic Carcinoma
1587,0.998114046,165.1722523,https://clinicaltrials.gov/study/NCT00056173,NCT00056173,"Carcinoma, Renal Cell|Metastases, Neoplasm"
1588,0.893105367,15.24691737,https://clinicaltrials.gov/study/NCT04351373,NCT04351373,Vestibular Schwannoma
1589,0.998222838,172.6090812,https://clinicaltrials.gov/study/NCT02649673,NCT02649673,Small Cell Lung Cancer|Ovarian Cancer
1590,0.999335311,178.5831827,https://clinicaltrials.gov/study/NCT00976573,NCT00976573,Melanoma (Skin)
1591,0.969295564,60.95463846,https://clinicaltrials.gov/study/NCT00301873,NCT00301873,Brain Tumors|Osteoporosis|Central Nervous System(CNS)Malignancies
1592,0.77745556,7.564903334,https://clinicaltrials.gov/study/NCT00892073,NCT00892073,Hypothalamic Obesity
1593,0.994725326,155.192669,https://clinicaltrials.gov/study/NCT01110473,NCT01110473,Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|B-cell Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplasia
1594,0.997781928,161.6605125,https://clinicaltrials.gov/study/NCT01548573,NCT01548573,Multiple Myeloma
1595,0.99227174,152.8588947,https://clinicaltrials.gov/study/NCT01334073,NCT01334073,"Malignant Advanced Solid Tumors|Carcinoma, Renal Cell"
1596,0.734318285,6.482686882,https://clinicaltrials.gov/study/NCT01924273,NCT01924273,Port-Wine Stain
1597,0.862700775,13.75806313,https://clinicaltrials.gov/study/NCT00151073,NCT00151073,Hormone-Refractory Prostate Cancer
1598,0.934864571,33.89519469,https://clinicaltrials.gov/study/NCT00738673,NCT00738673,Prostate Cancer
1599,0.986020996,150.3254653,https://clinicaltrials.gov/study/NCT00789373,NCT00789373,Non-Small Cell Lung Cancer
1600,0.879265736,16.31021901,https://clinicaltrials.gov/study/NCT00635973,NCT00635973,Cancer
1601,0.978482598,100.1454841,https://clinicaltrials.gov/study/NCT00719173,NCT00719173,Breast Cancer|Nausea and Vomiting
1602,0.975155113,67.32174253,https://clinicaltrials.gov/study/NCT00344773,NCT00344773,Pulmonary Cancer
1603,0.652493888,4.709244978,https://clinicaltrials.gov/study/NCT00171964,NCT00171964,Pain|Neoplasm Metastasis|Cancer
1604,0.999677269,187.3744195,https://clinicaltrials.gov/study/NCT00305864,NCT00305864,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma
1605,0.966598928,60.26656934,https://clinicaltrials.gov/study/NCT02028364,NCT02028364,Breast Cancer
1606,0.889680057,16.84798047,https://clinicaltrials.gov/study/NCT02744664,NCT02744664,Lung Neoplasms
1607,0.988949126,151.2759666,https://clinicaltrials.gov/study/NCT03070964,NCT03070964,Lymphoma
1608,0.996750814,158.1148571,https://clinicaltrials.gov/study/NCT01253564,NCT01253564,Malignant Melanoma
1609,0.987938401,150.1549865,https://clinicaltrials.gov/study/NCT01514864,NCT01514864,"Carcinoma, Non-small Cell Lung"
1610,0.995090475,155.5609709,https://clinicaltrials.gov/study/NCT02440464,NCT02440464,Multiple Myeloma
1611,0.999311433,187.3742752,https://clinicaltrials.gov/study/NCT00022464,NCT00022464,Melanoma (Skin)
1612,0.992280239,151.6482952,https://clinicaltrials.gov/study/NCT00502164,NCT00502164,Advanced Prostate Adenocarcinoma
1613,0.948678719,37.28964929,https://clinicaltrials.gov/study/NCT02202564,NCT02202564,Liver Cancer|Hepatocellular Carcinoma
1614,0.994812143,154.4207976,https://clinicaltrials.gov/study/NCT00574964,NCT00574964,Primary Glioblastoma Multiforme
1615,0.998498173,175.5971273,https://clinicaltrials.gov/study/NCT00006264,NCT00006264,Lymphoma
1616,0.994040793,154.1089646,https://clinicaltrials.gov/study/NCT03176264,NCT03176264,Metastatic Colorectal Cancer
1617,0.989511062,150.7004348,https://clinicaltrials.gov/study/NCT02874664,NCT02874664,Small Cell Lung Carcinoma
1618,0.995939574,155.8929294,https://clinicaltrials.gov/study/NCT02218164,NCT02218164,"Squamous Cell Carcinoma of Skin|Carcinoma, Squamous Cell"
1619,0.853980667,13.6270698,https://clinicaltrials.gov/study/NCT02816164,NCT02816164,Early Stage Breast Cancer
1620,0.995591758,155.533263,https://clinicaltrials.gov/study/NCT00439361,NCT00439361,Hodgkin Lymphoma|Lymphoma
1621,0.809558197,8.845203868,https://clinicaltrials.gov/study/NCT02464761,NCT02464761,Vertebral Metastases
1622,0.992730912,151.560932,https://clinicaltrials.gov/study/NCT00702572,NCT00702572,Non-small Cell Lung Cancer
1623,0.999595732,187.1834678,https://clinicaltrials.gov/study/NCT02094872,NCT02094872,Recurrent Melanoma|Stage IIIA Melanoma|Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV Melanoma
1624,0.989276657,151.274937,https://clinicaltrials.gov/study/NCT00112372,NCT00112372,Cancer
1625,0.985593678,138.0025202,https://clinicaltrials.gov/study/NCT02124772,NCT02124772,Cancer
1626,0.979482559,94.23739271,https://clinicaltrials.gov/study/NCT02513472,NCT02513472,Breast Neoplasm
1627,0.99720505,159.5569742,https://clinicaltrials.gov/study/NCT00326872,NCT00326872,Neurofibromatosis Type 1|Plexiform Neurofibroma|Spinal Cord Neurofibroma
1628,0.998214959,169.8787806,https://clinicaltrials.gov/study/NCT00002972,NCT00002972,Lung Cancer
1629,0.998871196,189.471038,https://clinicaltrials.gov/study/NCT00052572,NCT00052572,Leukemia|Lymphoma
1630,0.960190597,51.21754552,https://clinicaltrials.gov/study/NCT00943072,NCT00943072,Macular Edema Secondary to Central Retinal Vein Occlusion
1631,0.995020212,156.0379847,https://clinicaltrials.gov/study/NCT02174172,NCT02174172,Solid Cancers
1632,0.998684097,171.0172346,https://clinicaltrials.gov/study/NCT00425672,NCT00425672,Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
1633,0.999111359,187.7816829,https://clinicaltrials.gov/study/NCT00942162,NCT00942162,Melanoma
1634,0.979964966,83.7101144,https://clinicaltrials.gov/study/NCT01130662,NCT01130662,Acute Myeloid Leukemia
1635,0.996925063,161.8312572,https://clinicaltrials.gov/study/NCT00917462,NCT00917462,Esophageal Cancer|Gastroesophageal Junction Cancer
1636,0.999460036,186.2492802,https://clinicaltrials.gov/study/NCT00003462,NCT00003462,Brain and Central Nervous System Tumors
1637,0.998180938,171.4660389,https://clinicaltrials.gov/study/NCT00025662,NCT00025662,"Graft vs Host Disease|Myelodysplastic Syndromes|Leukemia|Leukemia, Myeloid|Leukemia, Myelomonocytic, Chronic|Leukemia, Lymphocytic|Lymphoma|Lymphoma, Mantle-cell|Lymphoma, Non-Hodgkin|Hodgkin Disease"
1638,0.964538947,54.5861878,https://clinicaltrials.gov/study/NCT02204462,NCT02204462,Breast Cancer
1639,0.99840046,175.2590637,https://clinicaltrials.gov/study/NCT00725062,NCT00725062,Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
1640,0.994052522,154.8124343,https://clinicaltrials.gov/study/NCT04071262,NCT04071262,Advanced Cancer
1641,0.604927852,4.114594888,https://clinicaltrials.gov/study/NCT01700062,NCT01700062,Colorectal Neoplasms
1642,0.999626718,192.0926251,https://clinicaltrials.gov/study/NCT00639262,NCT00639262,Brain Metastases|Primary Brain Tumors
1643,0.991961997,151.8650389,https://clinicaltrials.gov/study/NCT00702962,NCT00702962,Small Cell Lung Cancer
1644,0.997282419,160.8835166,https://clinicaltrials.gov/study/NCT00032110,NCT00032110,Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
1645,0.999309627,188.095165,https://clinicaltrials.gov/study/NCT00003710,NCT00003710,"Unspecified Adult Solid Tumor, Protocol Specific"
1646,0.99391654,154.6924543,https://clinicaltrials.gov/study/NCT01034410,NCT01034410,Acute Myeloid Leukemia
1647,0.997802145,168.175438,https://clinicaltrials.gov/study/NCT01096810,NCT01096810,Multiple Myeloma
1648,0.996039375,156.5428936,https://clinicaltrials.gov/study/NCT02853110,NCT02853110,Prostate Cancer Adenocarcinoma
1649,0.996915348,159.1433489,https://clinicaltrials.gov/study/NCT01914510,NCT01914510,Ovarian Clear Cell Carcinoma
1650,0.976980472,88.28299922,https://clinicaltrials.gov/study/NCT02274610,NCT02274610,Solid Tumor
1651,0.980780244,77.89393519,https://clinicaltrials.gov/study/NCT04422210,NCT04422210,Small Cell Lung Cancer
1652,0.928975704,34.14115151,https://clinicaltrials.gov/study/NCT00458510,NCT00458510,"Cancers, Pain"
1653,0.998520601,171.6297436,https://clinicaltrials.gov/study/NCT00977210,NCT00977210,Solid Tumors
1654,0.989838027,151.2821197,https://clinicaltrials.gov/study/NCT02636010,NCT02636010,Multiple Myeloma
1655,0.986219342,112.6280332,https://clinicaltrials.gov/study/NCT00663910,NCT00663910,Non-melanomatous Skin Cancer
1656,0.998572955,173.7145154,https://clinicaltrials.gov/study/NCT00717210,NCT00717210,Anaplastic Astrocytoma|Oligodendroglioma|Oligoastrocytoma
1657,0.980842896,106.52795,https://clinicaltrials.gov/study/NCT00500110,NCT00500110,Prostate Cancer
1658,0.992833695,151.6480016,https://clinicaltrials.gov/study/NCT01919710,NCT01919710,Underdose (Unintentional)|Cancer|Tumor
1659,0.98605926,133.686977,https://clinicaltrials.gov/study/NCT01830010,NCT01830010,Hematological Malignancies
1660,0.991013737,151.9365112,https://clinicaltrials.gov/study/NCT00670410,NCT00670410,Neuroblastoma
1661,0.999557179,185.8391303,https://clinicaltrials.gov/study/NCT01792310,NCT01792310,Glioma|Other Solid Tumours
1662,0.952624367,44.17939664,https://clinicaltrials.gov/study/NCT01441310,NCT01441310,Gastric Cancer
1663,0.997264383,161.9143431,https://clinicaltrials.gov/study/NCT02467010,NCT02467010,Multiple Myeloma
1664,0.955702482,48.50734176,https://clinicaltrials.gov/study/NCT03703310,NCT03703310,Basal Cell Nevus Syndrome
1665,0.905336368,16.0790757,https://clinicaltrials.gov/study/NCT01677910,NCT01677910,Carcinoid Syndrome
1666,0.988241791,150.0498754,https://clinicaltrials.gov/study/NCT02639910,NCT02639910,"Leukemia, Lymphocytic, Chronic, B-Cell|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma"
1667,0.972796803,63.24098393,https://clinicaltrials.gov/study/NCT00983710,NCT00983710,Prostate Cancer
1668,0.897986649,22.80157427,https://clinicaltrials.gov/study/NCT01004510,NCT01004510,Malignant Pleural Effusion|Non Small Cell Lung Cancer
1669,0.990853749,152.0304032,https://clinicaltrials.gov/study/NCT01620710,NCT01620710,Prostate Cancer
1670,0.989060478,150.5275287,https://clinicaltrials.gov/study/NCT04003610,NCT04003610,Metastatic Urothelial Carcinoma|Unresectable Urothelial Carcinoma
1671,0.998865789,185.7950216,https://clinicaltrials.gov/study/NCT00453310,NCT00453310,Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor
1672,0.979081205,88.00845909,https://clinicaltrials.gov/study/NCT04056910,NCT04056910,Advanced Solid Tumor|IDH1 Mutation|Glioma
1673,0.998873998,181.1523845,https://clinicaltrials.gov/study/NCT00019110,NCT00019110,Anal Cancer|Cervical Cancer|Esophageal Cancer|Head and Neck Cancer|Penile Cancer|Vulvar Cancer
1674,0.99452914,154.8290278,https://clinicaltrials.gov/study/NCT00006110,NCT00006110,Breast Cancer
1675,0.984735991,115.4338841,https://clinicaltrials.gov/study/NCT01703910,NCT01703910,Adenocarcinoma of Colon|Adenocarcinoma of Rectum|Metastatic Disease
1676,0.819909276,12.26309532,https://clinicaltrials.gov/study/NCT00088010,NCT00088010,"Osteoporosis, Postmenopausal"
1677,0.789773752,8.854002808,https://clinicaltrials.gov/study/NCT02632110,NCT02632110,Actinic Keratosis
1678,0.99728497,160.2639273,https://clinicaltrials.gov/study/NCT00062010,NCT00062010,Lung Cancer
1679,0.99926872,189.8451396,https://clinicaltrials.gov/study/NCT02038010,NCT02038010,HER2-positive Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
1680,0.986124188,143.1175035,https://clinicaltrials.gov/study/NCT00467610,NCT00467610,Myelodysplastic Syndrome
1681,0.997111121,159.4245678,https://clinicaltrials.gov/study/NCT02032810,NCT02032810,Melanoma|Skin Cancer
1682,0.987866958,136.352939,https://clinicaltrials.gov/study/NCT01187810,NCT01187810,Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Non-Hodgkin's Lymphoma
1683,0.957508967,38.12912609,https://clinicaltrials.gov/study/NCT00362310,NCT00362310,Classical Kaposi's Sarcoma
1684,0.974943943,80.49337609,https://clinicaltrials.gov/study/NCT03590210,NCT03590210,Metastatic Adult Soft Tissue Sarcoma
1685,0.952381071,45.91238336,https://clinicaltrials.gov/study/NCT01550510,NCT01550510,Stage IV Colorectal Cancer
1686,0.997076525,161.2248162,https://clinicaltrials.gov/study/NCT00006010,NCT00006010,Liver Cancer
1687,0.998841446,177.4848248,https://clinicaltrials.gov/study/NCT00003210,NCT00003210,Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrm Macroglobulinemia
1688,0.909846667,18.56348566,https://clinicaltrials.gov/study/NCT01059110,NCT01059110,Plantar Warts
1689,0.998738653,171.8668108,https://clinicaltrials.gov/study/NCT02275910,NCT02275910,Tumors
1690,0.994175664,154.1096251,https://clinicaltrials.gov/study/NCT01809210,NCT01809210,Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
1691,0.996033016,158.5187749,https://clinicaltrials.gov/study/NCT03150810,NCT03150810,Locally Advanced or Metastatic Solid Tumors
1692,0.992340176,152.745407,https://clinicaltrials.gov/study/NCT00877110,NCT00877110,"Neuroblastoma|Bone Marrow, Sympathetic Nervous System"
1693,0.998436768,169.525815,https://clinicaltrials.gov/study/NCT02082210,NCT02082210,Advanced Cancer|Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Hepatocellular Cancer|Renal Cell Carcinoma|Non-Small Cell Lung Cancer
1694,0.981383306,97.46490587,https://clinicaltrials.gov/study/NCT00527410,NCT00527410,Leptomeningeal Carcinomatosis
1695,0.977737102,103.4846741,https://clinicaltrials.gov/study/NCT00116610,NCT00116610,Small Cell Lung Cancer
1696,0.998629137,178.5031308,https://clinicaltrials.gov/study/NCT00003010,NCT00003010,Breast Cancer
1697,0.99794809,167.9160054,https://clinicaltrials.gov/study/NCT02122861,NCT02122861,Melanoma - Currently Enrolling|Non-small Cell Lung Cancer - Enrollment Completed|Sarcoma - Enrollment Completed
1698,0.997183518,160.4230282,https://clinicaltrials.gov/study/NCT03330561,NCT03330561,HER2-positive Breast Cancer|HER2-positive Gastric Cancer|HER2-positive Bladder Cancer|HER2-positive Solid Tumor
1699,0.999519895,188.443516,https://clinicaltrials.gov/study/NCT03425461,NCT03425461,Metastatic Melanoma|Stage III Cutaneous Melanoma AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7
1700,0.993191554,152.4286029,https://clinicaltrials.gov/study/NCT02468661,NCT02468661,Non-Small Cell Lung Cancer
1701,0.999217387,192.7033952,https://clinicaltrials.gov/study/NCT00003961,NCT00003961,Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
1702,0.962867897,53.57442146,https://clinicaltrials.gov/study/NCT00434161,NCT00434161,Multiple Myeloma
1703,0.980198018,118.792888,https://clinicaltrials.gov/study/NCT01019161,NCT01019161,Acute Myeloid Leukaemia
1704,0.981232377,98.23802263,https://clinicaltrials.gov/study/NCT00709761,NCT00709761,"Neoplasms, Breast"
1705,0.990173287,150.0146814,https://clinicaltrials.gov/study/NCT02674061,NCT02674061,Ovarian Neoplasms
1706,0.99839418,175.2329821,https://clinicaltrials.gov/study/NCT03318861,NCT03318861,Relapsed/Refractory Multiple Myeloma
1707,0.997403437,161.6926655,https://clinicaltrials.gov/study/NCT03411161,NCT03411161,Metastatic Breast Cancer|Metastatic Triple Negative Breast Cancer
1708,0.834150196,9.157052686,https://clinicaltrials.gov/study/NCT03387761,NCT03387761,Urothelial Carcinoma
1709,0.98603865,150.5314,https://clinicaltrials.gov/study/NCT03129061,NCT03129061,Squamous Cell Carcinoma of the Head and Neck
1710,0.7680968,7.465927382,https://clinicaltrials.gov/study/NCT03649061,NCT03649061,"Arthritis, Rheumatoid"
1711,0.992908098,152.1536335,https://clinicaltrials.gov/study/NCT01186861,NCT01186861,Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy
1712,0.819245236,8.758521214,https://clinicaltrials.gov/study/NCT00352261,NCT00352261,Barrett's Esophagus
1713,0.990166903,151.0066914,https://clinicaltrials.gov/study/NCT00640861,NCT00640861,Breast Cancer
1714,0.998956196,188.295685,https://clinicaltrials.gov/study/NCT02311361,NCT02311361,Pancreatic Neoplasms|Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer
1715,0.998856025,187.4391964,https://clinicaltrials.gov/study/NCT03240861,NCT03240861,HLA-A*0201 Positive Cells Present|Locally Advanced Malignant Neoplasm|NY-ESO-1 Positive|Unresectable Malignant Neoplasm|Sarcoma
1716,0.999231819,186.8553801,https://clinicaltrials.gov/study/NCT02921061,NCT02921061,Mixed Phenotype Acute Leukemia|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Myeloid Leukemia|Recurrent High Risk Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory High Risk Myelodysplastic Syndrome|Untreated Adult Acute Myeloid Leukemia
1717,0.996369153,156.3958844,https://clinicaltrials.gov/study/NCT02125461,NCT02125461,Non-Small Cell Lung Cancer
1718,0.992830089,152.7568601,https://clinicaltrials.gov/study/NCT02187861,NCT02187861,Follicular Lymphoma
1719,0.985328267,132.7313799,https://clinicaltrials.gov/study/NCT01946061,NCT01946061,Advanced Gastric Cancer
1720,0.990382035,151.3695964,https://clinicaltrials.gov/study/NCT00163761,NCT00163761,Non-Hodgkin's Lymphoma|Hodgkin's Disease
1721,0.997503328,163.3838019,https://clinicaltrials.gov/study/NCT00655161,NCT00655161,NSCLC
1722,0.718174394,5.689906807,https://clinicaltrials.gov/study/NCT00747461,NCT00747461,"Lung Diseases, Obstructive|Sarcoidosis|Wegener's Granulomatosis|Rhinoscleroma|Recurrent Respiratory Papillomatosis"
1723,0.976503267,97.53628907,https://clinicaltrials.gov/study/NCT02611661,NCT02611661,Metastatic Colorectal Cancer
1724,0.981985696,104.7237786,https://clinicaltrials.gov/study/NCT00302861,NCT00302861,B-Cell Chronic Lymphocytic Leukemia
1725,0.988718384,150.1336856,https://clinicaltrials.gov/study/NCT02061761,NCT02061761,Hematologic Neoplasms
1726,0.999658766,182.1768433,https://clinicaltrials.gov/study/NCT00365053,NCT00365053,Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
1727,0.997107695,159.7399119,https://clinicaltrials.gov/study/NCT00290953,NCT00290953,Lung Cancer|Pulmonary Neoplasms|Small Cell Lung Cancer
1728,0.998761672,183.5963164,https://clinicaltrials.gov/study/NCT00478361,NCT00478361,Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Urethral Cancer Associated With Invasive Bladder Cancer
1729,0.995737851,154.4454462,https://clinicaltrials.gov/study/NCT00400361,NCT00400361,Neoplasms
1730,0.953274378,41.9430874,https://clinicaltrials.gov/study/NCT01540461,NCT01540461,Hepatocellular Carcinoma
1731,0.993857931,153.894108,https://clinicaltrials.gov/study/NCT03117361,NCT03117361,Multiple Myeloma
1732,0.991352576,152.0152909,https://clinicaltrials.gov/study/NCT00652561,NCT00652561,Advanced Non-Small Cell Lung Cancer
1733,0.982433525,121.0672058,https://clinicaltrials.gov/study/NCT00367861,NCT00367861,Sarcoma|Gastro-intestinal Stromal Tumors (GIST)
1734,0.961757724,56.43342398,https://clinicaltrials.gov/study/NCT02820961,NCT02820961,Breast Cancer|Estrogen Receptor Positive Breast Cancer
1735,0.958609383,46.74647543,https://clinicaltrials.gov/study/NCT01383746,NCT01383746,"Cholestasis, Progressive Familial Intrahepatic 3"
1736,0.984931175,135.7819639,https://clinicaltrials.gov/study/NCT01243346,NCT01243346,D842-related Mutant GIST
1737,0.821759419,9.063082966,https://clinicaltrials.gov/study/NCT04852510,NCT04852510,Polycystic Ovary Syndrome (PCOS)
1738,0.972585281,68.50967495,https://clinicaltrials.gov/study/NCT02452346,NCT02452346,Myelodysplastic Syndrome
1739,0.96963185,77.09573005,https://clinicaltrials.gov/study/NCT02038946,NCT02038946,Lymphoma
1740,0.818811049,10.7210164,https://clinicaltrials.gov/study/NCT01568346,NCT01568346,Breast Cancer
1741,0.998443013,175.4875417,https://clinicaltrials.gov/study/NCT03333746,NCT03333746,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
1742,0.983140472,149.4248154,https://clinicaltrials.gov/study/NCT00000646,NCT00000646,HIV Infections
1743,0.993393985,152.9561428,https://clinicaltrials.gov/study/NCT01457846,NCT01457846,Gastro-oesophageal Junction Cancer|Gastric Cancer
1744,0.896726878,13.56822606,https://clinicaltrials.gov/study/NCT01022346,NCT01022346,Cervical Intraepithelial Neoplasia
1745,0.997410925,160.690677,https://clinicaltrials.gov/study/NCT02597946,NCT02597946,"Carcinoma, Non-Small-Cell Lung"
1746,0.97513125,85.95578807,https://clinicaltrials.gov/study/NCT03921073,NCT03921073,Angiosarcoma of Skin
1747,0.991957502,152.7590468,https://clinicaltrials.gov/study/NCT05176873,NCT05176873,"Lymphoma, Non-Hodgkin"
1748,0.998821957,177.9472642,https://clinicaltrials.gov/study/NCT00113373,NCT00113373,Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer
1749,0.996681298,159.6230191,https://clinicaltrials.gov/study/NCT02029573,NCT02029573,Glioblastoma Multiforme
1750,0.996293494,157.369079,https://clinicaltrials.gov/study/NCT01695473,NCT01695473,High Risk Prostate Cancer
1751,0.984517002,104.3329443,https://clinicaltrials.gov/study/NCT00083473,NCT00083473,"Leukemia, Lymphocytic, Chronic|Lymphoma, Small Lymphocytic"
1752,0.980257576,79.47174393,https://clinicaltrials.gov/study/NCT05223673,NCT05223673,Metastatic Colorectal Cancer
1753,0.99499922,153.3496153,https://clinicaltrials.gov/study/NCT03736473,NCT03736473,Advanced Solid Malignancies
1754,0.998240964,169.5156483,https://clinicaltrials.gov/study/NCT00001573,NCT00001573,Glioma|Sarcoma
1755,0.997410013,157.9473878,https://clinicaltrials.gov/study/NCT00003773,NCT00003773,Ovarian Cancer
1756,0.994921429,155.1810691,https://clinicaltrials.gov/study/NCT03996473,NCT03996473,"Carcinoma, Non-Small-Cell Lung"
1757,0.728828609,6.461636541,https://clinicaltrials.gov/study/NCT00886873,NCT00886873,Uterine Fibroids
1758,0.935991262,26.60002663,https://clinicaltrials.gov/study/NCT00550173,NCT00550173,Non-Small-Cell Lung Cancer
1759,0.998787302,179.89736,https://clinicaltrials.gov/study/NCT02938273,NCT02938273,"Carcinoma, Squamous Cell of Head and Neck"
1760,0.999395674,194.9862959,https://clinicaltrials.gov/study/NCT00021164,NCT00021164,"Melanoma (Skin)|Unspecified Adult Solid Tumor, Protocol Specific"
1761,0.995042502,155.2034852,https://clinicaltrials.gov/study/NCT00174564,NCT00174564,Biliary Tract Neoplasms
1762,0.989354489,150.3965131,https://clinicaltrials.gov/study/NCT02488564,NCT02488564,HER-2 Positive Breast Cancer
1763,0.998371031,173.2054129,https://clinicaltrials.gov/study/NCT00346164,NCT00346164,Adult Alveolar Soft-part Sarcoma|Adult Angiosarcoma|Adult Epithelioid Sarcoma|Adult Extraskeletal Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Fibrous Histiocytoma|Adult Malignant Hemangiopericytoma|Adult Malignant Mesenchymoma|Adult Neurofibrosarcoma|Adult Synovial Sarcoma|Childhood Alveolar Soft-part Sarcoma|Childhood Angiosarcoma|Childhood Epithelioid Sarcoma|Childhood Fibrosarcoma|Childhood Leiomyosarcoma|Childhood Liposarcoma|Childhood Malignant Mesenchymoma|Childhood Neurofibrosarcoma|Childhood Synovial Sarcoma|Dermatofibrosarcoma Protuberans|Metastatic Childhood Soft Tissue Sarcoma|Nonmetastatic Childhood Soft Tissue Sarcoma|Stage I Adult Soft Tissue Sarcoma|Stage II Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
1764,0.995674315,154.2039252,https://clinicaltrials.gov/study/NCT01183364,NCT01183364,Solid Tumor Malignancies
1765,0.999188024,189.4532522,https://clinicaltrials.gov/study/NCT00844064,NCT00844064,Pancreatic Neoplasms|Melanoma|Colorectal Neoplasms
1766,0.973137474,73.35786023,https://clinicaltrials.gov/study/NCT00222664,NCT00222664,Hepatitis B|Liver Neoplasms|Liver Diseases
1767,0.965889606,52.96882344,https://clinicaltrials.gov/study/NCT00387764,NCT00387764,"Carcinoma, Renal Cell"
1768,0.992705411,154.1479399,https://clinicaltrials.gov/study/NCT02108964,NCT02108964,Advanced Non-small Cell Lung Cancer
1769,0.986318655,150.3377776,https://clinicaltrials.gov/study/NCT00534664,NCT00534664,Advanced Hepatocellular Carcinoma
1770,0.9976363,166.2278093,https://clinicaltrials.gov/study/NCT00816764,NCT00816764,Carcinoma|Ovarian Cancer|Ovarian Diseases|Ovarian Neoplasms
1771,0.838695393,12.05684363,https://clinicaltrials.gov/study/NCT05222464,NCT05222464,Breast Cancer
1772,0.963048335,41.66148639,https://clinicaltrials.gov/study/NCT00188864,NCT00188864,Neoplasm Metastasis
1773,0.999485381,187.6454852,https://clinicaltrials.gov/study/NCT00301964,NCT00301964,Recurrent Endometrial Carcinoma
1774,0.99875298,179.6686137,https://clinicaltrials.gov/study/NCT00805961,NCT00805961,Glioblastoma Multiforme
1775,0.962684834,55.40599191,https://clinicaltrials.gov/study/NCT02563561,NCT02563561,Bladder Cancer
1776,0.993664258,154.5804024,https://clinicaltrials.gov/study/NCT02308761,NCT02308761,Acute Myeloid Leukemia|Myelodysplastic Syndromes
1777,0.991871832,152.4719955,https://clinicaltrials.gov/study/NCT00977561,NCT00977561,Small Cell Lung Carcinoma
1778,0.953555466,41.43248654,https://clinicaltrials.gov/study/NCT01038661,NCT01038661,Lung Neoplasms
1779,0.99219318,150.5518851,https://clinicaltrials.gov/study/NCT01732861,NCT01732861,Leukemia Lymphocytic Chronic B-Cell
1780,0.995334157,154.9353406,https://clinicaltrials.gov/study/NCT02191761,NCT02191761,Colorectal Cancer|Gastric Cancer|Hepatic Cancer|Pancreatic Cancer
1781,0.993702524,152.1101553,https://clinicaltrials.gov/study/NCT02237261,NCT02237261,Multiple Myeloma
1782,0.960075411,41.14782805,https://clinicaltrials.gov/study/NCT01941953,NCT01941953,Metastatic Colorectal Cancer
1783,0.999561037,189.7646741,https://clinicaltrials.gov/study/NCT00002553,NCT00002553,Leukemia|Lymphoma
1784,0.982173278,104.5253934,https://clinicaltrials.gov/study/NCT02997553,NCT02997553,"Breast Carcinoma|Head and Neck Cancer|Melanoma (Skin)|Squamous Cell Carcinoma, Skin|Cervix Cancer|Endometrium Cancer|Ovary Cancer|Vulva Cancer|Anus Cancer|Rectum Cancer"
1785,0.822182168,11.41490032,https://clinicaltrials.gov/study/NCT01506453,NCT01506453,Acute Lymphoblastic Leukemia|Neuropathy|Neuropathic Pain
1786,0.998721037,177.2238588,https://clinicaltrials.gov/study/NCT00356460,NCT00356460,"Carcinoma, Renal Cell|Melanoma"
1787,0.997289299,163.1116324,https://clinicaltrials.gov/study/NCT01246960,NCT01246960,Stomach Cancer|Esophageal Cancer
1788,0.946684997,37.52688348,https://clinicaltrials.gov/study/NCT04239560,NCT04239560,Radiodermatitis
1789,0.857010019,12.80509691,https://clinicaltrials.gov/study/NCT01172860,NCT01172860,Colorectal Cancer
1790,0.995267012,155.626014,https://clinicaltrials.gov/study/NCT01935960,NCT01935960,Healthy Subject
1791,0.998781003,182.1638244,https://clinicaltrials.gov/study/NCT00004060,NCT00004060,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
1792,0.995716934,156.5755534,https://clinicaltrials.gov/study/NCT03472560,NCT03472560,Non-Small Cell Lung Cancer|Urothelial Cancer
1793,0.868350015,14.76736609,https://clinicaltrials.gov/study/NCT00277160,NCT00277160,Neutropenia|Breast Cancer|Lung Cancer|Non-Hodgkin's Lymphoma|Ovarian Cancer
1794,0.998122095,168.8617243,https://clinicaltrials.gov/study/NCT00876460,NCT00876460,"Carcinoma, Non-Small-Cell Lung"
1795,0.997960741,164.4591709,https://clinicaltrials.gov/study/NCT00597129,NCT00597129,Pancreatic Cancer
1796,0.994741193,154.6218009,https://clinicaltrials.gov/study/NCT00263029,NCT00263029,Rectal Neoplasms
1797,0.993185033,153.89254,https://clinicaltrials.gov/study/NCT02093429,NCT02093429,MDS (Myelodysplastic Syndrome)
1798,0.993374718,152.5378598,https://clinicaltrials.gov/study/NCT01217229,NCT01217229,Hodgkin Lymphoma
1799,0.975079714,75.29615559,https://clinicaltrials.gov/study/NCT03743129,NCT03743129,Non-Small Cell Lung Cancer Stage III
1800,0.998721306,174.3184913,https://clinicaltrials.gov/study/NCT00002829,NCT00002829,Lymphoma
1801,0.979150843,113.9805496,https://clinicaltrials.gov/study/NCT00168129,NCT00168129,Bone Neoplasms
1802,0.984710302,93.04454802,https://clinicaltrials.gov/study/NCT00805129,NCT00805129,Bladder Cancer|Metastatic Transitional Cell Carcinoma
1803,0.987559543,150.3116383,https://clinicaltrials.gov/study/NCT00207077,NCT00207077,Neoplasms
1804,0.988950944,150.2007616,https://clinicaltrials.gov/study/NCT02779777,NCT02779777,Myelodysplastic Syndromes
1805,0.978373943,109.61656,https://clinicaltrials.gov/study/NCT00186277,NCT00186277,Bladder Cancer
1806,0.997460372,161.0747787,https://clinicaltrials.gov/study/NCT00079053,NCT00079053,Head and Neck Cancer
1807,0.998280139,167.1101273,https://clinicaltrials.gov/study/NCT02879760,NCT02879760,Non-Small Cell Lung Cancer
1808,0.998819174,183.3120541,https://clinicaltrials.gov/study/NCT00199160,NCT00199160,Head and Neck Neoplasms
1809,0.995215486,156.9350011,https://clinicaltrials.gov/study/NCT04121260,NCT04121260,Multiple Myeloma
1810,0.990388039,151.2924548,https://clinicaltrials.gov/study/NCT00180960,NCT00180960,Colon Tumors|Rectum Tumors|Appendix Tumors|Peritoneum Tumors|Endocrine Tumors
1811,0.998144653,170.2335359,https://clinicaltrials.gov/study/NCT00015860,NCT00015860,Leukemia
1812,0.98339063,126.1205547,https://clinicaltrials.gov/study/NCT02953860,NCT02953860,Breast Cancer
1813,0.999410132,181.1760291,https://clinicaltrials.gov/study/NCT00002960,NCT00002960,Fallopian Tube Cancer|Metastatic Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
1814,0.959472923,53.33544969,https://clinicaltrials.gov/study/NCT03282760,NCT03282760,Secondary-progressive Multiple Sclerosis
1815,0.999204187,187.276243,https://clinicaltrials.gov/study/NCT00003060,NCT00003060,Melanoma (Skin)
1816,0.99743748,162.3256609,https://clinicaltrials.gov/study/NCT00788060,NCT00788060,Renal Cell Carcinoma
1817,0.99789885,167.0554077,https://clinicaltrials.gov/study/NCT00838929,NCT00838929,Brain Metastases
1818,0.997246493,160.0132892,https://clinicaltrials.gov/study/NCT02448329,NCT02448329,Advanced Gastric Adenocarcinoma
1819,0.958552646,50.29116008,https://clinicaltrials.gov/study/NCT00985829,NCT00985829,Basal Cell Carcinoma
1820,0.998539479,176.5657471,https://clinicaltrials.gov/study/NCT00012129,NCT00012129,Breast Cancer
1821,0.998708867,173.1643284,https://clinicaltrials.gov/study/NCT00027729,NCT00027729,Colorectal Cancer
1822,0.743513144,5.438797536,https://clinicaltrials.gov/study/NCT01290029,NCT01290029,"Chronic Kidney Disease|Hyperparathyroidism, Secondary|Secondary Hyperparathyroidism"
1823,0.998969067,189.029781,https://clinicaltrials.gov/study/NCT02952729,NCT02952729,Advanced Breast Cancer|Advanced Nonsmall Cell Lung Cancer|Advanced Gastric Cancer
1824,0.98876261,150.2739417,https://clinicaltrials.gov/study/NCT00469729,NCT00469729,Hematologic Malignancies|Acute Myeloid Leukemia|Lymphoid Leukemia|Chronic Myeloid Leukemia|Hodgkin's Disease|Non-Hodgkin's Lymphoma|Myelodysplastic Syndromes
1825,0.996228363,158.8044293,https://clinicaltrials.gov/study/NCT00517829,NCT00517829,Gastric Cancer Adenocarcinoma Metastatic
1826,0.997851303,161.0667557,https://clinicaltrials.gov/study/NCT01836029,NCT01836029,"Carcinoma, Squamous Cell of Head and Neck"
1827,0.981355954,98.23715466,https://clinicaltrials.gov/study/NCT00220129,NCT00220129,Oesophageal Carcinoma
1828,0.999839004,187.054754,https://clinicaltrials.gov/study/NCT00022529,NCT00022529,"Unspecified Adult Solid Tumor, Protocol Specific"
1829,0.883948746,14.59204564,https://clinicaltrials.gov/study/NCT01261429,NCT01261429,Pigmented Villonodular Synovitis
1830,0.997287044,160.0875317,https://clinicaltrials.gov/study/NCT00858377,NCT00858377,Advanced Malignancy|Advanced Solid Tumors|Cancer|Solid Tumors|Tumors
1831,0.99060651,150.654397,https://clinicaltrials.gov/study/NCT00897377,NCT00897377,Astrocytomas|Oligodendrogliomas|Oligoastrocytoma
1832,0.998889276,182.3048354,https://clinicaltrials.gov/study/NCT00027677,NCT00027677,"Unspecified Adult Solid Tumor, Protocol Specific"
1833,0.988936377,150.2959966,https://clinicaltrials.gov/study/NCT00069277,NCT00069277,Cancer
1834,0.992045728,152.2353344,https://clinicaltrials.gov/study/NCT03555877,NCT03555877,Breast Cancer Metastatic
1835,0.997265665,161.593334,https://clinicaltrials.gov/study/NCT03338777,NCT03338777,Melanoma
1836,0.957661851,42.92450166,https://clinicaltrials.gov/study/NCT01783353,NCT01783353,Recalcitrant Cutaneous Warts
1837,0.997289958,165.5210578,https://clinicaltrials.gov/study/NCT03136653,NCT03136653,Multiple Myeloma in Relapse
1838,0.995688638,156.9878276,https://clinicaltrials.gov/study/NCT00047060,NCT00047060,Mycosis Fungoides|Sezary Syndrome
1839,0.984046764,117.2336388,https://clinicaltrials.gov/study/NCT01477060,NCT01477060,Metastatic Breast Cancer
1840,0.99624034,157.0785863,https://clinicaltrials.gov/study/NCT01197560,NCT01197560,Diffuse Large B-cell Lymphoma
1841,0.996060887,156.305471,https://clinicaltrials.gov/study/NCT02805660,NCT02805660,Advanced Cancer
1842,0.989853043,151.210937,https://clinicaltrials.gov/study/NCT00490360,NCT00490360,Cancer of the Pancreatic Head
1843,0.899188571,16.40941126,https://clinicaltrials.gov/study/NCT00420160,NCT00420160,Lung Cancer|Heart Disease|COPD
1844,0.996392885,156.4046632,https://clinicaltrials.gov/study/NCT02345460,NCT02345460,Pancreatic Adenocarcinoma|Poorly Differentiated Malignant Neoplasm|Resectable Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer|Undifferentiated Pancreatic Carcinoma
1845,0.992992646,152.2745494,https://clinicaltrials.gov/study/NCT00336960,NCT00336960,Colorectal Cancer
1846,0.950636588,42.49922168,https://clinicaltrials.gov/study/NCT00374660,NCT00374660,Liver Cancer
1847,0.991180125,151.2742055,https://clinicaltrials.gov/study/NCT01534260,NCT01534260,Acute Myeloid Leukemia
1848,0.995357474,156.886752,https://clinicaltrials.gov/study/NCT00521560,NCT00521560,Primary Non-Hodgkin-Lymphoma|Refractory Non-Hodgkin-Lymphoma|CD20+ Aggressive Non-Hodgkin's Lymphoma
1849,0.999354471,188.0274099,https://clinicaltrials.gov/study/NCT01924260,NCT01924260,"Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
1850,0.993772884,152.8176288,https://clinicaltrials.gov/study/NCT00460460,NCT00460460,Lymphoma
1851,0.998120892,170.153348,https://clinicaltrials.gov/study/NCT00496860,NCT00496860,Progressive Metastatic Malignancies
1852,0.968712264,56.43224102,https://clinicaltrials.gov/study/NCT00138060,NCT00138060,Metastatic Colorectal Cancer
1853,0.993808212,153.0222048,https://clinicaltrials.gov/study/NCT03552029,NCT03552029,Acute Myeloid Leukemia
1854,0.875339508,14.3417828,https://clinicaltrials.gov/study/NCT04727229,NCT04727229,Treatment Resistant Depression|Major Depressive Disorder
1855,0.997682535,163.8107749,https://clinicaltrials.gov/study/NCT03765229,NCT03765229,Melanoma
1856,0.981630861,103.4038529,https://clinicaltrials.gov/study/NCT01717729,NCT01717729,Liver Carcinoma
1857,0.988352732,150.6167501,https://clinicaltrials.gov/study/NCT00760929,NCT00760929,Non-Squamous Non-Small Cell Lung Cancer
1858,0.973578839,82.33291037,https://clinicaltrials.gov/study/NCT01919229,NCT01919229,Early Breast Cancer
1859,0.985014104,150.1073858,https://clinicaltrials.gov/study/NCT02795429,NCT02795429,Advanced Hepatocellular Carcinoma
1860,0.973397691,78.22953644,https://clinicaltrials.gov/study/NCT03697629,NCT03697629,Multiple Myeloma in Relapse
1861,0.996579098,158.5324659,https://clinicaltrials.gov/study/NCT03455829,NCT03455829,"Carcinoma, Non-Small-Cell Lung|Lung Cancer|Non-small Cell Lung Cancer"
1862,0.998069092,163.9771975,https://clinicaltrials.gov/study/NCT00065429,NCT00065429,Small Cell Lung Cancer
1863,0.995541202,156.2386388,https://clinicaltrials.gov/study/NCT03259529,NCT03259529,Diffuse Large B Cell Lymphoma
1864,0.984506655,129.0248576,https://clinicaltrials.gov/study/NCT03870529,NCT03870529,Non Small Cell Lung Cancer|Stage I Lung Cancer|Stage Ib Lung Carcinoma|Stage IA Lung Carcinoma AJCC V7|Stage IIA Lung Carcinoma|Stage IIIA Lung Carcinoma
1865,0.984937872,140.9889951,https://clinicaltrials.gov/study/NCT02287129,NCT02287129,Adenocarcinoma of the Esophagogastric Junction
1866,0.991348319,151.9011658,https://clinicaltrials.gov/study/NCT01756729,NCT01756729,Recurrent Glioblastoma Multiforme
1867,0.775707877,8.11145382,https://clinicaltrials.gov/study/NCT00333229,NCT00333229,Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
1868,0.990105748,150.2432734,https://clinicaltrials.gov/study/NCT01617629,NCT01617629,Epithelial Ovarian Cancer
1869,0.992923999,152.8539205,https://clinicaltrials.gov/study/NCT00434629,NCT00434629,B-cell Lymphoma|Non-Hodgkin's Lymphoma
1870,0.998891313,179.9477809,https://clinicaltrials.gov/study/NCT03207529,NCT03207529,Advanced Breast Carcinoma|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Androgen Receptor Positive|HER2/Neu Negative|Metastatic Breast Carcinoma|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|PTEN Positive|Recurrent Breast Carcinoma|Refractory Breast Carcinoma|Triple-Negative Breast Carcinoma
1871,0.904997524,25.13160818,https://clinicaltrials.gov/study/NCT02796729,NCT02796729,"Brain Neoplasms, Malignant|Metastasis"
1872,0.986465528,150.3111694,https://clinicaltrials.gov/study/NCT00712829,NCT00712829,Prostate Cancer
1873,0.926044338,30.49983403,https://clinicaltrials.gov/study/NCT01715129,NCT01715129,Prostate Cancer
1874,0.99898502,194.9139175,https://clinicaltrials.gov/study/NCT00091377,NCT00091377,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
1875,0.992609051,152.9972887,https://clinicaltrials.gov/study/NCT01694277,NCT01694277,Gastrointestinal Stromal Tumors
1876,0.994550326,153.619985,https://clinicaltrials.gov/study/NCT02144077,NCT02144077,Basal Cell Carcinoma (BCC)
1877,0.99688643,161.6247604,https://clinicaltrials.gov/study/NCT03636477,NCT03636477,Glioblastoma
1878,0.993924728,153.6131027,https://clinicaltrials.gov/study/NCT00087477,NCT00087477,Malignant Melanoma
1879,0.992281935,151.9740246,https://clinicaltrials.gov/study/NCT02627677,NCT02627677,Chronic Phase Chronic Myeloid Leukemia
1880,0.995300627,157.201415,https://clinicaltrials.gov/study/NCT01775553,NCT01775553,Relapse Multiple Myeloma|Refractory Multiple Myeloma
1881,0.99928678,186.0093533,https://clinicaltrials.gov/study/NCT00458653,NCT00458653,Multiple Myeloma
1882,0.998352548,170.3732488,https://clinicaltrials.gov/study/NCT00705653,NCT00705653,Cancer
1883,0.993513866,154.2539376,https://clinicaltrials.gov/study/NCT01741753,NCT01741753,Prostate Cancer
1884,0.997413078,163.1734173,https://clinicaltrials.gov/study/NCT00003853,NCT00003853,Multiple Myeloma and Plasma Cell Neoplasm
1885,0.999378425,187.0308695,https://clinicaltrials.gov/study/NCT00895960,NCT00895960,Glioblastoma|CNS Disease|Brain Diseases
1886,0.999409358,183.4434885,https://clinicaltrials.gov/study/NCT02221960,NCT02221960,Recurrent or Metastatic Solid Tumors
1887,0.992776297,151.9928276,https://clinicaltrials.gov/study/NCT01633060,NCT01633060,Metastatic Breast Cancer
1888,0.998475194,179.1399731,https://clinicaltrials.gov/study/NCT00654160,NCT00654160,Anal Cancer|Carcinoma of the Appendix|Colorectal Cancer|Esophageal Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastric Cancer|Gastrointestinal Carcinoid Tumor|Gastrointestinal Stromal Tumor|Liver Cancer|Pancreatic Cancer|Small Intestine Cancer
1889,0.946228706,40.33999662,https://clinicaltrials.gov/study/NCT02719860,NCT02719860,Lung Cancer Prevention
1890,0.996152607,158.2824007,https://clinicaltrials.gov/study/NCT01045460,NCT01045460,Multiple Myeloma
1891,0.999837469,188.5431745,https://clinicaltrials.gov/study/NCT00036660,NCT00036660,Brain and Central Nervous System Tumors
1892,0.985106748,139.0887666,https://clinicaltrials.gov/study/NCT04044560,NCT04044560,B-cell Adult Acute Lymphoblastic Leukemia|Stem Cell Leukemia|Minimal Residual Disease
1893,0.994328486,154.358789,https://clinicaltrials.gov/study/NCT01175460,NCT01175460,Esophageal Cancer
1894,0.997867284,165.5110622,https://clinicaltrials.gov/study/NCT00905060,NCT00905060,Brain and Central Nervous System Tumors
1895,0.988344585,150.0907427,https://clinicaltrials.gov/study/NCT00088829,NCT00088829,Breast Cancer
1896,0.980439458,108.8690167,https://clinicaltrials.gov/study/NCT02730429,NCT02730429,Endometrial Cancer
1897,0.899908069,15.66740819,https://clinicaltrials.gov/study/NCT01050829,NCT01050829,Magnetic Resonance Imaging
1898,0.964145813,52.70314141,https://clinicaltrials.gov/study/NCT01527929,NCT01527929,Neoplasm Malignant
1899,0.984627666,130.2716594,https://clinicaltrials.gov/study/NCT02518529,NCT02518529,Gastric Cancer
1900,0.997947878,169.1206731,https://clinicaltrials.gov/study/NCT02837029,NCT02837029,Stage IIIA Hepatocellular Carcinoma|Stage IIIB Hepatocellular Carcinoma|Stage IIIC Hepatocellular Carcinoma|Stage IVA Hepatocellular Carcinoma|Stage IVB Hepatocellular Carcinoma
1901,0.999464002,187.4549952,https://clinicaltrials.gov/study/NCT01232829,NCT01232829,Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage IV Pancreatic Cancer
1902,0.997312946,167.0623656,https://clinicaltrials.gov/study/NCT00023829,NCT00023829,Prostate Cancer
1903,0.999084687,191.3342766,https://clinicaltrials.gov/study/NCT00052429,NCT00052429,Head and Neck Cancer
1904,0.996247641,158.7904203,https://clinicaltrials.gov/study/NCT00577629,NCT00577629,"Lymphoma, B-Cell"
1905,0.991392615,151.0517761,https://clinicaltrials.gov/study/NCT01171729,NCT01171729,Prostatic Cancer
1906,0.987914867,150.5228225,https://clinicaltrials.gov/study/NCT00490529,NCT00490529,"Lymphoma, Mantle-Cell"
1907,0.998044404,162.3520208,https://clinicaltrials.gov/study/NCT00031629,NCT00031629,Recurrent Uterine Corpus Sarcoma|Uterine Corpus Leiomyosarcoma
1908,0.999807843,191.4738369,https://clinicaltrials.gov/study/NCT00021229,NCT00021229,Brain and Central Nervous System Tumors
1909,0.998710655,178.1921272,https://clinicaltrials.gov/study/NCT00017277,NCT00017277,Head and Neck Cancer
1910,0.9958464,157.8517097,https://clinicaltrials.gov/study/NCT01666977,NCT01666977,Non Small Cell Lung Cancer
1911,0.992850335,153.2199199,https://clinicaltrials.gov/study/NCT02303977,NCT02303977,Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
1912,0.998023998,171.0863005,https://clinicaltrials.gov/study/NCT00008177,NCT00008177,Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Refractory Anemia With Ringed Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Secondary Myelodysplastic Syndromes|Untreated Adult Acute Myeloid Leukemia
1913,0.960423168,44.39240428,https://clinicaltrials.gov/study/NCT00002277,NCT00002277,Mycoses|HIV Infections
1914,0.985937242,150.1285674,https://clinicaltrials.gov/study/NCT01777477,NCT01777477,Pancreatic Cancer
1915,0.997595526,163.8300696,https://clinicaltrials.gov/study/NCT00266877,NCT00266877,"Carcinoma, Non-Small-Cell Lung|Lung Neoplasms"
1916,0.99442828,154.2055269,https://clinicaltrials.gov/study/NCT00836277,NCT00836277,Esophageal Cancer
1917,0.997727685,164.0155902,https://clinicaltrials.gov/study/NCT02082977,NCT02082977,Cancer|Neoplasms
1918,0.988854327,150.4050412,https://clinicaltrials.gov/study/NCT01031953,NCT01031953,"Breakthrough Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific"
1919,0.995532155,155.8953793,https://clinicaltrials.gov/study/NCT00748553,NCT00748553,Advanced or Metastatic Solid Tumors|Advanced or Metastatic Breast Cancer
1920,0.989396683,145.9433473,https://clinicaltrials.gov/study/NCT00053053,NCT00053053,"Cachexia|Lymphoma|Lymphoproliferative Disorder|Unspecified Adult Solid Tumor, Protocol Specific"
1921,0.999234111,181.1387339,https://clinicaltrials.gov/study/NCT00005853,NCT00005853,Leukemia|Myelodysplastic Syndromes
1922,0.982281382,105.1508741,https://clinicaltrials.gov/study/NCT00729053,NCT00729053,Renal Cell Carcinoma
1923,0.970652728,72.28320988,https://clinicaltrials.gov/study/NCT01462253,NCT01462253,Acute Lymphoblastic Leukemia
1924,0.995388386,156.2987237,https://clinicaltrials.gov/study/NCT02431260,NCT02431260,Solid Tumors and Hematologic Malignancy
1925,0.97862194,94.5144595,https://clinicaltrials.gov/study/NCT00208260,NCT00208260,Colorectal Cancer|Liver Metastases|Chemotherapy
1926,0.990867728,151.824385,https://clinicaltrials.gov/study/NCT04067960,NCT04067960,Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Biliary Tract Carcinoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Malignant Brain Neoplasm|Malignant Genitourinary System Neoplasm|Malignant Solid Neoplasm|Pancreatobiliary Carcinoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage III Prostate Cancer AJCC v8|Stage IIIA Colorectal Cancer AJCC v8|Stage IIIA Ovarian Cancer AJCC v8|Stage IIIA Prostate Cancer AJCC v8|Stage IIIB Colorectal Cancer AJCC v8|Stage IIIB Ovarian Cancer AJCC v8|Stage IIIB Prostate Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Ovarian Cancer AJCC v8|Stage IIIC Prostate Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Pancreatic Cancer|Stage IVA Prostate Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Pancreatic Cancer|Stage IVB Prostate Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8
1927,0.98421285,140.545656,https://clinicaltrials.gov/study/NCT01679860,NCT01679860,"Lymphoma, T-Cell, Peripheral"
1928,0.991353123,152.4837391,https://clinicaltrials.gov/study/NCT02614560,NCT02614560,Acute Myeloid Leukemia
1929,0.983833509,121.8815542,https://clinicaltrials.gov/study/NCT00069160,NCT00069160,Lung Neoplasms|Ovarian Neoplasms|Cervix Neoplasms|Renal Neoplasms
1930,0.996597088,159.4527405,https://clinicaltrials.gov/study/NCT02598960,NCT02598960,Solid Tumors
1931,0.995511909,154.639237,https://clinicaltrials.gov/study/NCT00586560,NCT00586560,Solid Tumors
1932,0.986166865,123.7504129,https://clinicaltrials.gov/study/NCT02181660,NCT02181660,Acute Myeloid Leukemia (AML)
1933,0.998253234,168.1830128,https://clinicaltrials.gov/study/NCT01074060,NCT01074060,Refractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma
1934,0.999556306,184.1588242,https://clinicaltrials.gov/study/NCT04233060,NCT04233060,Advanced Solid Tumor
1935,0.994620853,154.3299967,https://clinicaltrials.gov/study/NCT01217060,NCT01217060,Esophageal Cancer
1936,0.997376345,159.5664997,https://clinicaltrials.gov/study/NCT00737360,NCT00737360,Head and Neck Cancer
1937,0.893183142,17.86408047,https://clinicaltrials.gov/study/NCT01669460,NCT01669460,Fatigue
1938,0.991926656,151.4670826,https://clinicaltrials.gov/study/NCT00860860,NCT00860860,Colorectal Neoplasms
1939,0.964521857,59.43365818,https://clinicaltrials.gov/study/NCT02819960,NCT02819960,Diarrhea|Cancer
1940,0.992079816,152.4651764,https://clinicaltrials.gov/study/NCT00002529,NCT00002529,Breast Cancer
1941,0.998559987,183.6026212,https://clinicaltrials.gov/study/NCT00003029,NCT00003029,Pancreatic Cancer
1942,0.981813792,125.3752323,https://clinicaltrials.gov/study/NCT00963729,NCT00963729,Breast Cancer
1943,0.908007564,22.61183697,https://clinicaltrials.gov/study/NCT01846429,NCT01846429,Tumor|Cancer|Pain|Malignant Solid Tumor|Unresectable Malignant Neoplasm|Hematologic Malignancy|Multiple Myeloma|Lymphoma|Neoplasm Metastasis
1944,0.986490335,150.073738,https://clinicaltrials.gov/study/NCT01955629,NCT01955629,Colorectal Cancer Metastatic
1945,0.991477321,151.2985447,https://clinicaltrials.gov/study/NCT00283829,NCT00283829,Prostate Cancer
1946,0.97606441,89.17210656,https://clinicaltrials.gov/study/NCT04057729,NCT04057729,Solid Tumor
1947,0.999016237,181.1197201,https://clinicaltrials.gov/study/NCT01147029,NCT01147029,"Unspecified Adult Solid Tumor, Protocol Specific"
1948,0.933622555,30.34115664,https://clinicaltrials.gov/study/NCT01576029,NCT01576029,Prostatic Neoplasms
1949,0.999533686,194.2653115,https://clinicaltrials.gov/study/NCT00004229,NCT00004229,"Unspecified Adult Solid Tumor, Protocol Specific"
1950,0.99787649,165.8052921,https://clinicaltrials.gov/study/NCT00335829,NCT00335829,Liver Cancer
1951,0.999563692,178.5905993,https://clinicaltrials.gov/study/NCT02608229,NCT02608229,Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer
1952,0.998941654,186.4343931,https://clinicaltrials.gov/study/NCT00858429,NCT00858429,Liver Cancer|Metastatic Cancer
1953,0.996114351,158.3174387,https://clinicaltrials.gov/study/NCT02417129,NCT02417129,"Lymphoma, Non-Hodgkin"
1954,0.999453855,184.8699651,https://clinicaltrials.gov/study/NCT00004929,NCT00004929,Prostate Cancer
1955,0.98435096,117.55225,https://clinicaltrials.gov/study/NCT01135329,NCT01135329,Lymphoma|Leukemia|Myelodysplastic Syndrome
1956,0.602073342,3.427179649,https://clinicaltrials.gov/study/NCT00099177,NCT00099177,Pain|Bone Neoplasm|Neoplasm Metastasis
1957,0.996702902,159.6835154,https://clinicaltrials.gov/study/NCT01133977,NCT01133977,Stage IV Melanoma
1958,0.99602388,158.7007955,https://clinicaltrials.gov/study/NCT00022477,NCT00022477,Colorectal Cancer
1959,0.795076765,8.406852242,https://clinicaltrials.gov/study/NCT02463877,NCT02463877,Cancer
1960,0.99563253,156.1341714,https://clinicaltrials.gov/study/NCT02668653,NCT02668653,Acute Myeloid Leukemia|Leukemia
1961,0.995741352,154.4209271,https://clinicaltrials.gov/study/NCT03836053,NCT03836053,Relapsed and/or Refractory Multiple Myeloma
1962,0.999135366,193.0673744,https://clinicaltrials.gov/study/NCT02415153,NCT02415153,Neurofibromatosis Type 1|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Visual Pathway Glioma|Recurrent Primary Central Nervous System Neoplasm|Refractory Primary Central Nervous System Neoplasm
1963,0.993444653,153.987941,https://clinicaltrials.gov/study/NCT01912053,NCT01912053,Cholangiocarcinoma
1964,0.995800423,157.272779,https://clinicaltrials.gov/study/NCT00673153,NCT00673153,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Untreated Adult Acute Myeloid Leukemia
1965,0.950471643,35.76788891,https://clinicaltrials.gov/study/NCT02369653,NCT02369653,Lymphoma|Acute Lymphoblastic Leukemia
1966,0.965535023,58.16330879,https://clinicaltrials.gov/study/NCT00121160,NCT00121160,Psychological Stress
1967,0.998972192,185.4176359,https://clinicaltrials.gov/study/NCT01266460,NCT01266460,"Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Recurrent Cervical Carcinoma"
1968,0.966571996,56.28884064,https://clinicaltrials.gov/study/NCT00151060,NCT00151060,Prostate Cancer
1969,0.997890141,166.0367088,https://clinicaltrials.gov/study/NCT04188860,NCT04188860,Recurrent Cervical Carcinoma|Persistent Advanced Cervical Carcinoma|Chemotherapy|Anti-PD-1 Antibody|Immunotherapy
1970,0.998521493,175.6485345,https://clinicaltrials.gov/study/NCT00003860,NCT00003860,Lung Cancer
1971,0.993669502,153.1823566,https://clinicaltrials.gov/study/NCT04465760,NCT04465760,Lymphoma|Malignant Solid Neoplasm|Plasma Cell Myeloma
1972,0.999511005,175.2317433,https://clinicaltrials.gov/study/NCT02370160,NCT02370160,Refractory B-Lineage Leukemia|Relapsed B-Lineage Leukemia|Refractory B-Lineage Lymphoma|Relapsed B-Lineage Lymphoma
1973,0.977051338,99.31394593,https://clinicaltrials.gov/study/NCT00231829,NCT00231829,Uterine Cancer
1974,0.958353965,56.01684245,https://clinicaltrials.gov/study/NCT00720629,NCT00720629,Graft Versus Host Disease
1975,0.662533507,4.442332666,https://clinicaltrials.gov/study/NCT02660229,NCT02660229,Cancer Pain
1976,0.989828224,150.8585316,https://clinicaltrials.gov/study/NCT03125629,NCT03125629,Cancer Diagnosis|Diagnostic Techniques and Procedures|Diagnostic Imaging
1977,0.995614245,157.2614939,https://clinicaltrials.gov/study/NCT03565029,NCT03565029,Colo-rectal Cancer
1978,0.848268193,12.49629265,https://clinicaltrials.gov/study/NCT03401229,NCT03401229,Nasal Polyposis
1979,0.895792929,17.28711321,https://clinicaltrials.gov/study/NCT01088529,NCT01088529,Prostate Cancer
1980,0.979155923,104.2432343,https://clinicaltrials.gov/study/NCT00532129,NCT00532129,"Lymphocytic Leukemia, Chronic"
1981,0.947879311,35.33184608,https://clinicaltrials.gov/study/NCT01418729,NCT01418729,Advanced Hepatocarcinoma
1982,0.973309594,75.68790002,https://clinicaltrials.gov/study/NCT02171429,NCT02171429,Ulcerative Colitis
1983,0.993587942,151.3708645,https://clinicaltrials.gov/study/NCT02462629,NCT02462629,Central Nervous System Tumors
1984,0.973726738,57.26306539,https://clinicaltrials.gov/study/NCT01401829,NCT01401829,Endometrial Cancer
1985,0.946015651,36.77032853,https://clinicaltrials.gov/study/NCT01331629,NCT01331629,Breast Cancer
1986,0.819940343,9.589550915,https://clinicaltrials.gov/study/NCT01934829,NCT01934829,Hepatocellular Carcinoma
1987,0.997687822,166.7976364,https://clinicaltrials.gov/study/NCT02318329,NCT02318329,Advanced Solid Tumors|Gastric Cancer|Transitional Cell Carcinoma of the Bladder
1988,0.999462043,177.9750503,https://clinicaltrials.gov/study/NCT01486329,NCT01486329,Stage IV Pancreatic Cancer
1989,0.944390345,29.87442448,https://clinicaltrials.gov/study/NCT02610777,NCT02610777,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Leukemia, Myeloid, Acute"
1990,0.994798681,155.7802036,https://clinicaltrials.gov/study/NCT02154529,NCT02154529,HER-2 Positive Breast Cancer|Metastatic Malignant Neoplasm to Brain
1991,0.997008923,160.6672463,https://clinicaltrials.gov/study/NCT00669877,NCT00669877,Burkitt's Lymphoma|Burkitt'S-like Lymphoma
1992,0.99828041,172.6100385,https://clinicaltrials.gov/study/NCT00602277,NCT00602277,Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
1993,0.924992685,23.47726,https://clinicaltrials.gov/study/NCT00452660,NCT00452660,Myelodysplastic Syndrome
1994,0.998861137,186.0680435,https://clinicaltrials.gov/study/NCT00096629,NCT00096629,Kidney Cancer
1995,0.994223972,154.0869083,https://clinicaltrials.gov/study/NCT03796429,NCT03796429,Biliary Tract Cancer
1996,0.980810273,106.1684691,https://clinicaltrials.gov/study/NCT00633529,NCT00633529,Non-Small Cell Lung Cancer
1997,0.999358597,184.7421917,https://clinicaltrials.gov/study/NCT02181829,NCT02181829,Synovial Sarcoma|Single or Multiple Lung Metastases
1998,0.989741998,151.494809,https://clinicaltrials.gov/study/NCT00234429,NCT00234429,Colorectal Cancer
1999,0.998437771,172.6539361,https://clinicaltrials.gov/study/NCT00329329,NCT00329329,Malignancies
2000,0.982459689,102.8709678,https://clinicaltrials.gov/study/NCT03683277,NCT03683277,Multiple Myeloma|Relapsed and Refractory Multiple Myeloma|Genetic Condition
2001,0.998415218,174.2481596,https://clinicaltrials.gov/study/NCT00084877,NCT00084877,"Unspecified Adult Solid Tumor, Protocol Specific"
2002,0.921680574,24.74653894,https://clinicaltrials.gov/study/NCT01227577,NCT01227577,Chronic Myelogenous Leukemia in Chronic Phase
2003,0.998592803,177.8291031,https://clinicaltrials.gov/study/NCT00005577,NCT00005577,"Unspecified Childhood Solid Tumor, Protocol Specific"
2004,0.996935355,161.4371566,https://clinicaltrials.gov/study/NCT00801177,NCT00801177,Solid Tumors
2005,0.997272732,162.7836732,https://clinicaltrials.gov/study/NCT02168777,NCT02168777,Neoplasms
2006,0.992452652,151.6093897,https://clinicaltrials.gov/study/NCT00100477,NCT00100477,Non-Hodgkin's Lymphoma|Leukemia
2007,0.990986052,150.7783133,https://clinicaltrials.gov/study/NCT00417677,NCT00417677,Renal Cell Carcinoma
2008,0.960706285,57.61036399,https://clinicaltrials.gov/study/NCT02914977,NCT02914977,Acute Lymphocytic Leukemia|Acute Myeloid Leukemia
2009,0.999623287,180.8603745,https://clinicaltrials.gov/study/NCT00002577,NCT00002577,Lung Cancer
2010,0.997950428,164.2270643,https://clinicaltrials.gov/study/NCT00066677,NCT00066677,Pancreatic Cancer
2011,0.999251922,195.0177502,https://clinicaltrials.gov/study/NCT03752177,NCT03752177,Solid Tumor
2012,0.980609501,97.96309094,https://clinicaltrials.gov/study/NCT01564277,NCT01564277,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Blastic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|de Novo Myelodysplastic Syndromes|Noncontiguous Stage II Adult Burkitt Lymphoma|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Stage I Adult Burkitt Lymphoma|Stage III Adult Burkitt Lymphoma|Stage IV Adult Burkitt Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia
2013,0.945867549,29.85893321,https://clinicaltrials.gov/study/NCT04294277,NCT04294277,Urothelial Cancer
2014,0.999242836,192.608996,https://clinicaltrials.gov/study/NCT03106077,NCT03106077,Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Anatomic Stage IV Breast Cancer AJCC v8|Estrogen Receptor Negative|Folate Receptor Alpha Positive|HER2/Neu Negative|Progesterone Receptor Negative|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Triple-Negative Breast Carcinoma
2015,0.824774365,9.385929507,https://clinicaltrials.gov/study/NCT00160953,NCT00160953,Prostatic Neoplasms
2016,0.997803739,165.42349,https://clinicaltrials.gov/study/NCT01221753,NCT01221753,Squamous Cell Carcinoma of the Head and Neck|Human Papilloma Virus
2017,0.995904406,156.1527161,https://clinicaltrials.gov/study/NCT00688753,NCT00688753,Carcinoma|Renal Cell|Non Clear Cell Renal Carcinoma|Papillary Cell Renal Carcinoma|Adenocarcinoma
2018,0.985798051,107.8718103,https://clinicaltrials.gov/study/NCT03871153,NCT03871153,Non Small Cell Lung Cancer|Stage III Non-small-cell Lung Cancer
2019,0.998697505,172.7484998,https://clinicaltrials.gov/study/NCT00968253,NCT00968253,Leukemia|Acute Lymphocytic Leukemia
2020,0.940006311,30.27859593,https://clinicaltrials.gov/study/NCT01338753,NCT01338753,Breast Neoplasms
2021,0.998463404,169.0265108,https://clinicaltrials.gov/study/NCT00055653,NCT00055653,Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic-Myeloproliferative Diseases
2022,0.99814516,165.3982988,https://clinicaltrials.gov/study/NCT02126553,NCT02126553,Alkylating Agent-Related Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia
2023,0.998401135,170.7703597,https://clinicaltrials.gov/study/NCT00500760,NCT00500760,Head and Neck Cancer|Squamous Cell Carcinoma
2024,0.997415369,161.5639512,https://clinicaltrials.gov/study/NCT01660360,NCT01660360,Advanced Cancer|Metastatic Cancer
2025,0.989295227,150.7583486,https://clinicaltrials.gov/study/NCT02171260,NCT02171260,Pediatrics|Solid Tumors
2026,0.992910564,151.4246352,https://clinicaltrials.gov/study/NCT01523860,NCT01523860,Follicular Lymphoma
2027,0.981014706,125.0856067,https://clinicaltrials.gov/study/NCT02534129,NCT02534129,Radiodermatitis
2028,0.999056453,178.8614638,https://clinicaltrials.gov/study/NCT00138229,NCT00138229,Melanoma (Skin)
2029,0.998959525,191.2515303,https://clinicaltrials.gov/study/NCT01214629,NCT01214629,Advanced Cancer|Metastatic Cancer
2030,0.996112288,157.2841172,https://clinicaltrials.gov/study/NCT01837329,NCT01837329,Non-Small Cell Lung Cancer
2031,0.997740653,161.7506847,https://clinicaltrials.gov/study/NCT02016729,NCT02016729,Advanced Malignancy|Cancer|Oncology|Oncology Patients|Acute Myeloid Leukemia
2032,0.999475966,185.9714714,https://clinicaltrials.gov/study/NCT01014429,NCT01014429,Advanced or Metastatic Solid Tumors
2033,0.986713893,148.0544404,https://clinicaltrials.gov/study/NCT00952029,NCT00952029,Colorectal Cancer
2034,0.939165699,34.88964584,https://clinicaltrials.gov/study/NCT01472029,NCT01472029,Adenocarcinoma of the Gastroesophageal Junction|Adenocarcinoma of the Stomach
2035,0.98864262,151.0448496,https://clinicaltrials.gov/study/NCT00222729,NCT00222729,Cancer
2036,0.982025318,101.2373099,https://clinicaltrials.gov/study/NCT02363829,NCT02363829,Uterine Cervix Cancer
2037,0.997651646,168.6156009,https://clinicaltrials.gov/study/NCT00003129,NCT00003129,Bladder Cancer
2038,0.998399399,169.5327615,https://clinicaltrials.gov/study/NCT01189929,NCT01189929,Pancreatic Cancer
2039,0.996402288,158.5295103,https://clinicaltrials.gov/study/NCT01068977,NCT01068977,Solid Cancers
2040,0.9811991,119.4418516,https://clinicaltrials.gov/study/NCT00545077,NCT00545077,Breast Cancer
2041,0.995760331,156.9578886,https://clinicaltrials.gov/study/NCT00473577,NCT00473577,Hematologic Neoplasms|Neoplasms
2042,0.997573775,166.9927915,https://clinicaltrials.gov/study/NCT02020577,NCT02020577,Neoplasms
2043,0.943657489,29.92743852,https://clinicaltrials.gov/study/NCT04599777,NCT04599777,Hepatocellular Carcinoma Non-resectable
2044,0.981845238,112.833774,https://clinicaltrials.gov/study/NCT00600353,NCT00600353,"Myeloma, Plasma-Cell|Lymphoma, Malignant"
2045,0.999314205,177.2632865,https://clinicaltrials.gov/study/NCT00069953,NCT00069953,Esophageal Cancer
2046,0.948041222,35.05014474,https://clinicaltrials.gov/study/NCT03109353,NCT03109353,"Cutaneous T-Cell Lymphoma, Unspecified|Chronic Graft Versus Host Disease in Skin"
2047,0.977382115,77.28176142,https://clinicaltrials.gov/study/NCT00574860,NCT00574860,Oral Mucositis|Head and Neck Cancer
2048,0.996303074,157.5824096,https://clinicaltrials.gov/study/NCT02049060,NCT02049060,Malignant Pleural Mesothelioma|Nonsquamous Nonsmall Cell Neoplasm of Lung
2049,0.997722445,169.1442728,https://clinicaltrials.gov/study/NCT00742560,NCT00742560,Hematologic Cancer
2050,0.980357378,115.1519138,https://clinicaltrials.gov/study/NCT03781960,NCT03781960,Hepatocellular Carcinoma
2051,0.999233287,183.8294044,https://clinicaltrials.gov/study/NCT00021060,NCT00021060,Adenocarcinoma of the Lung|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
2052,0.995736773,156.6445813,https://clinicaltrials.gov/study/NCT00006260,NCT00006260,Breast Cancer
2053,0.978832349,76.02606169,https://clinicaltrials.gov/study/NCT00388960,NCT00388960,Small Cell Lung Cancer
2054,0.994600856,154.183914,https://clinicaltrials.gov/study/NCT00448760,NCT00448760,Esophageal Cancer
2055,0.990309201,151.0962559,https://clinicaltrials.gov/study/NCT00188929,NCT00188929,"Lymphoma, Non-Hodgkin"
2056,0.989148198,151.0336537,https://clinicaltrials.gov/study/NCT01730729,NCT01730729,Recurrent Breast Cancer|Stage IV Breast Cancer
2057,0.951198987,35.44722931,https://clinicaltrials.gov/study/NCT00859729,NCT00859729,Prostate Cancer
2058,0.989547998,151.4026171,https://clinicaltrials.gov/study/NCT00581529,NCT00581529,Breast Cancer
2059,0.986544592,140.759616,https://clinicaltrials.gov/study/NCT00554229,NCT00554229,Prostate Cancer
2060,0.98530828,150.0441663,https://clinicaltrials.gov/study/NCT00311129,NCT00311129,"Lymphoma, Low-Grade"
2061,0.998365108,171.7805763,https://clinicaltrials.gov/study/NCT01781429,NCT01781429,Advanced Solid Tumors
2062,0.998378437,170.9962079,https://clinicaltrials.gov/study/NCT01594229,NCT01594229,Non-Hodgkin's Lymphoma
2063,0.929512542,27.55798759,https://clinicaltrials.gov/study/NCT04341129,NCT04341129,Breast Neoplasms|Breast Diseases|Breast Fibroadenoma|Breast Cancer
2064,0.921015462,26.41470704,https://clinicaltrials.gov/study/NCT00842829,NCT00842829,Cancer Pain|Breakthrough Pain
2065,0.993727179,153.4930432,https://clinicaltrials.gov/study/NCT00207129,NCT00207129,Advanced Solid Tumors|Neoplasms
2066,0.997806003,165.6997463,https://clinicaltrials.gov/study/NCT01183429,NCT01183429,Neuroblastoma
2067,0.997106463,161.9526491,https://clinicaltrials.gov/study/NCT02369029,NCT02369029,Neoplasms
2068,0.98562357,129.9799228,https://clinicaltrials.gov/study/NCT01369329,NCT01369329,Crohn's Disease|IBD|Colitis|Inflammatory Bowel Disease
2069,0.985720443,150.0586973,https://clinicaltrials.gov/study/NCT00450229,NCT00450229,Adenocarcinoma of the Prostate|Prostate Cancer|Stage I Prostate Cancer|Stage II Prostate Cancer
2070,0.834532409,11.36409785,https://clinicaltrials.gov/study/NCT01046929,NCT01046929,Breast Cancer
2071,0.931309283,28.47298055,https://clinicaltrials.gov/study/NCT00543829,NCT00543829,Breast Neoplasms
2072,0.998829405,186.6139354,https://clinicaltrials.gov/study/NCT04699929,NCT04699929,Advanced Solid Tumors
2073,0.979554604,97.36509885,https://clinicaltrials.gov/study/NCT04476329,NCT04476329,Hepatocellular Carcinoma
2074,0.991187795,151.0953111,https://clinicaltrials.gov/study/NCT03837353,NCT03837353,Prostate Cancer
2075,0.981300673,131.949578,https://clinicaltrials.gov/study/NCT00108953,NCT00108953,"Carcinoma, Hepatocellular"
2076,0.910024596,21.59106562,https://clinicaltrials.gov/study/NCT00810953,NCT00810953,Pancreatic Cancer
2077,0.999625789,182.4137702,https://clinicaltrials.gov/study/NCT00003153,NCT00003153,Multiple Myeloma and Plasma Cell Neoplasm
2078,0.97547966,95.46689449,https://clinicaltrials.gov/study/NCT04772053,NCT04772053,"Lung Cancer, Non-Small Cell|Neoplasms"
2079,0.942597896,37.4753125,https://clinicaltrials.gov/study/NCT01263353,NCT01263353,Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
2080,0.984442302,137.3287642,https://clinicaltrials.gov/study/NCT00946153,NCT00946153,Hepatocellular Carcinoma
2081,0.771317046,9.588711172,https://clinicaltrials.gov/study/NCT02649153,NCT02649153,Liver Cancer
2082,0.988063294,139.4149776,https://clinicaltrials.gov/study/NCT02151760,NCT02151760,Metastatic Prostate Cancer
2083,0.999120362,191.4828577,https://clinicaltrials.gov/study/NCT00690560,NCT00690560,Lymphoma
2084,0.999146861,188.7651489,https://clinicaltrials.gov/study/NCT01240460,NCT01240460,"Glioblastoma|Astrocytoma, Grade IV"
2085,0.953814068,47.06212115,https://clinicaltrials.gov/study/NCT01262560,NCT01262560,Dysphagia|Lung Cancer|Pain|Esophagitis
2086,0.906325382,18.9528211,https://clinicaltrials.gov/study/NCT00908960,NCT00908960,"Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer"
2087,0.991355664,151.1780672,https://clinicaltrials.gov/study/NCT00201760,NCT00201760,Breast Cancer
2088,0.990335066,150.8988469,https://clinicaltrials.gov/study/NCT00197860,NCT00197860,Advanced Renal Cell Carcinoma
2089,0.986483344,148.5992143,https://clinicaltrials.gov/study/NCT00801060,NCT00801060,Chronic Lymphocytic Leukemia
2090,0.985547351,113.0890115,https://clinicaltrials.gov/study/NCT01443260,NCT01443260,Peritoneal Carcinomatosis
2091,0.983619391,105.3117417,https://clinicaltrials.gov/study/NCT04672460,NCT04672460,Advanced Solid Tumors|Solid Tumors|Ovarian Cancer|Breast Cancer|Prostate Cancer|NSCLC|Pancreatic Cancer|Colorectal Cancer
2092,0.985393783,147.9823752,https://clinicaltrials.gov/study/NCT01404260,NCT01404260,Non-small Cell Lung Cancer
2093,0.605925584,3.617480469,https://clinicaltrials.gov/study/NCT01609660,NCT01609660,Colorectal Cancer
2094,0.999438205,185.442138,https://clinicaltrials.gov/study/NCT01015560,NCT01015560,"Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
2095,0.86978046,14.54170068,https://clinicaltrials.gov/study/NCT00711529,NCT00711529,Breast Cancer|Hot Flashes
2096,0.995065752,155.6021012,https://clinicaltrials.gov/study/NCT00039429,NCT00039429,Kidney Cancer
2097,0.992479559,153.2716684,https://clinicaltrials.gov/study/NCT00097929,NCT00097929,B-cell Lymphoma
2098,0.935025171,29.64794291,https://clinicaltrials.gov/study/NCT00545129,NCT00545129,Neoplasm Metastasis|Palliative Care
2099,0.999416721,187.9933588,https://clinicaltrials.gov/study/NCT02928029,NCT02928029,Multiple Myeloma
2100,0.959843668,43.8527097,https://clinicaltrials.gov/study/NCT01035229,NCT01035229,Carcinoma
2101,0.991575492,151.4475075,https://clinicaltrials.gov/study/NCT00667329,NCT00667329,Lymphoma
2102,0.968818876,57.1392337,https://clinicaltrials.gov/study/NCT00305929,NCT00305929,Prostate Cancer
2103,0.995884294,156.7121728,https://clinicaltrials.gov/study/NCT01761929,NCT01761929,Solid Tumors With Oligometastatic Spread
2104,0.616433388,4.456604312,https://clinicaltrials.gov/study/NCT00620529,NCT00620529,Polycystic Ovary Syndrome
2105,0.991409144,152.013627,https://clinicaltrials.gov/study/NCT00162929,NCT00162929,Metastatic Breast Cancer
2106,0.973907553,87.03337826,https://clinicaltrials.gov/study/NCT05516329,NCT05516329,Prostate Cancer
2107,0.887834795,16.50474941,https://clinicaltrials.gov/study/NCT02895529,NCT02895529,Hematologic Neoplasms
2108,0.998020201,167.6581839,https://clinicaltrials.gov/study/NCT01598077,NCT01598077,"HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma|HER2 + Breast Cancer|HER2 + Gastric Cancer|Squamous Cell Carcinoma of Head and Neck|Esophageal Squamous Cell Carcinoma"
2109,0.934684785,31.98029237,https://clinicaltrials.gov/study/NCT01388777,NCT01388777,Breast Cancer
2110,0.977347912,83.50279327,https://clinicaltrials.gov/study/NCT01904253,NCT01904253,Small Cell Lung Cancer (SCLC)
2111,0.995415606,156.1172613,https://clinicaltrials.gov/study/NCT03273153,NCT03273153,Advanced BRAFV600 Wild-type Melanoma
2112,0.991860325,152.2382199,https://clinicaltrials.gov/study/NCT03234153,NCT03234153,Muscle-invasive Bladder Cancer
2113,0.912279437,27.07861476,https://clinicaltrials.gov/study/NCT00402753,NCT00402753,Hematopoietic Stem Cell Transplantation
2114,0.967386677,57.63878133,https://clinicaltrials.gov/study/NCT04547153,NCT04547153,Gastric Cancer|Bone Marrow Metastasis|Disseminated Intravascular Coagulation
2115,0.875060692,12.19293188,https://clinicaltrials.gov/study/NCT01902953,NCT01902953,Colon Cancer|Rectal Cancer
2116,0.991214608,152.3955585,https://clinicaltrials.gov/study/NCT03816553,NCT03816553,Recurrent Cervical Carcinoma|Metastatic Cervical Cancer
2117,0.98549742,150.0559501,https://clinicaltrials.gov/study/NCT00569153,NCT00569153,Prostatic Neoplasms
2118,0.990520138,151.1268394,https://clinicaltrials.gov/study/NCT03353753,NCT03353753,Gastrointestinal Stromal Tumors
2119,0.999558709,186.6924512,https://clinicaltrials.gov/study/NCT01876953,NCT01876953,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
2120,0.998067324,168.1354597,https://clinicaltrials.gov/study/NCT03770260,NCT03770260,Recurrent Multiple Myeloma|Refractory Multiple Myeloma
2121,0.999137234,185.0063031,https://clinicaltrials.gov/study/NCT00425360,NCT00425360,Pancreatic Cancer
2122,0.99926831,195.4351899,https://clinicaltrials.gov/study/NCT01349660,NCT01349660,Glioblastoma Multiforme
2123,0.999027902,183.7169586,https://clinicaltrials.gov/study/NCT00408460,NCT00408460,Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
2124,0.997575102,160.1898717,https://clinicaltrials.gov/study/NCT05130060,NCT05130060,Metastatic Colon Adenocarcinoma|Metastatic Colorectal Adenocarcinoma|Metastatic Colorectal Carcinoma|Metastatic Microsatellite Stable Colon Carcinoma|Metastatic Microsatellite Stable Colorectal Carcinoma|Metastatic Rectal Adenocarcinoma|Microsatellite Stable Rectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8
2125,0.992413994,152.3700321,https://clinicaltrials.gov/study/NCT03563560,NCT03563560,Acute Myeloid Leukemia
2126,0.995838917,155.2562652,https://clinicaltrials.gov/study/NCT04762160,NCT04762160,Follicular Lymphoma
2127,0.995839961,158.2649142,https://clinicaltrials.gov/study/NCT00243529,NCT00243529,Melanoma Stage III or IV
2128,0.996655904,157.0773,https://clinicaltrials.gov/study/NCT00867529,NCT00867529,B-cell Adult Acute Lymphoblastic Leukemia|B-cell Childhood Acute Lymphoblastic Leukemia|B-cell Chronic Lymphocytic Leukemia|Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Post-transplant Lymphoproliferative Disorder|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstrm Macroglobulinemia
2129,0.998033809,169.9760556,https://clinicaltrials.gov/study/NCT00017329,NCT00017329,Kidney Cancer
2130,0.966246247,76.30355688,https://clinicaltrials.gov/study/NCT00658229,NCT00658229,Prostate Cancer
2131,0.991908691,152.4569155,https://clinicaltrials.gov/study/NCT00533429,NCT00533429,Non-small Cell Lung Cancer
2132,0.919112362,26.74745568,https://clinicaltrials.gov/study/NCT00174629,NCT00174629,Lung Neoplasms
2133,0.996644204,156.9957163,https://clinicaltrials.gov/study/NCT01200329,NCT01200329,Lymphoma
2134,0.786913592,7.493616939,https://clinicaltrials.gov/study/NCT00573729,NCT00573729,Port Wine Stains
2135,0.982147827,102.4045904,https://clinicaltrials.gov/study/NCT00403429,NCT00403429,Ovarian Cancer
2136,0.987294007,148.7502958,https://clinicaltrials.gov/study/NCT03360929,NCT03360929,Non Small Cell Lung Cancer
2137,0.968601249,52.75158533,https://clinicaltrials.gov/study/NCT00135577,NCT00135577,Cancer|Bowel Dysfunction
2138,0.951047674,38.37771339,https://clinicaltrials.gov/study/NCT00385177,NCT00385177,Breast Neoplasms|Colorectal Neoplasms|Pancreatic Neoplasms|Pelvic Neoplasms|Lung Neoplasms
2139,0.997933623,165.1391286,https://clinicaltrials.gov/study/NCT00238277,NCT00238277,Brain and Central Nervous System Tumors
2140,0.951690703,48.50455983,https://clinicaltrials.gov/study/NCT00966277,NCT00966277,Pancreatic Cancer|Venous Thromboembolism
2141,0.999654721,178.30183,https://clinicaltrials.gov/study/NCT00305877,NCT00305877,Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer
2142,0.992762542,152.4466827,https://clinicaltrials.gov/study/NCT02032277,NCT02032277,Triple Negative Breast Cancer
2143,0.997514979,163.4848968,https://clinicaltrials.gov/study/NCT00026377,NCT00026377,Prostate Cancer
2144,0.960358792,55.36752774,https://clinicaltrials.gov/study/NCT03228277,NCT03228277,Non Small Cell Lung Cancer
2145,0.993339822,151.7957346,https://clinicaltrials.gov/study/NCT00003077,NCT00003077,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm
2146,0.997697595,165.230439,https://clinicaltrials.gov/study/NCT03167853,NCT03167853,Neuroendocrine Tumors
2147,0.994341188,154.7011764,https://clinicaltrials.gov/study/NCT00222053,NCT00222053,Multiple Myeloma
2148,0.983735674,118.0618732,https://clinicaltrials.gov/study/NCT01524653,NCT01524653,Venous Thromboembolism|Deep Vein Thrombosis|Neoplasms
2149,0.992432739,150.8681978,https://clinicaltrials.gov/study/NCT00177853,NCT00177853,Pancreatic Cancer
2150,0.996913575,160.7427922,https://clinicaltrials.gov/study/NCT02552953,NCT02552953,Cancer
2151,0.937841869,28.15196225,https://clinicaltrials.gov/study/NCT00426153,NCT00426153,"Polycystic Kidney, Autosomal Dominant|Polycystic Liver Disease|Hepatomegaly|Liver Diseases|Kidney, Polycystic|Abdominal Pain"
2152,0.99598859,157.1732771,https://clinicaltrials.gov/study/NCT01143753,NCT01143753,Neoplasms
2153,0.99771531,164.8735119,https://clinicaltrials.gov/study/NCT01688960,NCT01688960,Solid Tumors
2154,0.990358744,124.5880858,https://clinicaltrials.gov/study/NCT01016860,NCT01016860,Colorectal Cancer
2155,0.992080659,152.2082247,https://clinicaltrials.gov/study/NCT01973660,NCT01973660,Breast Cancer
2156,0.997312668,160.6887976,https://clinicaltrials.gov/study/NCT00304460,NCT00304460,Metastatic Melanoma|Renal Cell Cancer
2157,0.986635952,138.4431464,https://clinicaltrials.gov/study/NCT00353860,NCT00353860,Immunosuppression|Leukemia
2158,0.994313411,152.8205975,https://clinicaltrials.gov/study/NCT00005060,NCT00005060,Gastric Cancer
2159,0.995528501,157.0095021,https://clinicaltrials.gov/study/NCT00195260,NCT00195260,Neoplasms
2160,0.994490339,153.7790724,https://clinicaltrials.gov/study/NCT00741260,NCT00741260,Breast Cancer
2161,0.996123514,156.8701602,https://clinicaltrials.gov/study/NCT02419560,NCT02419560,"Lymphoma, Mantle-Cell|Recurrent Lymphoma, Mantle-Cell"
2162,0.992413098,152.2767253,https://clinicaltrials.gov/study/NCT03299660,NCT03299660,Rectal Cancer
2163,0.991301274,151.7465723,https://clinicaltrials.gov/study/NCT00002860,NCT00002860,Melanoma (Skin)
2164,0.995769843,157.9302814,https://clinicaltrials.gov/study/NCT01408160,NCT01408160,Adult B Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia
2165,0.99913379,191.2492488,https://clinicaltrials.gov/study/NCT00004160,NCT00004160,Lung Cancer
2166,0.982843241,135.5071502,https://clinicaltrials.gov/study/NCT00001860,NCT00001860,Acromegaly|Pituitary Neoplasm
2167,0.944498619,40.20206577,https://clinicaltrials.gov/study/NCT01774760,NCT01774760,Squamous Cell Carcinoma of the Head and Neck
2168,0.998484274,181.9582578,https://clinicaltrials.gov/study/NCT00262860,NCT00262860,Lymphoma
2169,0.99932891,178.8921463,https://clinicaltrials.gov/study/NCT00006029,NCT00006029,Lymphoma
2170,0.996501364,162.2954708,https://clinicaltrials.gov/study/NCT03587129,NCT03587129,Ovarian Cancer
2171,0.956718961,40.12205284,https://clinicaltrials.gov/study/NCT00196729,NCT00196729,Thyroid Neoplasms
2172,0.990937988,151.6852097,https://clinicaltrials.gov/study/NCT00127829,NCT00127829,Tumors
2173,0.999097781,190.6079155,https://clinicaltrials.gov/study/NCT00798629,NCT00798629,Melanoma (Skin)
2174,0.999114577,190.3559947,https://clinicaltrials.gov/study/NCT00064129,NCT00064129,Recurrent Prostate Carcinoma|Stage IV Prostate Cancer AJCC v7
2175,0.904829973,21.03678852,https://clinicaltrials.gov/study/NCT01824329,NCT01824329,Bladder Cancer|Transitional Cell Carcinoma of the Bladder
2176,0.966972233,56.356714,https://clinicaltrials.gov/study/NCT02029729,NCT02029729,"Metastatic or Incurable Non-small Cell Lung Cancer|Relapsed, Refractory Melanoma"
2177,0.999067083,191.7396628,https://clinicaltrials.gov/study/NCT01196429,NCT01196429,Ovarian Clear Cell Cystadenocarcinoma|Stage III Ovarian Cancer|Stage IV Ovarian Cancer
2178,0.996493602,158.0429552,https://clinicaltrials.gov/study/NCT01240629,NCT01240629,Prostate Cancer|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
2179,0.999107763,178.6888569,https://clinicaltrials.gov/study/NCT00567229,NCT00567229,Multiple Myeloma and Plasma Cell Neoplasm
2180,0.980493892,112.4351413,https://clinicaltrials.gov/study/NCT01343277,NCT01343277,Advanced Liposarcoma or Leiomyosarcoma
2181,0.98237816,113.8430689,https://clinicaltrials.gov/study/NCT00945477,NCT00945477,Prostate Cancer
2182,0.980005017,70.88828633,https://clinicaltrials.gov/study/NCT00519077,NCT00519077,Head and Neck Neoplasms
2183,0.997000203,162.8309223,https://clinicaltrials.gov/study/NCT00556777,NCT00556777,Breast Cancer
2184,0.997364961,161.4880728,https://clinicaltrials.gov/study/NCT00028977,NCT00028977,Breast Cancer
2185,0.9993669,183.2034205,https://clinicaltrials.gov/study/NCT00006377,NCT00006377,Endometrial Cancer
2186,0.998286936,172.0051409,https://clinicaltrials.gov/study/NCT00976677,NCT00976677,Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
2187,0.997479389,163.2903023,https://clinicaltrials.gov/study/NCT00118053,NCT00118053,Breast Cancer
2188,0.996135852,156.13258,https://clinicaltrials.gov/study/NCT01156753,NCT01156753,Breast Cancer
2189,0.971930709,67.10950903,https://clinicaltrials.gov/study/NCT02083653,NCT02083653,Metastatic Colorectal Cancer
2190,0.972125427,74.48506803,https://clinicaltrials.gov/study/NCT04119453,NCT04119453,Adenoid Cystic Carcinoma
2191,0.998741025,180.4794997,https://clinicaltrials.gov/study/NCT00383760,NCT00383760,Adenocarcinoma of the Pancreas|Pancreatic Cancer|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
2192,0.98699362,150.020562,https://clinicaltrials.gov/study/NCT00258960,NCT00258960,Breast Cancer
2193,0.86080075,14.86424945,https://clinicaltrials.gov/study/NCT00216060,NCT00216060,Metastatic Prostate Cancer
2194,0.964255132,56.69432751,https://clinicaltrials.gov/study/NCT00489060,NCT00489060,Prostate Cancer
2195,0.997424063,164.9646377,https://clinicaltrials.gov/study/NCT00027560,NCT00027560,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
2196,0.982498482,99.53131673,https://clinicaltrials.gov/study/NCT02329860,NCT02329860,"Carcinoma, Hepatocellular"
2197,0.997554154,165.6126504,https://clinicaltrials.gov/study/NCT01245660,NCT01245660,Bladder Carcinoma|Infiltrative Bladder Carcinoma|Cystectomy
2198,0.580868091,3.709226923,https://clinicaltrials.gov/study/NCT05326360,NCT05326360,Postoperative Nausea and Vomiting|Breast Cancer Female
2199,0.998659436,177.9039671,https://clinicaltrials.gov/study/NCT00463060,NCT00463060,Cancer
2200,0.98572763,150.1173706,https://clinicaltrials.gov/study/NCT02611960,NCT02611960,Nasopharyngeal Neoplasms
2201,0.999756403,187.5528043,https://clinicaltrials.gov/study/NCT00022360,NCT00022360,Brain and Central Nervous System Tumors
2202,0.998894396,181.4508774,https://clinicaltrials.gov/study/NCT05156229,NCT05156229,Cutaneous T-cell Lymphoma (CTCL)
2203,0.992272925,151.470646,https://clinicaltrials.gov/study/NCT00259129,NCT00259129,Neoplasms
2204,0.999706016,184.8034947,https://clinicaltrials.gov/study/NCT00008229,NCT00008229,Multiple Myeloma and Plasma Cell Neoplasm
2205,0.992442812,151.7203289,https://clinicaltrials.gov/study/NCT00890929,NCT00890929,Acute Myeloid Leukemia (AML)|Adult Acute Myeloblastic Leukemia
2206,0.998227561,168.1643918,https://clinicaltrials.gov/study/NCT00005629,NCT00005629,Liver Cancer
2207,0.969683352,74.85046043,https://clinicaltrials.gov/study/NCT00179829,NCT00179829,Leukemia|Cancer
2208,0.993978362,153.2067105,https://clinicaltrials.gov/study/NCT02008929,NCT02008929,Hepatocellular Carcinoma
2209,0.993986954,155.0811313,https://clinicaltrials.gov/study/NCT03714529,NCT03714529,Basal Cell Carcinoma
2210,0.997913626,166.0700535,https://clinicaltrials.gov/study/NCT00662129,NCT00662129,Breast Cancer
2211,0.99575739,155.728877,https://clinicaltrials.gov/study/NCT02201329,NCT02201329,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic"
2212,0.979885238,91.71863253,https://clinicaltrials.gov/study/NCT05751629,NCT05751629,Ovarian Neoplasm
2213,0.999029115,178.5209373,https://clinicaltrials.gov/study/NCT00112229,NCT00112229,Melanoma
2214,0.978762994,81.77292488,https://clinicaltrials.gov/study/NCT02487277,NCT02487277,Adenocarcinoma
2215,0.97925963,106.6483568,https://clinicaltrials.gov/study/NCT01023477,NCT01023477,"Carcinoma, Intraductal, Noninfiltrating|DCIS|Ductal Carcinoma In Situ"
2216,0.964610823,53.3091513,https://clinicaltrials.gov/study/NCT01206777,NCT01206777,Indolent or Intermediate Grade B-cell Malignancy
2217,0.884154551,18.56480314,https://clinicaltrials.gov/study/NCT00426777,NCT00426777,Prostate Cancer
2218,0.998040545,163.7492431,https://clinicaltrials.gov/study/NCT02043860,NCT02043860,Multiple Myeloma
2219,0.988947355,151.2079333,https://clinicaltrials.gov/study/NCT02036060,NCT02036060,Metastatic Prostate Cancer
2220,0.912595095,21.37280693,https://clinicaltrials.gov/study/NCT01140360,NCT01140360,Neurofibromatosis|Neurofibromas
2221,0.99604006,156.6127787,https://clinicaltrials.gov/study/NCT02481960,NCT02481960,Glioma
2222,0.998186944,172.1258739,https://clinicaltrials.gov/study/NCT00147160,NCT00147160,Glioma
2223,0.990694665,151.7024817,https://clinicaltrials.gov/study/NCT03242460,NCT03242460,Relapsed and/or refractorY Multiple Myeloma
2224,0.99920908,181.2684266,https://clinicaltrials.gov/study/NCT00019760,NCT00019760,Recurrent Colon Cancer|Liver Metastases|Stage IV Rectal Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer
2225,0.971096239,58.2895739,https://clinicaltrials.gov/study/NCT00313560,NCT00313560,Pancreatic Cancer
2226,0.968869931,54.83617057,https://clinicaltrials.gov/study/NCT00460629,NCT00460629,Chronic Myeloid Leukemia
2227,0.998926169,185.7995756,https://clinicaltrials.gov/study/NCT01412229,NCT01412229,Head and Neck Cancer
2228,0.99802864,169.1064169,https://clinicaltrials.gov/study/NCT01313429,NCT01313429,Sarcoma|Melanoma|Epithelial Malignancies|Pleural Malignancies
2229,0.955177001,39.69884942,https://clinicaltrials.gov/study/NCT02063529,NCT02063529,Metastatic Colorectal Cancer
2230,0.995973208,157.9240469,https://clinicaltrials.gov/study/NCT01902329,NCT01902329,Acute Myelogenous Leukemia|Acute Myeloid Leukemia|Acute Promyelocytic Leukemia
2231,0.998568727,171.6462633,https://clinicaltrials.gov/study/NCT00025129,NCT00025129,"Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
2232,0.999663307,194.8398385,https://clinicaltrials.gov/study/NCT02194829,NCT02194829,Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Unresectable Pancreatic Carcinoma
2233,0.784837838,6.524509272,https://clinicaltrials.gov/study/NCT02513329,NCT02513329,Hot Flushes|Hot Flashes
2234,0.998974986,174.6896226,https://clinicaltrials.gov/study/NCT00308529,NCT00308529,"Carcinoma, Small Cell Lung|Lung Cancer"
2235,0.969498381,65.00722716,https://clinicaltrials.gov/study/NCT00461929,NCT00461929,Chronic Myeloid Leukemia|Gastrointestinal Stromal Cell Tumors|Chromosome Abnormality
2236,0.984047697,112.1557446,https://clinicaltrials.gov/study/NCT04342377,NCT04342377,Lung Cancer|Non Small Cell Lung Cancer|Non-small Cell Lung Cancer Stage I|Non-small Cell Lung Cancer Stage II
2237,0.99784053,166.9212122,https://clinicaltrials.gov/study/NCT01378377,NCT01378377,Advanced Solid Tumor
2238,0.890112991,19.47656214,https://clinicaltrials.gov/study/NCT00170677,NCT00170677,Ovarian Cancer
2239,0.999746643,182.758367,https://clinicaltrials.gov/study/NCT00004877,NCT00004877,"Unspecified Adult Solid Tumor, Protocol Specific"
2240,0.990244239,150.914894,https://clinicaltrials.gov/study/NCT01724177,NCT01724177,Adult T-Cell Leukemia-Lymphoma
2241,0.999789898,183.590871,https://clinicaltrials.gov/study/NCT01334177,NCT01334177,Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Salivary Gland Squamous Cell Carcinoma|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Verrucous Carcinoma of the Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVB Verrucous Carcinoma of the Larynx|Stage IVB Verrucous Carcinoma of the Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Larynx|Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Oropharynx|Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVC Verrucous Carcinoma of the Larynx|Stage IVC Verrucous Carcinoma of the Oral Cavity|Tongue Cancer
2242,0.990511176,150.8712961,https://clinicaltrials.gov/study/NCT01583777,NCT01583777,Advanced Cancer
2243,0.938694512,38.69802005,https://clinicaltrials.gov/study/NCT03291977,NCT03291977,"Glioblastoma, Adult"
2244,0.993552243,154.099693,https://clinicaltrials.gov/study/NCT04094077,NCT04094077,Brain Metastases
2245,0.996710762,162.0019405,https://clinicaltrials.gov/study/NCT00003553,NCT00003553,Kidney Cancer
2246,0.957123163,46.60750024,https://clinicaltrials.gov/study/NCT00510653,NCT00510653,Ovarian Cancer
2247,0.996906812,160.1904182,https://clinicaltrials.gov/study/NCT00747253,NCT00747253,"Brain Tumor|Brain Tumor, Recurrent|Brain Neoplasm|Brain Cancer|Glioblastoma Multiforme|Recurrent Glioblastoma Multiforme"
2248,0.952032921,33.39704866,https://clinicaltrials.gov/study/NCT02160353,NCT02160353,High Risk Localised Prostate Carcinoma
2249,0.985044733,129.8644008,https://clinicaltrials.gov/study/NCT00771953,NCT00771953,Lung Cancer|Non Small Cell Lung Cancer
2250,0.997219777,158.7585316,https://clinicaltrials.gov/study/NCT00920153,NCT00920153,Lymphoma
2251,0.996171789,156.8327277,https://clinicaltrials.gov/study/NCT00512460,NCT00512460,Neoplastic Meningitis|Solid Tumor|Lymphoma|Leukemia|Brain Tumor
2252,0.995838364,157.1708175,https://clinicaltrials.gov/study/NCT01547260,NCT01547260,Pancreatic Carcinoma Metastatic|Pancreatic Ductal Adenocarcinoma
2253,0.9995453,188.6860105,https://clinicaltrials.gov/study/NCT03359460,NCT03359460,Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Refractory High Risk Myelodysplastic Syndrome|Secondary Myelodysplastic Syndrome|Therapy-Related Myelodysplastic Syndrome
2254,0.973456615,70.48277375,https://clinicaltrials.gov/study/NCT03000660,NCT03000660,AL Amyloidosis
2255,0.999044447,181.2817867,https://clinicaltrials.gov/study/NCT00014560,NCT00014560,Leukemia|Lymphoma
2256,0.981294304,144.4917822,https://clinicaltrials.gov/study/NCT01228760,NCT01228760,Prostate Neoplasms
2257,0.711169219,6.473738925,https://clinicaltrials.gov/study/NCT00172029,NCT00172029,Breast Cancer With Metastatic Bone Disease
2258,0.98074012,99.66331172,https://clinicaltrials.gov/study/NCT02258529,NCT02258529,Follicular Lymphoma|Small Lymphocytic Lymphoma
2259,0.997081781,158.3675425,https://clinicaltrials.gov/study/NCT01332929,NCT01332929,Metastatic Malignant Neoplasm to Brain
2260,0.99944168,186.6109846,https://clinicaltrials.gov/study/NCT01005329,NCT01005329,Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Stage IA Uterine Corpus Cancer AJCC v7|Stage IB Uterine Corpus Cancer AJCC v7|Stage II Uterine Corpus Cancer AJCC v7|Stage IIIA Uterine Corpus Cancer AJCC v7|Stage IIIB Uterine Corpus Cancer AJCC v7|Stage IIIC Uterine Corpus Cancer AJCC v7|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7
2261,0.999510099,188.0062711,https://clinicaltrials.gov/study/NCT00217529,NCT00217529,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
2262,0.949541216,39.82882573,https://clinicaltrials.gov/study/NCT00201929,NCT00201929,Breast Cancer
2263,0.991701072,152.5730908,https://clinicaltrials.gov/study/NCT01998529,NCT01998529,Lung Cancer
2264,0.996618791,158.1839409,https://clinicaltrials.gov/study/NCT02138929,NCT02138929,Esophageal Cancer
2265,0.999029172,181.9931801,https://clinicaltrials.gov/study/NCT02041429,NCT02041429,Recurrent Breast Cancer|Metastatic Breast Cancer
2266,0.998494292,175.6574367,https://clinicaltrials.gov/study/NCT01105377,NCT01105377,Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
2267,0.978704951,101.2775042,https://clinicaltrials.gov/study/NCT04399577,NCT04399577,Warts
2268,0.988195616,150.5322282,https://clinicaltrials.gov/study/NCT00389077,NCT00389077,Tumors|Lymphomas
2269,0.986436207,147.9629695,https://clinicaltrials.gov/study/NCT01621477,NCT01621477,"Acute Lymphoblastic Leukemia|Acute Myelocytic Leukemia|Chronic Myelocytic Leukemia|Juvenile Myelomonocytic Leukemia|Myelodysplastic Syndrome|Hodgkin or Non-Hodgkin Lymphoma|Sarcoma, Myeloid"
2270,0.998692992,174.5750931,https://clinicaltrials.gov/study/NCT00138177,NCT00138177,"Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
2271,0.896424509,16.56198874,https://clinicaltrials.gov/study/NCT00543777,NCT00543777,Liver Cancer
2272,0.999162987,187.1701237,https://clinicaltrials.gov/study/NCT00316953,NCT00316953,"Accelerated Phase Chronic Myelogenous Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Childhood Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Meningeal Chronic Myelogenous Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Relapsing Chronic Myelogenous Leukemia|Unspecified Childhood Solid Tumor, Protocol Specific"
2273,0.933194571,29.66983303,https://clinicaltrials.gov/study/NCT00735553,NCT00735553,Uterine Fibroids
2274,0.995404151,156.1770363,https://clinicaltrials.gov/study/NCT01025453,NCT01025453,Thyroid Cancer
2275,0.999553477,190.9595213,https://clinicaltrials.gov/study/NCT00080353,NCT00080353,Melanoma
2276,0.980856345,99.26191256,https://clinicaltrials.gov/study/NCT04275960,NCT04275960,Solid Tumors Harboring NTRK Fusion
2277,0.994812176,155.5027698,https://clinicaltrials.gov/study/NCT00581360,NCT00581360,Adenoid Cystic Carcinoma
2278,0.997796595,165.4869616,https://clinicaltrials.gov/study/NCT02052960,NCT02052960,"Carcinoma, Squamous Cell of Head and Neck"
2279,0.970695985,66.19313953,https://clinicaltrials.gov/study/NCT00000660,NCT00000660,"Sarcoma, Kaposi|HIV Infections"
2280,0.990572853,150.7762419,https://clinicaltrials.gov/study/NCT00101660,NCT00101660,Chronic Myeloid Leukemia|Philadelphia-Positive Myeloid Leukemia
2281,0.968563206,73.53183013,https://clinicaltrials.gov/study/NCT04434560,NCT04434560,"Brain Metastases, Adult"
2282,0.996605331,159.4661001,https://clinicaltrials.gov/study/NCT01213160,NCT01213160,Cancer|Advanced Solid Malignancies
2283,0.98946153,150.1899453,https://clinicaltrials.gov/study/NCT02368860,NCT02368860,Pancreatic Cancer
2284,0.989120223,150.4558058,https://clinicaltrials.gov/study/NCT00235560,NCT00235560,Acute Myeloid Leukemia
2285,0.995706924,155.3221192,https://clinicaltrials.gov/study/NCT00113360,NCT00113360,Neuroendocrine Carcinoma|Islet Cell Carcinoma
2286,0.998279799,170.564403,https://clinicaltrials.gov/study/NCT03749460,NCT03749460,Metastatic Malignant Neoplasm in the Bone|Metastatic Malignant Neoplasm in the Lung|Salivary Gland Carcinoma|Stage IV Major Salivary Gland Cancer AJCC v8|Stage IVA Major Salivary Gland Cancer AJCC v8|Stage IVB Major Salivary Gland Cancer AJCC v8|Stage IVC Major Salivary Gland Cancer AJCC v8
2287,0.872214275,13.16262678,https://clinicaltrials.gov/study/NCT02485860,NCT02485860,Pilonidal Cysts
2288,0.998951733,183.409564,https://clinicaltrials.gov/study/NCT00659360,NCT00659360,Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Fibrous Histiocytoma|Adult Rhabdomyosarcoma|Dermatofibrosarcoma Protuberans|Endometrial Stromal Sarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Uterine Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage III Uterine Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Stage IV Uterine Sarcoma|Uterine Carcinosarcoma|Uterine Leiomyosarcoma
2289,0.995015364,155.6532547,https://clinicaltrials.gov/study/NCT00244829,NCT00244829,Leukemia
2290,0.791675159,8.723225894,https://clinicaltrials.gov/study/NCT02284529,NCT02284529,Stage- Colorectal Cancer
2291,0.99913006,192.8964971,https://clinicaltrials.gov/study/NCT00679029,NCT00679029,HER2-negative Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
2292,0.998084708,170.2686295,https://clinicaltrials.gov/study/NCT03006029,NCT03006029,Solid Tumors
2293,0.956598316,46.63743359,https://clinicaltrials.gov/study/NCT00380029,NCT00380029,Bladder Cancer
2294,0.991065507,150.936808,https://clinicaltrials.gov/study/NCT01303029,NCT01303029,Metastatic Pancreatic Cancer
2295,0.998321771,166.624759,https://clinicaltrials.gov/study/NCT03454529,NCT03454529,Invasive Breast Carcinoma|Stage I Breast Cancer AJCC v7|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage II Breast Cancer AJCC v6 and v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7
2296,0.677711993,4.309958108,https://clinicaltrials.gov/study/NCT03152929,NCT03152929,Breast Cancer
2297,0.999115268,185.0581251,https://clinicaltrials.gov/study/NCT00006229,NCT00006229,Lung Cancer
2298,0.993418555,154.6716962,https://clinicaltrials.gov/study/NCT01986829,NCT01986829,Osteosarcoma|Sarcoma
2299,0.995545304,156.8488899,https://clinicaltrials.gov/study/NCT00738829,NCT00738829,"Leukemia, Lymphocytic, Chronic, B-Cell"
2300,0.993434394,152.3621721,https://clinicaltrials.gov/study/NCT00645177,NCT00645177,Metastatic Breast Cancer
2301,0.92512506,26.54216272,https://clinicaltrials.gov/study/NCT00990977,NCT00990977,Breast Cancer
2302,0.994996206,155.005073,https://clinicaltrials.gov/study/NCT00015977,NCT00015977,Prostate Cancer
2303,0.9604087,54.09244693,https://clinicaltrials.gov/study/NCT00307177,NCT00307177,Influenza
2304,0.996236571,155.719491,https://clinicaltrials.gov/study/NCT01218477,NCT01218477,Leukemia
2305,0.976498989,89.99047058,https://clinicaltrials.gov/study/NCT00794053,NCT00794053,Thyroid Cancer|Lymph Node Metastasis
2306,0.984899727,138.3635627,https://clinicaltrials.gov/study/NCT00424853,NCT00424853,"Carcinoma, Non-Small-Cell Lung"
2307,0.997456813,164.7560406,https://clinicaltrials.gov/study/NCT03075553,NCT03075553,"Blastic Plasmacytoid Dendritic Cell Neoplasm|Hepatosplenic T-Cell Lymphoma|HTLV-1 Infection|NK-Cell Lymphoma, Unclassifiable|Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative|Recurrent Adult T-Cell Leukemia/Lymphoma|Recurrent Anaplastic Large Cell Lymphoma|Recurrent Angioimmunoblastic T-cell Lymphoma|Recurrent Enteropathy-Associated T-Cell Lymphoma|Recurrent Mycosis Fungoides|Refractory Adult T-Cell Leukemia/Lymphoma|Refractory Anaplastic Large Cell Lymphoma|Refractory Angioimmunoblastic T-cell Lymphoma|Refractory Enteropathy-Associated T-Cell Lymphoma|Refractory Mycosis Fungoides|Refractory Nasal Type Extranodal NK/T-Cell Lymphoma|Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified"
2308,0.92381014,24.93763859,https://clinicaltrials.gov/study/NCT00359060,NCT00359060,Breast Cancer
2309,0.856999615,14.53553525,https://clinicaltrials.gov/study/NCT02090660,NCT02090660,Lung Cancer
2310,0.999683851,192.9534793,https://clinicaltrials.gov/study/NCT00002560,NCT00002560,Neuroblastoma
2311,0.970674519,59.01429825,https://clinicaltrials.gov/study/NCT00469560,NCT00469560,Myelodysplastic Syndromes|Hemosiderosis
2312,0.995344237,156.4023547,https://clinicaltrials.gov/study/NCT00003760,NCT00003760,Pancreatic Cancer
2313,0.953190746,41.06715619,https://clinicaltrials.gov/study/NCT01222260,NCT01222260,AL Amyloidosis
2314,0.700134143,6.418628495,https://clinicaltrials.gov/study/NCT01269060,NCT01269060,Colorectal Cancer
2315,0.99568233,156.4970064,https://clinicaltrials.gov/study/NCT01581060,NCT01581060,Advanced Solid Tumours
2316,0.978619069,105.6150601,https://clinicaltrials.gov/study/NCT00442260,NCT00442260,Metastatic Breast Cancer
2317,0.998286888,167.8139285,https://clinicaltrials.gov/study/NCT01560260,NCT01560260,Carney Complex|Chondrosarcoma|Gastrointestinal Stromal Tumor|Paraganglioma
2318,0.994848755,153.8511598,https://clinicaltrials.gov/study/NCT00179660,NCT00179660,Non-Hodgkins Lymphoma
2319,0.999287109,188.1905423,https://clinicaltrials.gov/study/NCT00004029,NCT00004029,Prostate Cancer
2320,0.990364754,151.0593153,https://clinicaltrials.gov/study/NCT00368329,NCT00368329,"Esophageal Neoplasms|Carcinoma, Squamous Cell|Adenocarcinoma|Esophageal Cancer"
2321,0.997027946,161.9400623,https://clinicaltrials.gov/study/NCT01469429,NCT01469429,Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Salivary Gland Squamous Cell Carcinoma|Stage 0 Hypopharyngeal Cancer|Stage 0 Laryngeal Cancer|Stage 0 Lip and Oral Cavity Cancer|Stage 0 Nasopharyngeal Cancer|Stage 0 Oropharyngeal Cancer|Stage 0 Paranasal Sinus and Nasal Cavity Cancer|Stage I Salivary Gland Cancer|Stage I Squamous Cell Carcinoma of the Hypopharynx|Stage I Squamous Cell Carcinoma of the Larynx|Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage I Squamous Cell Carcinoma of the Nasopharynx|Stage I Squamous Cell Carcinoma of the Oropharynx|Stage I Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage I Verrucous Carcinoma of the Larynx|Stage I Verrucous Carcinoma of the Oral Cavity|Stage II Salivary Gland Cancer|Stage II Squamous Cell Carcinoma of the Hypopharynx|Stage II Squamous Cell Carcinoma of the Larynx|Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage II Squamous Cell Carcinoma of the Nasopharynx|Stage II Squamous Cell Carcinoma of the Oropharynx|Stage II Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage II Verrucous Carcinoma of the Larynx|Stage II Verrucous Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IVA Salivary Gland Cancer|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Oral Cavity Squamous Cell Carcinoma|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Nasal Cavity and Paranasal Sinus Cancer|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Verrucous Carcinoma of the Oral Cavity|Stage IVB Salivary Gland Cancer|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVB Oral Cavity Squamous Cell Carcinoma|Stage IVB Verrucous Carcinoma of the Larynx|Stage IVB Verrucous Carcinoma of the Oral Cavity|Stage IVC Salivary Gland Cancer|Stage IVC Squamous Cell Carcinoma of the Larynx|Stage IVC Oral Cavity Squamous Cell Carcinoma|Stage IVC Squamous Cell Carcinoma of the Oropharynx|Paranasal Sinus and Nasal Cavity Squamous Cell Carcinoma|Stage IVC Verrucous Carcinoma of the Larynx|Stage IVC Verrucous Carcinoma of the Oral Cavity|Tongue Cancer
2322,0.99834976,177.4112694,https://clinicaltrials.gov/study/NCT00369629,NCT00369629,Lymphoma
2323,0.990460313,151.7087326,https://clinicaltrials.gov/study/NCT02931929,NCT02931929,Gastrointestinal Stromal Tumors
2324,0.995016553,155.1541342,https://clinicaltrials.gov/study/NCT00426829,NCT00426829,Liver Cancer|Hepatocellular Carcinoma|Cholangiocarcinoma
2325,0.99352542,153.890428,https://clinicaltrials.gov/study/NCT02744729,NCT02744729,Esophageal Cancer
2326,0.998043105,170.9742868,https://clinicaltrials.gov/study/NCT00625729,NCT00625729,Leukemia|Lymphoma
2327,0.999466302,190.1408346,https://clinicaltrials.gov/study/NCT00499577,NCT00499577,Multiple Myeloma and Plasma Cell Neoplasm
2328,0.864574182,11.38323044,https://clinicaltrials.gov/study/NCT01803477,NCT01803477,Actinic Keratosis
2329,0.707118908,4.471837082,https://clinicaltrials.gov/study/NCT00953277,NCT00953277,Peripheral Nerve Injury|Prostate Cancer|Radical Prostatectomy|Nerve Reconstruction|Cavernous Nerve Injury
2330,0.994594784,153.2201488,https://clinicaltrials.gov/study/NCT03652077,NCT03652077,Cervical Cancer|Gastric Cancer|Stomach Cancer|Gastroesophageal Junction Cancer|Esophageal Cancer|Hepatocellular Carcinoma|Melanoma|Uveal Melanoma|Merkel Cell Carcinoma|Mesothelioma|MSI|Non-small Cell Lung Cancer|NSCLC|Ovarian Cancer|Squamous Cell Carcinoma of the Head and Neck|Small Cell Lung Cancer|Renal Cell Carcinoma|RCC|Triple-negative Breast Cancer|Urothelial Carcinoma|Mismatch Repair Deficiency
2331,0.992248071,152.299083,https://clinicaltrials.gov/study/NCT01221077,NCT01221077,NSCLC|Non Small Cell Lung Cancer
2332,0.999862414,189.5497641,https://clinicaltrials.gov/study/NCT00031577,NCT00031577,Brain and Central Nervous System Tumors
2333,0.994171736,153.3772243,https://clinicaltrials.gov/study/NCT03515577,NCT03515577,Recurrent Prostate Carcinoma
2334,0.995644119,155.1934156,https://clinicaltrials.gov/study/NCT03121677,NCT03121677,Follicular Lymphoma
2335,0.986431935,132.5331924,https://clinicaltrials.gov/study/NCT00867672,NCT00867672,Acute Myeloid Leukemia
2336,0.999374113,189.9447498,https://clinicaltrials.gov/study/NCT00025272,NCT00025272,Lung Cancer
2337,0.983729339,103.1719501,https://clinicaltrials.gov/study/NCT03344172,NCT03344172,Pancreatic Cancer Resectable
2338,0.987181689,127.5201843,https://clinicaltrials.gov/study/NCT02350972,NCT02350972,Metastatic Malignant Melanoma
2339,0.790275917,9.165564087,https://clinicaltrials.gov/study/NCT02880072,NCT02880072,Refeeding Syndrome|Cancer of the Head and Neck
2340,0.998693889,176.6760708,https://clinicaltrials.gov/study/NCT01663272,NCT01663272,Pancreatic Cancer
2341,0.929149301,28.79026756,https://clinicaltrials.gov/study/NCT01993472,NCT01993472,Colorectal Neoplasms
2342,0.994911529,153.8668219,https://clinicaltrials.gov/study/NCT00146172,NCT00146172,Breast Neoplasms
2343,0.985168889,110.545088,https://clinicaltrials.gov/study/NCT00215462,NCT00215462,Esophageal Cancer|Gastric Cancer|Stomach Cancer
2344,0.991764051,152.7320731,https://clinicaltrials.gov/study/NCT00146562,NCT00146562,Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer
2345,0.997981889,168.6640007,https://clinicaltrials.gov/study/NCT00003062,NCT00003062,Lung Cancer
2346,0.982365871,106.1564854,https://clinicaltrials.gov/study/NCT00047762,NCT00047762,Colorectal Cancer
2347,0.980161543,105.1005554,https://clinicaltrials.gov/study/NCT02918162,NCT02918162,Gastric Cancer|Adenocarcinoma of the Gastroesophageal Junction
2348,0.990024867,151.2989357,https://clinicaltrials.gov/study/NCT00106262,NCT00106262,Cervical Cancer
2349,0.997535796,162.5493413,https://clinicaltrials.gov/study/NCT03162562,NCT03162562,"Cancer of Ovary|Neoplasms, Ovarian|Ovarian Cancer Stage IV|Ovarian Cancer Recurrent|Ovarian Cancer Stage III|Ovary Cancer"
2350,0.918121108,23.05827423,https://clinicaltrials.gov/study/NCT00128362,NCT00128362,Cancer of the Breast
2351,0.997150364,162.3236418,https://clinicaltrials.gov/study/NCT00101062,NCT00101062,Breast Cancer
2352,0.995882197,154.2917459,https://clinicaltrials.gov/study/NCT00478062,NCT00478062,Lymphoma
2353,0.9938758,153.8718432,https://clinicaltrials.gov/study/NCT02004262,NCT02004262,"2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer"
2354,0.991057814,151.6867398,https://clinicaltrials.gov/study/NCT00569010,NCT00569010,Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Leukemia
2355,0.984387823,125.6530541,https://clinicaltrials.gov/study/NCT00003610,NCT00003610,Head and Neck Cancer|Radiation Toxicity
2356,0.975132495,83.22511753,https://clinicaltrials.gov/study/NCT01152710,NCT01152710,Resectable Rectal Cancer Clinical Stage II and III
2357,0.982290846,75.86956897,https://clinicaltrials.gov/study/NCT02480010,NCT02480010,Prostate Cancer
2358,0.996702691,161.4406108,https://clinicaltrials.gov/study/NCT00363610,NCT00363610,Tumors|Lymphoma
2359,0.872287056,15.7358019,https://clinicaltrials.gov/study/NCT01230710,NCT01230710,Non-Small Cell Lung Cancer
2360,0.956434777,34.16914981,https://clinicaltrials.gov/study/NCT00822510,NCT00822510,Prostate Cancer
2361,0.984326446,127.0263952,https://clinicaltrials.gov/study/NCT00039910,NCT00039910,Non-Hodgkin Lymphoma|Hodgkin Disease|Thrombocytopenia
2362,0.990875739,150.8702425,https://clinicaltrials.gov/study/NCT00490646,NCT00490646,Metastatic Breast Cancer
2363,0.998690593,174.5844787,https://clinicaltrials.gov/study/NCT00077246,NCT00077246,Lung Cancer
2364,0.938861169,28.21469429,https://clinicaltrials.gov/study/NCT00685646,NCT00685646,Metastatic Cancer|Prostate Cancer
2365,0.992000263,153.0364247,https://clinicaltrials.gov/study/NCT00204646,NCT00204646,"Sarcoma, Soft Tissue"
2366,0.998334277,174.8715113,https://clinicaltrials.gov/study/NCT03851146,NCT03851146,Advanced Cancer
2367,0.997370435,162.550357,https://clinicaltrials.gov/study/NCT00099346,NCT00099346,Colorectal Cancer|Advanced Solid Tumors
2368,0.994574415,154.3204972,https://clinicaltrials.gov/study/NCT01895946,NCT01895946,"Advanced Solid Malignancy,|Safety and Tolerability,|Pharmacokinetics, Pharmacodynamics,|Tumour Response,"
2369,0.991511238,150.8186329,https://clinicaltrials.gov/study/NCT02384746,NCT02384746,Breast Cancer
2370,0.990185184,150.7278248,https://clinicaltrials.gov/study/NCT00456846,NCT00456846,Metastatic Breast Cancer
2371,0.997986826,167.2843579,https://clinicaltrials.gov/study/NCT00516373,NCT00516373,Ovarian Neoplasms|BRCA1 Protein|BRCA2 Protein
2372,0.995515132,155.4864159,https://clinicaltrials.gov/study/NCT00179673,NCT00179673,Non-Hodgkins Lymphoma
2373,0.985207016,141.0034019,https://clinicaltrials.gov/study/NCT00437073,NCT00437073,"Neoplasms, Breast"
2374,0.971937371,66.019645,https://clinicaltrials.gov/study/NCT00378573,NCT00378573,Non-small Cell Lung Cancer
2375,0.997451535,162.830773,https://clinicaltrials.gov/study/NCT00238173,NCT00238173,Bone Marrow Suppression|Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ|Long-term Effects Secondary to Cancer Therapy in Children
2376,0.99861759,177.1597067,https://clinicaltrials.gov/study/NCT01898273,NCT01898273,Glioblastoma
2377,0.996309418,159.2575173,https://clinicaltrials.gov/study/NCT01072773,NCT01072773,Primary Systemic Amyloidosis
2378,0.993783892,153.2012398,https://clinicaltrials.gov/study/NCT03206073,NCT03206073,Colorectal Cancer|Colorectal Carcinoma|Colorectal Adenocarcinoma|Refractory Cancer|Colorectal Neoplasms
2379,0.999518415,196.3896481,https://clinicaltrials.gov/study/NCT00003573,NCT00003573,Brain Tumors|Central Nervous System Tumors
2380,0.932114597,25.61103219,https://clinicaltrials.gov/study/NCT01874873,NCT01874873,Tumor
2381,0.999646343,186.1104097,https://clinicaltrials.gov/study/NCT01352273,NCT01352273,Advanced Solid Tumors
2382,0.981948911,125.8131741,https://clinicaltrials.gov/study/NCT00405873,NCT00405873,Hepatocellular Carcinoma
2383,0.736951612,5.993294325,https://clinicaltrials.gov/study/NCT02926573,NCT02926573,Head and Neck Cancer|Acute Pain|Postoperative Pain
2384,0.971558591,77.50926802,https://clinicaltrials.gov/study/NCT02608073,NCT02608073,Nasopharyngeal Cancer
2385,0.994748678,153.8846251,https://clinicaltrials.gov/study/NCT01999673,NCT01999673,"Non-Small-Cell Lung Cancer Stage IIIB|Non-Small-Cell Lung Cancer Stage IV|Non-Small-Cell Lung Cancer Metastatic|Carcinoma, Non-Small-Cell Lung|Non-Small Cell Lung Cancer|Non-Small-Cell Lung Carcinoma|Nonsmall Cell Lung Cancer"
2386,0.999105287,188.754104,https://clinicaltrials.gov/study/NCT01955473,NCT01955473,Solid Tumors
2387,0.994356981,154.770425,https://clinicaltrials.gov/study/NCT02094573,NCT02094573,"Carcinoma, Non-Small-Cell Lung"
2388,0.999720373,194.870571,https://clinicaltrials.gov/study/NCT03272464,NCT03272464,Melanoma
2389,0.991219877,151.7565373,https://clinicaltrials.gov/study/NCT03076164,NCT03076164,Lung Adenocarcinoma|Lung Cancer|Lung Cancer Metastatic|Lung Cancer Stage IV|Recurrent Lung Adenocarcinoma|Recurrent Lung Cancer
2390,0.998792119,180.1843235,https://clinicaltrials.gov/study/NCT01869764,NCT01869764,Ductal Breast Carcinoma in Situ|Lobular Breast Carcinoma in Situ|Male Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
2391,0.995083477,155.5944665,https://clinicaltrials.gov/study/NCT01497964,NCT01497964,Gastric Cancer
2392,0.98825154,150.3954276,https://clinicaltrials.gov/study/NCT01185964,NCT01185964,"Sarcoma, Soft Tissue"
2393,0.697729091,5.817775343,https://clinicaltrials.gov/study/NCT05141864,NCT05141864,Analgesia in the Digital Rectal Examination
2394,0.875176024,15.13310456,https://clinicaltrials.gov/study/NCT00407264,NCT00407264,Bronchogenic Carcinoma
2395,0.998065822,167.0785645,https://clinicaltrials.gov/study/NCT00023764,NCT00023764,Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma
2396,0.998510977,172.9511371,https://clinicaltrials.gov/study/NCT03195764,NCT03195764,Advanced Refractory Solid Tumors
2397,0.993101181,153.2262461,https://clinicaltrials.gov/study/NCT00002564,NCT00002564,Breast Cancer
2398,0.99771189,163.9184366,https://clinicaltrials.gov/study/NCT00047164,NCT00047164,Lymphoma
2399,0.997850282,163.7862121,https://clinicaltrials.gov/study/NCT01806064,NCT01806064,Renal Cell Carcinoma
2400,0.943180834,38.35023108,https://clinicaltrials.gov/study/NCT03743064,NCT03743064,Cachexia; Cancer|Non Small Cell Lung Cancer
2401,0.999207764,179.0316868,https://clinicaltrials.gov/study/NCT02927964,NCT02927964,Grade 1 Follicular Lymphoma|Grade 2 Follicular Lymphoma|Grade 3a Follicular Lymphoma|Recurrent Follicular Lymphoma|Refractory Follicular Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma
2402,0.994281741,153.0747804,https://clinicaltrials.gov/study/NCT00849264,NCT00849264,Hepatocellular Carcinoma|Portal Vein Tumor Thrombus
2403,0.999334623,179.8922987,https://clinicaltrials.gov/study/NCT00433446,NCT00433446,Prostate Cancer
2404,0.995885621,157.0043889,https://clinicaltrials.gov/study/NCT00784446,NCT00784446,Stage IV Colorectal Cancer
2405,0.978582313,92.20380962,https://clinicaltrials.gov/study/NCT00575146,NCT00575146,Recurrent Glioblastoma
2406,0.993440266,153.2774199,https://clinicaltrials.gov/study/NCT01798446,NCT01798446,Renal Cell Carcinoma|Nonclear Cell|Temsirolimus Resistance
2407,0.86781318,13.6931167,https://clinicaltrials.gov/study/NCT05641246,NCT05641246,Hand and Foot Syndrome
2408,0.991104868,151.6084762,https://clinicaltrials.gov/study/NCT03329846,NCT03329846,Melanoma|Skin Cancer
2409,0.953639415,34.36196436,https://clinicaltrials.gov/study/NCT00267046,NCT00267046,Sarcoma|Oral Mucositis
2410,0.998007946,169.9911379,https://clinicaltrials.gov/study/NCT01125046,NCT01125046,Acoustic Schwannoma|Adult Anaplastic Meningioma|Adult Ependymoma|Adult Grade I Meningioma|Adult Grade II Meningioma|Adult Meningeal Hemangiopericytoma|Adult Papillary Meningioma|Neurofibromatosis Type 1|Neurofibromatosis Type 2|Recurrent Adult Brain Tumor
2411,0.976855635,83.44058264,https://clinicaltrials.gov/study/NCT00670046,NCT00670046,Prostate Cancer
2412,0.990547122,151.0741143,https://clinicaltrials.gov/study/NCT00932373,NCT00932373,Metastatic Breast Cancer
2413,0.924632757,23.72321054,https://clinicaltrials.gov/study/NCT00884273,NCT00884273,Prostate Cancer
2414,0.994682366,154.4614583,https://clinicaltrials.gov/study/NCT02501473,NCT02501473,Follicular Low Grade Non-Hodgkin's Lymphoma
2415,0.982798883,140.162949,https://clinicaltrials.gov/study/NCT00199173,NCT00199173,Colorectal Neoplasm|Secondary Malignant Neoplasm of Liver
2416,0.97760937,84.35567918,https://clinicaltrials.gov/study/NCT02627573,NCT02627573,"Leukemia, Chronic Myeloid|Myelodysplastic Syndromes|Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative"
2417,0.966012752,56.25383596,https://clinicaltrials.gov/study/NCT00050973,NCT00050973,Non-small Cell Lung Cancer
2418,0.996159211,155.9478343,https://clinicaltrials.gov/study/NCT00027573,NCT00027573,Kidney Cancer
2419,0.999261904,191.9722553,https://clinicaltrials.gov/study/NCT00047073,NCT00047073,Brain and Central Nervous System Tumors
2420,0.997580439,159.9906512,https://clinicaltrials.gov/study/NCT00011973,NCT00011973,Kidney Cancer
2421,0.933557875,31.05029441,https://clinicaltrials.gov/study/NCT00461773,NCT00461773,Hormone-Sensitive Breast Cancer|Breast Cancer
2422,0.966511988,61.27938272,https://clinicaltrials.gov/study/NCT04278573,NCT04278573,Warts
2423,0.847841274,11.41766842,https://clinicaltrials.gov/study/NCT02065973,NCT02065973,High-risk HPV Infection and Biopsy-proven CIN1
2424,0.987747467,150.1128175,https://clinicaltrials.gov/study/NCT00535873,NCT00535873,Leukemia|CLL|Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
2425,0.99958281,188.2199116,https://clinicaltrials.gov/study/NCT00040573,NCT00040573,Glioma|Brain Neoplasm
2426,0.998638363,173.2927097,https://clinicaltrials.gov/study/NCT01462773,NCT01462773,Melanoma
2427,0.978395629,87.27667694,https://clinicaltrials.gov/study/NCT00515073,NCT00515073,Endometrial Cancer
2428,0.992972688,153.7967479,https://clinicaltrials.gov/study/NCT02203773,NCT02203773,Acute Myelogenous Leukemia|Myelogenous Leukemia|Treatment Naive AML
2429,0.986615166,150.021628,https://clinicaltrials.gov/study/NCT01248273,NCT01248273,Fallopian Tubes|Ovarian Cancer|Peritoneal Cancer
2430,0.998771283,175.8596093,https://clinicaltrials.gov/study/NCT02017964,NCT02017964,Desmoplastic/Nodular Medulloblastoma|Medulloblastoma|Medulloblastoma With Extensive Nodularity|Nevoid Basal Cell Carcinoma Syndrome
2431,0.991308796,152.2165945,https://clinicaltrials.gov/study/NCT00019864,NCT00019864,Cardiac Toxicity|Sarcoma
2432,0.999821442,188.4540795,https://clinicaltrials.gov/study/NCT00738764,NCT00738764,Cancer
2433,0.898260199,21.4252816,https://clinicaltrials.gov/study/NCT02794064,NCT02794064,Breast Cancer Invasive Nos|Primary Invasive Breast Cancer
2434,0.976177533,94.97381851,https://clinicaltrials.gov/study/NCT00259064,NCT00259064,NSCLC
2435,0.99569165,157.8798605,https://clinicaltrials.gov/study/NCT01608464,NCT01608464,Carcinoma of Esophagus
2436,0.951154179,37.43641353,https://clinicaltrials.gov/study/NCT02756364,NCT02756364,Breast Neoplasms
2437,0.980713253,112.1852452,https://clinicaltrials.gov/study/NCT00201864,NCT00201864,Breast Cancer
2438,0.856638911,15.6962659,https://clinicaltrials.gov/study/NCT03280264,NCT03280264,Parathyroid Carcinoma|Primary Hyperparathyroidism
2439,0.999068279,182.9909842,https://clinicaltrials.gov/study/NCT00864864,NCT00864864,Glioblastoma|Brain Tumor
2440,0.993039096,153.7928452,https://clinicaltrials.gov/study/NCT03043664,NCT03043664,Gastroenteropancreatic Neuroendocrine Tumors
2441,0.999372449,191.6947279,https://clinicaltrials.gov/study/NCT00003264,NCT00003264,Head and Neck Cancer
2442,0.998852615,181.6705742,https://clinicaltrials.gov/study/NCT00002946,NCT00002946,"Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific"
2443,0.996293351,158.1636924,https://clinicaltrials.gov/study/NCT00040846,NCT00040846,"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Peripheral T-cell Lymphoma|Previously Treated Myelodysplastic Syndromes|Progressive Hairy Cell Leukemia, Initial Treatment|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Splenic Marginal Zone Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Mycosis Fungoides/Sezary Syndrome|Stage I Small Lymphocytic Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Mycosis Fungoides/Sezary Syndrome|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides/Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides/Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstrm Macroglobulinemia"
2444,0.962129237,46.18595098,https://clinicaltrials.gov/study/NCT00373646,NCT00373646,MALT Lymphoma
2445,0.998052446,169.8087597,https://clinicaltrials.gov/study/NCT00255346,NCT00255346,"Acute Myeloid Leukemia|Myelodysplastic Syndromes|Agnogenic Myeloid Metaplasia|Myelofibrosis|Hypereosinophilic Syndrome|Polycythemia Vera|Mastocytosis|Leukemia, Myelomonocytic, Chronic"
2446,0.997527594,163.1781453,https://clinicaltrials.gov/study/NCT00004046,NCT00004046,Breast Cancer
2447,0.900883542,19.80699044,https://clinicaltrials.gov/study/NCT00196846,NCT00196846,Breast Cancer
2448,0.985173353,132.1955445,https://clinicaltrials.gov/study/NCT02686346,NCT02686346,Hodgkin Disease
2449,0.990921095,152.035533,https://clinicaltrials.gov/study/NCT03985046,NCT03985046,Esophageal Squamous Cell Carcinoma
2450,0.98984978,151.5484401,https://clinicaltrials.gov/study/NCT02605746,NCT02605746,Glioblastoma|Brain Metastases
2451,0.999614158,190.72773,https://clinicaltrials.gov/study/NCT01009346,NCT01009346,Head and Neck Cancer
2452,0.994658783,153.4685645,https://clinicaltrials.gov/study/NCT00072046,NCT00072046,Kidney Cancer
2453,0.9867349,150.7169235,https://clinicaltrials.gov/study/NCT03109873,NCT03109873,Larynx|Lip|Oral Cavity|Pharynx
2454,0.989943618,151.3520253,https://clinicaltrials.gov/study/NCT00574873,NCT00574873,Chronic Myeloid Leukemia
2455,0.995529319,155.9629263,https://clinicaltrials.gov/study/NCT01921673,NCT01921673,Gastric Cancer
2456,0.991015335,151.6256745,https://clinicaltrials.gov/study/NCT01492673,NCT01492673,Neuroblastoma|Sarcoma
2457,0.996338073,157.0179967,https://clinicaltrials.gov/study/NCT00560573,NCT00560573,"Carcinoma, Non-Small-Cell Lung"
2458,0.996121875,157.2820205,https://clinicaltrials.gov/study/NCT01644773,NCT01644773,Diffuse Intrinsic Pontine Glioma|High-grade Glioma
2459,0.843578899,13.35450153,https://clinicaltrials.gov/study/NCT04775173,NCT04775173,Kaposiform Hemangioendothelioma
2460,0.999149805,186.7470976,https://clinicaltrials.gov/study/NCT01361464,NCT01361464,Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
2461,0.946088468,32.82514236,https://clinicaltrials.gov/study/NCT02402764,NCT02402764,Breast Cancer
2462,0.996073822,159.0995191,https://clinicaltrials.gov/study/NCT00015964,NCT00015964,Head and Neck Cancer
2463,0.997936526,166.5798037,https://clinicaltrials.gov/study/NCT02808364,NCT02808364,Glioblastoma
2464,0.982594603,118.7731615,https://clinicaltrials.gov/study/NCT00061464,NCT00061464,"Carcinoma, Non-Small-Cell Lung"
2465,0.934791964,30.21656803,https://clinicaltrials.gov/study/NCT00504764,NCT00504764,Acute Promyelocytic Leukemia
2466,0.989919956,151.2647538,https://clinicaltrials.gov/study/NCT01626664,NCT01626664,Adult T-cell Leukemia-Lymphoma
2467,0.994534437,155.4002018,https://clinicaltrials.gov/study/NCT00260364,NCT00260364,Pancreatic Cancer
2468,0.983269887,104.3626182,https://clinicaltrials.gov/study/NCT00000764,NCT00000764,HIV Infections|Anus Neoplasms
2469,0.998191275,169.8026233,https://clinicaltrials.gov/study/NCT00249964,NCT00249964,Lung Diseases|Cancer
2470,0.919247886,18.81799852,https://clinicaltrials.gov/study/NCT01199146,NCT01199146,Prostate Cancer
2471,0.984109566,119.8610163,https://clinicaltrials.gov/study/NCT01901146,NCT01901146,Breast Cancer
2472,0.998966105,187.4685071,https://clinicaltrials.gov/study/NCT00016146,NCT00016146,Prostate Cancer
2473,0.998027958,165.8951479,https://clinicaltrials.gov/study/NCT00309946,NCT00309946,Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Localized Malignant Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
2474,0.956006787,42.11739414,https://clinicaltrials.gov/study/NCT01152346,NCT01152346,Myelodysplastic Syndrome
2475,0.99260143,152.5842785,https://clinicaltrials.gov/study/NCT01700946,NCT01700946,Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood B-Lymphoblastic Lymphoma
2476,0.996677055,156.7694091,https://clinicaltrials.gov/study/NCT02292173,NCT02292173,Hepatocellular Cancer|Liver Cancer
2477,0.974806873,57.93251029,https://clinicaltrials.gov/study/NCT00925873,NCT00925873,Acute Myeloid Leukemia
2478,0.980729464,99.01475026,https://clinicaltrials.gov/study/NCT03254173,NCT03254173,Advanced Cancer|Cancer Associated Anorexia - Cachexia
2479,0.988875367,150.4441553,https://clinicaltrials.gov/study/NCT02177773,NCT02177773,Neuroendocrine Tumor|Paraganglioma|Carcinoid Tumors|Neuroblastoma
2480,0.999843839,190.5946136,https://clinicaltrials.gov/study/NCT00005973,NCT00005973,"Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific"
2481,0.993300547,152.9610676,https://clinicaltrials.gov/study/NCT02003573,NCT02003573,"Leukemia, Myeloid, Acute"
2482,0.991304511,152.1845164,https://clinicaltrials.gov/study/NCT01478373,NCT01478373,Gastrointestinal Stromal Tumors
2483,0.978582487,112.3223643,https://clinicaltrials.gov/study/NCT05152173,NCT05152173,Plantar Fibromatosis
2484,0.550443753,3.464790872,https://clinicaltrials.gov/study/NCT02458573,NCT02458573,Gastric Cancer
2485,0.986210999,131.6260591,https://clinicaltrials.gov/study/NCT00171873,NCT00171873,Neuroendocrine Tumors
2486,0.717137427,6.205032448,https://clinicaltrials.gov/study/NCT01555073,NCT01555073,Uterine Fibroids|Uterine Artery Embolization
2487,0.991036755,151.6109958,https://clinicaltrials.gov/study/NCT00225173,NCT00225173,Hodgkin Disease
2488,0.999139286,189.6031164,https://clinicaltrials.gov/study/NCT00888173,NCT00888173,Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mixed Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Transitional Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Carcinoma
2489,0.969655669,57.8834786,https://clinicaltrials.gov/study/NCT02086773,NCT02086773,Acute Lymphoblastic Leukemia|Acute Lymphocytic Leukemia (ALL)|Acute Myelogenous Leukemia (AML)|Acute Promyelocytic Leukemia (APL)
2490,0.954604747,39.04995161,https://clinicaltrials.gov/study/NCT00214864,NCT00214864,Metastatic Breast Cancer
2491,0.975564712,65.39540763,https://clinicaltrials.gov/study/NCT03527264,NCT03527264,Cervical Cancer
2492,0.975681719,100.2247909,https://clinicaltrials.gov/study/NCT01124864,NCT01124864,Non-small-cell Lung Cancer
2493,0.998974752,187.5681658,https://clinicaltrials.gov/study/NCT03406364,NCT03406364,Solid Tumor
2494,0.998192264,165.8450817,https://clinicaltrials.gov/study/NCT01431664,NCT01431664,Leukemia
2495,0.998762857,181.8548997,https://clinicaltrials.gov/study/NCT01517464,NCT01517464,Neoplasm
2496,0.968030253,61.04494534,https://clinicaltrials.gov/study/NCT01739764,NCT01739764,Neoplasms
2497,0.997769719,167.0031767,https://clinicaltrials.gov/study/NCT02797964,NCT02797964,Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL)
2498,0.980268659,95.76600057,https://clinicaltrials.gov/study/NCT01505764,NCT01505764,Cancer Cachexia
2499,0.989601734,150.8106364,https://clinicaltrials.gov/study/NCT02040064,NCT02040064,Non Small Cell Lung Cancer
2500,0.983090435,89.57836486,https://clinicaltrials.gov/study/NCT01139346,NCT01139346,Advanced Solid Tumors
2501,0.996820523,160.5779782,https://clinicaltrials.gov/study/NCT00569946,NCT00569946,"Carcinoma, Renal Cell"
2502,0.98414656,107.4083839,https://clinicaltrials.gov/study/NCT01165346,NCT01165346,Hepatocellular Carcinoma
2503,0.988377881,150.7281692,https://clinicaltrials.gov/study/NCT00592046,NCT00592046,Acute Leukemia|Chronic Myeloproliferative Disease|Chronic Lymphoproliferative Disease|Multiple Myeloma|Lymphoma|Poor-risk Myelodysplasia (MDS)
2504,0.997007798,163.501133,https://clinicaltrials.gov/study/NCT02960646,NCT02960646,"Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Aplastic Anemia|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Lymphoblastic Lymphoma|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Plasma Cell Myeloma|Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma|Recurrent Hodgkin Lymphoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Therapy-Related Myelodysplastic Syndrome"
2505,0.99253472,152.3324174,https://clinicaltrials.gov/study/NCT00322673,NCT00322673,Acute Myeloid Leukemia|AML
2506,0.998673952,175.8271113,https://clinicaltrials.gov/study/NCT01938573,NCT01938573,Recurrent Bladder Carcinoma|Stage II Bladder Cancer|Stage III Bladder Cancer|Stage IV Bladder Cancer
2507,0.981194376,107.1791482,https://clinicaltrials.gov/study/NCT01972373,NCT01972373,Rectal Cancer
2508,0.984326626,150.0655154,https://clinicaltrials.gov/study/NCT00879073,NCT00879073,Brain Metastases
2509,0.99921876,190.4479133,https://clinicaltrials.gov/study/NCT01720173,NCT01720173,Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
2510,0.982039879,112.1850001,https://clinicaltrials.gov/study/NCT03787264,NCT03787264,Chronic Lymphoid Leukemia
2511,0.999171454,193.5976064,https://clinicaltrials.gov/study/NCT03119064,NCT03119064,Glioblastoma Multiforme|Glioblastoma|GBM
2512,0.954116763,47.05743074,https://clinicaltrials.gov/study/NCT05917964,NCT05917964,Mantle Cell Lymphoma
2513,0.925940652,27.77343413,https://clinicaltrials.gov/study/NCT02173964,NCT02173964,Cancer
2514,0.996501481,157.3150968,https://clinicaltrials.gov/study/NCT01208064,NCT01208064,Lung Cancer
2515,0.994995705,156.8056902,https://clinicaltrials.gov/study/NCT00093964,NCT00093964,Glioblastoma Multiforme
2516,0.994271834,153.1369151,https://clinicaltrials.gov/study/NCT01319864,NCT01319864,Relapsed/Refractory AML|Relapsed/Refractory ALL|Secondary AML/MDS|Acute Leukemia of Ambiguous Lineage|AML|ALL
2517,0.87663771,18.73783316,https://clinicaltrials.gov/study/NCT00480064,NCT00480064,Acute Myeloid Leukemia
2518,0.994310545,152.6783728,https://clinicaltrials.gov/study/NCT01763164,NCT01763164,Metastatic or Unresectable Cutaneous Melanoma
2519,0.996683388,156.2669708,https://clinicaltrials.gov/study/NCT03128164,NCT03128164,Lymphomas
2520,0.998454943,174.8111067,https://clinicaltrials.gov/study/NCT00001564,NCT00001564,Ewing's Sarcoma|Rhabdomyosarcoma
2521,0.945008793,34.64323283,https://clinicaltrials.gov/study/NCT01678664,NCT01678664,Neuroendocrine Tumors|Hepatic Metastases|Metastases
2522,0.961305046,61.42772908,https://clinicaltrials.gov/study/NCT00849472,NCT00849472,"Neoplasms, Breast"
2523,0.96161615,57.0603316,https://clinicaltrials.gov/study/NCT00303472,NCT00303472,Thrombocytopenia|MDS|Myelodysplastic Syndromes|Refractory Cytopenias
2524,0.999412455,184.1596594,https://clinicaltrials.gov/study/NCT00006472,NCT00006472,Esophageal Cancer
2525,0.998073234,165.7368121,https://clinicaltrials.gov/study/NCT00003072,NCT00003072,Lung Cancer|Neurotoxicity|Ovarian Cancer
2526,0.960708719,49.21843106,https://clinicaltrials.gov/study/NCT03658772,NCT03658772,Microsatellite Stable Colorectal Cancer
2527,0.976566813,79.39123335,https://clinicaltrials.gov/study/NCT00147472,NCT00147472,Cancer of the Head and Neck
2528,0.999011748,187.9936561,https://clinicaltrials.gov/study/NCT02254772,NCT02254772,Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma
2529,0.980152859,110.2064173,https://clinicaltrials.gov/study/NCT01296672,NCT01296672,Prostate Cancer
2530,0.995849805,155.2356809,https://clinicaltrials.gov/study/NCT00309972,NCT00309972,Lung Cancer
2531,0.981809362,124.3935319,https://clinicaltrials.gov/study/NCT00852462,NCT00852462,Lung Cancer
2532,0.987279309,148.6729993,https://clinicaltrials.gov/study/NCT00379262,NCT00379262,Nasopharyngeal Carcinoma
2533,0.999240013,186.2956315,https://clinicaltrials.gov/study/NCT02129062,NCT02129062,Adult B Acute Lymphoblastic Leukemia|Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1|Recurrent Adult Acute Lymphoblastic Leukemia
2534,0.995095569,154.4530295,https://clinicaltrials.gov/study/NCT01012362,NCT01012362,Breast Cancer|Lung Cancer|Colon Cancer|Pancreatic Cancer|Head and Neck Cancer|Kidney Cancer|Sarcoma|Hepatocellular Cancer
2535,0.998533647,180.6168837,https://clinicaltrials.gov/study/NCT00357162,NCT00357162,de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Secondary Myelodysplastic Syndromes
2536,0.995292759,155.6360717,https://clinicaltrials.gov/study/NCT00150462,NCT00150462,Waldenstrom's Macroglobulinemia|Non-Hodgkin's Lymphoma|Hodgkin's Disease|Multiple Myeloma
2537,0.937967768,26.44422488,https://clinicaltrials.gov/study/NCT02604862,NCT02604862,Fibrosis|Lung Cancer
2538,0.998364093,166.5825947,https://clinicaltrials.gov/study/NCT00003662,NCT00003662,Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Thymic Carcinoma
2539,0.998292563,170.8532134,https://clinicaltrials.gov/study/NCT01407562,NCT01407562,Unspecified Adult Solid Tumor - Protocol Specific|Breast Cancer - Female
2540,0.985416799,147.7767152,https://clinicaltrials.gov/study/NCT01024062,NCT01024062,Non-Small Cell Lung Cancer
2541,0.99609022,158.2469845,https://clinicaltrials.gov/study/NCT00003762,NCT00003762,Lung Cancer
2542,0.994978599,155.4136243,https://clinicaltrials.gov/study/NCT00033462,NCT00033462,Adult Primary Cholangiocellular Carcinoma|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
2543,0.965683394,61.64490251,https://clinicaltrials.gov/study/NCT00996762,NCT00996762,"Neoplasms, Breast"
2544,0.747685925,7.150079729,https://clinicaltrials.gov/study/NCT00268710,NCT00268710,Prostatic Neoplasms
2545,0.563987462,3.504938219,https://clinicaltrials.gov/study/NCT00210210,NCT00210210,Postoperative Pain|Breast Cancer
2546,0.990730815,150.9688475,https://clinicaltrials.gov/study/NCT00038610,NCT00038610,Leukemia
2547,0.978206576,89.55671642,https://clinicaltrials.gov/study/NCT00394810,NCT00394810,Prostate Cancer
2548,0.989036493,151.0359647,https://clinicaltrials.gov/study/NCT04311710,NCT04311710,Tumor
2549,0.994567138,154.4418335,https://clinicaltrials.gov/study/NCT00002810,NCT00002810,Multiple Myeloma and Plasma Cell Neoplasm
2550,0.947748077,37.16786549,https://clinicaltrials.gov/study/NCT01163110,NCT01163110,Thrombocytopenia|Neoplasm|Cancer
2551,0.991576823,151.7704216,https://clinicaltrials.gov/study/NCT01580410,NCT01580410,Carcinoma of the Appendix|Primary Peritoneal Cavity Cancer
2552,0.723988354,6.47101787,https://clinicaltrials.gov/study/NCT01831310,NCT01831310,Malnutrition|Colorectal Cancer
2553,0.991800911,151.491069,https://clinicaltrials.gov/study/NCT00004910,NCT00004910,"Colorectal Cancer|Constipation, Impaction, and Bowel Obstruction|Extrahepatic Bile Duct Cancer|Gastric Cancer|Gastrointestinal Carcinoid Tumor|Gastrointestinal Stromal Tumor|Pancreatic Cancer|Quality of Life|Small Intestine Cancer"
2554,0.92779951,25.29936595,https://clinicaltrials.gov/study/NCT00280410,NCT00280410,Lesions of the Liver
2555,0.992434723,152.9191742,https://clinicaltrials.gov/study/NCT04177810,NCT04177810,Metastatic Pancreatic Cancer
2556,0.99739452,162.5778928,https://clinicaltrials.gov/study/NCT00006246,NCT00006246,Brain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Leukemia|Lymphoma|Metastatic Cancer|Retinoblastoma|Sarcoma
2557,0.925678975,29.26548099,https://clinicaltrials.gov/study/NCT02162446,NCT02162446,Gastroenteropancreatic Neuroendocrine Tumors
2558,0.974646141,86.77475477,https://clinicaltrials.gov/study/NCT00423046,NCT00423046,"Infections, Papillomavirus|Papillomavirus Vaccines"
2559,0.996558361,161.1635627,https://clinicaltrials.gov/study/NCT02639546,NCT02639546,Solid Tumors
2560,0.987089018,125.2232642,https://clinicaltrials.gov/study/NCT00642746,NCT00642746,Metastatic Colorectal Cancer
2561,0.999591445,188.8091857,https://clinicaltrials.gov/study/NCT00003146,NCT00003146,Multiple Myeloma and Plasma Cell Neoplasm
2562,0.999061727,180.9572242,https://clinicaltrials.gov/study/NCT00002746,NCT00002746,Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
2563,0.985680472,110.7227232,https://clinicaltrials.gov/study/NCT01024946,NCT01024946,Malignant Pleural Mesothelioma
2564,0.989318833,150.8749232,https://clinicaltrials.gov/study/NCT00034346,NCT00034346,Non-Small Cell Lung Cancer|Neoplasm Metastasis|Lung Cancer
2565,0.997184915,161.500102,https://clinicaltrials.gov/study/NCT00012246,NCT00012246,Colorectal Cancer|Esophageal Cancer|Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Gastric Cancer|Pancreatic Cancer|Small Intestine Cancer
2566,0.974669517,78.82554809,https://clinicaltrials.gov/study/NCT05041946,NCT05041946,Fatigue|Cancer
2567,0.98246798,129.0460021,https://clinicaltrials.gov/study/NCT02302846,NCT02302846,Leukemia
2568,0.99923905,188.5154906,https://clinicaltrials.gov/study/NCT02439346,NCT02439346,Medical Oncology
2569,0.89541053,17.37422504,https://clinicaltrials.gov/study/NCT01117246,NCT01117246,Secondary Malignant Neoplasm of Bone
2570,0.999722094,192.4281452,https://clinicaltrials.gov/study/NCT00499473,NCT00499473,Adult Anaplastic Astrocytoma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Adult Pineal Gland Astrocytoma
2571,0.998105038,169.1063226,https://clinicaltrials.gov/study/NCT01330173,NCT01330173,DS Stage I Plasma Cell Myeloma|DS Stage II Plasma Cell Myeloma|DS Stage III Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
2572,0.997662985,164.7006517,https://clinicaltrials.gov/study/NCT02809573,NCT02809573,Peripheral T-cell Lymphoma
2573,0.889846892,19.22749234,https://clinicaltrials.gov/study/NCT05253573,NCT05253573,Cigarette Smoking
2574,0.988970586,150.5925595,https://clinicaltrials.gov/study/NCT00496873,NCT00496873,Lymphoma
2575,0.999162177,181.1191458,https://clinicaltrials.gov/study/NCT00396864,NCT00396864,Cancer|Lymphomas
2576,0.989557897,150.4272691,https://clinicaltrials.gov/study/NCT01703364,NCT01703364,CLL|Chronic Lymphocytic Leukemia
2577,0.912248468,22.38927853,https://clinicaltrials.gov/study/NCT02323646,NCT02323646,Uterine Fibroids
2578,0.968880815,71.37763502,https://clinicaltrials.gov/study/NCT03205046,NCT03205046,DLBCL|Richter Syndrome
2579,0.987153557,115.2950797,https://clinicaltrials.gov/study/NCT01321346,NCT01321346,"Lymphoblastic Leukemia, Acute, Childhood|Myelogenous Leukemia, Acute, Childhood|Hodgkin's Disease|Non-Hodgkin's Lymphoma"
2580,0.995602851,154.8459958,https://clinicaltrials.gov/study/NCT01814046,NCT01814046,Metastatic Ocular Melanoma|Metastatic Uveal Melanoma
2581,0.993377241,152.7982767,https://clinicaltrials.gov/study/NCT01340846,NCT01340846,Cancer
2582,0.995443936,157.3216516,https://clinicaltrials.gov/study/NCT01134146,NCT01134146,Lung Cancer|Mesothelioma
2583,0.999720164,192.1761295,https://clinicaltrials.gov/study/NCT03003546,NCT03003546,Recurrent Aggressive Non-Hodgkin Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Aggressive Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Small Lymphocytic Lymphoma
2584,0.897248053,19.48117289,https://clinicaltrials.gov/study/NCT04040946,NCT04040946,Parathyroid Adenoma|Hyperparathyroidism|F18-choline
2585,0.675411483,4.465478599,https://clinicaltrials.gov/study/NCT01837446,NCT01837446,Stomatitis
2586,0.986724858,143.9854558,https://clinicaltrials.gov/study/NCT01724346,NCT01724346,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
2587,0.995106004,154.1075727,https://clinicaltrials.gov/study/NCT01886573,NCT01886573,Stage IA Non-Small Cell Lung Carcinoma|Stage IB Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer
2588,0.988099641,151.0926795,https://clinicaltrials.gov/study/NCT03412773,NCT03412773,Hepatocellular Carcinoma (HCC)
2589,0.990191262,150.9787012,https://clinicaltrials.gov/study/NCT02943473,NCT02943473,High Risk Smoldering Multiple Myeloma
2590,0.996842371,162.4309636,https://clinicaltrials.gov/study/NCT02038673,NCT02038673,Solid Tumors
2591,0.998839083,177.5824587,https://clinicaltrials.gov/study/NCT03182673,NCT03182673,Solid Tumor
2592,0.9955665,155.3551846,https://clinicaltrials.gov/study/NCT00006373,NCT00006373,Lymphoma
2593,0.971787389,63.8104506,https://clinicaltrials.gov/study/NCT00066573,NCT00066573,Breast Cancer
2594,0.998852578,182.5089822,https://clinicaltrials.gov/study/NCT00039273,NCT00039273,Colorectal Cancer
2595,0.999179616,188.786659,https://clinicaltrials.gov/study/NCT00052273,NCT00052273,Adult|Solid Tumor
2596,0.762656432,6.343550717,https://clinicaltrials.gov/study/NCT00747773,NCT00747773,Lung Cancer
2597,0.989109446,150.6320839,https://clinicaltrials.gov/study/NCT02933073,NCT02933073,Ovarian Cancer
2598,0.986670579,150.5631912,https://clinicaltrials.gov/study/NCT00001873,NCT00001873,Chronic Lymphocytic Leukemia|Graft vs Host Disease|Hematologic Neoplasm|Multiple Myeloma|Myelodysplastic Syndrome
2599,0.998993661,185.9400226,https://clinicaltrials.gov/study/NCT00398073,NCT00398073,Intraocular Melanoma|Melanoma (Skin)
2600,0.997186911,161.418816,https://clinicaltrials.gov/study/NCT04834973,NCT04834973,Melanoma
2601,0.972401637,80.42276597,https://clinicaltrials.gov/study/NCT00114764,NCT00114764,Myeloid Leukemia
2602,0.995384564,157.881965,https://clinicaltrials.gov/study/NCT00906373,NCT00906373,Hepatocellular Carcinoma
2603,0.993970912,152.4206057,https://clinicaltrials.gov/study/NCT03941964,NCT03941964,Acute Myeloid Leukemia (AML)|Cancer
2604,0.987423184,150.2534713,https://clinicaltrials.gov/study/NCT00981864,NCT00981864,Breast Cancer
2605,0.988930002,150.3690529,https://clinicaltrials.gov/study/NCT02252146,NCT02252146,Diffuse Large B Cell Lymphoma
2606,0.790613027,7.382011389,https://clinicaltrials.gov/study/NCT00237146,NCT00237146,Prostate Cancer
2607,0.980574209,85.2376492,https://clinicaltrials.gov/study/NCT02124746,NCT02124746,Primary Myelofibrosis|Post-Polycythemia Vera Myelofibrosis|Post-Essential Thrombocythemia Myelofibrosis|Polycythemia Vera|Essential Thrombocythemia
2608,0.970890898,73.65698169,https://clinicaltrials.gov/study/NCT00636610,NCT00636610,Metastatic Colorectal Cancer
2609,0.96802304,63.56479721,https://clinicaltrials.gov/study/NCT01405846,NCT01405846,Lung Cancer|Head and Neck Cancer
2610,0.888380507,16.35317362,https://clinicaltrials.gov/study/NCT01508546,NCT01508546,"Female Breast Neoplasms|Carcinoma, Ductal, Breast"
2611,0.990843404,152.0095773,https://clinicaltrials.gov/study/NCT01812746,NCT01812746,CRPC|Prostate Cancer
2612,0.993896625,154.0604285,https://clinicaltrials.gov/study/NCT02122146,NCT02122146,Neoplasms
2613,0.999198396,191.5521293,https://clinicaltrials.gov/study/NCT00005946,NCT00005946,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
2614,0.978977557,92.29024455,https://clinicaltrials.gov/study/NCT00053846,NCT00053846,"Dyspnea|Pulmonary Complications|Unspecified Adult Solid Tumor, Protocol Specific"
2615,0.998292201,170.8437149,https://clinicaltrials.gov/study/NCT02794246,NCT02794246,Multiple Myeloma
2616,0.9990408,186.3886415,https://clinicaltrials.gov/study/NCT05242146,NCT05242146,CNS Lymphoma
2617,0.919479383,29.27555072,https://clinicaltrials.gov/study/NCT04285346,NCT04285346,Tuberous Sclerosis
2618,0.995046268,155.615464,https://clinicaltrials.gov/study/NCT01938846,NCT01938846,Neoplasms
2619,0.997934717,161.5617195,https://clinicaltrials.gov/study/NCT01833546,NCT01833546,Solid Tumor|Pancreatic Cancer
2620,0.762751988,7.630784696,https://clinicaltrials.gov/study/NCT00576173,NCT00576173,Pain
2621,0.997921222,164.3245512,https://clinicaltrials.gov/study/NCT00191373,NCT00191373,Breast Neoplasms|Cancer of the Breast|Breast Cancer
2622,0.997491586,165.9573928,https://clinicaltrials.gov/study/NCT01748773,NCT01748773,Gastric Cancer|Gastroesophageal Junction Cancer
2623,0.999218621,181.7763825,https://clinicaltrials.gov/study/NCT00017173,NCT00017173,Head and Neck Cancer
2624,0.997832158,168.3009875,https://clinicaltrials.gov/study/NCT03637764,NCT03637764,Neoplasm
2625,0.996280109,158.4871556,https://clinicaltrials.gov/study/NCT01978964,NCT01978964,Solid Tumors
2626,0.99616799,158.3417862,https://clinicaltrials.gov/study/NCT04633564,NCT04633564,NSCLC Stage IV
2627,0.954792345,36.40750152,https://clinicaltrials.gov/study/NCT01950364,NCT01950364,Hodgkin Lymphoma|Anaplastic Large-cell Lymphoma
2628,0.994460929,155.5347,https://clinicaltrials.gov/study/NCT02669264,NCT02669264,Acute Lymphoblastic Leukemia
2629,0.939358308,30.60788396,https://clinicaltrials.gov/study/NCT00929188,NCT00929188,"Pain, Burning|Pain, Crushing|Pain, Migratory|Pain, Radiating|Pain, Splitting"
2630,0.999761909,197.0735527,https://clinicaltrials.gov/study/NCT03267888,NCT03267888,ISS Stage I Plasma Cell Myeloma|ISS Stage II Plasma Cell Myeloma|ISS Stage III Plasma Cell Myeloma|Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
2631,0.999072197,185.2558642,https://clinicaltrials.gov/study/NCT00556088,NCT00556088,Solid Tumors
2632,0.819807025,12.46584295,https://clinicaltrials.gov/study/NCT01768988,NCT01768988,Pancreatic Cancer|Visceral Pain
2633,0.994379658,154.215239,https://clinicaltrials.gov/study/NCT01791088,NCT01791088,"Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific"
2634,0.9957724,155.9811321,https://clinicaltrials.gov/study/NCT02439138,NCT02439138,Waldenstrom's Macroglobulinemia
2635,0.923094838,28.14692932,https://clinicaltrials.gov/study/NCT04534738,NCT04534738,Cancer
2636,0.999361046,187.897165,https://clinicaltrials.gov/study/NCT02678338,NCT02678338,Acute Myeloid Leukemia|Myelodysplastic Syndrome
2637,0.986685822,150.4182732,https://clinicaltrials.gov/study/NCT03891238,NCT03891238,Metastatic or Locally Advanced PD-L1 Positive Urothelial Cancer
2638,0.953675252,38.68251811,https://clinicaltrials.gov/study/NCT00131638,NCT00131638,Head and Neck Cancer
2639,0.995413928,155.8702695,https://clinicaltrials.gov/study/NCT03492138,NCT03492138,Multiple Myeloma
2640,0.994088207,155.8839835,https://clinicaltrials.gov/study/NCT02462538,NCT02462538,ALK+ Anaplastic Large Cell Lymphoma
2641,0.985632072,119.6014342,https://clinicaltrials.gov/study/NCT01969838,NCT01969838,Primary Myelofibrosis|Post-Polycythemia Vera Myelofibrosis|Post-Essential Thrombocythemia Myelofibrosis
2642,0.830328223,9.974428858,https://clinicaltrials.gov/study/NCT01201538,NCT01201538,Growing Vestibular Schwannomas
2643,0.992473396,151.0624716,https://clinicaltrials.gov/study/NCT00612638,NCT00612638,Glioblastoma|Gliosarcoma
2644,0.889894882,18.45780441,https://clinicaltrials.gov/study/NCT01299038,NCT01299038,Breast Cancer
2645,0.999450251,192.3319335,https://clinicaltrials.gov/study/NCT00052338,NCT00052338,Malignant Pleural Effusion|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
2646,0.999616675,189.6058863,https://clinicaltrials.gov/study/NCT02257138,NCT02257138,Blasts More Than 20 Percent of Bone Marrow Nucleated Cells|Blasts More Than 20 Percent of Peripheral Blood White Cells|Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia
2647,0.997899506,166.5263066,https://clinicaltrials.gov/study/NCT00012038,NCT00012038,Brain and Central Nervous System Tumors
2648,0.991694763,151.5931104,https://clinicaltrials.gov/study/NCT00491738,NCT00491738,Renal Cell Carcinoma
2649,0.973555486,61.81851897,https://clinicaltrials.gov/study/NCT01783938,NCT01783938,Advanced or Metastatic Melanoma
2650,0.992882228,151.671917,https://clinicaltrials.gov/study/NCT03217838,NCT03217838,Acute Myeloid Leukaemia
2651,0.87906378,16.85874605,https://clinicaltrials.gov/study/NCT00632138,NCT00632138,Nonmalignant Neoplasm|Prostate Cancer|Psychosocial Effects of Cancer and Its Treatment|Sexual Dysfunction|Urinary Incontinence
2652,0.996638392,155.0392415,https://clinicaltrials.gov/study/NCT04653038,NCT04653038,"Unresectable, Recurrent or Metastatic Melanoma|Untreated Mucosal or Acral Lentiginous Melanoma"
2653,0.975842888,74.93539621,https://clinicaltrials.gov/study/NCT02449538,NCT02449538,Solid Tumor
2654,0.995196748,155.1682206,https://clinicaltrials.gov/study/NCT01204372,NCT01204372,Metastatic Pancreatic Adenocarcinoma
2655,0.984584115,142.3891873,https://clinicaltrials.gov/study/NCT01225172,NCT01225172,Breast Cancer
2656,0.971856896,71.62539871,https://clinicaltrials.gov/study/NCT00610272,NCT00610272,Pain|Bone Metastasis
2657,0.984363611,112.7254971,https://clinicaltrials.gov/study/NCT00719472,NCT00719472,Non-Hodgkin's Lymphoma
2658,0.984190016,126.4100629,https://clinicaltrials.gov/study/NCT02686372,NCT02686372,Hepatocellular Carcinoma
2659,0.997940453,167.411317,https://clinicaltrials.gov/study/NCT02756572,NCT02756572,Blasts 10 Percent or More of Bone Marrow Nucleated Cells|Chronic Myelomonocytic Leukemia-2|High Grade Malignant Neoplasm|Myelodysplastic Syndrome|Myelodysplastic Syndrome With Excess Blasts-2|Myeloid Neoplasm|Previously Treated Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia
2660,0.997026865,162.2684234,https://clinicaltrials.gov/study/NCT02211872,NCT02211872,Neoplasms
2661,0.914074728,23.69161205,https://clinicaltrials.gov/study/NCT02595372,NCT02595372,Cancer of the Breast
2662,0.652777882,4.835789584,https://clinicaltrials.gov/study/NCT02935972,NCT02935972,Pain Relief During Prostate Biopsy
2663,0.999337532,191.6060489,https://clinicaltrials.gov/study/NCT00003572,NCT00003572,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
2664,0.99720717,162.5346339,https://clinicaltrials.gov/study/NCT01303172,NCT01303172,Advanced Pancreatic Cancer
2665,0.99232165,152.3091559,https://clinicaltrials.gov/study/NCT00312988,NCT00312988,Ovarian Cancer
2666,0.969197453,57.64180931,https://clinicaltrials.gov/study/NCT02688088,NCT02688088,Neoplasm Metastasis
2667,0.998411555,172.9006553,https://clinicaltrials.gov/study/NCT02222688,NCT02222688,Chronic Lymphocytic Leukemia
2668,0.998150013,169.7369678,https://clinicaltrials.gov/study/NCT02577588,NCT02577588,Colorectal Carcinoma
2669,0.990157782,150.8702643,https://clinicaltrials.gov/study/NCT02626338,NCT02626338,Relapsed/Refractory Acute Myeloid Leukemia (AML)
2670,0.994570745,154.6772398,https://clinicaltrials.gov/study/NCT00970138,NCT00970138,Gastric Carcinoma
2671,0.987349419,142.6979709,https://clinicaltrials.gov/study/NCT01483638,NCT01483638,Colorectal Carcinoma
2672,0.860990143,13.46374288,https://clinicaltrials.gov/study/NCT01344538,NCT01344538,Colorectal Cancer
2673,0.999299021,184.7171263,https://clinicaltrials.gov/study/NCT00516438,NCT00516438,Malignant Solid Tumors
2674,0.998121685,169.4537758,https://clinicaltrials.gov/study/NCT01022138,NCT01022138,Breast Cancer
2675,0.998819234,180.4686695,https://clinicaltrials.gov/study/NCT01999738,NCT01999738,Solid Tumors|Non Small Cell Lung Carcinoma
2676,0.99907527,182.7444602,https://clinicaltrials.gov/study/NCT03054038,NCT03054038,Non-Small Cell Lung Carcinoma
2677,0.999185294,186.3787151,https://clinicaltrials.gov/study/NCT01300572,NCT01300572,Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndrome|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Secondary Acute Myeloid Leukemia
2678,0.960921138,48.4842485,https://clinicaltrials.gov/study/NCT02076672,NCT02076672,Asbestos Exposure
2679,0.972283375,65.58268896,https://clinicaltrials.gov/study/NCT00944372,NCT00944372,Solid Tumors
2680,0.999054844,196.5520894,https://clinicaltrials.gov/study/NCT03338972,NCT03338972,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
2681,0.957301152,44.58052827,https://clinicaltrials.gov/study/NCT01606072,NCT01606072,Breast Cancer
2682,0.98104881,97.65055294,https://clinicaltrials.gov/study/NCT03985072,NCT03985072,"Tumor, Solid|Gall Bladder Cancer|Cervical Cancer|Gastric Cancer|Pancreatic Cancer|Colorectal Cancer"
2683,0.969982393,54.17195057,https://clinicaltrials.gov/study/NCT02200172,NCT02200172,Cancer
2684,0.993177391,152.1666755,https://clinicaltrials.gov/study/NCT01582672,NCT01582672,Advanced Renal Cell Carcinoma|Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma
2685,0.992544542,151.6694461,https://clinicaltrials.gov/study/NCT01106872,NCT01106872,Sarcoma|Soft Tissue Sarcoma|Locally Advanced Sarcoma|Unresectable Sarcoma|Metastatic Sarcoma
2686,0.972746314,62.88231401,https://clinicaltrials.gov/study/NCT00770172,NCT00770172,"Chemotherapeutic Agent Toxicity|Neutropenia|Unspecified Adult Solid Tumor, Protocol Specific"
2687,0.992866768,152.2146068,https://clinicaltrials.gov/study/NCT03012672,NCT03012672,Acute Leukemia of Ambiguous Lineage|Acute Myeloid Leukemia|Myeloid Neoplasm
2688,0.997198831,159.3786732,https://clinicaltrials.gov/study/NCT00005972,NCT00005972,Lung Cancer
2689,0.998745669,177.5928302,https://clinicaltrials.gov/study/NCT01959672,NCT01959672,Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma|Stage I Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage II Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer
2690,0.992192125,151.7650025,https://clinicaltrials.gov/study/NCT00580372,NCT00580372,Multiple Myeloma
2691,0.99674879,162.130402,https://clinicaltrials.gov/study/NCT00354172,NCT00354172,Leukemia|Myelodysplastic Syndromes
2692,0.971830133,69.44774188,https://clinicaltrials.gov/study/NCT02475772,NCT02475772,Ovarian Cancer
2693,0.998923056,189.1051324,https://clinicaltrials.gov/study/NCT03175172,NCT03175172,Malignant Pleural Mesothelioma
2694,0.969622715,71.0128238,https://clinicaltrials.gov/study/NCT00150072,NCT00150072,Chordoma
2695,0.817461365,11.36210792,https://clinicaltrials.gov/study/NCT00130962,NCT00130962,Neuroma
2696,0.955151763,37.86024523,https://clinicaltrials.gov/study/NCT00052962,NCT00052962,Gastrointestinal Neoplasm
2697,0.982304486,103.1379035,https://clinicaltrials.gov/study/NCT00667862,NCT00667862,Prostate Cancer
2698,0.970964715,81.80277153,https://clinicaltrials.gov/study/NCT00293462,NCT00293462,Head and Neck Cancer|Mucositis Oral|Radiation Toxicity|Tongue Cancer
2699,0.997953651,165.3098891,https://clinicaltrials.gov/study/NCT00005862,NCT00005862,Gastrointestinal Stromal Tumor|Sarcoma
2700,0.942274388,33.88315597,https://clinicaltrials.gov/study/NCT00372788,NCT00372788,Non-small Cell Lung Cancer
2701,0.978349638,93.93189555,https://clinicaltrials.gov/study/NCT00181688,NCT00181688,Ovarian Cancer|Peritoneal Carcinoma|Tubal Carcinoma
2702,0.987306165,150.1005795,https://clinicaltrials.gov/study/NCT00741988,NCT00741988,Non-Small Cell Lung Cancer
2703,0.996873088,160.1161386,https://clinicaltrials.gov/study/NCT00445588,NCT00445588,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
2704,0.999054637,185.6759349,https://clinicaltrials.gov/study/NCT00376688,NCT00376688,Recurrent Breast Carcinoma|Stage III Breast Cancer AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7
2705,0.999433905,177.088172,https://clinicaltrials.gov/study/NCT00666588,NCT00666588,Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Childhood Acute Basophilic Leukemia|Childhood Acute Eosinophilic Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Minimally Differentiated Myeloid Leukemia (M0)|Childhood Acute Monoblastic Leukemia (M5a)|Childhood Acute Monocytic Leukemia (M5b)|Childhood Acute Myeloblastic Leukemia With Maturation (M2)|Childhood Acute Myeloblastic Leukemia Without Maturation (M1)|Childhood Acute Myelomonocytic Leukemia (M4)|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia
2706,0.986191561,150.6290833,https://clinicaltrials.gov/study/NCT02451488,NCT02451488,Melanoma
2707,0.998905197,179.0015622,https://clinicaltrials.gov/study/NCT01468688,NCT01468688,3rd Line GIST
2708,0.969093991,58.36158707,https://clinicaltrials.gov/study/NCT00003138,NCT00003138,Anemia|Myelodysplastic Syndromes
2709,0.986938252,129.7899791,https://clinicaltrials.gov/study/NCT01416038,NCT01416038,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
2710,0.998489056,168.9714057,https://clinicaltrials.gov/study/NCT00004238,NCT00004238,Lung Cancer
2711,0.942888348,40.0985384,https://clinicaltrials.gov/study/NCT02523638,NCT02523638,Polycythemia Vera
2712,0.986190563,150.5985536,https://clinicaltrials.gov/study/NCT00191438,NCT00191438,Breast Neoplasms
2713,0.959593191,51.21201115,https://clinicaltrials.gov/study/NCT01756638,NCT01756638,Prostate Cancer
2714,0.995712174,155.5448174,https://clinicaltrials.gov/study/NCT00209638,NCT00209638,Gastric Cancer
2715,0.775341945,7.996838715,https://clinicaltrials.gov/study/NCT02138838,NCT02138838,"Chronic Kidney Disease, Secondary Hyperparathyroidism"
2716,0.970682761,59.64816858,https://clinicaltrials.gov/study/NCT00601172,NCT00601172,"Nausea and Vomiting, Chemotherapy-Induced"
2717,0.992819129,152.5811878,https://clinicaltrials.gov/study/NCT02973672,NCT02973672,Colon Cancer|Rectum Cancer|Pancreas Cancer|Metastatic Colorectal Cancer|Recurrent Colorectal Carcinoma
2718,0.945153644,39.20309973,https://clinicaltrials.gov/study/NCT00429572,NCT00429572,Breast Cancer
2719,0.999048704,184.3337102,https://clinicaltrials.gov/study/NCT01794572,NCT01794572,Multiple Myeloma in Relapse
2720,0.999366277,184.8856873,https://clinicaltrials.gov/study/NCT02313272,NCT02313272,Malignant Glioma
2721,0.998269353,164.7463683,https://clinicaltrials.gov/study/NCT01430572,NCT01430572,Advanced Cancers|Solid Tumors
2722,0.995829801,156.6741423,https://clinicaltrials.gov/study/NCT00504972,NCT00504972,Non-Hodgkin's Lymphoma|Chronic Lymphocytic Leukemia
2723,0.990324785,150.4534541,https://clinicaltrials.gov/study/NCT01697072,NCT01697072,Gastric Cancer
2724,0.990788478,151.5101716,https://clinicaltrials.gov/study/NCT02001272,NCT02001272,Ovarian Cancer
2725,0.991744456,150.4112295,https://clinicaltrials.gov/study/NCT00554372,NCT00554372,"Carcinoma, Hepatocellular"
2726,0.967838217,70.35567065,https://clinicaltrials.gov/study/NCT02995772,NCT02995772,Breast Cancer
2727,0.962459207,50.70679507,https://clinicaltrials.gov/study/NCT00048672,NCT00048672,"Leukemia, Myeloid, Chronic-Phase"
2728,0.707136059,6.019640848,https://clinicaltrials.gov/study/NCT05536362,NCT05536362,Colon Cancer|Post Operative Pain
2729,0.989326639,151.403665,https://clinicaltrials.gov/study/NCT00874562,NCT00874562,Acute Lymphoblastic Leukemia
2730,0.997091017,160.9068729,https://clinicaltrials.gov/study/NCT01433562,NCT01433562,Breast Cancer
2731,0.997438052,163.8724361,https://clinicaltrials.gov/study/NCT02402062,NCT02402062,Neuroendocrine Tumors|Pancreatic Neoplasms
2732,0.905762852,21.74431744,https://clinicaltrials.gov/study/NCT00237562,NCT00237562,Cervical Intraepithelial Neoplasia
2733,0.998372118,177.1688191,https://clinicaltrials.gov/study/NCT03781362,NCT03781362,Advanced Tumors
2734,0.998774295,173.600046,https://clinicaltrials.gov/study/NCT00817362,NCT00817362,Breast Cancer|HER2 Positive Breast Cancer|Metastatic Breast Cancer|Cancer of the Breast
2735,0.990815665,150.8833479,https://clinicaltrials.gov/study/NCT00002588,NCT00002588,Leukemia
2736,0.922335245,30.89004969,https://clinicaltrials.gov/study/NCT00591188,NCT00591188,"Carcinoma, Renal Cell"
2737,0.769193215,8.789196202,https://clinicaltrials.gov/study/NCT02385188,NCT02385188,"Paget Disease, Extramammary"
2738,0.991528702,151.2822438,https://clinicaltrials.gov/study/NCT03186638,NCT03186638,Cognitive Impairment|Malignant Neoplasm
2739,0.996804954,157.9060898,https://clinicaltrials.gov/study/NCT01527838,NCT01527838,Non-Hodgkin's Lymphoma (NHL)|Hodgkin's Disease|Chronic Lymphocytic Leukemia (CLL)|Acute Myelogenous Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)
2740,0.999734606,189.8060743,https://clinicaltrials.gov/study/NCT00005638,NCT00005638,Esophageal Cancer|Gastric Cancer
2741,0.999684607,190.3111499,https://clinicaltrials.gov/study/NCT00023738,NCT00023738,Sarcoma
2742,0.998571718,173.2661046,https://clinicaltrials.gov/study/NCT01817738,NCT01817738,Prostate Cancer
2743,0.959954151,47.38610599,https://clinicaltrials.gov/study/NCT00230438,NCT00230438,Prostatic Neoplasms
2744,0.995911635,155.9523452,https://clinicaltrials.gov/study/NCT00529438,NCT00529438,Advanced Solid Tumors|Lymphoid Malignancies
2745,0.975102992,71.94169578,https://clinicaltrials.gov/study/NCT00237172,NCT00237172,Gastrointestinal Stromal Tumors
2746,0.986680967,150.2813176,https://clinicaltrials.gov/study/NCT02226172,NCT02226172,Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
2747,0.993118016,152.7443585,https://clinicaltrials.gov/study/NCT00313872,NCT00313872,Gastric Cancer|Metastases
2748,0.998263942,172.7952697,https://clinicaltrials.gov/study/NCT01543672,NCT01543672,Lung Cancer|Metastatic Lung Cancer
2749,0.994734545,153.9918114,https://clinicaltrials.gov/study/NCT00608972,NCT00608972,Metastatic Breast Cancer
2750,0.999331083,186.2112978,https://clinicaltrials.gov/study/NCT00437372,NCT00437372,Cancer|Head and Neck Cancer|Pelvic Cancer|Nervous System Neoplasms|Thoracic Neoplasms
2751,0.999699213,177.1779806,https://clinicaltrials.gov/study/NCT01021072,NCT01021072,Advanced Cancers
2752,0.99867707,179.8029079,https://clinicaltrials.gov/study/NCT00002472,NCT00002472,Brain and Central Nervous System Tumors|Pediatric Germ Cell Tumor|Extragonadal Germ Cell Tumor
2753,0.999717249,185.854468,https://clinicaltrials.gov/study/NCT01894672,NCT01894672,Melanoma
2754,0.998993993,183.2382599,https://clinicaltrials.gov/study/NCT00103272,NCT00103272,Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrm Macroglobulinemia
2755,0.939742836,33.50668801,https://clinicaltrials.gov/study/NCT00572572,NCT00572572,Germ Cell Tumors
2756,0.961974356,52.69473739,https://clinicaltrials.gov/study/NCT01235572,NCT01235572,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia
2757,0.999477807,187.27918,https://clinicaltrials.gov/study/NCT00020462,NCT00020462,Lymphoma
2758,0.998120389,169.2504934,https://clinicaltrials.gov/study/NCT02597062,NCT02597062,Multiple Myeloma
2759,0.993992697,154.6356658,https://clinicaltrials.gov/study/NCT00299962,NCT00299962,Pleural Mesothelioma|Metastatic Pleural Effusions
2760,0.96231058,60.14364628,https://clinicaltrials.gov/study/NCT00978562,NCT00978562,Childhood Brain Neoplasm|Recurrent Childhood Brain Neoplasm
2761,0.996509573,160.934981,https://clinicaltrials.gov/study/NCT01000662,NCT01000662,Breast Cancer
2762,0.99703642,159.1825517,https://clinicaltrials.gov/study/NCT02028988,NCT02028988,Intermediate Risk Prostate Cancer
2763,0.958745266,44.42984276,https://clinicaltrials.gov/study/NCT00298688,NCT00298688,Small Cell Lung Cancer
2764,0.947295121,30.9891126,https://clinicaltrials.gov/study/NCT01204788,NCT01204788,Leukemia
2765,0.761955564,9.754306894,https://clinicaltrials.gov/study/NCT03331588,NCT03331588,"Lung Neoplasms|Thoracic Surgery|Carcinoma, Non-Small-Cell Lung|Lung Diseases|Carcinoma, Bronchogenic|Thoracic Neoplasm"
2766,0.992329164,152.6137638,https://clinicaltrials.gov/study/NCT00686088,NCT00686088,Locally Recurrent Prostate Cancer
2767,0.982867952,122.6820764,https://clinicaltrials.gov/study/NCT00773188,NCT00773188,Non-Squamous Non-Small Cell Lung Cancer
2768,0.996570818,158.4959983,https://clinicaltrials.gov/study/NCT01039038,NCT01039038,Prostate Cancer With Intermediate Risk
2769,0.960610972,46.70190089,https://clinicaltrials.gov/study/NCT02683538,NCT02683538,Hepatocellular Carcinoma|Metastasis|Cholangiocarcinoma
2770,0.998035239,172.4245647,https://clinicaltrials.gov/study/NCT01167738,NCT01167738,Pancreatic Cancer
2771,0.997897222,164.9182958,https://clinicaltrials.gov/study/NCT00027638,NCT00027638,Gastrointestinal Carcinoid Tumor|Islet Cell Tumor|Lung Cancer|Neoplastic Syndrome
2772,0.997521356,162.9525169,https://clinicaltrials.gov/study/NCT02092038,NCT02092038,Glioblastoma
2773,0.997650492,166.7880078,https://clinicaltrials.gov/study/NCT02458638,NCT02458638,Tumors
2774,0.997269496,162.5886145,https://clinicaltrials.gov/study/NCT00171938,NCT00171938,Glioblastoma
2775,0.998248864,174.4477878,https://clinicaltrials.gov/study/NCT00015938,NCT00015938,Breast Cancer
2776,0.984905995,82.9717482,https://clinicaltrials.gov/study/NCT01042938,NCT01042938,Breast Cancer
2777,0.917709858,21.02972493,https://clinicaltrials.gov/study/NCT00985738,NCT00985738,Prostate Cancer
2778,0.984644378,138.2918612,https://clinicaltrials.gov/study/NCT01639638,NCT01639638,Recurrent Condyloma|Nonrecurrent Condyloma
2779,0.624648035,3.847511659,https://clinicaltrials.gov/study/NCT00645138,NCT00645138,Breast Cancer
2780,0.995204095,155.6318938,https://clinicaltrials.gov/study/NCT02716272,NCT02716272,Mesothelioma
2781,0.99825195,170.7776149,https://clinicaltrials.gov/study/NCT03276572,NCT03276572,Prostate Cancer
2782,0.996742994,159.2930873,https://clinicaltrials.gov/study/NCT01538472,NCT01538472,Lymphoma
2783,0.714388982,7.104607461,https://clinicaltrials.gov/study/NCT00850772,NCT00850772,Epithelial Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
2784,0.999141339,191.1266319,https://clinicaltrials.gov/study/NCT00363272,NCT00363272,"Childhood Burkitt Lymphoma|Childhood Central Nervous System Germ Cell Tumor|Childhood Choroid Plexus Tumor|Childhood Craniopharyngioma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood High-grade Cerebral Astrocytoma|Childhood Infratentorial Ependymoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Spinal Cord Neoplasm|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Unspecified Childhood Solid Tumor, Protocol Specific"
2785,0.999038826,192.9517481,https://clinicaltrials.gov/study/NCT01222572,NCT01222572,Non-small Cell Lung Cancer|Lung Cancer|NSCLC
2786,0.997946413,169.6714459,https://clinicaltrials.gov/study/NCT01495572,NCT01495572,Metastatic Melanoma|Skin Cancer
2787,0.932157308,28.38304968,https://clinicaltrials.gov/study/NCT00432172,NCT00432172,Breast Cancer
2788,0.994476346,154.3851876,https://clinicaltrials.gov/study/NCT00783588,NCT00783588,Chronic Lymphocytic Leukemia
2789,0.970094813,65.28802225,https://clinicaltrials.gov/study/NCT00541788,NCT00541788,Prostate Cancer
2790,0.998656637,175.2798235,https://clinicaltrials.gov/study/NCT00002788,NCT00002788,Leukemia
2791,0.993998719,153.9498321,https://clinicaltrials.gov/study/NCT00380588,NCT00380588,Biliary Tract Cancer
2792,0.942588642,44.05329635,https://clinicaltrials.gov/study/NCT01565538,NCT01565538,Lung Cancer
2793,0.984969233,121.8904954,https://clinicaltrials.gov/study/NCT01759238,NCT01759238,Colorectal Cancer|Metastases
2794,0.989030428,150.6520448,https://clinicaltrials.gov/study/NCT02097238,NCT02097238,Recurrent Osteosarcoma
2795,0.995578108,156.7097319,https://clinicaltrials.gov/study/NCT02926638,NCT02926638,MET Positive|Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma AJCC v7
2796,0.965396554,54.98967634,https://clinicaltrials.gov/study/NCT02722538,NCT02722538,Urinary Bladder Cancer
2797,0.993440114,152.8670465,https://clinicaltrials.gov/study/NCT02716038,NCT02716038,"Carcinoma, Non-Small-Cell Lung"
2798,0.99658337,158.2725877,https://clinicaltrials.gov/study/NCT03389438,NCT03389438,Urinary Bladder Neoplasm
2799,0.990747649,151.3012772,https://clinicaltrials.gov/study/NCT01105338,NCT01105338,Prostate Cancer
2800,0.985996441,144.0929298,https://clinicaltrials.gov/study/NCT01461772,NCT01461772,Cervical Cancer
2801,0.99936799,180.0017521,https://clinicaltrials.gov/study/NCT00287872,NCT00287872,Multiple Myeloma
2802,0.99945205,191.5887021,https://clinicaltrials.gov/study/NCT00006372,NCT00006372,"Unspecified Adult Solid Tumor, Protocol Specific"
2803,0.997574799,163.5763133,https://clinicaltrials.gov/study/NCT01400672,NCT01400672,Diffuse Intrinsic Pontine Glioma
2804,0.997298618,161.9150281,https://clinicaltrials.gov/study/NCT00072072,NCT00072072,Lung Cancer
2805,0.979745218,96.50960828,https://clinicaltrials.gov/study/NCT01498172,NCT01498172,Bladder Cancer
2806,0.998025506,169.2377409,https://clinicaltrials.gov/study/NCT00030472,NCT00030472,Cervical Cancer
2807,0.999314564,191.156084,https://clinicaltrials.gov/study/NCT02283372,NCT02283372,Pancreatic Cancer
2808,0.978525276,93.53672741,https://clinicaltrials.gov/study/NCT00066872,NCT00066872,Non-melanomatous Skin Cancer
2809,0.996353626,157.8681273,https://clinicaltrials.gov/study/NCT00589472,NCT00589472,Prostate Adenocarcinoma|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer
2810,0.998982417,193.0537389,https://clinicaltrials.gov/study/NCT00036972,NCT00036972,Brain and Central Nervous System Tumors
2811,0.994500617,155.2137517,https://clinicaltrials.gov/study/NCT00736372,NCT00736372,Metastatic Cancer|Advanced Cancer
2812,0.994080516,153.2685527,https://clinicaltrials.gov/study/NCT03134872,NCT03134872,"Lung Neoplasms|Carcinoma, Non-Small-Cell Lung|Respiratory Tract Neoplasms|Thoracic Neoplasms|Lung Diseases|Respiratory Tract Disease|Neoplasms by Site|Neoplasm, Bronchial|Carcinoma, Bronchogenic"
2813,0.999339673,186.8567988,https://clinicaltrials.gov/study/NCT00002888,NCT00002888,Head and Neck Cancer
2814,0.999139041,189.1014745,https://clinicaltrials.gov/study/NCT00948688,NCT00948688,Pancreatic Cancer|Adenocarcinoma of the Pancreas
2815,0.997701724,164.4589879,https://clinicaltrials.gov/study/NCT00276588,NCT00276588,Lung Cancer
2816,0.988658566,150.009187,https://clinicaltrials.gov/study/NCT01576588,NCT01576588,B-Cell Chronic Lymphocytic Leukemia
2817,0.981360947,88.23249911,https://clinicaltrials.gov/study/NCT00514488,NCT00514488,Chronic Myeloid Leukemia
2818,0.968498681,74.6721996,https://clinicaltrials.gov/study/NCT00409188,NCT00409188,Non-small Cell Lung Cancer
2819,0.997042402,158.5943666,https://clinicaltrials.gov/study/NCT00067288,NCT00067288,"Lymphoma, Non-Hodgkin|Neoplasms"
2820,0.943416867,37.13914961,https://clinicaltrials.gov/study/NCT04157088,NCT04157088,"Prostatic Cancer, Castration-Resistant"
2821,0.998292059,177.2483618,https://clinicaltrials.gov/study/NCT00002638,NCT00002638,Leukemia
2822,0.841855689,11.85121863,https://clinicaltrials.gov/study/NCT00534638,NCT00534638,"Infections, Papillomavirus"
2823,0.985022587,122.6614152,https://clinicaltrials.gov/study/NCT05374538,NCT05374538,Non-small Cell Lung Cancer
2824,0.944955103,45.09036154,https://clinicaltrials.gov/study/NCT03312738,NCT03312738,Advanced Breast Cancer
2825,0.998976721,178.4920484,https://clinicaltrials.gov/study/NCT03029338,NCT03029338,Lymphomas Non-Hodgkin's B-Cell|Relapse
2826,0.930360806,30.45823287,https://clinicaltrials.gov/study/NCT00138138,NCT00138138,Fatigue|Prostate Cancer
2827,0.88379082,16.78130289,https://clinicaltrials.gov/study/NCT05045638,NCT05045638,Healthy Participants
2828,0.998986388,184.17177,https://clinicaltrials.gov/study/NCT00022438,NCT00022438,Melanoma (Skin)
2829,0.970172018,70.42113954,https://clinicaltrials.gov/study/NCT04569838,NCT04569838,Indolent B-Cell Non-Hodgkin's Lymphomas
2830,0.997562758,165.1936017,https://clinicaltrials.gov/study/NCT00044538,NCT00044538,"Carcinoma, Non-Small-Cell Lung"
2831,0.998861566,179.968863,https://clinicaltrials.gov/study/NCT02144038,NCT02144038,Relapsed and Refractory Multiple Myeloma
2832,0.960879635,39.99670987,https://clinicaltrials.gov/study/NCT00907738,NCT00907738,Advanced Cancer
2833,0.964089989,43.64524742,https://clinicaltrials.gov/study/NCT04664972,NCT04664972,Triple Negative Breast Cancer
2834,0.98576366,140.6542949,https://clinicaltrials.gov/study/NCT02395172,NCT02395172,"Carcinoma, Non-Small-Cell Lung"
2835,0.987603718,146.0920797,https://clinicaltrials.gov/study/NCT00195572,NCT00195572,Gastric Cancer
2836,0.952678889,37.7866272,https://clinicaltrials.gov/study/NCT03891472,NCT03891472,Cancer of Pancreas|Unresectable Pancreatic Cancer|Chemotherapy Effect|SBRT
2837,0.964160592,66.88232779,https://clinicaltrials.gov/study/NCT00005072,NCT00005072,Prostate Cancer
2838,0.968538507,70.66032358,https://clinicaltrials.gov/study/NCT01893372,NCT01893372,Leukemia
2839,0.77049499,6.7531108,https://clinicaltrials.gov/study/NCT00932672,NCT00932672,Prostate Cancer
2840,0.95487462,58.56945192,https://clinicaltrials.gov/study/NCT01502072,NCT01502072,Bone Marrow Transplant Infection|Infection in Marrow Transplant Recipients|Respiratory Syncytial Virus Infections|Respiratory Syncytial Virus Pneumonia|Cancer|Acute Leukemia
2841,0.999532444,186.8183709,https://clinicaltrials.gov/study/NCT00016172,NCT00016172,"Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
2842,0.81793166,9.767807496,https://clinicaltrials.gov/study/NCT00079872,NCT00079872,Colorectal Cancer
2843,0.997913955,165.7567683,https://clinicaltrials.gov/study/NCT01958372,NCT01958372,Adenocarcinoma of the Lung|Adenosquamous Cell Lung Cancer|Bronchoalveolar Cell Lung Cancer|Large Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer
2844,0.993271709,152.7515003,https://clinicaltrials.gov/study/NCT00397072,NCT00397072,Glioblastoma
2845,0.994408984,153.4857382,https://clinicaltrials.gov/study/NCT01347788,NCT01347788,Prostate Adenocarcinoma
2846,0.659116384,3.769777809,https://clinicaltrials.gov/study/NCT02568488,NCT02568488,Polycystic Ovarian Syndrome
2847,0.860960225,13.32915014,https://clinicaltrials.gov/study/NCT01289288,NCT01289288,Colorectal Cancer
2848,0.995775173,155.0305889,https://clinicaltrials.gov/study/NCT00722488,NCT00722488,Hematologic Malignancies|Multiple Myeloma|Lymphoma|Hodgkin Lymphoma
2849,0.963308408,48.74747795,https://clinicaltrials.gov/study/NCT01242488,NCT01242488,Rheumatoid Arthritis
2850,0.997056468,157.3624373,https://clinicaltrials.gov/study/NCT00691938,NCT00691938,"Leukemia, Myeloid, Acute|Myelodysplastic Syndromes"
2851,0.993981975,153.4488095,https://clinicaltrials.gov/study/NCT02142738,NCT02142738,Non-Small Cell Lung Carcinoma
2852,0.997613286,161.8091299,https://clinicaltrials.gov/study/NCT01800838,NCT01800838,Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IA Mycosis Fungoides/Sezary Syndrome|Stage IB Mycosis Fungoides/Sezary Syndrome|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IIA Mycosis Fungoides/Sezary Syndrome
2853,0.991428164,151.4636439,https://clinicaltrials.gov/study/NCT00522938,NCT00522938,"Carcinoma, Non-Small-Cell Lung"
2854,0.974334294,73.27529621,https://clinicaltrials.gov/study/NCT00931138,NCT00931138,Acute Myeloid Leukemia
2855,0.966454629,45.08370889,https://clinicaltrials.gov/study/NCT04274738,NCT04274738,Waldenstrom's Macroglobulinemia
2856,0.997729525,165.2981829,https://clinicaltrials.gov/study/NCT01383538,NCT01383538,Pancreatic Cancer|Adenocarcinoma|Pancreatic Neoplasms
2857,0.995147456,156.132071,https://clinicaltrials.gov/study/NCT04173338,NCT04173338,Non Small Cell Lung Cancer|Non-squamous Non-small-cell Lung Cancer|Urothelial Carcinoma|Malignant Mesothelioma
2858,0.992872626,151.8692395,https://clinicaltrials.gov/study/NCT01729338,NCT01729338,Multiple Myeloma
2859,0.996782476,160.8919969,https://clinicaltrials.gov/study/NCT00548938,NCT00548938,Glioblastoma Multiforme|High-Grade Glioma
2860,0.997516403,157.9522027,https://clinicaltrials.gov/study/NCT00753038,NCT00753038,"Carcinoma, Squamous Cell of the Head and Neck"
2861,0.981879724,102.4417128,https://clinicaltrials.gov/study/NCT00140738,NCT00140738,"Neoplasms, Breast"
2862,0.982992034,132.1671855,https://clinicaltrials.gov/study/NCT00773838,NCT00773838,Relapsed or Refractory Multiple Myeloma
2863,0.998912939,187.0935467,https://clinicaltrials.gov/study/NCT02737072,NCT02737072,Solid Tumor
2864,0.951959753,34.28488504,https://clinicaltrials.gov/study/NCT01681472,NCT01681472,Colonic Neoplasms
2865,0.993549147,152.3066479,https://clinicaltrials.gov/study/NCT01226472,NCT01226472,Peripheral T-cell Lymphoma|Cutaneous T-cell Lymphoma
2866,0.998643288,176.5016006,https://clinicaltrials.gov/study/NCT02454972,NCT02454972,Advanced Solid Tumors
2867,0.98483077,121.9650051,https://clinicaltrials.gov/study/NCT00191672,NCT00191672,Breast Neoplasms
2868,0.991849434,151.3101069,https://clinicaltrials.gov/study/NCT03164772,NCT03164772,Metastatic Non-small Cell Lung Cancer|NSCLC
2869,0.999543076,184.4744567,https://clinicaltrials.gov/study/NCT00004872,NCT00004872,"Unspecified Adult Solid Tumor, Protocol Specific"
2870,0.992019705,152.0634872,https://clinicaltrials.gov/study/NCT00853372,NCT00853372,Advanced Renal Cell Carcinoma
2871,0.998434166,166.9258208,https://clinicaltrials.gov/study/NCT00365872,NCT00365872,Soft Tissue Sarcoma
2872,0.996953603,164.3839693,https://clinicaltrials.gov/study/NCT01271972,NCT01271972,Solid Tumors
2873,0.998460243,179.5759075,https://clinicaltrials.gov/study/NCT02228772,NCT02228772,Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|B-cell Adult Acute Lymphoblastic Leukemia|T-cell Adult Acute Lymphoblastic Leukemia
2874,0.999240433,181.2298445,https://clinicaltrials.gov/study/NCT00021372,NCT00021372,Lymphoma
2875,0.969750926,47.08395637,https://clinicaltrials.gov/study/NCT01661972,NCT01661972,Metastatic Colorectal Cancer
2876,0.973981447,61.90199813,https://clinicaltrials.gov/study/NCT01980888,NCT01980888,Chronic Lymphocytic Leukemia
2877,0.977115653,53.00017988,https://clinicaltrials.gov/study/NCT02784288,NCT02784288,Oropharyngeal Squamous Cell Cancer
2878,0.855945348,12.72044428,https://clinicaltrials.gov/study/NCT00899288,NCT00899288,Breast Cancer|Osteoporosis
2879,0.90883508,19.57482092,https://clinicaltrials.gov/study/NCT02220088,NCT02220088,Hepatocellular Carcinoma
2880,0.977858096,81.13463759,https://clinicaltrials.gov/study/NCT00858338,NCT00858338,Gastric Cancer|Stomach Cancer
2881,0.99858232,173.3421564,https://clinicaltrials.gov/study/NCT00603538,NCT00603538,"Carcinoma, Non-Small-Cell Lung"
2882,0.998361661,173.4147537,https://clinicaltrials.gov/study/NCT00008138,NCT00008138,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
2883,0.998928088,185.0912793,https://clinicaltrials.gov/study/NCT03739138,NCT03739138,Advanced Solid Tumors
2884,0.998582656,176.0997559,https://clinicaltrials.gov/study/NCT00028938,NCT00028938,Lung Cancer
2885,0.973233675,67.39109216,https://clinicaltrials.gov/study/NCT00607438,NCT00607438,Breast Cancer
2886,0.915315213,24.7194327,https://clinicaltrials.gov/study/NCT00814138,NCT00814138,Myasthenia Gravis
2887,0.99602199,156.1126982,https://clinicaltrials.gov/study/NCT02799238,NCT02799238,Glioblastoma
2888,0.999130859,189.6891909,https://clinicaltrials.gov/study/NCT00729638,NCT00729638,Multiple Myeloma
2889,0.992928341,153.2283406,https://clinicaltrials.gov/study/NCT00515138,NCT00515138,"Lymphoma, B-Cell"
2890,0.997329559,164.59126,https://clinicaltrials.gov/study/NCT01434472,NCT01434472,Post-Transplant Lymphoproliferative Disorder|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Burkitt Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Burkitt Lymphoma|Refractory Diffuse Large B-Cell Lymphoma
2891,0.952683463,41.88965392,https://clinicaltrials.gov/study/NCT02144272,NCT02144272,Inflammatory Arthritis
2892,0.997917435,164.7797436,https://clinicaltrials.gov/study/NCT01349972,NCT01349972,Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
2893,0.919424985,26.88801175,https://clinicaltrials.gov/study/NCT03219372,NCT03219372,Hepatocellular Carcinoma|Liver Cirrhoses
2894,0.999540525,199.9606986,https://clinicaltrials.gov/study/NCT01005472,NCT01005472,Metastatic Melanoma
2895,0.999490412,181.793661,https://clinicaltrials.gov/study/NCT00644072,NCT00644072,Lymphoma|Neoplasms
2896,0.987380451,150.299568,https://clinicaltrials.gov/study/NCT03151772,NCT03151772,Glioblastoma
2897,0.991308555,150.6744365,https://clinicaltrials.gov/study/NCT00631072,NCT00631072,Malignant Melanoma
2898,0.719567797,6.443364973,https://clinicaltrials.gov/study/NCT02984072,NCT02984072,Actinic Keratosis
2899,0.989053667,150.2957441,https://clinicaltrials.gov/study/NCT00076388,NCT00076388,Non-Small-Cell Lung Carcinoma
2900,0.93653034,42.2946578,https://clinicaltrials.gov/study/NCT00333788,NCT00333788,Crohn's Disease
2901,0.994296049,154.6969112,https://clinicaltrials.gov/study/NCT02741388,NCT02741388,B-cell Lymphoma
2902,0.997685413,167.9874988,https://clinicaltrials.gov/study/NCT00883688,NCT00883688,Brain Cancer|Pediatric Cancers
2903,0.999487426,190.1074913,https://clinicaltrials.gov/study/NCT00002988,NCT00002988,Brain and Central Nervous System Tumors
2904,0.996493573,159.273762,https://clinicaltrials.gov/study/NCT01738438,NCT01738438,Breast Cancer
2905,0.939189777,37.05466219,https://clinicaltrials.gov/study/NCT00652938,NCT00652938,"Infections, Papillomavirus"
2906,0.857765951,12.70398529,https://clinicaltrials.gov/study/NCT03515538,NCT03515538,Oral Mucositis
2907,0.999630162,185.3769825,https://clinicaltrials.gov/study/NCT00004038,NCT00004038,Breast Cancer
2908,0.995331971,156.1088625,https://clinicaltrials.gov/study/NCT01045538,NCT01045538,Gastric Cancer|Histone Deacetylase Inhibitor
2909,0.977933523,106.2937223,https://clinicaltrials.gov/study/NCT00291538,NCT00291538,Multiple Myeloma
2910,0.997341908,163.7351144,https://clinicaltrials.gov/study/NCT00591838,NCT00591838,Inoperable Stage I/II Non-small Cell Lung Cancer
2911,0.982358956,110.8058908,https://clinicaltrials.gov/study/NCT04577638,NCT04577638,Non Small Cell Lung Cancer Stage III
2912,0.998493743,174.3269827,https://clinicaltrials.gov/study/NCT00521638,NCT00521638,"Lymphoma, B-Cell"
2913,0.989186665,147.5306057,https://clinicaltrials.gov/study/NCT01074138,NCT01074138,"Bone-Metastatic, Castration-Resistant Prostate Cancer"
2914,0.991921286,151.6706018,https://clinicaltrials.gov/study/NCT02544438,NCT02544438,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia
2915,0.989919947,151.2670295,https://clinicaltrials.gov/study/NCT00073138,NCT00073138,Colorectal Cancer
2916,0.993273502,152.7447865,https://clinicaltrials.gov/study/NCT02272738,NCT02272738,Pancreatic Cancer
2917,0.999245684,183.1264508,https://clinicaltrials.gov/study/NCT00526838,NCT00526838,Cancer|Lymphoma
2918,0.997829062,164.5050535,https://clinicaltrials.gov/study/NCT00290472,NCT00290472,B-cell Chronic Lymphocytic Leukemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Malignant Neoplasm|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Splenic Marginal Zone Lymphoma|Waldenstrm Macroglobulinemia
2919,0.999797158,191.4318565,https://clinicaltrials.gov/study/NCT00244972,NCT00244972,Advanced Malignant Neoplasm
2920,0.999179684,183.9189144,https://clinicaltrials.gov/study/NCT01267253,NCT01267253,"Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Persistent Disease|Recurrent Cervical Carcinoma"
2921,0.999412895,192.2300325,https://clinicaltrials.gov/study/NCT00003353,NCT00003353,Multiple Myeloma and Plasma Cell Neoplasm
2922,0.889394571,18.09870384,https://clinicaltrials.gov/study/NCT02966353,NCT02966353,Primary Myelofibrosis|Post-Polycythemia Vera-Myelofibrosis|Post-Essential Thrombocythemia Myelofibrosis
2923,0.996682331,160.0260813,https://clinicaltrials.gov/study/NCT00375453,NCT00375453,Tumors
2924,0.983557337,100.6983198,https://clinicaltrials.gov/study/NCT01194453,NCT01194453,Non-small Cell Lung Cancer|Efficacy
2925,0.98637099,137.1262201,https://clinicaltrials.gov/study/NCT01813253,NCT01813253,Gastric Cancer|Gastroesophageal Junction Cancer
2926,0.998649732,176.0824179,https://clinicaltrials.gov/study/NCT01022853,NCT01022853,Neoplasms
2927,0.997115936,158.442252,https://clinicaltrials.gov/study/NCT00957853,NCT00957853,Head and Neck Squamous Cell Carcinoma
2928,0.974320724,66.96627608,https://clinicaltrials.gov/study/NCT01717053,NCT01717053,Prostate Cancer
2929,0.999003754,186.140167,https://clinicaltrials.gov/study/NCT00033553,NCT00033553,Lung Cancer
2930,0.998513925,169.6645857,https://clinicaltrials.gov/study/NCT03490760,NCT03490760,Adenocarcinoma of the Pancreas
2931,0.992553041,152.1797503,https://clinicaltrials.gov/study/NCT01685060,NCT01685060,Non-Small Cell Lung Cancer
2932,0.990053648,150.7393193,https://clinicaltrials.gov/study/NCT01305460,NCT01305460,Myelodysplastic Syndrome
2933,0.997599768,161.3946452,https://clinicaltrials.gov/study/NCT00387660,NCT00387660,Lung Cancer
2934,0.983377655,119.7727199,https://clinicaltrials.gov/study/NCT04649060,NCT04649060,Relapsed Multiple Myeloma|Relapsed-Refractory Multiple Myeloma
2935,0.999172649,185.7657082,https://clinicaltrials.gov/study/NCT00006760,NCT00006760,Lymphoma
2936,0.992593798,152.6403327,https://clinicaltrials.gov/study/NCT00122460,NCT00122460,Head and Neck Cancer
2937,0.991858179,152.8020949,https://clinicaltrials.gov/study/NCT00468260,NCT00468260,Advanced Malignancies
2938,0.990921822,151.6464032,https://clinicaltrials.gov/study/NCT03087760,NCT03087760,Non-small Cell Lung Cancer
2939,0.707577575,6.070754324,https://clinicaltrials.gov/study/NCT02736760,NCT02736760,Actinic Keratoses|Photodamaged Skin
2940,0.99616501,158.099581,https://clinicaltrials.gov/study/NCT00083460,NCT00083460,Multiple Myeloma
2941,0.998681314,178.5322138,https://clinicaltrials.gov/study/NCT00019929,NCT00019929,Lung Cancer
2942,0.931618969,21.35898212,https://clinicaltrials.gov/study/NCT01247129,NCT01247129,Breast Neoplasms
2943,0.936230401,33.53505546,https://clinicaltrials.gov/study/NCT00411229,NCT00411229,Stomach Neoplasms
2944,0.998830491,182.8594614,https://clinicaltrials.gov/study/NCT02713529,NCT02713529,Pancreatic Cancer|Colorectal Cancer|Non-Small Cell Lung Cancer
2945,0.999192303,178.1298533,https://clinicaltrials.gov/study/NCT02987829,NCT02987829,"Metastatic Castrate-resistant Prostate Cancer|Adenocarcinoma, Prostate"
2946,0.998456544,176.5932824,https://clinicaltrials.gov/study/NCT02584829,NCT02584829,Merkel Cell Polyomavirus Infection|Stage IV Merkel Cell Carcinoma AJCC v7
2947,0.67862216,4.43488263,https://clinicaltrials.gov/study/NCT02219529,NCT02219529,"Gastric Diseases,|Gastric Ulcer,|Gastric Polyps,|Early Gastric Cancer,|Chronic Gastritis"
2948,0.988149587,142.9669612,https://clinicaltrials.gov/study/NCT02249429,NCT02249429,"Lymphoma, Malignant"
2949,0.997486646,165.404456,https://clinicaltrials.gov/study/NCT00393029,NCT00393029,Anti-p53 TCR-Gene
2950,0.995927658,156.024835,https://clinicaltrials.gov/study/NCT03307629,NCT03307629,Cancer
2951,0.988439014,150.3086713,https://clinicaltrials.gov/study/NCT01065129,NCT01065129,Myelodysplastic Syndromes
2952,0.98108859,95.75153497,https://clinicaltrials.gov/study/NCT03705429,NCT03705429,Breast Neoplasms
2953,0.973954976,81.89589013,https://clinicaltrials.gov/study/NCT06209229,NCT06209229,Nonsmall-cell Lung Cancer
2954,0.727568623,5.052906629,https://clinicaltrials.gov/study/NCT00446329,NCT00446329,Secondary Hyperparathyroidism
2955,0.993436304,153.6986262,https://clinicaltrials.gov/study/NCT01238029,NCT01238029,Metastatic Breast Cancer|HER2 Positive|First or Second Line Therapy|Failure or Contraindication of Trastuzumab Therapy
2956,0.986941949,140.6820947,https://clinicaltrials.gov/study/NCT01148446,NCT01148446,Elderly Patients (>65 Years)|Diffuse Large B Cell Lymphoma (DLBCL)
2957,0.95881541,55.2061831,https://clinicaltrials.gov/study/NCT00311246,NCT00311246,Sarcoidosis
2958,0.992153498,151.5195023,https://clinicaltrials.gov/study/NCT00545246,NCT00545246,Neoplasms
2959,0.998029911,167.980552,https://clinicaltrials.gov/study/NCT01892046,NCT01892046,Cancer
2960,0.99177122,151.3439031,https://clinicaltrials.gov/study/NCT03623646,NCT03623646,Oropharyngeal Squamous Cell Carcinoma
2961,0.992574648,151.5215536,https://clinicaltrials.gov/study/NCT01420146,NCT01420146,Breast Neoplasms|Secondary|HER2 Positive Carcinoma of Breast
2962,0.998385982,173.1988818,https://clinicaltrials.gov/study/NCT01014546,NCT01014546,Essential Thrombocythemia|Polycythemia Vera|Primary Myelofibrosis
2963,0.988696107,150.4150388,https://clinicaltrials.gov/study/NCT00983346,NCT00983346,Cancer|Myeloma|Multiple Myeloma
2964,0.906924902,22.21093471,https://clinicaltrials.gov/study/NCT01907646,NCT01907646,Uterine Cervical Neoplasms
2965,0.960357074,38.41529328,https://clinicaltrials.gov/study/NCT00494546,NCT00494546,Prostate Cancer
2966,0.988798711,150.7556015,https://clinicaltrials.gov/study/NCT00766246,NCT00766246,Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV
2967,0.998947567,182.1699876,https://clinicaltrials.gov/study/NCT00019773,NCT00019773,Carcinoma of the Appendix|Colorectal Cancer|Small Intestine Cancer
2968,0.995913615,157.3811759,https://clinicaltrials.gov/study/NCT00121173,NCT00121173,Cervical Cancer|Precancerous Condition
2969,0.987245461,150.6319552,https://clinicaltrials.gov/study/NCT05005273,NCT05005273,Non-Small Cell Lung Cancer
2970,0.997124217,159.9088632,https://clinicaltrials.gov/study/NCT04095273,NCT04095273,Advanced Solid Tumors
2971,0.922657897,25.73171845,https://clinicaltrials.gov/study/NCT00073073,NCT00073073,Breast Neoplasms
2972,0.999090476,186.7275739,https://clinicaltrials.gov/study/NCT00541073,NCT00541073,Malignant Mesothelioma
2973,0.98863167,150.7040518,https://clinicaltrials.gov/study/NCT01168973,NCT01168973,Non-Small Cell Lung Cancer
2974,0.995490183,156.0439973,https://clinicaltrials.gov/study/NCT01315873,NCT01315873,Multiple Myeloma
2975,0.978877498,87.83293053,https://clinicaltrials.gov/study/NCT00030173,NCT00030173,Neoplasms
2976,0.748364656,7.179616623,https://clinicaltrials.gov/study/NCT05328973,NCT05328973,Cancer Pain
2977,0.977672481,96.20512622,https://clinicaltrials.gov/study/NCT00400673,NCT00400673,Acute Myelogenous Leukemia
2978,0.822864796,10.62997544,https://clinicaltrials.gov/study/NCT00871273,NCT00871273,Adenocarcinoma of the Stomach
2979,0.999609483,192.6754678,https://clinicaltrials.gov/study/NCT01071564,NCT01071564,Estrogen Receptor Negative|HER2/Neu Negative|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|Triple-Negative Breast Carcinoma
2980,0.97912459,94.15377818,https://clinicaltrials.gov/study/NCT00600964,NCT00600964,Chronic Lymphocytic Leukemia
2981,0.975143179,71.06120351,https://clinicaltrials.gov/study/NCT02271464,NCT02271464,Metastatic Colorectal Cancer
2982,0.872216645,12.15566509,https://clinicaltrials.gov/study/NCT00529464,NCT00529464,Cervical Cancer
2983,0.99394472,153.540914,https://clinicaltrials.gov/study/NCT00568464,NCT00568464,Ewing's Sarcoma
2984,0.984747162,142.9655844,https://clinicaltrials.gov/study/NCT02419664,NCT02419664,Pituitary Tumours
2985,0.996286346,156.9909815,https://clinicaltrials.gov/study/NCT00192764,NCT00192764,Non-Hodgkin's Lymphoma
2986,0.998932369,187.8881049,https://clinicaltrials.gov/study/NCT02942264,NCT02942264,Brain Tumor|Astrocytoma|Astroglioma|Glioblastoma|Gliosarcoma
2987,0.893618114,19.62488742,https://clinicaltrials.gov/study/NCT01661764,NCT01661764,Colorectal Adenomatous Polyps
2988,1.0,175.8523361,https://clinicaltrials.gov/study/NCT00647764,NCT00647764,Solid Tumor Malignancy|Lymphoid Malignancy (Lymphoma and CLL)|Leukemia|Lymphoma
2989,0.95207811,35.34004453,https://clinicaltrials.gov/study/NCT02576964,NCT02576964,"Carcinoma, Hepatocellular"
2990,0.920014703,25.24126856,https://clinicaltrials.gov/study/NCT00376064,NCT00376064,Acromegaly
2991,0.988398402,150.2957377,https://clinicaltrials.gov/study/NCT03671564,NCT03671564,Acute Myeloid Leukemia
2992,0.992159702,153.0015186,https://clinicaltrials.gov/study/NCT00415064,NCT00415064,Multiple Myeloma
2993,0.996360701,157.5509364,https://clinicaltrials.gov/study/NCT00005064,NCT00005064,Adult Acute Promyelocytic Leukemia (M3)|Blastic Phase Chronic Myelogenous Leukemia|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Relapsing Chronic Myelogenous Leukemia
2994,0.954006908,40.14650213,https://clinicaltrials.gov/study/NCT03441464,NCT03441464,"Prostate Cancer|Neoplasm, Residual"
2995,0.95943973,51.65458337,https://clinicaltrials.gov/study/NCT00949364,NCT00949364,Myeloproliferative Neoplasms
2996,0.998098972,167.7557915,https://clinicaltrials.gov/study/NCT00054353,NCT00054353,Refractory Multiple Myeloma
2997,0.871438536,15.0304929,https://clinicaltrials.gov/study/NCT04166253,NCT04166253,Breast Cancer
2998,0.981178516,101.5579854,https://clinicaltrials.gov/study/NCT03748953,NCT03748953,Multiple Myeloma
2999,0.997631676,162.4693091,https://clinicaltrials.gov/study/NCT03035253,NCT03035253,Metastatic Colorectal Cancer
3000,0.991631928,151.1395022,https://clinicaltrials.gov/study/NCT03724253,NCT03724253,Breast Cancer|Prostate Cancer|Colorectal Cancer|Non Small Cell Lung Cancer|Small Cell Lung Cancer
3001,0.996487478,156.6480452,https://clinicaltrials.gov/study/NCT02516553,NCT02516553,Neoplasms|NUT Carcinoma
3002,0.998973564,179.9277155,https://clinicaltrials.gov/study/NCT00112853,NCT00112853,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
3003,0.999823764,182.076696,https://clinicaltrials.gov/study/NCT00006353,NCT00006353,Brain and Central Nervous System Tumors
3004,0.880303859,15.78031317,https://clinicaltrials.gov/study/NCT02113553,NCT02113553,Breast Cancer
3005,0.991589835,152.1814915,https://clinicaltrials.gov/study/NCT00227760,NCT00227760,Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer
3006,0.999404461,187.9781506,https://clinicaltrials.gov/study/NCT00502060,NCT00502060,Advanced Tumor
3007,0.999583289,180.7011023,https://clinicaltrials.gov/study/NCT00003960,NCT00003960,Leukemia|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
3008,0.981652475,93.55270388,https://clinicaltrials.gov/study/NCT00264160,NCT00264160,"Leukemia, Myeloid, Chronic"
3009,0.997145321,163.1949499,https://clinicaltrials.gov/study/NCT00165360,NCT00165360,Glioma|Astrocytoma|Oligodendroglioma
3010,0.99948238,187.3372911,https://clinicaltrials.gov/study/NCT00099060,NCT00099060,Brain and Central Nervous System Tumors
3011,0.987359844,150.0087885,https://clinicaltrials.gov/study/NCT00880360,NCT00880360,Epithelial Ovarian Cancer|Extraovarian Peritoneal Cancer|Fallopian Tube Carcinoma
3012,0.999332758,183.4413319,https://clinicaltrials.gov/study/NCT00003229,NCT00003229,Melanoma (Skin)
3013,0.994345955,154.4932911,https://clinicaltrials.gov/study/NCT01056029,NCT01056029,Advanced Solid Tumors
3014,0.998500271,168.3305389,https://clinicaltrials.gov/study/NCT00006929,NCT00006929,Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
3015,0.99970055,188.0407698,https://clinicaltrials.gov/study/NCT01481129,NCT01481129,Diffuse Large B Cell Lymphoma
3016,0.996604587,161.3890362,https://clinicaltrials.gov/study/NCT00390429,NCT00390429,"Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
3017,0.999516727,186.5375942,https://clinicaltrials.gov/study/NCT00474929,NCT00474929,Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm
3018,0.999540409,185.1294378,https://clinicaltrials.gov/study/NCT00077129,NCT00077129,Kidney Cancer
3019,0.94194883,25.71666702,https://clinicaltrials.gov/study/NCT00957229,NCT00957229,Basal Cell Nevus Syndrome|Gorlin Syndrome
3020,0.820789856,11.31380521,https://clinicaltrials.gov/study/NCT02149329,NCT02149329,Febrile Neutropenia|Hematological Malignancy
3021,0.9887502,150.2498051,https://clinicaltrials.gov/study/NCT00142129,NCT00142129,Waldenstrom's Macroglobulinemia|Lymphoplasmacytic Lymphoma
3022,0.987927904,150.1796673,https://clinicaltrials.gov/study/NCT00005829,NCT00005829,Leukemia
3023,0.984017219,134.7188267,https://clinicaltrials.gov/study/NCT00899353,NCT00899353,Monoclonal Gammopathy of Undetermined Significance|Smoldering Multiple Myeloma|Chronic Lymphocytic Leukemia
3024,0.934120031,25.5810585,https://clinicaltrials.gov/study/NCT02567253,NCT02567253,Ovarian Cancer|Primary Peritoneal Cancer
3025,0.987485083,150.7152603,https://clinicaltrials.gov/study/NCT00667953,NCT00667953,Melanoma|Advanced Melanoma
3026,0.918845418,20.07881614,https://clinicaltrials.gov/study/NCT00186953,NCT00186953,Abdominal Neoplasms|Pelvic Neoplasms
3027,0.988548461,150.4339539,https://clinicaltrials.gov/study/NCT01285453,NCT01285453,Advanced or Recurrent Solid Tumors
3028,0.981046334,104.881306,https://clinicaltrials.gov/study/NCT01466153,NCT01466153,Chronic Lymphocytic Leukemia (CLL)
3029,0.997747114,162.5375435,https://clinicaltrials.gov/study/NCT02038153,NCT02038153,Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia in Remission
3030,0.947612809,34.62713472,https://clinicaltrials.gov/study/NCT00483860,NCT00483860,Solid Tumours
3031,0.99261349,152.1038031,https://clinicaltrials.gov/study/NCT00724360,NCT00724360,Relapsed/Refractory Leukemia
3032,0.915011715,20.81735445,https://clinicaltrials.gov/study/NCT00256360,NCT00256360,Breast Cancer
3033,0.969819938,72.37835491,https://clinicaltrials.gov/study/NCT02498860,NCT02498860,Adenocarcinoma|Lung Neoplasm
3034,0.879136974,16.81444257,https://clinicaltrials.gov/study/NCT00414960,NCT00414960,Lung Cancer
3035,0.994341957,154.2607963,https://clinicaltrials.gov/study/NCT00343460,NCT00343460,"Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific"
3036,0.917190066,25.73737313,https://clinicaltrials.gov/study/NCT02739360,NCT02739360,Lymphoid Malignancies
3037,0.960314057,51.47004704,https://clinicaltrials.gov/study/NCT01097460,NCT01097460,Breast Neoplasms
3038,0.995099297,155.4666259,https://clinicaltrials.gov/study/NCT00292760,NCT00292760,Chronic Lymphocytic Leukaemia
3039,0.767276989,7.00544812,https://clinicaltrials.gov/study/NCT01126060,NCT01126060,Thyroid Carcinoma|Thyroidectomy
3040,0.994473657,153.3006017,https://clinicaltrials.gov/study/NCT00089960,NCT00089960,Gastrointestinal Cancer
3041,0.982871882,104.2894838,https://clinicaltrials.gov/study/NCT00002160,NCT00002160,HIV Infections|Cancer|Pain
3042,0.965918195,50.61089748,https://clinicaltrials.gov/study/NCT04142060,NCT04142060,Breast Cancer
3043,0.966844432,69.2717048,https://clinicaltrials.gov/study/NCT01798160,NCT01798160,Hepatocellular Carcinoma
3044,0.984716937,120.4469385,https://clinicaltrials.gov/study/NCT00821860,NCT00821860,Malignant Mesothelioma|Metastatic Cancer
3045,0.959334433,47.176254,https://clinicaltrials.gov/study/NCT00123929,NCT00123929,Breast Cancer
3046,0.990761421,151.4832716,https://clinicaltrials.gov/study/NCT00070629,NCT00070629,"Carcinoma, Non-Small Cell Lung"
3047,0.983883734,134.5950345,https://clinicaltrials.gov/study/NCT00861029,NCT00861029,"Carcinoma, Renal Cell"
3048,0.988800454,150.4338835,https://clinicaltrials.gov/study/NCT00113529,NCT00113529,"Carcinoma, Renal Cell"
3049,0.996220616,158.8985367,https://clinicaltrials.gov/study/NCT00324129,NCT00324129,Leukemia|Myelodysplastic Syndromes
3050,0.99788289,167.0366236,https://clinicaltrials.gov/study/NCT00400829,NCT00400829,Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
3051,0.996903177,158.6033189,https://clinicaltrials.gov/study/NCT00416429,NCT00416429,Kidney Cancer
3052,0.997125797,160.8378761,https://clinicaltrials.gov/study/NCT00313729,NCT00313729,"CNS Tumor, Adult"
3053,0.990076087,150.9073075,https://clinicaltrials.gov/study/NCT00506129,NCT00506129,Lymphoma|Disorder Related to Bone Marrow Transplantation
3054,0.995633489,156.8422199,https://clinicaltrials.gov/study/NCT00312429,NCT00312429,Hematologic Neoplasms
3055,0.992171552,152.1518474,https://clinicaltrials.gov/study/NCT00075829,NCT00075829,Multiple Myeloma
3056,0.998788731,183.4226439,https://clinicaltrials.gov/study/NCT00238329,NCT00238329,Intraocular Melanoma|Melanoma (Skin)
3057,0.985000894,150.2129426,https://clinicaltrials.gov/study/NCT05446129,NCT05446129,Colorectal Cancer
3058,0.989247345,150.5666354,https://clinicaltrials.gov/study/NCT00559429,NCT00559429,Prostate Cancer
3059,0.999060748,183.3195181,https://clinicaltrials.gov/study/NCT03665129,NCT03665129,Advanced Solid Tumors
3060,0.979967937,112.2898316,https://clinicaltrials.gov/study/NCT00647153,NCT00647153,Colorectal Cancer
3061,0.998669118,181.2523301,https://clinicaltrials.gov/study/NCT01965353,NCT01965353,Multiple Myeloma in Relapse
3062,0.996258087,156.8376059,https://clinicaltrials.gov/study/NCT02090153,NCT02090153,Gastric Cancer
3063,0.997363184,163.3552471,https://clinicaltrials.gov/study/NCT00303953,NCT00303953,Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma
3064,0.994868241,153.1414738,https://clinicaltrials.gov/study/NCT00010153,NCT00010153,Breast Cancer
3065,0.99511994,156.6831681,https://clinicaltrials.gov/study/NCT00093353,NCT00093353,Diarrhea|Drug/Agent Toxicity by Tissue/Organ|Neuroblastoma
3066,0.9485951,38.72939003,https://clinicaltrials.gov/study/NCT01488253,NCT01488253,"Acute Leukemia in Remission|Myelodysplastic Syndromes|Leukemia, Myeloid, Chronic-Phase|Leukemia, Myeloid, Accelerated-Phase"
3067,0.99835997,173.2974263,https://clinicaltrials.gov/study/NCT03506360,NCT03506360,Recurrent Plasma Cell Myeloma
3068,0.694513097,5.358258274,https://clinicaltrials.gov/study/NCT01948960,NCT01948960,Breast Neoplasms
3069,0.977571722,88.95391036,https://clinicaltrials.gov/study/NCT00544960,NCT00544960,Non-small Cell Lung Cancer
3070,0.93435233,27.42894731,https://clinicaltrials.gov/study/NCT04312360,NCT04312360,Right-sided Colon Cancer|Right-sided Colon Adenoma
3071,0.977861496,93.35455393,https://clinicaltrials.gov/study/NCT01144260,NCT01144260,B-Cell Chronic Lymphocytic Leukemia
3072,0.962917962,46.84276265,https://clinicaltrials.gov/study/NCT03610360,NCT03610360,Mesothelioma
3073,0.978306095,98.22491844,https://clinicaltrials.gov/study/NCT02015260,NCT02015260,Anogenital Warts|Condylomata Acuminata
3074,0.999496705,184.9559072,https://clinicaltrials.gov/study/NCT00305760,NCT00305760,Pancreatic Cancer
3075,0.998397016,165.3103303,https://clinicaltrials.gov/study/NCT00268229,NCT00268229,Leukemia
3076,0.995992614,158.5735669,https://clinicaltrials.gov/study/NCT03042429,NCT03042429,Neuroblastoma
3077,0.991749155,151.112544,https://clinicaltrials.gov/study/NCT02835729,NCT02835729,Acute Myeloid Leukemia
3078,0.994897759,153.7526114,https://clinicaltrials.gov/study/NCT01373229,NCT01373229,"Leukemia, Lymphocytic, Chronic, B-Cell"
3079,0.982753063,112.7307795,https://clinicaltrials.gov/study/NCT01997229,NCT01997229,Refractory Generalized Myasthenia Gravis
3080,0.99317973,152.4807718,https://clinicaltrials.gov/study/NCT03015129,NCT03015129,"Endometrial Cancer|Endometrial Carcinosarcoma|Endometrial Carcinoma|Endometrial Cancer Recurrent|Endometrial Carcinoma, Recurrent"
3081,0.986370545,133.3997034,https://clinicaltrials.gov/study/NCT01360853,NCT01360853,Metastatic Pancreatic Adenocarcinoma
3082,0.94278814,31.52866485,https://clinicaltrials.gov/study/NCT03949153,NCT03949153,Melanoma (Skin)
3083,0.973957914,89.19346896,https://clinicaltrials.gov/study/NCT01919853,NCT01919853,Fatigue
3084,0.993502875,154.3364527,https://clinicaltrials.gov/study/NCT02342353,NCT02342353,"Non-Small Cell Lung Cancer|Nonsmall Cell Lung Cancer|Carcinoma, Non-Small-Cell Lung"
3085,0.987746016,150.4209895,https://clinicaltrials.gov/study/NCT01184053,NCT01184053,Endometrial Carcinoma
3086,0.998904497,193.951173,https://clinicaltrials.gov/study/NCT02572453,NCT02572453,Recurrent Anaplastic Large Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma|Refractory Anaplastic Large Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Transformed Non-Hodgkin Lymphoma
3087,0.926092962,19.71649682,https://clinicaltrials.gov/study/NCT00450853,NCT00450853,Vomiting
3088,0.998741445,177.8241619,https://clinicaltrials.gov/study/NCT01970553,NCT01970553,Specific Advanced Solid Tumors
3089,0.998889451,190.4900478,https://clinicaltrials.gov/study/NCT02451553,NCT02451553,Advanced Malignant Solid Neoplasm|Bile Duct Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IVA Pancreatic Cancer|Stage IVB Pancreatic Cancer
3090,0.992627828,152.1435907,https://clinicaltrials.gov/study/NCT03472053,NCT03472053,Non Small Cell Lung Cancer Stage IIIB
3091,0.935569429,32.06435133,https://clinicaltrials.gov/study/NCT01380353,NCT01380353,Breast Cancer
3092,0.980792317,113.5316326,https://clinicaltrials.gov/study/NCT01358253,NCT01358253,Acute Lymphoblastic Leukemia
3093,0.988999403,150.4889606,https://clinicaltrials.gov/study/NCT02833753,NCT02833753,Colorectal Cancer|Appendix Cancer|Peritoneal Carcinomatosis
3094,0.996211092,156.7937449,https://clinicaltrials.gov/study/NCT00264953,NCT00264953,Hodgkins Lymphoma
3095,0.931806564,28.19472275,https://clinicaltrials.gov/study/NCT01349153,NCT01349153,Physical Activity
3096,0.776718593,7.761628534,https://clinicaltrials.gov/study/NCT04074460,NCT04074460,"Cancer, Breast|Cancer Colorectal|Cancer Prostate|Cancer, Lung|Cancer Melanoma Skin|Cancer, Other"
3097,0.999326967,194.5901823,https://clinicaltrials.gov/study/NCT00006360,NCT00006360,Head and Neck Cancer|Radiation Toxicity
3098,0.999459266,192.092661,https://clinicaltrials.gov/study/NCT00424060,NCT00424060,Brain and Central Nervous System Tumors
3099,0.994844529,155.1277155,https://clinicaltrials.gov/study/NCT00474760,NCT00474760,"Sarcoma, Ewing's"
3100,0.999025038,183.9673228,https://clinicaltrials.gov/study/NCT00028860,NCT00028860,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter
3101,0.961716451,33.14268889,https://clinicaltrials.gov/study/NCT03441360,NCT03441360,Relapsed/Refractory Rhabdomyosarcoma|Non-rhabdomyosarcoma Soft Tissue Sarcoma|Ewing Sarcoma
3102,0.906161728,22.05933268,https://clinicaltrials.gov/study/NCT01063660,NCT01063660,Acute Myeloid Leukaemia
3103,0.996069657,157.3635935,https://clinicaltrials.gov/study/NCT02900560,NCT02900560,Epithelial Ovarian Cancer
3104,0.997513513,161.5435791,https://clinicaltrials.gov/study/NCT00551460,NCT00551460,Leukemia
3105,0.987047573,135.7796999,https://clinicaltrials.gov/study/NCT00937560,NCT00937560,Ovarian Cancer
3106,0.919940527,19.3872382,https://clinicaltrials.gov/study/NCT00493129,NCT00493129,Leukemia|Systemic Mastocytosis
3107,0.998455337,174.7301319,https://clinicaltrials.gov/study/NCT01702129,NCT01702129,Solid Tumors
3108,0.911701106,23.56560334,https://clinicaltrials.gov/study/NCT00663429,NCT00663429,Neuroendocrine Carcinoma
3109,0.990088356,152.1259658,https://clinicaltrials.gov/study/NCT00204529,NCT00204529,Melanoma
3110,0.996972336,158.7096787,https://clinicaltrials.gov/study/NCT04000529,NCT04000529,Non-small Cell Lung Carcinoma|Head and Neck Squamous Cell Carcinoma|Esophageal SCC|Gastrointestinal Stromal Tumors|Colorectal Cancer
3111,0.993561513,153.5761023,https://clinicaltrials.gov/study/NCT03871829,NCT03871829,Multiple Myeloma
3112,0.936933826,37.46675053,https://clinicaltrials.gov/study/NCT03428529,NCT03428529,Rectal Neoplasm Malignant
3113,0.982742226,150.0839906,https://clinicaltrials.gov/study/NCT00477529,NCT00477529,Hormone Refractory Prostate Cancer
3114,0.992430581,152.8767727,https://clinicaltrials.gov/study/NCT04630353,NCT04630353,HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
3115,0.959399135,40.79685779,https://clinicaltrials.gov/study/NCT01782053,NCT01782053,Lung Cancer|Heart Disease
3116,0.815833503,8.998141638,https://clinicaltrials.gov/study/NCT00907153,NCT00907153,Polycystic Ovary Syndrome
3117,0.894709263,16.36712709,https://clinicaltrials.gov/study/NCT01533753,NCT01533753,Prostate Cancer
3118,0.998394986,170.6518186,https://clinicaltrials.gov/study/NCT01875653,NCT01875653,Stage IV Melanoma|Stage III Melanoma
3119,0.819384846,9.529684918,https://clinicaltrials.gov/study/NCT01733953,NCT01733953,Cardiovascular Disease|Childhood ALL|Childhood NHL
3120,0.995844711,156.4648847,https://clinicaltrials.gov/study/NCT01658553,NCT01658553,Cancer
3121,0.992982885,153.1974084,https://clinicaltrials.gov/study/NCT01327053,NCT01327053,Basal Cell Carcinoma
3122,0.999393896,193.5924628,https://clinicaltrials.gov/study/NCT04467853,NCT04467853,"Solid Tumors, Adult"
3123,0.998789622,176.5669878,https://clinicaltrials.gov/study/NCT00617253,NCT00617253,Cancer|Renal Cell Carcinoma
3124,0.965089486,50.18226504,https://clinicaltrials.gov/study/NCT00873353,NCT00873353,Metastatic Adenocarcinoma of the Pancreas
3125,0.990507643,151.5443281,https://clinicaltrials.gov/study/NCT00056160,NCT00056160,Multiple Myeloma
3126,0.997518465,159.4302396,https://clinicaltrials.gov/study/NCT02734160,NCT02734160,Metastatic Pancreatic Cancer
3127,0.991414669,151.8756283,https://clinicaltrials.gov/study/NCT00593060,NCT00593060,Colorectal Cancer|Colorectal Adenocarcinoma
3128,0.99619272,155.7602355,https://clinicaltrials.gov/study/NCT02644460,NCT02644460,"Diffuse Intrinsic Pontine Glioma|Brain Tumor, Recurrent|Solid Tumor, Recurrent|Neuroblastoma, Recurrent, Refractory|Ewing Sarcoma, Recurrent, Refractory|Rhabdomyosarcoma, Recurrent, Refractory|Osteosarcoma, Recurrent, Refractory|Rhabdoid Tumor, Recurrent, Refractory"
3129,0.998482874,167.7357143,https://clinicaltrials.gov/study/NCT00968760,NCT00968760,Lymphoma|B-cell Lymphoma
3130,0.998425066,166.4626567,https://clinicaltrials.gov/study/NCT00626860,NCT00626860,Metastatic Melanoma
3131,0.999259193,192.3251053,https://clinicaltrials.gov/study/NCT00023660,NCT00023660,Cervical Cancer
3132,0.777841983,7.769348117,https://clinicaltrials.gov/study/NCT03625960,NCT03625960,"Wart, Genital"
3133,0.915575763,25.47967536,https://clinicaltrials.gov/study/NCT02700360,NCT02700360,Chemotherapy-Induced Neutropenia
3134,0.989037564,150.1924796,https://clinicaltrials.gov/study/NCT01466660,NCT01466660,Lung Neoplasms
3135,0.999400387,198.2145503,https://clinicaltrials.gov/study/NCT00003360,NCT00003360,Colorectal Cancer
3136,0.910862071,23.69517791,https://clinicaltrials.gov/study/NCT01773460,NCT01773460,Metastatic Breast Cancer
3137,0.999614745,181.4743764,https://clinicaltrials.gov/study/NCT01397929,NCT01397929,Solid Organ Tumors
3138,0.978209036,104.8578059,https://clinicaltrials.gov/study/NCT03528629,NCT03528629,Gastric Cancer|Gastro-esophageal Junction (GEJ) Cancer
3139,0.98722559,150.6307771,https://clinicaltrials.gov/study/NCT01301729,NCT01301729,Breast Cancer
3140,0.997482036,162.941112,https://clinicaltrials.gov/study/NCT00610129,NCT00610129,Neuroendocrine Tumors|Metastatic Neuroendocrine Tumors
3141,0.995704166,156.8936087,https://clinicaltrials.gov/study/NCT01579929,NCT01579929,Lung Cancer
3142,0.992806532,152.5521503,https://clinicaltrials.gov/study/NCT00595829,NCT00595829,Polycythemia Vera
3143,0.994628901,154.2075831,https://clinicaltrials.gov/study/NCT00003829,NCT00003829,Leukemia
3144,0.81193031,9.973176863,https://clinicaltrials.gov/study/NCT02685553,NCT02685553,Pancreatic Neuroendocrine Tumors|Clear Cell Renal Carcinoma|Solid Pseudopapillary Tumors of the Pancreas
3145,0.993485325,153.1026984,https://clinicaltrials.gov/study/NCT01666353,NCT01666353,Melanoma|Renal Cell Carcinoma (RCC)|Non-small Cell Lung Cancer (NSCLC)
3146,0.99919356,182.8367178,https://clinicaltrials.gov/study/NCT01384253,NCT01384253,Breast Neoplasms|Peritoneal Neoplasms|Ovarian Neoplasms|Pancreatic Neoplasms|Stomach Neoplasms
3147,0.995697046,155.8342312,https://clinicaltrials.gov/study/NCT00246753,NCT00246753,Prostate Cancer
3148,0.988385402,150.4591215,https://clinicaltrials.gov/study/NCT01286753,NCT01286753,Neoplasms
3149,0.994368735,153.3202094,https://clinicaltrials.gov/study/NCT03599453,NCT03599453,Triple -Negative Breast Cancer|Estrogen Receptor Negative|HER2/Neu Negative|Anatomic Stage IV Breast Cancer AJCC|Progesterone Receptor Negative
3150,0.988798143,150.8722868,https://clinicaltrials.gov/study/NCT00521053,NCT00521053,Melanoma
3151,0.98766688,150.11919,https://clinicaltrials.gov/study/NCT00101153,NCT00101153,Leukemia
3152,0.998694785,183.8236397,https://clinicaltrials.gov/study/NCT00085553,NCT00085553,Solid Neoplasm
3153,0.99937747,191.9788261,https://clinicaltrials.gov/study/NCT00387153,NCT00387153,Cancer
3154,0.936478624,23.8153856,https://clinicaltrials.gov/study/NCT01138553,NCT01138553,Invasive Breast Cancer|Ductal Carcinoma in Situ
3155,0.998477181,176.2122996,https://clinicaltrials.gov/study/NCT03373760,NCT03373760,Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma AJCC v7
3156,0.995411682,154.4769805,https://clinicaltrials.gov/study/NCT03072160,NCT03072160,Medullary Thyroid Cancer (MTC)
3157,0.988755058,151.0005848,https://clinicaltrials.gov/study/NCT04365660,NCT04365660,Osteosarcoma
3158,0.96171487,46.42864195,https://clinicaltrials.gov/study/NCT05014360,NCT05014360,Adenomatous Polyposis Coli
3159,0.997827912,165.3088234,https://clinicaltrials.gov/study/NCT01902160,NCT01902160,Recurrent Adult Hodgkin Lymphoma
3160,0.983471537,105.0510722,https://clinicaltrials.gov/study/NCT01094860,NCT01094860,Leukemia
3161,0.995466569,156.1478991,https://clinicaltrials.gov/study/NCT00091260,NCT00091260,Multiple Myeloma
3162,0.951766708,40.84613933,https://clinicaltrials.gov/study/NCT02078960,NCT02078960,Chronic Myeloid Leukemia
3163,0.991166557,152.0395601,https://clinicaltrials.gov/study/NCT00960960,NCT00960960,Breast Cancer
3164,0.99890282,184.6466531,https://clinicaltrials.gov/study/NCT00005860,NCT00005860,Cancer
3165,0.635666377,3.705253532,https://clinicaltrials.gov/study/NCT02627560,NCT02627560,Postoperative Hemorrhage|Breast Neoplasms|Seroma
3166,0.990449645,150.8233543,https://clinicaltrials.gov/study/NCT01622660,NCT01622660,Bladder Cancer
3167,0.994741132,154.5950358,https://clinicaltrials.gov/study/NCT00602329,NCT00602329,Colorectal Cancer
3168,0.915958034,20.19826946,https://clinicaltrials.gov/study/NCT00255229,NCT00255229,Metastatic Colorectal Cancer
3169,0.973738149,82.54074954,https://clinicaltrials.gov/study/NCT03572829,NCT03572829,Vomiting|Nausea Post Chemotherapy|Head Neck Cancer
3170,0.996128466,159.2664596,https://clinicaltrials.gov/study/NCT00773929,NCT00773929,Solid Tumors
3171,0.943327165,25.87305161,https://clinicaltrials.gov/study/NCT03654729,NCT03654729,Colorectal Cancer|Chemotherapy-induced Peripheral Neuropathy
3172,0.983434816,126.9772539,https://clinicaltrials.gov/study/NCT04989829,NCT04989829,Advanced Solid Tumor
3173,0.997975028,164.0309466,https://clinicaltrials.gov/study/NCT00371553,NCT00371553,Relapsed or Cisplatin-Refractory Germ Cell Cancer
3174,0.983242672,102.6871862,https://clinicaltrials.gov/study/NCT00003453,NCT00003453,Stage IV Adrenocortical Carcinoma
3175,0.734129875,7.150629468,https://clinicaltrials.gov/study/NCT00302653,NCT00302653,Hyperuricemia
3176,0.998834816,177.5410817,https://clinicaltrials.gov/study/NCT00147953,NCT00147953,Non-Hodgkin's Lymphoma
3177,0.998876652,187.0968835,https://clinicaltrials.gov/study/NCT00496353,NCT00496353,Neoplasm
3178,0.985544009,150.478462,https://clinicaltrials.gov/study/NCT02903160,NCT02903160,Prostate Cancer
3179,0.923625384,20.99057786,https://clinicaltrials.gov/study/NCT00078260,NCT00078260,Non-Small Cell Lung Cancer
3180,0.984743054,150.1378622,https://clinicaltrials.gov/study/NCT02693860,NCT02693860,Prostate Cancer
3181,0.990328937,151.2659084,https://clinicaltrials.gov/study/NCT00157560,NCT00157560,Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer
3182,0.978572607,104.186131,https://clinicaltrials.gov/study/NCT00063960,NCT00063960,Colorectal Cancer|Metastatic Cancer
3183,0.993602167,153.2354947,https://clinicaltrials.gov/study/NCT01575860,NCT01575860,Lymphoma
3184,0.999119538,194.3521482,https://clinicaltrials.gov/study/NCT00630760,NCT00630760,Refractory Malignancies
3185,0.983764166,132.3340129,https://clinicaltrials.gov/study/NCT01253460,NCT01253460,Leukemia
3186,0.999371219,193.7204637,https://clinicaltrials.gov/study/NCT03516760,NCT03516760,Acute Myeloid Leukemia|Relapsed AML|Refractory AML
3187,0.997661969,166.8669618,https://clinicaltrials.gov/study/NCT00004860,NCT00004860,Colorectal Cancer
3188,0.99403193,153.2402766,https://clinicaltrials.gov/study/NCT02673060,NCT02673060,Bone Metastasis
3189,0.941819182,33.00787434,https://clinicaltrials.gov/study/NCT00531960,NCT00531960,Non-Small Cell Lung Cancer
3190,0.994744979,153.9496079,https://clinicaltrials.gov/study/NCT02992860,NCT02992860,Myelodysplastic Syndrome (MDS)|Acute Myeloid Leukemia (AML)
3191,0.988224007,145.1072955,https://clinicaltrials.gov/study/NCT01499160,NCT01499160,Breast Neoplasms|Endocrine Breast Diseases|Neoplasm Metastasis
3192,0.99929527,188.004694,https://clinicaltrials.gov/study/NCT02488629,NCT02488629,Head and Neck Squamous Cell Carcinoma
3193,0.999007352,180.8729329,https://clinicaltrials.gov/study/NCT04631029,NCT04631029,Extensive Stage Lung Small Cell Carcinoma|Malignant Solid Neoplasm|Metastatic Malignant Neoplasm in the Brain
3194,0.935420524,26.27085655,https://clinicaltrials.gov/study/NCT01660529,NCT01660529,Metastatic Breast Cancer
3195,0.992242525,152.217868,https://clinicaltrials.gov/study/NCT04166929,NCT04166929,Acute Myeloid Leukemia|Myelodysplasia
3196,0.998098168,170.8815722,https://clinicaltrials.gov/study/NCT00006453,NCT00006453,Ovarian Cancer
3197,0.998281968,175.4010608,https://clinicaltrials.gov/study/NCT00714753,NCT00714753,Prostate Cancer
3198,0.990853102,151.6381964,https://clinicaltrials.gov/study/NCT00193453,NCT00193453,Lung Cancer
3199,0.967242375,66.5780116,https://clinicaltrials.gov/study/NCT00587353,NCT00587353,Tobacco Use Disorder
3200,0.994468434,154.3880132,https://clinicaltrials.gov/study/NCT03444753,NCT03444753,Advanced Cancer
3201,0.976161468,85.76947729,https://clinicaltrials.gov/study/NCT01836653,NCT01836653,Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer
3202,0.997663808,161.1992771,https://clinicaltrials.gov/study/NCT02298153,NCT02298153,NSCLC (Non-small Cell Lung Carcinoma)|UC (Urothelial Cancer)
3203,0.997456977,161.8183422,https://clinicaltrials.gov/study/NCT01676753,NCT01676753,Advanced or Metastatic Breast Cancer|Triple Negative Breast Cancer
3204,0.994340236,153.0099211,https://clinicaltrials.gov/study/NCT00098553,NCT00098553,Melanoma (Skin)
3205,0.841937327,13.55454482,https://clinicaltrials.gov/study/NCT02745353,NCT02745353,Constipation
3206,0.981854561,129.8008105,https://clinicaltrials.gov/study/NCT03817853,NCT03817853,Advanced Follicular Lymphoma
3207,0.975422524,74.2320963,https://clinicaltrials.gov/study/NCT02597153,NCT02597153,Relapsed Cutaneous T Cell Lymphom
3208,0.958927633,50.50303798,https://clinicaltrials.gov/study/NCT01743560,NCT01743560,Oestrogen Receptor Positive Advanced Breast Cancer
3209,0.99473365,153.2890784,https://clinicaltrials.gov/study/NCT00140660,NCT00140660,Diffuse Large Cell Lymphoma
3210,0.926013678,23.32805855,https://clinicaltrials.gov/study/NCT03677960,NCT03677960,"HSIL, High-Grade Squamous Intraepithelial Lesions|Human Papilloma Virus Infection|HIV Infection|Anal Cancer|Anus Neoplasm"
3211,0.995956865,158.4576516,https://clinicaltrials.gov/study/NCT01636960,NCT01636960,Malignant Melanoma
3212,0.994993003,152.6987953,https://clinicaltrials.gov/study/NCT02080260,NCT02080260,Pancreatic Cancer
3213,0.991866689,152.951928,https://clinicaltrials.gov/study/NCT01090960,NCT01090960,Solid Cancers
3214,0.998809908,183.673346,https://clinicaltrials.gov/study/NCT00645060,NCT00645060,"Unspecified Adult Solid Tumor, Protocol Specific"
3215,0.866728081,13.2118622,https://clinicaltrials.gov/study/NCT02017860,NCT02017860,Neoplasms
3216,0.974627688,80.83096814,https://clinicaltrials.gov/study/NCT01874860,NCT01874860,Colorectal Cancer|Head and Neck Cancer
3217,0.99889941,178.8964945,https://clinicaltrials.gov/study/NCT00652860,NCT00652860,Metastatic Cancer|Sarcoma
3218,0.936954277,29.96495112,https://clinicaltrials.gov/study/NCT01339260,NCT01339260,Chemotherapy-Induced Nausea and Vomiting
3219,0.984624387,129.8772298,https://clinicaltrials.gov/study/NCT00529360,NCT00529360,Acute Lymphoblastic Leukemia|Acute Myelogenous Leukemia
3220,0.997276844,164.7390298,https://clinicaltrials.gov/study/NCT03680560,NCT03680560,Solid Tumor|HER-2 Protein Overexpression
3221,0.978836836,84.13375766,https://clinicaltrials.gov/study/NCT00619060,NCT00619060,Healthy
3222,0.996765631,159.9415551,https://clinicaltrials.gov/study/NCT00331760,NCT00331760,Cervical Cancer|Endometrial Cancer
3223,0.998856404,180.6340267,https://clinicaltrials.gov/study/NCT00466960,NCT00466960,Brenner Tumor|Fallopian Tube Cancer|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mixed Epithelial Carcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Adenocarcinoma|Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
3224,0.99212894,151.6866008,https://clinicaltrials.gov/study/NCT04436029,NCT04436029,Myeloma Multiple
3225,0.992152757,151.8444972,https://clinicaltrials.gov/study/NCT00328510,NCT00328510,Patients Receiving Fractionated Stereotactic Radiotherapy|for Brain Tumors
3226,0.982488514,122.9331436,https://clinicaltrials.gov/study/NCT02660710,NCT02660710,Diffuse Large B-cell Lymphoma|HIV
3227,0.979778896,111.0159363,https://clinicaltrials.gov/study/NCT01515046,NCT01515046,Pancreatic Neoplasms|Pancreatic Cancer
3228,0.998836633,182.6925266,https://clinicaltrials.gov/study/NCT00064246,NCT00064246,Post-transplant Lymphoproliferative Disorder|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Waldenstrm Macroglobulinemia
3229,0.879175878,13.63887525,https://clinicaltrials.gov/study/NCT01503346,NCT01503346,Non-organic Loss of Appetite
3230,0.979378245,105.7966175,https://clinicaltrials.gov/study/NCT00511446,NCT00511446,Stomach Neoplasms
3231,0.987868924,150.3457153,https://clinicaltrials.gov/study/NCT01330446,NCT01330446,Head And Neck Cancer|Fatigue
3232,0.998868277,182.426556,https://clinicaltrials.gov/study/NCT00075946,NCT00075946,Lymphoma
3233,0.99425094,154.212586,https://clinicaltrials.gov/study/NCT02564146,NCT02564146,Metastatic Pancreatic Cancer|Adenocarcinoma of the Pancreas
3234,0.991210617,151.315382,https://clinicaltrials.gov/study/NCT03639246,NCT03639246,Ovarian Cancer
3235,0.954431814,38.77239656,https://clinicaltrials.gov/study/NCT00840346,NCT00840346,Acute Myeloblastic Leukaemia
3236,0.998625565,171.7900038,https://clinicaltrials.gov/study/NCT00023946,NCT00023946,Adult Primary Cholangiocellular Carcinoma|Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Localized Extrahepatic Bile Duct Cancer|Localized Gallbladder Cancer|Localized Resectable Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
3237,0.998088579,170.6699913,https://clinicaltrials.gov/study/NCT00005646,NCT00005646,Lung Cancer
3238,0.874467203,12.53395543,https://clinicaltrials.gov/study/NCT02292446,NCT02292446,Polycythemia Vera
3239,0.992314303,151.8859196,https://clinicaltrials.gov/study/NCT03566446,NCT03566446,"Myeloproliferative Neoplasm, Unclassifiable|Essential Thrombocythemia|Myelofibrosis"
3240,0.982705103,121.2473595,https://clinicaltrials.gov/study/NCT00863746,NCT00863746,Carcinoma|Non-Small-Cell Lung
3241,0.99534996,155.7377773,https://clinicaltrials.gov/study/NCT01441973,NCT01441973,Smoldering Multiple Myeloma
3242,0.957324309,54.33186225,https://clinicaltrials.gov/study/NCT00002473,NCT00002473,Kidney Cancer
3243,0.995026429,156.0727623,https://clinicaltrials.gov/study/NCT00373373,NCT00373373,Acute Myeloid Leukemia
3244,0.99101494,151.1679335,https://clinicaltrials.gov/study/NCT00964873,NCT00964873,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Blast-phase Chronic Myelogenous Leukemia|AML|ALL|CML
3245,0.972254394,63.37867128,https://clinicaltrials.gov/study/NCT01243073,NCT01243073,Essential Thrombocythemia|Polycythemia Vera
3246,0.943815583,32.64725664,https://clinicaltrials.gov/study/NCT01507064,NCT01507064,Hepatocellular Carcinoma
3247,0.995845623,156.4176776,https://clinicaltrials.gov/study/NCT03366064,NCT03366064,Non-small Cell Lung Cancer
3248,0.989632971,151.0565211,https://clinicaltrials.gov/study/NCT00217464,NCT00217464,Prostate Cancer
3249,0.967324496,58.02195378,https://clinicaltrials.gov/study/NCT01718873,NCT01718873,Colorectal Cancer
3250,0.989541328,151.0145442,https://clinicaltrials.gov/study/NCT01746173,NCT01746173,T-cell Non-Hodgkin Lymphoma
3251,0.998881907,184.5800319,https://clinicaltrials.gov/study/NCT00216164,NCT00216164,"Lymphoma, B-Cell"
3252,0.997931191,165.2641754,https://clinicaltrials.gov/study/NCT01664910,NCT01664910,Hematopoietic and Lymphoid Cell Neoplasm
3253,0.795949628,9.336061052,https://clinicaltrials.gov/study/NCT00415246,NCT00415246,Prostate Cancer
3254,0.973074866,91.87925963,https://clinicaltrials.gov/study/NCT03928210,NCT03928210,Breast Cancer|Circulating Tumor Cells (CTCs)
3255,0.982315602,113.2513215,https://clinicaltrials.gov/study/NCT01807546,NCT01807546,Head and Neck Squamous Cell Carcinoma|Anal Squamous Cell Carcinoma|Lung Squamous Cell Carcinoma|Cervical Squamous Cell Carcinoma|Esophageal Squamous Cell Carcinoma|Skin Squamous Cell Carcinoma|Penile Squamous Cell Carcinoma
3256,0.980185927,98.7674731,https://clinicaltrials.gov/study/NCT02568046,NCT02568046,Metastatic Colorectal Cancer
3257,0.99528501,155.2273459,https://clinicaltrials.gov/study/NCT00985946,NCT00985946,Neuroendocrine Tumors
3258,0.987132157,150.198299,https://clinicaltrials.gov/study/NCT00602446,NCT00602446,Breast Cancer|Iron Overload|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Neuroblastoma|Ovarian Cancer
3259,0.948217616,38.01481624,https://clinicaltrials.gov/study/NCT03299946,NCT03299946,Locally Advanced Hepatocellular Carcinoma
3260,0.999267618,196.247681,https://clinicaltrials.gov/study/NCT00425646,NCT00425646,Lung Cancer
3261,0.999491116,183.85716,https://clinicaltrials.gov/study/NCT00003846,NCT00003846,Brain and Central Nervous System Tumors|Neuroblastoma
3262,0.981215878,94.28851794,https://clinicaltrials.gov/study/NCT00252746,NCT00252746,Non Small Cell Lung Carcinoma
3263,0.997044259,161.1679556,https://clinicaltrials.gov/study/NCT01688973,NCT01688973,Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma
3264,0.95795288,46.91151842,https://clinicaltrials.gov/study/NCT01664273,NCT01664273,Metastatic Malignant Neoplasm
3265,0.99482173,155.6062393,https://clinicaltrials.gov/study/NCT00026273,NCT00026273,Colorectal Cancer
3266,0.972036788,61.73560458,https://clinicaltrials.gov/study/NCT00439673,NCT00439673,Myelodysplastic Syndromes
3267,0.975363923,94.03349391,https://clinicaltrials.gov/study/NCT03930173,NCT03930173,Secondary Malignant Neoplasm of Brain and Cerebral Meninges
3268,0.996156724,156.5527533,https://clinicaltrials.gov/study/NCT00979173,NCT00979173,Glioma
3269,0.997911464,163.3806718,https://clinicaltrials.gov/study/NCT00004873,NCT00004873,Gastric Cancer
3270,0.992335284,152.0585702,https://clinicaltrials.gov/study/NCT01219673,NCT01219673,Head And Neck Cancer
3271,0.992955131,152.1271035,https://clinicaltrials.gov/study/NCT00216073,NCT00216073,Metastatic Breast Cancer
3272,0.998058013,173.5715392,https://clinicaltrials.gov/study/NCT03941873,NCT03941873,"Carcinoma, Hepatocellular|Gastric/Gastroesophageal Junction Cancer"
3273,0.997762672,166.0048614,https://clinicaltrials.gov/study/NCT01093573,NCT01093573,Untreated Adult Acute Myeloid Leukemia
3274,0.999298445,189.0560365,https://clinicaltrials.gov/study/NCT00087373,NCT00087373,Recurrent Melanoma|Stage IV Melanoma
3275,0.989891178,151.2544437,https://clinicaltrials.gov/study/NCT01387373,NCT01387373,Metastatic Breast Cancer|Liver Metastases
3276,0.989821876,151.5692395,https://clinicaltrials.gov/study/NCT02183246,NCT02183246,Head and Neck Neoplasms
3277,0.991438807,151.3041601,https://clinicaltrials.gov/study/NCT03556046,NCT03556046,Clear Cell Renal Carcinoma
3278,0.981833923,127.192118,https://clinicaltrials.gov/study/NCT04345146,NCT04345146,Non-small Cell Lung Cancer
3279,0.999337235,180.2860045,https://clinicaltrials.gov/study/NCT01031446,NCT01031446,Breast Cancer
3280,0.972129033,73.88810387,https://clinicaltrials.gov/study/NCT01403246,NCT01403246,Chronic Lymphocytic Leukemia
3281,0.953713418,48.12566504,https://clinicaltrials.gov/study/NCT01713946,NCT01713946,Tuberous Sclerosis Complex-associated Refractory Seizures
3282,0.998936429,181.030574,https://clinicaltrials.gov/study/NCT00394446,NCT00394446,Refractory Solid Tumors
3283,0.99778451,166.5087379,https://clinicaltrials.gov/study/NCT00959946,NCT00959946,Advanced Breast Cancer (Parts 1 and 2)|Advanced Pancreatic Cancer (Part 1)|Advanced Colorectal Cancer (Part 1)|Advanced Cholangiocarcinoma (Part 1)|Advanced Glioblastoma Multiforme (Part 1)
3284,0.999229344,196.5328062,https://clinicaltrials.gov/study/NCT00036946,NCT00036946,"Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific"
3285,0.997833875,167.6641614,https://clinicaltrials.gov/study/NCT00268346,NCT00268346,Esophageal Cancer
3286,0.991429206,151.2621048,https://clinicaltrials.gov/study/NCT01716546,NCT01716546,Gastric Cancer
3287,0.99673699,159.8575963,https://clinicaltrials.gov/study/NCT01738646,NCT01738646,Recurrent Glioblastoma Multiforme|Malignant Glioma|Adult Brain Tumor
3288,0.849162653,16.42193574,https://clinicaltrials.gov/study/NCT02852473,NCT02852473,Cancer
3289,0.994708033,154.107122,https://clinicaltrials.gov/study/NCT02429973,NCT02429973,Osteosarcoma
3290,0.874643787,12.64357963,https://clinicaltrials.gov/study/NCT00533273,NCT00533273,Advanced Dupuytren's Disease
3291,0.996726306,155.2181358,https://clinicaltrials.gov/study/NCT00416273,NCT00416273,Multiple Myeloma
3292,0.944250814,29.91760789,https://clinicaltrials.gov/study/NCT01279473,NCT01279473,Chronic Myelogenous Leukemia|Acute Lymphoblastic Leukemia
3293,0.986749355,146.3807795,https://clinicaltrials.gov/study/NCT05708573,NCT05708573,Healthy Participants
3294,0.998451205,169.3235923,https://clinicaltrials.gov/study/NCT00002973,NCT00002973,Melanoma (Skin)
3295,0.999269073,189.7133717,https://clinicaltrials.gov/study/NCT04819373,NCT04819373,"Tumor, Solid"
3296,0.964913813,48.57906721,https://clinicaltrials.gov/study/NCT03332173,NCT03332173,Waldenstrm's Macroglobulinemia (WM)
3297,0.954435354,50.93117453,https://clinicaltrials.gov/study/NCT00737373,NCT00737373,Gastric Cancer|Adenocarcinoma of the Esophagogastric Junction
3298,0.904472692,19.62656274,https://clinicaltrials.gov/study/NCT00642473,NCT00642473,Non-Squamous Non-Small Cell Lung Cancer
3299,0.913561751,21.74733509,https://clinicaltrials.gov/study/NCT02127073,NCT02127073,Breast Cancer|Ductal Carcinoma in Situ
3300,0.959337707,44.99140321,https://clinicaltrials.gov/study/NCT00055146,NCT00055146,"Leukemia, Lymphocytic, Chronic"
3301,0.874894861,12.24872049,https://clinicaltrials.gov/study/NCT00241046,NCT00241046,Metastatic Breast Cancer
3302,0.996715406,156.7566545,https://clinicaltrials.gov/study/NCT00697346,NCT00697346,B-cell Follicular Lymphoma|B-cell Marginal Zone Lymphoma|Diffuse Large B-cell Lymphoma|B-cell Mantle Cell Lymphoma|B-cell Small Lymphocytic Lymphoma|B-Cell Chronic Lymphocytic Leukemia|Multiple Myeloma|Waldenstrom's Macroglobulinemia|Noncutaneous Peripheral T-cell Lymphoma Not Otherwise Specified|Angioimmunoblastic T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Enteropathy Associated T-cell Lymphoma|NK Lymphoma
3303,0.999518804,192.6520377,https://clinicaltrials.gov/study/NCT00004246,NCT00004246,Head and Neck Cancer
3304,0.984256471,118.4288958,https://clinicaltrials.gov/study/NCT00662246,NCT00662246,"Carcinoma, Hepatocellular"
3305,0.953133338,45.97717495,https://clinicaltrials.gov/study/NCT01815346,NCT01815346,Breast Cancer
3306,0.777775412,8.462157784,https://clinicaltrials.gov/study/NCT03448146,NCT03448146,Nsclc
3307,0.998820415,175.046039,https://clinicaltrials.gov/study/NCT00126646,NCT00126646,Leukemia|Lymphoma
3308,0.999515738,179.4663764,https://clinicaltrials.gov/study/NCT02172846,NCT02172846,"Carcinoma, Non-Small-Cell Lung"
3309,0.999033853,187.4455366,https://clinicaltrials.gov/study/NCT00003646,NCT00003646,Stage IV Melanoma|Stage III Melanoma|Recurrent Melanoma
3310,0.995734495,158.5791148,https://clinicaltrials.gov/study/NCT00683046,NCT00683046,"Acute Myelogenous Leukemia|Lymphoid Leukemia|Chronic Myelogenous Leukemia|Malignant Lymphoma|Hodgkin's Disease|Chronic Lymphocytic Leukemia|Myeloproliferative Disorder|Anemia, Aplastic|Myelodysplastic Syndromes"
3311,0.918752641,27.80924267,https://clinicaltrials.gov/study/NCT00495846,NCT00495846,Advanced Hepatocellular Carcinoma
3312,0.99906733,183.6705505,https://clinicaltrials.gov/study/NCT01417546,NCT01417546,"Epithelial Neoplasms, Malignant|Epithelial Tumors, Malignant|Malignant Mesenchymal Tumor"
3313,0.998640544,183.1364863,https://clinicaltrials.gov/study/NCT00337246,NCT00337246,Leukemia
3314,0.966328767,50.909856,https://clinicaltrials.gov/study/NCT01269346,NCT01269346,Breast Cancer
3315,0.998646101,182.9421256,https://clinicaltrials.gov/study/NCT00002773,NCT00002773,Pancreatic Cancer
3316,0.988644553,150.2691779,https://clinicaltrials.gov/study/NCT00866073,NCT00866073,Acute Myeloid Leukemia
3317,0.942719589,36.05679532,https://clinicaltrials.gov/study/NCT01497873,NCT01497873,Small Cell Lung Cancer
3318,0.998951061,183.8630929,https://clinicaltrials.gov/study/NCT03451773,NCT03451773,Cancer of Pancreas|Pancreas Cancer|Pancreatic Adenocarcinoma|Pancreatic Cancer|Pancreatic Neoplasms
3319,0.999574844,184.7257509,https://clinicaltrials.gov/study/NCT02474173,NCT02474173,Advanced Breast Carcinoma|Metastatic Breast Carcinoma|Stage III Breast Cancer AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Triple-Negative Breast Carcinoma
3320,0.999237334,190.8311477,https://clinicaltrials.gov/study/NCT01935973,NCT01935973,Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mixed Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Undifferentiated Carcinoma|Recurrent Uterine Corpus Cancer
3321,0.996704427,159.7527028,https://clinicaltrials.gov/study/NCT01525446,NCT01525446,Non-small Cell Lung Cancer
3322,0.889581923,15.17818965,https://clinicaltrials.gov/study/NCT02166346,NCT02166346,Transverse Myelitis|Neuromyelitis Optica|Idiopathic Transverse Myelitis|Myelitis NOS
3323,0.982083306,89.34528926,https://clinicaltrials.gov/study/NCT01187446,NCT01187446,Cutaneous Lymphoma|Cutaneous T-cell Lymphoma
3324,0.991367063,151.0542702,https://clinicaltrials.gov/study/NCT01962246,NCT01962246,Gastroesophageal Junction Adenocarcinoma
3325,0.985076588,136.605381,https://clinicaltrials.gov/study/NCT01613846,NCT01613846,Renal Cell Carcinoma
3326,0.995518541,156.6250168,https://clinicaltrials.gov/study/NCT00001446,NCT00001446,Prostatic Neoplasm
3327,0.986805153,139.9748727,https://clinicaltrials.gov/study/NCT00871546,NCT00871546,"Lymphoma, Mantle-Cell|Leukemia, Lymphocytic, Chronic, B-Cell"
3328,0.998725142,176.0481409,https://clinicaltrials.gov/study/NCT00030446,NCT00030446,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
3329,0.99178653,152.3170978,https://clinicaltrials.gov/study/NCT00054873,NCT00054873,Esophageal Neoplasms|Stomach Neoplasms|Adenocarcinoma
3330,0.994494286,153.7046761,https://clinicaltrials.gov/study/NCT02457273,NCT02457273,Neuroendocrine Carcinomas
3331,0.968806988,63.32441615,https://clinicaltrials.gov/study/NCT03770273,NCT03770273,Indolent Systemic Mastocytosis
3332,0.998711351,175.2434395,https://clinicaltrials.gov/study/NCT00463073,NCT00463073,Malignant Gliomas
3333,0.90869118,21.13744615,https://clinicaltrials.gov/study/NCT02518373,NCT02518373,Colorectal Cancer
3334,0.988053119,150.4425921,https://clinicaltrials.gov/study/NCT00452673,NCT00452673,Advanced Breast Cancer
3335,0.96333518,55.67653303,https://clinicaltrials.gov/study/NCT02822573,NCT02822573,Cognitive Dysfunction|Memory Impairment
3336,0.947074097,38.08043483,https://clinicaltrials.gov/study/NCT02839473,NCT02839473,Breast Cancer|Radiation Dermatitis
3337,0.976066987,69.15712584,https://clinicaltrials.gov/study/NCT03209973,NCT03209973,Classical Hodgkin Lymphoma
3338,0.980844575,70.34954676,https://clinicaltrials.gov/study/NCT00058773,NCT00058773,Hodgkin Disease|Non-Hodgkins Lymphoma
3339,0.990344214,150.8220618,https://clinicaltrials.gov/study/NCT03945773,NCT03945773,Locally Advanced or Metastatic Renal Cell Carcinoma
3340,0.993125999,152.5671149,https://clinicaltrials.gov/study/NCT00440973,NCT00440973,"Carcinoma, Renal Cell"
3341,0.999236492,194.1883606,https://clinicaltrials.gov/study/NCT03463473,NCT03463473,Advanced Solid Tumors
3342,0.979267425,94.38640159,https://clinicaltrials.gov/study/NCT02273973,NCT02273973,Breast Cancer
3343,0.997629829,165.4070473,https://clinicaltrials.gov/study/NCT00708773,NCT00708773,Advanced Cancer
3344,0.982977898,118.8207173,https://clinicaltrials.gov/study/NCT00251446,NCT00251446,Non-Small Cell Lung Cancer
3345,0.985264678,150.037626,https://clinicaltrials.gov/study/NCT00871910,NCT00871910,"Solid Tumors|Lymphoma, Non-Hodgkin|Multiple Myeloma"
3346,0.985813021,115.0230304,https://clinicaltrials.gov/study/NCT01204710,NCT01204710,Prostate Cancer
3347,0.97771817,82.56181785,https://clinicaltrials.gov/study/NCT03195010,NCT03195010,"Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|B-Cell Non-Hodgkin Lymphoma|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematologic and Lymphocytic Disorder|Hematopoietic Cell Transplantation Recipient|Myelodysplastic Syndrome|Primary Myelofibrosis|Secondary Myelofibrosis|T-Cell Non-Hodgkin Lymphoma|Thrombocytopenia|Venous Thromboembolism"
3348,0.967723788,75.94173849,https://clinicaltrials.gov/study/NCT01063946,NCT01063946,"Neoplasms, Malignant"
3349,0.987254975,148.4209919,https://clinicaltrials.gov/study/NCT02204046,NCT02204046,Adenocarcinoma
3350,0.99786496,160.6644946,https://clinicaltrials.gov/study/NCT02471846,NCT02471846,Solid Tumor
3351,0.997984827,170.1584876,https://clinicaltrials.gov/study/NCT00066846,NCT00066846,Colorectal Cancer
3352,0.997842201,166.705211,https://clinicaltrials.gov/study/NCT00996346,NCT00996346,Sarcoma
3353,0.988525943,150.4038603,https://clinicaltrials.gov/study/NCT02860546,NCT02860546,Refractory Metastatic Colorectal Cancer
3354,0.970954982,72.54839779,https://clinicaltrials.gov/study/NCT00088946,NCT00088946,Bladder Cancer
3355,0.884175488,14.89150407,https://clinicaltrials.gov/study/NCT01890746,NCT01890746,Acute Leukaemia
3356,0.997547576,165.1273508,https://clinicaltrials.gov/study/NCT00615446,NCT00615446,Solid Tumors
3357,0.997757679,164.5461518,https://clinicaltrials.gov/study/NCT00610246,NCT00610246,Cancer
3358,0.997489235,164.1152564,https://clinicaltrials.gov/study/NCT00330746,NCT00330746,Advanced Non-Small Cell Lung Cancer
3359,0.958762338,47.49265511,https://clinicaltrials.gov/study/NCT01304446,NCT01304446,Malnutrition|Cancer
3360,0.89051749,17.98787455,https://clinicaltrials.gov/study/NCT05411146,NCT05411146,Healthy Participants
3361,0.999570961,187.1841884,https://clinicaltrials.gov/study/NCT00021346,NCT00021346,"Unspecified Adult Solid Tumor, Protocol Specific"
3362,0.996712696,159.2766936,https://clinicaltrials.gov/study/NCT00580073,NCT00580073,Rectal Cancer
3363,0.995239244,153.5044999,https://clinicaltrials.gov/study/NCT01090973,NCT01090973,Non-Hodgkin's Lymphoma
3364,0.997231538,162.1151174,https://clinicaltrials.gov/study/NCT00057473,NCT00057473,Neoplasms
3365,0.989116052,150.8120025,https://clinicaltrials.gov/study/NCT01562873,NCT01562873,Breast Cancer
3366,0.992304787,151.3505761,https://clinicaltrials.gov/study/NCT02791373,NCT02791373,Multiple Myeloma|Amyloidosis
3367,0.990721072,151.251683,https://clinicaltrials.gov/study/NCT02641873,NCT02641873,Metastatic Colorectal Cancer
3368,0.992603648,152.5165812,https://clinicaltrials.gov/study/NCT03925246,NCT03925246,High Grade Glioma|Brain Cancer
3369,0.988822799,150.0167563,https://clinicaltrials.gov/study/NCT00112346,NCT00112346,Non-Small-Cell Lung Carcinoma
3370,0.997411367,162.460602,https://clinicaltrials.gov/study/NCT00514046,NCT00514046,Medullary Thyroid Carcinoma|Multiple Endocrine Neoplasia Type 2A|Multiple Endocrine Neoplasia Type 2B
3371,0.972821533,74.27387144,https://clinicaltrials.gov/study/NCT00031746,NCT00031746,Prostate Cancer
3372,0.9192997,24.90062203,https://clinicaltrials.gov/study/NCT00400946,NCT00400946,Drug/Agent Toxicity by Tissue/Organ|Leukemia
3373,0.997850369,164.8678072,https://clinicaltrials.gov/study/NCT00430846,NCT00430846,"Lymphoma, Non-Hodgkin|Disease, Hodgkin|Lymphoma, Large-Cell, Anaplastic"
3374,0.997985137,169.1355842,https://clinicaltrials.gov/study/NCT00576446,NCT00576446,Malignant Glioma
3375,0.961719927,47.18647148,https://clinicaltrials.gov/study/NCT00243646,NCT00243646,Prostate Cancer
3376,0.545853264,3.280490004,https://clinicaltrials.gov/study/NCT00519246,NCT00519246,"Pain, Postoperative|Mastectomy"
3377,0.982966162,126.115275,https://clinicaltrials.gov/study/NCT00447473,NCT00447473,Prostatic Neoplasms
3378,0.99973929,181.5343857,https://clinicaltrials.gov/study/NCT00014573,NCT00014573,Brain and Central Nervous System Tumors
3379,0.996002257,155.8878459,https://clinicaltrials.gov/study/NCT04035473,NCT04035473,Solid Tumor
3380,0.997127226,160.1079479,https://clinicaltrials.gov/study/NCT02667873,NCT02667873,Solid Tumors
3381,0.999365891,190.421565,https://clinicaltrials.gov/study/NCT00093873,NCT00093873,Tumors
3382,0.995499013,157.2759801,https://clinicaltrials.gov/study/NCT00005873,NCT00005873,Breast Cancer
3383,0.990179357,151.4907655,https://clinicaltrials.gov/study/NCT00490373,NCT00490373,Pancreatic Cancer
3384,0.976519137,87.30072005,https://clinicaltrials.gov/study/NCT01313273,NCT01313273,Prostate Cancer
3385,0.998585259,174.7911825,https://clinicaltrials.gov/study/NCT03735446,NCT03735446,Acute Myeloid Leukemia|Myelodysplastic Syndromes
3386,0.990933611,151.5755669,https://clinicaltrials.gov/study/NCT00022646,NCT00022646,Lung Cancer
3387,0.829320792,10.71343437,https://clinicaltrials.gov/study/NCT01788046,NCT01788046,"Hyperparathyroidism, Secondary"
3388,0.994004475,154.2101867,https://clinicaltrials.gov/study/NCT03202446,NCT03202446,"Breast Cancer Stage IIIA|Breast Cancer, Stage IIIB|Breast Cancer Stage IV"
3389,0.983600166,117.2184309,https://clinicaltrials.gov/study/NCT01853046,NCT01853046,Neoplasms
3390,0.988697473,151.3246943,https://clinicaltrials.gov/study/NCT03579446,NCT03579446,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm
3391,0.996246583,157.1956557,https://clinicaltrials.gov/study/NCT02045446,NCT02045446,Stage IV Non-Small Cell Lung Cancer
3392,0.997960749,167.0634326,https://clinicaltrials.gov/study/NCT03083873,NCT03083873,Squamous Cell Carcinoma of the Head and Neck
3393,0.99741123,161.9869645,https://clinicaltrials.gov/study/NCT00262873,NCT00262873,Myelodysplastic Syndromes
3394,0.995967227,158.1487909,https://clinicaltrials.gov/study/NCT01526473,NCT01526473,HER2+ Cancer
3395,0.994414354,153.0851669,https://clinicaltrials.gov/study/NCT00070473,NCT00070473,"Unspecified Childhood Solid Tumor, Protocol Specific"
3396,0.999172359,190.0975931,https://clinicaltrials.gov/study/NCT00569673,NCT00569673,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
3397,0.997766914,166.9472575,https://clinicaltrials.gov/study/NCT01029873,NCT01029873,Metastatic Melanoma
3398,0.991859907,152.0438851,https://clinicaltrials.gov/study/NCT00279773,NCT00279773,Acute Myeloid Leukemia
3399,0.984946429,132.2828208,https://clinicaltrials.gov/study/NCT00807573,NCT00807573,Lung Cancer
3400,0.917493615,23.10921457,https://clinicaltrials.gov/study/NCT01831973,NCT01831973,Advanced/Metastasis Renal Cell Carcinoma
3401,0.996696078,159.6176723,https://clinicaltrials.gov/study/NCT00331773,NCT00331773,Prostate Cancer
3402,0.993664598,153.8399603,https://clinicaltrials.gov/study/NCT03349073,NCT03349073,Advanced Refractory Solid Tumors
3403,0.988619105,131.1831029,https://clinicaltrials.gov/study/NCT00170573,NCT00170573,Ovarian Cancer
3404,0.996445053,158.2811624,https://clinicaltrials.gov/study/NCT03542773,NCT03542773,Schwannomas|Malignant Tumors
3405,0.996929363,158.8482884,https://clinicaltrials.gov/study/NCT03425773,NCT03425773,Stomach Neoplasms
3406,0.997227152,161.3252278,https://clinicaltrials.gov/study/NCT01204073,NCT01204073,"Advanced Nonhematologic Malignancies|Carcinoma, Basal Cell"
3407,0.99677557,158.3486047,https://clinicaltrials.gov/study/NCT03780010,NCT03780010,Non Small Cell Lung Cancer
3408,0.866692464,15.52659428,https://clinicaltrials.gov/study/NCT05252546,NCT05252546,HER2-positive Recurrent / Metastatic Breast Cancer
3409,0.99603721,157.659406,https://clinicaltrials.gov/study/NCT00482846,NCT00482846,Mucositis|Multiple Myeloma
3410,0.771113515,8.987560318,https://clinicaltrials.gov/study/NCT00762346,NCT00762346,Non Small Cell Lung Cancer|Bone Metastases|High NTX Level
3411,0.96479863,52.60251947,https://clinicaltrials.gov/study/NCT01581346,NCT01581346,Non Small Cell Lung Cancer
3412,0.999177139,188.4595375,https://clinicaltrials.gov/study/NCT01828346,NCT01828346,Myelodysplastic Syndrome
3413,0.990073292,152.0066546,https://clinicaltrials.gov/study/NCT01138046,NCT01138046,"Neoplasms, Breast"
3414,0.99710536,163.4113592,https://clinicaltrials.gov/study/NCT01989546,NCT01989546,Advanced Ovarian Cancer|Primary Peritoneal Cancer|Advanced Breast Cancer|Advanced Solid Tumors
3415,0.996394776,158.0577087,https://clinicaltrials.gov/study/NCT02154646,NCT02154646,Pancreatic Neoplasms
3416,0.998486255,176.1715985,https://clinicaltrials.gov/study/NCT01287546,NCT01287546,Advanced Cancer
3417,0.996964446,161.5355087,https://clinicaltrials.gov/study/NCT01842646,NCT01842646,Myelodysplastic Syndrome (MDS)|Chronic Myelomonocytic Leukemia (CMML)
3418,0.991882028,152.3783852,https://clinicaltrials.gov/study/NCT03241173,NCT03241173,Advanced Malignancies
3419,0.999709398,189.0628111,https://clinicaltrials.gov/study/NCT02561273,NCT02561273,"Anaplastic Large Cell Lymphoma, ALK-Negative|Anaplastic Large Cell Lymphoma, ALK-Positive|Hepatosplenic T-Cell Lymphoma|Peripheral T-Cell Lymphoma, Not Otherwise Specified|Stage II Angioimmunoblastic T-cell Lymphoma|Stage II Enteropathy-Associated T-Cell Lymphoma|Stage III Angioimmunoblastic T-cell Lymphoma|Stage III Enteropathy-Associated T-Cell Lymphoma|Stage IV Angioimmunoblastic T-cell Lymphoma|Stage IV Enteropathy-Associated T-Cell Lymphoma"
3420,0.893874011,22.75414838,https://clinicaltrials.gov/study/NCT00775073,NCT00775073,Hepatocellular Carcinoma
3421,0.991365691,151.7734913,https://clinicaltrials.gov/study/NCT00002673,NCT00002673,Cancer
3422,0.969004909,60.63690492,https://clinicaltrials.gov/study/NCT00381173,NCT00381173,Breast Cancer|Ovarian Cancer|Prostate Cancer|Colon Cancer|Renal Cancer
3423,0.97848708,96.17440914,https://clinicaltrials.gov/study/NCT00622973,NCT00622973,Prostate Cancer|Bladder Cancer
3424,0.993505246,151.4684972,https://clinicaltrials.gov/study/NCT05412446,NCT05412446,Breast Cancer|Female
3425,0.998093713,171.8497687,https://clinicaltrials.gov/study/NCT00047710,NCT00047710,Pancreatic Cancer
3426,0.981241532,83.63607273,https://clinicaltrials.gov/study/NCT01331746,NCT01331746,Xerostomia in Advanced Cancer Patients
3427,0.99956336,185.2514486,https://clinicaltrials.gov/study/NCT00003346,NCT00003346,Melanoma (Skin)
3428,0.995034705,155.3334585,https://clinicaltrials.gov/study/NCT00003446,NCT00003446,Colorectal Cancer
3429,0.983944684,134.3566782,https://clinicaltrials.gov/study/NCT01721746,NCT01721746,Unresectable or Metastatic Melanoma
3430,0.999750559,184.4531657,https://clinicaltrials.gov/study/NCT00074646,NCT00074646,Glioblastoma|Malignant Gliomas
3431,0.996044323,156.1659624,https://clinicaltrials.gov/study/NCT00471146,NCT00471146,"Carcinoma, Pancreatic Ductal"
3432,0.995607733,153.8851843,https://clinicaltrials.gov/study/NCT00113646,NCT00113646,Lymphoma|Leukemia|Multiple Myeloma|Myelodysplastic Syndrome
3433,0.970741069,72.34139673,https://clinicaltrials.gov/study/NCT00321646,NCT00321646,Prostate Cancer|Adenocarcinoma of the Prostate
3434,0.850047335,11.91253619,https://clinicaltrials.gov/study/NCT02805946,NCT02805946,Allogeneic Stem Cell Transplant|Acute Graft Versus Host Disease|Acute Myeloid Leucaemia|Myelo Dysplastic Syndrome
3435,0.997647736,162.0139691,https://clinicaltrials.gov/study/NCT00857246,NCT00857246,Gastric Cancer|Stomach Cancer
3436,0.997814163,170.8754545,https://clinicaltrials.gov/study/NCT00003946,NCT00003946,Endometrial Cancer
3437,0.848380933,14.11660566,https://clinicaltrials.gov/study/NCT02434146,NCT02434146,Neoplasm|Oral Mucosa|Transplant-Related Disorder
3438,0.998351129,169.4598457,https://clinicaltrials.gov/study/NCT00183846,NCT00183846,Pancreatic Cancer|Gastric Cancer|Duodenum Cancer|Bile Duct Cancer
3439,0.993840258,151.8727255,https://clinicaltrials.gov/study/NCT00781846,NCT00781846,Solid Tumor
3440,0.997794944,165.8684855,https://clinicaltrials.gov/study/NCT00397046,NCT00397046,Tumors
3441,0.937732548,31.23661991,https://clinicaltrials.gov/study/NCT00626873,NCT00626873,Ovarian Cancer
3442,0.826194699,10.75987886,https://clinicaltrials.gov/study/NCT00869973,NCT00869973,Emesis
3443,0.997920417,166.8263117,https://clinicaltrials.gov/study/NCT01283373,NCT01283373,Prostate Cancer
3444,0.995206991,154.9475729,https://clinicaltrials.gov/study/NCT00431873,NCT00431873,"Lymphocytic Leukemia, Chronic"
3445,0.984630269,129.5159143,https://clinicaltrials.gov/study/NCT00001073,NCT00001073,"HIV Infections|Cervix, Dysplasia"
3446,0.973303435,60.22463829,https://clinicaltrials.gov/study/NCT03586973,NCT03586973,Advanced Hepatocellular Carcinoma
3447,0.991945016,152.040114,https://clinicaltrials.gov/study/NCT00102973,NCT00102973,Ovarian Neoplasms
3448,0.959513196,62.4415319,https://clinicaltrials.gov/study/NCT01246973,NCT01246973,Radiation-induced Dermatitis
3449,0.997562995,158.5025589,https://clinicaltrials.gov/study/NCT00003673,NCT00003673,Leukemia
3450,0.996857506,159.6873308,https://clinicaltrials.gov/study/NCT04204473,NCT04204473,NSCLC
3451,0.994574305,154.9402288,https://clinicaltrials.gov/study/NCT00788164,NCT00788164,Cervical Cancer|Precancerous Condition|HPV Disease|Human Papilomavirus
3452,0.985453494,141.0954533,https://clinicaltrials.gov/study/NCT03168464,NCT03168464,Non Small Cell Lung Cancer Metastatic
3453,0.994614943,156.3302683,https://clinicaltrials.gov/study/NCT00077064,NCT00077064,Lung Cancer|Pulmonary Complications|Radiation Fibrosis
3454,0.992171124,150.973527,https://clinicaltrials.gov/study/NCT00057564,NCT00057564,Multiple Myeloma
3455,0.927318534,27.37777369,https://clinicaltrials.gov/study/NCT03611764,NCT03611764,Hematological Malignancy
3456,0.94985856,42.66189172,https://clinicaltrials.gov/study/NCT04326764,NCT04326764,Acute Myeloid Leukaemia (AML)|Myelodysplastic Syndromes (MDS)
3457,0.84714655,9.097839558,https://clinicaltrials.gov/study/NCT02459964,NCT02459964,Advanced Cancers|Pain
3458,0.999138866,193.8088108,https://clinicaltrials.gov/study/NCT04642664,NCT04642664,Biliary Tract Cancer|Cholangiocarcinoma|Biomarker|Hepatobiliary Neoplasm
3459,0.991292747,152.8227573,https://clinicaltrials.gov/study/NCT02389764,NCT02389764,Breast Cancer
3460,0.980958905,105.6088053,https://clinicaltrials.gov/study/NCT04786964,NCT04786964,Metastatic Non-squamous Non Small Cell Lung Cancer
3461,0.953616721,48.35067666,https://clinicaltrials.gov/study/NCT00352664,NCT00352664,Advanced Cancer
3462,0.992099744,152.0308579,https://clinicaltrials.gov/study/NCT01578564,NCT01578564,Cancer
3463,0.998237947,165.4796733,https://clinicaltrials.gov/study/NCT01050764,NCT01050764,"Leukemia, Acute|Chronic Myelogenous Leukemia (CML)|Myelodysplastic Syndrome (MDS)|Non-Hodgkin Lymphoma (NHL)|Chronic Lymphocytic Leukemia (CLL)|Acute Myelogenous Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)"
3464,1.0,181.3375649,https://clinicaltrials.gov/study/NCT00238264,NCT00238264,Brain Tumor|Central Nervous System Tumor
3465,0.996868173,160.3719219,https://clinicaltrials.gov/study/NCT00616564,NCT00616564,Malignant Melanoma
3466,0.998463019,161.8752226,https://clinicaltrials.gov/study/NCT01172964,NCT01172964,Adult Anaplastic Astrocytoma|Recurrent Grade III Glioma|Recurrent Grade IV Glioma|Adult Anaplastic Oligodendroglioma|Adult Brain Tumor|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor|Adult Anaplastic Oligoastrocytoma|Recurrent High Grade Glioma
3467,0.999013483,179.9934649,https://clinicaltrials.gov/study/NCT01637961,NCT01637961,Recurrent Uterine Corpus Sarcoma|Uterine Corpus Leiomyosarcoma
3468,0.96297614,52.84691482,https://clinicaltrials.gov/study/NCT00128661,NCT00128661,Cervical Cancer|Precancerous Condition
3469,0.998759272,176.7467022,https://clinicaltrials.gov/study/NCT00005861,NCT00005861,Endometrial Cancer
3470,0.995591401,156.851243,https://clinicaltrials.gov/study/NCT00020761,NCT00020761,Esophageal Cancer|Gastric Cancer
3471,0.998800672,187.1619693,https://clinicaltrials.gov/study/NCT02467361,NCT02467361,Cancer
3472,0.996341179,159.36851,https://clinicaltrials.gov/study/NCT01357161,NCT01357161,Ovarian Cancer
3473,0.976593311,80.34321413,https://clinicaltrials.gov/study/NCT00111761,NCT00111761,Colorectal Cancer
3474,0.991904451,150.9600265,https://clinicaltrials.gov/study/NCT00412061,NCT00412061,Carcinoid Tumor|Malignant Carcinoid Syndrome
3475,0.96955276,64.36572958,https://clinicaltrials.gov/study/NCT04699461,NCT04699461,Relapsed Follicular Lymphoma|Refractory Follicular Lymphoma
3476,0.99913676,176.4733506,https://clinicaltrials.gov/study/NCT00969761,NCT00969761,Neoplasms
3477,0.98684001,137.0723913,https://clinicaltrials.gov/study/NCT02226861,NCT02226861,Acute Lymphoblastic Leukemia (ALL)|Acute Myelogenous Leukemia (AML)|Chronic Lymphocytic Leukemia (CLL)|Chronic Myelogenous Leukemia (CML)|MDS
3478,0.997311381,162.9294863,https://clinicaltrials.gov/study/NCT01049061,NCT01049061,Neoplasms|Solid Tumor
3479,0.994152176,152.3713813,https://clinicaltrials.gov/study/NCT02826161,NCT02826161,"Carcinoma, Non-Small-Cell Lung"
3480,0.898841527,17.7055795,https://clinicaltrials.gov/study/NCT04284761,NCT04284761,Prostate Adenocarcinoma|Lower Urinary Tract Symptoms
3481,0.997443755,159.0938984,https://clinicaltrials.gov/study/NCT02312661,NCT02312661,Epithelial Ovarian Cancer
3482,0.995625039,156.3566167,https://clinicaltrials.gov/study/NCT03047473,NCT03047473,Glioblastoma Multiforme of Brain
3483,0.671112207,5.446695299,https://clinicaltrials.gov/study/NCT03003273,NCT03003273,"Neutropenia, Febrile|Pediatric Cancer"
3484,0.976905448,77.29059047,https://clinicaltrials.gov/study/NCT00005073,NCT00005073,Prostate Cancer
3485,0.972253697,66.53829436,https://clinicaltrials.gov/study/NCT01174264,NCT01174264,Malignant Neoplasm
3486,0.886146244,15.21726915,https://clinicaltrials.gov/study/NCT01526564,NCT01526564,Peripheral Sensory Neuropathy
3487,0.981428911,121.4991076,https://clinicaltrials.gov/study/NCT00893464,NCT00893464,Lymphoma
3488,0.999703388,189.7033265,https://clinicaltrials.gov/study/NCT00121264,NCT00121264,"Unspecified Adult Solid Tumor, Protocol Specific"
3489,0.999089458,187.5464606,https://clinicaltrials.gov/study/NCT01734564,NCT01734564,Neoplasms
3490,0.996455125,156.6439357,https://clinicaltrials.gov/study/NCT00026364,NCT00026364,Colorectal Cancer
3491,0.919413855,24.35311443,https://clinicaltrials.gov/study/NCT00321464,NCT00321464,Bone Metastases
3492,0.986820322,143.3254059,https://clinicaltrials.gov/study/NCT03732664,NCT03732664,High-Risk Resectable NSCLC
3493,0.981761193,98.60800043,https://clinicaltrials.gov/study/NCT00754364,NCT00754364,NSCLC
3494,0.981492654,120.3218026,https://clinicaltrials.gov/study/NCT01588964,NCT01588964,Ovarian Epithelial Cancer Recurrent
3495,0.995415843,157.4437906,https://clinicaltrials.gov/study/NCT03171064,NCT03171064,PD-1 Antibodies|Exercise|Melanoma
3496,0.998725822,179.277249,https://clinicaltrials.gov/study/NCT01197664,NCT01197664,Mucinous Adenocarcinoma of the Rectum|Stage IIA Rectal Cancer|Stage IIB Rectal Cancer|Stage IIC Rectal Cancer|Stage IIIB Rectal Cancer|Stage IIIC Rectal Cancer
3497,0.990524365,151.540721,https://clinicaltrials.gov/study/NCT00457964,NCT00457964,Tuberous Sclerosis|Lymphangioleiomyomatosis
3498,0.995791193,156.8915604,https://clinicaltrials.gov/study/NCT00422864,NCT00422864,Rectal Cancer
3499,0.998849167,179.7554948,https://clinicaltrials.gov/study/NCT00326664,NCT00326664,Childhood Atypical Teratoid/Rhabdoid Tumor|Childhood Central Nervous System Germ Cell Tumor|Childhood Cerebral Anaplastic Astrocytoma|Childhood Cerebral Astrocytoma|Childhood Grade I Meningioma|Childhood Grade II Meningioma|Childhood Grade III Meningioma|Childhood Infratentorial Ependymoma|Childhood Oligodendroglioma|Childhood Spinal Cord Neoplasm|Childhood Supratentorial Ependymoma|Recurrent Childhood Brain Neoplasm|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Pineoblastoma|Recurrent Childhood Subependymal Giant Cell Astrocytoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway Glioma
3500,0.993400637,152.6697602,https://clinicaltrials.gov/study/NCT01393964,NCT01393964,Multiple Myeloma
3501,0.98964222,151.2555578,https://clinicaltrials.gov/study/NCT01159964,NCT01159964,"Lung Cancer, Non-Small Cell"
3502,0.9897202,151.2440436,https://clinicaltrials.gov/study/NCT00165464,NCT00165464,Esophageal Cancer|Gastric Cancer|GE Junction Cancer
3503,0.879140772,13.27434682,https://clinicaltrials.gov/study/NCT00506064,NCT00506064,Breast Cancer
3504,0.976901984,89.39042765,https://clinicaltrials.gov/study/NCT03248661,NCT03248661,Colo-rectal Cancer
3505,0.982025567,112.2303325,https://clinicaltrials.gov/study/NCT00094861,NCT00094861,Dysphagia|Non-Small Cell Lung Cancer|Lung Cancer
3506,0.948785733,37.92275949,https://clinicaltrials.gov/study/NCT03493061,NCT03493061,Colo-rectal Cancer|Liver Metastases
3507,0.568493152,3.597587831,https://clinicaltrials.gov/study/NCT04396561,NCT04396561,Unilateral U/S PVB
3508,0.993593434,153.4778229,https://clinicaltrials.gov/study/NCT00024661,NCT00024661,Neoplasms
3509,0.951142961,37.13604458,https://clinicaltrials.gov/study/NCT00911261,NCT00911261,Chronic Pain|Neuropathic Pain|Cancer
3510,0.697223511,7.112623677,https://clinicaltrials.gov/study/NCT00942461,NCT00942461,Colorectal Cancer
3511,0.994511731,154.2328474,https://clinicaltrials.gov/study/NCT02212561,NCT02212561,Acute Myeloid Leukemia (AML)|Acute Lymphoblastic Leukemia (ALL)|Myelodysplastic Syndrome (MDS)|Mixed Phenotype Acute Leukemia (MPAL)
3512,0.989678716,150.3827724,https://clinicaltrials.gov/study/NCT03463161,NCT03463161,Head and Neck Squamous Cell Carcinoma|Head and Neck Cancer
3513,0.998841109,185.5536842,https://clinicaltrials.gov/study/NCT00006461,NCT00006461,Untreated Childhood Medulloblastoma|Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
3514,0.659278864,5.021114894,https://clinicaltrials.gov/study/NCT00365261,NCT00365261,Sleep Initiation and Maintenance Disorders
3515,0.99456998,153.50988,https://clinicaltrials.gov/study/NCT01015261,NCT01015261,Acute Lymphoblastic Leukemia
3516,0.805876418,9.090215714,https://clinicaltrials.gov/study/NCT00746161,NCT00746161,Gastric Cancer
3517,0.994392218,153.6013404,https://clinicaltrials.gov/study/NCT00430261,NCT00430261,Lung Cancer|Adenocarcinoma
3518,0.995995215,156.2755043,https://clinicaltrials.gov/study/NCT01176461,NCT01176461,Melanoma (Skin)
3519,0.983632233,132.5287466,https://clinicaltrials.gov/study/NCT00995761,NCT00995761,Non-small Cell Lung Cancer
3520,0.801836548,9.161576729,https://clinicaltrials.gov/study/NCT03296553,NCT03296553,Kaposi Sarcoma|Human Immunodeficiency Virus|Immune Reconstitution Syndrome
3521,0.934810347,28.4844288,https://clinicaltrials.gov/study/NCT02883153,NCT02883153,Renal Cell Carcinoma
3522,0.992316313,151.7464413,https://clinicaltrials.gov/study/NCT01377753,NCT01377753,Prostate Cancer|Prostatic Neoplasms
3523,0.90542015,20.54339836,https://clinicaltrials.gov/study/NCT01952353,NCT01952353,Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
3524,0.996338271,157.6634559,https://clinicaltrials.gov/study/NCT00766753,NCT00766753,Malignant Glioma
3525,0.990085977,151.2372546,https://clinicaltrials.gov/study/NCT02684253,NCT02684253,Head and Neck Squamous Cell Carcinoma (HNSCC)
3526,0.998706398,180.4419474,https://clinicaltrials.gov/study/NCT03945253,NCT03945253,Advanced Solid Tumors
3527,0.993288625,153.5340308,https://clinicaltrials.gov/study/NCT01493453,NCT01493453,CD19 Positive Non-Hodgkin Lymphoma
3528,0.999357686,196.2565088,https://clinicaltrials.gov/study/NCT00385853,NCT00385853,Glioblastoma
3529,0.961094419,51.23186359,https://clinicaltrials.gov/study/NCT00563953,NCT00563953,Breast Cancer
3530,0.996498945,158.2368876,https://clinicaltrials.gov/study/NCT02110953,NCT02110953,Liver Metastases|Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
3531,0.992139784,152.0730562,https://clinicaltrials.gov/study/NCT00105053,NCT00105053,Prostate Cancer
3532,0.844969004,13.18118418,https://clinicaltrials.gov/study/NCT00883753,NCT00883753,Rheumatoid Arthritis
3533,0.979834325,91.71830825,https://clinicaltrials.gov/study/NCT02482753,NCT02482753,Breast Cancer
3534,0.991527847,151.6676918,https://clinicaltrials.gov/study/NCT01644253,NCT01644253,Chronic Lymphocytic Leukemia|Peripheral T-cell Lymphoma
3535,0.989844312,151.6015192,https://clinicaltrials.gov/study/NCT04103853,NCT04103853,Metastatic Breast Cancer
3536,0.99748524,159.8272943,https://clinicaltrials.gov/study/NCT04214860,NCT04214860,Myeloid Malignancy
3537,0.999454918,191.6125142,https://clinicaltrials.gov/study/NCT02895360,NCT02895360,Neoplasms
3538,0.981742946,108.7022046,https://clinicaltrials.gov/study/NCT01497860,NCT01497860,Low-grade Glioma
3539,0.997567398,161.1829353,https://clinicaltrials.gov/study/NCT00095160,NCT00095160,Neoplasms
3540,0.943738691,35.27434388,https://clinicaltrials.gov/study/NCT03679260,NCT03679260,Prostate Cancer
3541,0.999535837,177.5598586,https://clinicaltrials.gov/study/NCT00004260,NCT00004260,Lymphoma
3542,0.987014749,144.1108057,https://clinicaltrials.gov/study/NCT00096460,NCT00096460,Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Follicular Lymphoma
3543,0.992923996,151.447133,https://clinicaltrials.gov/study/NCT02574260,NCT02574260,Melanoma
3544,0.98425394,117.3546502,https://clinicaltrials.gov/study/NCT05560360,NCT05560360,B-cell Tumors
3545,0.989806712,151.306404,https://clinicaltrials.gov/study/NCT00833560,NCT00833560,Multiple Myeloma
3546,0.996277314,158.4540583,https://clinicaltrials.gov/study/NCT00005029,NCT00005029,Ovarian Cancer|Primary Peritoneal Cavity Cancer
3547,0.975191025,71.01449325,https://clinicaltrials.gov/study/NCT02203253,NCT02203253,Neoplasms
3548,0.999087606,178.6837649,https://clinicaltrials.gov/study/NCT04808453,NCT04808453,Advanced Tumors
3549,0.865170079,10.0916187,https://clinicaltrials.gov/study/NCT02257853,NCT02257853,"Stress, Psychological|Caregivers"
3550,0.996149307,158.8159053,https://clinicaltrials.gov/study/NCT05806853,NCT05806853,Prostate Cancer
3551,0.79000657,10.4007164,https://clinicaltrials.gov/study/NCT01523353,NCT01523353,Colorectal Cancer|Colorectal Liver Metastasis|Liver Surgery|Exercise Intervention
3552,0.973049611,77.406452,https://clinicaltrials.gov/study/NCT02437253,NCT02437253,Mucopolysaccharidosis Type I|Mucopolysaccharidosis Type II|Mucopolysaccharidosis Type VI
3553,0.998641901,174.0412899,https://clinicaltrials.gov/study/NCT00095953,NCT00095953,Melanoma (Skin)
3554,0.97133633,82.71767313,https://clinicaltrials.gov/study/NCT00106353,NCT00106353,Adenocarcinoma|Neoplasms
3555,0.925784884,34.70460218,https://clinicaltrials.gov/study/NCT00497653,NCT00497653,Polycystic Ovary Syndrome
3556,0.999149758,187.7958328,https://clinicaltrials.gov/study/NCT00115453,NCT00115453,Glioblastoma
3557,0.995262851,157.3375178,https://clinicaltrials.gov/study/NCT01069653,NCT01069653,Small Cell Lung Cancer
3558,0.998252768,166.8522867,https://clinicaltrials.gov/study/NCT00004853,NCT00004853,Ewing's Sarcoma|Rhabdomyosarcoma|MPNST|Synovial Sarcoma|High-risk Sarcoma
3559,0.810832876,9.003470988,https://clinicaltrials.gov/study/NCT04843553,NCT04843553,Actinic Keratoses
3560,0.992904499,152.9153007,https://clinicaltrials.gov/study/NCT01256853,NCT01256853,Nasopharyngeal Neoplasms|Epstein-Barr Virus Infections
3561,0.989494785,150.1967733,https://clinicaltrials.gov/study/NCT02094560,NCT02094560,Advanced Endstage Solid Carcinomas in Adults
3562,0.997154374,158.5866267,https://clinicaltrials.gov/study/NCT00357760,NCT00357760,Metastatic Renal Cell Carcinoma
3563,0.928876349,27.30545623,https://clinicaltrials.gov/study/NCT01064960,NCT01064960,Uterine Leiomyomas
3564,1.0,185.2732165,https://clinicaltrials.gov/study/NCT00906360,NCT00906360,Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Salivary Gland Squamous Cell Carcinoma|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Tongue Cancer|Untreated Metastatic Squamous Neck Cancer With Occult Primary
3565,0.850897009,12.38845047,https://clinicaltrials.gov/study/NCT00440960,NCT00440960,Lung Cancer
3566,0.994590798,152.9298927,https://clinicaltrials.gov/study/NCT02678260,NCT02678260,Advanced Malignancies
3567,0.990193351,151.0924448,https://clinicaltrials.gov/study/NCT01590160,NCT01590160,Lung Cancer - Malignant Pleural Mesothelioma
3568,0.807899339,9.804065993,https://clinicaltrials.gov/study/NCT02628860,NCT02628860,Pancreatic Cancer|Anemia
3569,0.89339095,18.09260827,https://clinicaltrials.gov/study/NCT04699760,NCT04699760,Cancer Cachexia|Side Effects|Quality of Life
3570,0.993811773,153.5103891,https://clinicaltrials.gov/study/NCT02308553,NCT02308553,Cutaneous Malignant Melanoma
3571,0.928916013,31.53626181,https://clinicaltrials.gov/study/NCT02747953,NCT02747953,Non-small Cell Lung Cancer
3572,0.986364826,147.9375088,https://clinicaltrials.gov/study/NCT01471353,NCT01471353,Colorectal Cancer Metastatic
3573,0.88826805,17.8681354,https://clinicaltrials.gov/study/NCT06014853,NCT06014853,Prostate Cancer
3574,0.935172203,35.57554311,https://clinicaltrials.gov/study/NCT00206453,NCT00206453,Breast Cancer
3575,0.952195315,40.11088661,https://clinicaltrials.gov/study/NCT03045653,NCT03045653,Breast Cancer Metastatic
3576,0.909572432,24.03185455,https://clinicaltrials.gov/study/NCT01130753,NCT01130753,Lung Neoplasms|Erlotinib|Neoadjuvant Therapy
3577,0.993754727,154.5259802,https://clinicaltrials.gov/study/NCT00657553,NCT00657553,Multiple Myeloma
3578,0.995470274,154.3697377,https://clinicaltrials.gov/study/NCT00777153,NCT00777153,Recurrent Glioblastoma
3579,0.997611727,165.8513535,https://clinicaltrials.gov/study/NCT04089553,NCT04089553,Prostate Cancer|Metastatic Castration-Resistant Prostate Cancer (mCRPC)
3580,0.99770202,162.65508,https://clinicaltrials.gov/study/NCT00580060,NCT00580060,Melanoma
3581,0.999798981,184.8487931,https://clinicaltrials.gov/study/NCT00011960,NCT00011960,Esophageal Cancer|Gastric Cancer
3582,0.993991933,151.6757235,https://clinicaltrials.gov/study/NCT00504660,NCT00504660,Anaplastic Glioma of Brain|Glioblastoma Multiforme|Brain Cancer
3583,0.995163721,154.5806228,https://clinicaltrials.gov/study/NCT03841760,NCT03841760,Cancer
3584,0.993333669,152.8997014,https://clinicaltrials.gov/study/NCT00412360,NCT00412360,Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome|Natural Killer Cell Lymphoblastic Leukemia/Lymphoma
3585,0.969489103,70.85160521,https://clinicaltrials.gov/study/NCT01415960,NCT01415960,Prostate Cancer
3586,0.990849753,151.5750568,https://clinicaltrials.gov/study/NCT01191060,NCT01191060,Myeloma
3587,0.991796354,152.1971919,https://clinicaltrials.gov/study/NCT04178460,NCT04178460,Gastric Cancer|Triple Negative Breast Cancer|Biliary Tract Carcinoma|Endometrial Carcinoma
3588,0.997650036,164.5807893,https://clinicaltrials.gov/study/NCT00820560,NCT00820560,Solid Tumors and Hematologic Malignancy
3589,0.981637166,101.5158657,https://clinicaltrials.gov/study/NCT01460160,NCT01460160,"Leukemia, Pediatric"
3590,0.994787291,153.4557148,https://clinicaltrials.gov/study/NCT00360360,NCT00360360,"Neoplasm, Unknown Primary"
3591,0.991474879,151.696301,https://clinicaltrials.gov/study/NCT00029029,NCT00029029,Metastatic Cancer|Pain
3592,0.738829276,6.685113601,https://clinicaltrials.gov/study/NCT00956553,NCT00956553,HPV Infections
3593,0.99593986,158.626955,https://clinicaltrials.gov/study/NCT00783653,NCT00783653,Acute Myeloid Leukemia
3594,0.7100105,5.974155462,https://clinicaltrials.gov/study/NCT02727153,NCT02727153,Colonic Cancer
3595,0.99927641,182.4317685,https://clinicaltrials.gov/study/NCT01432353,NCT01432353,Multiple Myeloma
3596,0.963856344,49.81409829,https://clinicaltrials.gov/study/NCT01018953,NCT01018953,Carcinoid Syndrome
3597,0.999049676,192.7157791,https://clinicaltrials.gov/study/NCT00504153,NCT00504153,Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
3598,0.798166979,11.16796536,https://clinicaltrials.gov/study/NCT04492553,NCT04492553,Hypogonadism
3599,0.976395042,85.55148785,https://clinicaltrials.gov/study/NCT03499353,NCT03499353,Early Breast Cancer
3600,0.99758147,163.2004938,https://clinicaltrials.gov/study/NCT00089453,NCT00089453,Multiple Myeloma
3601,0.971924286,72.30360204,https://clinicaltrials.gov/study/NCT02619253,NCT02619253,Renal Cell Carcinoma|Urinary Bladder Neoplasms
3602,0.990121498,151.116567,https://clinicaltrials.gov/study/NCT00886353,NCT00886353,Pulmonary Diseases|Cardiovascular Diseases|Kidney Diseases|Cancer Diseases
3603,0.963959665,59.6334274,https://clinicaltrials.gov/study/NCT01866553,NCT01866553,Chronic Myeloid Leukemia
3604,0.997484673,161.0036728,https://clinicaltrials.gov/study/NCT00075660,NCT00075660,Kidney Cancer
3605,0.664600612,4.515653324,https://clinicaltrials.gov/study/NCT02608060,NCT02608060,Anemia
3606,0.936551937,30.2148813,https://clinicaltrials.gov/study/NCT02085460,NCT02085460,Head and Neck Cancer
3607,0.958196836,43.2351171,https://clinicaltrials.gov/study/NCT00391560,NCT00391560,Leukemia
3608,0.987576729,145.6386443,https://clinicaltrials.gov/study/NCT00123760,NCT00123760,Brain Neoplasms|Lung Neoplasms|Thyroid Neoplasms|Colorectal Neoplasms|Lymphoma
3609,0.996083503,156.7489066,https://clinicaltrials.gov/study/NCT00008060,NCT00008060,Colorectal Cancer
3610,0.995227671,154.0032405,https://clinicaltrials.gov/study/NCT00049660,NCT00049660,Breast Cancer
3611,0.993470546,152.1190467,https://clinicaltrials.gov/study/NCT03768960,NCT03768960,Multiple Myeloma
3612,0.999101635,178.2965181,https://clinicaltrials.gov/study/NCT03177460,NCT03177460,Prostate Adenocarcinoma|Stage III Prostate Cancer AJCC v8|Stage IIIA Prostate Cancer AJCC v8|Stage IIIB Prostate Cancer AJCC v8|Stage IIIC Prostate Cancer AJCC v8|Testosterone Greater Than 150 ng/dL
3613,0.989874535,150.5190532,https://clinicaltrials.gov/study/NCT02106260,NCT02106260,Cutaneous Warts
3614,0.961071557,51.45793208,https://clinicaltrials.gov/study/NCT00050960,NCT00050960,Non-small Cell Lung Cancer
3615,0.993549958,152.9217868,https://clinicaltrials.gov/study/NCT01484860,NCT01484860,Adenocarcinoma of the Pancreas|Metastatic Disease
3616,0.990199175,151.2522109,https://clinicaltrials.gov/study/NCT00535353,NCT00535353,Colorectal Cancer
3617,0.999353864,190.799227,https://clinicaltrials.gov/study/NCT02529553,NCT02529553,Advanced Cancer|Metastatic Cancer
3618,0.993908327,154.8757134,https://clinicaltrials.gov/study/NCT01077453,NCT01077453,"Healthy, no Evidence of Disease|Lobular Breast Carcinoma in Situ"
3619,0.99931033,184.530199,https://clinicaltrials.gov/study/NCT00306553,NCT00306553,Malignant Melanoma
3620,0.96799295,72.58077698,https://clinicaltrials.gov/study/NCT02017353,NCT02017353,Endometrial Carcinoma
3621,0.988071668,150.6302002,https://clinicaltrials.gov/study/NCT00722553,NCT00722553,"Carcinoma, Transitional Cell|Bladder Cancer|Bladder Neoplasm"
3622,0.865693828,13.88864025,https://clinicaltrials.gov/study/NCT00042653,NCT00042653,Secondary Hyperparathyroidism|End Stage Renal Disease
3623,0.996139002,157.1804477,https://clinicaltrials.gov/study/NCT04335253,NCT04335253,Advanced Cancer
3624,0.997394371,164.9762859,https://clinicaltrials.gov/study/NCT02231853,NCT02231853,Chronic Lymphocytic Leukemia|CML (Chronic Myelogenous Leukemia)|MDS (Myelodysplastic Syndrome)|Acute Lymphoblastic Leukemia|AML (Acute Myelogenous Leukemia)
3625,0.994129025,152.5423032,https://clinicaltrials.gov/study/NCT00941460,NCT00941460,Glioblastoma
3626,0.998907642,176.7910957,https://clinicaltrials.gov/study/NCT04009460,NCT04009460,Solid Tumors|Neoplasms|Malignant Tumor
3627,0.979567386,106.8739569,https://clinicaltrials.gov/study/NCT00003460,NCT00003460,Childhood CNS Primitive Neuroectodermal Tumor
3628,0.990468068,151.1362332,https://clinicaltrials.gov/study/NCT00996060,NCT00996060,Lung Cancer
3629,0.996961769,160.2854099,https://clinicaltrials.gov/study/NCT00026260,NCT00026260,Cervical Cancer
3630,0.997557534,163.0347181,https://clinicaltrials.gov/study/NCT00278460,NCT00278460,Lung Cancer
3631,0.998898461,193.7263632,https://clinicaltrials.gov/study/NCT00615160,NCT00615160,Melanoma
3632,0.993711603,153.6749358,https://clinicaltrials.gov/study/NCT00903760,NCT00903760,Myelodysplastic Syndrome
3633,0.995892675,156.5086546,https://clinicaltrials.gov/study/NCT00531453,NCT00531453,Multiple Myeloma
3634,0.988359133,150.3394067,https://clinicaltrials.gov/study/NCT00350753,NCT00350753,Cholangiocarcinoma|Gallbladder Cancer
3635,0.997857709,168.085632,https://clinicaltrials.gov/study/NCT00730353,NCT00730353,Esophageal Cancer
3636,0.99278258,152.0268568,https://clinicaltrials.gov/study/NCT00210353,NCT00210353,"Lymphoma, Mucosa-Associated Lymphoid Tissue"
3637,0.975199344,72.35501148,https://clinicaltrials.gov/study/NCT01600053,NCT01600053,Chronic Lymphocytic Leukemia
3638,0.993248943,151.2743032,https://clinicaltrials.gov/study/NCT01555853,NCT01555853,"Lymphoma, Non-Hodgkin|Hodgkin Disease"
3639,0.999520964,182.4897577,https://clinicaltrials.gov/study/NCT02060253,NCT02060253,HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
3640,0.913381661,23.66085005,https://clinicaltrials.gov/study/NCT01588353,NCT01588353,Dupuytren's Contracture
3641,0.958288176,49.91239456,https://clinicaltrials.gov/study/NCT00584753,NCT00584753,Breast Cancer
3642,0.995456209,155.8722738,https://clinicaltrials.gov/study/NCT02994953,NCT02994953,Advanced Solid Tumors
3643,0.971505414,74.70869744,https://clinicaltrials.gov/study/NCT01772953,NCT01772953,Acute Myeloid Leukemia (AML)|Myelodysplastic Syndrome (MDS)
3644,0.991446469,151.9144085,https://clinicaltrials.gov/study/NCT00660153,NCT00660153,Colorectal Cancer|Gastrointestinal Cancer
3645,0.973688818,71.23555814,https://clinicaltrials.gov/study/NCT00194753,NCT00194753,Breast Neoplasm
3646,0.98130659,97.1116014,https://clinicaltrials.gov/study/NCT00002760,NCT00002760,Prostate Cancer
3647,0.922892919,27.18488897,https://clinicaltrials.gov/study/NCT01098760,NCT01098760,Hepatocellular Carcinoma
3648,0.966321565,55.96826988,https://clinicaltrials.gov/study/NCT00582660,NCT00582660,Colorectal Adenoma|Colorectal Carcinoma
3649,0.997268085,161.4786918,https://clinicaltrials.gov/study/NCT01729260,NCT01729260,Newly Diagnosed High-Grade Glioma
3650,0.902759585,19.56933773,https://clinicaltrials.gov/study/NCT00378560,NCT00378560,HPV Infections
3651,0.998745683,177.3762729,https://clinicaltrials.gov/study/NCT00248560,NCT00248560,Head and Neck Cancer
3652,0.997225505,161.7515271,https://clinicaltrials.gov/study/NCT00139360,NCT00139360,Metastatic Melanoma
3653,0.9992394,183.5650127,https://clinicaltrials.gov/study/NCT03050060,NCT03050060,Metastatic Kidney Carcinoma|Recurrent Lung Non-Small Cell Carcinoma|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Lung Non-Small Cell Cancer AJCC v7
3654,0.99750844,166.1273952,https://clinicaltrials.gov/study/NCT00003953,NCT00003953,Breast Cancer
3655,0.994168159,155.2125341,https://clinicaltrials.gov/study/NCT00144053,NCT00144053,Lung Cancer
3656,0.997450175,162.2594003,https://clinicaltrials.gov/study/NCT00877253,NCT00877253,Ovarian Cancer
3657,0.998548841,176.767125,https://clinicaltrials.gov/study/NCT01453153,NCT01453153,Stage IV Pancreatic Cancer
3658,0.977655335,84.17131046,https://clinicaltrials.gov/study/NCT02268253,NCT02268253,Myelofibrosis|Chronic Myelomonocytic Leukemia
3659,0.975934883,71.28993805,https://clinicaltrials.gov/study/NCT00268853,NCT00268853,Diffuse Large-Cell Lymphoma
3660,0.997485135,164.3349131,https://clinicaltrials.gov/study/NCT00005053,NCT00005053,Pancreatic Cancer
3661,0.994799107,155.3133144,https://clinicaltrials.gov/study/NCT00743353,NCT00743353,Sarcoma|Melanoma|Lung Cancer|Breast Cancer|High Grade Gliomas
3662,0.999556878,187.7266638,https://clinicaltrials.gov/study/NCT00509353,NCT00509353,Neuroblastoma
3663,0.994794683,155.8429466,https://clinicaltrials.gov/study/NCT00006053,NCT00006053,Leukemia
3664,0.99605576,155.811015,https://clinicaltrials.gov/study/NCT02525653,NCT02525653,Lung Cancer|Untreated Stage IV or Recurrent Squamous Cell Lung Cancers
3665,0.976469649,90.4191484,https://clinicaltrials.gov/study/NCT02426853,NCT02426853,Cancer Prevention
3666,0.974027621,84.85815244,https://clinicaltrials.gov/study/NCT01820260,NCT01820260,Actinic Keratosis
3667,0.982129969,106.9418727,https://clinicaltrials.gov/study/NCT01334060,NCT01334060,Leukaemia (Acute)|Leukaemia (Chronic)|Leukaemia (Acute Myeloid)|Leukaemia (Acute Lymphoblastic)|Leukaemia (Acute Promyelocytic)
3668,0.98921156,150.6331861,https://clinicaltrials.gov/study/NCT01532960,NCT01532960,Breast Cancer
3669,0.987866807,147.7886651,https://clinicaltrials.gov/study/NCT00560560,NCT00560560,Colorectal Neoplasm
3670,0.98595478,143.6631,https://clinicaltrials.gov/study/NCT00509860,NCT00509860,Sarcoma
3671,0.998842806,183.5597714,https://clinicaltrials.gov/study/NCT01304160,NCT01304160,Pancreatic Cancer|Unresectable Pancreatic Cancer
3672,0.990585916,150.6979334,https://clinicaltrials.gov/study/NCT02276560,NCT02276560,Stage IIIA Non-Small Cell Lung Cancer
3673,0.944219823,38.29516024,https://clinicaltrials.gov/study/NCT01194960,NCT01194960,Hormone Refractory Prostate Cancer
3674,0.979431303,101.366493,https://clinicaltrials.gov/study/NCT00824161,NCT00824161,Advanced Colorectal Cancer
3675,0.997760197,166.2799222,https://clinicaltrials.gov/study/NCT01189253,NCT01189253,Sarcoma
3676,0.987292364,150.4414817,https://clinicaltrials.gov/study/NCT01805453,NCT01805453,Newly-diagnosed Glioblastoma
3677,0.9893958,150.3722606,https://clinicaltrials.gov/study/NCT04102553,NCT04102553,Prostate Cancer|Prostate Cancer Recurrent
3678,0.979493399,98.14597511,https://clinicaltrials.gov/study/NCT02607553,NCT02607553,Clear Cell Renal Cell Carcinoma
3679,0.936130996,27.83682477,https://clinicaltrials.gov/study/NCT02224053,NCT02224053,Healthy Volunteer
3680,0.996820027,156.1746447,https://clinicaltrials.gov/study/NCT04230473,NCT04230473,Relapsed or Refractory Acute Lymphoblastic Leukemia
3681,0.996055082,158.0427708,https://clinicaltrials.gov/study/NCT02952573,NCT02952573,Multiple Myeloma|Relapsed/Refractory
3682,0.786829723,6.931201806,https://clinicaltrials.gov/study/NCT00219973,NCT00219973,Cancer|Venous Thromboembolism
3683,0.663104123,4.901407755,https://clinicaltrials.gov/study/NCT00377273,NCT00377273,Actinic Keratoses
3684,0.976070654,84.97606643,https://clinicaltrials.gov/study/NCT03891173,NCT03891173,Lung Adenocarcinoma
3685,0.999187109,191.2385414,https://clinicaltrials.gov/study/NCT03427073,NCT03427073,Solid Tumors|Ovarian Cancer
3686,0.997922927,167.6802589,https://clinicaltrials.gov/study/NCT03776864,NCT03776864,Hodgkin's Lymphoma
3687,0.989860238,150.8166899,https://clinicaltrials.gov/study/NCT00855764,NCT00855764,Head and Neck Cancer
3688,0.98653374,121.5415883,https://clinicaltrials.gov/study/NCT03145064,NCT03145064,Diffuse Large B-cell Lymphoma
3689,0.999519605,189.1452514,https://clinicaltrials.gov/study/NCT00039364,NCT00039364,Brain and Central Nervous System Tumors
3690,0.99798024,168.5499701,https://clinicaltrials.gov/study/NCT03782064,NCT03782064,Multiple Myeloma
3691,0.997339046,164.3319179,https://clinicaltrials.gov/study/NCT00330564,NCT00330564,Von Hippel-Lindau Syndrome|Renal Cell Carcinoma|Hemangioblastoma
3692,0.997445243,161.1708353,https://clinicaltrials.gov/study/NCT00875264,NCT00875264,Cancer
3693,0.998962575,194.9017957,https://clinicaltrials.gov/study/NCT01648764,NCT01648764,Malignant Solid Tumor|Solid Tumor|Metastatic Tumor
3694,0.997881614,164.7541101,https://clinicaltrials.gov/study/NCT00895661,NCT00895661,B-cell Lymphoma|Indolent B-cell Lymphoma
3695,0.981005713,97.86559658,https://clinicaltrials.gov/study/NCT02588261,NCT02588261,Non-small Cell Lung Cancer (NSCLC)
3696,0.93664592,32.79987813,https://clinicaltrials.gov/study/NCT01974661,NCT01974661,Hepatocellular Carcinoma
3697,0.999519282,191.8741546,https://clinicaltrials.gov/study/NCT00833261,NCT00833261,Head and Neck Cancer
3698,0.997944236,164.1363297,https://clinicaltrials.gov/study/NCT00016861,NCT00016861,"Unspecified Childhood Solid Tumor, Protocol Specific"
3699,0.99932231,174.6049381,https://clinicaltrials.gov/study/NCT00445861,NCT00445861,Esophageal Cancer
3700,0.998493899,169.7046478,https://clinicaltrials.gov/study/NCT00004261,NCT00004261,Breast Cancer|Cervical Cancer|Head and Neck Cancer|Prostate Cancer|Sarcoma
3701,0.524499353,3.439534523,https://clinicaltrials.gov/study/NCT03013361,NCT03013361,Functional Endoscopic Sinus Surgery (FESS)
3702,0.998652508,179.1952768,https://clinicaltrials.gov/study/NCT00185861,NCT00185861,Brain Cancer
3703,0.986356865,150.2580099,https://clinicaltrials.gov/study/NCT00525161,NCT00525161,Breast Cancer
3704,0.982429348,105.8008422,https://clinicaltrials.gov/study/NCT04076761,NCT04076761,Cholangiocarcinoma|Bile Duct Cancer
3705,0.930922959,26.17357049,https://clinicaltrials.gov/study/NCT00357110,NCT00357110,Breast Cancer
3706,0.989373338,150.926357,https://clinicaltrials.gov/study/NCT02278510,NCT02278510,Malignant Glioma|WHO Grade III or IV Recurrent Glioma
3707,0.964962329,64.35141235,https://clinicaltrials.gov/study/NCT02137746,NCT02137746,Prostate Cancer
3708,0.999352865,183.2710982,https://clinicaltrials.gov/study/NCT00020046,NCT00020046,Stage IV Prostate Cancer|Adenocarcinoma of the Prostate|Recurrent Prostate Cancer
3709,0.868846311,13.64534577,https://clinicaltrials.gov/study/NCT01164046,NCT01164046,Venous Thromboembolism|Neoplasms
3710,0.999418585,187.5924442,https://clinicaltrials.gov/study/NCT02508246,NCT02508246,Head and Neck Squamous Cell Carcinoma
3711,0.886411842,14.43403744,https://clinicaltrials.gov/study/NCT01591746,NCT01591746,"Breast Cancer|Pain, Postoperative|BRCA1 Mutation|BRCA2 Mutation|Breast Diseases|Neoplasms"
3712,0.987015085,150.9029727,https://clinicaltrials.gov/study/NCT00464646,NCT00464646,Breast Cancer
3713,0.985620544,150.1299182,https://clinicaltrials.gov/study/NCT01427946,NCT01427946,Non-small Cell Lung Cancer
3714,0.998021408,164.0859237,https://clinicaltrials.gov/study/NCT01951846,NCT01951846,Malignant Solid Tumour
3715,0.930228788,33.24341519,https://clinicaltrials.gov/study/NCT03410446,NCT03410446,Depression|Cancer|Palliative Care
3716,0.961454184,47.32423174,https://clinicaltrials.gov/study/NCT00295646,NCT00295646,Breast Cancer
3717,0.984752928,140.8295708,https://clinicaltrials.gov/study/NCT00748046,NCT00748046,Prostate Cancer|Metastases|Pharmacokinetics
3718,0.996286039,157.9165028,https://clinicaltrials.gov/study/NCT01682746,NCT01682746,"Brain Tumor, Recurrent"
3719,0.962003993,41.97394271,https://clinicaltrials.gov/study/NCT00273546,NCT00273546,Cancer
3720,0.994379785,155.241288,https://clinicaltrials.gov/study/NCT02176746,NCT02176746,"Neoplasms,Colorectal"
3721,0.860020216,14.08033531,https://clinicaltrials.gov/study/NCT05189873,NCT05189873,"Polycystic Ovary Syndrome|Infertility, Female"
3722,0.994569738,154.7598231,https://clinicaltrials.gov/study/NCT01220973,NCT01220973,Prostate Cancer
3723,0.991906947,152.1812972,https://clinicaltrials.gov/study/NCT00955773,NCT00955773,Cancer
3724,0.997940839,165.4945804,https://clinicaltrials.gov/study/NCT01577173,NCT01577173,Head and Neck Cancer
3725,0.985976238,140.2242813,https://clinicaltrials.gov/study/NCT00316173,NCT00316173,"Ovarian Cancer|Neoplasms, Ovarian"
3726,0.95404804,43.54653812,https://clinicaltrials.gov/study/NCT00625573,NCT00625573,Colorectal Cancer
3727,0.995559799,155.7185004,https://clinicaltrials.gov/study/NCT00305773,NCT00305773,Adult Acute Erythroid Leukemia (M6)|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Acute Promyelocytic Leukemia (M3)|Recurrent Adult Acute Myeloid Leukemia|Refractory Cytopenia With Multilineage Dysplasia|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
3728,0.803817903,8.010672594,https://clinicaltrials.gov/study/NCT01484873,NCT01484873,Obesity|Overweight|Craniopharyngioma
3729,0.992886495,152.6198261,https://clinicaltrials.gov/study/NCT00003873,NCT00003873,Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
3730,0.998697787,178.9884714,https://clinicaltrials.gov/study/NCT00021073,NCT00021073,"Unspecified Adult Solid Tumor, Protocol Specific"
3731,0.999778573,194.9445081,https://clinicaltrials.gov/study/NCT00006773,NCT00006773,Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
3732,0.996858369,158.754503,https://clinicaltrials.gov/study/NCT02350673,NCT02350673,Solid Tumors
3733,0.993899341,154.4922246,https://clinicaltrials.gov/study/NCT01046864,NCT01046864,Gastro-Intestinal Cancer
3734,0.994037687,154.7088302,https://clinicaltrials.gov/study/NCT02959164,NCT02959164,Pancreatic Ductal Adenocarcinoma|Sarcoma
3735,0.997198534,160.95027,https://clinicaltrials.gov/study/NCT00703664,NCT00703664,Recurrent Mantle Cell Lymphoma|Recurrent Non-Hodgkin Lymphoma
3736,0.99565289,156.943616,https://clinicaltrials.gov/study/NCT00028964,NCT00028964,Breast Cancer|Drug/Agent Toxicity by Tissue/Organ
3737,0.954716677,33.52596666,https://clinicaltrials.gov/study/NCT01465464,NCT01465464,Hepatocellular Carcinoma
3738,0.997703489,161.4930971,https://clinicaltrials.gov/study/NCT01946646,NCT01946646,Metastatic Pancreatic Cancer
3739,0.997448002,161.3725992,https://clinicaltrials.gov/study/NCT00854646,NCT00854646,Acute Myelocytic Leukemia|Acute Lymphocytic Leukemia|Chronic Myelocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplastic Syndromes
3740,0.997386077,162.8756184,https://clinicaltrials.gov/study/NCT01638546,NCT01638546,Recurrent Small Cell Lung Carcinoma
3741,0.987233425,150.4269673,https://clinicaltrials.gov/study/NCT02527746,NCT02527746,Neutropenia|Breast Cancer
3742,0.98086471,113.1243547,https://clinicaltrials.gov/study/NCT02432846,NCT02432846,"Renal Cell Carcinoma, Metastatic"
3743,0.63460082,4.590433236,https://clinicaltrials.gov/study/NCT02235246,NCT02235246,Gastric Neoplasm
3744,0.99784827,165.8077833,https://clinicaltrials.gov/study/NCT00714246,NCT00714246,Non Small Cell Lung Cancer
3745,0.996712131,159.2778968,https://clinicaltrials.gov/study/NCT00881946,NCT00881946,Hematologic Malignancies
3746,0.912881103,20.05756407,https://clinicaltrials.gov/study/NCT04447846,NCT04447846,Sturge-Weber Syndrome
3747,0.996296146,156.807777,https://clinicaltrials.gov/study/NCT00923273,NCT00923273,"Carcinoma, Non-Small-Cell Lung"
3748,0.98484041,119.6350788,https://clinicaltrials.gov/study/NCT01829373,NCT01829373,Lung Cancer
3749,0.978638241,86.58216288,https://clinicaltrials.gov/study/NCT01288573,NCT01288573,Ewing's Sarcoma/Soft Tissue Sarcoma|Neuroblastoma|Brain Tumors
3750,0.987367235,150.2390358,https://clinicaltrials.gov/study/NCT00201773,NCT00201773,Breast Cancer
3751,0.998442844,170.6977832,https://clinicaltrials.gov/study/NCT01132573,NCT01132573,Acute Leukemias of Ambiguous Lineage|Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Lymphoblastic Leukemia
3752,0.997820009,164.8287647,https://clinicaltrials.gov/study/NCT00629473,NCT00629473,Advanced Cancer
3753,0.996024241,156.1130736,https://clinicaltrials.gov/study/NCT03194373,NCT03194373,Squamous Cell Carcinoma of the Head and Neck
3754,0.858994474,10.907594,https://clinicaltrials.gov/study/NCT01374373,NCT01374373,Antineoplastic Chemotherapy Induced Anemia
3755,0.993251198,151.8210506,https://clinicaltrials.gov/study/NCT01356173,NCT01356173,"Non-Hodgkin's Lymphoma, Solid Tumor"
3756,0.999349947,191.1941315,https://clinicaltrials.gov/study/NCT02585973,NCT02585973,"Carcinoma, Squamous Cell of Head and Neck"
3757,0.9912195,150.5728864,https://clinicaltrials.gov/study/NCT02502864,NCT02502864,Breast Cancer|Breast Cancer Female
3758,0.993749939,153.3270687,https://clinicaltrials.gov/study/NCT00880464,NCT00880464,Breast Cancer
3759,0.589470465,3.857642097,https://clinicaltrials.gov/study/NCT02562664,NCT02562664,Reproductive Endocrinology|Polycystic Ovarian Syndrome
3760,0.991974888,151.0133933,https://clinicaltrials.gov/study/NCT00877773,NCT00877773,Advanced Cancers
3761,0.989375356,150.9053222,https://clinicaltrials.gov/study/NCT03250273,NCT03250273,Metastatic Cholangiocarcinoma|Cholangiocarcinoma|Pancreatic Cancer|Metastatic Pancreatic Cancer|Unresectable Pancreatic Cancer|Unresectable Cholangiocarcinoma
3762,0.974867833,97.22529131,https://clinicaltrials.gov/study/NCT02965573,NCT02965573,Myasthenia Gravis
3763,0.970434228,61.35985732,https://clinicaltrials.gov/study/NCT00674973,NCT00674973,Pancreatic Cancer
3764,0.96628897,52.7495683,https://clinicaltrials.gov/study/NCT05128773,NCT05128773,Breast Cancer
3765,0.963171425,46.24713507,https://clinicaltrials.gov/study/NCT01206764,NCT01206764,Renal Cell Carcinoma
3766,0.994229484,153.0109709,https://clinicaltrials.gov/study/NCT04116164,NCT04116164,Castration-Resistant Prostatic Cancer|Metastatic Disease
3767,0.930882727,36.19213061,https://clinicaltrials.gov/study/NCT03830164,NCT03830164,"Male Erectile Disorder|Prostate Adenocarcinoma|Erectile Dysfunction, CTCAE|Impotence"
3768,0.989862608,150.8869608,https://clinicaltrials.gov/study/NCT01943864,NCT01943864,Cancer
3769,0.940216949,34.67769694,https://clinicaltrials.gov/study/NCT01603264,NCT01603264,Healthy
3770,0.997538296,162.9631161,https://clinicaltrials.gov/study/NCT00045864,NCT00045864,"Lymphoma, Non-Hodgkin"
3771,0.999340571,184.8386252,https://clinicaltrials.gov/study/NCT02748564,NCT02748564,Metastatic Melanoma|Stage III Mucosal Melanoma of the Head and Neck|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin Melanoma|Stage IVA Mucosal Melanoma of the Head and Neck|Stage IVB Mucosal Melanoma of the Head and Neck|Stage IVC Mucosal Melanoma of the Head and Neck
3772,0.992644781,152.315605,https://clinicaltrials.gov/study/NCT00572364,NCT00572364,Advanced Solid Malignancies
3773,0.999550713,189.1002859,https://clinicaltrials.gov/study/NCT00003864,NCT00003864,Esophageal Cancer
3774,0.999636649,187.7550125,https://clinicaltrials.gov/study/NCT00036764,NCT00036764,Recurrent Melanoma|Stage IV Melanoma
3775,0.636023511,3.612139962,https://clinicaltrials.gov/study/NCT01284764,NCT01284764,Foreign Body Left During Endoscopic Examination
3776,0.982630063,119.7734837,https://clinicaltrials.gov/study/NCT01635764,NCT01635764,Hidradenitis Suppurativa
3777,0.990539638,150.5685421,https://clinicaltrials.gov/study/NCT03511664,NCT03511664,Prostate Cancer
3778,0.982848213,116.932982,https://clinicaltrials.gov/study/NCT04404361,NCT04404361,COVID19|COVID-19|COVID
3779,0.998707379,175.5817614,https://clinicaltrials.gov/study/NCT00431561,NCT00431561,Glioblastoma|Anaplastic Astrocytoma
3780,0.999608013,191.6325551,https://clinicaltrials.gov/study/NCT00028561,NCT00028561,"Unspecified Adult Solid Tumor, Protocol Specific"
3781,0.984212725,145.4166745,https://clinicaltrials.gov/study/NCT00102661,NCT00102661,Chronic Lymphocytic Leukemia
3782,0.999608087,183.3927395,https://clinicaltrials.gov/study/NCT01288261,NCT01288261,Human Epidermal Growth Factor 2 Negative Carcinoma of Breast|Male Breast Cancer|Recurrent Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
3783,0.99300302,153.0001479,https://clinicaltrials.gov/study/NCT03778073,NCT03778073,B-cell Non Hodgkin Lymphoma|Richter's Transformation
3784,0.990604982,152.1392036,https://clinicaltrials.gov/study/NCT01714973,NCT01714973,Radiation-induced Dermatitis
3785,0.969777137,79.20619107,https://clinicaltrials.gov/study/NCT00089973,NCT00089973,"Neoplasms, Breast"
3786,0.990715039,151.7316664,https://clinicaltrials.gov/study/NCT03827473,NCT03827473,Castration-Sensitive Prostate Carcinoma|Metastatic Prostatic Adenocarcinoma|Stage IV Prostate Cancer|Stage IVA Prostate Cancer|Stage IVB Prostate Cancer
3787,0.953619952,42.97937734,https://clinicaltrials.gov/study/NCT00814073,NCT00814073,Indolent Systemic Mastocytosis
3788,0.993073124,152.7935287,https://clinicaltrials.gov/study/NCT01668173,NCT01668173,Myeloproliferative Neoplasms
3789,0.980332059,82.84893752,https://clinicaltrials.gov/study/NCT02350764,NCT02350764,Advanced Stage Non-small Cell Lung Cancer
3790,0.993649833,153.4860285,https://clinicaltrials.gov/study/NCT01390064,NCT01390064,Stage IV Breast Cancer
3791,0.999408135,187.3171019,https://clinicaltrials.gov/study/NCT00343564,NCT00343564,Non-Hodgkin's Lymphoma|Hodgkin's Disease
3792,0.997032611,159.1894308,https://clinicaltrials.gov/study/NCT00044564,NCT00044564,"Carcinoma, Renal Cell"
3793,0.998401174,174.6656109,https://clinicaltrials.gov/study/NCT00002764,NCT00002764,Endometrial Cancer|Kidney Cancer|Metastatic Cancer|Ovarian Cancer|Pheochromocytoma|Sarcoma
3794,0.974163448,79.86415023,https://clinicaltrials.gov/study/NCT00546364,NCT00546364,Breast Neoplasms
3795,0.984007187,124.7528448,https://clinicaltrials.gov/study/NCT00136864,NCT00136864,Non-Small-Cell Lung Carcinoma
3796,0.974652551,84.19717941,https://clinicaltrials.gov/study/NCT00533364,NCT00533364,Breast Cancer
3797,0.996058818,157.1483845,https://clinicaltrials.gov/study/NCT01057264,NCT01057264,Advanced Cancers
3798,0.956988468,48.32406579,https://clinicaltrials.gov/study/NCT00948064,NCT00948064,Leukemia
3799,0.981429722,130.6636783,https://clinicaltrials.gov/study/NCT01683864,NCT01683864,Gastric Cancer|Peritoneal Carcinomatosis
3800,0.982738184,115.7737374,https://clinicaltrials.gov/study/NCT02310464,NCT02310464,Metastatic Gastric Cancer|Metastatic Breast Cancer|Metastatic Colorectal Cancer|Metastatic Lung Cancer
3801,0.994984658,155.829716,https://clinicaltrials.gov/study/NCT00244764,NCT00244764,"Carcinoma, Renal Cell"
3802,0.999123373,184.8361072,https://clinicaltrials.gov/study/NCT02316964,NCT02316964,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Recurrent Adult Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia
3803,0.996944418,157.4776253,https://clinicaltrials.gov/study/NCT00742261,NCT00742261,Solid Tumours
3804,0.996510431,159.3184107,https://clinicaltrials.gov/study/NCT01699061,NCT01699061,Solid Tumors
3805,0.986661387,150.6381688,https://clinicaltrials.gov/study/NCT00604461,NCT00604461,Mesothelioma
3806,0.998207005,168.7915612,https://clinicaltrials.gov/study/NCT00002961,NCT00002961,Leukemia
3807,0.998241068,163.1411536,https://clinicaltrials.gov/study/NCT00001561,NCT00001561,Graft vs Host Disease|Multiple Myeloma
3808,0.975010201,75.67090521,https://clinicaltrials.gov/study/NCT00187161,NCT00187161,"Non-Hodgkin Lymphoma|Acute Lymphoblastic Leukemia, Mature B-Cell"
3809,0.981258138,100.7799056,https://clinicaltrials.gov/study/NCT01719861,NCT01719861,Small Cell Lung Cancer (SCLC)|Neuroendocrine Tumors
3810,0.982991435,119.3166968,https://clinicaltrials.gov/study/NCT01485861,NCT01485861,Prostate Cancer
3811,0.988735486,150.6605829,https://clinicaltrials.gov/study/NCT00244361,NCT00244361,Opsoclonus-myoclonus Syndrome|Opsoclonus|Myoclonus|Ataxia
3812,0.998598226,179.9701298,https://clinicaltrials.gov/study/NCT00079261,NCT00079261,Lymphoma|Small Intestine Cancer
3813,0.989822138,150.7663102,https://clinicaltrials.gov/study/NCT01420861,NCT01420861,Prostate Cancer
3814,0.990229794,151.3505163,https://clinicaltrials.gov/study/NCT05252364,NCT05252364,Metastatic Castration-resistant Prostate Cancer
3815,0.951672201,37.87256646,https://clinicaltrials.gov/study/NCT00858364,NCT00858364,Non-Small Cell Lung Cancer|Anemia|Cancer|Lung Cancer
3816,0.998111419,166.973144,https://clinicaltrials.gov/study/NCT00083564,NCT00083564,Multiple Myeloma
3817,0.970301048,59.86491273,https://clinicaltrials.gov/study/NCT00486564,NCT00486564,Neuroblastoma
3818,0.99880266,175.6813977,https://clinicaltrials.gov/study/NCT00408564,NCT00408564,Pancreatic Cancer
3819,0.987808587,150.7653615,https://clinicaltrials.gov/study/NCT02231164,NCT02231164,"Carcinoma, Non-Small-Cell Lung"
3820,0.985983596,119.5670363,https://clinicaltrials.gov/study/NCT00467961,NCT00467961,CML (Chronic Myelogenous Leukemia)|CLL (Chronic Lymphocytic Leukemia)|AML (Acute Myelogenous Leukemia)|Acute Lymphocytic Leukemia|MDS (Myelodysplastic Syndrome)
3821,0.969160233,77.52931874,https://clinicaltrials.gov/study/NCT03443661,NCT03443661,Locally Advanced Rectal Cancer
3822,0.93026599,31.35758137,https://clinicaltrials.gov/study/NCT05414461,NCT05414461,Colorectal Cancer
3823,0.998655213,170.511442,https://clinicaltrials.gov/study/NCT00004861,NCT00004861,Pancreatic Cancer
3824,0.99208312,151.7371659,https://clinicaltrials.gov/study/NCT00443261,NCT00443261,Squamous Cell Carcinoma
3825,0.991138484,150.556711,https://clinicaltrials.gov/study/NCT00816361,NCT00816361,Cancer
3826,0.99943299,178.5200953,https://clinicaltrials.gov/study/NCT01531361,NCT01531361,Advanced Malignant Neoplasm|BRAF Gene Mutation|Metastatic Malignant Neoplasm|Recurrent Malignant Neoplasm|Refractory Malignant Neoplasm
3827,0.992841244,153.7098686,https://clinicaltrials.gov/study/NCT01918761,NCT01918761,Non Small Cell Lung Cancer
3828,0.997875476,164.5719633,https://clinicaltrials.gov/study/NCT00118261,NCT00118261,Colorectal Cancer
3829,0.959851568,50.86090028,https://clinicaltrials.gov/study/NCT02484261,NCT02484261,Leukemia
3830,0.997261227,164.2972825,https://clinicaltrials.gov/study/NCT00707161,NCT00707161,Cancer|Melanoma
3831,0.807896708,10.03309165,https://clinicaltrials.gov/study/NCT02624661,NCT02624661,Trigeminal Neuralgia|Headache Disorders
3832,0.997280133,162.1564023,https://clinicaltrials.gov/study/NCT00400764,NCT00400764,Non-Hodgkin's Lymphoma
3833,0.982896453,125.2190929,https://clinicaltrials.gov/study/NCT02151864,NCT02151864,Hepatocellular Carcinoma|Cirrhosis
3834,0.983863268,117.7305314,https://clinicaltrials.gov/study/NCT00002864,NCT00002864,Breast Cancer
3835,0.988359921,150.434928,https://clinicaltrials.gov/study/NCT00205764,NCT00205764,Multiple Myeloma
3836,0.988563836,150.0560826,https://clinicaltrials.gov/study/NCT00477464,NCT00477464,"Metastatic Breast Cancer|Neoplasms, Breast"
3837,0.997166282,164.2330725,https://clinicaltrials.gov/study/NCT00002964,NCT00002964,Head and Neck Cancer
3838,0.991728584,152.1917518,https://clinicaltrials.gov/study/NCT00123864,NCT00123864,Nasopharyngeal Neoplasms
3839,0.996639045,158.2651427,https://clinicaltrials.gov/study/NCT01088464,NCT01088464,Neoplasms
3840,0.998631553,182.1288123,https://clinicaltrials.gov/study/NCT01075464,NCT01075464,Solid Cancers
3841,0.998542778,176.770748,https://clinicaltrials.gov/study/NCT00821964,NCT00821964,Male Breast Cancer|Recurrent Breast Cancer|Skin Metastases|Stage IV Breast Cancer
3842,0.876823366,16.42058629,https://clinicaltrials.gov/study/NCT01384864,NCT01384864,Barrett's Esophagus|Intraepithelial Neoplasia
3843,0.998662702,176.5077208,https://clinicaltrials.gov/study/NCT01023061,NCT01023061,Adenocarcinoma of the Prostate|Stage II Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer
3844,0.997868887,165.7041734,https://clinicaltrials.gov/study/NCT02540161,NCT02540161,Malignant Glioma
3845,0.981178125,127.9374718,https://clinicaltrials.gov/study/NCT01830361,NCT01830361,Acute Myeloid Leukemia
3846,0.907792121,18.50615437,https://clinicaltrials.gov/study/NCT00558961,NCT00558961,Chronic Lymphocytic Leukemia
3847,0.978849311,78.63508403,https://clinicaltrials.gov/study/NCT03205761,NCT03205761,Advanced Breast Cancer
3848,0.985117271,135.2881843,https://clinicaltrials.gov/study/NCT00719264,NCT00719264,Carcinoma|Adenocarcinoma|Renal Cell|Nephroid Carcinoma|Hypernephroid
3849,0.999393289,179.7693261,https://clinicaltrials.gov/study/NCT00006464,NCT00006464,"Unspecified Adult Solid Tumor, Protocol Specific"
3850,0.994096924,153.6250186,https://clinicaltrials.gov/study/NCT00233961,NCT00233961,Leukemia
3851,0.997434774,162.866704,https://clinicaltrials.gov/study/NCT00077961,NCT00077961,Non-Hodgkin's Lymphoma
3852,0.997390386,162.1692185,https://clinicaltrials.gov/study/NCT00379561,NCT00379561,Prostate Cancer
3853,0.998840072,178.6278457,https://clinicaltrials.gov/study/NCT00656461,NCT00656461,Advanced Cancer
3854,0.984036072,120.0895005,https://clinicaltrials.gov/study/NCT01500161,NCT01500161,Acute Myelogenous Leukemia|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Hodgkins Disease|Non-Hodgkins Lymphoma|Aplastic Anemia|Multiple Myeloma|Myelodysplastic Syndrome
3855,0.931797992,32.29319588,https://clinicaltrials.gov/study/NCT03344861,NCT03344861,Lung Cancer|Lung Cancer Metastatic
3856,0.998083214,170.2836682,https://clinicaltrials.gov/study/NCT01943461,NCT01943461,Solid Tumors
3857,0.990909843,152.8171761,https://clinicaltrials.gov/study/NCT00003473,NCT00003473,Mixed Gliomas
3858,0.997710376,165.5396543,https://clinicaltrials.gov/study/NCT02645864,NCT02645864,Esophageal Squamous Cell Carcinoma
3859,0.997298492,161.3215061,https://clinicaltrials.gov/study/NCT02900664,NCT02900664,"Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma"
3860,0.983903084,123.7873179,https://clinicaltrials.gov/study/NCT01144364,NCT01144364,Non-Hodgkin's Lymphoma
3861,0.994895801,153.5561828,https://clinicaltrials.gov/study/NCT00725764,NCT00725764,"Neoplasms, Head and Neck"
3862,0.999310482,186.3573708,https://clinicaltrials.gov/study/NCT01215864,NCT01215864,Advanced Solid Tumors
3863,0.998279839,168.3736887,https://clinicaltrials.gov/study/NCT01522664,NCT01522664,Malignant Melanoma
3864,0.997735408,166.8405042,https://clinicaltrials.gov/study/NCT01364064,NCT01364064,Glioblastoma
3865,0.992425704,151.4943717,https://clinicaltrials.gov/study/NCT00903461,NCT00903461,"Carcinoma, Squamous Cell of Head and Neck|Squamous Cell Carcinoma of the Head and Neck|Squamous Cell Carcinoma, Head And Neck"
3866,0.812908936,9.894863667,https://clinicaltrials.gov/study/NCT01582061,NCT01582061,Cushing's Disease
3867,0.99704587,161.1120553,https://clinicaltrials.gov/study/NCT00874861,NCT00874861,Astrocytoma|Oligoastrocytoma|Oligodendroglioma
3868,0.997407651,158.4750273,https://clinicaltrials.gov/study/NCT02027961,NCT02027961,Melanoma
3869,0.995703528,158.9746743,https://clinicaltrials.gov/study/NCT03283761,NCT03283761,Gastro-Esophageal Junction Adenocarcinoma|Gastric Cancer
3870,0.9904758,150.9796612,https://clinicaltrials.gov/study/NCT02499861,NCT02499861,Cancer
3871,0.998402886,170.2069078,https://clinicaltrials.gov/study/NCT00527761,NCT00527761,Metastatic Melanoma
3872,0.998787949,183.6071022,https://clinicaltrials.gov/study/NCT01132664,NCT01132664,Metastatic Breast Cancer|HER2+ Breast Cancer
3873,0.997004117,159.2519364,https://clinicaltrials.gov/study/NCT01471964,NCT01471964,Non-small Cell Lung Cancer Metastatic|Non-small Cell Lung Cancer Recurrent
3874,0.997629528,163.2995548,https://clinicaltrials.gov/study/NCT00012064,NCT00012064,Melanoma (Skin)
3875,0.997329908,161.4573393,https://clinicaltrials.gov/study/NCT01373164,NCT01373164,Neoplasms|Neoplasm Metastasis|Pancreatic Cancer
3876,0.994970579,155.8943725,https://clinicaltrials.gov/study/NCT03580564,NCT03580564,Classical Hodgkin Lymphoma
3877,0.984556363,124.2365757,https://clinicaltrials.gov/study/NCT00633464,NCT00633464,Triple Negative Locally Advanced Non-resectable Breast Cancer|Metastatic Breast Cancer
3878,0.977611221,81.67150741,https://clinicaltrials.gov/study/NCT00252564,NCT00252564,Metastatic Colorectal Cancer
3879,0.743058788,5.895324994,https://clinicaltrials.gov/study/NCT01082861,NCT01082861,Human Papillomavirus Infection
3880,0.871585929,14.83544306,https://clinicaltrials.gov/study/NCT02025361,NCT02025361,Adenocarcinoma of Prostate
3881,0.988448001,150.4872852,https://clinicaltrials.gov/study/NCT02215161,NCT02215161,Castration Levels of Testosterone|Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma in the Soft Tissue|Prostate Carcinoma Metastatic in the Bone|PSA Progression|Stage IV Prostate Adenocarcinoma AJCC v7
3882,0.982567599,122.8641886,https://clinicaltrials.gov/study/NCT00345761,NCT00345761,Colorectal Cancer
3883,0.869743647,16.92391485,https://clinicaltrials.gov/study/NCT00402961,NCT00402961,"Postoperative Ileus|Colon Cancer|Pain, Postoperative|Postoperative Nausea and Vomiting"
3884,0.995106494,156.4785586,https://clinicaltrials.gov/study/NCT00136461,NCT00136461,Acute Myelogenous Leukemia|Myelodysplastic Syndrome
3885,0.753524799,6.864142293,https://clinicaltrials.gov/study/NCT02653261,NCT02653261,Hemorrhage
3886,0.896268782,19.4781449,https://clinicaltrials.gov/study/NCT04321161,NCT04321161,"Acute Myeloid Leukemia, in Relapse"
3887,0.975816582,72.69309042,https://clinicaltrials.gov/study/NCT01231061,NCT01231061,Spine Metastasis
3888,0.865182519,14.96979317,https://clinicaltrials.gov/study/NCT00837161,NCT00837161,Uterine Fibroids|Uterine Leiomyomata
3889,0.951974403,39.29222803,https://clinicaltrials.gov/study/NCT00165061,NCT00165061,Esophageal Cancer
3890,0.999113088,188.9894837,https://clinicaltrials.gov/study/NCT00006361,NCT00006361,Carcinoma of Unknown Primary|Head and Neck Cancer|Non-melanomatous Skin Cancer
3891,0.847203382,11.01773385,https://clinicaltrials.gov/study/NCT00375661,NCT00375661,"Hepatitis C, Chronic"
3892,0.998619795,178.978457,https://clinicaltrials.gov/study/NCT01537861,NCT01537861,Multiple Myeloma
3893,0.987862555,150.4500809,https://clinicaltrials.gov/study/NCT00881621,NCT00881621,Pancreas Cancer
3894,0.985150483,127.2757108,https://clinicaltrials.gov/study/NCT03726021,NCT03726021,Overall Survival
3895,0.999403373,184.5563492,https://clinicaltrials.gov/study/NCT00093821,NCT00093821,Childhood Chronic Myelogenous Leukemia|Childhood Desmoplastic Small Round Cell Tumor|Disseminated Neuroblastoma|Metastatic Childhood Soft Tissue Sarcoma|Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Metastatic Osteosarcoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Neuroblastoma|Recurrent Osteosarcoma
3896,0.998123954,164.3635977,https://clinicaltrials.gov/study/NCT02767921,NCT02767921,Infiltrating Bladder Urothelial Carcinoma|Recurrent Bladder Carcinoma|Stage I Prostate Cancer|Stage I Renal Cell Cancer|Stage II Bladder Urothelial Carcinoma|Stage II Renal Cell Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage III Renal Cell Cancer
3897,0.999287814,189.7639686,https://clinicaltrials.gov/study/NCT00329121,NCT00329121,"Carcinoma, Squamous Cell"
3898,0.999688432,186.5334611,https://clinicaltrials.gov/study/NCT03514121,NCT03514121,Breast Cancer|Ovarian Cancer|Endometrial Cancer|Advanced Solid Tumors
3899,0.901055086,14.55461105,https://clinicaltrials.gov/study/NCT00528931,NCT00528931,Dupuytren's Contracture
3900,0.994394086,152.9147896,https://clinicaltrials.gov/study/NCT03162731,NCT03162731,"Larynx|Lip, Oral Cavity and Pharynx"
3901,0.999006216,183.3644499,https://clinicaltrials.gov/study/NCT00193531,NCT00193531,Neuroendocrine Carcinoma
3902,0.988577015,132.9951066,https://clinicaltrials.gov/study/NCT00306631,NCT00306631,Breast Cancer
3903,0.995224871,156.0203514,https://clinicaltrials.gov/study/NCT01017731,NCT01017731,Cancer|Solid Tumor
3904,0.991527915,152.110282,https://clinicaltrials.gov/study/NCT04720131,NCT04720131,Biliary Tract Cancer|Anti-PD-1 Therapy|Targeted Molecular Therapy|Capecitabine
3905,0.974648327,81.88319293,https://clinicaltrials.gov/study/NCT02980731,NCT02980731,Chronic Lymphocytic Leukemia (CLL)
3906,0.987992703,150.3274308,https://clinicaltrials.gov/study/NCT04688931,NCT04688931,Bladder Cancer|Urothelial Carcinoma|Urothelial Carcinoma Bladder
3907,0.994774858,153.7345,https://clinicaltrials.gov/study/NCT00633542,NCT00633542,Multiple Myeloma
3908,0.974690316,64.56759235,https://clinicaltrials.gov/study/NCT00322842,NCT00322842,"Lymphoma, Non-Hodgkin|Multiple Myeloma"
3909,0.997355057,159.7844232,https://clinicaltrials.gov/study/NCT00686842,NCT00686842,Kaposi's Sarcoma
3910,0.977463374,97.25735044,https://clinicaltrials.gov/study/NCT02896842,NCT02896842,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
3911,0.996168586,156.5999344,https://clinicaltrials.gov/study/NCT00101842,NCT00101842,"Carcinoma, Transitional Cell"
3912,0.999151897,178.812932,https://clinicaltrials.gov/study/NCT00052065,NCT00052065,Ovarian Neoplasms
3913,0.995664236,155.2200233,https://clinicaltrials.gov/study/NCT00418665,NCT00418665,Myelodysplastic Syndromes|Thrombocytopenia
3914,0.997218868,158.9786912,https://clinicaltrials.gov/study/NCT03278665,NCT03278665,Malignant Melanoma
3915,0.996759611,159.150043,https://clinicaltrials.gov/study/NCT00499265,NCT00499265,Pancreatic Cancer
3916,0.995318692,156.1539917,https://clinicaltrials.gov/study/NCT02897765,NCT02897765,"Urinary Bladder Cancer|Bladder Tumors|Transitional Cell Carcinoma of the Bladder|Malignant Melanoma|Melanoma|Skin Cancer|Carcinoma, Non-Small-Cell Lung|Lung Cancer"
3917,0.98761551,150.4720117,https://clinicaltrials.gov/study/NCT00703365,NCT00703365,"Carcinoma, Hepatocellular"
3918,0.997848677,166.2592922,https://clinicaltrials.gov/study/NCT00003065,NCT00003065,Cervical Cancer
3919,0.95519013,39.67008339,https://clinicaltrials.gov/study/NCT01888965,NCT01888965,Colorectal Cancer|Pancreas Cancer
3920,0.998522756,175.9328891,https://clinicaltrials.gov/study/NCT02351765,NCT02351765,Biliary Tract Cancer|Gallbladder Cancer|Cholangiocarcinoma|Ampullary Cancer
3921,0.995315263,156.8833006,https://clinicaltrials.gov/study/NCT02394665,NCT02394665,Glioblastoma
3922,0.99906195,185.6102223,https://clinicaltrials.gov/study/NCT00509665,NCT00509665,Head and Neck Cancer
3923,0.998624508,173.0925192,https://clinicaltrials.gov/study/NCT03188965,NCT03188965,Advanced Solid Tumor|Non-Hodgkin's Lymphoma|Mantle Cell Lymphoma
3924,0.998917818,180.9269766,https://clinicaltrials.gov/study/NCT00689065,NCT00689065,Cancer|Solid Tumor
3925,0.998389918,170.1707478,https://clinicaltrials.gov/study/NCT00006465,NCT00006465,"Unspecified Adult Solid Tumor, Protocol Specific"
3926,0.999681834,189.5135822,https://clinicaltrials.gov/study/NCT00045565,NCT00045565,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma
3927,0.99838709,173.9074788,https://clinicaltrials.gov/study/NCT00336765,NCT00336765,Cancer
3928,0.984542933,150.0031197,https://clinicaltrials.gov/study/NCT00267865,NCT00267865,AIDS-Related-Primary Central Nervous System Lymphoma
3929,0.553398512,3.70502978,https://clinicaltrials.gov/study/NCT00400465,NCT00400465,Thyroid Neoplasms|Thyroid Nodules|Graves Disease|Goiter
3930,0.995009183,157.4336261,https://clinicaltrials.gov/study/NCT00950365,NCT00950365,Bronchioloalveolar Carcinoma|Large Cell Lung Carcinoma|Lung Adenocarcinoma|Recurrent Non-Small Cell Lung Carcinoma|Stage IIIB Non-Small Cell Lung Cancer|Stage IV Non-Small Cell Lung Cancer
3931,0.997780238,166.8743856,https://clinicaltrials.gov/study/NCT01337765,NCT01337765,"Unspecified Adult Solid Tumor, Protocol Specific|Solid Tumor"
3932,0.939315167,29.54443938,https://clinicaltrials.gov/study/NCT00721565,NCT00721565,Breast Cancer
3933,0.943771111,38.03589513,https://clinicaltrials.gov/study/NCT01249365,NCT01249365,"Infections, Papillomavirus"
3934,0.995270612,156.2687986,https://clinicaltrials.gov/study/NCT01355965,NCT01355965,Malignant Pleural Mesothelioma
3935,0.993289836,153.443768,https://clinicaltrials.gov/study/NCT02213289,NCT02213289,Adenocarcinoma
3936,0.998320357,169.3653251,https://clinicaltrials.gov/study/NCT02448589,NCT02448589,Advanced Solid Tumors
3937,0.993289706,152.811667,https://clinicaltrials.gov/study/NCT00183989,NCT00183989,Mantle Cell Lymphoma
3938,0.971440704,76.51826733,https://clinicaltrials.gov/study/NCT00090389,NCT00090389,Ovarian Neoplasms|Endometriosis|Pelvic Pain|Uterine Neoplasms
3939,0.99614866,155.6029484,https://clinicaltrials.gov/study/NCT00532389,NCT00532389,Multiple Myeloma
3940,0.902789099,19.9829613,https://clinicaltrials.gov/study/NCT01743989,NCT01743989,Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
3941,0.993886427,153.1649559,https://clinicaltrials.gov/study/NCT01915589,NCT01915589,"Carcinoma, Hepatocellular"
3942,0.957273083,56.84059819,https://clinicaltrials.gov/study/NCT01562821,NCT01562821,Acquired Bleeding Disorder|Cirrhosis
3943,0.98575028,145.1693726,https://clinicaltrials.gov/study/NCT00279721,NCT00279721,Thyroid Neoplasms
3944,0.997317012,162.607818,https://clinicaltrials.gov/study/NCT01022021,NCT01022021,Lymphoma
3945,0.999674039,185.2418451,https://clinicaltrials.gov/study/NCT04191421,NCT04191421,Metastatic Pancreatic Adenocarcinoma|Stage IV Pancreatic Cancer AJCC v8
3946,0.867919695,16.27027814,https://clinicaltrials.gov/study/NCT02101931,NCT02101931,Transitional Cell Carcinoma of the Bladder
3947,0.978105451,102.7517196,https://clinicaltrials.gov/study/NCT00378131,NCT00378131,Cancer Cachexia
3948,0.998622591,179.1120125,https://clinicaltrials.gov/study/NCT01358331,NCT01358331,"Tumor, Solid"
3949,0.996319916,156.6640913,https://clinicaltrials.gov/study/NCT02918331,NCT02918331,Multiple Myeloma
3950,0.986981606,150.3220518,https://clinicaltrials.gov/study/NCT00005931,NCT00005931,"Sarcoma, Kaposi|HIV Infections"
3951,0.995049009,154.2469413,https://clinicaltrials.gov/study/NCT00496431,NCT00496431,Hodgkin's Lymphoma
3952,0.979030001,88.07936383,https://clinicaltrials.gov/study/NCT01013831,NCT01013831,Dysplasia|Metaplasia|Pulmonary Precancerous Condition
3953,0.915054945,15.73735335,https://clinicaltrials.gov/study/NCT02477631,NCT02477631,Myelodysplastic Syndrome With Low-grade Lesions|Iron Overload Due to Repeated Red Blood Cell Transfusions
3954,0.949480036,44.15442112,https://clinicaltrials.gov/study/NCT00102531,NCT00102531,Osteosarcoma Metastatic
3955,0.985950876,143.7543804,https://clinicaltrials.gov/study/NCT02938442,NCT02938442,Triple Negative Breast Cancer|Breast Neoplasms
3956,0.992437433,152.5547471,https://clinicaltrials.gov/study/NCT02792842,NCT02792842,Postoperative Stage II/III Colon Cancer
3957,0.995744234,157.0456606,https://clinicaltrials.gov/study/NCT00494442,NCT00494442,Ovarian Neoplasm
3958,0.995368409,155.0911229,https://clinicaltrials.gov/study/NCT00268242,NCT00268242,Leukemia
3959,0.9720993,59.4403638,https://clinicaltrials.gov/study/NCT00146042,NCT00146042,HER-2 Positive Metastatic Breast Cancer
3960,0.998729792,182.9941118,https://clinicaltrials.gov/study/NCT00084942,NCT00084942,Extrahepatic Bile Duct Cancer|Gallbladder Cancer
3961,0.999686319,190.8562435,https://clinicaltrials.gov/study/NCT00006042,NCT00006042,Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
3962,0.982877824,114.8384231,https://clinicaltrials.gov/study/NCT04712942,NCT04712942,Acute Myeloid Leukemia in Remission|Myelodysplastic Syndromes|Minimal Residual Disease
3963,0.980641528,87.11797067,https://clinicaltrials.gov/study/NCT01007942,NCT01007942,HER2/Neu Over-expressing Locally Advanced Breast Cancer|Metastatic Breast Cancer
3964,0.961760037,40.37579719,https://clinicaltrials.gov/study/NCT01156142,NCT01156142,Head and Neck Cancer|Mucositis|Oral Complications of Radiation Therapy|Pain
3965,0.989685584,150.9938493,https://clinicaltrials.gov/study/NCT00961142,NCT00961142,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia
3966,0.999342694,184.504127,https://clinicaltrials.gov/study/NCT00003642,NCT00003642,Bladder Cancer
3967,0.981672491,84.28051843,https://clinicaltrials.gov/study/NCT03674242,NCT03674242,Triple Negative Breast Cancer
3968,0.995287168,155.5376378,https://clinicaltrials.gov/study/NCT01336842,NCT01336842,Solid Tumors|Non-Small Cell Lung Cancer (NSCLC)
3969,0.996286488,159.4887588,https://clinicaltrials.gov/study/NCT00955942,NCT00955942,Lung Cancer|Radiation Toxicity
3970,0.997563644,164.7242002,https://clinicaltrials.gov/study/NCT02642965,NCT02642965,Acute Myeloid Leukemia Post Cytotoxic Therapy|Recurrent Childhood Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia
3971,0.994818046,154.9206254,https://clinicaltrials.gov/study/NCT02336165,NCT02336165,Glioblastoma
3972,0.992590452,152.3221865,https://clinicaltrials.gov/study/NCT02015065,NCT02015065,GIST
3973,0.997565368,159.0172503,https://clinicaltrials.gov/study/NCT01807065,NCT01807065,Adenocarcinoma of the Prostate|Bone Metastases|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Soft Tissue Metastases|Stage IV Prostate Cancer
3974,0.998960899,186.1390604,https://clinicaltrials.gov/study/NCT00003565,NCT00003565,"Bladder Cancer|Breast Cancer|Head and Neck Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
3975,0.997015618,158.6626101,https://clinicaltrials.gov/study/NCT00141765,NCT00141765,"Wilms Tumor|Fibrosarcoma|Carcinoma, Round Cell|Nasopharyngeal Cancer|Brain Tumor, Recurrent"
3976,0.996921716,159.5705943,https://clinicaltrials.gov/study/NCT01192165,NCT01192165,Cancer
3977,0.91833293,27.33280627,https://clinicaltrials.gov/study/NCT00127465,NCT00127465,Breast Neoplasms|Prostatic Neoplasms|Laryngeal Neoplasms|Cervix Neoplasms
3978,0.662979176,5.066084087,https://clinicaltrials.gov/study/NCT02655965,NCT02655965,Locoregional Analgesia in Breast Surgery
3979,0.851414909,12.55219605,https://clinicaltrials.gov/study/NCT01254565,NCT01254565,Secondary Hyperparathyroidism
3980,0.913070745,26.70864567,https://clinicaltrials.gov/study/NCT02672865,NCT02672865,Locally Advanced Malignant Neoplasm|Gastric Cancer
3981,0.943090922,34.1478885,https://clinicaltrials.gov/study/NCT01749865,NCT01749865,"Carcinoma, Hepatocellular"
3982,0.973844118,82.37544916,https://clinicaltrials.gov/study/NCT00185965,NCT00185965,Non-Hodgkin Lymphoma|Mycosis Fungoides
3983,0.995011209,155.2498713,https://clinicaltrials.gov/study/NCT02944565,NCT02944565,Plasma Cell Myeloma
3984,0.997709563,165.1991572,https://clinicaltrials.gov/study/NCT05066165,NCT05066165,Acute Myeloid Leukemia
3985,0.996430026,159.7388055,https://clinicaltrials.gov/study/NCT02043665,NCT02043665,Non-small Cell Lung Cancer|Bladder Cancer
3986,0.784302188,8.583073536,https://clinicaltrials.gov/study/NCT00375765,NCT00375765,Benign Prostatic Hyperplasia|Prostate Cancer
3987,0.993582149,152.8173363,https://clinicaltrials.gov/study/NCT02181465,NCT02181465,Colorectal Cancer
3988,0.99792141,167.1523148,https://clinicaltrials.gov/study/NCT02620865,NCT02620865,Metastatic Pancreatic Adenocarcinoma|Recurrent Pancreatic Carcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
3989,0.996557653,157.7928414,https://clinicaltrials.gov/study/NCT02640365,NCT02640365,Unresectable Advanced Cancer
3990,0.989869668,151.8050056,https://clinicaltrials.gov/study/NCT00392665,NCT00392665,Squamous Cell Carcinoma of the Head and Neck (SCCHN)
3991,0.956215212,38.92972422,https://clinicaltrials.gov/study/NCT00478465,NCT00478465,Chronic Fatigue Syndrome
3992,0.993296587,153.159736,https://clinicaltrials.gov/study/NCT03190265,NCT03190265,Pancreatic Cancer
3993,0.96079881,44.49473583,https://clinicaltrials.gov/study/NCT01410565,NCT01410565,Bladder Cancer
3994,0.993736924,153.2978633,https://clinicaltrials.gov/study/NCT00041665,NCT00041665,Stomatitis
3995,0.916944917,22.29155694,https://clinicaltrials.gov/study/NCT04369365,NCT04369365,COVID
3996,0.99725833,162.4318917,https://clinicaltrials.gov/study/NCT00516165,NCT00516165,Hepatocellular Carcinoma
3997,0.997984145,168.0692492,https://clinicaltrials.gov/study/NCT02738489,NCT02738489,Advanced Melanoma
3998,0.999105911,193.447514,https://clinicaltrials.gov/study/NCT02319889,NCT02319889,Stage I Non-Small Cell Lung Cancer|Stage II Non-Small Cell Lung Cancer
3999,0.994838542,154.5511435,https://clinicaltrials.gov/study/NCT00707889,NCT00707889,Advanced Colorectal Cancer|Adenocarcinoma of the Colon|Adenocarcinoma of the Rectum
4000,0.999191705,184.4155951,https://clinicaltrials.gov/study/NCT00001189,NCT00001189,Sarcoma|Neoplasms
4001,0.996699556,156.9375298,https://clinicaltrials.gov/study/NCT01131689,NCT01131689,Hepatocellular Carcinoma
4002,0.993116658,152.8169402,https://clinicaltrials.gov/study/NCT01841489,NCT01841489,Chronic Lymphocytic Leukemia
4003,0.985701387,142.4494447,https://clinicaltrials.gov/study/NCT02137889,NCT02137889,Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
4004,0.985214674,136.1908139,https://clinicaltrials.gov/study/NCT00389389,NCT00389389,Neoplasms
4005,0.964068474,61.95599928,https://clinicaltrials.gov/study/NCT01200121,NCT01200121,Malignant Ascites|Gastrointestinal Cancers
4006,0.999002664,191.4424712,https://clinicaltrials.gov/study/NCT00043121,NCT00043121,"Unspecified Adult Solid Tumor, Protocol Specific"
4007,0.962527316,55.66971033,https://clinicaltrials.gov/study/NCT00569231,NCT00569231,Warts|HPV
4008,0.9970831,157.6367098,https://clinicaltrials.gov/study/NCT00294931,NCT00294931,"Carcinoma, Small Cell Lung"
4009,0.991835492,152.0103113,https://clinicaltrials.gov/study/NCT00003531,NCT00003531,Stage IV Pancreatic Cancer
4010,0.992162812,152.948626,https://clinicaltrials.gov/study/NCT00055731,NCT00055731,Prostate Cancer
4011,0.960809629,48.22125227,https://clinicaltrials.gov/study/NCT03252431,NCT03252431,Breast Cancer|Neutropenia
4012,0.993225259,154.0036488,https://clinicaltrials.gov/study/NCT00720031,NCT00720031,Immunotherapy
4013,0.999158576,187.877761,https://clinicaltrials.gov/study/NCT01472731,NCT01472731,Primary Brain Tumors
4014,0.970180449,65.61063359,https://clinicaltrials.gov/study/NCT00548431,NCT00548431,"Leukemia, Lymphocytic, Acute"
4015,0.993125128,153.5608407,https://clinicaltrials.gov/study/NCT01366131,NCT01366131,Non-Squamous Non-Small Cell Lung Cancer
4016,0.93553981,26.80669184,https://clinicaltrials.gov/study/NCT00007631,NCT00007631,"Carcinoma, Basal Cell|Carcinoma, Squamous Cell|Skin Neoplasms"
4017,0.989708944,150.6377997,https://clinicaltrials.gov/study/NCT01657331,NCT01657331,Hodgkin Lymphoma|Anaplastic Large Cell Lymphoma
4018,0.9966113,160.6009612,https://clinicaltrials.gov/study/NCT04504331,NCT04504331,Breast Cancer|HER2-negative Breast Cancer|ER Positive Breast Cancer|PR-Positive Breast Cancer
4019,0.990606039,150.9785659,https://clinicaltrials.gov/study/NCT02061631,NCT02061631,Squamous Cell Carcinoma of Head and Neck
4020,0.82412992,10.05723335,https://clinicaltrials.gov/study/NCT00805142,NCT00805142,Pain|Cancer
4021,0.985368016,135.3578147,https://clinicaltrials.gov/study/NCT01474642,NCT01474642,Advanced or Recurrent Esophageal Squamous Cell Carcinoma
4022,0.999886362,191.5186187,https://clinicaltrials.gov/study/NCT01001442,NCT01001442,Multiple Myeloma
4023,0.989799521,150.1761464,https://clinicaltrials.gov/study/NCT02401542,NCT02401542,Locally Advanced or Metastatic Urothelial Cell Carcinoma|Urinary Bladder Disease|Urological Diseases
4024,0.993763271,153.3747173,https://clinicaltrials.gov/study/NCT01872442,NCT01872442,Chronic Phase of Chronic Myeloid Leukemia
4025,0.987783638,148.4697769,https://clinicaltrials.gov/study/NCT02692742,NCT02692742,Chemotherapy-Induced Neutropenia|Myelosuppression|Breast Cancer
4026,0.999542317,192.7848055,https://clinicaltrials.gov/study/NCT00071942,NCT00071942,Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
4027,0.938666148,37.72955251,https://clinicaltrials.gov/study/NCT01139242,NCT01139242,Colorectal Cancer
4028,0.997279608,159.6601765,https://clinicaltrials.gov/study/NCT00352742,NCT00352742,Multiple Myeloma
4029,0.984184705,150.0732708,https://clinicaltrials.gov/study/NCT02028442,NCT02028442,Solid Tumours of Epithelial Origin|Metastatic Colorectal Cancer|Metastatic Bladder Cancer
4030,0.994923811,154.9402453,https://clinicaltrials.gov/study/NCT04627142,NCT04627142,Metastatic Colorectal Cancer (CRC)
4031,0.998322025,172.9239977,https://clinicaltrials.gov/study/NCT00954642,NCT00954642,Solid Cancers
4032,0.999546042,191.6311548,https://clinicaltrials.gov/study/NCT04653142,NCT04653142,Solid Tumors
4033,0.998119698,166.4889514,https://clinicaltrials.gov/study/NCT00309842,NCT00309842,Acute Myeloid Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelofibrosis|MDS|Refractory Anemia|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Non-Hodgkin's Lymphoma|Leukemia|Lymphoma|Multiple Myeloma|Myelodysplastic Syndromes
4034,0.967819777,58.81395509,https://clinicaltrials.gov/study/NCT01182142,NCT01182142,Metastatic Renal Cell Carcinoma
4035,0.998145335,165.0427563,https://clinicaltrials.gov/study/NCT00070642,NCT00070642,"Carcinoma, Melanoma"
4036,0.947661536,30.31821655,https://clinicaltrials.gov/study/NCT03666442,NCT03666442,Rectal Cancer
4037,0.997250175,161.2886641,https://clinicaltrials.gov/study/NCT00030342,NCT00030342,Colorectal Cancer|Kidney Cancer
4038,0.975020525,78.20944946,https://clinicaltrials.gov/study/NCT01026142,NCT01026142,Breast Cancer
4039,0.992370369,152.8342216,https://clinicaltrials.gov/study/NCT00219765,NCT00219765,Chronic Myeloid Leukemia
4040,0.975127039,82.24573707,https://clinicaltrials.gov/study/NCT00613665,NCT00613665,Helicobacter Pylori|Gastritis|Gastric Cancer|Gastroduodenal Ulcers|Lymphoma
4041,0.998610923,178.3145804,https://clinicaltrials.gov/study/NCT01654965,NCT01654965,Adult Solid Neoplasm
4042,0.982808134,119.0147461,https://clinicaltrials.gov/study/NCT00427765,NCT00427765,Multiple Myeloma|Lymphoma
4043,0.961896643,55.03542381,https://clinicaltrials.gov/study/NCT00223665,NCT00223665,Prostate Cancer
4044,0.997692387,166.464365,https://clinicaltrials.gov/study/NCT00080665,NCT00080665,Breast Cancer
4045,0.974933123,76.94391818,https://clinicaltrials.gov/study/NCT02411565,NCT02411565,Ovarian Cancer
4046,0.98090813,95.59406573,https://clinicaltrials.gov/study/NCT00643565,NCT00643565,Sarcoma
4047,0.938516976,33.64523691,https://clinicaltrials.gov/study/NCT03649165,NCT03649165,Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)|Healthy Participants
4048,0.981365236,125.1463673,https://clinicaltrials.gov/study/NCT01898065,NCT01898065,Prostate Adenocarcinoma
4049,0.942721666,35.57814017,https://clinicaltrials.gov/study/NCT01842165,NCT01842165,Gastroenteropancreatic Neuroendocrine Tumors
4050,0.988263224,150.1551992,https://clinicaltrials.gov/study/NCT01929265,NCT01929265,Indolent Non-follicular|Non-Hodgkin's Lymphoma
4051,0.988368652,150.8521937,https://clinicaltrials.gov/study/NCT00834665,NCT00834665,Multiple Myeloma
4052,0.845208051,12.5171771,https://clinicaltrials.gov/study/NCT03173365,NCT03173365,Hand-foot Syndrome
4053,0.994038823,153.6065982,https://clinicaltrials.gov/study/NCT00460265,NCT00460265,Recurrent and/or Metastatic Head and Neck Cancer
4054,0.663527343,5.858001923,https://clinicaltrials.gov/study/NCT04942665,NCT04942665,Cholecystitis|Hepatocellular Carcinoma|Liver Metastases
4055,0.998594058,172.3585541,https://clinicaltrials.gov/study/NCT00085189,NCT00085189,"Ciliary Body and Choroid Melanoma, Medium/Large Size|Ciliary Body and Choroid Melanoma, Small Size|Extraocular Extension Melanoma|Iris Melanoma|Metastatic Intraocular Melanoma|Mucosal Melanoma|Recurrent Intraocular Melanoma|Recurrent Melanoma|Stage IIC Melanoma|Stage IIIA Intraocular Melanoma|Stage IIIA Melanoma|Stage IIIB Intraocular Melanoma|Stage IIIB Melanoma|Stage IIIC Intraocular Melanoma|Stage IIIC Melanoma|Stage IV Intraocular Melanoma|Stage IV Melanoma"
4056,0.997515994,164.4034445,https://clinicaltrials.gov/study/NCT01222689,NCT01222689,Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer
4057,0.995607321,156.8570507,https://clinicaltrials.gov/study/NCT01342289,NCT01342289,Hodgkin's Lymphoma|Leukemia|Myelodysplastic Syndrome(MDS)|Multiple Myeloma|Non Hodgkin's Lymphoma
4058,0.997912924,164.8513263,https://clinicaltrials.gov/study/NCT03332589,NCT03332589,Malignant Melanoma|Brain Metastases
4059,0.68086063,4.702362726,https://clinicaltrials.gov/study/NCT01725789,NCT01725789,Anemia
4060,0.975887447,81.57145295,https://clinicaltrials.gov/study/NCT00228189,NCT00228189,Colorectal Cancer|Liver Metastases
4061,0.988811174,142.7811866,https://clinicaltrials.gov/study/NCT01712789,NCT01712789,Multiple Myeloma
4062,0.976174306,80.02262523,https://clinicaltrials.gov/study/NCT00503321,NCT00503321,Gastric Cancer
4063,0.948199626,40.55742654,https://clinicaltrials.gov/study/NCT05213221,NCT05213221,Advanced Hepatocellular Carcinoma
4064,0.614866652,3.944270444,https://clinicaltrials.gov/study/NCT01504321,NCT01504321,Polycystic Ovary Syndrome
4065,0.997008666,161.1315067,https://clinicaltrials.gov/study/NCT01284231,NCT01284231,Gastrointestinal Adenocarcinomas
4066,0.990544988,151.4565392,https://clinicaltrials.gov/study/NCT00038831,NCT00038831,Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Chronic Lymphocytic Leukemia
4067,0.985076128,150.0109858,https://clinicaltrials.gov/study/NCT01354431,NCT01354431,Renal Cell Carcinoma
4068,0.990378998,151.0663732,https://clinicaltrials.gov/study/NCT00031031,NCT00031031,Solid Tumors Refractory To Standard Therapy|Neoplasms
4069,0.995245941,155.608549,https://clinicaltrials.gov/study/NCT03600831,NCT03600831,Esophageal Squamous Cell Carcinoma
4070,0.997989295,162.8591451,https://clinicaltrials.gov/study/NCT00003131,NCT00003131,Leukemia
4071,0.980579986,100.7644053,https://clinicaltrials.gov/study/NCT02371031,NCT02371031,Glioma|Malignant Glioma
4072,0.994586837,155.2629012,https://clinicaltrials.gov/study/NCT00280631,NCT00280631,Myelodysplastic Syndrome (MDS)
4073,0.98798251,151.3825093,https://clinicaltrials.gov/study/NCT00864331,NCT00864331,Non Small Cell Lung Cancer
4074,0.845282508,11.78355844,https://clinicaltrials.gov/study/NCT00215631,NCT00215631,Prostate Cancer|Erectile Dysfunction
4075,0.997976235,167.1193003,https://clinicaltrials.gov/study/NCT01338831,NCT01338831,Castration-resistant Prostate Cancer|Metastatic Breast Cancer|Uterine Leiomyoma
4076,0.995955228,157.8055741,https://clinicaltrials.gov/study/NCT02254031,NCT02254031,Breast Neoplasms
4077,0.987374599,150.541902,https://clinicaltrials.gov/study/NCT03560531,NCT03560531,Breast Cancer
4078,0.988009255,132.8947722,https://clinicaltrials.gov/study/NCT00083031,NCT00083031,Breast Cancer
4079,0.981684511,100.7208476,https://clinicaltrials.gov/study/NCT00926731,NCT00926731,Acute Myeloid Leukemia
4080,0.995347885,156.2107863,https://clinicaltrials.gov/study/NCT02659631,NCT02659631,Neoplasms
4081,0.993391676,152.2563187,https://clinicaltrials.gov/study/NCT01050842,NCT01050842,Prostate Cancer|Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Stage IV Prostate Cancer
4082,0.987997757,150.4045254,https://clinicaltrials.gov/study/NCT00062842,NCT00062842,Cancer
4083,0.995135653,154.413195,https://clinicaltrials.gov/study/NCT01166542,NCT01166542,"Carcinoma, Squamous Cell of the Head and Neck"
4084,0.995677661,158.6869131,https://clinicaltrials.gov/study/NCT00274742,NCT00274742,"Non-Hodgkin's Lymphoma, Relapsed"
4085,0.995810896,154.4650595,https://clinicaltrials.gov/study/NCT00060242,NCT00060242,Head and Neck Cancer
4086,0.994404779,153.9658316,https://clinicaltrials.gov/study/NCT03102242,NCT03102242,"Carcinoma, Non-Small-Cell Lung"
4087,0.997130186,161.7699838,https://clinicaltrials.gov/study/NCT00507442,NCT00507442,Multiple Myeloma
4088,0.994628395,155.0871522,https://clinicaltrials.gov/study/NCT04995042,NCT04995042,Hormone Sensitive Prostate Cancer
4089,0.970499562,69.40467803,https://clinicaltrials.gov/study/NCT00002342,NCT00002342,"Sarcoma, Kaposi|HIV Infections"
4090,0.986682988,151.2016117,https://clinicaltrials.gov/study/NCT05613842,NCT05613842,Prostate Cancer
4091,0.792034081,9.317552722,https://clinicaltrials.gov/study/NCT02539342,NCT02539342,Oral Mucositis
4092,0.99374286,152.9318297,https://clinicaltrials.gov/study/NCT02590965,NCT02590965,Non-small Cell Lung Cancer
4093,0.990428229,150.9611706,https://clinicaltrials.gov/study/NCT02576665,NCT02576665,Colorectal Cancer|Triple Negative Breast Cancer|Pancreatic Cancer|Non-Small Cell Lung Cancer|Head and Neck Cancer|Ovarian Cancer|Lymphoma|Sarcoma|Bladder Cancer|Melanoma|IDH1 Mutated Solid Tumors|IDH1 Mutated or MGMT Methylated Recurrent HGG (Not Recruiting)
4094,0.999423313,189.0190288,https://clinicaltrials.gov/study/NCT01207765,NCT01207765,Multiple Myeloma
4095,0.993048436,152.3961743,https://clinicaltrials.gov/study/NCT00783965,NCT00783965,Skin Carcinoma
4096,0.911381671,21.02739219,https://clinicaltrials.gov/study/NCT01844765,NCT01844765,Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
4097,0.998269724,165.2391523,https://clinicaltrials.gov/study/NCT00496665,NCT00496665,Metastatic Breast Cancer
4098,0.994533546,153.575447,https://clinicaltrials.gov/study/NCT00630565,NCT00630565,Leukemia
4099,0.995666538,157.5923433,https://clinicaltrials.gov/study/NCT03454165,NCT03454165,Chronic Lymphocytic Leukemia
4100,0.984233807,148.8480404,https://clinicaltrials.gov/study/NCT02405065,NCT02405065,Neoplasms
4101,0.983508922,125.6954524,https://clinicaltrials.gov/study/NCT01443065,NCT01443065,Malignant Neoplasm of Esophagus|Malignant Neoplasm of Stomach
4102,0.868076918,14.51474179,https://clinicaltrials.gov/study/NCT01067365,NCT01067365,Secondary Hypogonadism
4103,0.950578776,39.05913185,https://clinicaltrials.gov/study/NCT02504489,NCT02504489,Non-Small Cell Lung Cancer
4104,0.999393639,194.5278941,https://clinicaltrials.gov/study/NCT00005089,NCT00005089,Lymphoma
4105,0.94711246,34.82244409,https://clinicaltrials.gov/study/NCT02404389,NCT02404389,Actinic Keratosis
4106,0.996965347,156.4567455,https://clinicaltrials.gov/study/NCT02332889,NCT02332889,"Gliomas|Medulloblastoma|Neuroectodermal Tumors, Primitive"
4107,0.992913504,153.1373487,https://clinicaltrials.gov/study/NCT00285389,NCT00285389,Mantle Cell Lymphoma
4108,0.999647604,188.445399,https://clinicaltrials.gov/study/NCT00573989,NCT00573989,Head and Neck Cancer
4109,0.996391986,159.5951963,https://clinicaltrials.gov/study/NCT01045421,NCT01045421,Advanced Nonhematological Malignancies|Non-Small Cell Lung Cancer|Small Cell Lung Cancer|Metastatic Breast Cancer|Head and Neck Squamous Cell Carcinoma|Gastroesophageal Adenocarcinoma
4110,0.966544672,60.95913996,https://clinicaltrials.gov/study/NCT01446731,NCT01446731,Prostatic Neoplasms
4111,0.987058287,136.5761533,https://clinicaltrials.gov/study/NCT03622931,NCT03622931,Ovarian Cancer
4112,0.990082904,150.5618346,https://clinicaltrials.gov/study/NCT02450331,NCT02450331,"Carcinoma, Transitional Cell"
4113,0.999455639,184.6225006,https://clinicaltrials.gov/study/NCT00098631,NCT00098631,Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Salivary Gland Squamous Cell Carcinoma|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Untreated Metastatic Squamous Neck Cancer With Occult Primary
4114,0.997952542,172.9177198,https://clinicaltrials.gov/study/NCT00073931,NCT00073931,Lymphoma
4115,0.994353012,153.0015697,https://clinicaltrials.gov/study/NCT02211131,NCT02211131,"Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma"
4116,0.992636406,152.2505933,https://clinicaltrials.gov/study/NCT01085331,NCT01085331,Metastatic Colorectal Cancer
4117,0.990134495,151.1661907,https://clinicaltrials.gov/study/NCT02290431,NCT02290431,Relapse/Refractory Multiple Myeloma
4118,0.968269798,58.36274781,https://clinicaltrials.gov/study/NCT05316831,NCT05316831,CLL|Vaccine Response
4119,0.998617429,176.0615537,https://clinicaltrials.gov/study/NCT00005831,NCT00005831,Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Squamous Cell Carcinoma of the Bladder|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder
4120,0.994163396,153.5408624,https://clinicaltrials.gov/study/NCT00840931,NCT00840931,Leukemia
4121,0.997744705,163.7378419,https://clinicaltrials.gov/study/NCT00138242,NCT00138242,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
4122,0.993821119,152.0605481,https://clinicaltrials.gov/study/NCT00434642,NCT00434642,Ovarian Cancer
4123,0.999075411,185.1839792,https://clinicaltrials.gov/study/NCT01339442,NCT01339442,Estrogen Receptor-positive Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
4124,0.933796739,32.82851629,https://clinicaltrials.gov/study/NCT01227642,NCT01227642,Clinical Stage T2b or Less of Prostate Cancer|Prostate Brachytherapy|Transrectal Prostate Ultrasound Treatment Planning
4125,0.965526421,64.11685532,https://clinicaltrials.gov/study/NCT01992042,NCT01992042,Prostate Cancer
4126,0.952554991,38.50687465,https://clinicaltrials.gov/study/NCT03591965,NCT03591965,Hepatocellular Carcinoma
4127,0.98443568,122.1783277,https://clinicaltrials.gov/study/NCT01619865,NCT01619865,Neuroendocrine Tumors|Carcinoid Tumors|Neuroblastoma|Medulloblastoma
4128,0.981661784,90.14355625,https://clinicaltrials.gov/study/NCT02278965,NCT02278965,Stage 0 Breast Carcinoma|Breast Neoplasms|Stage I Breast Carcinoma|Stage II Breast Carcinoma|Stage III Breast Carcinoma
4129,0.999639212,192.8975325,https://clinicaltrials.gov/study/NCT00004165,NCT00004165,Multiple Myeloma and Plasma Cell Neoplasm
4130,0.951050295,40.29731864,https://clinicaltrials.gov/study/NCT02333565,NCT02333565,Recurrent Meningiomas|Resistant Meningiomas
4131,0.999637993,176.0712888,https://clinicaltrials.gov/study/NCT02765165,NCT02765165,Solid Tumors (Phase 1)|Relapsed/Recurrent GBM (Phase 2)
4132,0.999462973,187.6538425,https://clinicaltrials.gov/study/NCT00982865,NCT00982865,Solid Tumors|Cancer
4133,0.935199472,22.0241217,https://clinicaltrials.gov/study/NCT03315065,NCT03315065,Lung Cancer
4134,0.999361644,189.2179459,https://clinicaltrials.gov/study/NCT00795665,NCT00795665,Glioma
4135,0.998531165,174.4985749,https://clinicaltrials.gov/study/NCT01313065,NCT01313065,Solid Tumors
4136,0.954717979,39.52922321,https://clinicaltrials.gov/study/NCT01073865,NCT01073865,Breast Cancer
4137,0.899289829,18.46323416,https://clinicaltrials.gov/study/NCT02767765,NCT02767765,Anemia
4138,0.999646017,195.0794227,https://clinicaltrials.gov/study/NCT01831089,NCT01831089,Breast Cancer|Ovarian Cancer|Gynecological Cancer|Head and Neck Carcinoma|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Non-squamous Cell Lung Cancer
4139,0.957074883,46.69007931,https://clinicaltrials.gov/study/NCT02997189,NCT02997189,Cisplatin Induced Hearing Loss
4140,0.990051772,150.8854996,https://clinicaltrials.gov/study/NCT03262389,NCT03262389,Multiple Myeloma
4141,0.998813763,170.4691508,https://clinicaltrials.gov/study/NCT00100789,NCT00100789,Head and Neck Cancer
4142,0.997865755,164.4811433,https://clinicaltrials.gov/study/NCT01309789,NCT01309789,"Lymphoma, Large-Cell, Anaplastic|Lymphoma, NK-cell|Lymphoma, T-cell"
4143,0.999460619,189.1406722,https://clinicaltrials.gov/study/NCT01946789,NCT01946789,Advanced Solid Tumors
4144,0.982422117,107.8086384,https://clinicaltrials.gov/study/NCT00083889,NCT00083889,"Carcinoma, Renal Cell"
4145,0.970238063,79.89622556,https://clinicaltrials.gov/study/NCT01359189,NCT01359189,Suspected Primary Prostate Cancer
4146,0.999290213,181.2679759,https://clinicaltrials.gov/study/NCT03058289,NCT03058289,Breast Cancer|Head and Neck Cancer|Squamous Cell Carcinoma|Lymphoma|Pancreatic Cancer|Liver Cancer|Colon Cancer|Lung Cancer|Bile Duct Cancer|Chordoma of Sacrum|Sarcoma
4147,0.995394065,156.1784374,https://clinicaltrials.gov/study/NCT00971789,NCT00971789,"Cowden's Disease|Hamartoma Syndrome, Multiple"
4148,0.998553406,170.6900858,https://clinicaltrials.gov/study/NCT00089089,NCT00089089,"Hematopoietic/Lymphoid Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
4149,0.991308725,152.3329228,https://clinicaltrials.gov/study/NCT00644189,NCT00644189,"Follicular Lymphoma|Marginal Zone Lymphoma|Mantle Cell Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma|Low Grade B-cell Lymphoma, Not Otherwise Specified|Diffuse Large B-cell Lymphoma|Peripheral T-cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Anaplastic Large-cell Lymphoma"
4150,0.997411373,159.6471246,https://clinicaltrials.gov/study/NCT00714948,NCT00714948,Bladder Cancer|URINARY BLADDER
4151,0.810143189,9.423489059,https://clinicaltrials.gov/study/NCT02588248,NCT02588248,Colonic Polyps|Colon Cancer
4152,0.980778682,95.75843435,https://clinicaltrials.gov/study/NCT00301548,NCT00301548,Breast Neoplasms|Carcinoma
4153,0.95051396,40.51417915,https://clinicaltrials.gov/study/NCT05471648,NCT05471648,Breast Cancer
4154,0.997245342,164.7628682,https://clinicaltrials.gov/study/NCT01094548,NCT01094548,Multiple Myeloma
4155,0.951857878,45.83465201,https://clinicaltrials.gov/study/NCT00952848,NCT00952848,"Chemotherapeutic Agent Toxicity|Neurotoxicity|Pain|Peripheral Neuropathy|Unspecified Adult Solid Tumor, Protocol Specific"
4156,0.994176293,154.4599154,https://clinicaltrials.gov/study/NCT01075048,NCT01075048,Metastatic Colorectal Cancer
4157,0.930548037,33.67032728,https://clinicaltrials.gov/study/NCT05045248,NCT05045248,Myasthenia Gravis|Ocular Myasthenia Gravis
4158,0.985360128,134.0450723,https://clinicaltrials.gov/study/NCT00305448,NCT00305448,Advanced Breast Cancer|Metastatic Breast Cancer
4159,0.994990233,155.8604467,https://clinicaltrials.gov/study/NCT03431948,NCT03431948,Cancer
4160,0.910774505,21.57249786,https://clinicaltrials.gov/study/NCT05007548,NCT05007548,Hepatic Carcinoma
4161,0.978902994,97.4813916,https://clinicaltrials.gov/study/NCT00136448,NCT00136448,Acute Myelogenous Leukemia
4162,0.989479367,150.8942592,https://clinicaltrials.gov/study/NCT01219348,NCT01219348,NSCLC|Lung Cancer
4163,0.999376968,183.6703542,https://clinicaltrials.gov/study/NCT00002748,NCT00002748,Neuroblastoma
4164,0.96924543,56.44429396,https://clinicaltrials.gov/study/NCT02117648,NCT02117648,Neoplasm|Neoplasm Metastasis
4165,0.991675814,151.4425184,https://clinicaltrials.gov/study/NCT04252248,NCT04252248,Head and Neck Cancer|Anogenital Cancer
4166,0.99093673,152.6510397,https://clinicaltrials.gov/study/NCT02371148,NCT02371148,Waldenstrom's Macroglobulinemia
4167,0.995978235,158.6823681,https://clinicaltrials.gov/study/NCT02393248,NCT02393248,Lung Cancer|Solid Tumor|Gastric Cancer|Urothelial Cancer|Endometrial Cancer|Multiple Myeloma|Myeloproliferative Neoplasms|Breast Cancer|Cholangiocarcinoma|UC|MPN
4168,0.967085235,65.40372597,https://clinicaltrials.gov/study/NCT01550848,NCT01550848,Metastatic Breast Cancer
4169,0.98935506,150.5218419,https://clinicaltrials.gov/study/NCT01396148,NCT01396148,Gastrointestinal Stromal Tumors
4170,0.642798576,3.958561805,https://clinicaltrials.gov/study/NCT00375648,NCT00375648,Pain
4171,0.990850741,151.6122965,https://clinicaltrials.gov/study/NCT00129948,NCT00129948,"Leukemia, Myeloid, Acute"
4172,0.998933145,184.8493275,https://clinicaltrials.gov/study/NCT00002548,NCT00002548,Multiple Myeloma
4173,0.982260328,115.9323719,https://clinicaltrials.gov/study/NCT04062448,NCT04062448,Waldenstrom Macroglobulinemia
4174,0.99219054,152.2809997,https://clinicaltrials.gov/study/NCT00185848,NCT00185848,"Brain Cancer|Arthritis, Rheumatoid|Central Nervous System Neoplasms|Glioma"
4175,0.935449334,26.66553568,https://clinicaltrials.gov/study/NCT00756548,NCT00756548,Colon Cancer
4176,0.987874985,150.5221544,https://clinicaltrials.gov/study/NCT00005648,NCT00005648,Pancreatic Neoplasms
4177,0.926832308,21.493703,https://clinicaltrials.gov/study/NCT00629148,NCT00629148,"Breast Cancer|Metastasis, Neoplasm"
4178,0.999004117,180.5654148,https://clinicaltrials.gov/study/NCT00033748,NCT00033748,Colorectal Cancer|Metastatic Cancer
4179,0.902426975,22.45401041,https://clinicaltrials.gov/study/NCT00434148,NCT00434148,Cushing's Disease
4180,0.992883272,151.9880632,https://clinicaltrials.gov/study/NCT03483948,NCT03483948,Acute Myeloid Leukemia
4181,0.993663024,152.5392744,https://clinicaltrials.gov/study/NCT01982448,NCT01982448,Triple Negative Breast Cancer
4182,0.968207957,75.67811404,https://clinicaltrials.gov/study/NCT01639248,NCT01639248,Triple Negative Breast Cancer
4183,0.953066948,44.78253176,https://clinicaltrials.gov/study/NCT03161548,NCT03161548,Tongue Cancer|Chemotherapy Effect|Surgery
4184,0.978816172,86.14655303,https://clinicaltrials.gov/study/NCT02115048,NCT02115048,Breast Neoplasms
4185,0.912846485,25.78121526,https://clinicaltrials.gov/study/NCT00248248,NCT00248248,Ovarian Neoplasm
4186,0.999722059,184.4324767,https://clinicaltrials.gov/study/NCT00022048,NCT00022048,Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
4187,0.99794255,166.0294161,https://clinicaltrials.gov/study/NCT00555048,NCT00555048,Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
4188,0.995777175,155.0287087,https://clinicaltrials.gov/study/NCT02276248,NCT02276248,Stage I/II Extranodal NK/T-cell Lymphoma
4189,0.979991586,98.82916173,https://clinicaltrials.gov/study/NCT01333748,NCT01333748,Hereditary Breast and Ovarian Cancer Syndrome
4190,0.805200182,7.571523228,https://clinicaltrials.gov/study/NCT02334748,NCT02334748,Systemic Juvenile Idiopathic Arthritis|Hereditary Periodic Fevers
4191,0.999375149,192.4586856,https://clinicaltrials.gov/study/NCT04366648,NCT04366648,Solid Tumor
4192,0.636340557,4.594735054,https://clinicaltrials.gov/study/NCT04111848,NCT04111848,Postoperative Analgesia
4193,0.962455191,45.73234997,https://clinicaltrials.gov/study/NCT02580448,NCT02580448,Cancer of the Breast|Breast Cancer|Advanced Breast Cancer|Metastatic Breast Cancer|Male Breast Cancer|Triple Negative Breast Cancer|ER+ Breast Cancer
4194,0.975973499,76.55996683,https://clinicaltrials.gov/study/NCT00042848,NCT00042848,"Fatigue|Unspecified Adult Solid Tumor, Protocol Specific"
4195,0.852600604,12.39458802,https://clinicaltrials.gov/study/NCT01309048,NCT01309048,Bone Metastasis
4196,0.993286587,152.8611156,https://clinicaltrials.gov/study/NCT00445848,NCT00445848,Lung Cancer
4197,0.951812884,49.84299553,https://clinicaltrials.gov/study/NCT00542048,NCT00542048,Liver Cancer|Neoplasm Metastasis
4198,0.987425491,150.284835,https://clinicaltrials.gov/study/NCT03006848,NCT03006848,Osteosarcoma
4199,0.993593434,153.5611684,https://clinicaltrials.gov/study/NCT00024648,NCT00024648,Neoplasms
4200,0.997685129,161.6193376,https://clinicaltrials.gov/study/NCT00176748,NCT00176748,Thyroid Cancer
4201,0.995010234,155.8155847,https://clinicaltrials.gov/study/NCT00525148,NCT00525148,"Carcinoma, Non-Small-Cell Lung"
4202,0.920528462,19.70460976,https://clinicaltrials.gov/study/NCT01020448,NCT01020448,Prostate Cancer
4203,0.916664955,20.64054271,https://clinicaltrials.gov/study/NCT00549848,NCT00549848,Acute Lymphoblastic Leukemia
4204,0.987828816,150.379607,https://clinicaltrials.gov/study/NCT00074048,NCT00074048,Leukemia
4205,0.986544581,144.8555343,https://clinicaltrials.gov/study/NCT02629848,NCT02629848,"Carcinoma, Non-Small-Cell Lung"
4206,0.999748873,188.5642029,https://clinicaltrials.gov/study/NCT00003348,NCT00003348,Brain and Central Nervous System Tumors
4207,0.995731904,156.4758875,https://clinicaltrials.gov/study/NCT04580121,NCT04580121,Acute Myeloid Leukemia
4208,0.998178053,170.3926279,https://clinicaltrials.gov/study/NCT00362921,NCT00362921,Recurrent Adult Brain Tumor
4209,0.983807767,96.99617711,https://clinicaltrials.gov/study/NCT02907021,NCT02907021,Heart Failure|Breast Cancer
4210,0.70522354,5.99520967,https://clinicaltrials.gov/study/NCT05370521,NCT05370521,Polycystic Ovary Syndrome
4211,0.98622132,150.3416579,https://clinicaltrials.gov/study/NCT00062621,NCT00062621,"Kidney Failure, Chronic|Multiple Myeloma"
4212,0.998324368,167.3321141,https://clinicaltrials.gov/study/NCT00953121,NCT00953121,Malignant Glioma
4213,0.995735616,155.1325059,https://clinicaltrials.gov/study/NCT02494921,NCT02494921,Prostate Cancer
4214,0.978020971,106.8168879,https://clinicaltrials.gov/study/NCT01205321,NCT01205321,Diagnostic Imaging
4215,0.975522034,87.58486192,https://clinicaltrials.gov/study/NCT00815321,NCT00815321,Chronic Myeloid Leukemia
4216,0.994934005,156.0423377,https://clinicaltrials.gov/study/NCT02050321,NCT02050321,Malignant Melanoma
4217,0.982272638,109.3265926,https://clinicaltrials.gov/study/NCT01198821,NCT01198821,Pancreatic Cancer
4218,0.98721012,150.2224339,https://clinicaltrials.gov/study/NCT00521521,NCT00521521,Head and Neck Neoplasms
4219,0.999682543,183.2362283,https://clinicaltrials.gov/study/NCT00028821,NCT00028821,"Refractory Multiple Myeloma|Stage III Multiple Myeloma|Unspecified Adult Solid Tumor, Protocol Specific"
4220,0.991068461,151.3492423,https://clinicaltrials.gov/study/NCT01289821,NCT01289821,Colorectal Neoplasms
4221,0.997537591,163.6984357,https://clinicaltrials.gov/study/NCT04899921,NCT04899921,Melanoma|Metastatic Melanoma
4222,0.989026308,150.3861636,https://clinicaltrials.gov/study/NCT01773421,NCT01773421,Advanced Solid Tumors
4223,0.997712268,165.2504891,https://clinicaltrials.gov/study/NCT00447421,NCT00447421,"Small Cell Lung Cancer|Carcinoma, Small Cell|SCLC"
4224,0.990616133,151.5883013,https://clinicaltrials.gov/study/NCT00002721,NCT00002721,Prostate Cancer
4225,0.999205647,184.8027894,https://clinicaltrials.gov/study/NCT00003421,NCT00003421,Lymphoma
4226,0.953999476,50.06715326,https://clinicaltrials.gov/study/NCT03969121,NCT03969121,Breast Cancer Female|Hormone Receptor Positive Malignant Neoplasm of Breast
4227,0.994454494,152.9015234,https://clinicaltrials.gov/study/NCT01685021,NCT01685021,Acute Lymphoblastic Leukemia
4228,0.96051019,49.41850791,https://clinicaltrials.gov/study/NCT00487721,NCT00487721,Prostate Cancer
4229,0.967435098,67.81727211,https://clinicaltrials.gov/study/NCT02836821,NCT02836821,Neoplasms
4230,0.992467341,151.4174722,https://clinicaltrials.gov/study/NCT00110721,NCT00110721,Colorectal Cancer
4231,0.963420962,58.24823672,https://clinicaltrials.gov/study/NCT03776721,NCT03776721,Lymphedema
4232,0.997796441,162.2607254,https://clinicaltrials.gov/study/NCT00681421,NCT00681421,Esophageal Cancer
4233,0.990232856,151.6162959,https://clinicaltrials.gov/study/NCT04659421,NCT04659421,Low-grade Glioma|Pediatric Brain Tumor
4234,0.993065368,152.980255,https://clinicaltrials.gov/study/NCT02234921,NCT02234921,Adenocarcinoma of the Prostate
4235,0.998474641,167.0285302,https://clinicaltrials.gov/study/NCT00006021,NCT00006021,Multiple Myeloma and Plasma Cell Neoplasm
4236,0.997841446,163.3766973,https://clinicaltrials.gov/study/NCT02086721,NCT02086721,Solid Tumour
4237,0.999201003,187.5489071,https://clinicaltrials.gov/study/NCT02324621,NCT02324621,Unspecified Adult Solid Tumor
4238,0.993144574,152.4521843,https://clinicaltrials.gov/study/NCT03165721,NCT03165721,"Paraganglioma|Gastrointestinal Stromal Tumors|Carcinoma, Renal Cell|Renal Neoplasms|Pheochromocytoma"
4239,0.954808306,42.67631135,https://clinicaltrials.gov/study/NCT02028221,NCT02028221,Breast Cancer Prevention
4240,0.922179016,25.15837378,https://clinicaltrials.gov/study/NCT01440621,NCT01440621,Cancer Related Fatigue|Quality of Life
4241,0.989979537,150.6400341,https://clinicaltrials.gov/study/NCT00970021,NCT00970021,Multiple Myeloma
4242,0.923888719,23.42749057,https://clinicaltrials.gov/study/NCT02879721,NCT02879721,Barrett's Esophagus
4243,0.989166769,150.5498207,https://clinicaltrials.gov/study/NCT01958021,NCT01958021,"Advanced, Metastatic Breast Cancer"
4244,0.976302591,95.25220851,https://clinicaltrials.gov/study/NCT01622621,NCT01622621,Lung Neoplasms
4245,0.997848566,168.1151656,https://clinicaltrials.gov/study/NCT00392821,NCT00392821,Kidney Cancer
4246,0.987899609,150.2983144,https://clinicaltrials.gov/study/NCT00642031,NCT00642031,Hematologic Malignancies|Leukemia
4247,0.995722202,156.5365351,https://clinicaltrials.gov/study/NCT01758731,NCT01758731,Squamous Cell Carcinoma of the Head and Neck
4248,0.99541309,154.3275407,https://clinicaltrials.gov/study/NCT00727831,NCT00727831,Chemotherapeutic Agent Toxicity|Lymphoma|Mucositis|Neurotoxicity
4249,0.821911579,11.50425398,https://clinicaltrials.gov/study/NCT00132431,NCT00132431,Kidney Disease|Secondary Hyperparathyroidism|Chronic Kidney Disease
4250,0.99892358,188.3449061,https://clinicaltrials.gov/study/NCT01831531,NCT01831531,Esophageal Squamous Cell Carcinoma
4251,0.99908939,189.8336436,https://clinicaltrials.gov/study/NCT00003231,NCT00003231,Lung Cancer
4252,0.997884717,167.1818756,https://clinicaltrials.gov/study/NCT00356031,NCT00356031,Soft Tissue Sarcoma|Fibrous Histiocytoma|Liposarcoma|Leiomyosarcoma|Fibrosarcoma|Synovial Sarcoma
4253,0.985737751,148.2943881,https://clinicaltrials.gov/study/NCT00965731,NCT00965731,Non-Small Cell Lung Cancer
4254,0.97905323,102.3548134,https://clinicaltrials.gov/study/NCT02837042,NCT02837042,Penile Squamous Cell Carcinoma
4255,0.995130001,156.1222197,https://clinicaltrials.gov/study/NCT00672542,NCT00672542,Metastatic Melanoma|Absence of CNS Metastases
4256,0.940042287,28.46647124,https://clinicaltrials.gov/study/NCT00608842,NCT00608842,Lipoma
4257,0.998688108,180.1142523,https://clinicaltrials.gov/study/NCT00428142,NCT00428142,Lymphoma
4258,0.992313101,151.8083062,https://clinicaltrials.gov/study/NCT00231842,NCT00231842,Uterine Cancer
4259,0.996418954,157.019457,https://clinicaltrials.gov/study/NCT00880542,NCT00880542,Sarcoma
4260,0.998537405,176.0153028,https://clinicaltrials.gov/study/NCT00002542,NCT00002542,Breast Cancer
4261,0.994179441,153.7161821,https://clinicaltrials.gov/study/NCT00617942,NCT00617942,Breast Cancer
4262,0.997190887,160.9855526,https://clinicaltrials.gov/study/NCT00183742,NCT00183742,Cancer|Carcinoma
4263,0.99820437,170.415773,https://clinicaltrials.gov/study/NCT00627042,NCT00627042,Hepatocellular Carcinoma
4264,0.997528817,163.2465197,https://clinicaltrials.gov/study/NCT00874042,NCT00874042,Advanced Solid Tumors
4265,0.979413808,103.3758565,https://clinicaltrials.gov/study/NCT03320642,NCT03320642,Hematologic Malignancies
4266,0.929229518,24.40895541,https://clinicaltrials.gov/study/NCT00801242,NCT00801242,Prostate Cancer
4267,0.955357703,41.21489733,https://clinicaltrials.gov/study/NCT03966742,NCT03966742,Desmoid|Desmoid Fibromatosis of Skin|Desmoid Neoplasm of Chest Wall|Desmoid Tumor Caused by Somatic Mutation|Aggressive Fibromatoses|Fibromatosis Desmoid|Desmoid Fibromatosis
4268,0.987729432,150.3787341,https://clinicaltrials.gov/study/NCT01600742,NCT01600742,Brain Metastasis
4269,0.538361478,2.651401293,https://clinicaltrials.gov/study/NCT04010942,NCT04010942,PCOS|Vitamin D Deficiency
4270,0.78412424,7.158447215,https://clinicaltrials.gov/study/NCT00283465,NCT00283465,Anemia|Neoplasm
4271,0.988457987,150.8664509,https://clinicaltrials.gov/study/NCT00260065,NCT00260065,Myelodysplastic Syndrome
4272,0.986272623,150.0562274,https://clinicaltrials.gov/study/NCT01830465,NCT01830465,Non Hodgkin's Follicular Lymphoma
4273,0.993653067,153.6894599,https://clinicaltrials.gov/study/NCT00089765,NCT00089765,Von Hippel-Lindau Syndrome
4274,0.998710637,176.3733192,https://clinicaltrials.gov/study/NCT00806065,NCT00806065,Multiple Myeloma
4275,0.994321647,153.6603423,https://clinicaltrials.gov/study/NCT00104065,NCT00104065,Stomatitis
4276,0.953347912,45.29637568,https://clinicaltrials.gov/study/NCT00776165,NCT00776165,Chemotherapy-Induced Neutropenia
4277,0.973968322,73.37295947,https://clinicaltrials.gov/study/NCT00072865,NCT00072865,Breast Cancer|Neoplasm Metastasis
4278,0.999608359,173.6631676,https://clinicaltrials.gov/study/NCT00087165,NCT00087165,Prostate Cancer
4279,0.999665675,186.9558751,https://clinicaltrials.gov/study/NCT00005065,NCT00005065,Stage IIIA Non-small Cell Lung Cancer
4280,0.997400165,161.2409166,https://clinicaltrials.gov/study/NCT01696565,NCT01696565,Neoplasm Metastasis|Neoplasm Recurrence
4281,0.978509257,83.07186201,https://clinicaltrials.gov/study/NCT00231465,NCT00231465,Non-Small Cell Lung Cancer
4282,0.966420244,60.42262074,https://clinicaltrials.gov/study/NCT03367689,NCT03367689,Breast Cancer
4283,0.99968848,187.1732074,https://clinicaltrials.gov/study/NCT00003989,NCT00003989,Lung Cancer|Melanoma (Skin)
4284,0.996592908,160.2830348,https://clinicaltrials.gov/study/NCT00016289,NCT00016289,Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer
4285,0.946338505,44.89763481,https://clinicaltrials.gov/study/NCT02887521,NCT02887521,Non-small Cell Lung Cancer (NSCLC)|Chronic Obstructive Pulmonary Disease (COPD)
4286,0.997763174,169.1736562,https://clinicaltrials.gov/study/NCT04611321,NCT04611321,Advanced Cutaneous Squamous Cell Carcinoma
4287,0.993711035,153.5049127,https://clinicaltrials.gov/study/NCT01497431,NCT01497431,No Evidence of Disease|Prostate Carcinoma
4288,0.996916726,159.7490096,https://clinicaltrials.gov/study/NCT03823131,NCT03823131,Metastatic Head and Neck Squamous Cell Carcinoma|Recurrent Head and Neck Squamous Cell Carcinoma|Unresectable Head and Neck Squamous Cell Carcinoma
4289,0.889794195,10.53050587,https://clinicaltrials.gov/study/NCT05279131,NCT05279131,"Keratosis, Actinic"
4290,0.997406365,165.7442935,https://clinicaltrials.gov/study/NCT00497731,NCT00497731,Solid Tumors
4291,0.993622532,154.5085335,https://clinicaltrials.gov/study/NCT01775631,NCT01775631,B-Cell Malignancies
4292,0.957735347,46.75589839,https://clinicaltrials.gov/study/NCT02023931,NCT02023931,Healthy Subject
4293,0.998741383,170.4934862,https://clinicaltrials.gov/study/NCT00792142,NCT00792142,Multiple Myeloma and Plasma Cell Neoplasm|Neurotoxicity
4294,0.994545853,154.0548683,https://clinicaltrials.gov/study/NCT01083342,NCT01083342,CNS Lymphoma
4295,0.568019694,3.569838757,https://clinicaltrials.gov/study/NCT00114842,NCT00114842,Colorectal Cancer|Polyps
4296,0.965712855,46.37347596,https://clinicaltrials.gov/study/NCT02445742,NCT02445742,Chronic Myeloblastic Leukaemia
4297,0.998370766,169.2335847,https://clinicaltrials.gov/study/NCT02808442,NCT02808442,Refractory B-cell Acute Lymphoblastic Leukemia|Relapsed B-cell Acute Lymphoblastic Leukemia
4298,0.996142901,157.7227512,https://clinicaltrials.gov/study/NCT00580242,NCT00580242,Myelodysplasia
4299,0.881464428,15.10287846,https://clinicaltrials.gov/study/NCT03194542,NCT03194542,Primary Myelofibrosis|Anemia
4300,0.977299735,88.88407914,https://clinicaltrials.gov/study/NCT00038142,NCT00038142,Ewing's Sarcoma
4301,0.926722191,23.02972533,https://clinicaltrials.gov/study/NCT04497142,NCT04497142,"Glioma, Malignant|Surgery|Seizures"
4302,0.993333334,152.6602001,https://clinicaltrials.gov/study/NCT01111942,NCT01111942,Head and Neck Cancer
4303,0.998925731,178.8938393,https://clinicaltrials.gov/study/NCT01239342,NCT01239342,Metastatic Kidney Carcinoma|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7
4304,0.999066572,189.7283105,https://clinicaltrials.gov/study/NCT01470365,NCT01470365,"Unspecified Adult Solid Tumor, Protocol Specific"
4305,0.984675213,136.2287314,https://clinicaltrials.gov/study/NCT02758665,NCT02758665,"Leukemia, Lymphocytic, Chronic"
4306,0.939732957,35.9912088,https://clinicaltrials.gov/study/NCT00332865,NCT00332865,Head and Neck Cancer
4307,0.979626705,123.2438065,https://clinicaltrials.gov/study/NCT03295565,NCT03295565,Prostate Cancer Metastatic|Metastasis
4308,0.990330649,151.3068616,https://clinicaltrials.gov/study/NCT00547365,NCT00547365,Multiple Myeloma|Plasma Cell Neoplasm
4309,0.968938346,73.1517601,https://clinicaltrials.gov/study/NCT04124965,NCT04124965,Generalized Myasthenia Gravis
4310,0.981136544,92.13825278,https://clinicaltrials.gov/study/NCT05020665,NCT05020665,Nucleophosmin 1-mutated Acute Myeloid Leukemia
4311,0.849705489,10.71161084,https://clinicaltrials.gov/study/NCT00976365,NCT00976365,Metastatic Breast Cancer
4312,0.955395331,54.15319832,https://clinicaltrials.gov/study/NCT01342965,NCT01342965,Non-Small Cell Lung Cancer
4313,0.972720895,68.15257142,https://clinicaltrials.gov/study/NCT03152565,NCT03152565,Colorectal Carcinoma
4314,0.974284351,65.43692368,https://clinicaltrials.gov/study/NCT03608865,NCT03608865,Metastatic Breast Cancer
4315,0.989555939,151.0408635,https://clinicaltrials.gov/study/NCT01969565,NCT01969565,Multiple Myeloma
4316,0.997343686,160.917692,https://clinicaltrials.gov/study/NCT00227565,NCT00227565,Lung Cancer
4317,0.997251015,161.5552939,https://clinicaltrials.gov/study/NCT00611689,NCT00611689,Refractory Malignancy|Solid Tumors
4318,0.988762498,150.3160382,https://clinicaltrials.gov/study/NCT00871689,NCT00871689,Leukemia
4319,0.947610186,39.68393673,https://clinicaltrials.gov/study/NCT02869789,NCT02869789,Lung Cancer
4320,0.945613827,37.88048628,https://clinicaltrials.gov/study/NCT03031821,NCT03031821,Prostate Cancer|Metabolic Syndrome
4321,0.998416747,170.7639884,https://clinicaltrials.gov/study/NCT02171221,NCT02171221,Solid Tumors|Cancer
4322,0.986552244,95.89941687,https://clinicaltrials.gov/study/NCT01945021,NCT01945021,Non Small Cell Lung Cancer|ROS1 Proto Oncogene|Crizotinib
4323,0.976159213,80.64908917,https://clinicaltrials.gov/study/NCT03677531,NCT03677531,Malignant Neoplasm
4324,0.99626036,158.2709509,https://clinicaltrials.gov/study/NCT02265731,NCT02265731,Non-Hodgkin Lymphoma (NHL)|Multiple Myeloma (MM)|Chronic Lymphocytic Leukemia (CLL)|Small Lymphocytic Lymphoma (SLL)|Acute Myeloid Leukemia (AML)
4325,0.997720273,168.7873817,https://clinicaltrials.gov/study/NCT02896231,NCT02896231,Non-Small Cell Lung Cancer
4326,0.987686526,150.0936883,https://clinicaltrials.gov/study/NCT00203931,NCT00203931,Non-small Cell Lung Cancer
4327,0.991152901,152.0852266,https://clinicaltrials.gov/study/NCT03002831,NCT03002831,Advanced Cancer
4328,0.995970521,157.3706116,https://clinicaltrials.gov/study/NCT01470131,NCT01470131,Multiple Myeloma
4329,0.982345015,101.2350378,https://clinicaltrials.gov/study/NCT01295931,NCT01295931,Melanoma
4330,0.996499747,158.5342753,https://clinicaltrials.gov/study/NCT00006231,NCT00006231,Malignant Mesothelioma|Perioperative/Postoperative Complications
4331,0.995729363,158.1135919,https://clinicaltrials.gov/study/NCT02582931,NCT02582931,"Cancer of Ovary|Cancer of the Ovary|Neoplasms, Ovarian|Ovarian Cancer|Ovary Cancer|Ovary Neoplasms"
4332,0.99133725,151.9494574,https://clinicaltrials.gov/study/NCT01024231,NCT01024231,Malignant Melanoma
4333,0.995394242,158.5070609,https://clinicaltrials.gov/study/NCT01896531,NCT01896531,Gastric Cancer
4334,0.990099268,151.0395335,https://clinicaltrials.gov/study/NCT00632931,NCT00632931,Advanced Cancer Relapsed|Advanced Cancer Refractory
4335,0.997800891,166.1621425,https://clinicaltrials.gov/study/NCT00114231,NCT00114231,Colorectal Cancer
4336,0.993712363,153.7927478,https://clinicaltrials.gov/study/NCT04337931,NCT04337931,Unresectable Melanoma|Metastatic Melanoma|Cancer|Cancer of Skin|Melanoma|Melanoma (Skin)
4337,0.986957285,150.5227575,https://clinicaltrials.gov/study/NCT00570531,NCT00570531,Loco-regional Esophageal Cancer
4338,0.989260334,150.4367917,https://clinicaltrials.gov/study/NCT01975831,NCT01975831,Breast Cancer|Ovarian Cancer|Colorectal Cancer|Cervical Cancer|Renal Cell Carcinoma
4339,0.982406284,107.0905765,https://clinicaltrials.gov/study/NCT00817531,NCT00817531,Breast Cancer
4340,0.965612307,59.10440336,https://clinicaltrials.gov/study/NCT01631331,NCT01631331,Basal Cell Carcinoma of the Skin|Recurrent Skin Cancer
4341,0.995479984,155.6831607,https://clinicaltrials.gov/study/NCT02012231,NCT02012231,Melanoma|Thyroid Cancer|Colorectal Cancer|Non-small Cell Lung Cancer|Cholangiocarcinoma|Histiocytosis|Hairy Cell Leukemia
4342,0.719647928,5.758137719,https://clinicaltrials.gov/study/NCT00746031,NCT00746031,Fibroid|Leiomyoma
4343,0.974935025,68.66801809,https://clinicaltrials.gov/study/NCT00989131,NCT00989131,Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer
4344,0.995198391,156.6556838,https://clinicaltrials.gov/study/NCT00027131,NCT00027131,Breast Neoplasms
4345,0.953173621,42.79291596,https://clinicaltrials.gov/study/NCT01475331,NCT01475331,Mucinous Pancreatic Cysts
4346,0.996716282,158.869168,https://clinicaltrials.gov/study/NCT01549431,NCT01549431,Multiple Myeloma
4347,0.945253202,37.26526776,https://clinicaltrials.gov/study/NCT00326131,NCT00326131,Cancer
4348,0.988786412,151.161525,https://clinicaltrials.gov/study/NCT02403531,NCT02403531,Neoplasms
4349,0.939837664,34.94523933,https://clinicaltrials.gov/study/NCT00668642,NCT00668642,Prostate Cancer
4350,0.988408965,150.4302301,https://clinicaltrials.gov/study/NCT00972842,NCT00972842,Peripheral T-Cell Non-Hodgkin's Lymphoma
4351,0.983929488,119.8301782,https://clinicaltrials.gov/study/NCT01444742,NCT01444742,Leukemia|Myeloproliferative Diseases
4352,0.991610098,151.3058883,https://clinicaltrials.gov/study/NCT00002842,NCT00002842,Colorectal Cancer|Metastatic Cancer
4353,0.982086239,118.9141003,https://clinicaltrials.gov/study/NCT00151242,NCT00151242,Acute Myeloid Leukemia
4354,0.996905487,162.1893026,https://clinicaltrials.gov/study/NCT03520842,NCT03520842,KRAS Gene Mutation|Metastatic Malignant Neoplasm in the Brain|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer AJCC v7
4355,0.99788683,167.5079715,https://clinicaltrials.gov/study/NCT01200342,NCT01200342,Melanoma
4356,0.982303335,114.1605481,https://clinicaltrials.gov/study/NCT01859442,NCT01859442,Locally Advanced Rectal Cancer
4357,0.991264104,151.8428177,https://clinicaltrials.gov/study/NCT00699842,NCT00699842,Myelodysplastic Syndrome|MDS|Low to Intermediate-1 MDS|Non-deletion 5q
4358,0.97342419,63.23775016,https://clinicaltrials.gov/study/NCT00477542,NCT00477542,Hematologic Malignancies
4359,0.997625878,163.0113588,https://clinicaltrials.gov/study/NCT00005642,NCT00005642,"Unspecified Adult Solid Tumor, Protocol Specific"
4360,0.998833078,183.7462636,https://clinicaltrials.gov/study/NCT01642342,NCT01642342,"Unspecified Adult Solid Tumor, Protocol Specific"
4361,0.969433771,60.66642945,https://clinicaltrials.gov/study/NCT00234442,NCT00234442,Brain Neoplasms|Non Small Cell Lung Cancer
4362,0.997681428,168.1098999,https://clinicaltrials.gov/study/NCT01147965,NCT01147965,Colon Cancer|Lung Cancer|Breast Cancer
4363,0.95438598,40.23950904,https://clinicaltrials.gov/study/NCT02523365,NCT02523365,Cervical Carcinoma
4364,0.994537779,153.7361187,https://clinicaltrials.gov/study/NCT00479765,NCT00479765,Glioblastoma Multiforme|Brain Neoplasms
4365,0.998831782,178.2515989,https://clinicaltrials.gov/study/NCT02888665,NCT02888665,Sarcoma
4366,0.998252256,164.797067,https://clinicaltrials.gov/study/NCT01926665,NCT01926665,Lymphoma
4367,0.992305446,151.8067026,https://clinicaltrials.gov/study/NCT01703065,NCT01703065,Adenocarcinoma of the Prostate|Castration-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer
4368,0.99921539,184.3156667,https://clinicaltrials.gov/study/NCT00002565,NCT00002565,Lymphoma
4369,0.989136321,150.8979211,https://clinicaltrials.gov/study/NCT01656265,NCT01656265,Advanced Hepatocellular Carcinoma
4370,0.999208118,191.8968213,https://clinicaltrials.gov/study/NCT01090765,NCT01090765,Prostate Cancer|Metastatic Castrate Resistant Prostate Cancer
4371,0.990484699,150.721068,https://clinicaltrials.gov/study/NCT02947165,NCT02947165,Breast Cancer|Lung Cancer|Hepatocellular Cancer|Colorectal Cancer|Pancreatic Cancer|Renal Cancer
4372,0.976483372,70.95724656,https://clinicaltrials.gov/study/NCT00001165,NCT00001165,Islet Cell Adenoma|Neoplasm Metastasis|Zollinger Ellison Syndrome
4373,0.982670723,83.83899304,https://clinicaltrials.gov/study/NCT02441465,NCT02441465,"Malignant Melanoma, Cancer"
4374,0.969612532,71.9350929,https://clinicaltrials.gov/study/NCT01367665,NCT01367665,Basal Cell Carcinoma
4375,0.993778282,154.1179974,https://clinicaltrials.gov/study/NCT01133665,NCT01133665,Squamous Cell Carcinoma
4376,0.985399896,139.0015027,https://clinicaltrials.gov/study/NCT01874665,NCT01874665,GIST
4377,0.995430986,155.5959112,https://clinicaltrials.gov/study/NCT01518465,NCT01518465,Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple Myeloma
4378,0.998725847,180.8018252,https://clinicaltrials.gov/study/NCT01686165,NCT01686165,Anaplastic Large Cell Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Mantle Cell Lymphoma
4379,0.846956343,9.629858354,https://clinicaltrials.gov/study/NCT01371565,NCT01371565,Cushing's Disease|Cushing's Syndrome
4380,0.994632054,154.7019754,https://clinicaltrials.gov/study/NCT02414165,NCT02414165,Glioblastoma Multiforme|Anaplastic Astrocytoma
4381,0.996813911,158.1284292,https://clinicaltrials.gov/study/NCT02426281,NCT02426281,Pancreatic Ductal Adenocarcinoma
4382,0.984314942,150.0208416,https://clinicaltrials.gov/study/NCT00166881,NCT00166881,Gastric Cancer
4383,0.993479535,153.4723625,https://clinicaltrials.gov/study/NCT02418481,NCT02418481,Breast Cancer
4384,0.993040269,153.0649321,https://clinicaltrials.gov/study/NCT02645981,NCT02645981,HCC
4385,0.996367334,159.6917551,https://clinicaltrials.gov/study/NCT02049281,NCT02049281,Solid Tumor
4386,0.991906408,151.5874047,https://clinicaltrials.gov/study/NCT02449681,NCT02449681,Metastatic Head-and-neck Squamous-cell Carcinoma
4387,0.984039534,124.3585419,https://clinicaltrials.gov/study/NCT00712881,NCT00712881,Breast Cancer
4388,0.985803708,150.3892582,https://clinicaltrials.gov/study/NCT02400281,NCT02400281,Acute Myeloid Leukemia
4389,0.987478055,149.5099227,https://clinicaltrials.gov/study/NCT01125176,NCT01125176,Chronic Lymphocytic Leukemia
4390,0.992446671,150.7214842,https://clinicaltrials.gov/study/NCT00004876,NCT00004876,Ovarian Cancer
4391,0.931073271,25.07647123,https://clinicaltrials.gov/study/NCT04180176,NCT04180176,Non-Small Cell Lung Cancer (NSCLC)|Small-Cell Lung Cancer (SCLC)
4392,0.810373839,9.863279076,https://clinicaltrials.gov/study/NCT02885376,NCT02885376,Oral Mucositis
4393,0.995357325,155.3714452,https://clinicaltrials.gov/study/NCT00696176,NCT00696176,Head and Neck Cancer
4394,0.984205333,122.9167218,https://clinicaltrials.gov/study/NCT01392976,NCT01392976,Advanced Solid Tumor
4395,0.99472572,154.0934219,https://clinicaltrials.gov/study/NCT03883776,NCT03883776,Neuroendocrine Tumors
4396,0.997985717,167.8759045,https://clinicaltrials.gov/study/NCT04197999,NCT04197999,HR+ Metastatic Breast Cancer|Breast Cancer|Breast Cancer Metastatic
4397,0.987824267,150.1019421,https://clinicaltrials.gov/study/NCT01005199,NCT01005199,Liver Cancer
4398,0.987577174,127.4189345,https://clinicaltrials.gov/study/NCT01482299,NCT01482299,Stomach Neoplasm
4399,0.968781882,61.1343271,https://clinicaltrials.gov/study/NCT00427999,NCT00427999,Prostate Cancer
4400,0.857813045,10.7062084,https://clinicaltrials.gov/study/NCT01423799,NCT01423799,Gastrointestinal Cancer
4401,0.993715501,153.1083753,https://clinicaltrials.gov/study/NCT00609999,NCT00609999,Glioblastoma|Gliosarcoma
4402,0.989126985,150.8253826,https://clinicaltrials.gov/study/NCT01839799,NCT01839799,Pancreatic Adenocarcinoma
4403,0.998796346,178.8735026,https://clinicaltrials.gov/study/NCT01231399,NCT01231399,Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction|Diffuse Adenocarcinoma of the Stomach|Intestinal Adenocarcinoma of the Stomach|Mixed Adenocarcinoma of the Stomach|Recurrent Esophageal Cancer|Recurrent Gastric Cancer|Stage IV Esophageal Cancer|Stage IV Gastric Cancer
4404,0.987398888,140.9165385,https://clinicaltrials.gov/study/NCT00456599,NCT00456599,Pancreatic Cancer
4405,0.998376561,173.3744157,https://clinicaltrials.gov/study/NCT00777699,NCT00777699,Cancer|Non-Small Cell Lung Cancer
4406,0.993288695,152.3479016,https://clinicaltrials.gov/study/NCT00619099,NCT00619099,Myelodysplastic Syndrome
4407,0.998208096,172.6493124,https://clinicaltrials.gov/study/NCT00788099,NCT00788099,Advanced Solid Tumors|Lymphomas
4408,0.967654487,59.0726781,https://clinicaltrials.gov/study/NCT01578499,NCT01578499,Primary Cutaneous Anaplastic Large Cell Lymphoma|Mycosis Fungoides|Cutaneous T-Cell Lymphoma
4409,0.998047454,164.9626583,https://clinicaltrials.gov/study/NCT03099499,NCT03099499,Endometrial Cancer
4410,0.997309808,163.2434882,https://clinicaltrials.gov/study/NCT00117299,NCT00117299,Sarcoma
4411,0.999398881,184.3769775,https://clinicaltrials.gov/study/NCT00001499,NCT00001499,"Carcinoma, Non-Small-Cell Lung|Lung Neoplasms"
4412,0.747897962,6.464811732,https://clinicaltrials.gov/study/NCT01670799,NCT01670799,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
4413,0.97872461,80.31010935,https://clinicaltrials.gov/study/NCT02241499,NCT02241499,Adenocarcinoma of the Esophagus or Esophagogastric Junction
4414,0.95859231,46.04584703,https://clinicaltrials.gov/study/NCT01081899,NCT01081899,Cancer
4415,0.996741001,159.3608323,https://clinicaltrials.gov/study/NCT01899599,NCT01899599,Ovarian Epithelial Cancer Recurrent|Fallopian Tube Cancer|Primary Peritoneal Cancer
4416,0.995787306,156.5669821,https://clinicaltrials.gov/study/NCT00550199,NCT00550199,Solid Tumors
4417,0.998179581,168.1584622,https://clinicaltrials.gov/study/NCT00942799,NCT00942799,Solid Tumors
4418,0.90882543,24.94482262,https://clinicaltrials.gov/study/NCT00122499,NCT00122499,Prostate Cancer|Erectile Dysfunction
4419,0.99926798,188.7074581,https://clinicaltrials.gov/study/NCT00015899,NCT00015899,Brain and Central Nervous System Tumors
4420,0.997367074,160.712404,https://clinicaltrials.gov/study/NCT00807599,NCT00807599,Multiple Myeloma
4421,0.987149705,150.0339448,https://clinicaltrials.gov/study/NCT03854799,NCT03854799,Colon Rectal Cancer
4422,0.97371288,78.86818491,https://clinicaltrials.gov/study/NCT02936999,NCT02936999,Breast Cancer
4423,0.992951668,153.7474058,https://clinicaltrials.gov/study/NCT00850499,NCT00850499,Follicular Lymphoma
4424,0.880622078,15.37453652,https://clinicaltrials.gov/study/NCT01409499,NCT01409499,Hepatectomy|Hepatocellular Carcinoma|Sorafenib
4425,0.983062443,110.8308531,https://clinicaltrials.gov/study/NCT03092999,NCT03092999,Leiomyoma
4426,0.988090409,150.2627563,https://clinicaltrials.gov/study/NCT00911170,NCT00911170,Cancer|Colon Cancer|Colorectal Cancer|Fever|Locally Advanced|Metastatic Colorectal Cancer|Neutropenia|Rectal Cancer
4427,0.997740473,167.1368811,https://clinicaltrials.gov/study/NCT03455270,NCT03455270,"Carcinoma, Ductal, Breast|Breast Cancer Female|Breast Neoplasm|Breast Cancer|Metastatic Breast Cancer|Advanced Breast Cancer|Stage IV Breast Cancer"
4428,0.998561546,173.8850512,https://clinicaltrials.gov/study/NCT01151670,NCT01151670,"Brain Neoplasms, Malignant|Brain Neoplasms, Benign|Malignant Meningioma|Glioblastoma Multiforme|Anaplastic Astrocytoma"
4429,0.993825178,151.723862,https://clinicaltrials.gov/study/NCT03411070,NCT03411070,Positive Axillary Lymph Node|Stage 0 Breast Cancer AJCC v6 and v7|Stage I Breast Cancer AJCC v7|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage II Breast Cancer AJCC v6 and v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage III Breast Cancer AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIC Breast Cancer AJCC v7
4430,0.998725537,180.4985912,https://clinicaltrials.gov/study/NCT00470470,NCT00470470,Acral Lentiginous Malignant Melanoma|Recurrent Melanoma|Stage IIIA Melanoma|Stage IIIB Melanoma|Stage IIIC Melanoma|Stage IV Melanoma
4431,0.993503923,153.4248244,https://clinicaltrials.gov/study/NCT00090870,NCT00090870,Kidney Cancer
4432,0.985997349,125.4109095,https://clinicaltrials.gov/study/NCT00414570,NCT00414570,Pancreatic Cancer
4433,0.986008914,145.7212103,https://clinicaltrials.gov/study/NCT01186081,NCT01186081,Rectal Cancer
4434,0.999732238,182.3172914,https://clinicaltrials.gov/study/NCT02658981,NCT02658981,Glioblastoma|Gliosarcoma|Recurrent Brain Neoplasm
4435,0.998374964,174.6567186,https://clinicaltrials.gov/study/NCT00071981,NCT00071981,Melanoma (Skin)
4436,0.997283967,166.672876,https://clinicaltrials.gov/study/NCT00034281,NCT00034281,Breast Neoplasm|Pancreatic Neoplasm|Lung Neoplasm|Ovarian Neoplasm|Renal Neoplasm
4437,0.989922325,150.2005413,https://clinicaltrials.gov/study/NCT02322281,NCT02322281,Non-small Cell Lung Cancer
4438,0.987922057,142.3450169,https://clinicaltrials.gov/study/NCT02864381,NCT02864381,Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma
4439,0.945840977,43.04153393,https://clinicaltrials.gov/study/NCT03536481,NCT03536481,Lung Cancer
4440,0.999464501,191.1613444,https://clinicaltrials.gov/study/NCT01474681,NCT01474681,Acute Myelocytic Leukemia|Acute Lymphocytic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndrome|Chronic Lymphocytic Leukemia|Marginal Zone Lymphoma|Follicular Lymphomas|Large-cell Lymphoma|Lymphoblastic Lymphoma|Burkitt's Lymphoma|High Grade Lymphomas|Mantle-cell Lymphoma|Lymphoplasmacytic Lymphoma
4441,0.99522234,152.8929665,https://clinicaltrials.gov/study/NCT03882281,NCT03882281,"Chronic Myeloid Leukemia, Chronic Phase"
4442,0.994632255,155.7021198,https://clinicaltrials.gov/study/NCT02415881,NCT02415881,Head and Neck Cancer
4443,0.963690695,58.50337235,https://clinicaltrials.gov/study/NCT03233776,NCT03233776,Multiple Myeloma
4444,0.971386518,70.48891122,https://clinicaltrials.gov/study/NCT01039376,NCT01039376,"Leukaemia, Lymphocytic, Chronic"
4445,0.985776327,100.1692684,https://clinicaltrials.gov/study/NCT01556776,NCT01556776,Chronic Lymphocytic Leukemia
4446,0.99127949,151.5484436,https://clinicaltrials.gov/study/NCT01693276,NCT01693276,Pancreatic Cancer
4447,0.92787886,25.89608241,https://clinicaltrials.gov/study/NCT02965976,NCT02965976,Esophageal Carcinoma
4448,0.941178299,38.08872808,https://clinicaltrials.gov/study/NCT03129776,NCT03129776,Uterine Cervical Neoplasms
4449,0.889343429,18.03982727,https://clinicaltrials.gov/study/NCT00706576,NCT00706576,Hepatocellular Cancer
4450,0.944625316,34.27974878,https://clinicaltrials.gov/study/NCT02887976,NCT02887976,Prostate Cancer
4451,0.999771539,187.5374259,https://clinicaltrials.gov/study/NCT00003176,NCT00003176,Brain and Central Nervous System Tumors
4452,0.994120348,152.9348132,https://clinicaltrials.gov/study/NCT03275376,NCT03275376,Overall Survival|Tumor Responses
4453,0.999266536,184.4966852,https://clinicaltrials.gov/study/NCT00720876,NCT00720876,Lymphoma
4454,0.996122435,158.3501225,https://clinicaltrials.gov/study/NCT00979576,NCT00979576,"Carcinoma, Non-Small-Cell Lung"
4455,0.999302325,190.7371527,https://clinicaltrials.gov/study/NCT00003376,NCT00003376,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer
4456,0.993033039,152.8597124,https://clinicaltrials.gov/study/NCT04009876,NCT04009876,Locally Advanced Rectal Cancer (LARC)
4457,0.9444254,41.08226138,https://clinicaltrials.gov/study/NCT03532776,NCT03532776,External Anogenital Warts
4458,0.992131214,150.9032905,https://clinicaltrials.gov/study/NCT00103376,NCT00103376,Prostate Cancer
4459,0.99750506,166.3788855,https://clinicaltrials.gov/study/NCT00016276,NCT00016276,Cardiac Toxicity|Inflammatory Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer
4460,0.994502853,153.9845204,https://clinicaltrials.gov/study/NCT01643499,NCT01643499,Acinar Cell Adenocarcinoma of the Pancreas|Adenocarcinoma of the Gallbladder|Adenocarcinoma of Unknown Primary|Adult Primary Cholangiocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Diffuse Adenocarcinoma of the Stomach|Duct Cell Adenocarcinoma of the Pancreas|Intestinal Adenocarcinoma of the Stomach|Localized Unresectable Adult Primary Liver Cancer|Metastatic Carcinoma of Unknown Primary|Metastatic Extrahepatic Bile Duct Cancer|Mixed Adenocarcinoma of the Stomach|Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Newly Diagnosed Carcinoma of Unknown Primary|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage III Pancreatic Cancer|Stage IIIA Colon Cancer|Stage IIIA Gallbladder Cancer|Stage IIIA Gastric Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Gallbladder Cancer|Stage IIIB Gastric Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Gastric Cancer|Stage IIIC Rectal Cancer|Stage IV Gastric Cancer|Stage IV Pancreatic Cancer|Stage IVA Colon Cancer|Stage IVA Gallbladder Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Gallbladder Cancer|Stage IVB Rectal Cancer|Unresectable Extrahepatic Bile Duct Cancer
4461,0.982296995,106.3290111,https://clinicaltrials.gov/study/NCT01317199,NCT01317199,Prostate Cancer
4462,0.908425288,26.24130778,https://clinicaltrials.gov/study/NCT00352599,NCT00352599,Neurofibromatosis 1
4463,0.960316215,46.27886774,https://clinicaltrials.gov/study/NCT03056599,NCT03056599,Soft Tissue Sarcoma Adult
4464,0.999470418,186.5912523,https://clinicaltrials.gov/study/NCT00003899,NCT00003899,"Unspecified Adult Solid Tumor, Protocol Specific"
4465,0.998478127,174.569136,https://clinicaltrials.gov/study/NCT01512199,NCT01512199,Metastatic Breast Cancer
4466,0.993248152,152.5046113,https://clinicaltrials.gov/study/NCT01565499,NCT01565499,Breast Cancer
4467,0.997774026,162.628647,https://clinicaltrials.gov/study/NCT00022399,NCT00022399,Prostate Cancer
4468,0.648542066,4.281843147,https://clinicaltrials.gov/study/NCT02034799,NCT02034799,Hemostasis|Meningioma Surgery
4469,0.942217072,39.4519141,https://clinicaltrials.gov/study/NCT02361099,NCT02361099,Lung Cancer
4470,0.998137891,167.1963876,https://clinicaltrials.gov/study/NCT04538599,NCT04538599,Hematologic Malignancies
4471,0.814774645,7.891007342,https://clinicaltrials.gov/study/NCT00160199,NCT00160199,Secondary Amenorrhea
4472,0.98523047,141.6673645,https://clinicaltrials.gov/study/NCT00047099,NCT00047099,Breast Cancer
4473,0.99687212,160.1228948,https://clinicaltrials.gov/study/NCT01106599,NCT01106599,Solid Cancers
4474,0.591258805,3.334128966,https://clinicaltrials.gov/study/NCT04148599,NCT04148599,Inflammatory Response
4475,0.954379627,46.57938854,https://clinicaltrials.gov/study/NCT04327999,NCT04327999,Thyroid Carcinoma|Radioactive Iodine Level
4476,0.999043363,183.5189231,https://clinicaltrials.gov/study/NCT03918499,NCT03918499,Clinical Stage IV Gastric Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVA Gastric Cancer AJCC v8|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVB Gastric Cancer AJCC v8|Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Metastatic Gastric Adenocarcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Pathologic Stage IV Gastric Cancer AJCC v8|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8|Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Recurrent Gastric Adenocarcinoma|Recurrent Gastroesophageal Junction Adenocarcinoma
4477,0.979767901,108.5146744,https://clinicaltrials.gov/study/NCT00316199,NCT00316199,Metastatic Breast Cancer
4478,0.990551571,151.4728068,https://clinicaltrials.gov/study/NCT02129699,NCT02129699,Lung Cancer Non-small Cell Stage IV
4479,0.998541031,178.205662,https://clinicaltrials.gov/study/NCT00014599,NCT00014599,Vulvar Cancer
4480,0.968662741,62.70109348,https://clinicaltrials.gov/study/NCT01422499,NCT01422499,"Children With Relapsed Solid Tumor, Lymphoma or Leukemia"
4481,0.999042742,189.8244226,https://clinicaltrials.gov/study/NCT00028899,NCT00028899,Leukemia|Myelodysplastic Syndromes
4482,0.992083259,152.1729991,https://clinicaltrials.gov/study/NCT00738699,NCT00738699,Ovarian Cancer
4483,0.992758822,152.5753652,https://clinicaltrials.gov/study/NCT03807999,NCT03807999,Pancreatic Neoplasm
4484,0.991312363,151.4692969,https://clinicaltrials.gov/study/NCT03384199,NCT03384199,Prostatic Adenocarcinoma
4485,0.988674985,142.4191641,https://clinicaltrials.gov/study/NCT00719199,NCT00719199,Colorectal Cancer
4486,0.978734414,83.58973006,https://clinicaltrials.gov/study/NCT01502670,NCT01502670,Lung Cancer
4487,0.969898672,56.86383899,https://clinicaltrials.gov/study/NCT01396070,NCT01396070,Non-Hodgkin Lymphoma (NHL)|Cutaneous Lymphoma|Cutaneous T-cell Lymphoma (CTCL)|Mycosis Fungoides|Sezary Syndrome
4488,0.997310436,162.8314131,https://clinicaltrials.gov/study/NCT00665470,NCT00665470,Skin Cancer|Metastatic Melanoma
4489,0.997360082,162.7857013,https://clinicaltrials.gov/study/NCT00083070,NCT00083070,Leukemia
4490,0.998880653,183.0260656,https://clinicaltrials.gov/study/NCT00441870,NCT00441870,Cancer
4491,0.996399399,158.453221,https://clinicaltrials.gov/study/NCT02178670,NCT02178670,"Neoplasms,Ovarian"
4492,0.814527014,10.80935179,https://clinicaltrials.gov/study/NCT02688270,NCT02688270,Raynaud's Phenomenon Secondary to Connective Tissue Disease
4493,0.997566887,165.838586,https://clinicaltrials.gov/study/NCT00324870,NCT00324870,Clear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer
4494,0.998899728,177.6678153,https://clinicaltrials.gov/study/NCT00005970,NCT00005970,Breast Adenocarcinoma|HER2 Positive Breast Carcinoma|Stage IA Breast Cancer AJCC v7|Stage IB Breast Cancer AJCC v7|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage IIIA Breast Cancer AJCC v7
4495,0.99789157,165.9024687,https://clinicaltrials.gov/study/NCT00794781,NCT00794781,Advanced Solid Tumors
4496,0.982961277,111.6908848,https://clinicaltrials.gov/study/NCT00494481,NCT00494481,Advanced Breast Cancer
4497,0.999315438,190.3841454,https://clinicaltrials.gov/study/NCT00309881,NCT00309881,Chronic Lymphocytic Leukemia
4498,0.935927471,35.98664449,https://clinicaltrials.gov/study/NCT04304781,NCT04304781,Cholangiocarcinoma
4499,0.999505656,187.6442194,https://clinicaltrials.gov/study/NCT00634881,NCT00634881,Chronic Lymphocytic Leukemia
4500,0.996877976,159.3769219,https://clinicaltrials.gov/study/NCT00064181,NCT00064181,Colorectal Cancer
4501,0.969219507,71.35101963,https://clinicaltrials.gov/study/NCT02969681,NCT02969681,Colorectal Neoplasms
4502,0.995932381,155.4151758,https://clinicaltrials.gov/study/NCT01164176,NCT01164176,Head and Neck Cancer
4503,0.833744464,10.02839627,https://clinicaltrials.gov/study/NCT01079676,NCT01079676,Neutropenia in Breast Cancer
4504,0.963714959,61.8197546,https://clinicaltrials.gov/study/NCT00476476,NCT00476476,Squamous Cell Carcinoma
4505,0.994888959,154.8061306,https://clinicaltrials.gov/study/NCT00090376,NCT00090376,Impotence|Prostate Cancer
4506,0.975150196,73.68012936,https://clinicaltrials.gov/study/NCT00349076,NCT00349076,Rectal Neoplasms
4507,0.986646654,149.7596787,https://clinicaltrials.gov/study/NCT02460276,NCT02460276,Relapsed/Refractory Mantle Cell Lymphoma
4508,0.940628492,31.10411545,https://clinicaltrials.gov/study/NCT03810976,NCT03810976,Sarcoma
4509,0.999332307,189.8276416,https://clinicaltrials.gov/study/NCT00077376,NCT00077376,HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
4510,0.794947414,7.901249434,https://clinicaltrials.gov/study/NCT00910676,NCT00910676,Metastatic Colorectal Cancer|Non-Small-Cell Lung Carcinoma
4511,0.989982796,150.8905015,https://clinicaltrials.gov/study/NCT02997176,NCT02997176,Advanced Solid Tumors
4512,0.990736032,151.9622431,https://clinicaltrials.gov/study/NCT00047476,NCT00047476,Fatigue|Neoplasms
4513,0.995634719,154.8022842,https://clinicaltrials.gov/study/NCT00703976,NCT00703976,Cancer
4514,0.998231704,170.7325294,https://clinicaltrials.gov/study/NCT01754376,NCT01754376,Melanoma
4515,0.90877672,16.09930095,https://clinicaltrials.gov/study/NCT03176199,NCT03176199,Cancer|Pain
4516,0.95914822,49.69905617,https://clinicaltrials.gov/study/NCT02377999,NCT02377999,Anogenital Warts
4517,0.968352757,57.62188152,https://clinicaltrials.gov/study/NCT00365599,NCT00365599,Breast Cancer
4518,0.839010765,12.19172922,https://clinicaltrials.gov/study/NCT00338299,NCT00338299,Anemia|Chemotherapy
4519,0.998744057,176.9002805,https://clinicaltrials.gov/study/NCT00040599,NCT00040599,Colorectal Cancer|Colon Cancer|Rectal Cancer|Colorectal Neoplasms|Colorectal Carcinoma|Colorectal Tumor
4520,0.976316587,88.12234424,https://clinicaltrials.gov/study/NCT00071799,NCT00071799,Myelodysplastic Syndromes
4521,0.98316305,126.8406513,https://clinicaltrials.gov/study/NCT00893399,NCT00893399,Acute Myeloid Leukemia
4522,0.640088825,4.87405619,https://clinicaltrials.gov/study/NCT03147599,NCT03147599,"Oncology|Incontinence|Incontinence, Daytime Urinary|Incontinence, Nighttime Urinary|Bladder Cancer|Orthotopic Neobladder"
4523,0.998415293,175.5853759,https://clinicaltrials.gov/study/NCT01562899,NCT01562899,Metastatic Pancreatic Adenocarcinoma|BRAF Mutated Melanoma
4524,0.95174136,46.30224041,https://clinicaltrials.gov/study/NCT00537199,NCT00537199,Head And Neck Cancer|Oropharynx Cancer
4525,0.979810024,102.1478355,https://clinicaltrials.gov/study/NCT02691299,NCT02691299,NSCLC
4526,0.999631033,187.3166647,https://clinicaltrials.gov/study/NCT00003799,NCT00003799,Adenocarcinoma of the Rectum|Mucinous Adenocarcinoma of the Rectum|Signet Ring Adenocarcinoma of the Rectum|Stage IIA Rectal Cancer|Stage IIB Rectal Cancer|Stage IIC Rectal Cancer|Stage IIIA Rectal Cancer|Stage IIIB Rectal Cancer|Stage IIIC Rectal Cancer
4527,0.998733964,176.3676989,https://clinicaltrials.gov/study/NCT01397799,NCT01397799,Acute Myelogenous Leukemia
4528,0.940793889,36.67540948,https://clinicaltrials.gov/study/NCT01987999,NCT01987999,Prostate Cancer
4529,0.965631442,58.38008023,https://clinicaltrials.gov/study/NCT00392899,NCT00392899,Colorectal Cancer
4530,0.9817076,110.4869615,https://clinicaltrials.gov/study/NCT00165399,NCT00165399,Adenocarcinoma of the Prostate|Prostate Cancer
4531,0.925868004,21.38326367,https://clinicaltrials.gov/study/NCT00576199,NCT00576199,Liver Cancer
4532,0.911284341,23.15209163,https://clinicaltrials.gov/study/NCT00832299,NCT00832299,Rectal Neoplasms
4533,0.96815239,63.36679022,https://clinicaltrials.gov/study/NCT00105599,NCT00105599,Terminal Care|Neoplasm
4534,0.976384247,94.4994473,https://clinicaltrials.gov/study/NCT00156299,NCT00156299,Leukemia
4535,0.992724671,152.0617338,https://clinicaltrials.gov/study/NCT00066599,NCT00066599,Kidney Cancer|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Neuroblastoma|Neutropenia|Sarcoma
4536,0.973729722,78.82959624,https://clinicaltrials.gov/study/NCT00517699,NCT00517699,Lymphoma
4537,0.995105127,152.7767263,https://clinicaltrials.gov/study/NCT00091299,NCT00091299,"Unspecified Adult Solid Tumor, Protocol Specific"
4538,0.995741694,156.9714806,https://clinicaltrials.gov/study/NCT02181699,NCT02181699,Acute Myeloid Leukemia|Myelodysplastic Syndrome
4539,0.971800007,71.05887711,https://clinicaltrials.gov/study/NCT03704870,NCT03704870,"Lung Cancer|Lung Diseases|Lung Cancer, Nonsmall Cell|Surgery|Lung Adenocarcinoma"
4540,0.991263352,151.8127669,https://clinicaltrials.gov/study/NCT02269670,NCT02269670,Estrogen Receptor-positive Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Recurrent Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer
4541,0.970953431,78.55419732,https://clinicaltrials.gov/study/NCT00841399,NCT00841399,Breast Cancer
4542,0.979432934,100.4836606,https://clinicaltrials.gov/study/NCT00188799,NCT00188799,Prostatic Neoplasms
4543,0.998998758,184.3665687,https://clinicaltrials.gov/study/NCT01174199,NCT01174199,Prostate Cancer|Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
4544,0.800459338,8.741710381,https://clinicaltrials.gov/study/NCT01101399,NCT01101399,Iron-Deficiency Anemia
4545,0.798166819,9.911436625,https://clinicaltrials.gov/study/NCT02005770,NCT02005770,Female Breast Carcinoma
4546,0.774070529,8.090532627,https://clinicaltrials.gov/study/NCT04145570,NCT04145570,Lung Cancer
4547,0.939724067,30.708194,https://clinicaltrials.gov/study/NCT00148070,NCT00148070,Metastatic Breast Cancer
4548,0.9945758,154.8281595,https://clinicaltrials.gov/study/NCT04123470,NCT04123470,Malignant Melanoma
4549,0.998908732,191.9991836,https://clinicaltrials.gov/study/NCT00387374,NCT00387374,Adenosquamous Cell Lung Cancer|Drug/Agent Toxicity by Tissue/Organ|Hemoptysis|Squamous Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
4550,0.975092816,99.60752223,https://clinicaltrials.gov/study/NCT02961374,NCT02961374,Attenuated Familial Adenomatous Polyposis|Familial Adenomatous Polyposis
4551,0.975571977,84.33174927,https://clinicaltrials.gov/study/NCT00478374,NCT00478374,Hepatocellular Carcinoma
4552,0.937647375,38.29400563,https://clinicaltrials.gov/study/NCT01043874,NCT01043874,Philadelphia Chromosome Positive|Chronic Myelogenous Leukemia in Chronic Phase
4553,0.873640058,12.93330918,https://clinicaltrials.gov/study/NCT00107081,NCT00107081,Fever|Neutropenia|Cancer
4554,0.959825835,45.39690252,https://clinicaltrials.gov/study/NCT01804374,NCT01804374,Metastatic Osteosarcoma|Relapsed Osteosarcoma
4555,0.799366731,8.376622399,https://clinicaltrials.gov/study/NCT01960374,NCT01960374,Healthy Volunteers Pharmacokinetic Study
4556,0.999822481,186.6102392,https://clinicaltrials.gov/study/NCT00096174,NCT00096174,Head and Neck Cancer
4557,0.967078181,48.34074464,https://clinicaltrials.gov/study/NCT01704274,NCT01704274,Prostate Cancer
4558,0.979426911,90.81793559,https://clinicaltrials.gov/study/NCT01379274,NCT01379274,MDS
4559,0.950398599,29.97949074,https://clinicaltrials.gov/study/NCT00794274,NCT00794274,Sarcoidosis|Cutaneous Sarcoidosis
4560,0.95478541,46.9191408,https://clinicaltrials.gov/study/NCT03472274,NCT03472274,Bladder Cancer
4561,0.957211084,41.59262476,https://clinicaltrials.gov/study/NCT03070574,NCT03070574,Colorectal Cancer
4562,0.86651237,14.84234983,https://clinicaltrials.gov/study/NCT01692340,NCT01692340,Healthy
4563,0.9945045,154.9340689,https://clinicaltrials.gov/study/NCT05181540,NCT05181540,Hodgkin Lymphoma|Non Hodgkin Lymphoma
4564,0.987892831,150.7207777,https://clinicaltrials.gov/study/NCT01360840,NCT01360840,Prostate Cancer Metastatic
4565,0.840244608,11.15740539,https://clinicaltrials.gov/study/NCT01393340,NCT01393340,Nasal Polyposis|Asthma
4566,0.994973425,155.4387573,https://clinicaltrials.gov/study/NCT03295240,NCT03295240,Mantle Cell Lymphoma|Lymphoma
4567,0.998277343,169.9988768,https://clinicaltrials.gov/study/NCT00692640,NCT00692640,Cancer|Non-small Cell Lung Cancer
4568,0.989745202,151.1892768,https://clinicaltrials.gov/study/NCT01265940,NCT01265940,Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.
4569,0.99878498,178.961601,https://clinicaltrials.gov/study/NCT00253474,NCT00253474,"Neoplasm of Uncertain Malignant Potential|Unspecified Childhood Solid Tumor, Protocol Specific"
4570,0.982317553,112.002406,https://clinicaltrials.gov/study/NCT01847274,NCT01847274,Ovarian Neoplasms|Platinum Sensitive Ovarian Cancer
4571,0.996175419,156.5135037,https://clinicaltrials.gov/study/NCT00985374,NCT00985374,Neoplasms
4572,0.99873144,177.6278079,https://clinicaltrials.gov/study/NCT00922974,NCT00922974,Metastatic Cancer|Pain
4573,0.975859149,81.2653981,https://clinicaltrials.gov/study/NCT00269074,NCT00269074,Actinic Keratosis
4574,0.998666555,174.6701016,https://clinicaltrials.gov/study/NCT00118274,NCT00118274,Melanoma (Skin)
4575,0.991502662,152.3486391,https://clinicaltrials.gov/study/NCT00111774,NCT00111774,Colorectal Cancer|Carcinoma
4576,0.998727319,174.9911576,https://clinicaltrials.gov/study/NCT01328574,NCT01328574,"Urothelial Carcinoma|Ureteral Neoplasms|Ureter Cancer|Neoplasm, Ureteral|Cancer of the Ureter"
4577,0.99797541,167.2459779,https://clinicaltrials.gov/study/NCT00003781,NCT00003781,Pain|Prostate Cancer
4578,0.999035466,185.9495334,https://clinicaltrials.gov/study/NCT04911881,NCT04911881,Advanced Solid Tumors
4579,0.995175322,156.437152,https://clinicaltrials.gov/study/NCT00923481,NCT00923481,"Head and Neck Neoplasms|Pheochromocytoma|Colorectal Neoplasms|Carcinoma, Non-Small-Cell Lung|Carcinoma, Renal Cell"
4580,0.989012772,150.5758277,https://clinicaltrials.gov/study/NCT00300781,NCT00300781,Breast Neoplasms|Neoplasms
4581,0.7568839,6.81782771,https://clinicaltrials.gov/study/NCT00238381,NCT00238381,Colorectal Cancer
4582,0.977157382,93.6238525,https://clinicaltrials.gov/study/NCT01017874,NCT01017874,Non Small Cell Lung Cancer
4583,0.998362012,173.9382889,https://clinicaltrials.gov/study/NCT00278174,NCT00278174,Kidney Cancer
4584,0.993774751,153.5674125,https://clinicaltrials.gov/study/NCT00064974,NCT00064974,Myelodysplastic Syndromes
4585,0.977629304,57.41044995,https://clinicaltrials.gov/study/NCT03500874,NCT03500874,Colorectal Cancer|Liver Metastases|HAI
4586,0.999594649,185.5604306,https://clinicaltrials.gov/study/NCT00003974,NCT00003974,Lung Cancer|Malignant Mesothelioma
4587,0.998732852,170.7642293,https://clinicaltrials.gov/study/NCT00074074,NCT00074074,Myelodysplastic Syndromes
4588,0.996172089,155.5060086,https://clinicaltrials.gov/study/NCT01851174,NCT01851174,Pancreatic Carcinoma Non-resectable|Stage IV Pancreatic Cancer
4589,0.991471907,153.0796226,https://clinicaltrials.gov/study/NCT00002624,NCT00002624,Lung Cancer
4590,0.994561432,154.0097069,https://clinicaltrials.gov/study/NCT00401024,NCT00401024,Brain and Central Nervous System Tumors
4591,0.994667022,156.252392,https://clinicaltrials.gov/study/NCT01363024,NCT01363024,Solid Tumor
4592,0.986673337,151.0173251,https://clinicaltrials.gov/study/NCT02725424,NCT02725424,Gastric Cancer
4593,0.952462553,42.60349312,https://clinicaltrials.gov/study/NCT00193024,NCT00193024,Breast Cancer
4594,0.998229274,169.9747202,https://clinicaltrials.gov/study/NCT04059224,NCT04059224,Stage IV Melanoma|Stage III Melanoma
4595,0.986060423,150.2344684,https://clinicaltrials.gov/study/NCT01708174,NCT01708174,Medulloblastoma
4596,0.988693464,150.3072651,https://clinicaltrials.gov/study/NCT00118040,NCT00118040,Recurrent Bladder Carcinoma|Stage I Bladder Cancer AJCC v6 and v7|Stage II Bladder Cancer AJCC v6 and v7|Stage III Bladder Cancer AJCC v6 and v7
4597,0.967479187,63.01587232,https://clinicaltrials.gov/study/NCT03248440,NCT03248440,Chalazion
4598,0.985881263,119.7153619,https://clinicaltrials.gov/study/NCT05305040,NCT05305040,Adenovirus Infection|BK Virus Infection|Cytomegalovirus Infections|Epstein-Barr Virus Infections|Human Herpes Virus-6 Infection|JC Virus Infection
4599,0.984173159,149.4646541,https://clinicaltrials.gov/study/NCT05810740,NCT05810740,Melanoma|BRAF V600 Mutation|Unresectable Melanoma|Metastatic Melanoma
4600,0.912298628,26.69408411,https://clinicaltrials.gov/study/NCT03389724,NCT03389724,Cardiotoxicity|Acute Myeloid Leukemia in Children|Bone Tumor
4601,0.999134162,192.0806471,https://clinicaltrials.gov/study/NCT02514824,NCT02514824,Merkel Cell Carcinoma
4602,0.856355951,12.35262754,https://clinicaltrials.gov/study/NCT02655224,NCT02655224,Uterine Fibroids
4603,0.718854016,3.240529041,https://clinicaltrials.gov/study/NCT01738724,NCT01738724,Uterine Leiomyoma
4604,0.999507103,191.7304202,https://clinicaltrials.gov/study/NCT00003081,NCT00003081,Sarcoma
4605,0.990110723,151.4555514,https://clinicaltrials.gov/study/NCT03371381,NCT03371381,Adenocarcinoma of Lung
4606,0.938059454,29.14303407,https://clinicaltrials.gov/study/NCT01543581,NCT01543581,Basal Cell Carcinoma
4607,0.998945982,194.5866888,https://clinicaltrials.gov/study/NCT00053781,NCT00053781,Melanoma (Skin)
4608,0.987914249,150.2645713,https://clinicaltrials.gov/study/NCT04313881,NCT04313881,Myelodysplastic Syndromes
4609,0.999353105,187.3074266,https://clinicaltrials.gov/study/NCT00088881,NCT00088881,Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Testicular Lymphoma|Waldenstrm Macroglobulinemia
4610,0.995103827,156.3205783,https://clinicaltrials.gov/study/NCT00190476,NCT00190476,Non-small-cell Lung Cancer
4611,0.975424171,97.0103668,https://clinicaltrials.gov/study/NCT00247676,NCT00247676,Liver Neoplasms|Unresectable Hepatocellular Carcinoma
4612,0.999223216,177.6973503,https://clinicaltrials.gov/study/NCT01777776,NCT01777776,Locally Advanced Metastatic BRAF Mutant Melanoma
4613,0.978702923,96.0735075,https://clinicaltrials.gov/study/NCT00810576,NCT00810576,Lymphoma
4614,0.984589318,138.8523128,https://clinicaltrials.gov/study/NCT02154776,NCT02154776,Advanced or Metastatic Breast Cancer
4615,0.997679237,164.0693399,https://clinicaltrials.gov/study/NCT02053376,NCT02053376,Metastatic Biliary Tract Carcinoma
4616,0.924434754,21.58747527,https://clinicaltrials.gov/study/NCT00135876,NCT00135876,Venous Thromboembolism|Brain Tumors
4617,0.999474201,179.3650332,https://clinicaltrials.gov/study/NCT00112476,NCT00112476,"Recurrent Melanoma|Recurrent Renal Cell Cancer|Stage IV Melanoma|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
4618,0.968382789,65.1257491,https://clinicaltrials.gov/study/NCT03070899,NCT03070899,Uterine Fibroids|Heavy Menstrual Bleeding
4619,0.991675921,151.3482944,https://clinicaltrials.gov/study/NCT01747499,NCT01747499,"Leukemia, Myeloid, Acute|Myelodysplastic Syndromes|Precursor Cell Lymphoblastic Leukemia-Lymphoma"
4620,0.998919562,179.9441569,https://clinicaltrials.gov/study/NCT00002899,NCT00002899,Metastatic Cancer
4621,0.997851899,165.1220037,https://clinicaltrials.gov/study/NCT00652899,NCT00652899,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
4622,0.824509785,9.76753688,https://clinicaltrials.gov/study/NCT02240199,NCT02240199,Post-mastectomy Pain Syndrome|Chronic Post-surgical Pain
4623,0.99498852,155.0768231,https://clinicaltrials.gov/study/NCT02845999,NCT02845999,Gastrointestinal Metastatic Cancer
4624,0.983983502,128.0364847,https://clinicaltrials.gov/study/NCT02513199,NCT02513199,Hepatocellular Carcinoma
4625,0.994826612,153.342736,https://clinicaltrials.gov/study/NCT00374699,NCT00374699,Peripheral T-Cell Lymphomas|Non-Hodgkin Lymphoma
4626,0.961458827,44.69405465,https://clinicaltrials.gov/study/NCT03261999,NCT03261999,Prostatic Neoplasms
4627,0.991114942,151.8339437,https://clinicaltrials.gov/study/NCT00095199,NCT00095199,Non Small Cell Lung Cancer
4628,0.959667711,56.46237478,https://clinicaltrials.gov/study/NCT00795899,NCT00795899,Breast Cancer
4629,0.995100048,155.12164,https://clinicaltrials.gov/study/NCT01517399,NCT01517399,Solid Tumors
4630,0.997037085,159.9523529,https://clinicaltrials.gov/study/NCT01001299,NCT01001299,Malignant Melanoma
4631,0.993052139,151.8552835,https://clinicaltrials.gov/study/NCT00422799,NCT00422799,Waldenstrom's Macroglobulinemia
4632,0.994539699,153.4542038,https://clinicaltrials.gov/study/NCT00003299,NCT00003299,Lung Cancer
4633,0.997480877,166.1831095,https://clinicaltrials.gov/study/NCT01263899,NCT01263899,Hodgkin Lymphoma|Mantle Cell Lymphoma|Indolent Lymphoma
4634,0.978381941,67.92390088,https://clinicaltrials.gov/study/NCT00569699,NCT00569699,Colorectal Cancer
4635,0.994323965,155.4914621,https://clinicaltrials.gov/study/NCT02567799,NCT02567799,"Carcinoma, Non-Small-Cell Lung"
4636,0.999201727,200.9108956,https://clinicaltrials.gov/study/NCT03856099,NCT03856099,Recurrent Glioblastoma
4637,0.999702704,185.3400519,https://clinicaltrials.gov/study/NCT04408599,NCT04408599,Advanced or Metastatic Solid Tumors|Ovarian Cancer|Gastric Cancer|Colo-rectal Cancer
4638,0.999392044,184.5121565,https://clinicaltrials.gov/study/NCT01062399,NCT01062399,Brain and Central Nervous System Tumors
4639,0.968573554,62.5854178,https://clinicaltrials.gov/study/NCT01810770,NCT01810770,Prostatic Neoplasms
4640,0.991115288,152.0978743,https://clinicaltrials.gov/study/NCT00061581,NCT00061581,Acute Lymphocytic Leukemia|Chronic Myeloid Leukemia|Acute Myelocytic Leukemia|Myelodysplastic Syndromes|Myeloproliferative Disorders
4641,0.997444378,162.5343633,https://clinicaltrials.gov/study/NCT00002581,NCT00002581,Breast Cancer
4642,0.962503372,46.01736869,https://clinicaltrials.gov/study/NCT00831181,NCT00831181,Colorectal Cancer
4643,0.960938439,60.09829378,https://clinicaltrials.gov/study/NCT00918281,NCT00918281,Solid Tumors|High Grade Gliomas|Lung Cancer|Head and Neck Cancer|Sarcoma|Renal Cell Carcinoma|Breast Cancer
4644,0.992458008,151.8498818,https://clinicaltrials.gov/study/NCT00866281,NCT00866281,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia
4645,0.994228026,153.7516151,https://clinicaltrials.gov/study/NCT01864681,NCT01864681,NSCLC|EGFR Gene Amplification|Advanced Cancer|Stage IIIB NSCLC|Stage IV NSCLC
4646,0.99563773,155.5015793,https://clinicaltrials.gov/study/NCT00234481,NCT00234481,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
4647,0.81493173,9.780931068,https://clinicaltrials.gov/study/NCT04073381,NCT04073381,Prehabilitation
4648,0.984657463,145.6000265,https://clinicaltrials.gov/study/NCT00538876,NCT00538876,Acute Myeloid Leukemia
4649,0.989291338,151.1934556,https://clinicaltrials.gov/study/NCT01844076,NCT01844076,Colorectal Adenocarcinoma
4650,0.993314563,152.5614644,https://clinicaltrials.gov/study/NCT01123876,NCT01123876,Gastric Cancer
4651,0.997796317,171.9315694,https://clinicaltrials.gov/study/NCT01282476,NCT01282476,Diffuse Large B Cell Lymphoma
4652,0.999799698,181.9025899,https://clinicaltrials.gov/study/NCT01727076,NCT01727076,Head and Neck Squamous Cell Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Non-Small Cell Lung Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Skin Carcinoma|Stage III Renal Cell Cancer|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Non-Small Cell Lung Cancer AJCC v7|Stage IV Renal Cell Cancer
4653,0.989427929,150.4710254,https://clinicaltrials.gov/study/NCT00388076,NCT00388076,"Neoplasms, Breast"
4654,0.99345872,153.1717338,https://clinicaltrials.gov/study/NCT00372476,NCT00372476,Breast Cancer
4655,0.891626099,16.36980302,https://clinicaltrials.gov/study/NCT02521376,NCT02521376,Oncology
4656,0.988292906,150.8489159,https://clinicaltrials.gov/study/NCT00412776,NCT00412776,"Carcinoma, Squamous Cell of Head and Neck|Carcinoma, Squamous Cell|Neoplasms, Squamous Cell|Head and Neck Neoplasms|Mouth Neoplasms|Head and Neck Cancer"
4657,0.575589222,3.107574356,https://clinicaltrials.gov/study/NCT01288599,NCT01288599,Ovarian Cyst
4658,0.997988212,169.8032109,https://clinicaltrials.gov/study/NCT00912899,NCT00912899,Refractory Multiple Myeloma
4659,0.997145988,159.7642746,https://clinicaltrials.gov/study/NCT00021099,NCT00021099,Distal Urethral Cancer|Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Proximal Urethral Cancer|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Regional Transitional Cell Cancer of the Renal Pelvis and Ureter|Stage III Bladder Cancer|Stage IV Bladder Cancer|Transitional Cell Carcinoma of the Bladder|Urethral Cancer Associated With Invasive Bladder Cancer
4660,0.991410463,151.8376531,https://clinicaltrials.gov/study/NCT01077999,NCT01077999,Squamous Cell Carcinoma|Adenocarcinoma|Esophageal Cancer|Gastro-esophageal Junction Cancer
4661,0.998905543,180.761922,https://clinicaltrials.gov/study/NCT02553499,NCT02553499,Advanced Solid Tumor
4662,0.964505689,45.32229135,https://clinicaltrials.gov/study/NCT04476199,NCT04476199,Acute Myeloid Leukemia
4663,0.965931132,56.08833531,https://clinicaltrials.gov/study/NCT00630799,NCT00630799,Prostate Cancer
4664,0.994602439,154.9130397,https://clinicaltrials.gov/study/NCT04685499,NCT04685499,Head and Neck Squamous Cell Carcinoma With Inoperable Recurrent or Progressive Disease
4665,0.996912546,160.0978169,https://clinicaltrials.gov/study/NCT00960999,NCT00960999,Lung Cancer
4666,0.998812589,179.9307905,https://clinicaltrials.gov/study/NCT00003199,NCT00003199,Estrogen Receptor-negative Breast Cancer|Estrogen Receptor-positive Breast Cancer|Inflammatory Breast Cancer|Male Breast Cancer|Progesterone Receptor-negative Breast Cancer|Progesterone Receptor-positive Breast Cancer|Stage IIIB Breast Cancer|Stage IV Breast Cancer
4667,0.988338739,150.6132983,https://clinicaltrials.gov/study/NCT02043899,NCT02043899,Metastatic Neuroblastoma
4668,0.995941139,156.7691973,https://clinicaltrials.gov/study/NCT00080899,NCT00080899,Adenocarcinoma of the Prostate|Recurrent Prostate Cancer
4669,0.991651663,152.3082645,https://clinicaltrials.gov/study/NCT01193699,NCT01193699,Polycythemia Vera
4670,0.997506438,162.5211113,https://clinicaltrials.gov/study/NCT00054899,NCT00054899,"Carcinoma, Non-Small-Cell Lung|Lung Neoplasm"
4671,0.986768157,150.1930007,https://clinicaltrials.gov/study/NCT01794299,NCT01794299,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Myelodysplastic Syndrome
4672,0.972638471,79.47814962,https://clinicaltrials.gov/study/NCT00006181,NCT00006181,Cardiovascular Diseases|Cancer|Physical Activity|Nutrition
4673,0.993777076,152.8902389,https://clinicaltrials.gov/study/NCT00005981,NCT00005981,Colorectal Cancer
4674,0.995855625,156.3182337,https://clinicaltrials.gov/study/NCT00512681,NCT00512681,Stomach Neoplasms
4675,0.999373815,185.341532,https://clinicaltrials.gov/study/NCT00459381,NCT00459381,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
4676,0.993086143,152.2312357,https://clinicaltrials.gov/study/NCT03349281,NCT03349281,Refractory Acute Lymphoblastic Leukemia|Relapsed Acute Lymphoblastic Leukemia
4677,0.989764643,150.7588702,https://clinicaltrials.gov/study/NCT02843581,NCT02843581,Metastatic Esophageal Cancer
4678,0.986955859,150.3723505,https://clinicaltrials.gov/study/NCT00607581,NCT00607581,Amyloidosis
4679,0.955891296,46.54358811,https://clinicaltrials.gov/study/NCT00196781,NCT00196781,Localized Prostate Cancer
4680,0.998529654,175.719399,https://clinicaltrials.gov/study/NCT04442581,NCT04442581,Advanced Hepatocellular Carcinoma|BCLC Stage B Hepatocellular Carcinoma|BCLC Stage C Hepatocellular Carcinoma
4681,0.999322238,191.2560909,https://clinicaltrials.gov/study/NCT00006381,NCT00006381,Breast Cancer
4682,0.998458989,174.6247767,https://clinicaltrials.gov/study/NCT00244881,NCT00244881,Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
4683,0.998274023,169.7236392,https://clinicaltrials.gov/study/NCT04346381,NCT04346381,Solid Tumor
4684,0.999276043,184.9572691,https://clinicaltrials.gov/study/NCT00012181,NCT00012181,"Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Liver Cancer|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Medulloblastoma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway and Hypothalamic Glioma|Recurrent Childhood Visual Pathway Glioma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Recurrent Retinoblastoma|Recurrent Wilms Tumor and Other Childhood Kidney Tumors|Recurrent/Refractory Childhood Hodgkin Lymphoma|Unspecified Childhood Solid Tumor, Protocol Specific"
4685,0.998119155,165.9419573,https://clinicaltrials.gov/study/NCT01888081,NCT01888081,Melanoma
4686,0.829904118,10.80862296,https://clinicaltrials.gov/study/NCT02036281,NCT02036281,"Terminally Ill|Histologically-confirmed Advanced Cancer|Pain, Intractable"
4687,0.992680891,152.537174,https://clinicaltrials.gov/study/NCT00003276,NCT00003276,Gallbladder Cancer
4688,0.999354321,180.7880973,https://clinicaltrials.gov/study/NCT00265876,NCT00265876,Pancreatic Cancer
4689,0.99080228,150.8720568,https://clinicaltrials.gov/study/NCT02015676,NCT02015676,Breast Cancer
4690,0.890078948,17.83818036,https://clinicaltrials.gov/study/NCT02400476,NCT02400476,Early Stage HER2+ Breast Cancer
4691,0.884277801,19.36125356,https://clinicaltrials.gov/study/NCT01190176,NCT01190176,"Infections, Papillomavirus"
4692,0.910871785,22.39879707,https://clinicaltrials.gov/study/NCT00605176,NCT00605176,Actinic Keratoses
4693,0.999324156,181.0955543,https://clinicaltrials.gov/study/NCT00334776,NCT00334776,Intraocular Melanoma|Melanoma (Skin)
4694,0.989360491,150.7062009,https://clinicaltrials.gov/study/NCT03291899,NCT03291899,Biliary Tract Cancer
4695,0.943671354,31.13190239,https://clinicaltrials.gov/study/NCT00919399,NCT00919399,Breast Neoplasms
4696,0.999536381,177.1215712,https://clinicaltrials.gov/study/NCT00003399,NCT00003399,Multiple Myeloma and Plasma Cell Neoplasm
4697,0.927670988,26.31786519,https://clinicaltrials.gov/study/NCT03238599,NCT03238599,Lymphoma|Myeloma|High-dose Chemotherapy|Autologous Stem Cell Transplantation
4698,0.99491293,154.7136942,https://clinicaltrials.gov/study/NCT04590599,NCT04590599,Advanced Cervical Cancer
4699,0.997829476,164.6239442,https://clinicaltrials.gov/study/NCT04398199,NCT04398199,"Nonsmall Cell Lung Cancer, Stage II|Nonsmall Cell Lung Cancer Stage III"
4700,0.999213895,189.5487727,https://clinicaltrials.gov/study/NCT00084799,NCT00084799,Lung Cancer
4701,0.98506304,123.5585042,https://clinicaltrials.gov/study/NCT00747799,NCT00747799,Nasopharyngeal Neoplasms
4702,0.998210335,169.9386894,https://clinicaltrials.gov/study/NCT01096199,NCT01096199,Cancer
4703,0.991072772,151.1418369,https://clinicaltrials.gov/study/NCT02448381,NCT02448381,Cutaneous T-Cell Lymphoma
4704,0.993683546,153.8391912,https://clinicaltrials.gov/study/NCT00528281,NCT00528281,"Lung Cancer, Non-Small Cell"
4705,0.998491855,171.0897053,https://clinicaltrials.gov/study/NCT01466881,NCT01466881,Adult Nasal Type Extranodal NK/T-Cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-Cell Lymphoma|Hepatosplenic T-Cell Lymphoma|Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Recurrent Adult Non-Hodgkin Lymphoma|Recurrent Adult T-Cell Leukemia/Lymphoma
4706,0.855204575,11.76300021,https://clinicaltrials.gov/study/NCT01789281,NCT01789281,Neoplasms
4707,0.871399855,15.94201875,https://clinicaltrials.gov/study/NCT00048581,NCT00048581,Rheumatoid Arthritis
4708,0.998856893,181.047398,https://clinicaltrials.gov/study/NCT00513981,NCT00513981,"Brain and Central Nervous System Tumors|Sarcoma|Unspecified Childhood Solid Tumor, Protocol Specific"
4709,0.948627194,42.66689521,https://clinicaltrials.gov/study/NCT00771381,NCT00771381,Breast Neoplasm
4710,0.982151467,109.3024424,https://clinicaltrials.gov/study/NCT02331381,NCT02331381,Cancer|Malignant Tumor
4711,0.995571223,157.9448241,https://clinicaltrials.gov/study/NCT00640081,NCT00640081,Colorectal Cancer
4712,0.998603751,176.1410073,https://clinicaltrials.gov/study/NCT01747876,NCT01747876,Malignant Rhabdoid Tumors (MRT)|Neuroblastoma
4713,0.983051361,130.5574627,https://clinicaltrials.gov/study/NCT01750281,NCT01750281,Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
4714,0.998225942,170.6542476,https://clinicaltrials.gov/study/NCT00030576,NCT00030576,Head and Neck Cancer
4715,0.999790791,179.9913414,https://clinicaltrials.gov/study/NCT00443976,NCT00443976,"Non-Hodgkins Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific"
4716,0.962674329,42.92948691,https://clinicaltrials.gov/study/NCT01340976,NCT01340976,Anemia
4717,0.896603905,17.26107933,https://clinicaltrials.gov/study/NCT00544076,NCT00544076,Prostate Cancer|Male Erectile Disorder|Stage I Prostate Cancer|Stage II Prostate Cancer
4718,0.979905319,97.66291324,https://clinicaltrials.gov/study/NCT01283776,NCT01283776,Multiple Myeloma|Non-Hodgkin-Lymphoma|Hodgkin's Disease
4719,0.918782073,19.27501362,https://clinicaltrials.gov/study/NCT01067976,NCT01067976,Breast Cancer|Diagnostic Imaging
4720,0.959877276,57.78116578,https://clinicaltrials.gov/study/NCT00129376,NCT00129376,Breast Cancer
4721,0.974879233,87.83097224,https://clinicaltrials.gov/study/NCT01613976,NCT01613976,Myelodysplastic Syndromes (MDS)|Chronic Myelomonocytic Leukemia (CMML)|Acute Myeloid Leukemia (AML)
4722,0.96925367,65.99388129,https://clinicaltrials.gov/study/NCT01379976,NCT01379976,Non Small Cell Lung Cancer
4723,0.991543861,150.6601378,https://clinicaltrials.gov/study/NCT02040376,NCT02040376,Brain Tumor Treated With Cranial or Cranial-Spinal Radiation
4724,0.996476517,158.7537897,https://clinicaltrials.gov/study/NCT03203876,NCT03203876,Advanced Cancer
4725,0.999458708,191.3565067,https://clinicaltrials.gov/study/NCT03125876,NCT03125876,Acute Myeloid Leukemia (AML)
4726,0.981842595,120.3006641,https://clinicaltrials.gov/study/NCT02565576,NCT02565576,"Myasthenia Gravis, Generalized"
4727,0.986274816,150.5136258,https://clinicaltrials.gov/study/NCT01610999,NCT01610999,Chronic Lymphocytic Leukemia|Lymphoma|Multiple Myeloma
4728,0.989092552,150.0477865,https://clinicaltrials.gov/study/NCT02783599,NCT02783599,Soft Tissue Sarcoma
4729,0.994379222,153.4298078,https://clinicaltrials.gov/study/NCT01893099,NCT01893099,Ocular Melanoma
4730,0.543629647,3.217314416,https://clinicaltrials.gov/study/NCT02962999,NCT02962999,Chronic Obstructive Pulmonary Disease Mild|Chronic Obstructive Pulmonary Disease Moderate|Chronic Obstructive Pulmonary Disease Severe|Lungcancer|Anesthesia
4731,0.996515517,156.9443734,https://clinicaltrials.gov/study/NCT02303899,NCT02303899,"Mesothelioma, Malignant"
4732,0.999030217,181.6755436,https://clinicaltrials.gov/study/NCT01396499,NCT01396499,Leukemia
4733,0.99832288,171.1175042,https://clinicaltrials.gov/study/NCT00023699,NCT00023699,Ovarian Cancer|Primary Peritoneal Cavity Cancer
4734,0.998249249,166.7495212,https://clinicaltrials.gov/study/NCT00217399,NCT00217399,Recurrent Breast Cancer|Stage IV Breast Cancer
4735,0.998124398,167.8350231,https://clinicaltrials.gov/study/NCT01334099,NCT01334099,Metastatic Breast Cancer
4736,0.996537872,159.2821662,https://clinicaltrials.gov/study/NCT02376699,NCT02376699,"Carcinoma, Non-Small-Cell Lung|Carcinoma, Squamous Cell|Hodgkin Disease|Lymphoma|Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, Diffuse|Melanoma|Neoplasm Metastasis|Neoplasms, Head and Neck|Neoplasms, Squamous Cell|Non-Small Cell Lung Cancer|Non-Small Cell Lung Cancer Metastatic|Non-small Cell Carcinoma|Squamous Cell Cancer|Squamous Cell Carcinoma|Squamous Cell Carcinoma of the Head and Neck|Squamous Cell Neoplasm|Lymphoma, Non-Hodgkin|Pancreatic Adenocarcinoma"
4737,0.997347599,157.4683772,https://clinicaltrials.gov/study/NCT00556699,NCT00556699,Non-Hodgkin's Lymphoma
4738,0.995352652,154.9005031,https://clinicaltrials.gov/study/NCT01179399,NCT01179399,Advanced Nonhematological Malignancies
4739,0.999889821,194.3552003,https://clinicaltrials.gov/study/NCT00313599,NCT00313599,Bladder Cancer|Brain and Central Nervous System Tumors|Breast Cancer|Esophageal Cancer|Extragonadal Germ Cell Tumor|Gastric Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer
4740,0.994620782,155.1863998,https://clinicaltrials.gov/study/NCT02760199,NCT02760199,Advanced Gastrointestinal Cancer
4741,0.991706984,151.4707723,https://clinicaltrials.gov/study/NCT01820299,NCT01820299,Solid Cancers
4742,0.961244281,51.75294648,https://clinicaltrials.gov/study/NCT00548899,NCT00548899,Breast Cancer
4743,0.985057964,141.2937457,https://clinicaltrials.gov/study/NCT00001381,NCT00001381,"Bladder Neoplasms|Carcinoma, Transitional Cell"
4744,0.991034277,151.5479564,https://clinicaltrials.gov/study/NCT03041181,NCT03041181,Non-Squamous Non-Small Cell Lung Cancer (NSCLC)|Adenocarcinoma of the Lung|Lung Cancer|Squamous Cell Lung Cancer
4745,0.995746489,156.8475886,https://clinicaltrials.gov/study/NCT00322881,NCT00322881,"Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer|Mixed Tumor, Mesodermal"
4746,0.942016578,35.17813078,https://clinicaltrials.gov/study/NCT02067481,NCT02067481,Breast Cancer
4747,0.985466236,129.2518018,https://clinicaltrials.gov/study/NCT02753881,NCT02753881,Liver Cancer
4748,0.999103991,190.1661639,https://clinicaltrials.gov/study/NCT01213381,NCT01213381,Advance Solid Tumors
4749,0.996118725,157.1347548,https://clinicaltrials.gov/study/NCT00968981,NCT00968981,Solid Cancers
4750,0.992100203,152.0929682,https://clinicaltrials.gov/study/NCT01396681,NCT01396681,Pancreatic Cancer
4751,0.996667429,159.6216787,https://clinicaltrials.gov/study/NCT02774681,NCT02774681,Breast Carcinoma Metastatic in the Brain|Estrogen Receptor Negative|HER2/Neu Negative|HER2/Neu Positive|Progesterone Receptor Negative|Recurrent Breast Carcinoma|Stage IV Breast Cancer
4752,0.998272156,170.8498764,https://clinicaltrials.gov/study/NCT00274781,NCT00274781,Leukemia|Myelodysplastic Syndromes
4753,0.996330151,157.4123695,https://clinicaltrials.gov/study/NCT02175381,NCT02175381,NSCLC
4754,0.990178032,151.5273717,https://clinicaltrials.gov/study/NCT01910181,NCT01910181,Malignant Melanoma
4755,0.999592735,178.3667895,https://clinicaltrials.gov/study/NCT00025181,NCT00025181,Intraocular Melanoma|Melanoma (Skin)
4756,0.997013464,160.2080409,https://clinicaltrials.gov/study/NCT00246181,NCT00246181,Non-small Cell Lung Cancer
4757,0.99969087,186.7216918,https://clinicaltrials.gov/study/NCT00006981,NCT00006981,Cervical Cancer|Fallopian Tube Cancer|Head and Neck Cancer|Lung Cancer|Malignant Mesothelioma|Ovarian Cancer|Pancreatic Cancer|Primary Peritoneal Cavity Cancer
4758,0.978643311,85.07153203,https://clinicaltrials.gov/study/NCT03013881,NCT03013881,Breast Neoplasm
4759,0.679504988,6.407707029,https://clinicaltrials.gov/study/NCT00212381,NCT00212381,Cervical Dysplasia
4760,0.993668756,154.4395095,https://clinicaltrials.gov/study/NCT01533181,NCT01533181,Recurrent Small Cell Lung Carcinoma
4761,0.995116122,156.202363,https://clinicaltrials.gov/study/NCT00097981,NCT00097981,Multiple Myeloma
4762,0.967209993,55.07678369,https://clinicaltrials.gov/study/NCT02994576,NCT02994576,Nonsmall Cell Lung Cancer
4763,0.995551039,154.6188574,https://clinicaltrials.gov/study/NCT03003676,NCT03003676,Advanced or Unresectable Melanoma Progressing After PD1 Blockade
4764,0.992306499,153.0807832,https://clinicaltrials.gov/study/NCT01243476,NCT01243476,Myelodysplastic Syndrome
4765,0.998302578,174.3639746,https://clinicaltrials.gov/study/NCT01230476,NCT01230476,Nasopharyngeal Carcinoma
4766,0.988541972,150.3730455,https://clinicaltrials.gov/study/NCT02027376,NCT02027376,Advanced Breast Cancer
4767,0.992700489,151.9890889,https://clinicaltrials.gov/study/NCT00460876,NCT00460876,Retinoblastoma
4768,0.996745847,157.1106925,https://clinicaltrials.gov/study/NCT00017576,NCT00017576,Prostate Cancer
4769,0.987888648,150.6263418,https://clinicaltrials.gov/study/NCT01370876,NCT01370876,"Cancer of the Head and Neck|Neoplasms, Head and Neck"
4770,0.845851079,14.79433283,https://clinicaltrials.gov/study/NCT00644176,NCT00644176,Pharmacokinetics
4771,0.974930376,91.46940907,https://clinicaltrials.gov/study/NCT01852799,NCT01852799,Multiple Myeloma
4772,0.991716888,151.05448,https://clinicaltrials.gov/study/NCT01659099,NCT01659099,Diffuse Large B Cell Lymphoma CD20 Positive
4773,0.998173399,169.9883495,https://clinicaltrials.gov/study/NCT00602199,NCT00602199,Melanoma (Skin)
4774,0.869076238,15.02633381,https://clinicaltrials.gov/study/NCT00971399,NCT00971399,Radiotherapy Induced Nausea and Vomiting
4775,0.999694019,187.4667825,https://clinicaltrials.gov/study/NCT00301899,NCT00301899,Breast Cancer
4776,0.999504059,185.08139,https://clinicaltrials.gov/study/NCT00121199,NCT00121199,Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma
4777,0.998429415,170.5044296,https://clinicaltrials.gov/study/NCT03415399,NCT03415399,"Lymphoma, B-Cell"
4778,0.975609409,76.11672135,https://clinicaltrials.gov/study/NCT00266799,NCT00266799,Breast Cancer
4779,0.997088242,159.9641395,https://clinicaltrials.gov/study/NCT03499899,NCT03499899,Triple-negative Breast Cancer
4780,0.981585909,117.3379479,https://clinicaltrials.gov/study/NCT00530699,NCT00530699,Acute Myeloid Leukaemia
4781,0.998075349,172.0669821,https://clinicaltrials.gov/study/NCT02575781,NCT02575781,Neoplasm Malignant
4782,0.985173878,140.4717099,https://clinicaltrials.gov/study/NCT02807181,NCT02807181,Intrahepatic Cholangiocarcinoma
4783,0.969444321,69.1723193,https://clinicaltrials.gov/study/NCT01205581,NCT01205581,HIV|Cancer
4784,0.994118429,154.3043371,https://clinicaltrials.gov/study/NCT00083681,NCT00083681,Multiple Myeloma
4785,0.997372772,161.555805,https://clinicaltrials.gov/study/NCT00430781,NCT00430781,"Neoplasms, Uterine Cervix|Metastatic Cervical Cancer"
4786,0.977329297,75.22794297,https://clinicaltrials.gov/study/NCT02055781,NCT02055781,Primary Myelofibrosis|Post-polycythemia Vera Myelofibrosis|Post-essential Thrombocythemia Myelofibrosis
4787,0.995634577,156.1897923,https://clinicaltrials.gov/study/NCT00038181,NCT00038181,Prostate Cancer
4788,0.998985279,188.8762894,https://clinicaltrials.gov/study/NCT01193881,NCT01193881,Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer
4789,0.987303258,150.6747175,https://clinicaltrials.gov/study/NCT02301481,NCT02301481,Stomach Neoplasms|Neoadjuvant Therapy|Chemoradiotherapy|Chemotherapy
4790,0.971547264,75.77370488,https://clinicaltrials.gov/study/NCT05465681,NCT05465681,Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy
4791,0.939364985,33.84642239,https://clinicaltrials.gov/study/NCT00781781,NCT00781781,Graft Versus Host Disease
4792,0.998841672,177.4843778,https://clinicaltrials.gov/study/NCT00003281,NCT00003281,Lung Cancer
4793,0.977566277,102.2821337,https://clinicaltrials.gov/study/NCT03463681,NCT03463681,Metastatic Renal Cell Carcinoma
4794,0.999118105,183.4164483,https://clinicaltrials.gov/study/NCT00217581,NCT00217581,Esophageal Cancer|Gastric Cancer
4795,0.98243304,85.53020086,https://clinicaltrials.gov/study/NCT00565981,NCT00565981,B-cell Chronic Lymphocytic Leukemia
4796,0.997310963,159.4750643,https://clinicaltrials.gov/study/NCT02839681,NCT02839681,Lung Neoplasms
4797,0.924354974,27.20623696,https://clinicaltrials.gov/study/NCT01176981,NCT01176981,Osteosarcoma
4798,0.913276832,22.29290173,https://clinicaltrials.gov/study/NCT00714376,NCT00714376,Prostate Cancer
4799,0.996471085,158.3051813,https://clinicaltrials.gov/study/NCT00390676,NCT00390676,Neoplasms
4800,0.999178722,189.2811976,https://clinicaltrials.gov/study/NCT01515176,NCT01515176,Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia
4801,0.990535105,151.7818081,https://clinicaltrials.gov/study/NCT03120676,NCT03120676,Hodgkin Lymphoma
4802,0.992672802,152.0276869,https://clinicaltrials.gov/study/NCT00809276,NCT00809276,Lymphoma|Multiple Myeloma|Leukemia|Myelodysplastic Syndrome
4803,0.997243014,164.271379,https://clinicaltrials.gov/study/NCT00837876,NCT00837876,Pancreatic Cancer
4804,0.925422222,26.51303716,https://clinicaltrials.gov/study/NCT02564276,NCT02564276,Endometrial Neoplasms
4805,0.938496036,33.16860499,https://clinicaltrials.gov/study/NCT02431676,NCT02431676,Breast Cancer|Prostate Cancer|Lung Cancer|Colon Cancer|Melanoma of Skin|Endometrial Cancer|Liver Cancer|Pancreatic Cancer|Rectal Cancer|Kidney Cancer|Other Solid Malignant Tumors
4806,0.997220995,159.0609688,https://clinicaltrials.gov/study/NCT03002376,NCT03002376,Melanoma
4807,0.998086368,169.5597429,https://clinicaltrials.gov/study/NCT01967576,NCT01967576,Pheochromocytoma|Paraganglioma
4808,0.999606631,187.0742456,https://clinicaltrials.gov/study/NCT00005976,NCT00005976,Brain and Central Nervous System Tumors
4809,0.967780382,59.23019748,https://clinicaltrials.gov/study/NCT00697476,NCT00697476,Small Cell Lung Cancer
4810,0.99671573,160.8121446,https://clinicaltrials.gov/study/NCT03407976,NCT03407976,Advanced Malignancies|Urothelial Carcinoma|MSI-H or dMMR Solid Tumors|Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
4811,0.987272416,150.6465581,https://clinicaltrials.gov/study/NCT00211276,NCT00211276,"Lymphoma, B-Cell"
4812,0.996990081,160.5146862,https://clinicaltrials.gov/study/NCT01212276,NCT01212276,Metastatic Melanoma|Malignant Metastatic Melanoma|Advanced Melanoma|Melanoma
4813,0.99359712,153.2836249,https://clinicaltrials.gov/study/NCT01209676,NCT01209676,Melanoma|Advanced Disease|Unresectable
4814,0.988272975,150.3279497,https://clinicaltrials.gov/study/NCT00716976,NCT00716976,Brain Tumor|Central Nervous System Tumor|Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Liver Cancer|Neuroblastoma|Ototoxicity|Ovarian Cancer|Sarcoma
4815,0.994167974,154.3887005,https://clinicaltrials.gov/study/NCT00005076,NCT00005076,Colorectal Cancer
4816,0.985812875,147.4493694,https://clinicaltrials.gov/study/NCT01049776,NCT01049776,Non Small Cell Lung Cancer
4817,0.986858232,150.4315855,https://clinicaltrials.gov/study/NCT02197676,NCT02197676,MDS
4818,0.998046679,164.7266621,https://clinicaltrials.gov/study/NCT00089076,NCT00089076,Adult Grade III Lymphomatoid Granulomatosis|B-cell Chronic Lymphocytic Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Refractory Hairy Cell Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Testicular Lymphoma|Waldenstrm Macroglobulinemia
4819,0.996853403,157.9943507,https://clinicaltrials.gov/study/NCT00036621,NCT00036621,Breast Cancer
4820,0.991097108,151.6952205,https://clinicaltrials.gov/study/NCT03103321,NCT03103321,Stage II Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage I Prostate Cancer|PSA Level Five to Ten|PSA Level Less Than Five|PSA Level Ten to Fifty
4821,0.996333136,157.7590876,https://clinicaltrials.gov/study/NCT00604721,NCT00604721,Adult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver Cancer
4822,0.996597823,159.2036208,https://clinicaltrials.gov/study/NCT02473731,NCT02473731,Squamous Cell Carcinoma of the Head and Neck
4823,0.934806643,26.94701999,https://clinicaltrials.gov/study/NCT01242631,NCT01242631,Testicular Cancer|Germ Cell Cancer
4824,0.998193831,161.682747,https://clinicaltrials.gov/study/NCT00001431,NCT00001431,Gastrointestinal Neoplasms|Pancreatic Neoplasms
4825,0.989452559,150.8863968,https://clinicaltrials.gov/study/NCT01639131,NCT01639131,Metastatic Colorectal Adenocarcinoma
4826,0.99836699,174.1827815,https://clinicaltrials.gov/study/NCT00361231,NCT00361231,Biliary Tract Cancer|Gallbladder Adenocarcinoma
4827,0.986707128,125.7669345,https://clinicaltrials.gov/study/NCT03093831,NCT03093831,"Lymphoma, B-Cell, Marginal Zone"
4828,0.957966209,51.03103696,https://clinicaltrials.gov/study/NCT02354131,NCT02354131,Ovarian Cancer
4829,0.966192683,46.1141226,https://clinicaltrials.gov/study/NCT00918931,NCT00918931,Leukemia|Systemic Mastocytosis
4830,0.982198358,125.5429163,https://clinicaltrials.gov/study/NCT00106431,NCT00106431,Cutaneous T-cell Lymphoma
4831,0.990375623,151.0631399,https://clinicaltrials.gov/study/NCT04068831,NCT04068831,Metastatic Renal Cell Carcinoma|Fumarate Hydratase Deficient Renal Cell Carcinoma|Succinate Dehydrogenase Deficient Renal Cell Carcinoma
4832,0.993018405,152.8172298,https://clinicaltrials.gov/study/NCT00059631,NCT00059631,Prostate Cancer
4833,0.88384652,13.75428833,https://clinicaltrials.gov/study/NCT04258631,NCT04258631,Malignant Female Reproductive System Neoplasm
4834,0.998207495,169.9809287,https://clinicaltrials.gov/study/NCT01076231,NCT01076231,Stage IIIA Non-small Cell Lung Cancer
4835,0.972071445,74.16252856,https://clinicaltrials.gov/study/NCT00068731,NCT00068731,Prostate Cancer
4836,0.995122726,156.0892109,https://clinicaltrials.gov/study/NCT00014131,NCT00014131,Kidney Cancer
4837,0.967840848,62.74010582,https://clinicaltrials.gov/study/NCT00050531,NCT00050531,"Leukemia, Myeloid, Chronic"
4838,0.993404885,153.9705376,https://clinicaltrials.gov/study/NCT02091531,NCT02091531,Metastatic Castration-Resistant Prostate Cancer
4839,0.993604276,151.7620944,https://clinicaltrials.gov/study/NCT03464942,NCT03464942,Breast Cancer
4840,0.970031572,67.28758044,https://clinicaltrials.gov/study/NCT01108042,NCT01108042,Oropharynx Cancer|Squamous Cell Carcinoma of the Oral Cavity
4841,0.998262162,165.5816985,https://clinicaltrials.gov/study/NCT00543842,NCT00543842,Rectal Cancer
4842,0.998068722,169.3864705,https://clinicaltrials.gov/study/NCT00790842,NCT00790842,Multiple Myeloma|Plasma Cell Neoplasm
4843,0.997776985,168.0677697,https://clinicaltrials.gov/study/NCT00052442,NCT00052442,Lymphoma
4844,0.986830675,150.2224191,https://clinicaltrials.gov/study/NCT01583842,NCT01583842,Neuroblastoma
4845,0.995984876,158.030924,https://clinicaltrials.gov/study/NCT01097642,NCT01097642,Breast Cancer
4846,0.998210747,176.49951,https://clinicaltrials.gov/study/NCT00005942,NCT00005942,Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation
4847,0.893823921,18.34937958,https://clinicaltrials.gov/study/NCT00172042,NCT00172042,Non-Small-Cell Lung Cancer
4848,0.989105037,150.7148257,https://clinicaltrials.gov/study/NCT02136342,NCT02136342,Advanced Cancer
4849,0.956800958,40.15542739,https://clinicaltrials.gov/study/NCT04979442,NCT04979442,Dedifferentiated Liposarcoma
4850,0.996798046,162.6459421,https://clinicaltrials.gov/study/NCT02203565,NCT02203565,Breast Cancer|Skin Reactions Secondary to Radiation Therapy
4851,0.992993528,152.4878306,https://clinicaltrials.gov/study/NCT01420965,NCT01420965,Prostatic Neoplasms
4852,0.998419873,173.1944575,https://clinicaltrials.gov/study/NCT00522665,NCT00522665,Colorectal Cancer
4853,0.999351064,172.5061118,https://clinicaltrials.gov/study/NCT00004242,NCT00004242,"Unspecified Adult Solid Tumor, Protocol Specific"
4854,0.997271639,162.1584161,https://clinicaltrials.gov/study/NCT00096265,NCT00096265,Metastatic Malignant Neoplasm in the Brain|Recurrent Non-Small Cell Lung Carcinoma|Stage IV Non-Small Cell Lung Cancer AJCC v7
4855,0.592161522,2.871847707,https://clinicaltrials.gov/study/NCT04266665,NCT04266665,Brain Tumor|Metabolic Disturbance|Inflammatory Response|Oxygen Deficiency
4856,0.973348404,65.78888334,https://clinicaltrials.gov/study/NCT00575965,NCT00575965,Waldenstrom's Macroglobulinemia
4857,0.999122256,186.0748496,https://clinicaltrials.gov/study/NCT00430365,NCT00430365,Myeloma
4858,0.990863572,151.0232742,https://clinicaltrials.gov/study/NCT01201265,NCT01201265,Breast Cancer
4859,0.992266465,151.8399373,https://clinicaltrials.gov/study/NCT05456165,NCT05456165,Colonic Neoplasms|Colorectal Neoplasms
4860,0.993243072,152.7194227,https://clinicaltrials.gov/study/NCT01830621,NCT01830621,Colorectal Carcinoma
4861,0.950887372,39.50085457,https://clinicaltrials.gov/study/NCT00978731,NCT00978731,Leukemia
4862,0.978549579,96.74068884,https://clinicaltrials.gov/study/NCT00032331,NCT00032331,Benign and Malignant Solitary Pulmonary Nodules
4863,0.975267438,74.81372732,https://clinicaltrials.gov/study/NCT00266331,NCT00266331,Breast Cancer
4864,0.984114608,124.889201,https://clinicaltrials.gov/study/NCT03890731,NCT03890731,Solid Cancer
4865,0.997056811,162.0601288,https://clinicaltrials.gov/study/NCT02259231,NCT02259231,Melanoma|Unresectable (Stage III) Melanoma|Metastatic (Stage IV) Melanoma
4866,0.996056048,155.0522064,https://clinicaltrials.gov/study/NCT04101331,NCT04101331,Peripheral T Cell Lymphoma|Transformed Mycosis Fungoides
4867,0.980763979,90.38790551,https://clinicaltrials.gov/study/NCT03862131,NCT03862131,Cardiotoxicity|Breast Cancer|Lymphoma|Sarcoma|Leukemia|Myeloma|Lung Cancer
4868,0.999548007,174.6898269,https://clinicaltrials.gov/study/NCT00001442,NCT00001442,Head and Neck Neoplasm|Squamous Cell Carcinoma
4869,0.999074228,194.489339,https://clinicaltrials.gov/study/NCT03953742,NCT03953742,Advanced Solid Tumor
4870,0.977968804,72.97291967,https://clinicaltrials.gov/study/NCT00317642,NCT00317642,Acute Myelogenous Leukemia
4871,0.983352537,99.39170873,https://clinicaltrials.gov/study/NCT00192842,NCT00192842,Pancreatic Cancer
4872,0.989650974,150.5356402,https://clinicaltrials.gov/study/NCT02696642,NCT02696642,Neoplasms
4873,0.989038126,150.4816205,https://clinicaltrials.gov/study/NCT00424242,NCT00424242,"Brain and Central Nervous System Tumors|Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Lymphoproliferative Disorder|Metastatic Cancer|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous Condition|Secondary Myelofibrosis|Unspecified Adult Solid Tumor, Protocol Specific"
4874,0.9923801,152.5053051,https://clinicaltrials.gov/study/NCT00064142,NCT00064142,AIDS-related Kaposi Sarcoma|Recurrent Kaposi Sarcoma
4875,0.992280969,152.7257343,https://clinicaltrials.gov/study/NCT01128842,NCT01128842,Advanced Malignant Solid Tumors
4876,0.86459668,15.27633188,https://clinicaltrials.gov/study/NCT01834742,NCT01834742,Colorectal Cancer
4877,0.99734772,162.9429606,https://clinicaltrials.gov/study/NCT00651742,NCT00651742,Locally Advanced or Metastatic Pancreatic Cancer
4878,0.996424522,159.660792,https://clinicaltrials.gov/study/NCT00766142,NCT00766142,Colorectal Cancer|Primary Peritoneal Cavity Cancer
4879,0.984887703,129.6102212,https://clinicaltrials.gov/study/NCT00161642,NCT00161642,Neoplasms
4880,0.990924381,150.8670633,https://clinicaltrials.gov/study/NCT02252042,NCT02252042,Head and Neck Squamous Cell Cancer
4881,0.58908956,4.713510652,https://clinicaltrials.gov/study/NCT02593942,NCT02593942,Supratentorial Neoplasms
4882,0.990329055,150.372276,https://clinicaltrials.gov/study/NCT00940342,NCT00940342,Leukemia
4883,0.999697044,187.0237924,https://clinicaltrials.gov/study/NCT02583165,NCT02583165,Advanced Solid Tumors
4884,0.999417971,184.0278619,https://clinicaltrials.gov/study/NCT00253565,NCT00253565,"Unspecified Adult Solid Tumor, Protocol Specific"
4885,0.998146742,169.6784986,https://clinicaltrials.gov/study/NCT03463265,NCT03463265,High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
4886,0.997723453,165.425078,https://clinicaltrials.gov/study/NCT02736565,NCT02736565,Ewing's Sarcoma|Ewing Family of Tumors|Ewing's Tumor Metastatic|Ewing's Sarcoma Metastatic|Ewing's Tumor Recurrent|Rare Diseases|Sarcoma
4887,0.998839053,177.190391,https://clinicaltrials.gov/study/NCT00005965,NCT00005965,Cervical Cancer
4888,0.982365208,120.6654752,https://clinicaltrials.gov/study/NCT00722865,NCT00722865,Hodgkin Lymphoma
4889,0.971254487,79.38732539,https://clinicaltrials.gov/study/NCT03234465,NCT03234465,Oral Mucositis
4890,0.99535541,157.5433298,https://clinicaltrials.gov/study/NCT00240565,NCT00240565,"Lymphoma, Non-Hodgkin"
4891,0.995511543,156.1180783,https://clinicaltrials.gov/study/NCT00486265,NCT00486265,Acute Myelogenous Leukemia
4892,0.882277438,15.76984583,https://clinicaltrials.gov/study/NCT00829465,NCT00829465,Unresectable Hepatocellular Carcinoma
4893,0.938000462,29.17800329,https://clinicaltrials.gov/study/NCT01851265,NCT01851265,Solid Tumours
4894,0.999119621,188.9459358,https://clinicaltrials.gov/study/NCT00098865,NCT00098865,"Central Nervous System Tumor, Pediatric|Neuroblastoma"
4895,0.970169547,56.46712584,https://clinicaltrials.gov/study/NCT03365765,NCT03365765,Apatinib
4896,0.998518206,173.9086244,https://clinicaltrials.gov/study/NCT00393965,NCT00393965,Brain Neoplasms
4897,0.886651236,18.24185758,https://clinicaltrials.gov/study/NCT01939665,NCT01939665,Locally Advanced Pancreatic Carcinoma (LAPC)|Non-metastasized Unresectable Pancreatic Carcinoma|Pancreatic Cancer
4898,0.987846919,150.2148144,https://clinicaltrials.gov/study/NCT02584465,NCT02584465,Ovarian Carcinoma
4899,0.993331736,153.9093717,https://clinicaltrials.gov/study/NCT03728465,NCT03728465,Metastatic Melanoma|Brain Metastases
4900,0.996600332,160.0909233,https://clinicaltrials.gov/study/NCT03131765,NCT03131765,Cancer
4901,0.996935611,160.3507359,https://clinicaltrials.gov/study/NCT00651365,NCT00651365,Neoplasms
4902,0.999483354,186.7353222,https://clinicaltrials.gov/study/NCT00108121,NCT00108121,Basal Cell Carcinoma
4903,0.987930303,150.481782,https://clinicaltrials.gov/study/NCT00565721,NCT00565721,High-grade Glioma|Lung Cancer|Head & Neck Cancer|Sarcoma|Melanoma
4904,0.999125911,183.7615437,https://clinicaltrials.gov/study/NCT00003721,NCT00003721,"Unspecified Adult Solid Tumor, Protocol Specific"
4905,0.545787133,3.086443398,https://clinicaltrials.gov/study/NCT01731821,NCT01731821,"Pancreatic Neoplasms|Biliary Tract Neoplasms|Pancreatitis, Chronic|Duodenal Neoplasms"
4906,0.929106225,24.84358175,https://clinicaltrials.gov/study/NCT01571921,NCT01571921,Healthy Subjects
4907,0.998702411,172.4429351,https://clinicaltrials.gov/study/NCT00238121,NCT00238121,Recurrent Uterine Sarcoma|Stage III Uterine Sarcoma|Stage IV Uterine Sarcoma|Uterine Carcinosarcoma
4908,0.89562618,20.6820296,https://clinicaltrials.gov/study/NCT00908531,NCT00908531,Operable Breast Neoplasms
4909,0.993526375,152.1576231,https://clinicaltrials.gov/study/NCT00085631,NCT00085631,Cervical Cancer
4910,0.993788403,151.1378868,https://clinicaltrials.gov/study/NCT01783431,NCT01783431,Melanoma
4911,0.994319358,152.7802404,https://clinicaltrials.gov/study/NCT02993731,NCT02993731,"Carcinoma, Pancreatic Ductal"
4912,0.999616457,192.0069597,https://clinicaltrials.gov/study/NCT00004231,NCT00004231,Lymphoma
4913,0.989753378,136.3869827,https://clinicaltrials.gov/study/NCT02374931,NCT02374931,Deep Fibromatosis/Desmoid Tumor|Familial Adenomatous Polyposis
4914,0.981937141,95.86173301,https://clinicaltrials.gov/study/NCT02923531,NCT02923531,Clear Cell Renal Cell Carcinoma
4915,0.99921489,185.0087057,https://clinicaltrials.gov/study/NCT01925131,NCT01925131,Acute Leukemias of Ambiguous Lineage|B-cell Adult Acute Lymphoblastic Leukemia|Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Burkitt Lymphoma
4916,0.999414863,187.0878183,https://clinicaltrials.gov/study/NCT00742131,NCT00742131,Solid Tumours
4917,0.99855912,173.3465058,https://clinicaltrials.gov/study/NCT05148442,NCT05148442,Myeloid Tumor
4918,0.99806452,167.1278105,https://clinicaltrials.gov/study/NCT00459342,NCT00459342,Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
4919,0.924289261,23.19453754,https://clinicaltrials.gov/study/NCT00014742,NCT00014742,Dupuytren's Contracture
4920,0.989823442,150.8494021,https://clinicaltrials.gov/study/NCT00021242,NCT00021242,Leukemia
4921,0.991339549,151.3668426,https://clinicaltrials.gov/study/NCT01449942,NCT01449942,Nasopharyngeal Carcinoma
4922,0.971046274,64.11625231,https://clinicaltrials.gov/study/NCT04118842,NCT04118842,Solid Tumors
4923,0.998499659,178.557975,https://clinicaltrials.gov/study/NCT00066742,NCT00066742,Limited Stage Small Cell Lung Cancer
4924,0.996398748,158.8346146,https://clinicaltrials.gov/study/NCT00230542,NCT00230542,Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
4925,0.995837517,155.5276617,https://clinicaltrials.gov/study/NCT04094142,NCT04094142,"Non-hodgkin Lymphoma,B Cell"
4926,0.816738631,10.67476334,https://clinicaltrials.gov/study/NCT02554942,NCT02554942,Anemia
4927,0.984931932,137.5050122,https://clinicaltrials.gov/study/NCT03892642,NCT03892642,Bladder Cancer
4928,0.940686227,32.35805109,https://clinicaltrials.gov/study/NCT05921942,NCT05921942,Colorectal Cancer
4929,0.998670897,176.5473792,https://clinicaltrials.gov/study/NCT01193842,NCT01193842,AIDS-Related Plasmablastic Lymphoma|AIDS-Related Primary Effusion Lymphoma|Ann Arbor Stage I Diffuse Large B-Cell Lymphoma|Ann Arbor Stage I Grade 3 Follicular Lymphoma|Ann Arbor Stage II Diffuse Large B-Cell Lymphoma|Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma|Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma|Ann Arbor Stage III Diffuse Large B-Cell Lymphoma|Ann Arbor Stage III Grade 3 Follicular Lymphoma|Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma|Ann Arbor Stage IV Grade 3 Follicular Lymphoma|HIV Infection|Plasmablastic Lymphoma|Primary Effusion Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Grade 3 Follicular Lymphoma
4930,0.90669737,17.73241913,https://clinicaltrials.gov/study/NCT01733342,NCT01733342,Cancer
4931,0.999555047,187.2206372,https://clinicaltrials.gov/study/NCT00004042,NCT00004042,Colorectal Cancer
4932,0.997289637,162.5576173,https://clinicaltrials.gov/study/NCT00467142,NCT00467142,Colorectal Cancer
4933,0.997745192,165.4887524,https://clinicaltrials.gov/study/NCT00412542,NCT00412542,Glioblastoma Multiforme|Glioma
4934,0.994506117,153.7736432,https://clinicaltrials.gov/study/NCT01240642,NCT01240642,Metastatic Cancer With Impaired Renal Function|Metastatic Cancer With Normal Renal Function
4935,0.915051071,21.56936835,https://clinicaltrials.gov/study/NCT01929642,NCT01929642,Tuberous Sclerosis Complex|Self-injury|Autism
4936,0.992768286,152.2705029,https://clinicaltrials.gov/study/NCT03472365,NCT03472365,Gastric Cancer|GastroEsophageal Cancer
4937,0.998841424,178.7242399,https://clinicaltrials.gov/study/NCT00409565,NCT00409565,Head and Neck Cancer|Squamous Cell Carcinoma
4938,0.978683548,99.31962138,https://clinicaltrials.gov/study/NCT03003065,NCT03003065,Cholangiocarcinoma|Tumor|Klatskin Tumor
4939,0.995607279,156.0279544,https://clinicaltrials.gov/study/NCT04602065,NCT04602065,"Extranodal NK/T Cell Lymphoma, Nasal Type"
4940,0.996162765,156.2554895,https://clinicaltrials.gov/study/NCT00261365,NCT00261365,Unresectable Stage III or IV Malignant Melanoma
4941,0.99318266,153.0063294,https://clinicaltrials.gov/study/NCT01497665,NCT01497665,Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
4942,0.997749239,164.7564892,https://clinicaltrials.gov/study/NCT00137865,NCT00137865,Ovarian Neoplasms
4943,0.722456722,7.186806296,https://clinicaltrials.gov/study/NCT05406765,NCT05406765,Rectal Cancer|Postoperative Pain
4944,0.999640339,195.6939419,https://clinicaltrials.gov/study/NCT00007865,NCT00007865,Lymphoma
4945,0.916542902,24.6665013,https://clinicaltrials.gov/study/NCT00258765,NCT00258765,Prostate Cancer
4946,0.988831839,150.9615856,https://clinicaltrials.gov/study/NCT00136565,NCT00136565,Peripheral T-cell Lymphoma
4947,0.998682344,176.1978449,https://clinicaltrials.gov/study/NCT00687765,NCT00687765,Glioblastoma
4948,0.838426638,12.08766299,https://clinicaltrials.gov/study/NCT01726465,NCT01726465,"Ischemic Reperfusion Injury|Insufficiency; Hepatic, Postoperative|Liver Tumour"
4949,0.9425731,27.01731051,https://clinicaltrials.gov/study/NCT00570921,NCT00570921,Breast Cancer
4950,0.991254121,151.5380433,https://clinicaltrials.gov/study/NCT02556931,NCT02556931,Myelodysplastic Syndrome|Chronic Myelomonocytic Leukemia|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia|Prolymphocytic Leukemia|Chronic Myeloid Leukemia|Chronic Myeloproliferative Disorders|Multiple Myeloma|Plasma Cell Neoplasm|Plasma Cell Dyscrasia|Myelofibrosis|Polycythemia Vera|Essential Thrombocythemia|Plasma Cell Leukemia
4951,0.996343486,155.0182723,https://clinicaltrials.gov/study/NCT00670631,NCT00670631,Multiple Myeloma
4952,0.908129231,21.05827643,https://clinicaltrials.gov/study/NCT01523431,NCT01523431,Metastatic Colorectal Cancer
4953,0.974984103,77.12092514,https://clinicaltrials.gov/study/NCT00740831,NCT00740831,Uterine Myomas
4954,0.99859043,178.2977783,https://clinicaltrials.gov/study/NCT03576131,NCT03576131,Colorectal Cancer|Non-small Cell Lung Cancer|Triple Negative Breast Cancer|Renal Cell Carcinoma|Gastric Cancer|Pancreatic Cancer|Urothelial Cancer
4955,0.657547735,5.730631892,https://clinicaltrials.gov/study/NCT01770431,NCT01770431,Hepatic Carcinoma
4956,0.996213189,159.2694835,https://clinicaltrials.gov/study/NCT03333031,NCT03333031,Solid Tumor
4957,0.99652539,159.2298703,https://clinicaltrials.gov/study/NCT00843531,NCT00843531,Neuroendocrine Tumors
4958,0.966668264,56.45888914,https://clinicaltrials.gov/study/NCT00109031,NCT00109031,Cancer|Lymphoma|Leukemia
4959,0.992988892,152.1410677,https://clinicaltrials.gov/study/NCT01264731,NCT01264731,Melanoma
4960,0.996979462,160.4880285,https://clinicaltrials.gov/study/NCT01496131,NCT01496131,Prostate Cancer
4961,0.996078813,155.1774338,https://clinicaltrials.gov/study/NCT00039442,NCT00039442,Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Recurrent Cervical Carcinoma
4962,0.979850948,94.72659712,https://clinicaltrials.gov/study/NCT02604342,NCT02604342,Non-small Cell Lung Cancer
4963,0.992360419,152.3004607,https://clinicaltrials.gov/study/NCT02874742,NCT02874742,Multiple Myeloma
4964,0.983418913,93.82103879,https://clinicaltrials.gov/study/NCT02900742,NCT02900742,Cancer
4965,0.997115425,160.7876549,https://clinicaltrials.gov/study/NCT00950742,NCT00950742,Breast Neoplasms
4966,0.989900711,151.1770464,https://clinicaltrials.gov/study/NCT01543542,NCT01543542,Metastasis to Brain of Primary Cancer
4967,0.994337596,153.8753239,https://clinicaltrials.gov/study/NCT01615042,NCT01615042,Acute Leukemia
4968,0.994798485,154.9418684,https://clinicaltrials.gov/study/NCT00130442,NCT00130442,Melanoma
4969,0.965133392,57.38068748,https://clinicaltrials.gov/study/NCT00901342,NCT00901342,Prostate Cancer
4970,0.99467724,154.7302161,https://clinicaltrials.gov/study/NCT00003542,NCT00003542,Kidney Cancer
4971,0.998928697,184.4121473,https://clinicaltrials.gov/study/NCT00023842,NCT00023842,Bladder Cancer
4972,0.996568192,159.9317108,https://clinicaltrials.gov/study/NCT00350142,NCT00350142,Pancreatic Cancer
4973,0.996907945,159.6560509,https://clinicaltrials.gov/study/NCT04407442,NCT04407442,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
4974,0.99600068,158.7784547,https://clinicaltrials.gov/study/NCT01189942,NCT01189942,Colorectal Cancer
4975,0.992128169,151.9417369,https://clinicaltrials.gov/study/NCT01594242,NCT01594242,Multiple Myeloma
4976,0.998387167,173.2857836,https://clinicaltrials.gov/study/NCT00012142,NCT00012142,Prostate Cancer
4977,0.999544027,182.4481175,https://clinicaltrials.gov/study/NCT01503242,NCT01503242,Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
4978,0.997361705,158.6440225,https://clinicaltrials.gov/study/NCT01485042,NCT01485042,Solid Tumors
4979,0.998039077,163.1972867,https://clinicaltrials.gov/study/NCT00017342,NCT00017342,Leukemia
4980,0.999752436,183.2737892,https://clinicaltrials.gov/study/NCT00003242,NCT00003242,"Unspecified Adult Solid Tumor, Protocol Specific"
4981,0.978498765,91.59865281,https://clinicaltrials.gov/study/NCT02419742,NCT02419742,Breast Cancer
4982,0.913763412,20.06080408,https://clinicaltrials.gov/study/NCT01888042,NCT01888042,Kidney Cancer
4983,0.992997519,153.4810632,https://clinicaltrials.gov/study/NCT02824042,NCT02824042,Medical Oncology
4984,0.945322694,38.28132785,https://clinicaltrials.gov/study/NCT00646165,NCT00646165,B-cell Chronic Lymphocytic Leukemia
4985,0.983969735,110.5041563,https://clinicaltrials.gov/study/NCT02496065,NCT02496065,"Tumors, Breast"
4986,0.999548549,192.9234567,https://clinicaltrials.gov/study/NCT00003665,NCT00003665,Melanoma (Skin)
4987,0.967376298,56.66395481,https://clinicaltrials.gov/study/NCT02340221,NCT02340221,Breast Cancer
4988,0.995743194,154.3265174,https://clinicaltrials.gov/study/NCT02435121,NCT02435121,Neoplasm Malignant
4989,0.996185886,157.5979481,https://clinicaltrials.gov/study/NCT01102231,NCT01102231,Stage III Non-small Cell Lung Cancer
4990,0.998509023,175.38592,https://clinicaltrials.gov/study/NCT00519831,NCT00519831,Lung Cancer
4991,0.998732015,173.7286694,https://clinicaltrials.gov/study/NCT00931931,NCT00931931,Rhabdomyosarcoma|Osteosarcoma|Ewing Sarcoma|Soft Tissue Sarcoma|Neuroblastoma|Wilms Tumor|Malignant Peripheral Nerve Sheath Tumor|Clival Chordoma|Non-CNS Solid Tumors
4992,0.970818952,74.97554881,https://clinicaltrials.gov/study/NCT00187031,NCT00187031,Wilms Tumor
4993,0.995480529,157.191089,https://clinicaltrials.gov/study/NCT00265031,NCT00265031,Hodgkins Lymphoma
4994,0.987685337,150.4069039,https://clinicaltrials.gov/study/NCT00480831,NCT00480831,Non-Small Cell Lung Cancer
4995,0.968527262,59.80421572,https://clinicaltrials.gov/study/NCT01466231,NCT01466231,Germ Cell Tumor
4996,0.999403471,186.6048704,https://clinicaltrials.gov/study/NCT00350831,NCT00350831,Cancer
4997,0.995908053,158.0814417,https://clinicaltrials.gov/study/NCT01542931,NCT01542931,Stage III Oral Cavity Squamous Cell Carcinoma|Stage IVA Oral Cavity Squamous Cell Carcinoma
4998,0.995789358,155.2335804,https://clinicaltrials.gov/study/NCT00770731,NCT00770731,Advanced Cancer
4999,0.991152855,152.4438782,https://clinicaltrials.gov/study/NCT00899431,NCT00899431,Chronic Lymphocytic Leukemia
5000,0.985412865,130.2728978,https://clinicaltrials.gov/study/NCT00288431,NCT00288431,Cancer|Sarcoma
5001,0.991728164,151.1841137,https://clinicaltrials.gov/study/NCT01485731,NCT01485731,Cervical Cancer
5002,0.992176311,151.0482138,https://clinicaltrials.gov/study/NCT01711242,NCT01711242,Gastric Cancer
5003,0.982546823,110.6227925,https://clinicaltrials.gov/study/NCT00445042,NCT00445042,"Carcinoma, Renal Cell"
5004,0.968954219,65.37904477,https://clinicaltrials.gov/study/NCT03546842,NCT03546842,Papillomavirus Infections|Uterine Cervical Neoplasms|Vulvar Neoplasms|Vaginal Neoplasms|Adenocarcinoma in Situ|Condylomata Acuminata
5005,0.998958491,180.4903823,https://clinicaltrials.gov/study/NCT00217542,NCT00217542,Recurrent Melanoma|Recurrent Renal Cell Cancer|Stage III Melanoma|Stage IV Melanoma|Stage IV Renal Cell Cancer
5006,0.987179723,150.2032855,https://clinicaltrials.gov/study/NCT01895842,NCT01895842,Leukemia
5007,0.999072726,185.7938162,https://clinicaltrials.gov/study/NCT02141542,NCT02141542,Metastatic Melanoma
5008,0.97699667,79.08885136,https://clinicaltrials.gov/study/NCT03493542,NCT03493542,"Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ"
5009,0.928627557,27.33575806,https://clinicaltrials.gov/study/NCT00892242,NCT00892242,Adenocarcinoma
5010,0.998283764,169.6007245,https://clinicaltrials.gov/study/NCT01674842,NCT01674842,Breast Cancer
5011,0.841790382,12.60639038,https://clinicaltrials.gov/study/NCT05981742,NCT05981742,Polycystic Ovary Syndrome
5012,0.998622304,179.0683363,https://clinicaltrials.gov/study/NCT01096342,NCT01096342,Refractory Multiple Myeloma
5013,0.998364113,169.5303229,https://clinicaltrials.gov/study/NCT03730142,NCT03730142,Advanced Cancer
5014,0.99625826,159.7721805,https://clinicaltrials.gov/study/NCT00667342,NCT00667342,Osteosarcoma|Malignant Fibrous Histiocytoma (MFH) of Bone
5015,0.98665073,150.004919,https://clinicaltrials.gov/study/NCT01439542,NCT01439542,Prostate Cancer
5016,0.998331122,167.0235804,https://clinicaltrials.gov/study/NCT00002942,NCT00002942,Breast Cancer
5017,0.99777065,165.433366,https://clinicaltrials.gov/study/NCT00864942,NCT00864942,Chronic Lymphocytic Leukemia|Non-Hodgkin's Lymphoma
5018,0.990152411,150.4315624,https://clinicaltrials.gov/study/NCT00506142,NCT00506142,Metastatic Malignant Uveal Melanoma
5019,0.997894779,164.8956998,https://clinicaltrials.gov/study/NCT01375842,NCT01375842,Tumors|Hematologic Malignancies
5020,0.996272221,159.6595138,https://clinicaltrials.gov/study/NCT01496742,NCT01496742,Non-Squamous Non-Small Cell Lung Cancer
5021,0.97145387,79.00101166,https://clinicaltrials.gov/study/NCT00544765,NCT00544765,Breast Cancer
5022,0.964169487,56.12124943,https://clinicaltrials.gov/study/NCT01648465,NCT01648465,Gastrointestinal Tumors|Pancreatic Tumors|Gastrointestinal Neuroendocrine Tumors|Pancreatic Neuroendocrine Tumors
5023,0.999458327,185.0720557,https://clinicaltrials.gov/study/NCT00002765,NCT00002765,Leukemia|Lymphoma
5024,0.991506898,152.4171931,https://clinicaltrials.gov/study/NCT02013765,NCT02013765,Urinary Tract Cancer
5025,0.992605683,152.7150259,https://clinicaltrials.gov/study/NCT03361865,NCT03361865,UC (Urothelial Cancer)
5026,0.920510629,26.28853476,https://clinicaltrials.gov/study/NCT02048865,NCT02048865,Venous Thromboembolism|Cancer
5027,0.792082782,7.598231472,https://clinicaltrials.gov/study/NCT00512265,NCT00512265,Pulmonary Morbidity
5028,0.978616359,99.90885098,https://clinicaltrials.gov/study/NCT02342665,NCT02342665,Lymphoma Non-Hodgkin
5029,0.968530763,48.88636364,https://clinicaltrials.gov/study/NCT00414765,NCT00414765,Metastatic Renal Cell Carcinoma|Metastatic Melanoma
5030,0.985150108,150.0949236,https://clinicaltrials.gov/study/NCT00365365,NCT00365365,Breast Cancer
5031,0.986277874,149.5566487,https://clinicaltrials.gov/study/NCT02473965,NCT02473965,Myasthenia Gravis
5032,0.998101986,171.9668031,https://clinicaltrials.gov/study/NCT00361621,NCT00361621,Non-Hodgkin's Lymphoma
5033,0.864732244,15.32238754,https://clinicaltrials.gov/study/NCT01564121,NCT01564121,Giant Cell Tumors of Bone
5034,0.952269014,44.18393004,https://clinicaltrials.gov/study/NCT03138421,NCT03138421,Neuromyelitis Optica Spectrum Disorder|Transverse Myelitis|Multiple Sclerosis|Longitudinally Extensive Transverse Myelitis
5035,0.990043112,152.485983,https://clinicaltrials.gov/study/NCT02186821,NCT02186821,Tumors With Aberrations in ALK or ROS1
5036,0.999168906,178.0345987,https://clinicaltrials.gov/study/NCT01222221,NCT01222221,Brain and Central Nervous System Tumors
5037,0.997334187,162.7285054,https://clinicaltrials.gov/study/NCT00403221,NCT00403221,Prostatic Neoplasms
5038,0.994018167,153.6305212,https://clinicaltrials.gov/study/NCT03980821,NCT03980821,Advanced Solid Malignancies
5039,0.998038057,171.285061,https://clinicaltrials.gov/study/NCT00853021,NCT00853021,Kidney Cancer
5040,0.87357466,11.74029782,https://clinicaltrials.gov/study/NCT00764621,NCT00764621,Colorectal Neoplasms|Neoplasm Metastasis
5041,0.99237707,152.1429985,https://clinicaltrials.gov/study/NCT03912831,NCT03912831,Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer
5042,0.997010925,159.3470827,https://clinicaltrials.gov/study/NCT01787331,NCT01787331,Prostate Adenocarcinoma|Recurrent Prostate Carcinoma|Stage I Prostate Adenocarcinoma AJCC v7|Stage II Prostate Adenocarcinoma AJCC v7|Stage III Prostate Adenocarcinoma AJCC v7
5043,0.995203824,155.1181678,https://clinicaltrials.gov/study/NCT03992131,NCT03992131,Ovarian Cancer|Triple-negative Breast Cancer|Urothelial Carcinoma|Solid Tumor
5044,0.708354924,5.962894688,https://clinicaltrials.gov/study/NCT01181531,NCT01181531,"Hyperparathyroidism, Secondary"
5045,0.974429595,78.31595023,https://clinicaltrials.gov/study/NCT03364231,NCT03364231,Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia|Non Follicular Indolent Non-Hodgkin Lymphoma
5046,0.944708288,41.36494741,https://clinicaltrials.gov/study/NCT00661531,NCT00661531,"Breast Cancer|Cancer of the Breast|Neoplasms, Breast"
5047,0.998525142,165.6955268,https://clinicaltrials.gov/study/NCT00004931,NCT00004931,Stage II Colon Cancer|Stage III Colon Cancer
5048,0.997322096,160.0241504,https://clinicaltrials.gov/study/NCT03166631,NCT03166631,"Neoplasms|Neoplasm Metastasis|Carcinoma, Non-Small-Cell Lung"
5049,0.945345434,33.85163494,https://clinicaltrials.gov/study/NCT00388531,NCT00388531,Lymphoblastic Leukemia|Lymphoma
5050,0.994258957,154.6964929,https://clinicaltrials.gov/study/NCT03139331,NCT03139331,Sarcoma|Refractory Sarcoma
5051,0.967530696,62.39870005,https://clinicaltrials.gov/study/NCT00383331,NCT00383331,Non-Small-Cell Lung Cancer
5052,0.999138645,183.0041262,https://clinicaltrials.gov/study/NCT00003631,NCT00003631,Lymphoma
5053,0.996682866,157.2193345,https://clinicaltrials.gov/study/NCT00053131,NCT00053131,Leukemia
5054,0.961965512,50.81459227,https://clinicaltrials.gov/study/NCT00003831,NCT00003831,Lung Cancer
5055,0.98261526,121.9339105,https://clinicaltrials.gov/study/NCT01660542,NCT01660542,Locally Advanced Breast Cancer
5056,0.990980722,151.3751065,https://clinicaltrials.gov/study/NCT01318642,NCT01318642,Adenocarcinoma of the Pancreas|Locally Advanced|Unresectable
5057,0.99946711,175.6696541,https://clinicaltrials.gov/study/NCT00003342,NCT00003342,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter
5058,0.972572573,78.32147539,https://clinicaltrials.gov/study/NCT03518242,NCT03518242,Breast Cancer Female|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Invasive Breast Carcinoma|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8
5059,0.98429552,121.6937265,https://clinicaltrials.gov/study/NCT01418742,NCT01418742,Colorectal Carcinoma
5060,0.79621331,9.707993969,https://clinicaltrials.gov/study/NCT00204542,NCT00204542,Photosensitivity Disorders
5061,0.99209708,152.4255989,https://clinicaltrials.gov/study/NCT02731742,NCT02731742,"Neoplasms, Advanced"
5062,0.996113001,156.9111963,https://clinicaltrials.gov/study/NCT02021942,NCT02021942,Primary Inoperable Thymoma|Local Recurrent Thymoma
5063,0.971433964,53.56246735,https://clinicaltrials.gov/study/NCT03420742,NCT03420742,"Carcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors"
5064,0.992380898,154.1137205,https://clinicaltrials.gov/study/NCT02096042,NCT02096042,Leukemia
5065,0.99460061,152.4714246,https://clinicaltrials.gov/study/NCT01057342,NCT01057342,Lung Cancer
5066,0.996604311,158.2884042,https://clinicaltrials.gov/study/NCT02787642,NCT02787642,Soft-tissue Sarcoma
5067,0.983796167,77.24690389,https://clinicaltrials.gov/study/NCT03308942,NCT03308942,Neoplasms
5068,0.998208083,173.8130405,https://clinicaltrials.gov/study/NCT00199342,NCT00199342,Stage IV Melanoma
5069,0.917633248,23.118677,https://clinicaltrials.gov/study/NCT02868242,NCT02868242,Hepatitis C Virus Infection
5070,0.995354365,157.6248732,https://clinicaltrials.gov/study/NCT01306942,NCT01306942,Metastatic Breast Cancer
5071,0.999304425,188.0303268,https://clinicaltrials.gov/study/NCT00047242,NCT00047242,"Unspecified Adult Solid Tumor, Protocol Specific"
5072,0.992964044,152.9253761,https://clinicaltrials.gov/study/NCT02755142,NCT02755142,Brain Neoplasm
5073,0.999595035,187.7429538,https://clinicaltrials.gov/study/NCT00003742,NCT00003742,"Unspecified Adult Solid Tumor, Protocol Specific"
5074,0.995551316,155.9490624,https://clinicaltrials.gov/study/NCT02257242,NCT02257242,"Lymphoma, Non-Hodgkin|Lymphoma, Follicular|Lymphoma, Mantle-Cell|Lymphoma, Small-Cell|Waldenstrom Macroglobulinemia|Lymphoma, B-Cell, Marginal Zone"
5075,0.785606025,8.089837412,https://clinicaltrials.gov/study/NCT00814242,NCT00814242,Hepatocellular Carcinoma
5076,0.987001418,150.3191124,https://clinicaltrials.gov/study/NCT00094965,NCT00094965,Gastrointestinal Cancer
5077,0.998594587,181.1501559,https://clinicaltrials.gov/study/NCT01540565,NCT01540565,BRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Ovarian Epithelial Tumor|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
5078,0.959173818,56.97573287,https://clinicaltrials.gov/study/NCT00188565,NCT00188565,Colorectal Neoplasms
5079,0.992658735,152.6296415,https://clinicaltrials.gov/study/NCT00765765,NCT00765765,Breast Cancer
5080,0.999014792,178.4592864,https://clinicaltrials.gov/study/NCT00006365,NCT00006365,Prostate Cancer
5081,0.996457522,161.6767149,https://clinicaltrials.gov/study/NCT01198665,NCT01198665,"Peripheral T Cell Lymphoma Unspecified|Anaplastic Large Cell Lymphoma, ALK-negative|Angioimmunoblastic T Cell Lymphoma|Cutaneous T Cell Lymphoma"
5082,0.970686681,52.66745058,https://clinicaltrials.gov/study/NCT01479465,NCT01479465,Colorectal Cancer
5083,0.915667088,21.61163602,https://clinicaltrials.gov/study/NCT00919321,NCT00919321,Chronic Lymphocytic Leukemia (CLL)
5084,0.995101626,155.9280747,https://clinicaltrials.gov/study/NCT01497821,NCT01497821,Renal Cell Adenocarcinoma|Clear Cell Renal Carcinoma|Clear Cell Renal Cell Carcinoma|Renal Cell Carcinoma
5085,0.98231941,120.3059085,https://clinicaltrials.gov/study/NCT00530621,NCT00530621,Non-small Cell Lung Cancer
5086,0.995635156,155.9952827,https://clinicaltrials.gov/study/NCT00099021,NCT00099021,Head and Neck Cancer|Oral Leukoplakia
5087,0.995891913,158.2890119,https://clinicaltrials.gov/study/NCT00070421,NCT00070421,"Leukemia|Lymphoma|Psychosocial Effects of Cancer and Its Treatment|Unspecified Childhood Solid Tumor, Protocol Specific"
5088,0.986817258,144.4456235,https://clinicaltrials.gov/study/NCT04521621,NCT04521621,Neoplasm Metastasis
5089,0.99659901,159.6662424,https://clinicaltrials.gov/study/NCT02829931,NCT02829931,Malignant Glioma
5090,0.9789034,100.223615,https://clinicaltrials.gov/study/NCT01433731,NCT01433731,"Lymphoma, T-Cell, Cutaneous"
5091,0.998082745,170.9754646,https://clinicaltrials.gov/study/NCT00977431,NCT00977431,Glioblastoma
5092,0.94715648,37.36290952,https://clinicaltrials.gov/study/NCT04145531,NCT04145531,Acute Lymphoblastic Leukemia|Lymphoblastic Leukemia
5093,0.953456781,41.72641079,https://clinicaltrials.gov/study/NCT02000531,NCT02000531,"Carcinoma, Non-Small-Cell Lung"
5094,0.993899823,152.1705432,https://clinicaltrials.gov/study/NCT00547131,NCT00547131,Brain and Central Nervous System Tumors|Metastatic Cancer
5095,0.996981092,161.7057512,https://clinicaltrials.gov/study/NCT04168931,NCT04168931,Gastric Cancer Stage IV
5096,0.999381152,184.9677987,https://clinicaltrials.gov/study/NCT00054431,NCT00054431,"Accelerated Phase Chronic Myelogenous Leukemia|Blastic Phase Chronic Myelogenous Leukemia|Childhood Chronic Myelogenous Leukemia|Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Relapsing Chronic Myelogenous Leukemia"
5097,0.999235576,193.2105326,https://clinicaltrials.gov/study/NCT03256331,NCT03256331,Advanced Solid Tumors
5098,0.999621942,180.6602009,https://clinicaltrials.gov/study/NCT00019331,NCT00019331,"Colorectal Cancer|Endometrial Cancer|Head and Neck Cancer|Liver Cancer|Lung Cancer|Melanoma (Skin)|Pancreatic Cancer|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific"
5099,0.997478466,160.4688213,https://clinicaltrials.gov/study/NCT00509431,NCT00509431,Brain and Central Nervous System Tumors
5100,0.988274089,150.4960816,https://clinicaltrials.gov/study/NCT00072631,NCT00072631,Advanced Non Small Cell Lung Cancer|Failed Prior Chemotherapy
5101,0.971686053,79.57520641,https://clinicaltrials.gov/study/NCT03030131,NCT03030131,"Carcinoma, Non-Small-Cell Lung"
5102,0.991790044,150.7822606,https://clinicaltrials.gov/study/NCT00382031,NCT00382031,Head and Neck Cancer|Squamous Cell Cancer
5103,0.702471527,5.932048931,https://clinicaltrials.gov/study/NCT00253331,NCT00253331,Raynaud Disease|Raynaud Disease Secondary to Scleroderma|Raynaud Secondary to Other Autoimmune Disease
5104,0.989410266,147.5309903,https://clinicaltrials.gov/study/NCT04150731,NCT04150731,Breast Cancer
5105,0.990175236,150.4869187,https://clinicaltrials.gov/study/NCT01715142,NCT01715142,Pancreatic Adenocarcinoma Resectable|Pancreatic Adenocarcinoma Locally Advanced|Pancreatic Adenocarcinoma Metastatic
5106,0.957047983,35.34976327,https://clinicaltrials.gov/study/NCT00312442,NCT00312442,Prostate Cancer
5107,0.998598699,179.876876,https://clinicaltrials.gov/study/NCT02747342,NCT02747342,Neoplasm|Prostate Cancer
5108,0.998977553,185.7304432,https://clinicaltrials.gov/study/NCT00454142,NCT00454142,Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx
5109,0.963112772,46.26107163,https://clinicaltrials.gov/study/NCT00075842,NCT00075842,"Fatigue|Sleep Disorders|Unspecified Adult Solid Tumor, Protocol Specific"
5110,0.99003767,150.5987437,https://clinicaltrials.gov/study/NCT01975142,NCT01975142,"Metastatic Breast Cancer, HER2 Negative Primary Tumor"
5111,0.760886377,7.795949242,https://clinicaltrials.gov/study/NCT01204242,NCT01204242,Breast Cancer
5112,0.991170258,152.3097446,https://clinicaltrials.gov/study/NCT02040142,NCT02040142,Peritoneal Carcinomatosis|Colorectal Cancer|Appendiceal Cancer|Peritoneal Mesothelioma|Pseudomyxoma Peritonei|Gastric Cancer
5113,0.998878025,176.0865635,https://clinicaltrials.gov/study/NCT00077142,NCT00077142,Liver Cancer
5114,0.994993929,155.0238019,https://clinicaltrials.gov/study/NCT03818542,NCT03818542,Head and Neck Cancer
5115,0.98563178,150.521725,https://clinicaltrials.gov/study/NCT00065442,NCT00065442,Prostate Cancer
5116,0.84677272,13.66628225,https://clinicaltrials.gov/study/NCT02761642,NCT02761642,Anemia
5117,0.988163233,150.9316388,https://clinicaltrials.gov/study/NCT01078142,NCT01078142,Follicular Lymphoma|Mantle Cell Lymphoma
5118,0.961394877,56.44324261,https://clinicaltrials.gov/study/NCT00577642,NCT00577642,Multiple Myeloma
5119,0.906402764,25.05129124,https://clinicaltrials.gov/study/NCT00201942,NCT00201942,Breast Cancer
5120,0.886619633,19.61627188,https://clinicaltrials.gov/study/NCT02335242,NCT02335242,Lymphatic Malformations|Lymphatic Diseases
5121,0.991156397,152.029389,https://clinicaltrials.gov/study/NCT00616642,NCT00616642,Brain and Central Nervous System Tumors
5122,0.910018081,23.34381494,https://clinicaltrials.gov/study/NCT02166242,NCT02166242,"Carcinoma, Non-small Cell Lung"
5123,0.99983663,187.5794632,https://clinicaltrials.gov/study/NCT00031642,NCT00031642,Lymphoma
5124,0.95902943,47.65648061,https://clinicaltrials.gov/study/NCT00684242,NCT00684242,Advanced Cancer|Pain
5125,0.995005867,156.6497439,https://clinicaltrials.gov/study/NCT01743365,NCT01743365,Gastric Cancer|Gastroesophageal Junction Cancer
5126,0.996211167,157.6508783,https://clinicaltrials.gov/study/NCT00006265,NCT00006265,Leukemia
5127,0.979057527,97.01069476,https://clinicaltrials.gov/study/NCT00811265,NCT00811265,Prostate Cancer
5128,0.998216071,171.2136579,https://clinicaltrials.gov/study/NCT00423865,NCT00423865,"Unspecified Adult Solid Tumor, Protocol Specific"
5129,0.829833418,10.74767453,https://clinicaltrials.gov/study/NCT00837265,NCT00837265,Chemotherapy-induced Neutropenia
5130,0.996259149,158.1156817,https://clinicaltrials.gov/study/NCT00984165,NCT00984165,Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Chronic Lymphocytic Leukemias|Multiple Myeloma With Plasmacytoma
5131,0.998415712,173.2228651,https://clinicaltrials.gov/study/NCT01206465,NCT01206465,"Unspecified Adult Solid Tumor, Protocol Specific"
5132,0.999318789,184.0406298,https://clinicaltrials.gov/study/NCT00301821,NCT00301821,Lymphoma
5133,0.979655975,73.39973008,https://clinicaltrials.gov/study/NCT05025631,NCT05025631,Colorectal Cancer
5134,0.732276631,5.006825452,https://clinicaltrials.gov/study/NCT03430531,NCT03430531,Post-Dural Puncture Headache|Sphenopalatine Ganglion Block
5135,0.995807793,154.6746158,https://clinicaltrials.gov/study/NCT03624231,NCT03624231,Squamous Cell Carcinoma of the Head and Neck
5136,0.992820048,153.3922917,https://clinicaltrials.gov/study/NCT01034631,NCT01034631,Renal Cell Carcinoma
5137,0.994440422,153.0564166,https://clinicaltrials.gov/study/NCT01099631,NCT01099631,Cancer of the Liver|Liver Cancer|Hepatoma|Liver Neoplasms|Biliary Cancer
5138,0.999202695,190.0352857,https://clinicaltrials.gov/study/NCT00003431,NCT00003431,Colorectal Cancer|Metastatic Cancer
5139,0.598265366,4.261685388,https://clinicaltrials.gov/study/NCT02308631,NCT02308631,Colonic Neoplasms|Rectal Neoplasms|Fecal Incontinence
5140,0.994677929,153.3814365,https://clinicaltrials.gov/study/NCT00101231,NCT00101231,Adult Acute Basophilic Leukemia|Adult Acute Eosinophilic Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Blastic Phase Chronic Myelogenous Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Relapsing Chronic Myelogenous Leukemia
5141,0.968363199,55.91472358,https://clinicaltrials.gov/study/NCT00626431,NCT00626431,Prostate Cancer
5142,0.98800895,142.2617736,https://clinicaltrials.gov/study/NCT04635631,NCT04635631,Neoplasms
5143,0.988503078,151.1740857,https://clinicaltrials.gov/study/NCT01702831,NCT01702831,Multiple Myeloma
5144,0.982541,141.8856225,https://clinicaltrials.gov/study/NCT03257631,NCT03257631,Central Nervous System Neoplasms|Medulloblastoma
5145,0.983946618,125.4768139,https://clinicaltrials.gov/study/NCT00788931,NCT00788931,HER-2 Positive Breast Cancer|Metastatic Breast Cancer
5146,0.84131538,12.37184189,https://clinicaltrials.gov/study/NCT03327831,NCT03327831,Actinic Keratosis
5147,0.991706786,151.7667506,https://clinicaltrials.gov/study/NCT03799731,NCT03799731,Colorectal Cancer
5148,0.678518164,5.142295907,https://clinicaltrials.gov/study/NCT00766831,NCT00766831,Cancer Pain
5149,0.983700497,128.0374647,https://clinicaltrials.gov/study/NCT00976131,NCT00976131,Breast Cancer
5150,0.972977113,80.41799283,https://clinicaltrials.gov/study/NCT03955042,NCT03955042,Chordoma
5151,0.659914563,4.929391946,https://clinicaltrials.gov/study/NCT00539942,NCT00539942,Venous Thrombosis
5152,0.859435367,16.04483514,https://clinicaltrials.gov/study/NCT01825642,NCT01825642,Prostate Cancer
5153,0.994225268,155.0503408,https://clinicaltrials.gov/study/NCT00112242,NCT00112242,Melanoma
5154,0.949710309,39.24873039,https://clinicaltrials.gov/study/NCT01917942,NCT01917942,Cancer of the Head and Neck
5155,0.999821786,180.0549447,https://clinicaltrials.gov/study/NCT00006242,NCT00006242,"Unspecified Adult Solid Tumor, Protocol Specific"
5156,0.999853466,179.697955,https://clinicaltrials.gov/study/NCT04430842,NCT04430842,Astrocytoma|Brain Cancer|Brain Metastases|Bladder Cancer|Breast Cancer|Cervical Cancer|Cholangiocarcinoma|Colorectal Cancer|Esophagus Cancer|Gastric Cancer|Head and Neck Cancer|Kidney Cancer|Liver Cancer|Lung Cancer|Melanoma|Ovarian Cancer|Pancreatic Cancer|Pleural Mesothelioma|Prostate Cancer|Sarcoma|Tongue Cancer|Thymic Carcinoma|Urinary Tract Cancer
5157,0.974773864,84.50334374,https://clinicaltrials.gov/study/NCT02213042,NCT02213042,"Neoplasms, Breast"
5158,0.995545951,154.1065363,https://clinicaltrials.gov/study/NCT01555242,NCT01555242,Neoplasms
5159,0.99116419,151.2545099,https://clinicaltrials.gov/study/NCT02220842,NCT02220842,Lymphoma
5160,0.848299731,12.76157562,https://clinicaltrials.gov/study/NCT00989742,NCT00989742,Lymphangioleiomyomatosis|Tuberous Sclerosis
5161,0.997716128,165.9107288,https://clinicaltrials.gov/study/NCT01130142,NCT01130142,Metastatic Pancreatic Cancer
5162,0.980699752,104.2253272,https://clinicaltrials.gov/study/NCT00862342,NCT00862342,Metastatic Colorectal Cancer
5163,0.92019734,23.93251633,https://clinicaltrials.gov/study/NCT03083665,NCT03083665,Partial Seizures With or Without Secondary Generalization|Epilepsy
5164,0.998886209,183.626638,https://clinicaltrials.gov/study/NCT01419665,NCT01419665,Follicular Lymphoma
5165,0.9875814,129.5413315,https://clinicaltrials.gov/study/NCT03575065,NCT03575065,HER2-negative Breast Cancer
5166,0.997616255,162.9947822,https://clinicaltrials.gov/study/NCT01107665,NCT01107665,Stage III Melanoma|Stage IV Melanoma|Unresectable Melanoma
5167,0.977337877,81.25863514,https://clinicaltrials.gov/study/NCT03343665,NCT03343665,Hodgkin Lymphoma
5168,0.996537861,157.19606,https://clinicaltrials.gov/study/NCT00002665,NCT00002665,Leukemia|Neutropenia|Thrombocytopenia
5169,0.935659595,34.34777409,https://clinicaltrials.gov/study/NCT01804465,NCT01804465,Prostate Cancer
5170,0.980643158,103.8816508,https://clinicaltrials.gov/study/NCT00053365,NCT00053365,Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer
5171,0.933952152,31.39121618,https://clinicaltrials.gov/study/NCT03576521,NCT03576521,Breast Cancer|Breast Carcinoma|Adriamycin Toxicity|Cyclosporine Toxicity
5172,0.999106811,189.1866219,https://clinicaltrials.gov/study/NCT00002931,NCT00002931,Brain and Central Nervous System Tumors|Extragonadal Germ Cell Tumor|Ovarian Cancer|Teratoma|Testicular Germ Cell Tumor
5173,0.986150066,143.223933,https://clinicaltrials.gov/study/NCT01110031,NCT01110031,"Leukaemia, Lymphocytic, Chronic"
5174,0.999136743,183.5072994,https://clinicaltrials.gov/study/NCT03886831,NCT03886831,Relapsed/Refractory Advanced Solid Tumors|Relapsed/Refractory Diffuse Large B-cell Lymphoma|Relapsed/Refractory Myelodysplasia|Relapsed/Refractory Myelofibrosis|Adenoid Cystic Carcinoma|Relapsed/Refractory Mantle Cell Lymphoma|Relapsed/Refractory Acute Myeloid Leukemia|Refractory Chronic Myelomonocytic Leukemia
5175,0.950239179,35.32366952,https://clinicaltrials.gov/study/NCT02239731,NCT02239731,Rash Due to Epidermal Growth Factor Receptor Inhibitors
5176,0.995646617,154.7210734,https://clinicaltrials.gov/study/NCT00275431,NCT00275431,Follicular Lymphoma|Diffuse Large Cell Lymphoma|Mantle Cell Lymphoma|Small Lymphocytic Lymphoma|Chronic Lymphocytic Leukemia
5177,0.999629175,191.7485411,https://clinicaltrials.gov/study/NCT00499031,NCT00499031,Cervical Squamous Cell Carcinoma|Recurrent Cervical Carcinoma
5178,0.997028428,159.1921258,https://clinicaltrials.gov/study/NCT02358031,NCT02358031,Recurrent Head and Neck Cancer|Metastatic Head and Neck Cancer
5179,0.990672247,150.9973066,https://clinicaltrials.gov/study/NCT00599131,NCT00599131,Cancer of Larynx
5180,0.979660753,109.2156364,https://clinicaltrials.gov/study/NCT00439231,NCT00439231,Chronic Lymphocytic Leukemia (CLL)|Small Lymphocytic Lymphoma
5181,0.998932294,179.6481104,https://clinicaltrials.gov/study/NCT00796731,NCT00796731,Lymphoma|Non-Hodgkin
5182,0.997453367,162.9959031,https://clinicaltrials.gov/study/NCT03411031,NCT03411031,Multiple Myeloma
5183,0.993925672,153.6824186,https://clinicaltrials.gov/study/NCT02963831,NCT02963831,Colorectal Cancer|Ovarian Cancer|Appendiceal Cancer
5184,0.989029934,142.4736036,https://clinicaltrials.gov/study/NCT00837031,NCT00837031,Metastatic Pancreatic Cancer
5185,0.993096339,152.5915855,https://clinicaltrials.gov/study/NCT02409342,NCT02409342,"Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer"
5186,0.9969529,161.7489968,https://clinicaltrials.gov/study/NCT00126542,NCT00126542,Fallopian Tube Cancer|Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
5187,0.964281586,57.44972571,https://clinicaltrials.gov/study/NCT00361842,NCT00361842,Colorectal Neoplasms
5188,0.987677512,150.1009669,https://clinicaltrials.gov/study/NCT02115542,NCT02115542,Cancer of the Bile Duct
5189,0.997922622,166.933906,https://clinicaltrials.gov/study/NCT01998542,NCT01998542,Cancer of Head and Neck|Squamous Cell Carcinoma of the Head and Neck
5190,0.999530166,191.7659187,https://clinicaltrials.gov/study/NCT00441142,NCT00441142,Glioblastoma Multiforme|Gliosarcoma
5191,0.965836381,43.04022551,https://clinicaltrials.gov/study/NCT00928642,NCT00928642,Ovarian Cancer|Primary Peritoneal Cancer
5192,0.818304104,10.90192516,https://clinicaltrials.gov/study/NCT00991042,NCT00991042,Interleukines
5193,0.990616208,150.5862216,https://clinicaltrials.gov/study/NCT02981342,NCT02981342,Pancreatic Ductal Adenocarcinoma
5194,0.891997528,17.6195639,https://clinicaltrials.gov/study/NCT01901042,NCT01901042,Radiation Proctitis|Prostate Cancer
5195,0.997708308,162.5234491,https://clinicaltrials.gov/study/NCT01052142,NCT01052142,Melanoma
5196,0.998289918,171.9890604,https://clinicaltrials.gov/study/NCT04508842,NCT04508842,Refractory and Relapsed B Cell Acute Leukemia
5197,0.993865741,152.9078827,https://clinicaltrials.gov/study/NCT02296242,NCT02296242,Acute Myelogenous Leukemia|Myelodysplastic Syndrome
5198,0.744505496,7.256315404,https://clinicaltrials.gov/study/NCT00542542,NCT00542542,Breast Cancer
5199,0.981335219,114.5468736,https://clinicaltrials.gov/study/NCT01283542,NCT01283542,Non-functioning Pituitary Adenoma
5200,0.992506022,152.7310613,https://clinicaltrials.gov/study/NCT00578942,NCT00578942,Lymphoma|Myeloma|Leukemia|Myelodysplasia|Solid Tumors
5201,0.989899566,150.6559059,https://clinicaltrials.gov/study/NCT00002742,NCT00002742,Chronic Myeloproliferative Disorders|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
5202,0.99890433,189.2089032,https://clinicaltrials.gov/study/NCT03545165,NCT03545165,Prostate Cancer
5203,0.999548481,185.7145692,https://clinicaltrials.gov/study/NCT02541565,NCT02541565,Composite Lymphoma|Grade 3b Follicular Lymphoma|Stage I Diffuse Large B-Cell Lymphoma|Stage I Follicular Lymphoma|Stage II Diffuse Large B-Cell Lymphoma|Stage II Follicular Lymphoma|Stage III Diffuse Large B-Cell Lymphoma|Stage III Follicular Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma|Stage IV Follicular Lymphoma
5204,0.977218858,87.17927687,https://clinicaltrials.gov/study/NCT00951665,NCT00951665,Metastatic Breast Cancer
5205,0.997494415,162.5384978,https://clinicaltrials.gov/study/NCT02603965,NCT02603965,Prostate Adenocarcinoma|Stage IIB Prostate Cancer|Stage III Prostate Cancer|Stage IV Prostate Cancer
5206,0.986806823,117.5605494,https://clinicaltrials.gov/study/NCT00401765,NCT00401765,Prostatic Neoplasms
5207,0.996582172,162.1478724,https://clinicaltrials.gov/study/NCT02839265,NCT02839265,Non-small Cell Lung Cancer (NSCLC)
5208,0.9871099,126.721481,https://clinicaltrials.gov/study/NCT01774721,NCT01774721,Non-small Cell Lung Cancer With EGFR-Activating Mutations
5209,0.999390281,191.1632518,https://clinicaltrials.gov/study/NCT00014521,NCT00014521,Brain and Central Nervous System Tumors
5210,0.995316813,156.3956808,https://clinicaltrials.gov/study/NCT00412321,NCT00412321,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Giant Lymph Node Hyperplasia"
5211,0.985287079,132.1622866,https://clinicaltrials.gov/study/NCT00002621,NCT00002621,"Leukemia|Lymphoma|Unspecified Childhood Solid Tumor, Protocol Specific"
5212,0.992342458,152.1982216,https://clinicaltrials.gov/study/NCT03958721,NCT03958721,Resistant Breast Cancer|Non-metastatic Invasive Breast Cancer
5213,0.979469603,82.1294989,https://clinicaltrials.gov/study/NCT03911921,NCT03911921,Cancer-related Problem/Condition
5214,0.994563053,154.8849774,https://clinicaltrials.gov/study/NCT00207831,NCT00207831,Rectal Cancer|Stage II/III|T3 or T4 (Only Anal Extension) Rectal Cancer|N0-2|M0
5215,0.999620142,192.9826651,https://clinicaltrials.gov/study/NCT00005631,NCT00005631,Lymphoma
5216,0.997354114,163.8103921,https://clinicaltrials.gov/study/NCT01136031,NCT01136031,Advanced Gastric Cancer
5217,0.99082492,152.1152961,https://clinicaltrials.gov/study/NCT01463631,NCT01463631,Metastatic Cancer
5218,0.998976609,179.3147269,https://clinicaltrials.gov/study/NCT00096031,NCT00096031,Esophageal Cancer
5219,0.986370767,139.0302848,https://clinicaltrials.gov/study/NCT00952731,NCT00952731,Ductal Breast Carcinoma in Situ|Estrogen Receptor-positive Breast Cancer
5220,0.750263384,7.409927957,https://clinicaltrials.gov/study/NCT00526331,NCT00526331,Esophageal Diseases|Gastrointestinal Diseases|Disorder of the Genitourinary System|Gynecologic Diseases|Kidney Diseases|Liver Diseases|Pancreatic Diseases|Prostate Cancer|Spinal Disease
5221,0.992827283,152.172233,https://clinicaltrials.gov/study/NCT00892931,NCT00892931,Glioblastoma Multiforme
5222,0.985712269,150.0563671,https://clinicaltrials.gov/study/NCT02581631,NCT02581631,Non-Hodgkin's Disease
5223,0.998413233,172.054774,https://clinicaltrials.gov/study/NCT05327231,NCT05327231,Gastric Cancer
5224,0.999057654,189.5588366,https://clinicaltrials.gov/study/NCT02025231,NCT02025231,Malignant Glioma|Glioblastoma
5225,0.997709443,164.8689078,https://clinicaltrials.gov/study/NCT02532231,NCT02532231,Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia in Remission|Blasts Under 10 Percent of Bone Marrow Nucleated Cells|Therapy-Related Myeloid Neoplasm
5226,0.993674921,153.7211084,https://clinicaltrials.gov/study/NCT01604031,NCT01604031,B-cell Chronic Lymphocytic Leukemia
5227,0.999842123,184.1545979,https://clinicaltrials.gov/study/NCT01307631,NCT01307631,Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Uterine Corpus Carcinoma
5228,0.853753786,13.10298904,https://clinicaltrials.gov/study/NCT00144131,NCT00144131,Anemia|Cancer
5229,0.996193839,158.638966,https://clinicaltrials.gov/study/NCT00539331,NCT00539331,"Carcinoma, Non-Small-Cell Lung"
5230,0.994761071,154.7967498,https://clinicaltrials.gov/study/NCT02009631,NCT02009631,Breast Cancer|Ovarian Cancer|Colon Cancer|Lung Cancer|Gastric Cancer|Solid Tumors
5231,0.996414067,158.6714716,https://clinicaltrials.gov/study/NCT00525031,NCT00525031,Melanoma
5232,0.990537477,152.009989,https://clinicaltrials.gov/study/NCT01186731,NCT01186731,Pancreatic Cancer
5233,0.975781007,67.64666968,https://clinicaltrials.gov/study/NCT00103831,NCT00103831,Non-small Cell Lung Cancer
5234,0.988424138,150.3556313,https://clinicaltrials.gov/study/NCT02442531,NCT02442531,Cancer|Metastatic Cancer|Solid Tumors
5235,0.867680094,13.44052383,https://clinicaltrials.gov/study/NCT00367042,NCT00367042,Skin Cancer
5236,0.544519621,2.589074218,https://clinicaltrials.gov/study/NCT02684942,NCT02684942,Pain|Quality of Life
5237,0.999016305,192.1211449,https://clinicaltrials.gov/study/NCT01214642,NCT01214642,Advanced Cancer
5238,0.985540943,150.0664281,https://clinicaltrials.gov/study/NCT00250042,NCT00250042,"Leukemia, Other|Cancer"
5239,0.996338081,157.7624896,https://clinicaltrials.gov/study/NCT00486642,NCT00486642,Hormone-Resistant Prostate Cancer|Recurrent Prostate Carcinoma
5240,0.984578451,116.288052,https://clinicaltrials.gov/study/NCT00446342,NCT00446342,B-lymphoid Malignancies|Chronic Lymphocytic Leukemia|Mantle Cell Lymphoma|Multiple Myeloma
5241,0.99484881,156.0169126,https://clinicaltrials.gov/study/NCT00614042,NCT00614042,Chronic Lymphocytic Leukemia (CLL)|Non-Hodgkin's Lymphoma (NHL)
5242,0.994836272,155.4245682,https://clinicaltrials.gov/study/NCT01620242,NCT01620242,Recurrent Head and Neck Cancer|Metastatic Head and Neck Cancer
5243,0.982139257,115.3076832,https://clinicaltrials.gov/study/NCT00040742,NCT00040742,Nausea|Vomiting
5244,0.927418049,26.20380002,https://clinicaltrials.gov/study/NCT00708942,NCT00708942,Cervical Intraepithelial Neoplasia
5245,0.999123696,185.4398924,https://clinicaltrials.gov/study/NCT00027742,NCT00027742,Intraocular Melanoma|Melanoma (Skin)
5246,0.98868524,134.6239767,https://clinicaltrials.gov/study/NCT02133742,NCT02133742,Renal Cell Carcinoma
5247,0.9928684,152.3883001,https://clinicaltrials.gov/study/NCT02454842,NCT02454842,Non-small Cell Lung Cancer|NSCLC|Non-squamous NSCLC
5248,0.997446793,160.9751595,https://clinicaltrials.gov/study/NCT00005042,NCT00005042,Sarcoma
5249,0.997788545,169.0319538,https://clinicaltrials.gov/study/NCT00088998,NCT00088998,Breast Cancer
5250,0.996735238,160.1392363,https://clinicaltrials.gov/study/NCT01364844,NCT01364844,Solid Tumor|Colorectal Cancer|Endometrial Cancer
5251,0.998152547,173.2624077,https://clinicaltrials.gov/study/NCT00331344,NCT00331344,Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage IV Prostate Cancer
5252,0.989202066,150.6357956,https://clinicaltrials.gov/study/NCT02989844,NCT02989844,Acute Myelogenous Leukemia (AML)|Myelodysplastic Syndrome (MDS)
5253,0.988786942,151.117986,https://clinicaltrials.gov/study/NCT02853344,NCT02853344,Renal Cell Carcinoma
5254,0.974889409,75.17216801,https://clinicaltrials.gov/study/NCT01190644,NCT01190644,Solid Tumors
5255,0.998689175,180.914714,https://clinicaltrials.gov/study/NCT00634244,NCT00634244,Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia
5256,0.961851897,52.09868563,https://clinicaltrials.gov/study/NCT00358644,NCT00358644,Acute Myeloid Leukemia
5257,0.923161913,23.04611589,https://clinicaltrials.gov/study/NCT00626444,NCT00626444,Non-Hodgkin Lymphoma
5258,0.997866973,163.4010946,https://clinicaltrials.gov/study/NCT00096044,NCT00096044,Leukemia
5259,0.98516913,138.692764,https://clinicaltrials.gov/study/NCT01892644,NCT01892644,Hemochromatosis|Myelodysplastic Syndromes
5260,0.987786859,150.0016504,https://clinicaltrials.gov/study/NCT02369874,NCT02369874,Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN
5261,0.981988824,150.1780576,https://clinicaltrials.gov/study/NCT00375674,NCT00375674,Kidney Neoplasms
5262,0.974455803,57.45970252,https://clinicaltrials.gov/study/NCT04431674,NCT04431674,Breast Cancer
5263,0.974534408,91.47887142,https://clinicaltrials.gov/study/NCT04744974,NCT04744974,Myeloproliferative Neoplasm
5264,0.992562908,152.6359651,https://clinicaltrials.gov/study/NCT00401674,NCT00401674,Ovarian Cancer
5265,0.862009116,13.28681513,https://clinicaltrials.gov/study/NCT04313374,NCT04313374,Brain Tumors
5266,0.9950087,154.6320708,https://clinicaltrials.gov/study/NCT03573544,NCT03573544,Metastatic Solid Tumors|Locally Advanced Solid Tumors
5267,0.993253788,153.6422664,https://clinicaltrials.gov/study/NCT02109744,NCT02109744,Acute Myelogenous Leukemia
5268,0.998123107,169.4059497,https://clinicaltrials.gov/study/NCT00005944,NCT00005944,Colorectal Cancer|Metastatic Cancer|Primary Peritoneal Cavity Cancer
5269,0.98006533,111.3116045,https://clinicaltrials.gov/study/NCT00742144,NCT00742144,"Leukaemia, Lymphocytic, Chronic and Lymphoma, Follicular"
5270,0.999433679,183.0234346,https://clinicaltrials.gov/study/NCT00621244,NCT00621244,Lymphoma|Leukemia|Multiple Myeloma
5271,0.996370807,158.1253246,https://clinicaltrials.gov/study/NCT00123474,NCT00123474,"Myeloid Leukemia, Chronic, Chronic-Phase"
5272,0.997242601,160.3156418,https://clinicaltrials.gov/study/NCT00079274,NCT00079274,Adenocarcinoma of the Colon|Stage III Colon Cancer
5273,0.999146602,186.6919031,https://clinicaltrials.gov/study/NCT00687674,NCT00687674,Multiple Myeloma and Plasma Cell Neoplasm
5274,0.996193827,158.5753118,https://clinicaltrials.gov/study/NCT02635074,NCT02635074,Recurrent Adult Acute Myeloid Leukemia
5275,0.995961285,157.3796358,https://clinicaltrials.gov/study/NCT00880074,NCT00880074,Malignant Neoplasm
5276,0.977248711,97.23841525,https://clinicaltrials.gov/study/NCT01862874,NCT01862874,Anogenital Human Papilloma Virus Infection|Condyloma Acuminata
5277,0.998157596,169.5555598,https://clinicaltrials.gov/study/NCT02503774,NCT02503774,Solid Tumors
5278,0.977801289,97.0547228,https://clinicaltrials.gov/study/NCT01559844,NCT01559844,Hepatitis C|Hepatocellular Carcinoma
5279,0.985762907,129.7682222,https://clinicaltrials.gov/study/NCT01305044,NCT01305044,Cancer Survivorship|Safety and Efficacy|Quality of Life
5280,0.994368233,155.1468592,https://clinicaltrials.gov/study/NCT02215044,NCT02215044,Pancreatic Neoplasms
5281,0.997982766,165.0003877,https://clinicaltrials.gov/study/NCT01957644,NCT01957644,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic"
5282,0.989419441,151.1011152,https://clinicaltrials.gov/study/NCT00661544,NCT00661544,Multiple Myeloma|Stem Cell Transplantation
5283,0.999784892,183.0313424,https://clinicaltrials.gov/study/NCT00101244,NCT00101244,"Adult Grade III Lymphomatoid Granulomatosis|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Waldenstrm Macroglobulinemia"
5284,0.996865047,160.7625418,https://clinicaltrials.gov/study/NCT00002544,NCT00002544,Breast Cancer
5285,0.978538354,73.66255897,https://clinicaltrials.gov/study/NCT01308944,NCT01308944,Invasive Epithelial Ovarian Cancer|Primary Peritoneal Carcinoma|Fallopian Tube Cancer
5286,0.99912929,191.15417,https://clinicaltrials.gov/study/NCT00243074,NCT00243074,Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
5287,0.956523855,47.13332318,https://clinicaltrials.gov/study/NCT00674674,NCT00674674,Neoplastic Meningitis
5288,0.989947492,150.7836701,https://clinicaltrials.gov/study/NCT00508274,NCT00508274,"Neoplasms, Breast"
5289,0.998221553,169.9290829,https://clinicaltrials.gov/study/NCT00042874,NCT00042874,"Unspecified Adult Solid Tumor, Protocol Specific"
5290,0.998033882,169.9060668,https://clinicaltrials.gov/study/NCT00049374,NCT00049374,Multiple Myeloma and Plasma Cell Neoplasm
5291,0.998052007,171.7578132,https://clinicaltrials.gov/study/NCT03396874,NCT03396874,Prostate Cancer|Prostate Adenocarcinoma|Prostate Cancer Metastatic|Prostate Cancer Recurrent
5292,0.994739125,153.5945724,https://clinicaltrials.gov/study/NCT01233544,NCT01233544,Colorectal Carcinoma|Liver Metastases
5293,0.999387511,188.474231,https://clinicaltrials.gov/study/NCT00005644,NCT00005644,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer
5294,0.921169993,20.92052747,https://clinicaltrials.gov/study/NCT00427544,NCT00427544,Fibroid
5295,0.99548346,154.4087173,https://clinicaltrials.gov/study/NCT02941744,NCT02941744,Stage IIIC Skin Melanoma|Stage IV Skin Melanoma
5296,0.990309973,150.8842783,https://clinicaltrials.gov/study/NCT01225744,NCT01225744,Metastatic Colorectal Cancer
5297,0.993988456,153.7650591,https://clinicaltrials.gov/study/NCT00283244,NCT00283244,Lung Cancer
5298,0.981410172,89.43291846,https://clinicaltrials.gov/study/NCT01216644,NCT01216644,Gastric Cancer
5299,0.998666095,176.2794371,https://clinicaltrials.gov/study/NCT00068744,NCT00068744,Anal Cancer
5300,0.999473519,191.2819994,https://clinicaltrials.gov/study/NCT01462474,NCT01462474,Locally Advanced Nasopharyngeal Carcinoma
5301,0.997366055,158.1314217,https://clinicaltrials.gov/study/NCT00608374,NCT00608374,Lymphoma
5302,0.986647242,136.3986442,https://clinicaltrials.gov/study/NCT01362374,NCT01362374,Neoplasms
5303,0.996374138,157.5695253,https://clinicaltrials.gov/study/NCT02555644,NCT02555644,Head and Neck Neoplasms
5304,0.988774385,150.860262,https://clinicaltrials.gov/study/NCT02014844,NCT02014844,Glioblastoma
5305,0.993356703,153.610634,https://clinicaltrials.gov/study/NCT02894944,NCT02894944,Pancreatic Cancer
5306,0.990695911,151.4927781,https://clinicaltrials.gov/study/NCT01640444,NCT01640444,Colorectal Cancer Metastatic
5307,0.981031852,86.33410883,https://clinicaltrials.gov/study/NCT01665144,NCT01665144,Secondary Progressive Multiple Sclerosis
5308,0.997462815,163.6038097,https://clinicaltrials.gov/study/NCT00495144,NCT00495144,Tumors|Hypoxia
5309,0.992190981,152.0298173,https://clinicaltrials.gov/study/NCT00005974,NCT00005974,Sarcoma
5310,0.997360333,160.763954,https://clinicaltrials.gov/study/NCT00963274,NCT00963274,Leukemia|Lymphoma
5311,0.999781337,188.2369338,https://clinicaltrials.gov/study/NCT01619774,NCT01619774,Melanoma
5312,0.986709843,116.4625382,https://clinicaltrials.gov/study/NCT03382574,NCT03382574,Ovarian Carcinoma
5313,0.993712482,153.5065244,https://clinicaltrials.gov/study/NCT01849874,NCT01849874,Low-grade Serous Ovarian Cancer|Low-grade Serous Fallopian Tube Cancer|Low-grade Serous Peritoneal Cancer
5314,0.998299356,167.2350362,https://clinicaltrials.gov/study/NCT01403974,NCT01403974,Neoplasms
5315,0.997538571,166.3677713,https://clinicaltrials.gov/study/NCT01039844,NCT01039844,Melanoma
5316,0.986070061,127.7161543,https://clinicaltrials.gov/study/NCT00452244,NCT00452244,Lung Cancer
5317,0.969213778,74.62118084,https://clinicaltrials.gov/study/NCT00421044,NCT00421044,Advanced Malignancies|Tumors
5318,0.929262372,31.95056276,https://clinicaltrials.gov/study/NCT04436744,NCT04436744,Early Breast Cancer
5319,0.995097674,154.2224245,https://clinicaltrials.gov/study/NCT00540644,NCT00540644,Multiple Myeloma
5320,0.994075347,153.837323,https://clinicaltrials.gov/study/NCT01054144,NCT01054144,Multiple Myeloma
5321,0.996437738,157.9140972,https://clinicaltrials.gov/study/NCT00452374,NCT00452374,Leukemia
5322,0.996318875,158.5941087,https://clinicaltrials.gov/study/NCT05054374,NCT05054374,Breast Cancer|Breast Cancer Stage IV|HER2-negative Breast Cancer|Solid Carcinoma|MEK1 Gene Mutation|MEK2 Gene Mutation|Metastatic Breast Cancer
5323,0.998289775,168.406485,https://clinicaltrials.gov/study/NCT02432274,NCT02432274,Tumors|Solid Malignant Tumors|Osteosarcoma|Differentiated Thyroid Cancer (DTC)
5324,0.984187911,147.223806,https://clinicaltrials.gov/study/NCT00882674,NCT00882674,Breast Cancer
5325,0.99961728,190.6935464,https://clinicaltrials.gov/study/NCT02317874,NCT02317874,Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Unresectable Malignant Solid Neoplasm
5326,0.993265174,152.7150359,https://clinicaltrials.gov/study/NCT00080574,NCT00080574,Thyroid Cancer
5327,0.992505224,151.6631995,https://clinicaltrials.gov/study/NCT00137774,NCT00137774,Neuroendocrine Tumors
5328,0.875423422,12.81366946,https://clinicaltrials.gov/study/NCT00831974,NCT00831974,Mastocytosis
5329,0.999239932,185.9147133,https://clinicaltrials.gov/study/NCT00085540,NCT00085540,Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
5330,0.965946974,58.48474502,https://clinicaltrials.gov/study/NCT00177840,NCT00177840,Fatigue
5331,0.574743251,3.403870333,https://clinicaltrials.gov/study/NCT04941040,NCT04941040,Supratentorial Neoplasms
5332,0.996259142,157.9571045,https://clinicaltrials.gov/study/NCT00168740,NCT00168740,Low-Grade or Follicular B-Cell Non-Hodgkin's Lymphoma
5333,0.872064279,14.46806499,https://clinicaltrials.gov/study/NCT01255644,NCT01255644,Chronic Lymphocytic Leukemia
5334,0.998357677,167.5410403,https://clinicaltrials.gov/study/NCT02807844,NCT02807844,Triple Negative Breast Cancer|Pancreatic Carcinoma|Melanoma|Endometrial Carcinoma
5335,0.924620516,24.66064357,https://clinicaltrials.gov/study/NCT01297244,NCT01297244,Renal Cell Carcinoma
5336,0.999606284,177.414675,https://clinicaltrials.gov/study/NCT01178944,NCT01178944,Adenocarcinoma of the Gastroesophageal Junction|Esophageal Undifferentiated Carcinoma|Gastric Adenocarcinoma|Gastric Squamous Cell Carcinoma|Recurrent Esophageal Adenocarcinoma|Recurrent Esophageal Squamous Cell Carcinoma|Recurrent Gastric Carcinoma|Stage IIIB Esophageal Adenocarcinoma|Stage IIIB Esophageal Squamous Cell Carcinoma|Stage IIIB Gastric Cancer|Stage IIIC Esophageal Adenocarcinoma|Stage IIIC Esophageal Squamous Cell Carcinoma|Stage IIIC Gastric Cancer|Stage IV Esophageal Adenocarcinoma|Stage IV Esophageal Squamous Cell Carcinoma|Stage IV Gastric Cancer|Undifferentiated Gastric Carcinoma
5337,0.94195662,33.1387157,https://clinicaltrials.gov/study/NCT00773474,NCT00773474,Metastatic Breast Cancer
5338,0.968967913,74.35612744,https://clinicaltrials.gov/study/NCT01813474,NCT01813474,Cancer|Advanced Solid Malignancies
5339,0.971372147,65.15009598,https://clinicaltrials.gov/study/NCT03927274,NCT03927274,Glioma of Brain
5340,0.959080358,41.26203615,https://clinicaltrials.gov/study/NCT00556374,NCT00556374,Breast Cancer
5341,0.994573696,152.8047969,https://clinicaltrials.gov/study/NCT00077974,NCT00077974,"Carcinoma, Renal Cell"
5342,0.997036051,158.365696,https://clinicaltrials.gov/study/NCT02850744,NCT02850744,Glioblastoma Multiforme
5343,0.999761786,181.4168952,https://clinicaltrials.gov/study/NCT00570674,NCT00570674,Squamous Cell Carcinoma of the Head and Neck|Basaloid Squamous Cell Carcinoma|Undifferentiated Carcinoma|Adenosquamous Cell Carcinoma
5344,0.993853248,152.7474033,https://clinicaltrials.gov/study/NCT00863174,NCT00863174,Multiple Myeloma
5345,0.999559497,186.8112785,https://clinicaltrials.gov/study/NCT00986674,NCT00986674,Recurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer
5346,0.997806808,161.6488468,https://clinicaltrials.gov/study/NCT00522574,NCT00522574,"Myeloproliferative Disorders|Myelofibrosis|Polycythemia Vera|Thrombocythemia, Essential"
5347,0.996317423,156.7372114,https://clinicaltrials.gov/study/NCT00560144,NCT00560144,Neoplasms
5348,0.968767966,57.76804599,https://clinicaltrials.gov/study/NCT01665274,NCT01665274,Gastric Cancer
5349,0.996642348,158.8336614,https://clinicaltrials.gov/study/NCT03758781,NCT03758781,Metastatic Cancer|Recurrent Cancer|Solid Tumor|Renal Cell Carcinoma|Urothelial Carcinoma|NSCLC|Squamous Cell Carcinoma|Non-Small Cell Lung Cancer|Squamous Cell Carcinoma of the Head and Neck
5350,0.989076451,150.7112992,https://clinicaltrials.gov/study/NCT00537381,NCT00537381,Prostatic Neoplasms
5351,0.962287109,47.61779368,https://clinicaltrials.gov/study/NCT00153881,NCT00153881,Esophageal Neoplasms
5352,0.997703288,166.4751353,https://clinicaltrials.gov/study/NCT01296581,NCT01296581,Advanced Solid Tumors
5353,0.945632863,37.45337366,https://clinicaltrials.gov/study/NCT02343081,NCT02343081,"Brain Neoplasms, Malignant, Primary"
5354,0.963459835,53.67147729,https://clinicaltrials.gov/study/NCT00036881,NCT00036881,Dysgeusia|Head and Neck Cancer|Oral Complications|Radiation Toxicity
5355,0.996915461,158.11858,https://clinicaltrials.gov/study/NCT01406574,NCT01406574,Hepatocellular Carcinoma
5356,0.985606328,124.0588366,https://clinicaltrials.gov/study/NCT00313781,NCT00313781,Prostatic Neoplasms
5357,0.979364043,96.71678474,https://clinicaltrials.gov/study/NCT00521781,NCT00521781,Prostatic Neoplasms
5358,0.981377362,115.579269,https://clinicaltrials.gov/study/NCT01206881,NCT01206881,Breast Cancer
5359,0.932189766,24.91848352,https://clinicaltrials.gov/study/NCT00850681,NCT00850681,Actinic Keratosis
5360,0.998167506,173.1297833,https://clinicaltrials.gov/study/NCT03476174,NCT03476174,Melanoma
5361,0.983699728,102.3107309,https://clinicaltrials.gov/study/NCT02001974,NCT02001974,Metastatic Breast Cancer
5362,0.999150897,182.2420736,https://clinicaltrials.gov/study/NCT00321581,NCT00321581,Refractory or Recurrent Solid Tumors|Acute Myelogenous Leukemia
5363,0.996766493,160.3483762,https://clinicaltrials.gov/study/NCT04959981,NCT04959981,Advanced Non-squamous Non-small-cell Lung Cancer
5364,0.9924285,152.5047877,https://clinicaltrials.gov/study/NCT02499081,NCT02499081,Multiple Myeloma
5365,0.988624626,150.6834125,https://clinicaltrials.gov/study/NCT01472081,NCT01472081,Renal Cell Carcinoma|Clear-cell Metastatic Renal Cell Carcinoma
5366,0.994833217,155.8702339,https://clinicaltrials.gov/study/NCT00136474,NCT00136474,Lymphoma|Hodgkin's Disease|Non-Hodgkin's Lymphoma
5367,0.997514436,161.6447964,https://clinicaltrials.gov/study/NCT01279681,NCT01279681,Cognitive/Functional Effects|Colorectal Cancer|Neurotoxicity
5368,0.975355134,90.25633153,https://clinicaltrials.gov/study/NCT03610581,NCT03610581,Human Papillomavirus Infections
5369,0.998779831,185.0690199,https://clinicaltrials.gov/study/NCT00635024,NCT00635024,Multiple Myeloma and Plasma Cell Neoplasm
5370,0.991537568,150.94199,https://clinicaltrials.gov/study/NCT00004124,NCT00004124,Prostate Cancer
5371,0.982538488,105.1228533,https://clinicaltrials.gov/study/NCT03316274,NCT03316274,Kaposi Sarcoma|HIV/AIDS|Immunosuppression
5372,0.95028208,41.88952111,https://clinicaltrials.gov/study/NCT01149174,NCT01149174,Superficial Bladder Cancer
5373,0.997022541,160.3792525,https://clinicaltrials.gov/study/NCT05422781,NCT05422781,Merkel Cell Carcinoma
5374,0.996818105,160.0944054,https://clinicaltrials.gov/study/NCT02843074,NCT02843074,Multiple Myeloma
5375,0.851289919,14.07165012,https://clinicaltrials.gov/study/NCT00539474,NCT00539474,Breast Cancer
5376,0.996902518,159.8608046,https://clinicaltrials.gov/study/NCT02823574,NCT02823574,Head and Neck Cancer
5377,0.987932065,147.2231949,https://clinicaltrials.gov/study/NCT00466674,NCT00466674,Myeloma
5378,0.99692314,160.251052,https://clinicaltrials.gov/study/NCT00001569,NCT00001569,Carcinoma|Peritoneal Neoplasm
5379,0.914132711,19.52535328,https://clinicaltrials.gov/study/NCT00315796,NCT00315796,Cancer
5380,0.997457415,162.5864006,https://clinicaltrials.gov/study/NCT00276796,NCT00276796,Cervical Cancer
5381,0.999156755,184.4286931,https://clinicaltrials.gov/study/NCT00684996,NCT00684996,Recurrent Renal Cell Cancer|Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer
5382,0.985429513,135.265878,https://clinicaltrials.gov/study/NCT01423695,NCT01423695,Metastatic Breast Cancer
5383,0.984916134,150.0297302,https://clinicaltrials.gov/study/NCT00709995,NCT00709995,Metastatic Renal Cell Carcinoma
5384,0.989182646,150.9108183,https://clinicaltrials.gov/study/NCT00505895,NCT00505895,Multiple Myeloma
5385,0.99140401,150.9316011,https://clinicaltrials.gov/study/NCT00404495,NCT00404495,Glioma|Medulloblastoma
5386,0.994992371,154.6621808,https://clinicaltrials.gov/study/NCT04790695,NCT04790695,Metastatic Pancreatic Cancer
5387,0.998804058,182.6216646,https://clinicaltrials.gov/study/NCT00007995,NCT00007995,Multiple Myeloma and Plasma Cell Neoplasm
5388,0.992736197,153.6263684,https://clinicaltrials.gov/study/NCT00056095,NCT00056095,Kidney Cancer
5389,0.997547874,164.7688827,https://clinicaltrials.gov/study/NCT00022295,NCT00022295,"Unspecified Adult Solid Tumor, Protocol Specific"
5390,0.978963413,98.68843581,https://clinicaltrials.gov/study/NCT00334295,NCT00334295,Endometrial Carcinoma
5391,0.996704622,157.8828928,https://clinicaltrials.gov/study/NCT01164995,NCT01164995,Epithelial Ovarian Cancer
5392,0.753852853,6.08351702,https://clinicaltrials.gov/study/NCT01127295,NCT01127295,Hormono-depending Adjuvant Breast Cancer
5393,0.994379215,151.6952867,https://clinicaltrials.gov/study/NCT01380795,NCT01380795,Non-small Cell Lung Cancer Metastatic
5394,0.702525055,6.190632586,https://clinicaltrials.gov/study/NCT00596895,NCT00596895,Biochemical Recurrent Prostate Cancer
5395,0.990692739,150.9594193,https://clinicaltrials.gov/study/NCT00088595,NCT00088595,Carcinoid Tumors
5396,0.92087925,28.20653752,https://clinicaltrials.gov/study/NCT03049735,NCT03049735,Heavy Menstrual Bleeding|Uterine Fibroid
5397,0.996115849,157.3112829,https://clinicaltrials.gov/study/NCT01498835,NCT01498835,Soft Tissue Sarcoma
5398,0.999535897,183.3752858,https://clinicaltrials.gov/study/NCT00404235,NCT00404235,Melanoma (Skin)
5399,0.999303967,193.7310272,https://clinicaltrials.gov/study/NCT00513435,NCT00513435,Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Verrucous Carcinoma of the Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVB Verrucous Carcinoma of the Larynx|Stage IVB Verrucous Carcinoma of the Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Larynx|Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Oropharynx|Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IVC Verrucous Carcinoma of the Larynx|Stage IVC Verrucous Carcinoma of the Oral Cavity|Tongue Cancer
5400,0.925223727,25.73082922,https://clinicaltrials.gov/study/NCT00443235,NCT00443235,Multiple Myeloma
5401,0.980164502,120.3919193,https://clinicaltrials.gov/study/NCT03769935,NCT03769935,Progression Free Survival
5402,0.998894381,183.4085525,https://clinicaltrials.gov/study/NCT02367196,NCT02367196,Hematologic Neoplasms
5403,0.997852316,168.9981541,https://clinicaltrials.gov/study/NCT01870596,NCT01870596,Adult Acute Megakaryoblastic Leukemia|Adult Acute Monoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|Recurrent Adult Acute Myeloid Leukemia
5404,0.999368286,190.1068095,https://clinicaltrials.gov/study/NCT00519896,NCT00519896,Recurrent Thyroid Cancer|Stage IVA Follicular Thyroid Cancer|Stage IVA Papillary Thyroid Cancer|Stage IVB Follicular Thyroid Cancer|Stage IVB Papillary Thyroid Cancer|Stage IVC Follicular Thyroid Cancer|Stage IVC Papillary Thyroid Cancer|Thyroid Gland Medullary Carcinoma
5405,0.991262442,152.057164,https://clinicaltrials.gov/study/NCT00003796,NCT00003796,Breast Cancer
5406,0.990678631,151.327663,https://clinicaltrials.gov/study/NCT00982696,NCT00982696,"Carcinoma, Squamous Cell of Head and Neck"
5407,0.992627761,152.0726945,https://clinicaltrials.gov/study/NCT00003496,NCT00003496,Small Cell Lung Cancer Extensive Stage
5408,0.997607354,163.0655576,https://clinicaltrials.gov/study/NCT00558896,NCT00558896,Multiple Myeloma and Plasma Cell Neoplasm
5409,0.999376113,189.0074263,https://clinicaltrials.gov/study/NCT00043095,NCT00043095,"Unspecified Adult Solid Tumor, Protocol Specific"
5410,0.999523689,179.5803395,https://clinicaltrials.gov/study/NCT00433095,NCT00433095,Carcinoma Breast Stage IV
5411,0.982486949,133.4814239,https://clinicaltrials.gov/study/NCT00830895,NCT00830895,Renal Cell Carcinoma
5412,0.99916086,180.3988075,https://clinicaltrials.gov/study/NCT01800695,NCT01800695,Glioblastoma Multiforme
5413,0.992310327,150.8435489,https://clinicaltrials.gov/study/NCT00586495,NCT00586495,"Carcinoma, Renal Cell"
5414,0.948493043,35.09513763,https://clinicaltrials.gov/study/NCT00188695,NCT00188695,Uterine Neoplasms|Cervix Neoplasms|Bladder Neoplasms|Prostatic Neoplasms
5415,0.998566857,180.9630146,https://clinicaltrials.gov/study/NCT00003995,NCT00003995,Colorectal Cancer
5416,0.977320291,85.74150919,https://clinicaltrials.gov/study/NCT03402295,NCT03402295,Multiple Myeloma|Effects of Chemotherapy
5417,0.599730575,3.377768414,https://clinicaltrials.gov/study/NCT03502395,NCT03502395,"Cancer, Breast"
5418,0.899409152,18.69936854,https://clinicaltrials.gov/study/NCT00929695,NCT00929695,Graft Versus Host Disease|Recurrent Adult Acute Lymphoblastic Leukemia
5419,0.996500702,157.4987214,https://clinicaltrials.gov/study/NCT00087295,NCT00087295,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer
5420,0.92820681,23.52508514,https://clinicaltrials.gov/study/NCT03459781,NCT03459781,Cancer Survivors|Informal Cancer Caregivers (Family and Friends of Cancer Survivors)
5421,0.995872029,158.7224739,https://clinicaltrials.gov/study/NCT00520481,NCT00520481,Adenocarcinoma of the Prostate
5422,0.99944331,180.2438259,https://clinicaltrials.gov/study/NCT00040781,NCT00040781,"Unspecified Childhood Solid Tumor, Protocol Specific"
5423,0.998716489,167.3180702,https://clinicaltrials.gov/study/NCT01273181,NCT01273181,Metastatic Cancer|Metastatic Renal Cancer|Metastatic Melanoma
5424,0.995455132,156.055406,https://clinicaltrials.gov/study/NCT00039481,NCT00039481,"Cardiac Toxicity|Unspecified Childhood Solid Tumor, Protocol Specific"
5425,0.997038259,159.7680646,https://clinicaltrials.gov/study/NCT00113581,NCT00113581,Esophageal Cancer|Gastric Cancer
5426,0.99666356,158.0528088,https://clinicaltrials.gov/study/NCT00978081,NCT00978081,Head and Neck Cancer|Precancerous Condition
5427,0.889997753,14.07577878,https://clinicaltrials.gov/study/NCT05396781,NCT05396781,Suspected or Known Squamous Cell Neoplasia|Prior History of Squamous Cell Dysplasia and /or Neoplasia
5428,0.967639681,59.52210068,https://clinicaltrials.gov/study/NCT01530581,NCT01530581,Transplantation for Hematologic Malignancies
5429,0.996561672,158.3585575,https://clinicaltrials.gov/study/NCT00356681,NCT00356681,Breast Neoplasms|Breast Tumors|Breast Cancer|Locally Recurrent and Metastatic Breast Cancer
5430,0.996048894,158.2983497,https://clinicaltrials.gov/study/NCT00094081,NCT00094081,Head and Neck Neoplasms
5431,0.98949793,150.2653046,https://clinicaltrials.gov/study/NCT02961881,NCT02961881,Non-Hodgkin's Lymphoma
5432,0.602248689,4.278439045,https://clinicaltrials.gov/study/NCT02462681,NCT02462681,Acute Pain|Chronic Pain
5433,0.998762499,176.5792313,https://clinicaltrials.gov/study/NCT01195376,NCT01195376,Advanced Solid Tumor
5434,0.987102053,146.3107418,https://clinicaltrials.gov/study/NCT00278876,NCT00278876,Sarcoma|Gastrointestinal Stromal Tumors
5435,0.996200346,157.1925539,https://clinicaltrials.gov/study/NCT01118676,NCT01118676,Locally Advanced Non Small Cell Lung Cancer (NSCLC)
5436,0.994319478,154.1030024,https://clinicaltrials.gov/study/NCT03014076,NCT03014076,Breastcancer
5437,0.996429138,157.444335,https://clinicaltrials.gov/study/NCT00755976,NCT00755976,Melanoma (Skin)
5438,0.99898249,192.5447476,https://clinicaltrials.gov/study/NCT00002576,NCT00002576,Lymphoma
5439,0.977195643,91.1127374,https://clinicaltrials.gov/study/NCT00651976,NCT00651976,Breast Cancer
5440,0.99604025,159.2550757,https://clinicaltrials.gov/study/NCT02540876,NCT02540876,Metastatic Malignant Neoplasm|Solid Neoplasm|Unresectable Malignant Neoplasm
5441,0.986183362,150.3859357,https://clinicaltrials.gov/study/NCT02209376,NCT02209376,Patients With Residual or Reccurent EGFRvIII+ Glioma
5442,0.999274214,189.960461,https://clinicaltrials.gov/study/NCT00360776,NCT00360776,Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic Leukemia|T-cell Large Granular Lymphocyte Leukemia
5443,0.991986071,152.0423931,https://clinicaltrials.gov/study/NCT03507699,NCT03507699,Colorectal Neoplasms Malignant|Liver Metastases
5444,0.959998395,53.93159922,https://clinicaltrials.gov/study/NCT01792999,NCT01792999,Breast Cancer
5445,0.995422737,158.3984541,https://clinicaltrials.gov/study/NCT02630199,NCT02630199,Refractory Cancer
5446,0.983465309,147.0230192,https://clinicaltrials.gov/study/NCT00997399,NCT00997399,Advanced Solid Tumors
5447,0.997385756,163.9431901,https://clinicaltrials.gov/study/NCT02706899,NCT02706899,Myelodysplastic Syndrome
5448,0.995746562,155.6310585,https://clinicaltrials.gov/study/NCT00355199,NCT00355199,Diffuse Large B-Cell Lymphoma
5449,0.804700147,9.297164258,https://clinicaltrials.gov/study/NCT01083199,NCT01083199,Prostate Cancer
5450,0.946042877,28.90599004,https://clinicaltrials.gov/study/NCT02332499,NCT02332499,Metastatic Colorectal Cancer
5451,0.987116958,150.0923189,https://clinicaltrials.gov/study/NCT04205799,NCT04205799,Advanced/Metastatic Cervical Cancer
5452,0.972244458,82.94670361,https://clinicaltrials.gov/study/NCT01828099,NCT01828099,Non-Small Cell Lung Cancer
5453,0.997591969,159.2002606,https://clinicaltrials.gov/study/NCT00128999,NCT00128999,"Carcinoma, Non-Small-Cell Lung"
5454,0.981338943,114.1356201,https://clinicaltrials.gov/study/NCT01215799,NCT01215799,Hormone Refractory Prostate Cancer
5455,0.985025256,115.3782583,https://clinicaltrials.gov/study/NCT00580970,NCT00580970,Prostate Cancer
5456,0.986136319,126.2891986,https://clinicaltrials.gov/study/NCT00002570,NCT00002570,Colorectal Cancer
5457,0.993812236,152.7559695,https://clinicaltrials.gov/study/NCT00756470,NCT00756470,Breast Cancer
5458,0.986933798,120.0190424,https://clinicaltrials.gov/study/NCT00003470,NCT00003470,Anaplastic Astrocytoma
5459,0.990782091,150.9468886,https://clinicaltrials.gov/study/NCT00591370,NCT00591370,Melanoma
5460,0.989315496,145.8161476,https://clinicaltrials.gov/study/NCT00318370,NCT00318370,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Neoplasms
5461,0.950220245,41.75658551,https://clinicaltrials.gov/study/NCT00710970,NCT00710970,Urinary Bladder Neoplasms
5462,0.98926864,151.091582,https://clinicaltrials.gov/study/NCT01466270,NCT01466270,Anxiety Disorder|Breast Cancer|Cognition Disorders|Depression|Fatigue|Sleep Disorders
5463,0.987342023,150.4240526,https://clinicaltrials.gov/study/NCT01497470,NCT01497470,Cancer
5464,0.990346848,151.5184684,https://clinicaltrials.gov/study/NCT00671970,NCT00671970,Glioblastoma|Gliosarcoma
5465,0.998989193,187.9270681,https://clinicaltrials.gov/study/NCT02250170,NCT02250170,Solid Tumor
5466,0.991453177,151.7892833,https://clinicaltrials.gov/study/NCT02488070,NCT02488070,Recurrent Prostate Carcinoma
5467,0.997071901,160.9221562,https://clinicaltrials.gov/study/NCT00004870,NCT00004870,Colorectal Cancer
5468,0.945103035,39.88118503,https://clinicaltrials.gov/study/NCT02179970,NCT02179970,Pancreatic Adenocarcinoma Metastatic|Ovarian Serous Adenocarcinoma|Colorectal Cancer Metastatic
5469,0.995405497,156.0787808,https://clinicaltrials.gov/study/NCT01145170,NCT01145170,Diffuse Intrinsic Brainstem Gliomas
5470,0.989378245,151.2715955,https://clinicaltrials.gov/study/NCT00109070,NCT00109070,Colorectal Cancer
5471,0.858099666,12.97610507,https://clinicaltrials.gov/study/NCT00241111,NCT00241111,Prostate Cancer With Bone Metastasis
5472,0.992190797,151.8612505,https://clinicaltrials.gov/study/NCT02754011,NCT02754011,Breast Cancer
5473,0.798471776,9.485984998,https://clinicaltrials.gov/study/NCT01387711,NCT01387711,Actinic Keratosis
5474,0.988826787,150.6788652,https://clinicaltrials.gov/study/NCT00320411,NCT00320411,"Neoplasms, Breast"
5475,0.986711,143.8621498,https://clinicaltrials.gov/study/NCT00668811,NCT00668811,Papillary Thyroid Cancer|Follicular Thyroid Cancer|Differentiated Thyroid Cancer
5476,0.999421204,186.342115,https://clinicaltrials.gov/study/NCT03215511,NCT03215511,Solid Tumors Harboring NTRK Fusion
5477,0.986955069,120.5284688,https://clinicaltrials.gov/study/NCT00139711,NCT00139711,"Carcinoma, Non-Small-Cell Lung"
5478,0.998930078,180.8519043,https://clinicaltrials.gov/study/NCT00430911,NCT00430911,Primary Brain Tumor|Anaplastic Astrocytoma|Glioblastoma Multiforme
5479,0.966466641,45.91784936,https://clinicaltrials.gov/study/NCT00191711,NCT00191711,Superficial Bladder Cancer
5480,0.995795091,156.0611931,https://clinicaltrials.gov/study/NCT04185311,NCT04185311,"Anatomic Stage 0 Breast Cancer AJCC v8|Anatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|HER2/Neu Negative|Invasive Ductal Carcinoma, Not Otherwise Specified|Progesterone Receptor Negative|Prognostic Stage 0 Breast Cancer AJCC v8|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Triple-Negative Breast Carcinoma"
5481,0.99544719,154.4881351,https://clinicaltrials.gov/study/NCT02570711,NCT02570711,Metastatic Pancreatic Cancer
5482,0.999292209,182.9219077,https://clinicaltrials.gov/study/NCT00003311,NCT00003311,Lymphoma
5483,0.972314777,59.39197914,https://clinicaltrials.gov/study/NCT00306111,NCT00306111,Non-Hodgkin Lymphoma
5484,0.782066073,10.86308723,https://clinicaltrials.gov/study/NCT00941811,NCT00941811,HPV
5485,0.997958348,164.7302894,https://clinicaltrials.gov/study/NCT00664911,NCT00664911,Solid Tumor Regardless of Localization and Stage
5486,0.99949616,182.2111146,https://clinicaltrials.gov/study/NCT04060511,NCT04060511,Advanced Solid Tumor
5487,0.886857028,18.82458873,https://clinicaltrials.gov/study/NCT00036270,NCT00036270,Breast Neoplasms
5488,0.98583456,133.9827388,https://clinicaltrials.gov/study/NCT02161770,NCT02161770,Solid Tumours
5489,0.995444977,156.5675078,https://clinicaltrials.gov/study/NCT03093870,NCT03093870,Biliary Tract Cancer
5490,0.962793906,40.57365962,https://clinicaltrials.gov/study/NCT00265070,NCT00265070,Prostate Cancer
5491,0.916112774,23.96972406,https://clinicaltrials.gov/study/NCT02771470,NCT02771470,Lung Cancer|Effects of Chemotherapy|Tumor Immunity|Malnutrition
5492,0.996918726,161.230825,https://clinicaltrials.gov/study/NCT02914470,NCT02914470,Breast Cancer|Cervix Cancer|Ovarian Cancer|Endometrial Cancer
5493,0.977586882,85.88581196,https://clinicaltrials.gov/study/NCT00475670,NCT00475670,Breast Cancer
5494,0.97433494,80.62804903,https://clinicaltrials.gov/study/NCT02598570,NCT02598570,Lymphoma
5495,0.976741085,76.50398506,https://clinicaltrials.gov/study/NCT00003070,NCT00003070,"Cardiac Toxicity|Unspecified Childhood Solid Tumor, Protocol Specific"
5496,0.99333027,152.5717297,https://clinicaltrials.gov/study/NCT00822770,NCT00822770,Stem Cell Transplantation|Leukemia
5497,0.988287543,150.433915,https://clinicaltrials.gov/study/NCT01298570,NCT01298570,Colorectal Cancer Metastatic
5498,0.998157478,171.431092,https://clinicaltrials.gov/study/NCT00040170,NCT00040170,Prostatic Neoplasms
5499,0.993693287,152.8792053,https://clinicaltrials.gov/study/NCT00623870,NCT00623870,Hematologic Neoplasms
5500,0.996648543,158.7835672,https://clinicaltrials.gov/study/NCT01593670,NCT01593670,Myelodysplastic Syndrome
5501,0.999684613,183.5214463,https://clinicaltrials.gov/study/NCT00939770,NCT00939770,Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Neuroblastoma|Refractory Anaplastic Large Cell Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Neuroblastoma
5502,0.998994411,187.5267155,https://clinicaltrials.gov/study/NCT00131911,NCT00131911,Gastrinoma|Glucagonoma|Insulinoma|Metastatic Gastrointestinal Carcinoid Tumor|Neuroendocrine Tumor|Pancreatic Polypeptide Tumor|Recurrent Gastrointestinal Carcinoid Tumor|Recurrent Islet Cell Carcinoma|Somatostatinoma|WDHA Syndrome
5503,0.998027072,169.3046466,https://clinicaltrials.gov/study/NCT01061411,NCT01061411,Clear Cell Sarcoma of the Kidney|Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer
5504,0.999387854,192.9737365,https://clinicaltrials.gov/study/NCT01903811,NCT01903811,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma
5505,0.994484028,154.0254014,https://clinicaltrials.gov/study/NCT01871311,NCT01871311,Colorectal Cancer|Head and Neck Cancer
5506,0.995276045,155.4024806,https://clinicaltrials.gov/study/NCT00527111,NCT00527111,Rectal Cancer
5507,0.83192849,12.97826013,https://clinicaltrials.gov/study/NCT00151411,NCT00151411,Polycystic Ovary Syndrome
5508,0.998909095,178.5891657,https://clinicaltrials.gov/study/NCT02890511,NCT02890511,Solid Tumor|Stage IV Gastric Cancer
5509,0.990070879,150.8296333,https://clinicaltrials.gov/study/NCT00809211,NCT00809211,Leukemia
5510,0.789695013,9.976362221,https://clinicaltrials.gov/study/NCT00211211,NCT00211211,Osteopenia|Osteoporosis|Multiple Myeloma|Bone Neoplasms
5511,0.992789087,151.8024263,https://clinicaltrials.gov/study/NCT00878111,NCT00878111,Solid Tumors
5512,0.988183127,150.6675044,https://clinicaltrials.gov/study/NCT00384111,NCT00384111,"Follicular Lymphoma|Lymphoma, Follicular"
5513,0.894710913,17.92643757,https://clinicaltrials.gov/study/NCT00636311,NCT00636311,Hodgkin Disease
5514,0.995596634,156.2257475,https://clinicaltrials.gov/study/NCT00182611,NCT00182611,Gastric Cancer
5515,0.956360516,35.24371233,https://clinicaltrials.gov/study/NCT00489411,NCT00489411,"Neurotoxicity|Pain|Peripheral Neuropathy|Unspecified Adult Solid Tumor, Protocol Specific"
5516,0.99340498,153.0035204,https://clinicaltrials.gov/study/NCT01619111,NCT01619111,HER2-negative Metastatic Breast Cancer|HER2-positive Circulating Tumor Cells
5517,0.999574574,183.1302253,https://clinicaltrials.gov/study/NCT01468311,NCT01468311,Hodgkin Disease|Hodgkin Lymphoma
5518,0.932619203,27.60138083,https://clinicaltrials.gov/study/NCT00661011,NCT00661011,Non Small Cell Lung Carcinoma
5519,0.990532857,151.928652,https://clinicaltrials.gov/study/NCT03151811,NCT03151811,Multiple Myeloma
5520,0.996741934,158.245829,https://clinicaltrials.gov/study/NCT00781911,NCT00781911,Carcinoma|Neuroendocrine Tumors
5521,0.879634829,13.63469462,https://clinicaltrials.gov/study/NCT00169611,NCT00169611,Neurofibromatosis Type 1
5522,0.53402138,2.426067976,https://clinicaltrials.gov/study/NCT01959711,NCT01959711,Adrenal Tumor|Pheochromocytoma|Conn's Syndrome|Cushing's Syndrome
5523,0.999049811,179.6774333,https://clinicaltrials.gov/study/NCT00003411,NCT00003411,Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Pancreatic Cancer
5524,0.999632071,188.5406434,https://clinicaltrials.gov/study/NCT00227513,NCT00227513,"Unspecified Adult Solid Tumor, Protocol Specific"
5525,0.997932459,165.4375008,https://clinicaltrials.gov/study/NCT01814813,NCT01814813,Recurrent Glioblastoma|Recurrent Adult Brain Tumor|Gliosarcoma
5526,0.999271147,191.3780348,https://clinicaltrials.gov/study/NCT00049413,NCT00049413,Leukemia|Lymphoma
5527,0.991783503,152.6537688,https://clinicaltrials.gov/study/NCT00553813,NCT00553813,Pancreatic Cancer
5528,0.981642158,121.7409057,https://clinicaltrials.gov/study/NCT03559413,NCT03559413,"Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults"
5529,0.998524951,172.0157526,https://clinicaltrials.gov/study/NCT01462513,NCT01462513,Colon Carcinoma|Rectum Carcinoma
5530,0.98286457,120.975178,https://clinicaltrials.gov/study/NCT01263613,NCT01263613,Breast Cancer
5531,0.999485849,189.3296955,https://clinicaltrials.gov/study/NCT00004013,NCT00004013,Breast Cancer
5532,0.990645451,151.3586898,https://clinicaltrials.gov/study/NCT01994213,NCT01994213,Gastroenteropancreatic Neuroendocrine Tumor
5533,0.985611578,118.8070124,https://clinicaltrials.gov/study/NCT02653313,NCT02653313,"Carcinoma, Pancreatic Ductal"
5534,0.989255,151.2449471,https://clinicaltrials.gov/study/NCT01732913,NCT01732913,Indolent Non-Hodgkin's Lymphomas
5535,0.988569334,150.4678524,https://clinicaltrials.gov/study/NCT00270413,NCT00270413,Metastatic Breast Cancer
5536,0.990779254,151.0144509,https://clinicaltrials.gov/study/NCT00364013,NCT00364013,Metastatic Colorectal Cancer
5537,0.824394771,10.14624605,https://clinicaltrials.gov/study/NCT01718613,NCT01718613,Septic Shock
5538,0.99336327,152.84252,https://clinicaltrials.gov/study/NCT02047513,NCT02047513,Resectable Pancreatic Cancer|Ductal Adenocarcinoma of the Pancreas
5539,0.990777732,151.8095954,https://clinicaltrials.gov/study/NCT02875613,NCT02875613,Nasopharyngeal Cancer
5540,0.929167131,24.97972832,https://clinicaltrials.gov/study/NCT00907413,NCT00907413,Cholangiocarcinoma
5541,0.988426976,150.352912,https://clinicaltrials.gov/study/NCT03190213,NCT03190213,Neuroendocrine Tumors
5542,0.994782117,156.0376625,https://clinicaltrials.gov/study/NCT01782313,NCT01782313,Recurrent Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma
5543,0.999407617,183.6400586,https://clinicaltrials.gov/study/NCT01753713,NCT01753713,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
5544,0.865918169,12.73679614,https://clinicaltrials.gov/study/NCT01493713,NCT01493713,Colorectal Cancer|Hepatic Metastasis
5545,0.99955111,182.3628783,https://clinicaltrials.gov/study/NCT00004913,NCT00004913,"Unspecified Adult Solid Tumor, Protocol Specific"
5546,0.998689195,178.8321553,https://clinicaltrials.gov/study/NCT00003013,NCT00003013,Breast Cancer
5547,0.998325494,169.1914942,https://clinicaltrials.gov/study/NCT03343613,NCT03343613,Solid Tumor|Non Small Cell Lung Cancer|Renal Cell Carcinoma|Triple Negative Breast Cancer
5548,0.935739939,30.16460294,https://clinicaltrials.gov/study/NCT00707213,NCT00707213,Cancer
5549,0.99122994,151.6569648,https://clinicaltrials.gov/study/NCT02471313,NCT02471313,Liver Cancer|Liver Neoplasm|Hepatocellular Carcinoma|HCC
5550,0.999227025,178.8440638,https://clinicaltrials.gov/study/NCT00118313,NCT00118313,Melanoma (Skin)
5551,0.996501202,159.3356258,https://clinicaltrials.gov/study/NCT00881569,NCT00881569,Advanced Cancer
5552,0.999548744,190.5160596,https://clinicaltrials.gov/study/NCT00134069,NCT00134069,Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage III Colon Cancer|Stage III Rectal Cancer|Stage IV Colon Cancer|Stage IV Rectal Cancer
5553,0.99240909,151.7227851,https://clinicaltrials.gov/study/NCT00227669,NCT00227669,Sarcoma
5554,0.995137862,156.2430026,https://clinicaltrials.gov/study/NCT00633269,NCT00633269,Neoplasm Metastasis
5555,0.988226332,151.1131378,https://clinicaltrials.gov/study/NCT01262469,NCT01262469,Metastatic Breast Cancer|70 Years Old Patients and Over|After One Line of Chemotherapy With Trastuzumab
5556,0.987199528,144.7422715,https://clinicaltrials.gov/study/NCT00006269,NCT00006269,Colorectal Cancer|Diarrhea
5557,0.999147661,188.5774069,https://clinicaltrials.gov/study/NCT00384969,NCT00384969,Renal Cell Carcinoma
5558,0.998970198,179.2355713,https://clinicaltrials.gov/study/NCT01171469,NCT01171469,Brain Tumor|Glioblastoma|Medulloblastoma|Ependymoma|Anaplastic Astrocytoma
5559,0.681637427,5.839807994,https://clinicaltrials.gov/study/NCT00647569,NCT00647569,Incisional Hernia|Pelvic Cancer
5560,0.996641764,159.1375848,https://clinicaltrials.gov/study/NCT00000769,NCT00000769,"Sarcoma, Kaposi|HIV Infections"
5561,0.997264122,161.4641189,https://clinicaltrials.gov/study/NCT01016769,NCT01016769,Squamous Cell Cancer|Head and Neck Cancer
5562,0.986360931,146.4118503,https://clinicaltrials.gov/study/NCT00191269,NCT00191269,Metastatic Breast Cancer
5563,0.992882057,152.7111955,https://clinicaltrials.gov/study/NCT03203369,NCT03203369,Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
5564,0.983357065,117.1578934,https://clinicaltrials.gov/study/NCT00036569,NCT00036569,Diffuse Intrinsic Pontine Glioma
5565,0.998807131,179.8379616,https://clinicaltrials.gov/study/NCT00750269,NCT00750269,Lung Cancer
5566,0.989054924,151.6280185,https://clinicaltrials.gov/study/NCT01969669,NCT01969669,Non-Hodgkin's Lymphoma
5567,0.985355815,113.2964248,https://clinicaltrials.gov/study/NCT01889069,NCT01889069,Lymphoma
5568,0.999411992,184.438579,https://clinicaltrials.gov/study/NCT00301769,NCT00301769,Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Blastic Phase Chronic Myelogenous Leukemia|de Novo Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes
5569,0.989222446,150.7751155,https://clinicaltrials.gov/study/NCT00212069,NCT00212069,Metastatic Breast Cancer
5570,0.902797757,16.78856116,https://clinicaltrials.gov/study/NCT01393769,NCT01393769,Retinoblastoma
5571,0.813896511,10.67817145,https://clinicaltrials.gov/study/NCT01203969,NCT01203969,Colon Cancer
5572,0.569699395,4.293641839,https://clinicaltrials.gov/study/NCT02821169,NCT02821169,Pain
5573,0.945346013,33.90700018,https://clinicaltrials.gov/study/NCT02983799,NCT02983799,"Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity"
5574,0.899845546,19.18797709,https://clinicaltrials.gov/study/NCT01035099,NCT01035099,Breast Cancer|Infertility
5575,0.98612207,150.7387041,https://clinicaltrials.gov/study/NCT03131999,NCT03131999,Lymphangioleiomyomatosis
5576,0.568968888,3.974104874,https://clinicaltrials.gov/study/NCT02216799,NCT02216799,Diabetic Patients With Gastrointestinal Cancer Undergoing Surgery and Receiving Parenteral Nutrition
5577,0.999052976,190.8337571,https://clinicaltrials.gov/study/NCT00660699,NCT00660699,Cholangiocarcinoma Cancer|Gallbladder Cancer|Pancreatic Cancer|Ampullary Cancer
5578,0.997889314,166.0474296,https://clinicaltrials.gov/study/NCT00723099,NCT00723099,Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Chronic Myelogenous Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Indolent Non-Hodgkin Lymphoma|Lymphoma|Mixed Phenotype Acute Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Recurrent Chronic Lymphocytic Leukemia|Recurrent Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Recurrent T-Cell Non-Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia|Refractory Follicular Lymphoma|Refractory Hodgkin Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Small Lymphocytic Lymphoma|T-Cell Non-Hodgkin Lymphoma
5579,0.871139856,14.17696369,https://clinicaltrials.gov/study/NCT02055170,NCT02055170,Non-small Cell Lung Cancer
5580,0.982628757,110.8349553,https://clinicaltrials.gov/study/NCT00946270,NCT00946270,Polycythemia Vera|Thrombocythemia
5581,0.876675867,15.81456763,https://clinicaltrials.gov/study/NCT02408770,NCT02408770,Breast Cancer
5582,0.980068217,96.96182372,https://clinicaltrials.gov/study/NCT01484470,NCT01484470,Hematologic Malignancies
5583,0.997006194,160.949905,https://clinicaltrials.gov/study/NCT03845270,NCT03845270,Non Small Cell Lung Cancer Metastatic|Non Small Cell Lung Cancer Stage III|HER2 Gene Mutation
5584,0.998222681,174.3879087,https://clinicaltrials.gov/study/NCT02857270,NCT02857270,Advanced Cancer|Metastatic Melanoma|Metastatic Non-small Cell Lung Cancer|Colorectal Cancer
5585,0.984109473,96.74255523,https://clinicaltrials.gov/study/NCT00241670,NCT00241670,"Brain Cancer|Brain Tumors|Cancer of Brain|Primary Brain Tumors|Brain Tumor, Primary"
5586,0.895262745,19.46742181,https://clinicaltrials.gov/study/NCT04792970,NCT04792970,Malignant Pleural Effusion
5587,0.968141151,68.93710853,https://clinicaltrials.gov/study/NCT01475370,NCT01475370,Acute Myeloid Leukemia
5588,0.989045672,150.8552034,https://clinicaltrials.gov/study/NCT01999270,NCT01999270,"Astrocytoma, Oligoastrocytoma, Mixed|Ganglioneuroma|Glioma|Ganglioglioma|Glioblastoma Multiforme Glioma"
5589,0.99279373,152.1710894,https://clinicaltrials.gov/study/NCT03557970,NCT03557970,Recurrent Acute Myeloid Leukemia|Refractory Acute Myeloid Leukemia
5590,0.990150013,151.2526915,https://clinicaltrials.gov/study/NCT01074970,NCT01074970,Breast Cancer
5591,0.966409212,59.5740644,https://clinicaltrials.gov/study/NCT03970070,NCT03970070,Malignant Neoplasm
5592,0.996570596,159.2014749,https://clinicaltrials.gov/study/NCT00268970,NCT00268970,Non-small Cell Lung Cancer
5593,0.973431491,80.24099909,https://clinicaltrials.gov/study/NCT00978770,NCT00978770,Breast Cancer
5594,0.997511452,166.9787716,https://clinicaltrials.gov/study/NCT00272870,NCT00272870,Glioblastoma Multiforme (WHO Grade IV)|Anaplastic Astrocytoma (WHO Grade III)
5595,0.995258138,155.6421136,https://clinicaltrials.gov/study/NCT00073970,NCT00073970,Prostate Cancer
5596,0.982837426,108.9829313,https://clinicaltrials.gov/study/NCT02083770,NCT02083770,Cancer
5597,0.963605526,47.37103531,https://clinicaltrials.gov/study/NCT01618370,NCT01618370,Prostatic Neoplasms
5598,0.993238039,152.4336322,https://clinicaltrials.gov/study/NCT00362570,NCT00362570,"Oligoastrocytoma, Mixed|Anaplastic Oligodendroglioma"
5599,0.663626944,5.422859547,https://clinicaltrials.gov/study/NCT02112370,NCT02112370,Thyroid Neoplasm|Goiter
5600,0.993534449,153.9979282,https://clinicaltrials.gov/study/NCT02508870,NCT02508870,Myelodysplastic Syndromes
5601,0.982355392,113.2028687,https://clinicaltrials.gov/study/NCT01834170,NCT01834170,Pancreatic Adenocarcinoma
5602,0.987393176,150.2104649,https://clinicaltrials.gov/study/NCT03856411,NCT03856411,Treatment-naive Advanced Non-small Cell Lung Cancer
5603,0.990220579,150.9661285,https://clinicaltrials.gov/study/NCT00417911,NCT00417911,Multiple Myeloma
5604,0.99101847,152.3343729,https://clinicaltrials.gov/study/NCT03396211,NCT03396211,Cancer
5605,0.79785673,11.08359073,https://clinicaltrials.gov/study/NCT02709811,NCT02709811,Colorectal Adenocarcinoma
5606,0.990387759,151.2066592,https://clinicaltrials.gov/study/NCT01313611,NCT01313611,Follicular Lymphoma
5607,0.99288226,153.3435564,https://clinicaltrials.gov/study/NCT02698111,NCT02698111,Nasopharyngeal Carcinoma
5608,0.998669382,179.4791359,https://clinicaltrials.gov/study/NCT00016211,NCT00016211,Lung Cancer
5609,0.994915084,153.923303,https://clinicaltrials.gov/study/NCT01829711,NCT01829711,"Leukemia, Hairy Cell"
5610,0.990758843,151.558336,https://clinicaltrials.gov/study/NCT00003511,NCT00003511,Multiple Myeloma
5611,0.998372753,174.7068569,https://clinicaltrials.gov/study/NCT01238211,NCT01238211,Acute Myeloid Leukemia|Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1|Core Binding Factor Acute Myeloid Leukemia|Secondary Acute Myeloid Leukemia|Therapy-Related Acute Myeloid Leukemia
5612,0.928861579,28.476525,https://clinicaltrials.gov/study/NCT01381211,NCT01381211,Hepatocellular Carcinoma
5613,0.990128069,151.7087589,https://clinicaltrials.gov/study/NCT01415011,NCT01415011,"Carcinoma, Non-Small-Cell Lung"
5614,0.985869215,137.359918,https://clinicaltrials.gov/study/NCT00679211,NCT00679211,Metastatic Breast Cancer
5615,0.999154151,189.390257,https://clinicaltrials.gov/study/NCT00030511,NCT00030511,Extrahepatic Bile Duct Cancer|Liver Cancer
5616,0.999566222,187.8177612,https://clinicaltrials.gov/study/NCT00003211,NCT00003211,Brain and Central Nervous System Tumors
5617,0.99066667,151.8114668,https://clinicaltrials.gov/study/NCT04685811,NCT04685811,Metastatic Prostate Adenocarcinoma
5618,0.605385149,3.350296592,https://clinicaltrials.gov/study/NCT03199911,NCT03199911,"Antibiotic Side Effect|Eyelid; Wound|Eyelid Diseases|Surgical Wound Infection|Surgical Wound, Recent|Surgical Incision|Skin Cancer Face|Antibiotic Allergy|Surgical Site Infection"
5619,0.987927057,133.1041641,https://clinicaltrials.gov/study/NCT00076011,NCT00076011,Kidney Neoplasms
5620,0.999470871,195.1564011,https://clinicaltrials.gov/study/NCT02228811,NCT02228811,Locally Advanced Tumors|Metastatic Solid Tumors|Cancers With MET Genomic Alterations|Cancers With TRK Genomic Alterations
5621,0.998691599,175.3974479,https://clinicaltrials.gov/study/NCT01827111,NCT01827111,Melanoma
5622,0.997369575,162.4649789,https://clinicaltrials.gov/study/NCT00107211,NCT00107211,Breast Cancer
5623,0.981086738,98.36698259,https://clinicaltrials.gov/study/NCT05246111,NCT05246111,Advanced Solid Tumor
5624,0.996309212,159.4021433,https://clinicaltrials.gov/study/NCT00503711,NCT00503711,"Advanced Solid, Malignant Tumors"
5625,0.998306651,171.0176044,https://clinicaltrials.gov/study/NCT03324113,NCT03324113,Neoplasm Malignant
5626,0.837144766,11.49741885,https://clinicaltrials.gov/study/NCT01848613,NCT01848613,Non-small Cell Lung Cancer Metastatic
5627,0.991414108,150.7998397,https://clinicaltrials.gov/study/NCT01173913,NCT01173913,Cancer
5628,0.945410876,40.63284115,https://clinicaltrials.gov/study/NCT01215513,NCT01215513,Prostate Cancer
5629,0.995440023,155.2038246,https://clinicaltrials.gov/study/NCT00105313,NCT00105313,Lymphoma|Leukemia|Cancer
5630,0.949999427,42.00905523,https://clinicaltrials.gov/study/NCT03433313,NCT03433313,Breast Cancer
5631,0.945297014,39.5489002,https://clinicaltrials.gov/study/NCT04595513,NCT04595513,Tuberous Sclerosis Complex|Epilepsy
5632,0.989390086,151.1660261,https://clinicaltrials.gov/study/NCT02780713,NCT02780713,Breast Cancer
5633,0.994618267,154.6898657,https://clinicaltrials.gov/study/NCT00145613,NCT00145613,"Acute Lymphoblastic Leukemia (ALL)|Acute Myeloid Leukemia (AML)|Secondary AML|Myelodysplastic Syndrome (MDS)|Secondary MDS|Chronic Myeloid Leukemia|Juvenile Myelomonocytic Leukemia (JMML)|Paroxysmal Nocturnal Hemoglobinuria (PNH)|Lymphoma, Non-Hodgkin|Hodgkin Disease"
5634,0.987562362,125.045321,https://clinicaltrials.gov/study/NCT02252913,NCT02252913,Gastric Cancer
5635,0.998718346,174.9634323,https://clinicaltrials.gov/study/NCT02785913,NCT02785913,Recurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma
5636,0.999160029,179.9666398,https://clinicaltrials.gov/study/NCT00007813,NCT00007813,Brain and Central Nervous System Tumors|Childhood Germ Cell Tumor|Extragonadal Germ Cell Tumor|Liver Cancer|Neuroblastoma|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor
5637,0.977136938,89.5148743,https://clinicaltrials.gov/study/NCT01999413,NCT01999413,Acute Myeloid Leukemia (AML)
5638,0.999119982,185.5386298,https://clinicaltrials.gov/study/NCT01410513,NCT01410513,Indolent Non-Hodgkin Lymphoma|Mantle Cell Lymphoma|Chronic Lymphocytic Leukemia
5639,0.991483555,151.8161645,https://clinicaltrials.gov/study/NCT00431613,NCT00431613,Non Small Cell Lung Cancer
5640,0.843216949,12.45692966,https://clinicaltrials.gov/study/NCT00932113,NCT00932113,Psoriasis
5641,0.967303821,55.33438109,https://clinicaltrials.gov/study/NCT01024413,NCT01024413,Thoracic Neoplasms
5642,0.984313842,118.6521923,https://clinicaltrials.gov/study/NCT00253513,NCT00253513,Leukemia|Myelodysplastic Syndromes
5643,0.999709705,178.7004643,https://clinicaltrials.gov/study/NCT00093613,NCT00093613,Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Giant Cell Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Tumor
5644,0.994649032,154.9856527,https://clinicaltrials.gov/study/NCT00599170,NCT00599170,"Diffuse, Large B-Cell, Lymphoma"
5645,0.992942843,152.9309394,https://clinicaltrials.gov/study/NCT00150670,NCT00150670,Gastric Cancer
5646,0.996257913,155.4062509,https://clinicaltrials.gov/study/NCT00677170,NCT00677170,Advanced Nonhematologic Malignancies
5647,0.986379066,130.9958261,https://clinicaltrials.gov/study/NCT01420770,NCT01420770,Hematopoietic Neoplasm
5648,0.998340341,173.7982254,https://clinicaltrials.gov/study/NCT00086970,NCT00086970,"Unspecified Adult Solid Tumor, Protocol Specific"
5649,0.947422635,34.52691345,https://clinicaltrials.gov/study/NCT00042770,NCT00042770,Metastatic Cancer|Pulmonary Complications
5650,0.982987357,117.0593727,https://clinicaltrials.gov/study/NCT00313170,NCT00313170,Advanced Breast Cancer|Metastatic Breast Cancer
5651,0.998096824,163.2329514,https://clinicaltrials.gov/study/NCT00002970,NCT00002970,Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Lymphoblastic Lymphoma|T-cell Childhood Acute Lymphoblastic Leukemia
5652,0.994785793,156.3105162,https://clinicaltrials.gov/study/NCT02412670,NCT02412670,High Grade Upper Tract Urothelial Carcinoma
5653,0.989304177,147.0156581,https://clinicaltrials.gov/study/NCT01220570,NCT01220570,Breast Cancer
5654,0.996863466,158.7477379,https://clinicaltrials.gov/study/NCT02406170,NCT02406170,Esophageal Neoplasms|Stomach Neoplasms|Neoplasm Metastasis
5655,0.998085773,166.7131283,https://clinicaltrials.gov/study/NCT00105170,NCT00105170,Tumors
5656,0.996106656,156.3254984,https://clinicaltrials.gov/study/NCT01087970,NCT01087970,Head and Neck Neoplasms
5657,0.960340186,46.68689667,https://clinicaltrials.gov/study/NCT00129870,NCT00129870,Colorectal Cancer
5658,0.999539203,181.667486,https://clinicaltrials.gov/study/NCT00658970,NCT00658970,Solid Tumors|Lymphoma
5659,0.92794172,31.53282997,https://clinicaltrials.gov/study/NCT01749111,NCT01749111,Acute Myelogenous Leukemia|Acute Lymphoid Leukemia|Myeloproliferative Disease|Myelodysplastic Syndrome|Chronic Myeloid Leukemia|Chronic Myelomonocytic Leukemia
5660,0.999743425,190.149326,https://clinicaltrials.gov/study/NCT00037011,NCT00037011,Neuroblastoma
5661,0.974025489,74.6898492,https://clinicaltrials.gov/study/NCT00742911,NCT00742911,Cancer
5662,0.996621885,158.9227567,https://clinicaltrials.gov/study/NCT03508011,NCT03508011,Advanced Solid Tumours|Breast Cancer|Ovarian Cancer|Prostate Cancer
5663,0.995603242,158.3107411,https://clinicaltrials.gov/study/NCT00008411,NCT00008411,Breast Cancer
5664,0.999478761,182.0945034,https://clinicaltrials.gov/study/NCT01521611,NCT01521611,Acute Leukaemia|Chronic Leukaemia|Myeloma|Lymphoma
5665,0.987841625,150.6527652,https://clinicaltrials.gov/study/NCT02083211,NCT02083211,Cervical Cancer Recurrent or Persistent|Palliative Treatment|Monoclonal Antibody in Cervical Cancer Treatment
5666,0.998717296,177.127225,https://clinicaltrials.gov/study/NCT01229111,NCT01229111,Adult Primary Cholangiocellular Carcinoma|Advanced Adult Primary Liver Cancer|Cholangiocarcinoma of the Extrahepatic Bile Duct|Cholangiocarcinoma of the Gallbladder|Localized Unresectable Adult Primary Liver Cancer|Periampullary Adenocarcinoma|Recurrent Adult Primary Liver Cancer|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer
5667,0.998148753,173.2212776,https://clinicaltrials.gov/study/NCT00394511,NCT00394511,Prostate Cancer
5668,0.991864956,152.6870797,https://clinicaltrials.gov/study/NCT00053911,NCT00053911,Breast Cancer
5669,0.999568714,187.4037925,https://clinicaltrials.gov/study/NCT00060411,NCT00060411,Mucinous Adenocarcinoma of the Colon|Mucinous Adenocarcinoma of the Rectum|Recurrent Colon Cancer|Recurrent Rectal Cancer|Signet Ring Adenocarcinoma of the Colon|Signet Ring Adenocarcinoma of the Rectum|Stage IIIA Colon Cancer|Stage IIIA Rectal Cancer|Stage IIIB Colon Cancer|Stage IIIB Rectal Cancer|Stage IIIC Colon Cancer|Stage IIIC Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
5670,0.995334637,156.4179265,https://clinicaltrials.gov/study/NCT00477711,NCT00477711,Gastric Cancer
5671,0.998750193,177.236242,https://clinicaltrials.gov/study/NCT00609011,NCT00609011,Metastatic Melanoma
5672,0.996146902,158.2981656,https://clinicaltrials.gov/study/NCT03431311,NCT03431311,Colorectal Cancer
5673,0.523037543,3.417380714,https://clinicaltrials.gov/study/NCT02166411,NCT02166411,Fibroid
5674,0.998177788,172.7658648,https://clinicaltrials.gov/study/NCT02608411,NCT02608411,"Carcinoma, Small Cell"
5675,0.994472094,153.8666074,https://clinicaltrials.gov/study/NCT05835011,NCT05835011,Myelodysplastic Syndromes
5676,0.982802487,131.5354407,https://clinicaltrials.gov/study/NCT02340611,NCT02340611,Ovarian Cancer
5677,0.995715152,154.7571869,https://clinicaltrials.gov/study/NCT00602511,NCT00602511,Multiple Myeloma
5678,0.962104217,43.38682005,https://clinicaltrials.gov/study/NCT00468611,NCT00468611,"Multiple Sclerosis, Secondary Progressive"
5679,0.623322024,4.070760141,https://clinicaltrials.gov/study/NCT03715413,NCT03715413,Breast Fibroadenoma
5680,0.996324689,159.7573361,https://clinicaltrials.gov/study/NCT01284413,NCT01284413,Biliary Tract Cancer
5681,0.957418864,56.65461336,https://clinicaltrials.gov/study/NCT03253913,NCT03253913,Lymphangioleiomyomatosis
5682,0.999295763,198.1568709,https://clinicaltrials.gov/study/NCT00616213,NCT00616213,"Unspecified Adult Solid Tumor, Protocol Specific"
5683,0.996892042,161.2520504,https://clinicaltrials.gov/study/NCT01890213,NCT01890213,Stage III Colon Cancer
5684,0.992010178,152.1259865,https://clinicaltrials.gov/study/NCT01829113,NCT01829113,Non Squamous Non Small Cell Lung Cancer
5685,0.978325083,99.03767779,https://clinicaltrials.gov/study/NCT00656513,NCT00656513,Head and Neck Cancer|Xerostomia
5686,0.928421347,29.82827268,https://clinicaltrials.gov/study/NCT04423913,NCT04423913,Prostate Cancer
5687,0.974154101,81.76635333,https://clinicaltrials.gov/study/NCT02628613,NCT02628613,Breast Cancer
5688,0.989764803,150.2759448,https://clinicaltrials.gov/study/NCT00798213,NCT00798213,"Leukemia, Myeloid, Acute|Lymphoblastic Leukemia, Acute"
5689,0.817317863,11.41054766,https://clinicaltrials.gov/study/NCT01938313,NCT01938313,Gastric Cancer
5690,0.980642737,83.74255445,https://clinicaltrials.gov/study/NCT02291913,NCT02291913,Breast Cancer
5691,0.639311871,4.046229674,https://clinicaltrials.gov/study/NCT01396369,NCT01396369,Polycystic Ovarian Syndrome
5692,0.998938651,190.1535937,https://clinicaltrials.gov/study/NCT00002669,NCT00002669,Melanoma (Skin)
5693,0.993858116,153.4361299,https://clinicaltrials.gov/study/NCT01006369,NCT01006369,Colorectal Cancer
5694,0.998225851,171.295953,https://clinicaltrials.gov/study/NCT00726869,NCT00726869,Multiple Myeloma
5695,0.996620406,158.8763684,https://clinicaltrials.gov/study/NCT00178269,NCT00178269,Cervix Neoplasm
5696,0.997116376,161.5938903,https://clinicaltrials.gov/study/NCT04097769,NCT04097769,Advanced Solid Tumor
5697,0.982486563,104.5012602,https://clinicaltrials.gov/study/NCT03135769,NCT03135769,Gestational Trophoblastic Neoplasias (GTN)
5698,0.998463544,176.0808008,https://clinicaltrials.gov/study/NCT03008369,NCT03008369,Malignant Adrenal Gland Pheochromocytoma|Malignant Paraganglioma|Metastatic Adrenal Gland Pheochromocytoma
5699,0.974301448,85.10228696,https://clinicaltrials.gov/study/NCT00539669,NCT00539669,Ovarian Neoplasms
5700,0.993835978,153.6839926,https://clinicaltrials.gov/study/NCT01662869,NCT01662869,Gastric Cancer
5701,0.92192841,23.0971245,https://clinicaltrials.gov/study/NCT03361969,NCT03361969,Prostatic Neoplasm
5702,0.999614654,193.5912632,https://clinicaltrials.gov/study/NCT00098670,NCT00098670,B-cell Chronic Lymphocytic Leukemia|Stage I Chronic Lymphocytic Leukemia|Stage II Chronic Lymphocytic Leukemia|Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic Leukemia
5703,0.986810498,150.5603053,https://clinicaltrials.gov/study/NCT00692770,NCT00692770,"Carcinoma, Hepatocellular"
5704,0.999778298,181.3013917,https://clinicaltrials.gov/study/NCT03524170,NCT03524170,Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8
5705,0.97860505,88.23033517,https://clinicaltrials.gov/study/NCT04802070,NCT04802070,Sarcoma
5706,0.999505934,188.6052699,https://clinicaltrials.gov/study/NCT00281970,NCT00281970,Lung Cancer
5707,0.989575714,151.1813393,https://clinicaltrials.gov/study/NCT00943670,NCT00943670,Metastatic Breast Cancer
5708,0.999007847,189.4720779,https://clinicaltrials.gov/study/NCT00014170,NCT00014170,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma
5709,0.826645695,10.46824918,https://clinicaltrials.gov/study/NCT01932970,NCT01932970,"Hyperparathyroidism, Secondary"
5710,0.99771447,164.6214885,https://clinicaltrials.gov/study/NCT02452970,NCT02452970,Cholangiocarcinoma
5711,0.999278614,183.6713816,https://clinicaltrials.gov/study/NCT04747470,NCT04747470,Advanced Solid Tumors
5712,0.997366183,163.287106,https://clinicaltrials.gov/study/NCT01653470,NCT01653470,Cancer
5713,0.990379764,151.4024198,https://clinicaltrials.gov/study/NCT01910870,NCT01910870,Metastatic Breast Cancer
5714,0.97044429,74.48046509,https://clinicaltrials.gov/study/NCT00718770,NCT00718770,Thyroid Cancer
5715,1.0,188.0317344,https://clinicaltrials.gov/study/NCT01269411,NCT01269411,Adult Anaplastic Oligodendroglioma|Adult Brain Stem Glioma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Recurrent Adult Brain Tumor
5716,0.983610344,117.5497179,https://clinicaltrials.gov/study/NCT02579811,NCT02579811,Metastatic Renal Cell Cancer
5717,0.97633432,90.48258452,https://clinicaltrials.gov/study/NCT03041311,NCT03041311,Small Cell Lung Cancer
5718,0.974832263,90.41473704,https://clinicaltrials.gov/study/NCT00124111,NCT00124111,Breast Cancer
5719,0.990579535,151.3118542,https://clinicaltrials.gov/study/NCT02167711,NCT02167711,Cholangio Carcinoma
5720,0.99273086,153.3815141,https://clinicaltrials.gov/study/NCT01684111,NCT01684111,"Carcinoma, Non-Small-Cell Lung"
5721,0.993931405,153.0624486,https://clinicaltrials.gov/study/NCT01647711,NCT01647711,"Carcinoma, Non-Small-Cell Lung"
5722,0.998591496,174.5882982,https://clinicaltrials.gov/study/NCT00490711,NCT00490711,Epithelial Ovarian Cancer
5723,0.673000293,6.408354551,https://clinicaltrials.gov/study/NCT01248611,NCT01248611,Chronic Pain|Cancer
5724,0.997067107,160.084439,https://clinicaltrials.gov/study/NCT00293111,NCT00293111,Multiple Myeloma
5725,0.908082788,20.54413347,https://clinicaltrials.gov/study/NCT03332511,NCT03332511,"Chronic Myeloid Leukemia, Chronic Phase"
5726,0.981284549,100.195096,https://clinicaltrials.gov/study/NCT04169711,NCT04169711,Clear Cell Renal Cell Carcinoma
5727,0.98246061,137.8140902,https://clinicaltrials.gov/study/NCT00186511,NCT00186511,"Breast Cancer|Stress Disorders, Post-Traumatic|Depression"
5728,0.989377717,150.4621366,https://clinicaltrials.gov/study/NCT00000611,NCT00000611,Bone Diseases|Breast Neoplasms|Cardiovascular Diseases|Colonic Neoplasms|Coronary Disease|Heart Diseases|Myocardial Ischemia|Osteoporosis|Postmenopause
5729,0.995227275,155.0412672,https://clinicaltrials.gov/study/NCT01123811,NCT01123811,Adenocarcinoma of Stomach or Esophagogastric Junction
5730,0.744422791,5.82645884,https://clinicaltrials.gov/study/NCT02819011,NCT02819011,Accidental Falls|Fall Due to Loss of Equilibrium|High Risk of Falls Due to Mobility Limitation|Diabetes|Arthritis|Cancer|Peripheral Arterial Disease|Parkinson's Disease|End Stage Renal Failure on Dialysis
5731,0.983002964,138.1024122,https://clinicaltrials.gov/study/NCT00978211,NCT00978211,Neuroendocrine Tumors
5732,0.74972647,7.656278208,https://clinicaltrials.gov/study/NCT02027311,NCT02027311,Choledocholithiasis|Cholangiocarcinoma|Pancreatitis|Pancreatic Cancer
5733,0.951182433,45.74410708,https://clinicaltrials.gov/study/NCT00408213,NCT00408213,Myasthenia Gravis Generalised
5734,0.895350087,20.00471131,https://clinicaltrials.gov/study/NCT00432913,NCT00432913,Adenomatous Polyps
5735,0.994069785,154.4431687,https://clinicaltrials.gov/study/NCT03809013,NCT03809013,Urothelial Carcinoma
5736,0.653200982,4.163706379,https://clinicaltrials.gov/study/NCT01101113,NCT01101113,Secondary Hyperparathyroidism
5737,0.998632704,173.8704909,https://clinicaltrials.gov/study/NCT02264613,NCT02264613,Solid Tumor|Lymphoma|Peripheral T-Cell Lymphoma
5738,0.879309948,14.06523866,https://clinicaltrials.gov/study/NCT01298713,NCT01298713,Breast Neoplasms|mTor Protein
5739,0.993745688,153.6762071,https://clinicaltrials.gov/study/NCT04070313,NCT04070313,Resected Pancreatic Cancer|Pancreatic Cancer|Adjuvant Chemotherapy
5740,0.9998414,182.0561183,https://clinicaltrials.gov/study/NCT01488513,NCT01488513,"Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
5741,0.983979331,111.061746,https://clinicaltrials.gov/study/NCT01628913,NCT01628913,Pancreatic Neuroendocrine Tumors (pNET)
5742,0.997100591,162.0767915,https://clinicaltrials.gov/study/NCT02273713,NCT02273713,Esophageal Cancer|Toxicity
5743,0.998360072,171.3920555,https://clinicaltrials.gov/study/NCT00556413,NCT00556413,Colorectal Cancer
5744,0.996548112,156.2255822,https://clinicaltrials.gov/study/NCT02100813,NCT02100813,Actinic Keratosis
5745,0.999752649,185.4184944,https://clinicaltrials.gov/study/NCT00084513,NCT00084513,"Unspecified Adult Solid Tumor, Protocol Specific"
5746,0.991073542,152.092767,https://clinicaltrials.gov/study/NCT00607113,NCT00607113,Neuroendocrine Carcinoma
5747,0.987181476,150.2177168,https://clinicaltrials.gov/study/NCT00137813,NCT00137813,Esophageal Cancer|Gastric Cancer
5748,0.998915911,185.8787913,https://clinicaltrials.gov/study/NCT02146313,NCT02146313,Pancreatic Neoplasms|Ovarian Neoplasms
5749,0.921739947,23.26246508,https://clinicaltrials.gov/study/NCT00132613,NCT00132613,Malignant Pericardial Effusion
5750,0.997522625,162.8867097,https://clinicaltrials.gov/study/NCT00002813,NCT00002813,Cervical Cancer
5751,0.947743118,26.15616107,https://clinicaltrials.gov/study/NCT01465113,NCT01465113,Short Segment Barrett's Esophagus|Long Segment Barrett's Esophagus
5752,0.708416811,4.975383863,https://clinicaltrials.gov/study/NCT00947713,NCT00947713,Endocrine System Diseases|Gonadal Disorders
5753,0.850137105,14.19752181,https://clinicaltrials.gov/study/NCT00566813,NCT00566813,"Diabetes Mellitus, Type 1"
5754,0.958283937,44.93536227,https://clinicaltrials.gov/study/NCT00590213,NCT00590213,Prostate Cancer
5755,0.972765475,73.61004321,https://clinicaltrials.gov/study/NCT01853813,NCT01853813,Colorectal Cancer Stage II
5756,0.991207097,150.6390125,https://clinicaltrials.gov/study/NCT00063713,NCT00063713,Mantle Cell Lymphoma
5757,0.993809996,154.9524012,https://clinicaltrials.gov/study/NCT00291369,NCT00291369,Metastatic Renal Cell Carcinoma
5758,0.947920429,42.97022473,https://clinicaltrials.gov/study/NCT02799069,NCT02799069,Actinic Keratosis
5759,0.947759151,42.08422246,https://clinicaltrials.gov/study/NCT00319969,NCT00319969,Small Cell Lung Cancer
5760,0.664872311,5.302496473,https://clinicaltrials.gov/study/NCT03930069,NCT03930069,Submucous Leiomyoma of Uterus
5761,0.99246785,151.9162625,https://clinicaltrials.gov/study/NCT01345669,NCT01345669,Head and Neck Neoplasms
5762,0.978946684,129.0073043,https://clinicaltrials.gov/study/NCT01519869,NCT01519869,Primary Peritoneal Carcinoma|Ovarian Carcinoma|Fallopian Tube Carcinoma
5763,0.997999783,168.1736909,https://clinicaltrials.gov/study/NCT04349969,NCT04349969,Neoplasms Malignant
5764,0.999284391,189.5338261,https://clinicaltrials.gov/study/NCT00403169,NCT00403169,Kidney Cancer
5765,0.998314331,167.2797527,https://clinicaltrials.gov/study/NCT00169169,NCT00169169,CD20-Positive Large B-Cell Lymphoma
5766,0.984092819,120.9968195,https://clinicaltrials.gov/study/NCT00043069,NCT00043069,Osteoporosis|Prostate Cancer
5767,0.97551198,84.7519683,https://clinicaltrials.gov/study/NCT00518869,NCT00518869,Quality of Life|Fatigue|Complementary
5768,0.705438262,4.597545394,https://clinicaltrials.gov/study/NCT00122681,NCT00122681,"Infections, Papillomavirus"
5769,0.997893895,170.4273047,https://clinicaltrials.gov/study/NCT01041781,NCT01041781,Lung Cancer
5770,0.99612696,155.9546553,https://clinicaltrials.gov/study/NCT00043381,NCT00043381,Myelodysplastic Syndrome
5771,0.998096065,166.6862245,https://clinicaltrials.gov/study/NCT00031681,NCT00031681,"Advanced Adult Primary Liver Cancer|Carcinoma of the Appendix|Estrogen Receptor-negative Breast Cancer|Extensive Stage Small Cell Lung Cancer|Gastrointestinal Stromal Tumor|HER2-negative Breast Cancer|Metastatic Gastrointestinal Carcinoid Tumor|Ovarian Sarcoma|Ovarian Stromal Cancer|Progesterone Receptor-negative Breast Cancer|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Adult Primary Liver Cancer|Recurrent Anal Cancer|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor|Recurrent Breast Cancer|Recurrent Cervical Cancer|Recurrent Colon Cancer|Recurrent Endometrial Carcinoma|Recurrent Esophageal Cancer|Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Recurrent Extrahepatic Bile Duct Cancer|Recurrent Gallbladder Cancer|Recurrent Gastric Cancer|Recurrent Gastrointestinal Carcinoid Tumor|Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Metastatic Squamous Neck Cancer With Occult Primary|Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Pancreatic Cancer|Recurrent Prostate Cancer|Recurrent Rectal Cancer|Recurrent Salivary Gland Cancer|Recurrent Small Cell Lung Cancer|Recurrent Small Intestine Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Small Intestine Adenocarcinoma|Small Intestine Leiomyosarcoma|Small Intestine Lymphoma|Stage IV Adenoid Cystic Carcinoma of the Oral Cavity|Stage IV Anal Cancer|Stage IV Basal Cell Carcinoma of the Lip|Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor|Stage IV Breast Cancer|Stage IV Colon Cancer|Stage IV Endometrial Carcinoma|Stage IV Esophageal Cancer|Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity|Stage IV Gastric Cancer|Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Lymphoepithelioma of the Oropharynx|Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity|Stage IV Mucoepidermoid Carcinoma of the Oral Cavity|Stage IV Non-small Cell Lung Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Ovarian Germ Cell Tumor|Stage IV Pancreatic Cancer|Stage IV Prostate Cancer|Stage IV Rectal Cancer|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Verrucous Carcinoma of the Larynx|Stage IV Verrucous Carcinoma of the Oral Cavity|Stage IVA Cervical Cancer|Stage IVB Cervical Cancer|Triple-negative Breast Cancer|Unresectable Extrahepatic Bile Duct Cancer|Unresectable Gallbladder Cancer|Unspecified Adult Solid Tumor, Protocol Specific|Untreated Metastatic Squamous Neck Cancer With Occult Primary"
5772,0.999703487,190.0412574,https://clinicaltrials.gov/study/NCT03095781,NCT03095781,Colorectal Adenocarcinoma|Metastatic Pancreatic Adenocarcinoma|Recurrent Colorectal Carcinoma|Recurrent Pancreatic Carcinoma|Stage III Colorectal Cancer|Stage III Pancreatic Cancer|Stage IIIA Colorectal Cancer|Stage IIIB Colorectal Cancer|Stage IV Colorectal Cancer|Stage IV Pancreatic Cancer|Stage IVA Colorectal Cancer|Stage IVA Pancreatic Cancer|Stage IVB Colorectal Cancer|Stage IVB Pancreatic Cancer|Unresectable Pancreatic Carcinoma
5773,0.997580201,163.444132,https://clinicaltrials.gov/study/NCT01478581,NCT01478581,Multiple Myeloma
5774,0.980828521,101.9054891,https://clinicaltrials.gov/study/NCT01079481,NCT01079481,Small Cell Lung Cancer
5775,0.999689064,189.7906473,https://clinicaltrials.gov/study/NCT00896181,NCT00896181,Stage II Lymphoepithelioma of the Nasopharynx|Stage II Squamous Cell Carcinoma of the Nasopharynx|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx
5776,0.997333407,163.528349,https://clinicaltrials.gov/study/NCT01902381,NCT01902381,Previously Treated Myelodysplastic Syndromes
5777,0.990383069,151.0124921,https://clinicaltrials.gov/study/NCT00247481,NCT00247481,Breast Cancer
5778,0.999157809,189.7386403,https://clinicaltrials.gov/study/NCT00003981,NCT00003981,"Unspecified Adult Solid Tumor, Protocol Specific"
5779,0.962991675,54.32119033,https://clinicaltrials.gov/study/NCT00414076,NCT00414076,Leiomyosarcoma|Uterine Neoplasm
5780,0.998137979,165.437519,https://clinicaltrials.gov/study/NCT00020176,NCT00020176,Breast Cancer
5781,0.989900717,151.41173,https://clinicaltrials.gov/study/NCT00976976,NCT00976976,Resected Advanced Gastric Cancer
5782,0.983104329,130.2170014,https://clinicaltrials.gov/study/NCT01701076,NCT01701076,Multiple Myeloma
5783,0.99339916,154.1946047,https://clinicaltrials.gov/study/NCT03427476,NCT03427476,Renal Cell Carcinoma
5784,0.989457304,150.9258534,https://clinicaltrials.gov/study/NCT03180476,NCT03180476,Nasopharyngeal Neoplasms
5785,0.996353123,156.7092648,https://clinicaltrials.gov/study/NCT00122876,NCT00122876,"Carcinoma, Hepatocellular|Liver Neoplasms"
5786,0.888704146,15.48373247,https://clinicaltrials.gov/study/NCT01993576,NCT01993576,Breast Cancer.
5787,0.996569781,156.9505756,https://clinicaltrials.gov/study/NCT00005999,NCT00005999,Cervical Cancer
5788,0.996862274,156.0534322,https://clinicaltrials.gov/study/NCT00004199,NCT00004199,Lung Cancer
5789,0.998827594,187.0806279,https://clinicaltrials.gov/study/NCT03316599,NCT03316599,Pancreatic Cancer
5790,0.979950789,95.11925751,https://clinicaltrials.gov/study/NCT00236899,NCT00236899,Metastatic Breast Cancer (MBC)
5791,0.984986628,118.8184502,https://clinicaltrials.gov/study/NCT00171899,NCT00171899,Chronic Myelogenous Leukemia
5792,0.994863692,156.1512152,https://clinicaltrials.gov/study/NCT01219699,NCT01219699,Advanced Solid Tumors With an Alteration of the PIK3CA Gene|Estrogen Receptor Positive Breast Cancer
5793,0.997261505,161.2822353,https://clinicaltrials.gov/study/NCT00676299,NCT00676299,"Protein Kinase Inhibitors|Antineoplastic Protocols|Clinical Trial, Phase 1|Maximum Tolerated Dose|Pharmacokinetics|Advanced Malignancies|Solid Malignancies"
5794,0.997882555,167.7437741,https://clinicaltrials.gov/study/NCT05223699,NCT05223699,Acute Myeloid Leukemia|Myelodysplasia
5795,0.648702774,5.202193501,https://clinicaltrials.gov/study/NCT00638599,NCT00638599,Breast Cancer
5796,0.983436871,117.2401947,https://clinicaltrials.gov/study/NCT04716699,NCT04716699,Glioblastoma
5797,0.998362356,163.0565726,https://clinicaltrials.gov/study/NCT00408499,NCT00408499,"Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
5798,0.998563193,171.4040194,https://clinicaltrials.gov/study/NCT01520870,NCT01520870,"Glioblastoma|Brain Tumor, Recurrent"
5799,0.998410603,171.2576821,https://clinicaltrials.gov/study/NCT00045370,NCT00045370,Kidney Cancer
5800,0.967351212,61.54955876,https://clinicaltrials.gov/study/NCT02582970,NCT02582970,Colorectal Cancer
5801,0.998747456,174.9643604,https://clinicaltrials.gov/study/NCT00253370,NCT00253370,Adenocarcinoma of the Gastroesophageal Junction|Metastatic Gastric Cancer|Advanced Unresectable Gastric Cancer
5802,0.988053272,150.5479036,https://clinicaltrials.gov/study/NCT00870870,NCT00870870,Non-Small Cell Lung Cancer
5803,0.722477704,6.13196679,https://clinicaltrials.gov/study/NCT03060070,NCT03060070,Postoperative Analgesia|Lower Abdominal Cancer
5804,0.941899342,28.04005476,https://clinicaltrials.gov/study/NCT00634270,NCT00634270,Neurofibromatosis Type 1
5805,0.994599266,153.739858,https://clinicaltrials.gov/study/NCT00440570,NCT00440570,Cancer|Brain Tumor
5806,0.987387371,150.6130957,https://clinicaltrials.gov/study/NCT01238770,NCT01238770,Epithelial Ovarian Cancer
5807,0.998134521,170.5605062,https://clinicaltrials.gov/study/NCT00002470,NCT00002470,Gastrointestinal Carcinoid Tumor|Lung Cancer
5808,0.983588566,116.6540966,https://clinicaltrials.gov/study/NCT02494570,NCT02494570,Malignant PEComa
5809,0.999287049,186.7856532,https://clinicaltrials.gov/study/NCT00024570,NCT00024570,Malignant Glioma|Glioblastoma Multiforme|Anaplastic Astrocytoma|Mixed Oligoastrocytoma
5810,0.974048521,70.06124027,https://clinicaltrials.gov/study/NCT00188370,NCT00188370,"Lymphoma|Lymphoma, Non-Hodgkin|Melanoma|Carcinoma, Basal Cell"
5811,0.84330372,10.1424426,https://clinicaltrials.gov/study/NCT02562170,NCT02562170,Breast Cancer|Hereditary Breast and Ovarian Cancer Syndrome
5812,0.987237864,150.0384297,https://clinicaltrials.gov/study/NCT03184870,NCT03184870,Colorectal Cancer|Pancreatic Cancer
5813,0.998056476,164.1965253,https://clinicaltrials.gov/study/NCT02740270,NCT02740270,Solid Tumors|Lymphomas
5814,0.974213125,81.89323723,https://clinicaltrials.gov/study/NCT00072670,NCT00072670,Prostate Cancer
5815,0.997183358,160.324216,https://clinicaltrials.gov/study/NCT02085070,NCT02085070,Melanoma|Non-Small Cell Lung Cancer|Brain Metastases
5816,0.976344595,87.61840772,https://clinicaltrials.gov/study/NCT02604511,NCT02604511,Waldenstrom's Macroglobulinemia
5817,0.998711132,179.7338391,https://clinicaltrials.gov/study/NCT02648711,NCT02648711,Solid Tumors
5818,0.997434952,163.9952541,https://clinicaltrials.gov/study/NCT02471911,NCT02471911,Diffuse Large B-Cell Lymphoma
5819,0.999641385,186.4369405,https://clinicaltrials.gov/study/NCT02271711,NCT02271711,Recurrent Childhood Medulloblastoma|Recurrent Ependymoma|Recurrent Medulloblastoma
5820,0.98550522,150.2258316,https://clinicaltrials.gov/study/NCT00484211,NCT00484211,Hepatocellular Carcinoma
5821,0.997130031,160.0815795,https://clinicaltrials.gov/study/NCT00537511,NCT00537511,"Carcinoma, Small Cell"
5822,0.993737067,151.0217406,https://clinicaltrials.gov/study/NCT03190811,NCT03190811,Neoplasms
5823,0.99298767,152.6901457,https://clinicaltrials.gov/study/NCT00515411,NCT00515411,Gastroesophageal Junction Adenocarcinoma|Gastric Cancer
5824,0.998741299,176.2808429,https://clinicaltrials.gov/study/NCT00057811,NCT00057811,Childhood Burkitt Lymphoma|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Untreated Childhood Acute Lymphoblastic Leukemia
5825,0.999346561,193.0282482,https://clinicaltrials.gov/study/NCT02168270,NCT02168270,Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Anaplastic Oligoastrocytoma|Glioblastoma|Gliosarcoma
5826,0.997216354,160.1727928,https://clinicaltrials.gov/study/NCT00062270,NCT00062270,Lung Cancer
5827,0.990726096,151.2566342,https://clinicaltrials.gov/study/NCT00736970,NCT00736970,Breast Cancer|Breast Neoplasms
5828,0.996119755,158.0437128,https://clinicaltrials.gov/study/NCT00683670,NCT00683670,Melanoma
5829,0.994625835,154.9229644,https://clinicaltrials.gov/study/NCT02906670,NCT02906670,Oncology
5830,0.968159618,59.81426854,https://clinicaltrials.gov/study/NCT01830270,NCT01830270,Stomach Neoplasms|Oesophageal Junction Cancer|Lower Oesophagus Cancer
5831,0.984763551,111.5658903,https://clinicaltrials.gov/study/NCT01351870,NCT01351870,Medulloblastoma
5832,0.980364167,97.48230014,https://clinicaltrials.gov/study/NCT01796470,NCT01796470,Chronic Lymphocytic Leukemia|Mantle Cell Lymphoma|Diffuse Large B-cell Lymphoma|Indolent Non-Hodgkin's Lymphoma
5833,0.994137114,154.4975251,https://clinicaltrials.gov/study/NCT01202370,NCT01202370,Solid Malignancies
5834,0.993819379,153.1820352,https://clinicaltrials.gov/study/NCT00924170,NCT00924170,Adult T-Cell Leukemia (ATL)
5835,0.994866692,153.9834061,https://clinicaltrials.gov/study/NCT00401570,NCT00401570,Pancreatic Cancer
5836,0.997100651,159.7172852,https://clinicaltrials.gov/study/NCT00703170,NCT00703170,Resistant Solid Malignancies
5837,0.98511839,117.7025199,https://clinicaltrials.gov/study/NCT01025570,NCT01025570,Pancreatic Cancer
5838,0.997768518,166.1224405,https://clinicaltrials.gov/study/NCT00003270,NCT00003270,Graft Versus Host Disease|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
5839,0.997501241,160.984841,https://clinicaltrials.gov/study/NCT00752570,NCT00752570,Cancer|Carcinoma|Colon Cancer|Colorectal Cancer|Gastrointestinal Cancer|Metastases|Metastatic Cancer|Metastatic Colorectal Cancer|Oncology|Rectal Cancer
5840,0.996658284,157.3791073,https://clinicaltrials.gov/study/NCT00495170,NCT00495170,Lung Cancer
5841,0.995976011,156.9578067,https://clinicaltrials.gov/study/NCT03693170,NCT03693170,BRAF V600E-mutant Metastatic Colorectal Cancer
5842,0.996897771,156.7862517,https://clinicaltrials.gov/study/NCT01581970,NCT01581970,Head and Neck Cancer|Head and Neck Squamous Cell Carcinoma
5843,0.998156541,167.9980522,https://clinicaltrials.gov/study/NCT02396511,NCT02396511,Choriocarcinoma
5844,0.83005415,9.629092133,https://clinicaltrials.gov/study/NCT00671411,NCT00671411,Renal Cancer|Kidney Cancer
5845,0.95237795,37.65279804,https://clinicaltrials.gov/study/NCT01776411,NCT01776411,Recurrent or Refractory PTCL
5846,0.819387345,10.41162034,https://clinicaltrials.gov/study/NCT00726011,NCT00726011,Pain|Cancer
5847,0.998450943,175.578565,https://clinicaltrials.gov/study/NCT00265811,NCT00265811,Colorectal Cancer
5848,0.998879398,186.2311581,https://clinicaltrials.gov/study/NCT02916511,NCT02916511,Esophageal Squamous Cell Carcinoma
5849,0.991401164,152.7292145,https://clinicaltrials.gov/study/NCT00089011,NCT00089011,Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Chronic Phase Chronic Myelogenous Leukemia|Contiguous Stage II Adult Burkitt Lymphoma|Contiguous Stage II Adult Diffuse Large Cell Lymphoma|Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Contiguous Stage II Adult Lymphoblastic Lymphoma|Contiguous Stage II Grade 1 Follicular Lymphoma|Contiguous Stage II Grade 2 Follicular Lymphoma|Contiguous Stage II Grade 3 Follicular Lymphoma|Contiguous Stage II Mantle Cell Lymphoma|Contiguous Stage II Marginal Zone Lymphoma|Contiguous Stage II Small Lymphocytic Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Essential Thrombocythemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Polycythemia Vera|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Prolymphocytic Leukemia|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Relapsing Chronic Myelogenous Leukemia|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage I Adult Burkitt Lymphoma|Stage I Adult Diffuse Large Cell Lymphoma|Stage I Adult Diffuse Mixed Cell Lymphoma|Stage I Adult Diffuse Small Cleaved Cell Lymphoma|Stage I Adult Immunoblastic Large Cell Lymphoma|Stage I Adult Lymphoblastic Lymphoma|Stage I Adult T-cell Leukemia/Lymphoma|Stage I Childhood Anaplastic Large Cell Lymphoma|Stage I Childhood Large Cell Lymphoma|Stage I Childhood Lymphoblastic Lymphoma|Stage I Childhood Small Noncleaved Cell Lymphoma|Stage I Chronic Lymphocytic Leukemia|Stage I Cutaneous T-cell Non-Hodgkin Lymphoma|Stage I Grade 1 Follicular Lymphoma|Stage I Grade 2 Follicular Lymphoma|Stage I Grade 3 Follicular Lymphoma|Stage I Mantle Cell Lymphoma|Stage I Marginal Zone Lymphoma|Stage I Multiple Myeloma|Stage I Small Lymphocytic Lymphoma|Stage IA Mycosis Fungoides/Sezary Syndrome|Stage IB Mycosis Fungoides/Sezary Syndrome|Stage II Adult T-cell Leukemia/Lymphoma|Stage II Childhood Anaplastic Large Cell Lymphoma|Stage II Childhood Large Cell Lymphoma|Stage II Childhood Lymphoblastic Lymphoma|Stage II Childhood Small Noncleaved Cell Lymphoma|Stage II Chronic Lymphocytic Leukemia|Stage II Cutaneous T-cell Non-Hodgkin Lymphoma|Stage II Multiple Myeloma|Stage IIA Mycosis Fungoides/Sezary Syndrome|Stage IIB Mycosis Fungoides/Sezary Syndrome|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia/Lymphoma|Stage III Childhood Anaplastic Large Cell Lymphoma|Stage III Childhood Large Cell Lymphoma|Stage III Childhood Lymphoblastic Lymphoma|Stage III Childhood Small Noncleaved Cell Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Small Lymphocytic Lymphoma|Stage IIIA Mycosis Fungoides/Sezary Syndrome|Stage IIIB Mycosis Fungoides/Sezary Syndrome|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Childhood Anaplastic Large Cell Lymphoma|Stage IV Childhood Large Cell Lymphoma|Stage IV Childhood Lymphoblastic Lymphoma|Stage IV Childhood Small Noncleaved Cell Lymphoma|Stage IV Chronic Lymphocytic Leukemia|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Stage IVA Mycosis Fungoides/Sezary Syndrome|Stage IVB Mycosis Fungoides/Sezary Syndrome|Testicular Lymphoma|Untreated Adult Acute Lymphoblastic Leukemia|Untreated Adult Acute Myeloid Leukemia|Untreated Childhood Acute Lymphoblastic Leukemia|Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies|Waldenstrm Macroglobulinemia
5850,0.980685072,102.2550606,https://clinicaltrials.gov/study/NCT00962611,NCT00962611,Neoplasms
5851,0.886830126,15.08842466,https://clinicaltrials.gov/study/NCT02456311,NCT02456311,Lung Cancer
5852,0.98522002,150.157684,https://clinicaltrials.gov/study/NCT03558711,NCT03558711,Prostate Cancer
5853,0.993385727,153.8362494,https://clinicaltrials.gov/study/NCT02301611,NCT02301611,Melanoma
5854,0.97637823,64.59513154,https://clinicaltrials.gov/study/NCT00137111,NCT00137111,"Lymphoblastic Leukemia, Acute"
5855,0.990170281,151.5477282,https://clinicaltrials.gov/study/NCT03790111,NCT03790111,Biliary Tract Cancer (BTC)
5856,0.936403833,41.17379325,https://clinicaltrials.gov/study/NCT02685111,NCT02685111,Breast Cancer|Neutropenia|Febrile Neutropenia
5857,0.963643938,53.61564499,https://clinicaltrials.gov/study/NCT01207011,NCT01207011,Lung Cancer
5858,0.936152853,30.34915842,https://clinicaltrials.gov/study/NCT03354611,NCT03354611,Breast Cancer
5859,0.979180308,98.13414886,https://clinicaltrials.gov/study/NCT05357911,NCT05357911,Solid Tumor
5860,0.999734886,189.1170298,https://clinicaltrials.gov/study/NCT00002711,NCT00002711,Esophageal Cancer
5861,0.980077978,96.00615247,https://clinicaltrials.gov/study/NCT01929811,NCT01929811,pCR Rate|BCT Rate|Safety
5862,0.989577528,151.6224067,https://clinicaltrials.gov/study/NCT02430311,NCT02430311,Advanced Solid Tumours
5863,0.995694663,157.6130783,https://clinicaltrials.gov/study/NCT02252211,NCT02252211,Malignant Solid Tumor|Metastatic EphA2 Positive Cancer
5864,0.99920695,185.1528846,https://clinicaltrials.gov/study/NCT00072111,NCT00072111,"Unspecified Adult Solid Tumor, Protocol Specific"
5865,0.547573532,3.315010548,https://clinicaltrials.gov/study/NCT03700411,NCT03700411,Colorectal Cancer|Circulating Tumor Cell
5866,0.996465606,157.2888137,https://clinicaltrials.gov/study/NCT00064311,NCT00064311,Breast Cancer|Chronic Myeloproliferative Disorders|Gestational Trophoblastic Tumor|Infection|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Neuroblastoma|Ovarian Cancer|Testicular Germ Cell Tumor
5867,0.964245421,58.47905113,https://clinicaltrials.gov/study/NCT00592111,NCT00592111,Pediatric|Hodgkin's Disease
5868,0.98650256,142.8749645,https://clinicaltrials.gov/study/NCT03513211,NCT03513211,Prostate Cancer
5869,0.987224795,150.0656486,https://clinicaltrials.gov/study/NCT02762513,NCT02762513,Squamous Cell Carcinoma of the Head and Neck
5870,0.998497043,176.708539,https://clinicaltrials.gov/study/NCT00022113,NCT00022113,"Unspecified Adult Solid Tumor, Protocol Specific"
5871,0.974475091,91.95080697,https://clinicaltrials.gov/study/NCT00972413,NCT00972413,Breast Cancer
5872,0.974320368,82.91574729,https://clinicaltrials.gov/study/NCT01150513,NCT01150513,Breast Cancer
5873,0.982712193,98.8071402,https://clinicaltrials.gov/study/NCT02655913,NCT02655913,"Carcinoma, Non-Small-Cell Lung|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung Cancer|Recurrent Non-small Cell Lung Cancer"
5874,0.941551507,35.41418022,https://clinicaltrials.gov/study/NCT00003213,NCT00003213,"Nausea and Vomiting|Unspecified Adult Solid Tumor, Protocol Specific"
5875,0.996669853,158.5418938,https://clinicaltrials.gov/study/NCT00286013,NCT00286013,"Locally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma"
5876,0.981404211,101.4032563,https://clinicaltrials.gov/study/NCT01995513,NCT01995513,Prostate Cancer
5877,0.989986416,151.4419056,https://clinicaltrials.gov/study/NCT03276013,NCT03276013,Endometrial Neoplasms
5878,0.724442396,7.377532612,https://clinicaltrials.gov/study/NCT03649113,NCT03649113,Hemangioma Liver
5879,0.99561316,156.5213567,https://clinicaltrials.gov/study/NCT00156013,NCT00156013,"Lymphoma, B-Cell|Lymphoma, Non-Hodgkin"
5880,0.998019535,165.94915,https://clinicaltrials.gov/study/NCT00331513,NCT00331513,"Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Promyelocytic Leukemia (M3)|Blastic Phase Chronic Myelogenous Leukemia|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes"
5881,0.987075054,150.25183,https://clinicaltrials.gov/study/NCT03399513,NCT03399513,Diffuse Large B Cell Lymphoma
5882,0.995634036,156.6641496,https://clinicaltrials.gov/study/NCT00464113,NCT00464113,"Chronic Myeloid Leukemia|Leukemia, Lymphoblastic, Acute, Philadelphia-Positive"
5883,0.992833427,152.091282,https://clinicaltrials.gov/study/NCT00113113,NCT00113113,Tumors
5884,0.997350868,158.9413687,https://clinicaltrials.gov/study/NCT02148913,NCT02148913,Multiple Myeloma
5885,0.992933663,151.9444309,https://clinicaltrials.gov/study/NCT01433913,NCT01433913,Adenocarcinoma of the Prostate|Recurrent Prostate Cancer|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer
5886,0.96866742,62.99775324,https://clinicaltrials.gov/study/NCT00486213,NCT00486213,"Dermatologic Complications|Palmar-plantar Erythrodysesthesia|Unspecified Adult Solid Tumor, Protocol Specific"
5887,0.999037981,177.5701291,https://clinicaltrials.gov/study/NCT02516813,NCT02516813,Advanced Solid Tumors
5888,0.972273822,79.40776188,https://clinicaltrials.gov/study/NCT02247869,NCT02247869,Hodgkin Lymphoma
5889,0.996682396,158.1640511,https://clinicaltrials.gov/study/NCT00160069,NCT00160069,"Carcinoma, Non Small Cell Lung"
5890,0.996917883,160.0916119,https://clinicaltrials.gov/study/NCT00006469,NCT00006469,Lung Cancer
5891,0.979674113,108.2859155,https://clinicaltrials.gov/study/NCT00514969,NCT00514969,Chronic Myeloid Leukemia
5892,0.998606827,174.1143534,https://clinicaltrials.gov/study/NCT00923169,NCT00923169,Renal Cell Carcinoma
5893,0.990983925,152.2969021,https://clinicaltrials.gov/study/NCT01045681,NCT01045681,Multiple Myeloma
5894,0.979318089,92.13888638,https://clinicaltrials.gov/study/NCT03359681,NCT03359681,Colon Cancer
5895,0.932384216,28.50702948,https://clinicaltrials.gov/study/NCT00168181,NCT00168181,Cancer|Head and Neck Cancer
5896,0.999198614,180.7378283,https://clinicaltrials.gov/study/NCT00257881,NCT00257881,Neoplasms
5897,0.956761672,53.13699338,https://clinicaltrials.gov/study/NCT02866981,NCT02866981,Cancer|Metastatic Cancer
5898,0.970164333,60.70010296,https://clinicaltrials.gov/study/NCT02721576,NCT02721576,Esophageal Neoplasms
5899,0.997007966,156.9704938,https://clinicaltrials.gov/study/NCT00789776,NCT00789776,"Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Aggressive Non-Hodgkin Lymphoma|Diffuse Large B-Cell Lymphoma|Previously Treated Myelodysplastic Syndrome|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Indolent Adult Non-Hodgkin Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Small Lymphocytic Lymphoma|Waldenstrom Macroglobulinemia"
5900,0.998025112,168.3849551,https://clinicaltrials.gov/study/NCT00364676,NCT00364676,Tumors|Hodgkins Disease|Non-Hodgkins Lymphoma
5901,0.999157809,172.7470307,https://clinicaltrials.gov/study/NCT00003976,NCT00003976,"Unspecified Adult Solid Tumor, Protocol Specific"
5902,0.997482203,166.3973249,https://clinicaltrials.gov/study/NCT00953576,NCT00953576,Prostate Cancer
5903,0.998962814,189.3318379,https://clinicaltrials.gov/study/NCT00081276,NCT00081276,Primary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial Cancer|Stage III Ovarian Epithelial Cancer|Stage IV Ovarian Epithelial Cancer
5904,0.889799333,15.28473258,https://clinicaltrials.gov/study/NCT02414776,NCT02414776,Estrogen Receptor Positive Breast Cancer
5905,0.996828893,159.7129582,https://clinicaltrials.gov/study/NCT01694576,NCT01694576,Nasopharyngeal Carcinoma
5906,0.949353361,37.21805103,https://clinicaltrials.gov/study/NCT00688376,NCT00688376,Attention Impairment
5907,0.993567715,153.2259598,https://clinicaltrials.gov/study/NCT01795976,NCT01795976,Oesophageal Cancer
5908,0.902248738,16.12078631,https://clinicaltrials.gov/study/NCT02647476,NCT02647476,Gastric Cancer
5909,0.896085563,16.36631027,https://clinicaltrials.gov/study/NCT02600299,NCT02600299,Breast Cancer|Cancer|Anxiety|Cognitive Dysfunction
5910,0.993129619,152.5533371,https://clinicaltrials.gov/study/NCT00388999,NCT00388999,Multiple Myeloma
5911,0.911195586,21.02766816,https://clinicaltrials.gov/study/NCT02387099,NCT02387099,Breast Cancer|Hormone Receptor Positive Tumor
5912,0.990961504,151.769691,https://clinicaltrials.gov/study/NCT00808899,NCT00808899,Neuroblastoma
5913,0.989490125,151.0009919,https://clinicaltrials.gov/study/NCT02979899,NCT02979899,Advanced Angiosarcoma
5914,0.934146238,25.35219734,https://clinicaltrials.gov/study/NCT00123799,NCT00123799,Breast Neoplasms
5915,0.924180784,21.8546732,https://clinicaltrials.gov/study/NCT00667199,NCT00667199,Hormone Refractory Prostate Cancer|Bone Metastases
5916,0.999510555,189.5774075,https://clinicaltrials.gov/study/NCT03953599,NCT03953599,B Cell Malignancy
5917,0.97557829,81.18708046,https://clinicaltrials.gov/study/NCT01340599,NCT01340599,Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer
5918,0.977801949,104.7125529,https://clinicaltrials.gov/study/NCT00776399,NCT00776399,Lung Metastasis|Colorectal Cancer
5919,0.995693475,157.3253758,https://clinicaltrials.gov/study/NCT01435499,NCT01435499,Melanoma
5920,0.983199798,130.6023669,https://clinicaltrials.gov/study/NCT00003099,NCT00003099,Breast Cancer
5921,0.999531727,181.7462926,https://clinicaltrials.gov/study/NCT00390299,NCT00390299,Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Glioma|Recurrent Glioblastoma
5922,0.999093171,184.5301124,https://clinicaltrials.gov/study/NCT00027599,NCT00027599,Prostate Cancer
5923,0.87246743,13.46817554,https://clinicaltrials.gov/study/NCT01669499,NCT01669499,Bone Metastases
5924,0.861138016,16.17104222,https://clinicaltrials.gov/study/NCT00119899,NCT00119899,Colorectal Liver Metastases|Colorectal Cancer|Neoplasm Metastasis
5925,0.988634114,151.1615155,https://clinicaltrials.gov/study/NCT01939899,NCT01939899,Follicular Lymphoma
5926,0.997594047,169.1544207,https://clinicaltrials.gov/study/NCT00941499,NCT00941499,Advanced Cancers
5927,0.791422242,7.346864605,https://clinicaltrials.gov/study/NCT01781299,NCT01781299,Breast Cancer|Mastectomy
5928,0.997494379,161.0204077,https://clinicaltrials.gov/study/NCT01718899,NCT01718899,Smoldering Multiple Myeloma
5929,0.995119019,154.8659956,https://clinicaltrials.gov/study/NCT00827099,NCT00827099,Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes
5930,0.979356067,109.2268403,https://clinicaltrials.gov/study/NCT04528199,NCT04528199,Metastatic Prostate Cancer
5931,0.99784418,167.294037,https://clinicaltrials.gov/study/NCT00655499,NCT00655499,Colorectal Cancer
5932,0.834444576,8.920223098,https://clinicaltrials.gov/study/NCT01889199,NCT01889199,Polycystic Ovary Syndrome (PCOS)
5933,0.939848765,31.38480117,https://clinicaltrials.gov/study/NCT00086099,NCT00086099,Leukemia|Acute Myeloid Leukemia
5934,0.886525389,17.92224301,https://clinicaltrials.gov/study/NCT01206270,NCT01206270,Klinefelter Syndrome|Hypergonadotropic Hypogonadism|Hypergonadotropic Azospermia|Hypergonadotropic Cryptozoospermia
5935,0.961443233,57.58837643,https://clinicaltrials.gov/study/NCT01661270,NCT01661270,Colorectal Cancer Metastatic
5936,0.977535586,72.96829157,https://clinicaltrials.gov/study/NCT01392170,NCT01392170,Leukemia
5937,0.999053198,191.3051196,https://clinicaltrials.gov/study/NCT00101270,NCT00101270,"Childhood Burkitt Lymphoma|Childhood Central Nervous System Germ Cell Tumor|Childhood Diffuse Large Cell Lymphoma|Childhood Grade III Lymphomatoid Granulomatosis|Childhood Immunoblastic Large Cell Lymphoma|Recurrent Childhood Brain Stem Glioma|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Liver Cancer|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Medulloblastoma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Childhood Visual Pathway Glioma|Recurrent Colon Cancer|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Melanoma|Recurrent Nasopharyngeal Cancer|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Recurrent Wilms Tumor and Other Childhood Kidney Tumors|Recurrent/Refractory Childhood Hodgkin Lymphoma|Unspecified Childhood Solid Tumor, Protocol Specific"
5938,0.998491484,174.550419,https://clinicaltrials.gov/study/NCT00427570,NCT00427570,Colorectal Cancer
5939,0.995811559,156.8404756,https://clinicaltrials.gov/study/NCT01253070,NCT01253070,Acute Myeloid Leukemia With FLT3/ITD Mutation|Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11|Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1|Acute Promyelocytic Leukemia With PML-RARA|FLT3 Gene Mutation|Therapy-Related Acute Myeloid Leukemia
5940,0.946009356,36.18306066,https://clinicaltrials.gov/study/NCT01832870,NCT01832870,Prostate Cancer|Castrate Resistant Prostate Cancer
5941,0.996019314,156.8907495,https://clinicaltrials.gov/study/NCT03104270,NCT03104270,Multiple Myeloma
5942,0.773244155,7.013082568,https://clinicaltrials.gov/study/NCT00535470,NCT00535470,Mycosis Fungoides
5943,0.995615388,155.9837883,https://clinicaltrials.gov/study/NCT00088270,NCT00088270,Locally Advanced or Metastatic Adenoca of the Biliary Tract
5944,0.963514027,50.05828585,https://clinicaltrials.gov/study/NCT03316170,NCT03316170,Smoking Cessation|Social Stress
5945,0.996644568,161.1091084,https://clinicaltrials.gov/study/NCT02272270,NCT02272270,Newly Diagnosed High Grade Glioma
5946,0.994284431,154.9946214,https://clinicaltrials.gov/study/NCT02516670,NCT02516670,Hormone-Resistant Prostate Cancer|Metastatic Prostate Carcinoma|Stage IV Prostate Cancer
5947,0.977152187,70.85151078,https://clinicaltrials.gov/study/NCT04114370,NCT04114370,Glioma
5948,0.987738065,150.3604392,https://clinicaltrials.gov/study/NCT01860170,NCT01860170,Hematological Malignancy
5949,0.994044859,154.5880334,https://clinicaltrials.gov/study/NCT02007070,NCT02007070,Non-small Cell Lung Cancer
5950,0.994628721,155.3865519,https://clinicaltrials.gov/study/NCT03895970,NCT03895970,Liver Neoplasm Malignant Primary|Cholangiocarcinoma|Combinational Immunotherapy|Biomarker
5951,0.997933928,168.2082852,https://clinicaltrials.gov/study/NCT03139370,NCT03139370,Solid Tumor
5952,0.980555943,92.89925526,https://clinicaltrials.gov/study/NCT02485470,NCT02485470,Head and Neck Neoplasms
5953,0.990651605,151.2358068,https://clinicaltrials.gov/study/NCT00369070,NCT00369070,Advanced Non-squamous NSCLC
5954,0.976279331,77.61932351,https://clinicaltrials.gov/study/NCT00664170,NCT00664170,Advanced Cancer
5955,0.975691921,65.67034576,https://clinicaltrials.gov/study/NCT03708211,NCT03708211,"Neoplasms, Advanced Solid"
5956,0.998158055,165.0083819,https://clinicaltrials.gov/study/NCT00093470,NCT00093470,Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Adult Acute Megakaryoblastic Leukemia|Adult Acute Monocytic Leukemia|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With Maturation|Adult Acute Myeloid Leukemia With Minimal Differentiation|Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11|Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1|Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A|Adult Acute Myeloid Leukemia Without Maturation|Adult Acute Myelomonocytic Leukemia|Adult Erythroleukemia|Adult Pure Erythroid Leukemia|Alkylating Agent-Related Acute Myeloid Leukemia|Myelodysplastic Syndrome With Excess Blasts|Recurrent Adult Acute Myeloid Leukemia
5957,0.996643976,157.7894772,https://clinicaltrials.gov/study/NCT00099970,NCT00099970,Melanoma|Metastases
5958,0.994243084,153.914175,https://clinicaltrials.gov/study/NCT05725070,NCT05725070,Metastatic Castration-resistant Prostate Cancer
5959,0.992349756,152.7719304,https://clinicaltrials.gov/study/NCT02046070,NCT02046070,Multiple Myeloma
5960,0.981760779,99.95454075,https://clinicaltrials.gov/study/NCT00493870,NCT00493870,Breast Cancer
5961,0.997551599,163.1622053,https://clinicaltrials.gov/study/NCT01370070,NCT01370070,Recurrent Nasopharyngeal Carcinoma
5962,0.988094456,150.1471677,https://clinicaltrials.gov/study/NCT00866970,NCT00866970,NSCLC|Fatigue|Cachexia
5963,0.992384765,151.5183193,https://clinicaltrials.gov/study/NCT00389870,NCT00389870,Colorectal Cancer
5964,0.959055045,51.58077368,https://clinicaltrials.gov/study/NCT01032070,NCT01032070,Recurrent or Refractory Pediatric Ependymoma
5965,0.979483277,96.86901632,https://clinicaltrials.gov/study/NCT03698370,NCT03698370,Prostate Adenocarcinoma|PSA Progression|Recurrent Prostate Carcinoma
5966,0.994854516,155.0683429,https://clinicaltrials.gov/study/NCT00118170,NCT00118170,"Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Refractory Multiple Myeloma|Splenic Marginal Zone Lymphoma|Stage II Multiple Myeloma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Waldenstrm Macroglobulinemia"
5967,0.995327918,155.2884634,https://clinicaltrials.gov/study/NCT03248570,NCT03248570,Castration Resistant Prostatic Cancer|Metastatic Prostate Cancer
5968,0.996476094,157.2595389,https://clinicaltrials.gov/study/NCT01156870,NCT01156870,Neoplasm Malignant
5969,0.998027211,167.1204469,https://clinicaltrials.gov/study/NCT01610570,NCT01610570,Ewing Sarcoma|Sarcoma
5970,0.852246078,13.84752045,https://clinicaltrials.gov/study/NCT00248170,NCT00248170,Breast Cancer
5971,0.995180144,155.885918,https://clinicaltrials.gov/study/NCT00408070,NCT00408070,Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Stage 3 Cancer|Stage 4 Cancer
5972,0.989657229,151.6089157,https://clinicaltrials.gov/study/NCT00379470,NCT00379470,Recurrent Glioblastoma Multiforme
5973,0.944388846,32.93085307,https://clinicaltrials.gov/study/NCT00700570,NCT00700570,Colorectal Cancer
5974,0.996012336,156.8406166,https://clinicaltrials.gov/study/NCT01051570,NCT01051570,Prostate Cancer
5975,0.991809176,152.0908495,https://clinicaltrials.gov/study/NCT00051311,NCT00051311,Hematologic Neoplasms
5976,0.993261652,152.7505093,https://clinicaltrials.gov/study/NCT02482311,NCT02482311,"Ovarian Cancer, TNBC, SCLC, Other Solid Tumours"
5977,0.996112566,156.7893239,https://clinicaltrials.gov/study/NCT00290511,NCT00290511,Lymphoma
5978,0.996113133,156.6873918,https://clinicaltrials.gov/study/NCT01728311,NCT01728311,Neoplasms
5979,0.999611736,186.140762,https://clinicaltrials.gov/study/NCT01074411,NCT01074411,Fallopian Tube Clear Cell Adenocarcinoma|Fallopian Tube Endometrioid Adenocarcinoma|Fallopian Tube Mucinous Adenocarcinoma|Fallopian Tube Serous Adenocarcinoma|Fallopian Tube Transitional Cell Carcinoma|Ovarian Brenner Tumor|Ovarian Clear Cell Adenocarcinoma|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Mucinous Adenocarcinoma|Ovarian Mucinous Cystadenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Adenocarcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Transitional Cell Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma|Undifferentiated Fallopian Tube Carcinoma|Undifferentiated Ovarian Carcinoma
5980,0.997888846,167.4577577,https://clinicaltrials.gov/study/NCT00970411,NCT00970411,Solid Tumors
5981,0.974807072,61.77641341,https://clinicaltrials.gov/study/NCT00982111,NCT00982111,Non Small Cell Lung Cancer
5982,0.997975045,172.3045508,https://clinicaltrials.gov/study/NCT02042911,NCT02042911,Chronic Lymphocytic Leukemia
5983,0.99523633,157.8827677,https://clinicaltrials.gov/study/NCT02492711,NCT02492711,HER-2 Positive Breast Cancer|Metastatic Neoplasm
5984,0.986340589,150.0633607,https://clinicaltrials.gov/study/NCT00316511,NCT00316511,Malignancies|B-Cell Lymphoma
5985,0.757368983,8.679587762,https://clinicaltrials.gov/study/NCT00573911,NCT00573911,Barrett's Esophagus|GERD
5986,0.993553454,153.1720435,https://clinicaltrials.gov/study/NCT02669511,NCT02669511,Primary Central Nervous System Lymphoma
5987,0.835598351,12.15276138,https://clinicaltrials.gov/study/NCT00358111,NCT00358111,Dysplasia|Cancer
5988,0.998587221,175.9973011,https://clinicaltrials.gov/study/NCT01090011,NCT01090011,"Carcinoma, Non-Small-Cell Lung"
5989,0.95707477,40.94282753,https://clinicaltrials.gov/study/NCT00950911,NCT00950911,Bone Metastases in Men With Hormone-Refractory Prostate Cancer|Bone Metastases in Subjects With Advanced Breast Cancer|Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
5990,0.995492038,154.9869041,https://clinicaltrials.gov/study/NCT00579111,NCT00579111,Myelodysplastic and Myeloproliferative Disorders|Acute Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Multiple Myeloma|Plasma Cell Dyscrasia|Lymphoproliferative Disorders|Hematologic Diseases
5991,0.99396247,154.6603795,https://clinicaltrials.gov/study/NCT00499811,NCT00499811,"Adult Grade III Lymphomatoid Granulomatosis|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Cutaneous B-cell Non-Hodgkin Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Primary Central Nervous System Hodgkin Lymphoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia/Lymphoma|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides/Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides/Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Waldenstrm Macroglobulinemia"
5992,0.998882778,176.9857931,https://clinicaltrials.gov/study/NCT01532011,NCT01532011,Advanced Cancers|Solid Tumors
5993,0.95094247,44.02693886,https://clinicaltrials.gov/study/NCT00237211,NCT00237211,Postmenopausal Women With Advanced Breast Cancer
5994,0.998953135,183.0527788,https://clinicaltrials.gov/study/NCT00310011,NCT00310011,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter
5995,0.995617267,156.6134766,https://clinicaltrials.gov/study/NCT01132911,NCT01132911,Lymphoma|Sarcoma|WilmsTumor|Neuroblastoma
5996,0.996652308,160.6246422,https://clinicaltrials.gov/study/NCT02865811,NCT02865811,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
5997,0.991898283,150.8760252,https://clinicaltrials.gov/study/NCT02919111,NCT02919111,Prostate Cancer
5998,0.981784676,90.13662591,https://clinicaltrials.gov/study/NCT00035113,NCT00035113,Prostatic Neoplasms
5999,0.991645476,152.105382,https://clinicaltrials.gov/study/NCT02272413,NCT02272413,"Carcinoma, Non-Small-Cell Lung"
6000,0.989601609,150.6376841,https://clinicaltrials.gov/study/NCT04925713,NCT04925713,Cutaneous Squamous Cell Carcinoma|Basal Cell Carcinoma
6001,0.969682507,60.6815891,https://clinicaltrials.gov/study/NCT01613313,NCT01613313,Lipoma
6002,0.999201124,188.1663145,https://clinicaltrials.gov/study/NCT00003913,NCT00003913,Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
6003,0.993900253,153.9231134,https://clinicaltrials.gov/study/NCT00397813,NCT00397813,"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndrome|Essential Thrombocythemia|Myeloproliferative Neoplasm|Paroxysmal Nocturnal Hemoglobinuria|Polycythemia Vera|Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase|Primary Myelofibrosis|Refractory Anemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Ring Sideroblasts|Refractory Cytopenia With Multilineage Dysplasia|Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts"
6004,0.903220228,20.58203862,https://clinicaltrials.gov/study/NCT01757613,NCT01757613,Actinic Keratosis Olsen Grade I/II
6005,0.998591428,182.7203264,https://clinicaltrials.gov/study/NCT00066313,NCT00066313,Lung Cancer
6006,0.974239941,75.65362902,https://clinicaltrials.gov/study/NCT01077713,NCT01077713,Non-Squamous Non-Small Cell Lung Cancer
6007,0.998331789,173.15407,https://clinicaltrials.gov/study/NCT00003113,NCT00003113,Lymphoma
6008,0.950465817,41.48050916,https://clinicaltrials.gov/study/NCT02726113,NCT02726113,Prostate Cancer
6009,0.948258428,43.39677939,https://clinicaltrials.gov/study/NCT00261313,NCT00261313,Breast Cancer
6010,0.997998271,166.3351271,https://clinicaltrials.gov/study/NCT00003713,NCT00003713,"Unspecified Adult Solid Tumor, Protocol Specific"
6011,0.874808096,12.60916777,https://clinicaltrials.gov/study/NCT02575313,NCT02575313,Mucositis
6012,0.896749925,20.42678982,https://clinicaltrials.gov/study/NCT00096213,NCT00096213,Sarcoma
6013,0.980622258,112.9768221,https://clinicaltrials.gov/study/NCT00269113,NCT00269113,Non-Hodgkin's Lymphoma
6014,0.989783724,150.2893426,https://clinicaltrials.gov/study/NCT02176213,NCT02176213,"Multiple Myeloma in Relapse|Multiple Myeloma, Refractory"
6015,0.997706696,164.9555556,https://clinicaltrials.gov/study/NCT04176913,NCT04176913,Diffuse Large B Cell Lymphoma|Follicular Lymphoma|Mantle Cell Lymphoma|Small Lymphocytic Lymphoma
6016,0.993398844,153.2659526,https://clinicaltrials.gov/study/NCT00427713,NCT00427713,Colorectal Cancer
6017,0.997743575,165.4274759,https://clinicaltrials.gov/study/NCT01372813,NCT01372813,Advanced Clear Cell Renal Carcinoma
6018,0.990988583,150.791009,https://clinicaltrials.gov/study/NCT01505413,NCT01505413,Pancreatic Cancer
6019,0.987297815,112.7966357,https://clinicaltrials.gov/study/NCT00924313,NCT00924313,Prostate Cancer
6020,0.994608442,155.4963652,https://clinicaltrials.gov/study/NCT05008913,NCT05008913,Advanced Solid Tumors
6021,0.966069705,58.11989196,https://clinicaltrials.gov/study/NCT04303013,NCT04303013,Quality of Life|Relaxation During Radiation Therapy|Cancer|Radiation Toxicity
6022,0.900106348,23.50517113,https://clinicaltrials.gov/study/NCT01867723,NCT01867723,Fatigue
6023,0.976290772,87.51679098,https://clinicaltrials.gov/study/NCT00084123,NCT00084123,Cervix Neoplasms
6024,0.99919804,191.1359036,https://clinicaltrials.gov/study/NCT00258323,NCT00258323,Esophageal Cancer
6025,0.967070662,58.99955667,https://clinicaltrials.gov/study/NCT02681523,NCT02681523,Breast Cancer
6026,0.99628279,158.865149,https://clinicaltrials.gov/study/NCT00994123,NCT00994123,"Carcinoma, Non-Small-Cell Lung"
6027,0.985696211,150.1297254,https://clinicaltrials.gov/study/NCT00871923,NCT00871923,Non-small Cell Lung Cancer|Brain Cancer
6028,0.992736501,152.3140785,https://clinicaltrials.gov/study/NCT01566123,NCT01566123,Retroperitoneal Soft Tissue Sarcoma
6029,0.998295002,172.3964361,https://clinicaltrials.gov/study/NCT01866423,NCT01866423,Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate Cancer
6030,0.977000137,102.1230788,https://clinicaltrials.gov/study/NCT01027923,NCT01027923,"Leukemia, Myeloid, Acute"
6031,0.998178729,168.3027771,https://clinicaltrials.gov/study/NCT02361723,NCT02361723,For Participants With Advanced Solid Tumors Failed With Previous Lines of Treatment
6032,0.997916225,163.3567586,https://clinicaltrials.gov/study/NCT00190723,NCT00190723,Malignant Glioma
6033,0.995468259,157.1043396,https://clinicaltrials.gov/study/NCT00104923,NCT00104923,Chronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm
6034,0.999092036,186.8347207,https://clinicaltrials.gov/study/NCT02231723,NCT02231723,Metastatic Pancreatic Adenocarcinoma
6035,0.997895567,169.8211923,https://clinicaltrials.gov/study/NCT02073123,NCT02073123,Metastatic Melanoma|Stage III Melanoma|Stage IV Melanoma
6036,0.948014778,40.44216519,https://clinicaltrials.gov/study/NCT00570323,NCT00570323,Breast Cancer
6037,0.989204778,151.2603885,https://clinicaltrials.gov/study/NCT00726323,NCT00726323,"Carcinoma, Renal Cell"
6038,0.985475967,150.0239135,https://clinicaltrials.gov/study/NCT01013623,NCT01013623,Stage IV Resectable Melanoma
6039,0.994965263,155.1916537,https://clinicaltrials.gov/study/NCT01248923,NCT01248923,"Multiple Myeloma, Plasma Cell Leukemia"
6040,0.996301276,157.4986037,https://clinicaltrials.gov/study/NCT03644823,NCT03644823,Non-small Cell Lung Cancer
6041,0.951946124,40.3018406,https://clinicaltrials.gov/study/NCT01355523,NCT01355523,Breast Cancer|Depression
6042,0.995770127,155.5738139,https://clinicaltrials.gov/study/NCT00086723,NCT00086723,"Unspecified Adult Solid Tumor, Protocol Specific"
6043,0.997859368,164.1969473,https://clinicaltrials.gov/study/NCT02415023,NCT02415023,Gastric Cancer
6044,0.97928917,99.49406229,https://clinicaltrials.gov/study/NCT00171223,NCT00171223,"Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
6045,0.637066814,5.306882316,https://clinicaltrials.gov/study/NCT00589823,NCT00589823,"Cancers, Pain"
6046,0.998644645,173.2333313,https://clinicaltrials.gov/study/NCT04475523,NCT04475523,Solid Tumor
6047,0.998590363,174.0859923,https://clinicaltrials.gov/study/NCT02426723,NCT02426723,Multiple Myeloma
6048,0.999200519,182.2847305,https://clinicaltrials.gov/study/NCT00049023,NCT00049023,"Brain and Central Nervous System Tumors|Gastrointestinal Carcinoid Tumor|Islet Cell Tumor|Neuroblastoma|Pheochromocytoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol Specific"
6049,0.997296593,159.7421464,https://clinicaltrials.gov/study/NCT00756223,NCT00756223,Neoplasms
6050,0.999549473,191.9986771,https://clinicaltrials.gov/study/NCT00033423,NCT00033423,Lymphoma
6051,0.989924467,151.4803796,https://clinicaltrials.gov/study/NCT03284723,NCT03284723,Breast Neoplasms
6052,0.995056834,154.4644268,https://clinicaltrials.gov/study/NCT01456923,NCT01456923,Colorectal Cancer
6053,0.998554495,172.9028843,https://clinicaltrials.gov/study/NCT00088023,NCT00088023,Neoplasms
6054,0.994257147,152.3626382,https://clinicaltrials.gov/study/NCT02487823,NCT02487823,Non Castrate Metastatic Prostate Cancer
6055,0.892660698,19.42570562,https://clinicaltrials.gov/study/NCT02860923,NCT02860923,Craniopharyngiomas|Hypothalamic Obesity
6056,0.994020741,153.147682,https://clinicaltrials.gov/study/NCT00193323,NCT00193323,Lung Cancer
6057,0.953083948,42.44597483,https://clinicaltrials.gov/study/NCT01356823,NCT01356823,Cervical Intraepithelial Neoplasia|Cervical Cancer
6058,0.996720787,162.8813071,https://clinicaltrials.gov/study/NCT03878823,NCT03878823,Prostate Cancer Metastatic|Advanced Breast Cancer|Castration-resistant Prostate Cancer|Metastatic Breast Cancer
6059,0.997888957,166.6376156,https://clinicaltrials.gov/study/NCT05017623,NCT05017623,Advanced Solid Tumors
6060,0.970552522,71.86535381,https://clinicaltrials.gov/study/NCT00806923,NCT00806923,Non-Squamous Non-Small Cell Lung Cancer
6061,0.986980409,150.017782,https://clinicaltrials.gov/study/NCT00182741,NCT00182741,Prostate Cancer
6062,0.988907725,150.9288053,https://clinicaltrials.gov/study/NCT00073541,NCT00073541,Ovarian Cancer
6063,0.998002691,167.821716,https://clinicaltrials.gov/study/NCT00938041,NCT00938041,"Lymphoma, Non-Hodgkin"
6064,0.995367649,156.6846721,https://clinicaltrials.gov/study/NCT03007836,NCT03007836,Metastatic Nasopharyngeal Cancer
6065,0.734055631,8.300769886,https://clinicaltrials.gov/study/NCT02229136,NCT02229136,Stomatitis|Oral Mucositis|Neoplasm of the Breast|Malignant Tumor of Breast
6066,0.999074393,192.4447911,https://clinicaltrials.gov/study/NCT00006036,NCT00006036,"Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
6067,0.998962449,180.5656347,https://clinicaltrials.gov/study/NCT00856336,NCT00856336,Refractory Tumors
6068,0.987326995,150.6869787,https://clinicaltrials.gov/study/NCT00363636,NCT00363636,"Lymphoma, Non-Hodgkin's"
6069,0.985733127,131.5295481,https://clinicaltrials.gov/study/NCT01511536,NCT01511536,Prostate Cancer
6070,0.995693879,155.7808927,https://clinicaltrials.gov/study/NCT02553941,NCT02553941,Chronic Myelomonocytic Leukemia|de Novo Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Refractory Anemia With Excess Blasts in Transformation|Secondary Myelodysplastic Syndrome
6071,0.997048983,161.8379571,https://clinicaltrials.gov/study/NCT02754141,NCT02754141,Malignant Solid Tumor
6072,0.998765818,174.2265548,https://clinicaltrials.gov/study/NCT00719836,NCT00719836,Acute Myelogenous Leukemia|Chronic Myelogenous Leukemia|Chronic Myelomonocytic Leukemia|Myelodysplastic Syndromes|Myelofibrosis
6073,0.995367273,155.4411992,https://clinicaltrials.gov/study/NCT01216436,NCT01216436,Metastatic Melanoma
6074,0.961712029,45.6817349,https://clinicaltrials.gov/study/NCT03556436,NCT03556436,Non-Small Cell Lung Cancer
6075,0.919419489,23.50704508,https://clinicaltrials.gov/study/NCT04563936,NCT04563936,Prostate Cancer
6076,0.994624961,154.583914,https://clinicaltrials.gov/study/NCT01713036,NCT01713036,Locally Advanced or Metastatic Solid Tumors
6077,0.967192111,65.39416414,https://clinicaltrials.gov/study/NCT00904423,NCT00904423,Breast Cancer|Bone Diseases
6078,0.969901995,64.34568722,https://clinicaltrials.gov/study/NCT02533323,NCT02533323,"Lymphoma, Extranodal NK-T-Cell"
6079,0.996650427,158.7856624,https://clinicaltrials.gov/study/NCT03760523,NCT03760523,Acute Myeloid Leukemia
6080,0.99055979,151.1424992,https://clinicaltrials.gov/study/NCT00364923,NCT00364923,Peripheral T-cell Lymphoma
6081,0.997121704,160.1334097,https://clinicaltrials.gov/study/NCT00946023,NCT00946023,Lymphoma|B-cell Lymphoma|Non Hodgkin Lymphoma|Chronic Lymphocytic Leukemia
6082,0.996865532,157.594454,https://clinicaltrials.gov/study/NCT02451423,NCT02451423,"Carcinoma, Transitional Cell"
6083,0.995561214,156.2034958,https://clinicaltrials.gov/study/NCT00912223,NCT00912223,"Lymphoma, Non-Hodgkin"
6084,0.989496555,151.3859722,https://clinicaltrials.gov/study/NCT00003323,NCT00003323,Prostate Cancer|Sexual Dysfunction and Infertility
6085,0.898429483,18.91852099,https://clinicaltrials.gov/study/NCT03048123,NCT03048123,Hepatocellular Carcinoma
6086,0.996817797,159.8434674,https://clinicaltrials.gov/study/NCT03310541,NCT03310541,Breast Cancer|Prostate Cancer|Advanced Solid Tumors
6087,0.976057413,75.75060482,https://clinicaltrials.gov/study/NCT01677741,NCT01677741,"Neoplasms, Brain"
6088,0.986668096,141.9633274,https://clinicaltrials.gov/study/NCT01116336,NCT01116336,"Cancer of Head and Neck|Neoplasms, Head and Neck"
6089,0.816312548,9.798878153,https://clinicaltrials.gov/study/NCT01859936,NCT01859936,Breast Neoplasm
6090,0.664563551,3.832616706,https://clinicaltrials.gov/study/NCT02438436,NCT02438436,Hepatocellular Carcinoma
6091,0.999405392,188.0024689,https://clinicaltrials.gov/study/NCT00003236,NCT00003236,Breast Cancer
6092,0.879538128,16.07815625,https://clinicaltrials.gov/study/NCT00210236,NCT00210236,Breast Cancer
6093,0.982875856,118.0400011,https://clinicaltrials.gov/study/NCT04479436,NCT04479436,Metastatic Colorectal Cancer
6094,0.998897006,191.8489384,https://clinicaltrials.gov/study/NCT00003136,NCT00003136,Ovarian Cancer|Primary Peritoneal Cavity Cancer
6095,0.995236363,154.2247984,https://clinicaltrials.gov/study/NCT03829436,NCT03829436,Hepatocellular Carcinoma|Metastatic Castration Resistant Prostate Cancer|Renal Cell Carcinoma|Non-small Cell Lung Cancer|Colorectal Cancer|Squamous Cell Carcinoma of Head and Neck|Triple-Negative Breast Cancer|Urothelial Carcinoma|Cholangiocarcinoma|GastroEsophageal Cancer|Pancreatic Cancer|Sarcoma
6096,0.751993591,7.051984913,https://clinicaltrials.gov/study/NCT01365936,NCT01365936,Polycystic Ovary Syndrome
6097,0.835272326,13.59968733,https://clinicaltrials.gov/study/NCT01499836,NCT01499836,Postoperative Pain|Quality of Recovery|Satisfaction
6098,0.990274859,151.5202853,https://clinicaltrials.gov/study/NCT00923936,NCT00923936,"Sarcoma, Kaposi"
6099,0.996378861,159.1041088,https://clinicaltrials.gov/study/NCT02125136,NCT02125136,Ductal Adenocarcinoma of the Pancreas
6100,0.998926898,180.778401,https://clinicaltrials.gov/study/NCT00002936,NCT00002936,Lymphoma|Sarcoma
6101,0.994884208,155.7316314,https://clinicaltrials.gov/study/NCT00972036,NCT00972036,Colon Cancer|Rectal Cancer
6102,0.989437619,150.9410968,https://clinicaltrials.gov/study/NCT02265536,NCT02265536,Neoplasms|Neoplasm Metastasis
6103,0.999187814,182.4193562,https://clinicaltrials.gov/study/NCT00072436,NCT00072436,"Unspecified Adult Solid Tumor, Protocol Specific"
6104,0.977724746,88.87501608,https://clinicaltrials.gov/study/NCT02517736,NCT02517736,Uveal Melanoma
6105,0.996171012,158.3957302,https://clinicaltrials.gov/study/NCT04521335,NCT04521335,Multiple Myeloma
6106,0.998927131,190.3515651,https://clinicaltrials.gov/study/NCT02628535,NCT02628535,Mesothelioma|Bladder Cancer|Melanoma|Squamous Cell Carcinoma of the Head and Neck|Non Small Cell Lung Cancer|Clear Cell Renal Cell Carcinoma|Ovarian Cancer|Thyroid Cancer|Breast Cancer|Pancreatic Cancer|Prostate Cancer|Colon Cancer|Soft Tissue Sarcoma
6107,0.998705504,179.3130193,https://clinicaltrials.gov/study/NCT00002735,NCT00002735,Head and Neck Cancer
6108,0.999862449,186.2288272,https://clinicaltrials.gov/study/NCT01103635,NCT01103635,Recurrent Melanoma|Stage IV Melanoma
6109,0.821872601,9.537577264,https://clinicaltrials.gov/study/NCT05380635,NCT05380635,Cutaneous T-Cell Lymphoma/Mycosis Fungoides
6110,0.695724429,5.725887799,https://clinicaltrials.gov/study/NCT02029235,NCT02029235,Carpal Tunnel|Ganglion Cyst|Trigger Finger|De Quervain Disease
6111,0.977512898,75.4886241,https://clinicaltrials.gov/study/NCT02302235,NCT02302235,Glioblastoma Multiforme of Brain
6112,0.861748761,13.31079355,https://clinicaltrials.gov/study/NCT03443635,NCT03443635,Cardiovascular Diseases|Cardiovascular Risk Factor|Nutrition Disorders|Diabetes|Hypertension|Cancer|Depression|Obesity|Physical Activity
6113,0.997030567,156.8577495,https://clinicaltrials.gov/study/NCT00001296,NCT00001296,Melanoma
6114,0.974112792,59.36140064,https://clinicaltrials.gov/study/NCT00961896,NCT00961896,Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
6115,0.999524233,188.8307673,https://clinicaltrials.gov/study/NCT00101296,NCT00101296,Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Erythroid Leukemia (M6)|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Recurrent Adult Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia
6116,0.998664519,180.4647898,https://clinicaltrials.gov/study/NCT02679196,NCT02679196,"Lymphoma, B Cell"
6117,0.982676222,129.7907839,https://clinicaltrials.gov/study/NCT00000996,NCT00000996,"Sarcoma, Kaposi|HIV Infections"
6118,0.977252067,91.55612557,https://clinicaltrials.gov/study/NCT01281696,NCT01281696,Breast Neoplasms|Leptomeningeal Metastasis|Brain Metastases
6119,0.995562787,154.625717,https://clinicaltrials.gov/study/NCT00185796,NCT00185796,Myeloproliferative Disorders|Blood Cancer|Myelodysplastic Syndromes
6120,0.965921033,48.39126724,https://clinicaltrials.gov/study/NCT01015196,NCT01015196,Acute Myeloid Leukemia
6121,0.99588042,154.9183681,https://clinicaltrials.gov/study/NCT00267696,NCT00267696,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
6122,0.983868073,123.4045661,https://clinicaltrials.gov/study/NCT01958996,NCT01958996,High Grade Lymphomas CD20 Positive
6123,0.982544074,104.4539794,https://clinicaltrials.gov/study/NCT01267695,NCT01267695,Gastrointestinal Stromal Tumor
6124,0.986582071,150.3384763,https://clinicaltrials.gov/study/NCT01956695,NCT01956695,Lymphoma|Relapse
6125,0.986424198,146.2585199,https://clinicaltrials.gov/study/NCT00351195,NCT00351195,Hepatocellular Carcinoma
6126,0.922237328,25.9776952,https://clinicaltrials.gov/study/NCT03104595,NCT03104595,Febrile Neutropenia
6127,0.991187595,151.8011857,https://clinicaltrials.gov/study/NCT02341495,NCT02341495,Acute Myeloid Leukemia
6128,0.989215647,150.9347919,https://clinicaltrials.gov/study/NCT02730195,NCT02730195,"Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive"
6129,0.991692159,151.9299072,https://clinicaltrials.gov/study/NCT02916095,NCT02916095,Solid Tumors
6130,0.928284848,29.13690453,https://clinicaltrials.gov/study/NCT00200395,NCT00200395,Non-Small Cell Lung Cancer
6131,0.976935241,80.87064054,https://clinicaltrials.gov/study/NCT00150995,NCT00150995,Prostate Cancer
6132,0.994887095,155.5158816,https://clinicaltrials.gov/study/NCT03875495,NCT03875495,Multiple Myeloma
6133,0.788831224,7.962891585,https://clinicaltrials.gov/study/NCT00712595,NCT00712595,Uterine Fibroids
6134,0.996888037,158.9649444,https://clinicaltrials.gov/study/NCT01131195,NCT01131195,Breast Cancer
6135,0.987377885,150.0418428,https://clinicaltrials.gov/study/NCT00741195,NCT00741195,Non-small-cell Lung Cancer
6136,0.980057637,101.5737763,https://clinicaltrials.gov/study/NCT01887795,NCT01887795,Multiple Brain Metastases|Non-small-cell Lung Cancer
6137,0.990243278,150.998546,https://clinicaltrials.gov/study/NCT00162695,NCT00162695,Rhabdomyosarcoma|Malignant Soft Tissue
6138,0.996774941,158.0884325,https://clinicaltrials.gov/study/NCT01125995,NCT01125995,Small Cell Lung Cancer
6139,0.999559118,186.0970167,https://clinicaltrials.gov/study/NCT00815295,NCT00815295,Squamous Cell Cancer
6140,0.990810206,150.8621064,https://clinicaltrials.gov/study/NCT00522795,NCT00522795,Esophageal Cancer
6141,0.868252235,16.33257015,https://clinicaltrials.gov/study/NCT00288795,NCT00288795,Fatigue
6142,0.99557462,158.1520196,https://clinicaltrials.gov/study/NCT01357395,NCT01357395,Small Cell Lung Carcinoma
6143,0.981097631,129.3140755,https://clinicaltrials.gov/study/NCT00256711,NCT00256711,Non-Small-Cell Lung Carcinoma
6144,0.998572721,173.6601508,https://clinicaltrials.gov/study/NCT00245011,NCT00245011,Sarcoma
6145,0.921460079,22.67812204,https://clinicaltrials.gov/study/NCT00518011,NCT00518011,Non-Squamous Non-Small Cell Lung Cancer
6146,0.904216908,16.85634141,https://clinicaltrials.gov/study/NCT03510611,NCT03510611,Non-Small Cell Lung Cancer
6147,0.995224092,156.3377177,https://clinicaltrials.gov/study/NCT04122911,NCT04122911,Neuroendocrine Carcinomas
6148,0.980343949,113.8661817,https://clinicaltrials.gov/study/NCT00263211,NCT00263211,Breast Neoplasms
6149,0.998855088,184.7145502,https://clinicaltrials.gov/study/NCT01561911,NCT01561911,Cancer|Neoplasms|Lymphoma|Non-Hodgkin|B-Cell
6150,0.993742188,153.1164911,https://clinicaltrials.gov/study/NCT03384511,NCT03384511,Malignancies|Stomach Cancer|Non-small Cell Lung Cancer|Esophageal Cancer|Breast Cancer|Ovary Cancer|Cervical Cancer
6151,0.994713334,154.5213736,https://clinicaltrials.gov/study/NCT01608711,NCT01608711,"Pancreatic Cancer|Carcinoma, Pancreatic Ductal|Pancreatic Disease"
6152,0.954789249,49.74379608,https://clinicaltrials.gov/study/NCT02423811,NCT02423811,Cancer Stem Cell
6153,0.996468352,159.3012617,https://clinicaltrials.gov/study/NCT00003811,NCT00003811,Childhood Germ Cell Tumor|Drug/Agent Toxicity by Tissue/Organ|Extragonadal Germ Cell Tumor|Ovarian Cancer
6154,0.998538607,172.6646667,https://clinicaltrials.gov/study/NCT00020111,NCT00020111,Leukemia|Lymphoma
6155,0.960022734,56.77032447,https://clinicaltrials.gov/study/NCT00203411,NCT00203411,Colorectal Cancer
6156,0.996038583,156.1077653,https://clinicaltrials.gov/study/NCT00502411,NCT00502411,Soft Tissue Sarcoma
6157,0.924263534,25.39360368,https://clinicaltrials.gov/study/NCT03317613,NCT03317613,Neuropathic Pain
6158,0.994712797,155.4586788,https://clinicaltrials.gov/study/NCT00601913,NCT00601913,Head and Neck Cancer
6159,0.996910386,160.0905974,https://clinicaltrials.gov/study/NCT01518413,NCT01518413,Rhabdomyosarcoma and Other Soft Tissue Sarcomas|Ewing's Sarcoma Family of Tumors|Osteosarcoma|Neuroblastoma|Brain Tumors
6160,0.549210777,3.193131301,https://clinicaltrials.gov/study/NCT01056913,NCT01056913,Colonic Neoplasms|Rectal Neoplasms|Diverticulitis|Inflammatory Bowel Diseases|Rectal Prolapse
6161,0.997187818,157.4563317,https://clinicaltrials.gov/study/NCT02203513,NCT02203513,Ovarian Cancer|Breast Cancer|Prostate Cancer
6162,0.992626834,153.0239376,https://clinicaltrials.gov/study/NCT01682213,NCT01682213,Melanoma
6163,0.99597178,156.6021709,https://clinicaltrials.gov/study/NCT00176813,NCT00176813,Pancreatic Cancer
6164,0.995466985,155.3758015,https://clinicaltrials.gov/study/NCT00006413,NCT00006413,Mastocytosis
6165,0.990770018,151.0022733,https://clinicaltrials.gov/study/NCT01968213,NCT01968213,Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer
6166,0.964164654,48.29008736,https://clinicaltrials.gov/study/NCT01196013,NCT01196013,Acute Lymphoblastic Leukemia
6167,0.999514824,190.8020875,https://clinicaltrials.gov/study/NCT00006213,NCT00006213,Adult Acute Promyelocytic Leukemia (M3)|Blastic Phase Chronic Myelogenous Leukemia|Childhood Myelodysplastic Syndromes|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Refractory Anemia With Excess Blasts|Refractory Anemia With Excess Blasts in Transformation|Relapsing Chronic Myelogenous Leukemia
6168,0.982450415,133.4503891,https://clinicaltrials.gov/study/NCT02945813,NCT02945813,Prostate Cancer
6169,0.996564024,159.1695328,https://clinicaltrials.gov/study/NCT04963413,NCT04963413,Glioblastoma
6170,0.999058834,184.0765227,https://clinicaltrials.gov/study/NCT03617913,NCT03617913,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall|Stage II Bladder Cancer AJCC v8|Stage II Renal Pelvis Cancer AJCC v8|Stage II Ureter Cancer AJCC v8|Stage II Urethral Cancer AJCC v8|Stage III Bladder Cancer AJCC v8|Stage III Renal Pelvis Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage III Urethral Cancer AJCC v8|Stage IIIA Bladder Cancer AJCC v8|Stage IIIB Bladder Cancer AJCC v8|Urethral Urothelial Carcinoma
6171,0.95597445,41.1605198,https://clinicaltrials.gov/study/NCT01745913,NCT01745913,Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Acute Lymphocytic Leukemia|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma
6172,0.990812371,151.3186762,https://clinicaltrials.gov/study/NCT00421213,NCT00421213,Hematologic Neoplasms|Bone Marrow Neoplasms|Non-Hodgkin's Lymphoma
6173,0.927160955,30.69998434,https://clinicaltrials.gov/study/NCT02249013,NCT02249013,Ovarian Cancer
6174,0.999660741,181.8068055,https://clinicaltrials.gov/study/NCT00004113,NCT00004113,Brain and Central Nervous System Tumors
6175,0.99904541,186.5376366,https://clinicaltrials.gov/study/NCT03426969,NCT03426969,Primary Myelofibrosis|Secondary Myelofibrosis
6176,0.913043173,23.15266112,https://clinicaltrials.gov/study/NCT00309569,NCT00309569,Early Stage Breast Cancer
6177,0.988991104,150.777651,https://clinicaltrials.gov/study/NCT01525069,NCT01525069,Cholangiocarcinoma|Liver Neoplasms
6178,0.997053754,157.3765335,https://clinicaltrials.gov/study/NCT00431769,NCT00431769,Multiple Myeloma
6179,0.998760084,180.4565279,https://clinicaltrials.gov/study/NCT00945269,NCT00945269,Recurrent Melanoma|Stage III Melanoma|Stage IV Melanoma
6180,0.99516488,153.0757796,https://clinicaltrials.gov/study/NCT02955069,NCT02955069,Well-differentiated Non-functional NET of Thoracic Origin|Well-differentiated Non-functional NET of Gastrointestinal Origin|Well-differentiated Non-functional NET of Pancreatic Origin|Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
6181,0.992102827,151.4711589,https://clinicaltrials.gov/study/NCT00202969,NCT00202969,Gastric Cancer
6182,0.99290338,151.1294852,https://clinicaltrials.gov/study/NCT01610869,NCT01610869,Ovarian Cancer|Fallopian Tube Cancer
6183,0.99322112,152.4402717,https://clinicaltrials.gov/study/NCT00689169,NCT00689169,"Lymphoma, Large Cell, Diffuse"
6184,0.997915313,167.9630218,https://clinicaltrials.gov/study/NCT00678769,NCT00678769,Malignant Neoplasm
6185,0.996994599,164.6394748,https://clinicaltrials.gov/study/NCT01749969,NCT01749969,Plasma Cell Myeloma
6186,0.994414648,153.8801077,https://clinicaltrials.gov/study/NCT00256269,NCT00256269,Esophageal Cancer|Gastroesophageal Cancer
6187,0.998313237,170.3476654,https://clinicaltrials.gov/study/NCT00234169,NCT00234169,Multiple Myeloma|Lymphoma
6188,0.936522365,30.27674297,https://clinicaltrials.gov/study/NCT03303469,NCT03303469,Hepatocellular Carcinoma
6189,0.999270572,181.5294802,https://clinicaltrials.gov/study/NCT00459069,NCT00459069,Multiple Myeloma
6190,0.972651825,77.55075676,https://clinicaltrials.gov/study/NCT01380769,NCT01380769,Non-Small Cell Lung Cancer
6191,0.99912914,178.185678,https://clinicaltrials.gov/study/NCT00007969,NCT00007969,Melanoma (Skin)
6192,0.99450461,153.8482899,https://clinicaltrials.gov/study/NCT02903381,NCT02903381,Smoldering Multiple Myeloma
6193,0.999488892,180.2478829,https://clinicaltrials.gov/study/NCT00714181,NCT00714181,"Unspecified Adult Solid Tumor, Protocol Specific"
6194,0.994213926,154.8827651,https://clinicaltrials.gov/study/NCT01862081,NCT01862081,"Breast Cancer, Non-small Lung Cancer"
6195,0.881260032,14.56123715,https://clinicaltrials.gov/study/NCT01165281,NCT01165281,Pain
6196,0.972170832,68.32962382,https://clinicaltrials.gov/study/NCT00849381,NCT00849381,"Infections, Papillomavirus"
6197,0.931362353,26.21168775,https://clinicaltrials.gov/study/NCT00541281,NCT00541281,Hormone Resistant Prostate Cancer|Metastatic Prostate Cancer
6198,0.970624045,72.27663744,https://clinicaltrials.gov/study/NCT01592981,NCT01592981,Waldenstrom's Macroglobulinaemia
6199,0.997027492,161.5033683,https://clinicaltrials.gov/study/NCT01511081,NCT01511081,Non-small-cell Lung Cancer
6200,0.997137851,159.2548903,https://clinicaltrials.gov/study/NCT01031381,NCT01031381,Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Carcinoma
6201,0.999388562,186.7994092,https://clinicaltrials.gov/study/NCT00884676,NCT00884676,"Unspecified Adult Solid Tumor, Protocol Specific"
6202,0.975613348,75.81168162,https://clinicaltrials.gov/study/NCT01246076,NCT01246076,Myelodysplastic Syndromes
6203,0.882689598,15.83857135,https://clinicaltrials.gov/study/NCT01438476,NCT01438476,Liver Cancer|Pancreatic Cancer
6204,0.934337564,26.0899492,https://clinicaltrials.gov/study/NCT02445976,NCT02445976,Prostate Cancer
6205,0.961835935,51.73725907,https://clinicaltrials.gov/study/NCT04108676,NCT04108676,Advanced Solid Tumor
6206,0.988662716,150.5224591,https://clinicaltrials.gov/study/NCT01971476,NCT01971476,Leukemia|Neoplasms
6207,0.988719912,150.7882957,https://clinicaltrials.gov/study/NCT02998476,NCT02998476,Lymphoma
6208,0.983338631,122.3438417,https://clinicaltrials.gov/study/NCT02227576,NCT02227576,Thrombocytopenia|Glioblastoma
6209,0.99816116,168.9971332,https://clinicaltrials.gov/study/NCT00057876,NCT00057876,Pancreatic Cancer
6210,0.796446778,10.29722912,https://clinicaltrials.gov/study/NCT03210376,NCT03210376,Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Urinary Tract
6211,0.990671627,151.4161269,https://clinicaltrials.gov/study/NCT01075399,NCT01075399,Head and Neck Cancer|Lung Cancer|Liver Cancer|Rectal Cancer|Cervical Cancer
6212,0.997525818,161.9662148,https://clinicaltrials.gov/study/NCT00063999,NCT00063999,Recurrent Uterine Corpus Carcinoma|Stage IIIA Uterine Corpus Cancer AJCC v7|Stage IIIB Uterine Corpus Cancer AJCC v7|Stage IIIC Uterine Corpus Cancer AJCC v7|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7
6213,0.989048238,150.8642392,https://clinicaltrials.gov/study/NCT00330499,NCT00330499,Transitional Cell Carcinoma of Urinary Bladder
6214,0.994972561,154.7520221,https://clinicaltrials.gov/study/NCT00478699,NCT00478699,Non-small-cell Lung Cancer
6215,0.993822739,153.12645,https://clinicaltrials.gov/study/NCT01036399,NCT01036399,Peripheral T-cell Lymphoma
6216,0.970110026,77.86156765,https://clinicaltrials.gov/study/NCT00087399,NCT00087399,Breast Cancer|Hot Flashes
6217,0.99595783,155.5777991,https://clinicaltrials.gov/study/NCT00541099,NCT00541099,Lung Cancer
6218,0.941318225,33.44728838,https://clinicaltrials.gov/study/NCT04754399,NCT04754399,Arthralgia|Breast Cancer
6219,0.998121812,168.3215907,https://clinicaltrials.gov/study/NCT04441099,NCT04441099,Advanced Solid Tumor|Advanced Cancer|Triple Negative Breast Cancer
6220,0.993070546,151.4562946,https://clinicaltrials.gov/study/NCT03544099,NCT03544099,Nasopharyngeal Carcinoma
6221,0.995197317,155.6890023,https://clinicaltrials.gov/study/NCT03537599,NCT03537599,Minimal Residual Disease|Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes|Recurrent Adult Acute Myeloid Leukemia|Recurrent Childhood Acute Myeloid Leukemia
6222,0.958853763,43.8108305,https://clinicaltrials.gov/study/NCT00230399,NCT00230399,Colorectal Cancer
6223,0.956481076,46.06674386,https://clinicaltrials.gov/study/NCT00375999,NCT00375999,Stomach Neoplasms
6224,0.992996084,152.0051725,https://clinicaltrials.gov/study/NCT02899299,NCT02899299,Mesothelioma
6225,0.987395459,136.2813371,https://clinicaltrials.gov/study/NCT00629499,NCT00629499,Breast Cancer
6226,0.996794782,159.5704442,https://clinicaltrials.gov/study/NCT01335399,NCT01335399,Multiple Myeloma
6227,0.98663176,141.882562,https://clinicaltrials.gov/study/NCT02364999,NCT02364999,Non-Small Cell Lung Cancer
6228,0.981828655,114.5956161,https://clinicaltrials.gov/study/NCT00695370,NCT00695370,Solid Malignancies
6229,0.988211408,150.6625329,https://clinicaltrials.gov/study/NCT03925870,NCT03925870,Esophageal Squamous Cell Carcinoma
6230,0.996632277,157.8741941,https://clinicaltrials.gov/study/NCT00001570,NCT00001570,Kidney Neoplasms|Neoplasm Metastasis
6231,0.894219049,18.85243993,https://clinicaltrials.gov/study/NCT00721370,NCT00721370,Breast Cancer
6232,0.638641652,4.342317208,https://clinicaltrials.gov/study/NCT00991770,NCT00991770,Cancer|Anxiety|Pain|Surgery
6233,0.736680282,7.036849416,https://clinicaltrials.gov/study/NCT02304770,NCT02304770,Cervical Persistent High Risk HPV Infection|Cervical Intraepithelial Neoplasia
6234,0.98389545,97.90349091,https://clinicaltrials.gov/study/NCT00395070,NCT00395070,Metastatic Melanoma
6235,0.99563692,156.118157,https://clinicaltrials.gov/study/NCT01620970,NCT01620970,Transitional Cell Carcinoma of Bladder
6236,0.999619755,189.4950855,https://clinicaltrials.gov/study/NCT00567970,NCT00567970,Metastatic Cancer
6237,0.979836877,104.9276821,https://clinicaltrials.gov/study/NCT02333370,NCT02333370,"Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer"
6238,0.606626759,3.904383348,https://clinicaltrials.gov/study/NCT00131170,NCT00131170,Breast Cancer
6239,0.995827446,154.7813908,https://clinicaltrials.gov/study/NCT00660270,NCT00660270,Pancreatic Cancer
6240,0.985621588,143.4288865,https://clinicaltrials.gov/study/NCT05244070,NCT05244070,"Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoma"
6241,0.988229416,150.4150826,https://clinicaltrials.gov/study/NCT03300570,NCT03300570,Colorectal Carcinoma
6242,0.999548709,187.6962807,https://clinicaltrials.gov/study/NCT00002670,NCT00002670,Head and Neck Cancer
6243,0.781555253,7.516398424,https://clinicaltrials.gov/study/NCT03543670,NCT03543670,Prostate Cancer
6244,0.993332519,152.761763,https://clinicaltrials.gov/study/NCT01711970,NCT01711970,Platinum Resistant Ovarian Cancer
6245,0.854280792,11.07601718,https://clinicaltrials.gov/study/NCT01674270,NCT01674270,Prostate Cancer
6246,0.98228925,123.3954251,https://clinicaltrials.gov/study/NCT03235570,NCT03235570,Solid Tumors
6247,0.939052152,30.38084733,https://clinicaltrials.gov/study/NCT01129570,NCT01129570,Advanced Hepatocellular Carcinoma
6248,0.989204781,150.2597512,https://clinicaltrials.gov/study/NCT00003970,NCT00003970,"AIDS-related Peripheral/Systemic Lymphoma|AIDS-related Primary CNS Lymphoma|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Adult T-cell Leukemia/Lymphoma|Stage III Cutaneous T-cell Non-Hodgkin Lymphoma|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Mycosis Fungoides/Sezary Syndrome|Stage III Small Lymphocytic Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia/Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides/Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific"
6249,0.997345952,162.5453965,https://clinicaltrials.gov/study/NCT02454270,NCT02454270,"Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoma, Large B-Cell, Diffuse|Lymphoma, Follicular|Lymphoma, Mantle-Cell|Precursor Cell Lymphoblastic Leukemia-Lymphoma"
6250,0.915328413,23.50827742,https://clinicaltrials.gov/study/NCT01120470,NCT01120470,Castration Resistant Prostate Cancer
6251,0.951433038,43.07983399,https://clinicaltrials.gov/study/NCT00561470,NCT00561470,Colorectal Neoplasms|Neoplasm Metastasis
6252,0.996569569,157.7971155,https://clinicaltrials.gov/study/NCT02437370,NCT02437370,Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter|Recurrent Bladder Carcinoma|Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter|Regional Urothelial Carcinoma of the Renal Pelvis and Ureter|Stage III Bladder Urothelial Carcinoma|Stage III Urethral Cancer|Stage IV Bladder Urothelial Carcinoma|Stage IV Urethral Cancer|Urethral Urothelial Carcinoma
6253,0.998578482,167.9103087,https://clinicaltrials.gov/study/NCT01596270,NCT01596270,Neoplasm Malignant
6254,0.953334387,47.80177239,https://clinicaltrials.gov/study/NCT01699581,NCT01699581,Hodgkin's Lymphoma|Multiple Myeloma|Non-Hodgkin's Lymphoma
6255,0.999143647,181.4554578,https://clinicaltrials.gov/study/NCT03769181,NCT03769181,Lymphoma
6256,0.995398351,154.6045842,https://clinicaltrials.gov/study/NCT02185781,NCT02185781,Acute Lymphoblastic Leukemia|Complete Hematologic Remission (CHR)|Persistent/Recurrent Minimal Residual Disease (MRD)
6257,0.999643829,182.2090289,https://clinicaltrials.gov/study/NCT02041481,NCT02041481,Recurrent Colon Cancer|Recurrent Rectal Cancer|Stage IVA Colon Cancer|Stage IVA Rectal Cancer|Stage IVB Colon Cancer|Stage IVB Rectal Cancer
6258,0.978710847,91.02788699,https://clinicaltrials.gov/study/NCT02200081,NCT02200081,Small Cell Lung Cancer
6259,0.995297658,153.9383239,https://clinicaltrials.gov/study/NCT00272181,NCT00272181,"Squamous Cell Carcinoma of the Head and Neck|Carcinoma, Squamous Cell|Neoplasms, Squamous Cell|Head and Neck Neoplasms|Mouth Neoplasms|Head and Neck Cancer"
6260,0.819128012,8.949362578,https://clinicaltrials.gov/study/NCT00355381,NCT00355381,Breast Neoplasms|Premature Birth
6261,0.995940448,156.3927595,https://clinicaltrials.gov/study/NCT01427881,NCT01427881,Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Myeloid Leukemia in Remission|Adult Erythroleukemia (M6a)|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Adult Pure Erythroid Leukemia (M6b)|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Blastic Phase Chronic Myelogenous Leukemia|Childhood Acute Erythroleukemia (M6)|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Megakaryocytic Leukemia (M7)|Childhood Acute Myeloid Leukemia in Remission|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Childhood Myelodysplastic Syndromes|Childhood Nasal Type Extranodal NK/T-cell Lymphoma|Chronic Myelomonocytic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|Cutaneous B-cell Non-Hodgkin Lymphoma|de Novo Myelodysplastic Syndromes|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Hepatosplenic T-cell Lymphoma|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Noncutaneous Extranodal Lymphoma|Peripheral T-cell Lymphoma|Philadelphia Chromosome Negative Chronic Myelogenous Leukemia|Post-transplant Lymphoproliferative Disorder|Previously Treated Myelodysplastic Syndromes|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia/Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Anaplastic Large Cell Lymphoma|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage III Multiple Myeloma|Testicular Lymphoma|Waldenstrm Macroglobulinemia
6262,0.767804324,6.92264953,https://clinicaltrials.gov/study/NCT00389181,NCT00389181,"Arteriovenous Malformations, Cerebral"
6263,0.992649945,151.125697,https://clinicaltrials.gov/study/NCT00637481,NCT00637481,Atypical Ductal Breast Hyperplasia|Breast Cancer|Ductal Breast Carcinoma in Situ|Lobular Breast Carcinoma in Situ
6264,0.972192798,69.39946661,https://clinicaltrials.gov/study/NCT01178281,NCT01178281,Primary Myelofibrosis|MPN-associated Myelofibrosis
6265,0.974177615,71.99551458,https://clinicaltrials.gov/study/NCT00538681,NCT00538681,Lung Cancer
6266,0.961730026,61.43285218,https://clinicaltrials.gov/study/NCT02688881,NCT02688881,Refractory Solid Tumors
6267,0.986107797,150.2473933,https://clinicaltrials.gov/study/NCT03271281,NCT03271281,Neuroendocrine Tumors
6268,0.985859103,142.8926347,https://clinicaltrials.gov/study/NCT03723681,NCT03723681,Acute Myeloid Leukemia (AML)
6269,0.996873549,161.0354929,https://clinicaltrials.gov/study/NCT01207076,NCT01207076,Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia
6270,0.987341961,150.5368827,https://clinicaltrials.gov/study/NCT01831076,NCT01831076,Breast Cancer|Stage II Breast Cancer|Stage III Breast Cancer
6271,0.997126289,164.0295659,https://clinicaltrials.gov/study/NCT01443676,NCT01443676,Glioblastoma
6272,0.988650362,151.1588298,https://clinicaltrials.gov/study/NCT00064376,NCT00064376,Leukemia|Myelodysplastic Syndromes
6273,0.993214611,153.1923702,https://clinicaltrials.gov/study/NCT02087176,NCT02087176,Previously Treated Non Small Cell Lung Cancer
6274,0.998490418,168.5032148,https://clinicaltrials.gov/study/NCT00602576,NCT00602576,Melanoma (Skin)
6275,0.971839451,66.13082169,https://clinicaltrials.gov/study/NCT03071276,NCT03071276,Acute Myeloid Leukemia (AML)
6276,0.992694108,152.9562751,https://clinicaltrials.gov/study/NCT03010176,NCT03010176,Solid Tumors|Lymphoma
6277,0.995904818,157.4584925,https://clinicaltrials.gov/study/NCT00526799,NCT00526799,Ovarian Cancer
6278,0.988311654,150.5607001,https://clinicaltrials.gov/study/NCT02374099,NCT02374099,Breast Neoplasms
6279,0.982945583,109.5546057,https://clinicaltrials.gov/study/NCT02091999,NCT02091999,Metastatic Urothelial Cancer and Other Malignant Solid Tumors
6280,0.771381175,7.415853707,https://clinicaltrials.gov/study/NCT01648699,NCT01648699,Pain
6281,0.989507204,150.0666307,https://clinicaltrials.gov/study/NCT03382899,NCT03382899,Non Small Cell Lung Cancer
6282,0.971151032,62.94435594,https://clinicaltrials.gov/study/NCT01136499,NCT01136499,Soft Tissue Sarcoma
6283,0.543059255,3.185779423,https://clinicaltrials.gov/study/NCT03904199,NCT03904199,Hyperglycemia
6284,0.998316469,168.615296,https://clinicaltrials.gov/study/NCT01384799,NCT01384799,Head and Neck Cancer
6285,0.98806072,133.348319,https://clinicaltrials.gov/study/NCT00238199,NCT00238199,Pancreatic Cancer
6286,0.99416962,153.7051225,https://clinicaltrials.gov/study/NCT00491699,NCT00491699,Non-Small-Cell Lung Cancer
6287,0.987816782,145.6796006,https://clinicaltrials.gov/study/NCT00058799,NCT00058799,Leukemia
6288,0.791846139,10.11439033,https://clinicaltrials.gov/study/NCT01817699,NCT01817699,"Kidney Transplantation|Anemia|Vitamin D Deficiency|Renal Insufficiency, Chronic"
6289,0.985776087,150.123409,https://clinicaltrials.gov/study/NCT01003899,NCT01003899,"Carcinoma, Non-Small-Cell Lung"
6290,0.993817224,153.5194286,https://clinicaltrials.gov/study/NCT03752099,NCT03752099,Metastatic Castration Resistant Prostate Cancer
6291,0.872599885,13.15258368,https://clinicaltrials.gov/study/NCT01682499,NCT01682499,Paclitaxel-induced Neuropathy
6292,0.996869523,159.42126,https://clinicaltrials.gov/study/NCT00006799,NCT00006799,Anorexia|Cachexia|Head and Neck Cancer|Quality of Life
6293,0.998754082,179.8821537,https://clinicaltrials.gov/study/NCT00049699,NCT00049699,"Lymphoma|Small Intestine Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
6294,0.978673352,94.32631183,https://clinicaltrials.gov/study/NCT00050999,NCT00050999,"Lymphoma, T-Cell, Cutaneous|Mycosis Fungoides|Sezary Syndrome"
6295,0.999196812,182.4848499,https://clinicaltrials.gov/study/NCT00348699,NCT00348699,"Male Breast Cancer|Recurrent Breast Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer|Recurrent Renal Cell Cancer|Stage IV Breast Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Primary Peritoneal Cavity Cancer|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor, Protocol Specific"
6296,0.963632428,59.05758962,https://clinicaltrials.gov/study/NCT01984099,NCT01984099,Hydatidiform Mole
6297,0.996653242,160.2203091,https://clinicaltrials.gov/study/NCT00551070,NCT00551070,Borderline Ovarian Serous Tumor|Low Grade Ovarian Serous Adenocarcinoma|Micropapillary Serous Carcinoma|Primary Peritoneal Carcinoma|Primary Peritoneal Low Grade Serous Adenocarcinoma|Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor
6298,0.991509746,152.4539104,https://clinicaltrials.gov/study/NCT00075270,NCT00075270,"Neoplasms, Breast"
6299,0.960348593,46.65604987,https://clinicaltrials.gov/study/NCT02225470,NCT02225470,HER2-Negative Breast Cancer|Triple Negative Breast Cancer|Breast Cancer|Cancer of Breast|Breast Tumors
6300,0.998964031,190.549234,https://clinicaltrials.gov/study/NCT00976170,NCT00976170,Hepatocellular Carcinoma
6301,0.998719165,175.752389,https://clinicaltrials.gov/study/NCT01449370,NCT01449370,Metastatic Solid Tumors
6302,0.999394682,199.6029492,https://clinicaltrials.gov/study/NCT00055770,NCT00055770,Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Salivary Gland Squamous Cell Carcinoma|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Stage IV Salivary Gland Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
6303,0.995161981,155.034712,https://clinicaltrials.gov/study/NCT00807170,NCT00807170,Non-small Cell Lung Cancer (NSCLC)
6304,0.996303479,161.3064992,https://clinicaltrials.gov/study/NCT00193570,NCT00193570,Cancer
6305,0.987573483,150.9930671,https://clinicaltrials.gov/study/NCT03745170,NCT03745170,Gastric Cancer
6306,0.999575306,188.0054078,https://clinicaltrials.gov/study/NCT00096070,NCT00096070,Adenocarcinoma of the Pancreas|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer
6307,0.99945604,187.7158748,https://clinicaltrials.gov/study/NCT00004070,NCT00004070,Head and Neck Cancer
6308,0.95119993,38.08485556,https://clinicaltrials.gov/study/NCT03083470,NCT03083470,Actinic Keratosis
6309,0.995806543,154.9612899,https://clinicaltrials.gov/study/NCT03152370,NCT03152370,Neoadjuvant Therapy in Rectal Cancer
6310,0.994098098,154.5457975,https://clinicaltrials.gov/study/NCT02183870,NCT02183870,Lung Cancer|Adenocarcinoma|NSCLC
6311,0.988339314,151.3499266,https://clinicaltrials.gov/study/NCT01294670,NCT01294670,Solid Tumors|Relapsed/Refractory Sarcomas
6312,0.983529172,126.8232618,https://clinicaltrials.gov/study/NCT01172470,NCT01172470,Head and Neck Cancer
6313,0.996243806,155.5225341,https://clinicaltrials.gov/study/NCT03255070,NCT03255070,Breast Neoplasms|Gastric Neoplasm|Solid Tumors
6314,0.996702027,160.335224,https://clinicaltrials.gov/study/NCT05177770,NCT05177770,Metastatic Castration-resistant Prostate Cancer|Prostate Cancer
6315,0.982922278,116.1061287,https://clinicaltrials.gov/study/NCT03867370,NCT03867370,Hepatocellular Carcinoma
6316,0.98121799,94.47140882,https://clinicaltrials.gov/study/NCT01171170,NCT01171170,Non Small Cell Lung Cancer
6317,0.989881741,150.5757344,https://clinicaltrials.gov/study/NCT00781170,NCT00781170,Multiple Myeloma|Stem Cell Transplantation
6318,0.995868342,155.3713419,https://clinicaltrials.gov/study/NCT00052611,NCT00052611,Head and Neck Cancer
6319,0.952854718,39.35787838,https://clinicaltrials.gov/study/NCT00004311,NCT00004311,Acanthosis Nigricans|Polycystic Ovary Syndrome
6320,0.987345438,131.6343509,https://clinicaltrials.gov/study/NCT01846611,NCT01846611,Ovarian Neoplasms|Peritoneal Neoplasms|Fallopian Tube Neoplasms
6321,0.999000617,183.5987194,https://clinicaltrials.gov/study/NCT03080311,NCT03080311,Small Cell Lung Cancer|Solid Tumor
6322,0.978116555,112.7040961,https://clinicaltrials.gov/study/NCT01216111,NCT01216111,Triple Negative Breast Cancer
6323,0.994036772,153.359259,https://clinicaltrials.gov/study/NCT00390611,NCT00390611,Ovarian Cancer
6324,0.995852702,156.8282156,https://clinicaltrials.gov/study/NCT01015911,NCT01015911,"Carcinoma, Renal Cell|Lymphoma, Non-Hodgkin"
6325,0.987117892,150.5703465,https://clinicaltrials.gov/study/NCT00017511,NCT00017511,Head and Neck Cancer|Oral Complications|Radiation Toxicity
6326,0.975328877,78.41097961,https://clinicaltrials.gov/study/NCT00251511,NCT00251511,Myelodysplastic Syndrome
6327,0.97872467,108.4913038,https://clinicaltrials.gov/study/NCT02123511,NCT02123511,Mucositis|Oral Complications|Recurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Basal Cell Carcinoma of the Lip|Recurrent Lymphoepithelioma of the Nasopharynx|Recurrent Lymphoepithelioma of the Oropharynx|Recurrent Mucoepidermoid Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Verrucous Carcinoma of the Larynx|Recurrent Verrucous Carcinoma of the Oral Cavity|Stage I Adenoid Cystic Carcinoma of the Oral Cavity|Stage I Basal Cell Carcinoma of the Lip|Stage I Lymphoepithelioma of the Nasopharynx|Stage I Lymphoepithelioma of the Oropharynx|Stage I Mucoepidermoid Carcinoma of the Oral Cavity|Stage I Salivary Gland Cancer|Stage I Squamous Cell Carcinoma of the Larynx|Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage I Squamous Cell Carcinoma of the Nasopharynx|Stage I Squamous Cell Carcinoma of the Oropharynx|Stage I Verrucous Carcinoma of the Larynx|Stage I Verrucous Carcinoma of the Oral Cavity|Stage II Adenoid Cystic Carcinoma of the Oral Cavity|Stage II Basal Cell Carcinoma of the Lip|Stage II Lymphoepithelioma of the Nasopharynx|Stage II Lymphoepithelioma of the Oropharynx|Stage II Mucoepidermoid Carcinoma of the Oral Cavity|Stage II Salivary Gland Cancer|Stage II Squamous Cell Carcinoma of the Larynx|Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage II Squamous Cell Carcinoma of the Nasopharynx|Stage II Squamous Cell Carcinoma of the Oropharynx|Stage II Verrucous Carcinoma of the Larynx|Stage II Verrucous Carcinoma of the Oral Cavity|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Basal Cell Carcinoma of the Lip|Stage III Lymphoepithelioma of the Nasopharynx|Stage III Lymphoepithelioma of the Oropharynx|Stage III Mucoepidermoid Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage III Verrucous Carcinoma of the Larynx|Stage III Verrucous Carcinoma of the Oral Cavity|Stage IV Lymphoepithelioma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity|Stage IVA Basal Cell Carcinoma of the Lip|Stage IVA Lymphoepithelioma of the Oropharynx|Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity|Stage IVA Salivary Gland Cancer|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVA Verrucous Carcinoma of the Larynx|Stage IVA Verrucous Carcinoma of the Oral Cavity|Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity|Stage IVB Basal Cell Carcinoma of the Lip|Stage IVB Lymphoepithelioma of the Oropharynx|Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity|Stage IVB Salivary Gland Cancer|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVB Verrucous Carcinoma of the Larynx|Stage IVB Verrucous Carcinoma of the Oral Cavity|Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity|Stage IVC Basal Cell Carcinoma of the Lip|Stage IVC Lymphoepithelioma of the Oropharynx|Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity|Stage IVC Salivary Gland Cancer|Stage IVC Squamous Cell Carcinoma of the Larynx|Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Oropharynx|Stage IVC Verrucous Carcinoma of the Larynx|Stage IVC Verrucous Carcinoma of the Oral Cavity|Tongue Cancer
6328,0.997412976,159.4795856,https://clinicaltrials.gov/study/NCT01390311,NCT01390311,"Leukemia, Myeloid, Acute|Myelodysplastic Syndromes"
6329,0.997168951,159.0552477,https://clinicaltrials.gov/study/NCT03852511,NCT03852511,Metastatic Cancer|Epithelial Tumor
6330,0.997320154,163.2424152,https://clinicaltrials.gov/study/NCT03427411,NCT03427411,Human Papilloma Virus|Cervical Cancer|Oropharyngeal Cancer|Anal Cancer|Vaginal or Penile Cancer
6331,0.997585067,163.1057773,https://clinicaltrials.gov/study/NCT00450411,NCT00450411,Prostate Cancer
6332,0.910220191,23.22323204,https://clinicaltrials.gov/study/NCT00315211,NCT00315211,Mediastinal Neoplasms
6333,0.991065776,151.4107641,https://clinicaltrials.gov/study/NCT05302011,NCT05302011,Esophageal Squamous Cell Carcinoma
6334,0.984460416,108.9200623,https://clinicaltrials.gov/study/NCT00915811,NCT00915811,"Myelodysplastic Syndromes|Leukemia, Myeloid, Acute"
6335,0.999483258,191.7984631,https://clinicaltrials.gov/study/NCT00482911,NCT00482911,Intraocular Melanoma|Malignant Conjunctival Neoplasm
6336,0.982238718,94.23219072,https://clinicaltrials.gov/study/NCT01288911,NCT01288911,Prostatic Neoplasms
6337,0.988959584,150.6262028,https://clinicaltrials.gov/study/NCT00091611,NCT00091611,Kidney Neoplasms
6338,0.946687516,28.7262555,https://clinicaltrials.gov/study/NCT00363311,NCT00363311,"Neoplasms, Prostate"
6339,0.894059485,17.77843278,https://clinicaltrials.gov/study/NCT04631211,NCT04631211,Thrombocytopenia|Hematologic Malignancy|Bone Marrow Aplasia|Myeloproliferative Disorders|Myelodysplastic Syndromes|Platelet Refractoriness
6340,0.999058685,186.5017438,https://clinicaltrials.gov/study/NCT00006111,NCT00006111,Bladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer
6341,0.981738324,144.2007986,https://clinicaltrials.gov/study/NCT03831711,NCT03831711,Breast Carcinoma|Estrogen Receptor Positive
6342,0.986985975,150.1182252,https://clinicaltrials.gov/study/NCT00321711,NCT00321711,MDS|Myelodysplastic Syndromes|Thrombocytopenia
6343,0.994630752,154.0200957,https://clinicaltrials.gov/study/NCT00698711,NCT00698711,Prostate Cancer
6344,0.999427091,194.3950713,https://clinicaltrials.gov/study/NCT03430011,NCT03430011,Multiple Myeloma
6345,0.997928624,166.4392459,https://clinicaltrials.gov/study/NCT00326911,NCT00326911,Metastatic Pancreatic Cancer
6346,0.999005253,182.6780527,https://clinicaltrials.gov/study/NCT00014313,NCT00014313,Sarcoma
6347,0.999498356,181.9293668,https://clinicaltrials.gov/study/NCT02017613,NCT02017613,"Lymphoma, B-Cell|T-Cell Lymphoma"
6348,0.99398903,154.1329061,https://clinicaltrials.gov/study/NCT00370513,NCT00370513,"Carcinoma, Hepatocellular"
6349,0.981806549,104.6261241,https://clinicaltrials.gov/study/NCT01384513,NCT01384513,"Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Nasal Type Extranodal NK/T-cell Lymphoma|Aplastic Anemia|Childhood Acute Lymphoblastic Leukemia in Remission|Childhood Acute Myeloid Leukemia in Remission|Childhood Myelodysplastic Syndromes|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Essential Thrombocythemia|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Juvenile Myelomonocytic Leukemia|Mastocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Polycythemia Vera|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Anemia|Refractory Anemia With Ringed Sideroblasts|Refractory Hairy Cell Leukemia|Refractory Multiple Myeloma|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|T-cell Large Granular Lymphocyte Leukemia|Waldenstrm Macroglobulinemia"
6350,0.980243082,99.66912849,https://clinicaltrials.gov/study/NCT00087113,NCT00087113,Cervical Cancer
6351,0.797705763,8.244213153,https://clinicaltrials.gov/study/NCT04366713,NCT04366713,HER2 Amplified Breast Cancer
6352,0.967748689,71.43073202,https://clinicaltrials.gov/study/NCT03495713,NCT03495713,Hodgkin Lymphoma
6353,0.999471082,187.9195034,https://clinicaltrials.gov/study/NCT03994913,NCT03994913,Refractory B-Cell Non-Hodgkin Lymphoma|Relapsed B-cell Non-Hodgkin Lymphoma
6354,0.999738469,188.7419325,https://clinicaltrials.gov/study/NCT00028613,NCT00028613,Lymphoma
6355,0.99884584,178.859375,https://clinicaltrials.gov/study/NCT00243113,NCT00243113,Head and Neck Cancer
6356,0.986888854,150.7328648,https://clinicaltrials.gov/study/NCT01155713,NCT01155713,Neoplasm|Cancer|Tumors
6357,0.682246544,4.645842877,https://clinicaltrials.gov/study/NCT00891813,NCT00891813,"Secondary Hyperparathyroidism|Renal Insufficiency, Chronic|Parathyroid Hormone|Hemodialysis|Hypercalcemia"
6358,0.989874032,151.3074937,https://clinicaltrials.gov/study/NCT00106613,NCT00106613,"Carcinoma, Renal Cell|Neoplasm Metastasis"
6359,0.989405073,150.4650817,https://clinicaltrials.gov/study/NCT00188513,NCT00188513,Prostatic Neoplasms
6360,0.998687652,169.9596319,https://clinicaltrials.gov/study/NCT00055913,NCT00055913,Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity|Salivary Gland Squamous Cell Carcinoma|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Larynx|Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IV Squamous Cell Carcinoma of the Oropharynx|Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity
6361,0.943734523,33.05833927,https://clinicaltrials.gov/study/NCT00345813,NCT00345813,Prostate Cancer
6362,0.996964924,160.1041065,https://clinicaltrials.gov/study/NCT01723813,NCT01723813,Metastatic Melanoma
6363,0.999193966,179.3856795,https://clinicaltrials.gov/study/NCT00730613,NCT00730613,Brain and Central Nervous System Tumors
6364,0.997140258,163.9870677,https://clinicaltrials.gov/study/NCT00276913,NCT00276913,Advanced or Metastatic Solid Tumors
6365,0.999304133,195.2546541,https://clinicaltrials.gov/study/NCT00458913,NCT00458913,Malignant Mesothelioma
6366,0.916215139,15.32937999,https://clinicaltrials.gov/study/NCT00595413,NCT00595413,Rheumatoid Arthritis
6367,0.769587202,7.24548044,https://clinicaltrials.gov/study/NCT00679913,NCT00679913,Pancreatic Cancer
6368,0.992713861,152.2494662,https://clinicaltrials.gov/study/NCT02323113,NCT02323113,Acute Myelogenous Leukemia
6369,0.997266467,161.7863222,https://clinicaltrials.gov/study/NCT04434469,NCT04434469,Refractory Multiple Myeloma|Relapsed Multiple Myeloma
6370,0.798593238,9.852435367,https://clinicaltrials.gov/study/NCT00247169,NCT00247169,Cervical Intraepithelial Neoplasia
6371,0.99360194,154.021554,https://clinicaltrials.gov/study/NCT01172769,NCT01172769,Head and Neck Squamous Cell Carcinoma
6372,0.96248312,58.96102135,https://clinicaltrials.gov/study/NCT00306969,NCT00306969,Cutaneous T-Cell Lymphoma
6373,0.917669896,24.14560965,https://clinicaltrials.gov/study/NCT00332969,NCT00332969,Thymoma
6374,0.996571282,155.2103746,https://clinicaltrials.gov/study/NCT00574769,NCT00574769,Prostate Cancer
6375,0.976372767,70.63246898,https://clinicaltrials.gov/study/NCT02311569,NCT02311569,Myeloproliferative Neoplasm|Primary Myelofibrosis|Essential Thrombocythemia|Polycythemia Vera
6376,0.997868735,162.4913146,https://clinicaltrials.gov/study/NCT00072969,NCT00072969,Myelodysplastic Syndromes
6377,0.996893464,159.6743366,https://clinicaltrials.gov/study/NCT02713269,NCT02713269,Malignant Digestive System Neoplasm|Metastatic Head and Neck Carcinoma|Metastatic Kidney Carcinoma|Metastatic Malignant Neoplasm in the Spine|Metastatic Malignant Neoplasm of Unknown Primary|Metastatic Melanoma|Prostate Carcinoma Metastatic in the Bone|Sarcoma|Solid Neoplasm|Spinal Cord Compression|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Lung Non-Small Cell Cancer AJCC v7|Thyroid Gland Carcinoma
6378,0.997827958,165.4468578,https://clinicaltrials.gov/study/NCT00639769,NCT00639769,Head and Neck Cancer
6379,0.998989392,193.1927788,https://clinicaltrials.gov/study/NCT00093769,NCT00093769,Lymphoma
6380,0.821434644,9.759830368,https://clinicaltrials.gov/study/NCT00188669,NCT00188669,Breast Neoplasms
6381,0.99143237,151.5914994,https://clinicaltrials.gov/study/NCT00046969,NCT00046969,Anemia|Cervical Cancer
6382,0.977727082,83.72870769,https://clinicaltrials.gov/study/NCT00201669,NCT00201669,Non-Hodgkin's Lymphoma
6383,0.995727939,155.3092413,https://clinicaltrials.gov/study/NCT00609869,NCT00609869,Lymphocytic Leukemia|Mantle Cell Lymphoma
6384,0.984481044,103.9027878,https://clinicaltrials.gov/study/NCT00807781,NCT00807781,Metastatic Breast Cancer
6385,0.935831898,34.31575643,https://clinicaltrials.gov/study/NCT02434081,NCT02434081,Non-small Cell Lung Cancer Stage III
6386,0.988432204,151.0064567,https://clinicaltrials.gov/study/NCT01963481,NCT01963481,Metastatic Beast Cancer
6387,0.990958184,151.0796968,https://clinicaltrials.gov/study/NCT00402181,NCT00402181,Multiple Myeloma
6388,0.997322337,160.1646075,https://clinicaltrials.gov/study/NCT00664781,NCT00664781,brca1 Mutation Carrier|brca2 Mutation Carrier|Breast Cancer|Ovarian Cancer
6389,0.993846394,155.0545075,https://clinicaltrials.gov/study/NCT00025376,NCT00025376,Kidney Cancer
6390,0.993001317,152.0455936,https://clinicaltrials.gov/study/NCT01582776,NCT01582776,Follicular Lymphoma Patients (Phase IB)|Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)
6391,0.994709882,153.8726312,https://clinicaltrials.gov/study/NCT00973076,NCT00973076,Cancer|Solid Tumors|Advanced Solid Malignancies
6392,0.905703895,19.74452028,https://clinicaltrials.gov/study/NCT02534376,NCT02534376,Prostate Cancer
6393,0.951566607,33.85287085,https://clinicaltrials.gov/study/NCT02468076,NCT02468076,Pancreas Cancer|Cholangiocarcinoma|Obstructive Jaundice
6394,0.999504707,185.2351446,https://clinicaltrials.gov/study/NCT00002476,NCT00002476,Head and Neck Cancer
6395,0.959092127,53.07374806,https://clinicaltrials.gov/study/NCT00846976,NCT00846976,Prostate Cancer
6396,0.996285582,156.9493748,https://clinicaltrials.gov/study/NCT04233476,NCT04233476,Lung Cancer Metastatic
6397,0.963082285,64.16952788,https://clinicaltrials.gov/study/NCT01000376,NCT01000376,Cancer
6398,0.989792761,151.0100985,https://clinicaltrials.gov/study/NCT03463876,NCT03463876,Hepatocellular Carcinoma
6399,0.994709579,156.0277886,https://clinicaltrials.gov/study/NCT01454076,NCT01454076,Nonhematologic Malignancies|Lymphoma
6400,0.972474852,74.52770073,https://clinicaltrials.gov/study/NCT02912676,NCT02912676,Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma
6401,0.996457288,157.3783814,https://clinicaltrials.gov/study/NCT00183976,NCT00183976,Non-Hodgkin's Lymphoma|Burkitt Lymphoma|Primary Effusion Lymphomas
6402,0.999635236,180.4896794,https://clinicaltrials.gov/study/NCT00002676,NCT00002676,Lymphoma
6403,0.998019901,169.276643,https://clinicaltrials.gov/study/NCT00044876,NCT00044876,Leiomyoma
6404,0.979643226,114.1122923,https://clinicaltrials.gov/study/NCT00490776,NCT00490776,Cutaneous T-Cell Lymphoma
6405,0.98746274,150.7300372,https://clinicaltrials.gov/study/NCT00780676,NCT00780676,Breast Cancer
6406,0.981535007,97.88427806,https://clinicaltrials.gov/study/NCT00629876,NCT00629876,Anemia
6407,0.980661418,102.7997761,https://clinicaltrials.gov/study/NCT00375076,NCT00375076,Cancer
6408,0.99449141,153.7631488,https://clinicaltrials.gov/study/NCT02279576,NCT02279576,Penile Squamous Cell Carcinoma Stage IV
6409,0.984050592,150.34149,https://clinicaltrials.gov/study/NCT00003499,NCT00003499,Low-Grade Lymphoma
6410,0.999214296,187.541602,https://clinicaltrials.gov/study/NCT03216499,NCT03216499,Recurrent Glioblastoma
6411,0.931367382,28.07127433,https://clinicaltrials.gov/study/NCT01487499,NCT01487499,Small Cell Lung Cancer
6412,0.998982511,184.045824,https://clinicaltrials.gov/study/NCT00004899,NCT00004899,Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
6413,0.997165738,162.3439573,https://clinicaltrials.gov/study/NCT02562599,NCT02562599,Nasopharyngeal Carcinoma
6414,0.993193359,154.1712471,https://clinicaltrials.gov/study/NCT03043599,NCT03043599,Small Cell Lung Cancer|Extensive-stage Small Cell Lung Cancer
6415,0.99554444,155.3133141,https://clinicaltrials.gov/study/NCT00490399,NCT00490399,Biliary Tract Carcinoma
6416,0.999617148,193.4199061,https://clinicaltrials.gov/study/NCT00607399,NCT00607399,Advanced Cancer
6417,0.992574115,152.1818934,https://clinicaltrials.gov/study/NCT02154399,NCT02154399,Stage IA Non-Small Cell Lung Carcinoma|Stage IB Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer|Stage IIIB Non-Small Cell Lung Cancer
6418,0.970504163,66.50506018,https://clinicaltrials.gov/study/NCT00661999,NCT00661999,"Anemia|Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Precancerous Condition|Unspecified Adult Solid Tumor, Protocol Specific"
6419,0.998668991,177.9358595,https://clinicaltrials.gov/study/NCT03412799,NCT03412799,Pancreatic Cancer Metastatic|Pancreatic Cancer Stage IV|Stage IV Pancreatic Cancer
6420,0.998846483,187.5644317,https://clinicaltrials.gov/study/NCT00326599,NCT00326599,Lung Cancer
6421,0.990020591,150.1474452,https://clinicaltrials.gov/study/NCT00179699,NCT00179699,Non-Small Cell Lung Cancer
6422,0.998659724,180.8445142,https://clinicaltrials.gov/study/NCT00702299,NCT00702299,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
6423,0.997926827,164.1225667,https://clinicaltrials.gov/study/NCT01261299,NCT01261299,"Carcinoma, Non-Small-Cell Lung|Urinary Bladder Neoplasms"
6424,0.987986483,135.5374217,https://clinicaltrials.gov/study/NCT00869999,NCT00869999,Diffuse Large B-cell Lymphoma
6425,0.995183857,154.902456,https://clinicaltrials.gov/study/NCT02224599,NCT02224599,Progressive Solid Malignancies|Refractory Solid Malignancies|Cancer
6426,0.833251976,10.2978019,https://clinicaltrials.gov/study/NCT03268499,NCT03268499,Hepatocellular Carcinoma
6427,0.960214416,50.00774973,https://clinicaltrials.gov/study/NCT01472770,NCT01472770,Metastatic Colorectal Cancer
6428,0.978549035,73.52796173,https://clinicaltrials.gov/study/NCT00003170,NCT00003170,Cancer
6429,0.996436692,157.9761243,https://clinicaltrials.gov/study/NCT01585870,NCT01585870,Neoplasms
6430,0.991023547,151.3631239,https://clinicaltrials.gov/study/NCT00020670,NCT00020670,Leukemia
6431,0.991369327,152.6612802,https://clinicaltrials.gov/study/NCT02057770,NCT02057770,"Leukemia, Myeloid, Acute"
6432,0.99775265,167.8562037,https://clinicaltrials.gov/study/NCT03808870,NCT03808870,Malignant Neoplasm
6433,0.931432335,25.1185959,https://clinicaltrials.gov/study/NCT00328770,NCT00328770,Liver Carcinoma
6434,0.963674615,56.55129266,https://clinicaltrials.gov/study/NCT02416570,NCT02416570,Cachexia|Lung Cancer
6435,0.999503897,198.0036665,https://clinicaltrials.gov/study/NCT00070070,NCT00070070,Transitional Cell Carcinoma
6436,0.989443078,150.5837429,https://clinicaltrials.gov/study/NCT00765570,NCT00765570,Advanced Bulky Malignancies
6437,0.996903403,159.8938644,https://clinicaltrials.gov/study/NCT01342770,NCT01342770,Stage IA Non-Small Cell Lung Carcinoma|Stage IB Non-Small Cell Lung Carcinoma|Stage IIA Non-Small Cell Lung Carcinoma|Stage IIB Non-Small Cell Lung Carcinoma|Stage IIIA Non-Small Cell Lung Cancer
6438,0.99559942,156.6274044,https://clinicaltrials.gov/study/NCT00869570,NCT00869570,Colorectal Cancer
6439,0.996779419,161.0460548,https://clinicaltrials.gov/study/NCT00730470,NCT00730470,Advanced Solid Tumors
6440,0.984022257,150.0474336,https://clinicaltrials.gov/study/NCT00041470,NCT00041470,Breast Cancer
6441,0.974999299,79.68221197,https://clinicaltrials.gov/study/NCT02126670,NCT02126670,Actinic Keratosis
6442,0.982435992,120.7232281,https://clinicaltrials.gov/study/NCT00100711,NCT00100711,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
6443,0.999725574,181.1719444,https://clinicaltrials.gov/study/NCT00752011,NCT00752011,Cancer|Solid Tumors
6444,0.999021251,183.7722528,https://clinicaltrials.gov/study/NCT01195311,NCT01195311,Solid Tumors and Hematologic Malignancy
6445,0.999575701,184.8147341,https://clinicaltrials.gov/study/NCT01118611,NCT01118611,"Unspecified Adult Solid Tumor, Protocol Specific"
6446,0.993373156,154.3395716,https://clinicaltrials.gov/study/NCT00888511,NCT00888511,Non-small Cell Lung Cancer
6447,0.978765116,92.38338624,https://clinicaltrials.gov/study/NCT03128411,NCT03128411,"Leukemia, Chronic Myelogenous"
6448,0.964453479,46.52467807,https://clinicaltrials.gov/study/NCT04882111,NCT04882111,Cancer
6449,0.972143393,93.31551863,https://clinicaltrials.gov/study/NCT02828111,NCT02828111,Basal Cell Carcinomas
6450,0.999266583,192.9141555,https://clinicaltrials.gov/study/NCT03342911,NCT03342911,Name Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma|Stage II Oropharyngeal Squamous Cell Carcinoma|Stage III Hypopharyngeal Squamous Cell Carcinoma|Stage III Laryngeal Squamous Cell Carcinoma|Stage III Oral Cavity Squamous Cell Carcinoma|Stage III Oropharyngeal Squamous Cell Carcinoma|Stage IV Hypopharyngeal Squamous Cell Carcinoma|Stage IV Laryngeal Squamous Cell Carcinoma|Stage IV Oral Cavity Squamous Cell Carcinoma|Stage IV Oropharyngeal Squamous Cell Carcinoma|Stage IVA Hypopharyngeal Squamous Cell Carcinoma|Stage IVA Laryngeal Squamous Cell Carcinoma|Stage IVA Oral Cavity Squamous Cell Carcinoma|Stage IVA Oropharyngeal Squamous Cell Carcinoma|Stage IVB Hypopharyngeal Squamous Cell Carcinoma|Stage IVB Laryngeal Squamous Cell Carcinoma|Stage IVB Oral Cavity Squamous Cell Carcinoma|Stage IVB Oropharyngeal Squamous Cell Carcinoma|Stage IVC Hypopharyngeal Squamous Cell Carcinoma|Stage IVC Laryngeal Squamous Cell Carcinoma|Stage IVC Oral Cavity Squamous Cell Carcinoma|Stage IVC Oropharyngeal Squamous Cell Carcinoma
6451,0.990410121,152.2075785,https://clinicaltrials.gov/study/NCT02386111,NCT02386111,"Carcinoma, Renal Cell|Kidney Diseases|Kidney Neoplasms|Urogenital Neoplasms|Urologic Diseases|Urologic Neoplasms|Neoplasms|Neoplasms by Histologic Type|Clear-cell Metastatic Renal Cell Carcinoma"
6452,0.985261569,150.3243605,https://clinicaltrials.gov/study/NCT03978611,NCT03978611,Melanoma
6453,0.995741852,157.9085172,https://clinicaltrials.gov/study/NCT00936611,NCT00936611,Waldenstrom's Macroglobulinemia
6454,0.985884239,133.4296354,https://clinicaltrials.gov/study/NCT02756611,NCT02756611,Chronic Lymphocytic Leukemia
6455,0.974247614,78.6677308,https://clinicaltrials.gov/study/NCT01298011,NCT01298011,Resectable Pancreatic Cancer
6456,0.991229721,150.7625592,https://clinicaltrials.gov/study/NCT03994211,NCT03994211,Solid Tumor
6457,0.998112296,170.3832742,https://clinicaltrials.gov/study/NCT00004011,NCT00004011,Lung Cancer
6458,0.991704478,152.059552,https://clinicaltrials.gov/study/NCT05546411,NCT05546411,Pancreatic Cancer|Resectable Pancreatic Cancer|Borderline Resectable Pancreatic Adenocarcinoma|Pancreatic Adenocarcinoma
6459,0.997781908,166.2983152,https://clinicaltrials.gov/study/NCT00002911,NCT00002911,Lung Cancer
6460,0.99472755,155.366995,https://clinicaltrials.gov/study/NCT02011113,NCT02011113,Multiple Myeloma
6461,0.996133523,156.8028325,https://clinicaltrials.gov/study/NCT00088413,NCT00088413,Adenocarcinoma|Colorectal Cancer|Ovarian Cancer|Breast Cancer
6462,0.954985465,44.31539838,https://clinicaltrials.gov/study/NCT00635713,NCT00635713,Advanced Breast Cancer
6463,0.981353443,101.8918389,https://clinicaltrials.gov/study/NCT00373113,NCT00373113,Breast Neoplasms
6464,0.966284417,58.3235279,https://clinicaltrials.gov/study/NCT01259713,NCT01259713,Invasive Fungal Disease
6465,0.998913665,183.2075952,https://clinicaltrials.gov/study/NCT00003413,NCT00003413,Ovarian Cancer
6466,0.974909813,71.09547438,https://clinicaltrials.gov/study/NCT02228213,NCT02228213,Secondary Progressive Multiple Sclerosis
6467,0.965729478,64.25862643,https://clinicaltrials.gov/study/NCT00841113,NCT00841113,Prostate Cancer
6468,0.945604546,28.65809459,https://clinicaltrials.gov/study/NCT00119613,NCT00119613,Small Cell Lung Cancer
6469,0.997955466,168.6290527,https://clinicaltrials.gov/study/NCT00470613,NCT00470613,Neoplasm
6470,0.8601432,12.436795,https://clinicaltrials.gov/study/NCT02501213,NCT02501213,Cancer
6471,0.997137007,159.7031663,https://clinicaltrials.gov/study/NCT00399113,NCT00399113,Metastatic Melanoma
6472,0.982076259,87.5657833,https://clinicaltrials.gov/study/NCT03989713,NCT03989713,AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
6473,0.990023013,151.3326674,https://clinicaltrials.gov/study/NCT00570713,NCT00570713,Pancreatic Cancer
6474,0.982736094,95.81712761,https://clinicaltrials.gov/study/NCT00802113,NCT00802113,Non-Hodgkin's Lymphoma|Hodgkins Disease
6475,0.963240022,47.27072891,https://clinicaltrials.gov/study/NCT01885013,NCT01885013,Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
6476,0.997295588,160.6346559,https://clinicaltrials.gov/study/NCT01822613,NCT01822613,Esophageal Squamous Cell Carcinoma
6477,0.990890939,150.3105006,https://clinicaltrials.gov/study/NCT03926013,NCT03926013,Neoplasms
6478,0.861742129,10.84540304,https://clinicaltrials.gov/study/NCT00462813,NCT00462813,Cervical Cancer|Precancerous Condition
6479,0.992907212,154.2418928,https://clinicaltrials.gov/study/NCT02399813,NCT02399813,Anal Cancer|Rectal Cancer
6480,0.894078862,18.47599235,https://clinicaltrials.gov/study/NCT03933813,NCT03933813,Epithelial Ovarian Cancer|Anemia|Iron Deficiency Anemia
6481,0.99491569,154.9495097,https://clinicaltrials.gov/study/NCT03875313,NCT03875313,Solid Tumor|Clear Cell Renal Cell Carcinoma|TNBC - Triple-Negative Breast Cancer|Colorectal Cancer|CRC|RCC|ccRCC
6482,0.998390124,173.2481396,https://clinicaltrials.gov/study/NCT00529113,NCT00529113,Pancreatic Neoplasms|Pancreatic Cancer
6483,0.998071285,168.0873006,https://clinicaltrials.gov/study/NCT01067469,NCT01067469,Brain Cancer|Glioblastoma
6484,0.976988232,107.9545419,https://clinicaltrials.gov/study/NCT00096369,NCT00096369,Breast Cancer
6485,0.987204589,150.3597235,https://clinicaltrials.gov/study/NCT02722369,NCT02722369,Small Cell Lung Cancer
6486,0.971871331,70.33384074,https://clinicaltrials.gov/study/NCT03447769,NCT03447769,Non-Small Cell Lung Cancer
6487,0.974906349,82.92232328,https://clinicaltrials.gov/study/NCT01926769,NCT01926769,Previously Treated Advanced Colorectal Cancer
6488,0.996266852,158.6613495,https://clinicaltrials.gov/study/NCT03911869,NCT03911869,Brain Metastases
6489,0.994620293,155.2333427,https://clinicaltrials.gov/study/NCT01803269,NCT01803269,Extensive Stage Small Cell Lung Cancer|Recurrent Small Cell Lung Cancer
6490,0.961016758,55.4431023,https://clinicaltrials.gov/study/NCT01480869,NCT01480869,Breast Cancer
6491,0.993585621,153.0431989,https://clinicaltrials.gov/study/NCT02419469,NCT02419469,Leukemia|Precursor-B Acute Lymphoblastic Leukemia|Lymphoblastic Lymphoma|Lymphoma
6492,0.997623727,164.6055227,https://clinicaltrials.gov/study/NCT00768469,NCT00768469,Advanced Malignant Solid Tumors
6493,0.997053056,158.6519826,https://clinicaltrials.gov/study/NCT01891669,NCT01891669,"Neoplasms|Carcinoma, Non Small Cell Lung|Breast Neoplasms|Ovarian Neoplasms"
6494,0.922490182,25.61330345,https://clinicaltrials.gov/study/NCT02100969,NCT02100969,Myasthenia Gravis
6495,0.995119052,153.8468503,https://clinicaltrials.gov/study/NCT01526369,NCT01526369,Metastatic Breast Cancer
6496,0.999203148,186.8943382,https://clinicaltrials.gov/study/NCT00787969,NCT00787969,Lymphoma
6497,0.949451996,44.41232555,https://clinicaltrials.gov/study/NCT00850811,NCT00850811,Actinic Keratosis
6498,0.999420369,180.0118482,https://clinicaltrials.gov/study/NCT04301011,NCT04301011,Solid Tumor|Microsatellite Stable Colorectal Cancer|HPV Positive Oropharyngeal Squamous Cell Carcinoma|Cervical Cancer|Melanoma (Skin)|Cutaneous Squamous Cell Carcinoma|Mesothelioma|Renal Cell Carcinoma|Oropharynx Cancer
6499,0.995446345,156.2082581,https://clinicaltrials.gov/study/NCT02120911,NCT02120911,Esophageal Carcinoma
6500,0.999769476,188.9579651,https://clinicaltrials.gov/study/NCT00003911,NCT00003911,Melanoma (Skin)|Metastatic Cancer
6501,0.997817154,167.9915685,https://clinicaltrials.gov/study/NCT00109811,NCT00109811,Adenocarcinoma of the Prostate|Recurrent Prostate Cancer
6502,0.998484188,173.0541903,https://clinicaltrials.gov/study/NCT00002611,NCT00002611,Kidney Cancer
6503,0.99066431,151.2737877,https://clinicaltrials.gov/study/NCT00217711,NCT00217711,Colorectal Cancer
6504,0.994942337,155.5405455,https://clinicaltrials.gov/study/NCT00382811,NCT00382811,Fallopian Tube Cancer|Peritoneal Neoplasms|Ovarian Cancer
6505,0.999608073,183.2161337,https://clinicaltrials.gov/study/NCT00024011,NCT00024011,Recurrent Melanoma|Stage IV Melanoma
6506,0.999629774,186.6445748,https://clinicaltrials.gov/study/NCT00662311,NCT00662311,Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer
6507,0.998592898,173.7715643,https://clinicaltrials.gov/study/NCT01161511,NCT01161511,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
6508,0.998922039,176.2903548,https://clinicaltrials.gov/study/NCT00006011,NCT00006011,"Endometrial Adenocarcinoma|Endometrial Adenosquamous Carcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation|Endometrial Serous Adenocarcinoma|Stage III Uterine Corpus Cancer"
6509,0.984177691,135.6769226,https://clinicaltrials.gov/study/NCT00111813,NCT00111813,Multiple Myeloma
6510,0.999644019,184.1371461,https://clinicaltrials.gov/study/NCT01413113,NCT01413113,Recurrent Thyroid Cancer|Stage IVA Follicular Thyroid Cancer|Stage IVA Papillary Thyroid Cancer|Stage IVB Follicular Thyroid Cancer|Stage IVB Papillary Thyroid Cancer|Stage IVC Follicular Thyroid Cancer|Stage IVC Papillary Thyroid Cancer
6511,0.997319893,164.1212981,https://clinicaltrials.gov/study/NCT00354913,NCT00354913,Glioblastoma|Gliosarcoma
6512,0.991391355,152.1735336,https://clinicaltrials.gov/study/NCT00037713,NCT00037713,"Carcinoma, Small Cell Lung"
6513,0.991496058,152.2643725,https://clinicaltrials.gov/study/NCT01176513,NCT01176513,Prostate Cancer
6514,0.989004899,151.0515943,https://clinicaltrials.gov/study/NCT00117013,NCT00117013,Neoplasms
6515,0.998619224,172.2056077,https://clinicaltrials.gov/study/NCT03201913,NCT03201913,Metastatic ER+ Breast Cancer
6516,0.980185605,95.33634889,https://clinicaltrials.gov/study/NCT01253213,NCT01253213,Prostate Cancer
6517,0.995891065,155.7594845,https://clinicaltrials.gov/study/NCT03742713,NCT03742713,Cancer|Ovarian Cancer
6518,0.99943563,191.1692235,https://clinicaltrials.gov/study/NCT02776813,NCT02776813,Lymphoma
6519,0.981135564,118.3387632,https://clinicaltrials.gov/study/NCT00166413,NCT00166413,Amyloidosis
6520,0.969282456,53.11431953,https://clinicaltrials.gov/study/NCT00956813,NCT00956813,"Breast Cancer|Hot Flashes|Menopausal Symptoms|Unspecified Adult Solid Tumor, Protocol Specific"
6521,0.995407147,154.7838344,https://clinicaltrials.gov/study/NCT01599013,NCT01599013,Bladder Transitional Cell Carcinoma Stage IV
6522,0.987496716,150.3456914,https://clinicaltrials.gov/study/NCT01054313,NCT01054313,Advanced Cancer
6523,0.949824288,39.04185979,https://clinicaltrials.gov/study/NCT00735813,NCT00735813,Bacteremia|Neoplasms
6524,0.999487441,187.7820972,https://clinicaltrials.gov/study/NCT02817113,NCT02817113,Head and Neck Neoplasms
6525,0.995970918,159.5277671,https://clinicaltrials.gov/study/NCT00003513,NCT00003513,Neuroblastoma
6526,0.942703029,34.00320761,https://clinicaltrials.gov/study/NCT00178113,NCT00178113,Prostatic Intraepithelial Neoplasia
6527,0.993025338,152.3006081,https://clinicaltrials.gov/study/NCT01415713,NCT01415713,Metastatic Pancreatic Adenocarcinoma
6528,0.947192015,35.76897486,https://clinicaltrials.gov/study/NCT01229813,NCT01229813,Colorectal Cancer
6529,0.984364289,146.8746979,https://clinicaltrials.gov/study/NCT00867113,NCT00867113,Gastrointestinal Stromal Tumor (GIST)
6530,0.998448166,168.4566871,https://clinicaltrials.gov/study/NCT00083213,NCT00083213,Cancer
6531,0.986852874,146.5393594,https://clinicaltrials.gov/study/NCT05526313,NCT05526313,Diffuse Large B Cell LymphomaDLBCL
6532,0.991041792,150.5425696,https://clinicaltrials.gov/study/NCT03043313,NCT03043313,Metastatic Colorectal Adenocarcinoma
6533,0.992279391,152.298444,https://clinicaltrials.gov/study/NCT01406769,NCT01406769,Lymphedema|Perioperative/Postoperative Complications|Stage IA Vulvar Cancer AJCC v7|Stage IB Vulvar Cancer AJCC v7|Stage II Vulvar Cancer AJCC v7|Stage IIIA Vulvar Cancer AJCC v7|Stage IIIB Vulvar Cancer AJCC v7|Stage IIIC Vulvar Cancer AJCC v7|Stage IVA Vulvar Cancer AJCC v7|Stage IVB Vulvar Cancer AJCC v6 and v7
6534,0.988665086,151.3915237,https://clinicaltrials.gov/study/NCT00786669,NCT00786669,Solid Tumor
6535,0.994673281,155.2088732,https://clinicaltrials.gov/study/NCT00803569,NCT00803569,Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer
6536,0.998280791,173.909986,https://clinicaltrials.gov/study/NCT00551369,NCT00551369,Lung Cancer
6537,0.997678563,164.9896195,https://clinicaltrials.gov/study/NCT01335269,NCT01335269,Neoplasms
6538,0.986620775,149.9609568,https://clinicaltrials.gov/study/NCT02241369,NCT02241369,Aerodigestive Precancerous Lesions and Malignancies
6539,0.996308378,158.0025248,https://clinicaltrials.gov/study/NCT00468169,NCT00468169,Head and Neck Cancer
6540,0.987341095,144.630605,https://clinicaltrials.gov/study/NCT00908869,NCT00908869,Advanced Neoplasm
6541,0.972482895,58.59738818,https://clinicaltrials.gov/study/NCT00274469,NCT00274469,Metastatic Breast Cancer
6542,0.998754223,181.8591058,https://clinicaltrials.gov/study/NCT02536469,NCT02536469,Solid Tumor
6543,0.995904682,157.9560835,https://clinicaltrials.gov/study/NCT00901069,NCT00901069,"Lymphoma|Hodgkin Disease|Lymphoma, Non-Hodgkin"
6544,0.960964742,42.47189763,https://clinicaltrials.gov/study/NCT00929669,NCT00929669,Gonadotroph Adenomas
6545,0.987415045,150.2793872,https://clinicaltrials.gov/study/NCT01896869,NCT01896869,Metastatic Pancreatic Adenocarcinoma
6546,0.999717736,176.0969786,https://clinicaltrials.gov/study/NCT01851369,NCT01851369,Lymphomas|Solid Tumors|NSCLC|Metastatic Colon Carcinoma|Granulosa Cell Ovarian Cancer
6547,0.799452386,8.343953241,https://clinicaltrials.gov/study/NCT03185169,NCT03185169,Genitourinary Abnormality|Breast Cancer Female|Vaginal Abnormality|Urinary Tract Infections|Dyspareunia|Dysuria
6548,0.992362142,151.710361,https://clinicaltrials.gov/study/NCT00882869,NCT00882869,Advanced Hepatocellular Carcinoma
6549,0.94910713,30.06572301,https://clinicaltrials.gov/study/NCT01339169,NCT01339169,Chronic Atrophic Gastritis|Hypergastrinaemia|Type I Gastric Carcinoids
6550,0.994260627,154.1291488,https://clinicaltrials.gov/study/NCT02890069,NCT02890069,"Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma"
6551,0.963265616,51.31700626,https://clinicaltrials.gov/study/NCT01220869,NCT01220869,Prostate Cancer
6552,0.893176759,17.4632189,https://clinicaltrials.gov/study/NCT02654769,NCT02654769,Actinic Keratosis
6553,0.992383046,152.314476,https://clinicaltrials.gov/study/NCT02708511,NCT02708511,Ovarian Carcinoma|Breast Carcinoma
6554,0.993779284,153.9511272,https://clinicaltrials.gov/study/NCT02991911,NCT02991911,Metastatic Castration Resistant Prostate Cancer
6555,0.984523198,114.133771,https://clinicaltrials.gov/study/NCT02520011,NCT02520011,Acute Myeloid Leukemia
6556,0.993838587,154.092356,https://clinicaltrials.gov/study/NCT04594811,NCT04594811,Gastric or Gastro-esophageal Junction (GEJ) or Esophageal Adenocarcinoma (EAC)
6557,0.803666821,8.437699364,https://clinicaltrials.gov/study/NCT05859711,NCT05859711,Head and Neck Cancer Patients
6558,0.985947545,116.3397615,https://clinicaltrials.gov/study/NCT04327011,NCT04327011,"Glioblastoma Multiforme|Astrocytoma|Gliomas, Malignant"
6559,0.986126646,126.2131493,https://clinicaltrials.gov/study/NCT03573011,NCT03573011,Prostate Cancer
6560,0.990626834,150.7515333,https://clinicaltrials.gov/study/NCT01469611,NCT01469611,Colorectal Carcinoma
6561,0.994737472,155.2757385,https://clinicaltrials.gov/study/NCT01325311,NCT01325311,Prostate Adenocarcinoma|Stage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate Cancer
6562,0.991645853,151.3394473,https://clinicaltrials.gov/study/NCT00731211,NCT00731211,Renal Cell Carcinoma
6563,0.999343561,187.14347,https://clinicaltrials.gov/study/NCT00610311,NCT00610311,Metastatic Melanoma|Skin Cancer
6564,0.959622134,48.53470724,https://clinicaltrials.gov/study/NCT01953913,NCT01953913,"Carcinoma, Non-Small-Cell Lung"
6565,0.995448309,156.9226964,https://clinicaltrials.gov/study/NCT01064713,NCT01064713,Advanced Melanoma|Cancer
6566,0.997652741,161.8291727,https://clinicaltrials.gov/study/NCT01166113,NCT01166113,Multiple Myeloma
6567,0.997616757,165.6847168,https://clinicaltrials.gov/study/NCT03543813,NCT03543813,"Solid Tumor, Adult|Head and Neck Cancer|Non Small Cell Lung Cancer|Diffuse Large B Cell Lymphoma|Esophageal Cancer"
6568,0.998293142,172.1409534,https://clinicaltrials.gov/study/NCT01118013,NCT01118013,Leukemia|Lymphoma|Lymphoproliferative Disorder|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
6569,0.960847442,44.10898128,https://clinicaltrials.gov/study/NCT02585713,NCT02585713,Cerebral Vein Thrombosis|Deep Vein Thrombosis|Gonadal Thrombosis|Hepatic Thrombosis|Malignant Neoplasm|Mesenteric Thrombosis|Metastatic Malignant Neoplasm|Portal Vein Thrombosis|Pulmonary Embolism|Renal Vein Thrombosis|Splenic Thrombosis|Venous Thromboembolism
6570,0.997681415,168.2245269,https://clinicaltrials.gov/study/NCT02122913,NCT02122913,Solid Tumors Harboring NTRK Fusion
6571,0.995192526,154.9595272,https://clinicaltrials.gov/study/NCT02973113,NCT02973113,NonHodgkin Lymphoma|Lymphoproliferative Disorders|EBV Related Lymphoma|EBV-Related PTLD|Hodgkin Lymphoma|EBV Related Non-Hodgkin's Lymphoma|EBV Related Hodgkin's Lymphoma
6572,0.996596094,155.1747573,https://clinicaltrials.gov/study/NCT03246113,NCT03246113,Glioblastoma
6573,0.968899699,56.12410142,https://clinicaltrials.gov/study/NCT01296113,NCT01296113,Non-small Cell Lung Cancer|Hiv-positive
6574,0.981893939,108.6748544,https://clinicaltrials.gov/study/NCT02477813,NCT02477813,Small Cell Lung Cancer Recurrent
6575,0.999748568,179.848323,https://clinicaltrials.gov/study/NCT00006113,NCT00006113,Melanoma (Skin)
6576,0.997468831,162.0000073,https://clinicaltrials.gov/study/NCT02529813,NCT02529813,Acute Biphenotypic Leukemia|Acute Lymphoblastic Leukemia|Blasts 5 Percent or More of Bone Marrow Nucleated Cells|CD19 Positive|Minimal Residual Disease|Non-Hodgkin Lymphoma|Small Lymphocytic Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic Leukemia
6577,0.995850068,154.4199154,https://clinicaltrials.gov/study/NCT00410813,NCT00410813,Breast Cancer|Metastatic Cancer
6578,0.988490742,128.6669657,https://clinicaltrials.gov/study/NCT00001113,NCT00001113,"Sarcoma, Kaposi|HIV Infections"
6579,0.965582021,65.27923287,https://clinicaltrials.gov/study/NCT01797913,NCT01797913,THE Efficacy and Safety of Gemcitabine in the Maintenance Treatment of Advanced Non-small Cell Lung Cancer
6580,0.998732633,175.813031,https://clinicaltrials.gov/study/NCT00161213,NCT00161213,Pancreatic Cancer
6581,0.928221042,27.2931949,https://clinicaltrials.gov/study/NCT01043913,NCT01043913,Signs and Symptoms|Neoplasms|Neoplasms by Site|Fatigue|Breast Neoplasms|Breast Diseases
6582,0.999055304,188.9608833,https://clinicaltrials.gov/study/NCT00921869,NCT00921869,Solid Tumors
6583,0.974569819,63.58882252,https://clinicaltrials.gov/study/NCT01752569,NCT01752569,AIDS-related Kaposi's Sarcoma
6584,0.982556997,116.6650988,https://clinicaltrials.gov/study/NCT02176369,NCT02176369,Non-small Cell Lung Cancer Stage IIIB|Non-small Cell Lung Cancer Stage IV
6585,0.722213933,6.230205888,https://clinicaltrials.gov/study/NCT01622569,NCT01622569,Bilateral Nasal Polyposis
6586,0.694199503,5.364220596,https://clinicaltrials.gov/study/NCT03352869,NCT03352869,Polycystic Ovary Syndrome|Overweight and Obesity|Disorder of Glucose Regulation
6587,0.997910259,166.0958341,https://clinicaltrials.gov/study/NCT00037869,NCT00037869,"Neuroendocrine Tumors|Metastases, Neoplasm"
6588,0.99960628,195.413154,https://clinicaltrials.gov/study/NCT00026169,NCT00026169,"Malignant Neoplasm|Unspecified Adult Solid Tumor, Protocol Specific"
6589,0.997908688,168.9465024,https://clinicaltrials.gov/study/NCT01434069,NCT01434069,Gastrointestinal Tumor
6590,0.998132828,166.8369441,https://clinicaltrials.gov/study/NCT01983969,NCT01983969,Advanced Cancers|Lymphoma
6591,0.978457438,93.62259201,https://clinicaltrials.gov/study/NCT01558869,NCT01558869,Pancreatic Adenocarcinoma
6592,0.987788194,150.7603945,https://clinicaltrials.gov/study/NCT00052169,NCT00052169,Breast Neoplasms
6593,0.989722892,145.7856476,https://clinicaltrials.gov/study/NCT02228369,NCT02228369,EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
6594,0.995632722,154.8654959,https://clinicaltrials.gov/study/NCT00139269,NCT00139269,Advanced Squamous Cell Carcinoma|Squamous Cell Carcinoma of Head and Neck|SSCHN
6595,0.998223107,167.247093,https://clinicaltrials.gov/study/NCT00308269,NCT00308269,Cancer
6596,0.988986237,150.3558304,https://clinicaltrials.gov/study/NCT02077569,NCT02077569,Invasive Breast Cancer
6597,0.99965848,187.4657482,https://clinicaltrials.gov/study/NCT00005813,NCT00005813,Brain and Central Nervous System Tumors
6598,0.995497718,156.0699893,https://clinicaltrials.gov/study/NCT00052013,NCT00052013,Von Hippel-Lindau Disease|CNS Hemangioblastoma|Retinal Hemangioblastoma
6599,0.965191403,56.71682625,https://clinicaltrials.gov/study/NCT02848911,NCT02848911,"Leukemia, B-Cell"
6600,0.852695759,14.40415312,https://clinicaltrials.gov/study/NCT01449513,NCT01449513,Actinic Keratosis
6601,0.962054859,47.79693595,https://clinicaltrials.gov/study/NCT02494713,NCT02494713,Prostate Cancer
6602,0.985484257,114.7904017,https://clinicaltrials.gov/study/NCT02398513,NCT02398513,Oncology
6603,0.997984041,167.4824862,https://clinicaltrials.gov/study/NCT00278213,NCT00278213,Prolymphocytic Leukemia
6604,0.941392146,29.30732109,https://clinicaltrials.gov/study/NCT01254513,NCT01254513,Prostate Cancer
6605,0.910989721,20.89896773,https://clinicaltrials.gov/study/NCT03469713,NCT03469713,Renal Cancer Metastatic
6606,0.997825439,166.3855271,https://clinicaltrials.gov/study/NCT00505713,NCT00505713,Sarcoma
6607,0.748078562,6.63508318,https://clinicaltrials.gov/study/NCT01574313,NCT01574313,Vertigo|Meniere Disease
6608,0.999884569,191.2498486,https://clinicaltrials.gov/study/NCT00352313,NCT00352313,Brain and Central Nervous System Tumors
6609,0.994607354,153.7817368,https://clinicaltrials.gov/study/NCT01075113,NCT01075113,Liver Cancer
6610,0.909474201,22.22655429,https://clinicaltrials.gov/study/NCT02150213,NCT02150213,Adrenocortical Adenoma|Endometrial Stromal Sarcomas
6611,0.587907504,4.394459447,https://clinicaltrials.gov/study/NCT01116713,NCT01116713,Postoperative Pain|Postoperative Nausea|Postoperative Vomiting
6612,0.99084347,150.6549219,https://clinicaltrials.gov/study/NCT01053013,NCT01053013,Pancreatic Adenocarcinoma Non-resectable|Pancreatic Adenocarcinoma Metastatic|Colorectal Cancer Metastatic
6613,0.997274281,160.8209803,https://clinicaltrials.gov/study/NCT01049113,NCT01049113,Lymphoma|Acute Lymphocytic Leukemia
6614,0.920947927,20.72194631,https://clinicaltrials.gov/study/NCT01619813,NCT01619813,Prostate Cancer
6615,0.997868018,166.0482931,https://clinicaltrials.gov/study/NCT00101413,NCT00101413,"Cancer|Carcinoma, Non-Small Cell Lung"
6616,0.99910519,182.5754133,https://clinicaltrials.gov/study/NCT00014469,NCT00014469,Graft Versus Host Disease|Leukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms
6617,0.996681418,160.83937,https://clinicaltrials.gov/study/NCT03690869,NCT03690869,Relapsed Solid Tumor|Refractory Solid Tumor|Relapsed Central Nervous System Tumor|Refractory Central Nervous System Tumor|Diffuse Intrinsic Pontine Glioma|High Grade Glioma
6618,0.998065822,161.9930413,https://clinicaltrials.gov/study/NCT00098813,NCT00098813,Recurrent Thyroid Cancer|Stage IV Follicular Thyroid Cancer|Stage IV Papillary Thyroid Cancer
6619,0.963099831,53.25970874,https://clinicaltrials.gov/study/NCT01986569,NCT01986569,Recurrent Breast Cancer|Stage IV Breast Cancer
6620,0.97296898,69.67247386,https://clinicaltrials.gov/study/NCT02371369,NCT02371369,Pigmented Villonodular Synovitis|Giant Cell Tumors of the Tendon Sheath|Tenosynovial Giant Cell Tumor
6621,0.902690669,19.1919786,https://clinicaltrials.gov/study/NCT05304169,NCT05304169,Prostate Cancer
6622,0.999009097,184.4968769,https://clinicaltrials.gov/study/NCT02903069,NCT02903069,Glioblastoma|Malignant Glioma
6623,0.994865759,156.6714585,https://clinicaltrials.gov/study/NCT01515969,NCT01515969,"Non-small Cell Lung Cancer (NSCLC), Recurrent|Non-small Cell Lung Cancer (NSCLC), Stage IV"
6624,0.996163027,157.0185424,https://clinicaltrials.gov/study/NCT00278369,NCT00278369,Kidney Cancer
6625,0.98709408,150.1100238,https://clinicaltrials.gov/study/NCT00452569,NCT00452569,Multiple Myeloma
6626,0.966913329,50.12431064,https://clinicaltrials.gov/study/NCT01144169,NCT01144169,Renal Cell Carcinoma
6627,0.996562595,156.2537157,https://clinicaltrials.gov/study/NCT00075569,NCT00075569,Cervical Cancer|Precancerous Condition
6628,0.938351745,25.85570731,https://clinicaltrials.gov/study/NCT00221169,NCT00221169,Non-Small Cell Lung Cancer
6629,0.997342993,162.7352799,https://clinicaltrials.gov/study/NCT01976169,NCT01976169,Advanced Breast Cancer
6630,0.99667052,160.9101438,https://clinicaltrials.gov/study/NCT01003769,NCT01003769,Recurrent Chronic Lymphocytic Leukemia
6631,0.997439945,164.0914474,https://clinicaltrials.gov/study/NCT02130869,NCT02130869,Neuroblastoma|Lymphoma|High-risk Tumor
6632,0.99424004,155.5134397,https://clinicaltrials.gov/study/NCT00562913,NCT00562913,Cancer
6633,0.998885085,178.8362416,https://clinicaltrials.gov/study/NCT01305213,NCT01305213,Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma
6634,0.594856429,3.786002624,https://clinicaltrials.gov/study/NCT01233713,NCT01233713,Surgery|Diverticulitis|Neoplasms|Postoperative Complications
6635,0.92499115,27.08186,https://clinicaltrials.gov/study/NCT01869413,NCT01869413,Bladder Cancer
6636,0.980535205,99.42069386,https://clinicaltrials.gov/study/NCT04044313,NCT04044313,Hepatocellular Carcinoma
6637,0.818052776,11.12816939,https://clinicaltrials.gov/study/NCT00829413,NCT00829413,Liver Neoplasms
6638,0.988692786,150.6903188,https://clinicaltrials.gov/study/NCT04838613,NCT04838613,Prostatic Neoplasms|Prostate Cancer|Recurrence
6639,0.902644528,18.81557202,https://clinicaltrials.gov/study/NCT03088813,NCT03088813,Small Cell Lung Cancer
6640,0.994991633,155.8947629,https://clinicaltrials.gov/study/NCT00520013,NCT00520013,Ovarian Cancer|Fallopian Tube Cancer|Primary Peritoneal Cancer|Papillary Serous Mullerian Tumor|Clear Cell Mullerian Tumor
6641,0.996841292,160.7355052,https://clinicaltrials.gov/study/NCT01376713,NCT01376713,Stage III Melanoma|Stage IV Melanoma
6642,0.9386818,32.16032568,https://clinicaltrials.gov/study/NCT02267213,NCT02267213,Hepatocellular Carcinoma
6643,0.998863886,180.0167871,https://clinicaltrials.gov/study/NCT00045513,NCT00045513,Leukemia|Lymphoma
6644,0.997639266,164.3259403,https://clinicaltrials.gov/study/NCT00978913,NCT00978913,Breast Cancer|Malignant Melanoma
6645,0.99882413,170.6559699,https://clinicaltrials.gov/study/NCT01311713,NCT01311713,Solid Tumors
6646,0.968138509,73.84100394,https://clinicaltrials.gov/study/NCT00864513,NCT00864513,Pancreas Cancer
6647,0.99882462,177.9708424,https://clinicaltrials.gov/study/NCT00861913,NCT00861913,Recurrent Melanoma|Stage IV Cutaneous Melanoma AJCC v6 and v7
6648,0.967122078,51.81774967,https://clinicaltrials.gov/study/NCT00795769,NCT00795769,"Accelerated Phase Chronic Myelogenous Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Atypical Chronic Myeloid Leukemia, BCR-ABL Negative|Blastic Phase Chronic Myelogenous Leukemia|Chronic Eosinophilic Leukemia|Chronic Myelomonocytic Leukemia|Chronic Neutrophilic Leukemia|Chronic Phase Chronic Myelogenous Leukemia|de Novo Myelodysplastic Syndromes|Disseminated Neuroblastoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Nodal Marginal Zone B-cell Lymphoma|Noncontiguous Stage II Adult Burkitt Lymphoma|Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma|Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma|Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma|Noncontiguous Stage II Adult Lymphoblastic Lymphoma|Noncontiguous Stage II Grade 1 Follicular Lymphoma|Noncontiguous Stage II Grade 2 Follicular Lymphoma|Noncontiguous Stage II Grade 3 Follicular Lymphoma|Noncontiguous Stage II Mantle Cell Lymphoma|Noncontiguous Stage II Marginal Zone Lymphoma|Noncontiguous Stage II Small Lymphocytic Lymphoma|Poor Prognosis Metastatic Gestational Trophoblastic Tumor|Previously Treated Myelodysplastic Syndromes|Primary Myelofibrosis|Recurrent Adult Acute Lymphoblastic Leukemia|Recurrent Adult Acute Myeloid Leukemia|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Malignant Testicular Germ Cell Tumor|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides/Sezary Syndrome|Recurrent Neuroblastoma|Recurrent Ovarian Epithelial Cancer|Recurrent Ovarian Germ Cell Tumor|Recurrent Small Lymphocytic Lymphoma|Recurrent/Refractory Childhood Hodgkin Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Hairy Cell Leukemia|Relapsing Chronic Myelogenous Leukemia|Secondary Acute Myeloid Leukemia|Secondary Myelodysplastic Syndromes|Splenic Marginal Zone Lymphoma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage II Ovarian Epithelial Cancer|Stage III Adult Burkitt Lymphoma|Stage III Adult Diffuse Large Cell Lymphoma|Stage III Adult Diffuse Mixed Cell Lymphoma|Stage III Adult Diffuse Small Cleaved Cell Lymphoma|Stage III Adult Hodgkin Lymphoma|Stage III Adult Immunoblastic Large Cell Lymphoma|Stage III Adult Lymphoblastic Lymphoma|Stage III Chronic Lymphocytic Leukemia|Stage III Grade 1 Follicular Lymphoma|Stage III Grade 2 Follicular Lymphoma|Stage III Grade 3 Follicular Lymphoma|Stage III Malignant Testicular Germ Cell Tumor|Stage III Mantle Cell Lymphoma|Stage III Marginal Zone Lymphoma|Stage III Multiple Myeloma|Stage III Ovarian Epithelial Cancer|Stage III Small Lymphocytic Lymphoma|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Breast Cancer|Stage IV Chronic Lymphocytic Leukemia|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Ovarian Epithelial Cancer|Stage IV Small Lymphocytic Lymphoma"
6649,0.998990248,189.0289142,https://clinicaltrials.gov/study/NCT02676869,NCT02676869,Stage IV Melanoma|Stage III Melanoma
6650,0.751843101,8.124976701,https://clinicaltrials.gov/study/NCT01332669,NCT01332669,Hepatocellular Carcinoma
6651,0.997906784,165.4328642,https://clinicaltrials.gov/study/NCT00001269,NCT00001269,Breast Neoplasms|Neoplasm Metastasis
6652,0.995471208,156.1094726,https://clinicaltrials.gov/study/NCT01588769,NCT01588769,Glioblastoma Multiforme
6653,0.980593737,82.08050034,https://clinicaltrials.gov/study/NCT00526669,NCT00526669,"Neoplasms, Gastrointestinal Tract"
6654,0.847173725,10.04634949,https://clinicaltrials.gov/study/NCT00122369,NCT00122369,Breast Cancer|Anxiety|Pain
6655,0.954895464,46.44115751,https://clinicaltrials.gov/study/NCT00004935,NCT00004935,Breast Cancer
6656,0.995404692,153.9046797,https://clinicaltrials.gov/study/NCT00319735,NCT00319735,Esophageal Cancer
6657,0.888181195,13.91077583,https://clinicaltrials.gov/study/NCT03092635,NCT03092635,Breast Cancer
6658,0.950191969,42.50735924,https://clinicaltrials.gov/study/NCT01442935,NCT01442935,Colorectal Cancer
6659,0.996954307,159.4895726,https://clinicaltrials.gov/study/NCT00059735,NCT00059735,"Kidney Neoplasms|Carcinoma, Renal Cell|Adenocarcinoma, Renal Cell"
6660,0.996050598,154.8879294,https://clinicaltrials.gov/study/NCT00948935,NCT00948935,Biliary Cancer|Cholangiocarcinoma
6661,0.998239483,176.0156529,https://clinicaltrials.gov/study/NCT01328535,NCT01328535,Recurrent Melanoma|Stage IV Melanoma
6662,0.994496165,153.5422519,https://clinicaltrials.gov/study/NCT00496535,NCT00496535,Head and Neck Cancer|Head and Neck Neoplasms
6663,0.994674047,154.2301214,https://clinicaltrials.gov/study/NCT00001535,NCT00001535,Acquired Immunodeficiency Syndrome|HIV Infection|Kaposi's Sarcoma
6664,0.999432818,183.6494735,https://clinicaltrials.gov/study/NCT03168035,NCT03168035,Advanced Cancer|Lymphoma
6665,0.878489933,14.5979144,https://clinicaltrials.gov/study/NCT00588835,NCT00588835,Tumor
6666,0.985773125,134.9319126,https://clinicaltrials.gov/study/NCT01428635,NCT01428635,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Primary Myelofibrosis|Thrombocytopenia"
6667,0.99336376,151.89228,https://clinicaltrials.gov/study/NCT02369835,NCT02369835,Head and Neck Carcinoma|Radiation-Induced Dermatitis
6668,0.984046628,130.9832749,https://clinicaltrials.gov/study/NCT01324596,NCT01324596,"Lymphoma, Large B-Cell, Diffuse"
6669,0.99789518,165.6833319,https://clinicaltrials.gov/study/NCT00089596,NCT00089596,Acute Lymphocytic Leukemia|Acute Myeloid Leukemia|Myelodysplastic Syndrome|Non-Hodgkin Lymphoma|Chronic Myelogenous Leukemia
6670,0.993674265,153.1401707,https://clinicaltrials.gov/study/NCT00489996,NCT00489996,Non-Small Cell Lung Cancer
6671,0.996300008,157.6372778,https://clinicaltrials.gov/study/NCT01128296,NCT01128296,Pancreatic Cancer
6672,0.913577489,17.95153473,https://clinicaltrials.gov/study/NCT04083196,NCT04083196,HPV Infection|HPV-Related Cervical Carcinoma
6673,0.981026986,91.16308025,https://clinicaltrials.gov/study/NCT01450696,NCT01450696,Gastric Cancer
6674,0.80211833,8.841033548,https://clinicaltrials.gov/study/NCT00627796,NCT00627796,Acromegaly
6675,0.99872144,172.2500782,https://clinicaltrials.gov/study/NCT01702896,NCT01702896,Melanoma Metastatic
6676,0.943742823,38.75340519,https://clinicaltrials.gov/study/NCT01222195,NCT01222195,Leukemia
6677,0.990720163,150.8077578,https://clinicaltrials.gov/study/NCT00876395,NCT00876395,Breast Cancer
6678,0.998545067,174.8054069,https://clinicaltrials.gov/study/NCT01538095,NCT01538095,Central Nervous System Neoplasm|Solid Neoplasm
6679,0.998015704,167.6634766,https://clinicaltrials.gov/study/NCT00672295,NCT00672295,Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
6680,0.997953486,174.42239,https://clinicaltrials.gov/study/NCT02942095,NCT02942095,Solid Tumors
6681,0.998624221,183.7002088,https://clinicaltrials.gov/study/NCT00127595,NCT00127595,"Carcinoma, Transitional Cell"
6682,0.987540759,150.1203304,https://clinicaltrials.gov/study/NCT02403895,NCT02403895,Squamous Non Small Cell Lung Cancer
6683,0.910202096,25.68407567,https://clinicaltrials.gov/study/NCT00698035,NCT00698035,"Sexual Dysfunction, Physiological"
6684,0.993800295,153.8810599,https://clinicaltrials.gov/study/NCT00477035,NCT00477035,Leukemia|Multiple Myeloma
6685,0.993477263,152.8118223,https://clinicaltrials.gov/study/NCT00003335,NCT00003335,Graft Versus Host Disease|Leukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases
6686,0.968380779,62.75431258,https://clinicaltrials.gov/study/NCT00540735,NCT00540735,Cholangiocarcinoma
6687,0.993194552,152.8201877,https://clinicaltrials.gov/study/NCT01383135,NCT01383135,Breast Cancer|Non-Small-Cell Lung Cancer|Glioblastoma|Other Cancers
6688,0.986374328,146.1189033,https://clinicaltrials.gov/study/NCT01292135,NCT01292135,B-cell Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
6689,0.996596404,160.8796799,https://clinicaltrials.gov/study/NCT03953235,NCT03953235,Non-Small Cell Lung Cancer|Colorectal Cancer|Pancreatic Cancer|Solid Tumor|Shared Neoantigen-Positive Solid Tumors
6690,0.932212769,27.58720122,https://clinicaltrials.gov/study/NCT01441635,NCT01441635,Heavy Uterine Bleeding|Uterine Fibroids
6691,0.992489406,153.042888,https://clinicaltrials.gov/study/NCT01303835,NCT01303835,Malignant Glioma
6692,0.914955958,16.14856745,https://clinicaltrials.gov/study/NCT02150135,NCT02150135,"Cancer, Pancreas"
6693,0.999488138,181.3935173,https://clinicaltrials.gov/study/NCT00618735,NCT00618735,Advanced Solid Tumors
6694,0.998496778,171.9129899,https://clinicaltrials.gov/study/NCT00001335,NCT00001335,Ewing's Sarcoma|Neuroblastoma|Rhabdomyosarcoma
6695,0.998181957,169.7160189,https://clinicaltrials.gov/study/NCT02432235,NCT02432235,Hodgkin Lymphoma|Non-Hodgkin Lymphoma
6696,0.926159567,24.80860485,https://clinicaltrials.gov/study/NCT00293696,NCT00293696,Prostate Cancer
6697,0.915532213,19.76190103,https://clinicaltrials.gov/study/NCT01206296,NCT01206296,Pancreatic Adenocarcinoma
6698,0.99538874,155.2663646,https://clinicaltrials.gov/study/NCT00696696,NCT00696696,Pancreatic Cancer
6699,0.996990876,159.2423287,https://clinicaltrials.gov/study/NCT00374296,NCT00374296,"Myelogenous Leukemia, Acute|Myelodysplastic Syndromes"
6700,0.991800509,151.1148032,https://clinicaltrials.gov/study/NCT02238496,NCT02238496,"Brain Tumor, Recurrent|Glioblastoma|Anaplastic Astrocytoma|Anaplastic Oligodendroglioma|Mixed Glioma"
6701,0.972396033,70.80149107,https://clinicaltrials.gov/study/NCT00694096,NCT00694096,Renal Cell Cancer
6702,0.998101287,166.0661246,https://clinicaltrials.gov/study/NCT04675996,NCT04675996,Solid Tumor
6703,0.974272792,82.04031887,https://clinicaltrials.gov/study/NCT00385996,NCT00385996,"Carcinoma, Non-small Cell Lung"
6704,0.986889108,124.5312077,https://clinicaltrials.gov/study/NCT01069796,NCT01069796,Triple Negative Metastatic Breast Cancer
6705,0.981322418,128.8441234,https://clinicaltrials.gov/study/NCT01051596,NCT01051596,Colorectal Cancer
6706,0.890340859,18.52979823,https://clinicaltrials.gov/study/NCT01279096,NCT01279096,Acute Lymphoid Leukemia Relapse|Acute Lymphoid Leukemia Relapse After Bone Marrow Transplant
6707,0.99429701,152.6876099,https://clinicaltrials.gov/study/NCT04003896,NCT04003896,Biliary Tract Carcinoma
6708,0.975176293,86.34626427,https://clinicaltrials.gov/study/NCT02486796,NCT02486796,Quality of Life
6709,0.996891344,160.1665874,https://clinicaltrials.gov/study/NCT01302496,NCT01302496,Malignant Melanoma Stage III|Malignant Melanoma Stage IV
6710,0.999482264,188.1779193,https://clinicaltrials.gov/study/NCT00352495,NCT00352495,Brain and Central Nervous System Tumors|Neurofibromatosis Type 1
6711,0.994222126,154.0950762,https://clinicaltrials.gov/study/NCT02379195,NCT02379195,Metastatic Melanoma
6712,0.997695592,166.2111751,https://clinicaltrials.gov/study/NCT01838395,NCT01838395,Acute Myeloid Leukemia
6713,0.999305694,199.7789729,https://clinicaltrials.gov/study/NCT01109095,NCT01109095,Glioblastoma Multiforme (GBM)
6714,0.997060754,158.0536466,https://clinicaltrials.gov/study/NCT00063895,NCT00063895,Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Squamous Cell Carcinoma of the Hypopharynx|Recurrent Squamous Cell Carcinoma of the Larynx|Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity|Recurrent Squamous Cell Carcinoma of the Nasopharynx|Recurrent Squamous Cell Carcinoma of the Oropharynx|Stage III Squamous Cell Carcinoma of the Hypopharynx|Stage III Squamous Cell Carcinoma of the Larynx|Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage III Squamous Cell Carcinoma of the Nasopharynx|Stage III Squamous Cell Carcinoma of the Oropharynx|Stage IIIA Non-small Cell Lung Cancer|Stage IIIA Ovarian Epithelial Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IIIB Ovarian Epithelial Cancer|Stage IIIC Ovarian Epithelial Cancer|Stage IV Non-small Cell Lung Cancer|Stage IV Ovarian Epithelial Cancer|Stage IV Squamous Cell Carcinoma of the Hypopharynx|Stage IV Squamous Cell Carcinoma of the Nasopharynx|Stage IVA Squamous Cell Carcinoma of the Larynx|Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVA Squamous Cell Carcinoma of the Oropharynx|Stage IVB Squamous Cell Carcinoma of the Larynx|Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVB Squamous Cell Carcinoma of the Oropharynx|Stage IVC Squamous Cell Carcinoma of the Larynx|Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity|Stage IVC Squamous Cell Carcinoma of the Oropharynx
6715,0.993342773,153.2966004,https://clinicaltrials.gov/study/NCT00002595,NCT00002595,Desmoid Tumor
6716,0.992430937,151.6569539,https://clinicaltrials.gov/study/NCT00503295,NCT00503295,"Osteosarcoma|Ewing Sarcoma Family Tumors|Malignant Fibrous Histiocytoma|Sarcoma, Synovial|Fibrosarcoma|Leiomyosarcoma"
6717,0.999226281,187.6285286,https://clinicaltrials.gov/study/NCT04030195,NCT04030195,"Non-Hodgkin's Lymphoma, Relapsed|Chronic Lymphoid Leukemia in Relapse|Non-Hodgkin's Lymphoma Refractory|Chronic Lymphocytic Leukemia|Lymphoma, Non-Hodgkin|Leukemia, Lymphocytic, Chronic|B-cell Chronic Lymphocytic Leukemia|B-cell Non Hodgkin Lymphoma|Small Lymphocytic Lymphoma"
6718,0.850018976,13.49136603,https://clinicaltrials.gov/study/NCT02459795,NCT02459795,Actinic Keratosis
6719,0.98704482,150.0681747,https://clinicaltrials.gov/study/NCT02529995,NCT02529995,"Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive"
6720,0.989258172,113.9739526,https://clinicaltrials.gov/study/NCT03551795,NCT03551795,Malignant Solid Tumor
6721,0.989011119,150.5931871,https://clinicaltrials.gov/study/NCT01351935,NCT01351935,B Cell Non-Hodgkin's Lymphoma|Chronic Lymphocytic Leukemia|Waldenstrom Macroglobulinemia
6722,0.99943542,190.8093905,https://clinicaltrials.gov/study/NCT00006235,NCT00006235,Fallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity Cancer
6723,0.996773463,160.9454194,https://clinicaltrials.gov/study/NCT01284335,NCT01284335,Advanced Solid Tumors
6724,0.99750975,163.9674595,https://clinicaltrials.gov/study/NCT01485835,NCT01485835,Multiple Myeloma
6725,0.896490024,19.29992252,https://clinicaltrials.gov/study/NCT06015035,NCT06015035,Sintilimab and Anlotinib in Combination With Chemotherapy
6726,0.997247716,159.4246914,https://clinicaltrials.gov/study/NCT00304135,NCT00304135,Extrahepatic Bile Duct Cancer|Gallbladder Cancer|Liver Cancer
6727,0.972735999,80.52078265,https://clinicaltrials.gov/study/NCT00434135,NCT00434135,Non-Small Cell Lung Cancer|Stage IIIB or IV
6728,0.997426171,160.6378093,https://clinicaltrials.gov/study/NCT00968435,NCT00968435,Head and Neck Cancer
6729,0.863902645,15.81152852,https://clinicaltrials.gov/study/NCT01116635,NCT01116635,Hepatocellular Carcinoma
6730,0.996859247,159.9392016,https://clinicaltrials.gov/study/NCT00451035,NCT00451035,Chronic Myeloid Leukemia in Chronic Phase
6731,0.9339675,24.94311411,https://clinicaltrials.gov/study/NCT04676035,NCT04676035,Prostate Cancer Patients
6732,0.940376932,36.77234604,https://clinicaltrials.gov/study/NCT02038296,NCT02038296,Liver Cancer
6733,0.988005275,150.332369,https://clinicaltrials.gov/study/NCT03317496,NCT03317496,Non-small Cell Lung Cancer|Urothelial Cancer
6734,0.991673703,152.4224612,https://clinicaltrials.gov/study/NCT00349596,NCT00349596,Acute Lymphocytic Leukemia
6735,0.977009714,76.53781063,https://clinicaltrials.gov/study/NCT00798096,NCT00798096,T Cell Lymphoma
6736,0.995060055,154.4169693,https://clinicaltrials.gov/study/NCT00591396,NCT00591396,Solid Tumors
6737,0.996204513,158.3068723,https://clinicaltrials.gov/study/NCT02296996,NCT02296996,Malignant Melanoma
6738,0.999580252,187.7674069,https://clinicaltrials.gov/study/NCT01822496,NCT01822496,Stage III Non-Small Cell Lung Cancer AJCC v7|Stage IIIA Non-Small Cell Lung Cancer AJCC v7|Stage IIIB Non-Small Cell Lung Cancer AJCC v7
6739,0.999599632,191.156443,https://clinicaltrials.gov/study/NCT00014196,NCT00014196,Lung Cancer
6740,0.996971909,158.8759301,https://clinicaltrials.gov/study/NCT01188096,NCT01188096,Brain Tumors
6741,0.993157165,153.150805,https://clinicaltrials.gov/study/NCT00466895,NCT00466895,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Chronic Lymphocytic Leukemia
6742,0.982201967,112.2550482,https://clinicaltrials.gov/study/NCT00776295,NCT00776295,Small Cell Lung Cancer
6743,0.981968227,103.7607172,https://clinicaltrials.gov/study/NCT00464295,NCT00464295,"Carcinoma, Hepatocellular"
6744,0.995303257,155.9405523,https://clinicaltrials.gov/study/NCT00003495,NCT00003495,Stage IV Lung Cancer
6745,0.968078508,45.43617128,https://clinicaltrials.gov/study/NCT00465595,NCT00465595,Depressive Symptoms|Anxiety|Cancer
6746,0.9981644,168.5499095,https://clinicaltrials.gov/study/NCT02683395,NCT02683395,Solid Tumors|Acute Myeloid Leukemia|Myelodysplastic Syndrome|Non-Hodgkin's Lymphoma
6747,0.964014299,55.03623657,https://clinicaltrials.gov/study/NCT00165295,NCT00165295,Waldenstrom's Macroglobulinemia
6748,0.983811578,114.1738743,https://clinicaltrials.gov/study/NCT00193895,NCT00193895,Skin Cancer
6749,0.997544637,163.4674108,https://clinicaltrials.gov/study/NCT00869895,NCT00869895,Cancer
6750,0.897961534,17.33153958,https://clinicaltrials.gov/study/NCT00462995,NCT00462995,Non Small Cell Lung Cancer
6751,0.849723425,10.46215978,https://clinicaltrials.gov/study/NCT00867295,NCT00867295,Solid Tumor
6752,0.999600009,196.6781056,https://clinicaltrials.gov/study/NCT00482495,NCT00482495,Multiple Myeloma and Plasma Cell Neoplasm
6753,0.978395401,100.9675895,https://clinicaltrials.gov/study/NCT04524195,NCT04524195,Non-small Cell Lung Cancer (NSCLC)
6754,0.999678654,190.2901587,https://clinicaltrials.gov/study/NCT00920595,NCT00920595,Solid Tumor
6755,0.992164113,152.1894044,https://clinicaltrials.gov/study/NCT00878995,NCT00878995,Cachexia|Squamous Cell Carcinoma
6756,0.997875762,163.3324073,https://clinicaltrials.gov/study/NCT02358395,NCT02358395,Hepatocellular Carcinoma
6757,0.994518742,155.0382514,https://clinicaltrials.gov/study/NCT00566995,NCT00566995,Renal Cancer|Von Hippel Lindau
6758,0.990539909,150.0875344,https://clinicaltrials.gov/study/NCT02337595,NCT02337595,"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Myeloid, Acute|Immune Deficiency Disease|Bone Marrow Failure Syndromes|Opportunistic Infections|Graft vs Host Disease"
6759,0.998579827,176.0678732,https://clinicaltrials.gov/study/NCT00227695,NCT00227695,Lymphoma
6760,0.982960752,105.1830926,https://clinicaltrials.gov/study/NCT00860535,NCT00860535,Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML)|Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)
6761,0.998080852,168.0557755,https://clinicaltrials.gov/study/NCT00005835,NCT00005835,Neuroblastoma
6762,0.998936191,193.5788736,https://clinicaltrials.gov/study/NCT02978235,NCT02978235,Multiple Myeloma|NonHodgkin Lymphoma
6763,0.999576135,181.7562955,https://clinicaltrials.gov/study/NCT01700335,NCT01700335,Myelodysplastic Syndrome
6764,0.990714363,151.2363363,https://clinicaltrials.gov/study/NCT00003535,NCT00003535,High Grade Glioma
6765,0.975830697,79.55498173,https://clinicaltrials.gov/study/NCT02436135,NCT02436135,Myelofibrosis
6766,0.950830744,45.59753912,https://clinicaltrials.gov/study/NCT02706535,NCT02706535,Drug Interactions|Neoplasms
6767,0.998212702,169.9192768,https://clinicaltrials.gov/study/NCT03314935,NCT03314935,Biliary Tract Cancer (BTC)|Colorectal Cancer (CRC)|Endometrial Cancer|Gastroesophageal Cancer (GC)|Ovarian Cancer|Solid Tumors
6768,0.997000699,160.1643097,https://clinicaltrials.gov/study/NCT00049296,NCT00049296,Cancer
6769,0.706883935,5.654739244,https://clinicaltrials.gov/study/NCT05803096,NCT05803096,Prostate Disease|Malignancy|Benign Prostatic Hyperplasia|Prostate Cancer|Prostate Adenocarcinoma|Anxiety and Fear|Pain
6770,0.968915477,63.97239696,https://clinicaltrials.gov/study/NCT01232296,NCT01232296,Hepatocellular Carcinoma
6771,0.98453703,103.5514746,https://clinicaltrials.gov/study/NCT00882596,NCT00882596,Breast Cancer
6772,0.990400507,151.264838,https://clinicaltrials.gov/study/NCT00112996,NCT00112996,"Neurotoxicity|Unspecified Adult Solid Tumor, Protocol Specific|Unspecified Childhood Solid Tumor, Protocol Specific"
6773,0.9987605,169.642408,https://clinicaltrials.gov/study/NCT00004096,NCT00004096,Lung Cancer
6774,0.998390408,167.2601942,https://clinicaltrials.gov/study/NCT01851096,NCT01851096,Cancer
6775,0.913455891,22.05158591,https://clinicaltrials.gov/study/NCT00487695,NCT00487695,Barrett's Esophagus|Esophageal Adenocarcinoma
6776,0.996900291,158.9422404,https://clinicaltrials.gov/study/NCT00764595,NCT00764595,Gastrointestinal Stromal Tumor|Metastatic Cancer
6777,0.822729352,9.651695918,https://clinicaltrials.gov/study/NCT04308395,NCT04308395,Basal Cell Nevus Syndrome
6778,0.994070387,153.3214146,https://clinicaltrials.gov/study/NCT00446095,NCT00446095,Lymphoma
6779,0.998180971,171.9508781,https://clinicaltrials.gov/study/NCT00560235,NCT00560235,Ewing's Sarcoma Family of Tumors
6780,0.920320069,18.18260711,https://clinicaltrials.gov/study/NCT03013335,NCT03013335,Metastatic Renal Cell Carcinoma
6781,0.999270839,188.6404269,https://clinicaltrials.gov/study/NCT00842335,NCT00842335,Advanced Solid Tumors
6782,0.997304369,160.3231473,https://clinicaltrials.gov/study/NCT01998035,NCT01998035,Lymphoid Malignancies|Lymphoma|Hodgkin Lymphoma|Non-hodgkin Lymphoma
6783,0.994026511,152.4373018,https://clinicaltrials.gov/study/NCT00707135,NCT00707135,Advanced Cancer
6784,0.998656276,180.6273295,https://clinicaltrials.gov/study/NCT00239135,NCT00239135,Keratosis
6785,0.952817363,44.63356241,https://clinicaltrials.gov/study/NCT01735396,NCT01735396,Prostate Cancer
6786,0.597323058,3.940294688,https://clinicaltrials.gov/study/NCT02910596,NCT02910596,Bladder Dysfunction
6787,0.961287235,48.47316678,https://clinicaltrials.gov/study/NCT02267096,NCT02267096,Smoking|Lung Cancer
6788,0.990121526,151.3001601,https://clinicaltrials.gov/study/NCT01497496,NCT01497496,Chronic Lymphocytic Leukemia|Small Lymphocytic Lymphoma
6789,0.968921357,70.84593542,https://clinicaltrials.gov/study/NCT00402896,NCT00402896,Lung Cancer|Pleural Effusion
6790,0.867543137,14.06771242,https://clinicaltrials.gov/study/NCT00311896,NCT00311896,Cancer|Thrombosis
6791,0.996391179,158.9454059,https://clinicaltrials.gov/study/NCT01462396,NCT01462396,Neuroblastoma
6792,0.997277503,161.4353071,https://clinicaltrials.gov/study/NCT00418496,NCT00418496,Renal Cancer|Melanoma
6793,0.999342699,200.2008859,https://clinicaltrials.gov/study/NCT01435096,NCT01435096,Malignant Solid Tumour
6794,0.991187108,151.2297786,https://clinicaltrials.gov/study/NCT01094496,NCT01094496,Bladder Cancer
6795,0.99951174,184.1902269,https://clinicaltrials.gov/study/NCT00635596,NCT00635596,Solid Tumors
6796,0.993190669,152.1837268,https://clinicaltrials.gov/study/NCT01362296,NCT01362296,"Lung Cancer, Non-Small Cell"
6797,0.957975391,45.03107445,https://clinicaltrials.gov/study/NCT02225496,NCT02225496,Oropharyngeal Cancer
6798,0.808538611,10.21688802,https://clinicaltrials.gov/study/NCT02063295,NCT02063295,Obesity|Over-weight|Hypothalamic Injury|Craniopharyngioma
6799,0.832500297,11.90326844,https://clinicaltrials.gov/study/NCT02866695,NCT02866695,Actinic Keratosis
6800,0.999022166,183.8904288,https://clinicaltrials.gov/study/NCT00039195,NCT00039195,Lymphoma
6801,0.998366395,170.0411402,https://clinicaltrials.gov/study/NCT01233895,NCT01233895,Multiple Myeloma
6802,0.983439224,129.5851786,https://clinicaltrials.gov/study/NCT00101595,NCT00101595,"Chronic Myeloid Leukemia|Leukemia, Lymphoblastic, Acute, Philadelphia-positive"
6803,0.999565354,187.7601329,https://clinicaltrials.gov/study/NCT01885195,NCT01885195,Solid Tumor and Hematologic Malignancies
6804,0.998988744,189.8489715,https://clinicaltrials.gov/study/NCT00096395,NCT00096395,Recurrent Ovarian Epithelial Cancer|Recurrent Primary Peritoneal Cavity Cancer
6805,0.977550733,94.71355685,https://clinicaltrials.gov/study/NCT00388895,NCT00388895,Acute Lymphoblastic Leukemia|Cromosome Philadelphia Positive
6806,0.950654777,39.68704532,https://clinicaltrials.gov/study/NCT00637195,NCT00637195,"Infections, Papillomavirus|Papillomavirus Vaccines"
6807,0.993790194,153.8529175,https://clinicaltrials.gov/study/NCT00027495,NCT00027495,Colorectal Cancer
6808,0.99972032,190.45646,https://clinicaltrials.gov/study/NCT03831295,NCT03831295,Advanced Malignant Solid Neoplasm|Extracranial Solid Neoplasm|Metastatic Malignant Solid Neoplasm
6809,0.965553558,63.36891561,https://clinicaltrials.gov/study/NCT02316795,NCT02316795,Breast Cancer|Cancer of Breast|Cancer of the Breast|Melanoma|Malignant Melanoma
6810,0.927171941,23.49603614,https://clinicaltrials.gov/study/NCT00004195,NCT00004195,Colorectal Cancer
6811,0.99724815,159.4860649,https://clinicaltrials.gov/study/NCT03478995,NCT03478995,Locally Advanced or Metastatic Solid Tumors
6812,0.996149014,158.4814703,https://clinicaltrials.gov/study/NCT01193595,NCT01193595,"Neoplasms, Malignant"
6813,0.983347257,107.4486482,https://clinicaltrials.gov/study/NCT02085395,NCT02085395,Actinic Keratosis|Bowen's Disease
6814,0.990856182,151.6408131,https://clinicaltrials.gov/study/NCT00041795,NCT00041795,Peripheral Nervous System Diseases|Chemotherapy-Induced Peripheral Neuropathy
6815,0.993189499,153.9072389,https://clinicaltrials.gov/study/NCT02184195,NCT02184195,Germline BRCA1/2 Mutations and|Metastatic Adenocarcinoma of the Pancreas
6816,0.994481009,154.0028404,https://clinicaltrials.gov/study/NCT00460395,NCT00460395,Brain Cancer
6817,0.99269258,152.2432945,https://clinicaltrials.gov/study/NCT02438995,NCT02438995,"Carcinoma, Squamous Cell|Carcinoma, Squamous Cell of Head and Neck"
6818,0.983573675,134.435801,https://clinicaltrials.gov/study/NCT00655395,NCT00655395,Acute Myeloid Leukemia (AML)|Myelodysplastic Syndrome (MDS)
